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The EDTA-European Renal Association
The European Dialysis and Transplant Association (EDTA) was founded in 1964 to
gather and publish information on what were then new arts of clinical transplantation
and dialysis; during the next two decades it has grown into a major international
society. Its Registry of dialysis and transplanted patients in Europe is a unique fund
of data, internationally known and cited.
More recently, the Association has broadened its base, changed its name to the
EDTA-European Renal Association, and is now in fact, as well as in name, a
European Society of Nephrology, with the purpose of encouraging and reporting
advances across the whole field of renal disease.
The annual congress of our Association is no longer limited, therefore, to reports
on dialysis and transplantation alone, but also the whole of general nephrology: renal
pathology, pathophysiology, immunology, clinical nephrology, and so forth. It
receives the support and contribution of an outstanding advisory panel composed of
the presidents of the national nephrology societies of Europe. In recent years, this
important cooperation has greatly increased the scientific program of our Congress-
es, which is proven by the increasing number of high quality abstracts dealing with
general nephrology.
In agreement with these changes we present on the following pages of Kidney
International for the first time all the submitted abstracts of The EDTA-European
Renal Association Meeting held in Florence, Italy, September 26—29, 1984. The
publication of the abstracts has been made possible by a donation from Gambro
Lundia AB whom we thank on behalf of the Association. Next year, in 1985, the
Brussels Congress of the EDTA-ERA will be longer by an entire day permitting us to
include a greater proportion of abstracts on general nephrology. The papers
presented at the meeting are, as usual, included in the publication Proceedings of the
EDTA-ERA edited by Dr. A. S. Davison of Leeds, England, and published by Pitman
Medical of London.
J. STEWART CAMERON
President
EDTA-European Renal Association
VITTORIO E. ANDREUCCI
Immediate Past President
EDTA-European Renal Association
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ACUTE CHANGES OF THE RENAL FUNCTION AFTER I.V. VERA
PAMIL (VE)ADMINISTRATION IN DOGS .E.Alexopoulos,V.
Vargemezis,G.Sakellariou,I .Kosmidou and M.Papadimi—
triou. B'Prop.Dept.of Medicine,"Aghia SophiaT' Ho-
spital, Thessaloniki, Greece
It has already been demonstrated by us that the
preventive administration of VE has a favorable ef-
fect on the course of the acute ischaemic renal
failure by clamping the renal pedicie for 60 mm.
During those experiments we also examined the
changes of the renal function after a bolus i.v. in
jection of yE. In 15 healthy dogs o mannitol di—
uresis both kidneys were exposed by retroperitone-
al incisions. After clamping of the renal pedicle
on one side,o,5mg/kgB.W. of the VE was given I.V.
and the renal function of the other kidney was exa-
mined during the next 10 mm period. All kidneys
became softer and urine flow almost completely
stopped for the first 3-4mm after injection. The
results are given at the table (M±SE).
Before VE After VE P
Vu(ml/min) 2.82+0.28 1.90+0.22 <0.001
Ccr(ml/min) 2O47±2.64 13.78+2.51 <0.01
Curea(mi/mjn) 13.20±2.33 9.39+1.70 (0.05
Cosm(ml/min) 4.27±0.41 2.95-1-0.40 <0.01
Systolic BP 137.20±2.44 116.00±2.95 <0.001
Pulse rate 154.20±3.54 132.60-1-3.48 <0.001
The FENa,FEK,FEosm and CH2O presented no signifi
cant changes. These data indicate that the acute
administration of VE produced an immediate signi-
ficant reduction of the urine volume and GFR in
euvolaemic dogs. This effect may be due to the de—
crease of the renal perfusion pressure by systemic
vasodilation and combined negative inotropic and
chronotropic effect on the heart. As FENa,FEK and
FEosm remained rather steady, a specific vasodila-
tive effect on the efferent arteriole.of the glome-
rulus seems to oe a possioie expianafion.
NON—IgA PRIMARY MESANGIAL PROLIFERATIVE GLOMERULO—
NEPHRITIS (PMPG )
L.Allegri, P.P. Dall'Aglio, C. Dascola, E.PaganelU,
L .Migone
Medical Clinic and Nephrology—Univ. of Parma— Italy
70 patients(p.)affected by Non—IgA PMPG,age:6—66
years(y.),follow—up:l_12y.(mean 5y.),were studied.
Clinical Syndromes:persistent proteinuria,isola—
ted or associated with microhematuria:55p.(79%);re_
current gross hematuria:7p.(10%);nephrotic syndro—
me:8p.(1l%). Outcome: renal failure:6p.(9%);hyper_
tension:lOp.(l4%);remission:4p.(6p). Histology: dif
fuse masangial enlargement:global6lp.(97%)(grade
l+:4lp.;2+:2Op.);segmental9p.(13%)(1+:6p.;2+:3p.).
IMF: 1gM prevalent(pr.)mesangjal(m.)deposits(d.)
18p.;IgG pr.m.d.=3p.;C3pr.m.d.32p.;no pr.Ig=8p.;
no d.=9p. Serum Globulins:IgG,IgA,C normal;IgM ra-
ised only in association with 1gM pr.m.d.
ing Immune Complexes:(C1 ,conglutinin binding as—
says):50% of p. A subdiision of the whole popula-
tion was made on the basis of the foregoing 5 types
of IMF and also related to our clinical findings
on IgA nephropathy.
Conclusions: Non—IgA PMPG outlines a group which
does not reveal statistically significant correlati
ons between single IMF patterns and clinical syndro
mes. Even the 1gM subgroup,though presenting with a
greater incidence of serum 1gM increase,does not
show specific diagnostic features. All clinical and
morphological aspects are common to those presented
by IgA nephropathy with the oniy differences of se-
rum Ig levels and lesser incidence of recurrent he-
maturia and outcome to renal failure.
RENI'L FUNCTION EOLtL]ING OPEN HEtIRT SU3ERY: I)LE
OF CARDIOPUI PRY BY-PASS.
H. Sancho, A.Martin-Malo, R. Guerrero, J.Ccmez, R.Pe-
rez, E.M)reno, F.Alvarez arid P.Aljaxna.
C. S. Reina Sofia. University of Cordoba. Spain.
Acute renal failure (ARF) attrib.itable to open
heart surgery is multifactorial. We have eva1uat
the effect of preoperative renal function arid extra
corporeal circulation as determinant causative fac—
tors. The study was undertaken in 68 consecutive pa
tients: gluerular filtration rate (GFR), fractio-
nal excretion of sodium (FNa), onolar and free wa-
ter clearance as well as enzynu1ria expressed as mU/
min/GFR x 100 including N-acetyl-B-glicosaininidase(NAG) and alanineaininopeptidase (AAP). These measu-
rm-nents were obtained 1 day preoperatively, intrao-
peratively (INT) and 1 day postoperatively (PCS).
There was no deterioration of renal function by
conventional criteria (maintained. GFR) in 44 pati-
ents (-A); whereas 24 developed postoperative ARF(-B), in wham GFR decreased below the mean-2 SD of
normal paired age controls.
Main results ( % of preoperative data) p<. 05
GFR FNa NAG APPINTPc INTPC6 INTP INT P05
—A 55* —9 240* 51* 251* 191* 315* 188*
—B 18* _55* 344* 337* 495* 901* 333* 519*
-A showed a mean preoperative GF'R value greater
when canpared with -B (pC. 005). There was a positi-
ve correlation between time of duration of the by-
pass and urinary NAG (r=0.65, p4. 001).
These data suggest that cardiopu]menary by-pass
itself induces renal dysfunction, since significant
enzymuria could be danonstrated even in patients
with normal GFR. Preoperative depressed GFR and ro
longed cardiopthnonary by-pass time are determinant
factors of ARF in relation to open heart surgery.
$1 LCAL r:I2J2Chc--nlflJh 031:rL]CdsT LEVLLP
CiRCiLdT1hC TT:JNE (:oitplFxfb (GIG) in ACJTE
PJPT STREPT000CCAL CLOHER1JLOPEPj[RITIS (APSGE)
A .B AL3LJ,B.3rLwier,J.Saatçj ,Y.Jdur, .bebar,
.Lrsoy.
acettepe Jniveraity,Ins-titute of Child health,
Ankara—Turkey.
ihe air of tria si:dy is to evaluate the comple—
cent state of JtlC ano roint out the ulace and in—
portance of tOe dIG i Cailowing un the dieease.This
researcu was carried at on h8 sex-jul serum samples
obtained from patients with ilPbCfl 1: acute peri-
od and 8 weeks loter(are raned;3—l6and compared
to 42 normal controls .ihe serur - levels of C3 C4 ajir
ne onred by rad±al inounodiffosion,factor B was de—
t ermined. by haernolL,-tin t echniq a. Cil50 was oct imat ed.
by method of Ilayer .hetection of CIC in sora wan car-
ried out usin rher:ato C factor bindiar radioirnrnu—
noascay technique.Ver-y low levels of Clmean:21.80T
12 .? mo/di )and ClfrC( 70, was 0 /t1 ,mean 20 .ST .(2
n/ni) were obtained at the acute er:od.In the 14
of the patients factor B have been decreatned.CIC
were fo nd very 11 i-h(327.l4190.8O jp/al ,control:25
15 ig/ml) in the 6% of the patients at acute pe-
riod and they were Ligoly positive U weeks after
oneet(64).C3,C4,fac tar B levela of the patienta
were found in fbi-nd limits at contro1 a ,hnt low Cd
50 and high CIC levels iiere persisted U weeks after
tan onset of the diose. in conclueion:alternative
complement activation was operative in the 2O; of
the AJ'S(dT patients,the measurement of C1[50 and GIG
were useful for followjnp the disease.
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"OSM)TIC NPHROSIS" BY CONTRAST MEDIA IN PATIENTS
WITH PRIMARY GLOMERULONEPHRITIS (GN).
Stanziale P., Balletta M.M., Amendola 0., Santopie-
tro A., Esposito A., ftndreucci V.E..
Chair of Nephrology, II Faculty of Medicine,
Naples, Italy.
In order to verify the osmotic effects of the
contrast media on renal tubules, we studied 15 pa-
tients who undervent a renal biopsy because affec-
ted by primary GN.
-
The renal biopsy was performed within 24-72 hours
after the urography. Any changes of azotemia, crea-
tininemia, diuresis and urinary excretion of sodium
and potassium were also detected. 7 patients were
excluded since a considerable infiltration and intel
stitial sclerosis were found at light microscopy.
In the remaining 8 patients we found a "vacuoliza-
tion" of the epithelial cells in the proximal tubu-
les and/or in the loops of Henle with loss of cyto-
plasmic elements. These changes were not correlated
to an impairment of the renal function as most of
the patients (87%) had a normal renal function.
These preliminary data suggest that the contrast
media may cause osmotic tubular changes even withoul
impair the renal function.
DISTAL TUBULAR (DT) Na AND H20 RESORPTION IN MAN.
.
E.Bartoli,R.Faedda,A.Satta,M.Sanria,G.F.Branca.
Istituto Patologia Medica,Univ.of Sassari,Italy.
In a previous study(J.Clin.Pharmacol.23:56;1983)
we measured the volumes of solute—free water formed
by the ascending limb(CH2O—HL),DT(CH2O—DT),and the
volume back—diffusing across collecting ducts(CH2O—
BD) during H20 diuresis.CH2O—BD can be split into
its DT and collecting ducts (CD) components.During
maximal ADH output isotonicity is attained within
the cortex.Thus,TcH2O measures H20 resorption from
the point of' icotonicity to the papilla.When subtra
cted from CH2O—BD it yields a minimum estimate o.f
H20 reabsorbed by DT during antidiuresis,the maxi-
mum being given by CH2O—HL + CH2O—DT.The true va-
lue is given by 'f— (' + TcH2O)where Yf and \Y are
urine flow rates with and without Furosemide.We stu
died 4 normal volunteers both during water diuresis
and durirg water deprivation with hypertoni NaC1
jnfusion.Data are expressed in ml.min .GFR 100.
For equivalent deliveries from proximal tubule,the
true DT water resorption during antidiuresis was
22.O+1O.],with a minimum estimate of 13.1+5.2. The
latter was significantly less than CH2O—HL + CH2O—
DT(31.l÷1l.l).This difference was accounted for by
CH2O excretion (l5.7÷4.2).Thus,in water diuresis a
flow of 18.3±10.2 mlmin (CH2O—BD) is reabsored
across CD,while it amounts to 5.2÷0.3 ml•min (Tc
H20) during antidiuresis,where the bulk of solvent
diffuses across DT.Distal water resorption is better
approximated by the free water formed by the dilut-
ing segments than by CH2O—BD — TcH2O.
NEMBRANOUS CLOMERULOREPRRITTh (jdui'). COMBA1TN
OF THE CLINICAL, MJRPHOLOGICAL AND LABORATORY PARA-
METERS.
Stanziale P., Balletta N.M., Amendola 0., Santopie—
tro A., Esposito A., Andreucci V.E..
Chair of Nephrology, II Faculty of Medicine,
Naples, Italy.
In this study, the relation of clinical, morpho-
logical and laboratory parameters with the impair-
ment in renal function was retrospectively investi-
gated in 27 patients with primitive GN, treated
with Indomethacin or Prednisone.
The diagnosis was done by renal biopsy and the
follow-up was carried out for 3525 months. The pa-
tients were divided in two groups, i.e.those with
or without renal failure at the last control. Compa-
rison between the two groups was based on values of
Clq,C4,C3,C3A,C5,C9,KAF,lH,Prop,ICls,AT III,protei-
nuria during the follow-up, glomerular and tubulo-
interstitial histologic changes, therapeutic prograi
Clq and lH were significantly lower in the grou1
with normal renal function (pO,O2). A higher score
for tubulo—interstitial changes (phlogistic infi1tr
tion, interstitial sclerosis, tubular dilatation an4
atrophy) than glomerular ones was found in the grouj
that developed renal failure when compared to the
group with normal renal function (p.(O,00I). The in-
cidence of RF was higher in patients treated with
Indomethacin (41%) than in those treated with Predni
sone. These data suggest that tubulo-interstitial
changes are of great value in the prognosis of MGN
and that the Prednisone may he the drug of choise
in the treatment of this disease.
PREGNANCY ACCELERATES RENAL FAILURE IN REFLUX
NEPHROPATHY
G. Becker, B. Ihle, K. Fairley, M. Bastos,
P. Kincaid-Smith.
Department of' Nephrology, Royal Melbourne Hospital,
Melbourne, Australia.
There is considerable controversy regarding the
eI'('ect of' pregnancy on renal disease. This is
largely due to the lack of' prospective studies
comparing the course of' pregnant and non pregnantpatients with similar renal diseases and renal
f'unction.
During a ten year prospective study or 217
patients with ref'lux nephropathy (183 f'emale, 34
male), 19 women had plasma creatinine concamtrations
in the range 0.20-0.40 mmol/l. Of' these six ex-
perienced pregnancies exceeding 12 weeks gestation.
Pregnancy was associated with rapid deterioration
in ('unction, particularly in the postpartum period,
in all 6 patients, resulting in end—stage renal
f'ailure (ESRF) in 4 women within two years of' de-
livery despite adequate (diastolic BP <100 mmHg)
control of' blood pressure. Of' the 13 non pregnant
patients 4 experienced periods of' uncontrolled
hypertension (diastolic BP >120 inmHg), all related
to noncompliance and/or loss f'roin ('0110w up. Un-
controlled hypertension was associated with accele-
rated renal ('allure and all 4 progressed quickly to
ESRF. The remaining 9 women were observed ('or
periods ('rom 3-10 years with slow renal f'unctional
deterioration, norwreaching ESRF within 8 years.
This study clearly demonstrates that pregnancy
in patients with re('lux nephropathy and plasma
creatinine concentrations >0.20 xnmol/1 leads to a
rapid decline in renal ('unction, particularly if'
the year postpartum is taken into account.
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URI'.RY LEPD cRE'TION IN URMtC PATINS WITh GJtYP
D. Behringer, P. Craswell, M. Stoe5pler, E. Ritz
Dept. Internal Medicine, Univ.of Heidelberg (FFG),
kyal Brisbane Hosp., Brisbane (Australia) and Kern—
forschungszentrum JUlich (F1)
Lead (Pb) intcacication is a well known cause of gout
and renal failure (RF). The role of Pb inthxicaticn
in the genesis of gouty nepnopathy on the one hand
(Batuman, NEJM 304 ,520,1981) and gout of pat.with
RF (Richet, Presse ical 73,633,1965) has been the
subject of controversy. The Na2 Ca-2YTA Pb mbilisa-
tion test after Emerson (Austr.Arin.Med. 12,310,1973
was used to evaluate nobilisable Pb in healthy Ger-
man controls, RF pat. without gout, and pat. with
both renal disease and gout. Measur.nt of urinary
Pb with atanic absorption using IMca1 platfonns, Ht'D3
and Triton-X-100 pretreated urine and Zeenan canpen-
sation. in 21 controls, madian basal urinary Pb
(29.6 nnol/day,range 9—122)ath postinfusion Pb(299
nnol/4 d, 131-1587) was considerably lower than
values reported in literature, possibly pointing to
nethological difficulties in past studies, In l9pat.
with RF without gout (nedian S-crea 5.8 m/dl, 1.6-
13.8), basal Pb was 20.5 (2.9—84.3) and postinfusiorl
849 (160—2664). 7 pat. had nobilisable Pb)1CXX nnol
4d; of these 5 had certain (professional history)
and 2 probable past Pb exposure. nrxig 8 pat. with
known renal disease prior to 1St episode of gout(4 c, 2 ref lux; 1 uret. strict., 1 polycystic) Pb
excess was,> 1(U) nnol/4d in all bit one. Nlong 8
pat.with gout prior to docunented renal disease (4
with known gout family history) Pb excess was <1CCO
in 6/8. It is concluded that Pb irobilisation test
identifies past Pb exposure in a]srost all our pat.
who developed gout during renal failure due to known
renal disease, In our pop.ilat. Pb exposure is not a
major cause of renal dis. in pat. with primary
gout.
USE OF A EW VASCULAR ACCESS SYSTEM
(FIEMASITE') IN RIGH EFFICIENCY HEMO—
H LTRATION
A. Vegeto, L. Berardinelli, F. Masi, F.Civardi
C. Avanz , R .Marangori
PolicI inico Hospital,Mi lan,and Dialysis
Service,Bol lateR Italy.
The Ilemasite blood access device appe-
ars to be a 900d solution for difficult pa
tients in maintenance hemodialysis.ln our
experience,too,one of these devices is well
functioning in a patient from 21 months
without any complication or replacement of
septum. iqh efficiency hemofi Itrat ion
needs high blood flow, in order to reduce
the lenqht of time in the treatment.
Therefore the Authors have planted this
dev!ce in two patients,having their artero
venous fistula inadequate for a high effi-
ciency hemofltration treatment.
The emasite system was placed in the
upper arm,anastomosing the PTFE graft
between the brachial artery and the hume—
ral vein,in a right fashion.
The results are satisfactory:high and easy
mon itor ing blood f low, no comp licat ion
after 2 and 9 months respectively,enthu—
siastic tolerance of this device by the
patient,because of atraumatic access to
his vasculature and high staff acceptance.
Ct' ThE PREVALCE OF KIDNEY DISEAS IN SCUThERN
ARABIA
Gerda WUrtzen Nielsen, Bent Nielsen.
Dept.of nephrology.King Fahd Central Hospital,
Gizan, Saudi Arabia.
A survey of the records of 8225 consecutive dispen-
sary patients in southern Saudi Arabia shed 2% to
have nephxo—urological diseases.
However, the records fran the first 14 nonths of
operation of the Gizan King Fand Central Hospital
revealed 23% of admissions to be caused entirely
or partly by kidney diseases.
Out of a population of appr.3CXD.CXX) inh. 44
young patients were admitted with end stage rena].
failure. The majority of patients suffered fran
chronic GN partly bioptically verified.A prevalen-
ce of 120/mill inh./year,thrice that observed in
western countries 'is nost certainly a xnininnsn f i-
gure.The number increased markedly with the esta-blishnent of a nephxology service.
These observations prapted a nephrological exa-
mination of a consecutive series of dispensary pa-
tients .A kidney and/or urinary tract disease was
established by the staff of the dispensary in 3.8%
of the patients. Examination of the urine,BP and Se-
rum creatinine together with a clinical history re-
vealed 27% of the patients to have such signs or
syltptans that further investigations were warran-
ted. In 50% of both male and female patients pre-
vious or on—going urinary tract infections were re-
corded.
The results indicate that expansion of the faci-
lities in the Prinary Health Care and availability
of nephrologic expertise on more levels are manda-
tory to reduce the morbidity fran renal disease -
and eventually the need for dialysis and transplan-
tation therapy.
RENAL EFFECTS OF SULINDAC (S) AND INDOMETI-IACIN (I)
IN PATIENTS WITH CHRONIC RENAL FAILURE (CRF).
X.3.Berg, T.Taiseth
Section of Nephrology, Rikshospitalet,Oslo,Norway
In CRF glomerular hemodynamics and function is
dependent upon renal prostglandin production.
S may be the drug of choice among non—steroidal
antiinflammatory drugs in CRF, as it recently has
been shown not to interfere with renal prostaglan—
din synthesis in patients with GFR above 40 el/mm.
We have compared the renal effects of S (75 ag
bid) and I (200 mg bid) in an open cross over study
in 8 patients (mean age 53.3 yrs) with CRF.S or I
was given for 2 days, the 2 precedings days served
as control. The treatment sequence was balanced,
with at least 1 week washout. Blood samples were
obtained at the end of each 2 days period, Urine
analysis was performed in each 24 hrs portion, and
the average for each control or treatment period
is presented (mean (SE))
Indomethacjn Sulind
control treatment control
ac
treatment
Bodyweight (kg)
s—cr (umol!!)
Ccr (mi/sin)
uNaV (moi/24h)
uPGE2(ng/24h)
78.3(5.3) 79.7(5.3)XX 78.9(3.4)
285(5) J0(62)X 288(57)
41.0(7.9) 33.3(6•3X 34.8(6.3)
144(18) 86(10)XX 126(12)
107(28) 27(5)XXX 94(20)
78.8(5.4)
O256)
34.8(7.2)
103(13)
30(l4)XXX
x p<O.05 xx p<O.02 xxx p<O.O1
r increased seriim.beta..-microglobulmn by 47.3%
(p<0.05), reduced renin (PRA) by 33% (n.s.), while
S had an inconsistent effect on these parameters.
Neither drug affected urinary NAG or kallikrein
excretion. The main effect of S and I in CRF is
probably inhibition of prostaglandin synthesis,
which is profound after I but also recognizable
after S administration.
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RENAL REABSORPTION OF L-CARNITINE IN
PATIENTS WITH CARNITINE DEFICIENCY.
M. Bertoli, M. Rebeschini, A. Ruffatti,G.F.
Romagnoli,L. FreddoL. Vergani'C. Ange1ini
D. Di Landro (Intr. by G. La Greca).
Hemodialysis Service - *Neurological Clinic
University of Padua. Italy.
In order to ascertain the L—carnitine
renal handling, the Authors evaluated the
urinary excretion after i.v. administration
of L—carnitine in 12 controls, in 2 pa-
tients with carnitine deficiency and in 2
of their relatives. In 2 controls carnitine
renal excretion was analyzed during frusemi
de infusion, to evaluate the existence of
Na—related carnitine tubular reabsorption.
1) In the most of controls (10/12) L-carni
tine was reabsorbed with Tm related
mechanism (mean 6.98±2.59 jM/m).
2) In patients with carnitine deficiency
and in their relatives, tubular reabsor
ption was decreased (mean l.34±1.25iM/m)
3) In 2 controls, renal reabsorption was
decreased (1.59 and 0.59 iM/m).
4) Carnitine reabsorption was not modified
by frusemide infusion.
The Authors suggest that: a) earnitine dei
cient patients have reduced renal reabsor
ption;b) this defect may be genetically
—
determined; c) sporadically this abnormali
ty may be detected in normal subjects;
d) carnitine renal reabsorption seems not
to be Na-related.
• VACCINATION POLICY IN UREMIC PATIENTS
.
J.Bommer,M.Grusendorf,W.Jilg,D.Deinhardt ,H.-G.KocF
GIYi7. Bommer ,M . Rambausek,E .Ritz
Departm.Internal Medicine & Virology,Beidelberg and
Max-v,-Pettenkofer Institut, MUnchen (FRG)
There is agreement that dialysis patients res-
pond less to HB5 vaccination than non-uremic pat.,
but the time course of anti-BBS concentrations,i.e.
the need for recall vaccination,and the optimal
time for vaccination,i.e.the time onset of hypores-
ponsiveness, have not been clarified.In the present
longterm follow up study,34 staff members,46 hemo-
dialysed (HD) pat.,12 predial.pat. with terminal
uremia and 25 pat. with renal disease and incipient
renal failure (Serum crea 1.5-3 mg/dl) were vaccina
ted with HB-Vax(MSD).2o ug were used for staff and
4o ug for HO pat.Vaccination schedules were:months
o,l,6 for controls and group I of MD pat.(regular)
and o,l,2,4,6 for group II of RD pat.(frequent).
Neasurements with Abbott RIA).The table gives con-
version rate and anti-HBs concentrations(median mU!
ml). 8 months 24 months
Staff 31/34 (91%) 28/34 (82%)
489 (6.5-14112) 42 (4.4—8o9)
MD I reg. 3x 14/26 (54%) 5/26 (19%)
26 (2.7—5o9) 19 (5.1-66)
HD II freq. 5x 15/22 (68%) 11/22 (5o%)
338 (3—8516) 13o (6.3—8oo)
Data sho that anti-HB5 concentrations decay rapidly
in regularly vaccinated, but less (even compared to
controls) in frequently vaccinated HD pat.This has
implications for vaccination policy.In a prelimina-
ry 5 months follow up study after 2 vaccinations,
pat. with incipient renal failure had less serocon-
version (7/15) and anti-HBs (median 67 mU/ial,7.7 -
437) than staff (28/34, 2o2 mU/ml) Preliminary data
suggest that hyporesponsiveness is present even in
incipient renal failure.
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PRIMARY GLOMERULONEPHRITIS (GM) IN THE ELDERLY (E).
S.Bertoli, A.Volpi, L.Radaelli, G.Barbiano,A.Sessa
Renal Unit CaGranda end Vimercate Hospitals -
Milano, Italy
In order to characterize primary glomerular dise
ases in the E, the clinical and histological data
concerning 73 out of 1400 patients (pts) have been
reviewed. Criteria for selection were: 1) age of 60
or above, 2) adequate renal biopsy, excluding syste
mic diseases. Age ranged from 60 to 79. The inciden
ce of single Gil was: minimal changes (MC) 5%, focal
glomerulosclerosis (FGS) 15%, membranous GN (MGN)
36%, crescentic GN (CGN) 15%, IgA GN 4%, membrano-
proliferative (MPGN) 15%. The clinical presentati-
ons were: acute nephritic syndrome in 12 pts, ne-
phrotic syndrome in 28, urinary abnormalities in 31
renal insufficiency in 16, gross hematuria in 1. No
peculiar morphological aspects were present, except
for a mild increase of mesangium, interstitial and
arteriolar sclerosis which were referred to the age
At immunofluorescence we found: a low incidence of
negative pattern in CGN; C3 always associated with
lyG in MGN,absence of isolated C3 pattern in MPGN.
At follow up 12 pts were lost, 31 had normal renal
function, 19 renal insufficiency, 5 were on ED and
6 died. In conclusion we observed an higher inciden
ce of LM and IgAGN, while the clinical and histolo-
gical findings and the outcome were similar. There-
fore the natural history of the primary GN in the E
seems to depend on the nature of the GM rather than:
on the age.
SLOW PENETRATION OF PIPERACILLIN INTO RENAL CYSTS.
M.Bonadio, B. Catania, 0. Marino, P. Giannotti
University of Pisa, Italy.
Poor clinical response to antibiotic therapy in
patients (pts) with infected renal cyst is probably
related to the low concentration of antimicrobial
drugs reached in the cysts. In this study the level
of piperacillin (PIP), a new semisynthetic penicil-
lin , was measured in the cyst fluid (CF) of 2
groups of pts with uninfected solitary cysts of the
kidney. Group A included 3 pts to whom PIP was admi
nistered i.m. and/or i.v. in different dosages only
in the 12 hrs prior to CF collection. Group B inclu
ded 5 pts who were given repeated injections of PIP
in the two days before CF collection. CF samples we
re obtained at varying intervals following the last
dose by either percutaneous needle puncture or by
surgery. Blood and urine samples were also taken si
multaneously. Sodium and creatinine measurement in
the CF confirmed the cysts had to be considered as
solitary cysts. PIP assay was performed by a micro-
biological agar—diffusion method. PIP resulted unde
tectable in CF despite the high levels achieved in
both serum and urine,when the drug was administered
only few hours before CF collection (group A pts).
PIP was detectable ( 1.5 - 8.6 - 9 - 4.1 - 1.3 rncg/
ml respectively) when the drug was also administe-
red several times two days before CF collection
(group B pts). These date suggest that systemic ad-
ministration of PIP results in slow penetration of
the drug in CF.
REGULATION OF RENAL BLOOD FLOW BY KININS
G.Bdnner, D.Beck, M.Deeg, G.Sponer ( Intr. by G.
Meider
Department of mt. Med. II, Univ. of Cologne;
Boehringer Mannhein AG, Mannheim; F.R.G.
Abstracts
In dogs synthetic bradykinin (BK) continuously
infused into the left renal artery at a dose of 1
ig/kg/min provoked a marked and permanent increase
in renal blood flow about 26 ÷ 6 %. The following
investigations in rats were performed to study
whether the renal kallikrein—kjnin system is involv-
ed in the regulation of renal blood flow.—
Renal plasma flow (RPF) was determined by PAH—
clearance. The excretion of kinins in urine (UKinV)
was measured by means of a BK—radioimmunoassay after
alcohol extraction. The studies were performed after
injection of either dihydralazine i.v. (H; o.l mgi
kg) or frusemide s.c. (F; 5.0 mg/kg), and after oral
application of triamterene (T; 50 mg/kg).—
All three drugs provoked a significant increase
in RPF which was accompanied by marked diuresis
after F and T. By H, however, urine flow was not
effected. UKinV were increased significantly in all
three experiments with increased RPF : controls:
7.9 + o.7; H: 27.9 + 7.2, po.ool; T: 22.o 2.7,
p<o.o25; F: 63.3 6.4 pg/mm, p<o.ool).— No
correlation was found between UKInV and urinary vol-
ume, but the time course of UKinV was the same as
that of changes in RPF.—
The results of the reported experiments showed
that UK1nV were well correlated to the drug induced
changes in RPF, probably indicating an important
role of the intrarenal kinins in the physiological
regulation of renal blood flow. In this mechanism
the vasodilating effect of kinins could be a direct
one or mediated by stimulation of proataglandin
synthesis in renal tissue.—
RENAL KALLIKREIN IN HYPERTENSION
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G.Bbnner, G.Wambach, J.Evers (Intr. by G. Meider
Department of mt. Med. II, Univ. of Cologne;
Department of mt. Med. I, Merheim Hospital; F.R.G.
Renal kallikrein—kinin system is involved in
the regulation of renal blood flow and of excretion
of sodium and water. Reduced renal kallikrein acti-
vity might induce hypertension by retention of
sodium and water and diminished vasodilation. There-
fore we studied renal kallikrein activity in pati-
ents with essential hypertension.—
Urinary kallikrein activity (UKa1Va) was mea-
sured by amidolytic assay (S2266) and urinary kalli-
krein concentration (UKaIVc) by radioimmunoaasay.
Activation of renal kallikrein (UKa1V—act) was per-
formed by trypsin, inactivation of trypsin by SBTI
which had no effect on renal kallikrein activity.
Salt intake of controls (C) and hypertenaives (EM)
was identical.—
In EH renal kallikrein activity was reduced
in the active and activated form:
C : UKa1Va (U/d): o.67+o.o9 UKa1Va—act: 2.o9+o.3o
EM: UKalVa (U/d): 0.30÷0.10 UkalVa—act: 0.64÷0.20
Renal kalljkrejn concentration was reduced too:
C : UKaIVc (gid): 17o÷21 UKa1Vc—act: 237÷27
EM: UKaIVc (g/d): 89÷26 UKaIVc—act: 14o÷34
Even specific kallikrein activity (UKaIVa—act/UKaIV
c—act) was reduced in EM with significance of p<o.ol
C: 8.88 + o.74 (U/mg) vs EM: 6.oS ÷ o.44 (U/mg).—
The results of the reported investigation indi-
cate reduced activity and concentration of renal
kallikrein in urine of EM. After activation of kal—
likrein by trypsin the difference remained signifi-
cant. Even specific activity of renal kallikrein
was lower in hypertensives than in controls probab—
iy playing a role in pathogenesis of hypertension by
reduced diuresis, natriuresis and vaaodilation.—
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PTH AND PROTEIN CATABOLISM IN UREMIA
F.Bono,R.Menta,F.Gardjnj,A.Corradj ,V.Cambi.
Cattedra di Nefrologia,tiniversitâ di Parma.
PTH is considered an uremic toxin and can influ=
ence both Ca—P and protein metabolism.We have studi
edserum AA concentration in nine uremic patients to
evaluate the role of PTH on protein catabolism.
Five patients hive hyperparathyrojdim , four
were PTX.The blood was withdroven in the post abs=
orb State before dialysis in the morning between 8
and 9 a.m..
TREATMENT OF RENAL OSTEODYSTROPHY IN CHILDREN.
COMPARISON OR 25.OH AND 1—ALPHA CHOLECALCIFEROL
ALONE OR IN ASSOCIATION.
F.BOUISSOU,D.CORIATT,M.REMEZY,M.ROSTIN,Ph.BARTHE.
Med. Inf. C — CHU PURPAN — TOULOUSE — FRANCE
In 23 uremic children (age 2 to 16 Y.) three
regimen therapy have been successively evaluated
—A:25 OH Vit.D = 20 Treatmts (m.duration 12 8m)
—B:l ALPHA.V±t.D = 11 Treatmts (m.duratiori 9
— Cr25 01-1+1 ALPHA = 14 Treatmts (m.duration 11
Comparison (STUDENT Pair test) has been made
between biochemical parameters (serum Ca,P,A1K.P,
+ PTH) radiological bone status (fingers extremities)
— st p and nerve conduction.
6 ns In chronic uremicthildren before end stage renal
23 failure there is no statistical difference between
8 the three groups except a decrease of A1K.P in
B and C.
ns
In children undergoing hemodialysis there is a
477 80 better control of osteodystrophy in group C, with
325 127 ns a significant improvement of radiological patterns
387 19 ns (p <0,05) a lower PTH level (p(O,0l) and A1K.P.
122 18 ns (p-O,O1), and an increase of nerve velocity
189 19 ns (p<O,O5).
Regarding the cases with a marked osteodystrophy
78 5 flS at the begining of each period of treatment, the
116 10 ns improvement of' RX and biochemical parameters is
59 10 ns better in group C (respectively 0/5 in A, 3/6 en B,
59 3ns 5/8inC.
197 40 ri This improvement cannot be explained by the
137 10 variation of Ca x P product or by the mean plasman
Ca and P. levels, or by the amountof oral74 22
Aluminium hydroxyde intake, all remaining similar
during the three periods. We conclude to the better
affect of the association in hemodialysed children.
Histhydine
3—Methyihistidine
No difference in the serum AA pattern of the two
-
group of patients was found.
An hyperparathyroidisa related protein catabolism
cannot be confirmed.
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PROGNOSIS IN GLOMERULONEPHRITIS WITH RESPECT TO
HISTOLOGICAL SUBGROUPS
M Brahm, JT Balsløv, C Brun, J Gerstoft, F Jørgen-
sen, HE Jørgensen, M Larsen, S Larsen, I Lorenzen
M L0ber and Ac Thomsen.
Department of nephrology and of Data processing
Copenhagen County Hospital Herlev, Department of
clinical chemistery Kommunehospitalet Copenhagen
Department of Rheumatology and Nephrology HvidovrE
Hospital and from Medical department B Bispebjerg
Hospital Copenhagen Denmark.
During 1967 — 1977 395 consecutive cases of gb
merulonephritis (GN) were collected by a study
group. The diagnosis was established by histolo-
gical and biochemical criteria. In a follow up
in 1980 all cases were catagorized as to one of
the following end points: Death without uremia,
uremia, recovery or censored cases.
The Study shows that each histological sub-
group of GN has its own characteristic course
with respect to initial rates of changes in the
renal state, as well as to the frequensy of
recovery, uremia and death. The prognosis was
good in minimal changes and proliferative GM,
bad in unclassified GN and worst in extracapil-
lary GN. The changes in renal state mainly
occured during the first five years of the course.
We conclude that histological classification
of GN based on light microscopy offers a reliable
means of predicting the longterm prognosis of the
disease.
SHORT AND LONG TERM EFFECTS OF l,25(OH)2D3 AND 24,25
(OH)2D3 IN ALUMINIUM—RELATED OSTEOMALACIA.
S.A. Charhon, P.M. Chavassieux, M.C. Chapuy,
P.J. Meunier. (Intr. by J, Trseger).
INSERM U 234, Lyon, France.
Clinical and histological improvement of dialysis
osteomalacia (OM) after long term therapy with 1,25
(OH)2D3 and 24,25(OH)2D3 has already beer, reported
(1). In order to assess the early bone changes indu-
ced by this combined therapy after 6 months, histo—
morphometric analysis was done on doubly labelled
iliac bone biopsies obtained from 3 hemodialyzed
uremic patients (2 males and 1 female, aged 19—33)
all having bone fractures and OM, Before treatment,
there was an increased thickness index of osteoid
seams (TIOS), a low calcification rate (CR) and alu-
minium deposits at the calcification fronts. After
6 months of therapy with l,25(OH)2D3 (mean dose
0.32 pg/d) and 24,25(OH)2D3 (3.2±0.8 pg/d),
one patient improved his clinical condition, one
had no change and the third had new fractures. A
transient increase in serum alkaline phosohatase
levels was noted in all cases. A second bone bionsy
showed morphological and dynamic improvement of 01"
in case 1, a greater osteoid volume and TIOS in case
2 in spite of an increase of double labelled osteoid
surfaces and CR, and a complete failure in case 3.
A third bone biopsy done after 17.5 and 21 months
of treatment in casea 1 and 2 confirmed the improve-
ment but without complete healing of osteomalacia.
In conclusion, (1) long term therapy with 1,25
(OH)2D3 and 24,25(OH)2D3 may improve aluminium rela-
ted OM but the effects are inconstant and often
partial. (2) A second bone biopsy with tetracycline
double labelling taken after few months of treat—
Bent iS thus imperative to assess the response of
the mineralization process to the vitamin D metabo—
lites.
(l)Hodsman at al.(Am.J.Med. 1983, 74, 407—414)
HANTAAN VIRUS NEPHROPATRY IN FRANCE.
J.Chanard, J.P.Melin, S.Lavaud, 0.Toupance,
T.Milcent and J.P.Brunois - Centre Hospitalier et
Universitaire, Reims, France.
Hantaan virus nephropathy has not been documen-
ted in France before 1983. This disease belongs to
the group of haemorrhagic fevers with renal syn-
drome or muroid virus nephropathies that includes
Corean Haemorrhagic Fever and Scandinavian Epidemic
Nephropathy.
We report on a cluster of seven cases of acute
renal failure due to Hantaan virus or Hantaan—l Ike
virus observed in northestern France. All patients
had rural Occupations with exposure to wild rodents
They presented with infectious syndrome and diffuse
myalgia. Few Haemorrhagic symptoms were observed
con jonctival purpura in one case and gross haematu—
na in an other case thrombopenia was quoted in
two instances. Acute renal failure started after
5—7 days and was associated with massive proteinu—
na and microscopic haematunia. Tubulo-interstitial
nephritis was shown in two cases who had a biopsy.
Two patients required haemodialysis. In all instan-
ces recovery was without sequelae and occured after
15 to 60 days.
The serological diagnosis was made by indirect
immunofluorescence on spot—slides of Vero cells
infected with the Hantaan virus.
These seven cases and two similar cases from
the same country recently reported indicate the
existence in France of a previously unidentified
disease of clinical importance requiring epidemio—
logical investigation.
HISTIOCYTIC INTERSTITIAL NEPHRITIS AN EXCEPTIONAL
AND EXCEPTIONALLY CURABLE CAUSE OF ACUTE RENAL FAI-
LURE.
J. CLEDES, J.P. HERVE, P. YOTJINOU, J.P. LEROY, M,
GARRE, B. BOURBIGOT, D. TOLLU.
University Hospital 1'dical School, F. 29279 BREST
CEDEX, FRANCE.
Histiocytic interstitial nephritis is characteri-
zed by an infiltration consisting predominantly of
macrophages. Bilateral involvement brings on acute
renal insuffisiency.
We had the opportunity to follow up two females,
68—and 59—year—old, presenting with an acute oh—
guric renal failure. H. Coli was demonstrated in
the former's haemo—and uro- cultures, Xrays showed
enlarged kidney (15 1.7 cm), gallium 67 fixation
was observed in one case. Each patient underwent
renal—biopsy. The specimens displayed polymorphic
inflammatory infiltration, consisting mainly of
large histiocytea. MICHABLIS GUTMANN bodies were
found in one case. (M..B)
Thanks to antibiotics and haemodialysis, both the
patients recovered a normal renal function. A year
later, creatininemia were 260 and 290 pHil, respec-
tively and the kidney size was 9.2 + 0.2 cm in the
two patients.
Three features may be underlined 1) firstly, the
clinical biological and radiological pattern appe-
ars to be rather reproductible ; ii) secondly, the
evolution is getting more and more favourable, now-
adays ; iii) finally, the only criterion to distin-
guish malacoplakia from megalocytic interstitial
nephritis relates to presence of MOB. From a prac-
tical standpoint, this taxonomic dogma seems to be
quite overestimated.
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PROXIMAL AND DISTAL TUBULAR FUNCTION IN IDIOPATHIC
HYPERCALCIURIA (IR)
G.Colussi,G.Pontoriero,G.RombolA,M.E.De Ferrari,M.
Suriari,F.Malberti ,L.Minetti
Renal Unit ,E .O.Niguarda,Mi lan, Italy
It has been suggested that in IH there is redu—
ced reabsorption of Ca,P,1'lg,Na and fluid in the pro
ximgl tubule.We have evaluated proximal and distal
reabsorption of Na and fluid (free water clearance
methodology) and the reabsorption of Ca,Mg and Na
in the ascending limb of Henle's loop (net incremeni
of urine excretion after furosemide administration)
in 12 pts with IH and 9 controls(C).IH pts had high
er basal Ca excretion (CaE=.23+.l4mg/d1GFR),Na excr
tion (NsE.r2.76+.9mEq/d1OFR) and distal delivery of
filtrate (DD..14.6÷4.6%) and distal Na/fluid reabsor
ption (CR2O12+4%) than (Cab,,.033+.O17,p<.OO1;Nav
..94+.46,pc.OO1;DD=7.9+2.9,p.OO1;CH2O6.7+2.2,p
.OO1),w±th similar Mg excretion (MgE:IH=.04+.O1;C=
.039+.Ol8mg/d1GFR) and plasma Ca,Mg and Na levels.
After furosemide(4Omg iv) IH pts had higher net in-
crement of Na than C ( NaE=27+12.5,p<'.05 vs 0:18.9+
3.8) but similar Oaf (1.09+.5 vs .79+.17) and MgE
(.29+.15 vs .22+.045),indicating increased reabsorp
tion of Na,but not of Ca and Mg in Henle's loop.
ConclusionsIH pta have decreased proximal reabsOr
tion of Na/fluid,which is partially compensated forj
by more distal segments of the tubule;inoreased Ca
excretion is best explained by selective impairemea
of Ca reabsorption in megments past the Henle's]oo
(distal convoluted or collecting tubule),due to the:
lack of compensatory increase of Ca reabsorption ir
the ascending limb and normal Mg tubular handling.
RENAl ULTRASONIC(U.S.)MONITORING IN PHYSIO*
LOGICAL PREGNANCY.
G.Cuzzocreafl.M.MauroS.FlottaC .Pata
S .Grilio*T.Mannarjno A.Antone1lj
5Nephrology Departrnent,**Obstetrjcll Depar—
tment,U.S.L. N°16 "Alcmeone" Crotone,Italid
The aim of this study is to document the
crimges,U.S. detectable,of urinary system
during physiological pregnancy.
5 pregnant women aged 19 to 40 were follo-
wed from the 9th week of gestation to the
90th day after delivery.
All the subjects were followed monthly by
renal U.S. evaluating echogenicity,cortical
thickness,and dilatation of proximal excre-
tory pathways.At the same time blood and
urine tests,B.P. and EKG were performed.
7 pregnant women were excluded from the stJ.
dy because of complication.In the remaining
18 women increased creatinine clearance to
170± 38m4/m(means.D.) in the last weeks
from 113— 11,5ml/m of 90th day post partum
(taken as control vaiue)was accompanied by
morphologic changes of kidneys:U.S. docu—
niented increased renal dimension(sagittal
diameter from 110,38—3,33 to 121—5,06), in-
rement of arenchymal thickness from 21,8
—1,9 to 2,7—1,9mm and cortical echogenici—
ty;at same time early dilatation of proxi-
mal excretory pathways was confirmed in
all the women.
• VITAMIN D METABOLITES AND OSTEOMALACIA (OH) IN THE
0 ADULT FANCONI SYNDROHE (Fs)C.Colussi ,M.E.De Ferrari ,M.Surian,FJ'talberti,O.Rom..
bolA ,G.Pontoriero,L.Minetti
Renal Unit,E.O.Niguarda,Milan,Italy
Reduced bioconversjon of 3E—250RD ham been shown
to exist in animal models of FS.Thu,i-t has been
suggested that altered vit D metabolism could play
a role in the pathogenesis of OH in human FS.
We have studied 3 adult pts with F5 (Sjigren's
disease,idiopathic and mieloma),only 2 having seve-
re OH (osteoid volume 51 and 53%,osteoid surface—in
active—99 and 93%,reeorption surface 0 and 1.1%). —
In the 3rd pt the bone biopsy showed slight hyperpa
rathyroidism,secondsry to CRF.Plasma P was 2+0.3 —
and 3.3+O.3mgl in the OH pts and 4.1+0.4 in the3rd.Plasma Ca was normal in all (2.17,2.04 and 2.1
mEq/L).Plasma HCO3 was similarly low (18+1.2,15+0.9
and 17+O.5mEq/L).Prevjous prolonged alkali therapyin the OH pta did not modify radiographic OM.GFR
was reduced in 2 (14 and 20m1/min),one with OH.Uri-.
ne cAMP was normal in the OH pts,increased in the
3rd.Plaema 250HD was normal in all (12,15,2mg/mi,
n.v.3—30);24,25(OH)2D slightly reduced (0.22,0.27,
0.2Ong/ml,n.v.0.3_3);1,25(OH)2D was low in the 2 OH
pts (14,18pg/ml,n.v.40...80) and normal in the 3rd
(50).
Conclusions: i) 1,d..OHase activity might be impai
red,as other tubular funotiona in FS,resulting in —
low 1,25(OH)2D levels. 2) The presence of OH in FS
seems to be related to low 1,25(OH)2D levels,but
not to plasma P or acidosis.
ADRENORECEPTOR RESPONSIVENESS IN UREMIC PATIENTS IN
CONSERVATIVE AND HEMODIALYTIC TREATT4ENT.
Fuiano G., Dal Canton A., °Maj M., Testa A., °Aria—
no M.G., Conte G., Guarriello L., Memoli S., Fabia—
ni F., Andreucci V.Ed
Nefrologia Medics, 2 Fgulty of Medicine and
°Clinica Psichiatrica, 1 Faculty of Medicine,
University of' Naples.
A reduced adrenoreceptor responsiveness is a
possible pathogenic mechanism of autonomic neuro—
pathy in uremia. The studies performed to verify
this hypothesis, however, are inconclusive as yet,
mainly because the methods used, as blood pressure
or heart rate response to administration of cate—
cholamines, are not reliable.
In this study adrenoreceptor reactivity was eva—
luated from the changes in plasma cycle AMP (AMPC
before and after administration of 7 ug/kg/b.w. of
Adrenaline (A). The rate of release of AMPc from
sympathetic receptors is, in fact, a reliable index
of their functional integrity. 3 groups of patients
were studied: (1) patients with normal renal func-
tion; (2) patients with chronic renal failure (GFR=
5—15 mi/mm); (3) patients i regular dialytc
treatment (ROT).
In Group (1) AMPC increased progressively after
A and plateaud to ÷76% of control after 50 mm.,
then decreasing to +23% after 70 mm. No significant
change was observed in the uremic patients, even
those on RDT.
These results demonstrate that the adrenorece—
ptor reactivity is unaffected by uremia.
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IMPAIRED RENAL AtJIOREXULATION AND SALT-LOSING
TENDENCY IN HYPEHENSIVE PPEflP.NT PATS.
Dal Canton A,Esposito C,Altanmate M,Sabbatini M,
Roimno G,Uccello F,Conte G, Russo D,Fuiano G, and
lndreucci VE. dDpt of Nephrology, 2I Faculty of dicine, Naples.
This study was perforned in female Wistar-Munich
rats with a clip on the right renal artery. Three
weeks after clipping,the rats were mated for 2 days
then were housed in netabolic cages for 2 weeks,
during which Na and water balance and tail-cuff
systolic blood pressure (BP) were nonitored daily.
The follcMing groups of rats were included in the
study: Pregnant and non-Pregnant Hypertensive (PH
and n-PH,respectively, with BP steadily>150 ran Hg);
Pregnant and non-Pregnant Norrrotensive (PN and n-PN,
respectively, with BP steadily<130 ran Hg). At the
end of rretabolic studies, glonerular dynamics was
studied by ruicropuncture in the left kidney of PH
and PN. Urinary excretion of Na (UNav) and water (V)
was noderately greater in PN than n-PN, and in n-PH
than n-PN, indicating that both pregnancy and hyper
tension separately increase UNaV and V. In PN and
n-PH, however, normal balance was maintained by in
creased water arid Na intake. In PH, UNaV and V
were markedly greater than in PN, so that PH re
tamed less Na and water during gestation, despite
increased intake. In micropuncture studies, gloin
erular blood flow was increased in PH vs PN.
These results show that hypertension causes a
salt-losing tendency in pregnancy. This phencenenon
is accounted for by impaired renal autoregulation.
• ECTOPIC CALCIFICATION. THE 1&OLE Ui' PAPAIHYKOII)
HO1*4ONE.
A.M. De Francisco, M.J.D. Cassidy, *J.P. Owen,
+H.A. Ellis'*J.R. Farudon, M.K. gard, D.N.S. Kerr.
Departments of Medicine, *Radiology, +Pathology and
Surgery, University of Newcastle upon Tyne, U.K.In order to study the relationship of arterial
(enall peripheral vessels)(PAC) and soft tissue
calcification (SIC) to parathyroid activity in
uremia, we studied 42 paLients (pts) who underwent
parathyroidectomy (PIX). X—ray skeletal survey,
biochemistry and oone histology were compared Pre
(42 pts) and 6—12 months (42 pts) or 12—24 months(26 pta) after PTX. The presence of PAC or SIC was
not related to the age, sex, duration of d stage
renal failure treatsent, total serum c1cium,
magnesii, phosphate, Ca x P product, alkaline
phosphatase, ionised calcium, serum aluminium, iPTH,
radiological erosions, severity of histological
osteitis fibrosa or parathyroid gland weight.
PERIPIi. ART. CALCIF • SOFT TISSUE CALCIF.
n (Ca)x(P04) iPTH n (Ca)x(P04 it'll!
PRE
6—lan
12—24
23 5.ll.4 6.41.727 3.9—0.9 0.7—0.5
18 4.0—0.9 0.9—0.7
20 5.41.4 s.4i.17 4.2—1.2 0.6—0.
8 4.2—1.1 0.8—0.,
a = number of pta with FAG or
iPTH normal range 0.3—1.4 U/i
SIC
Despite marked improvement in sub—periosteal
erosions (37 healed, 5 improved) and healing of
osteitis fibrosa histologically 7 patients devebped
new and 6 increased PAC while in 10 patients SIC
disappeared and in 2 decreased.
We conclude that successful PTX improves non—
visceral calcification but not arterial calcifica-
tion despite reduction in Ca x P product and it'll!.
• }OLE OF P1DSTAGLANDINS (PG) IN CAPIOPPIL (C)
NATRIURESIS.
Conte G, Dal Canton A, Maglionico G, Di Spigno C,
Russo D, Di Minno G, Andreucci yE. Chair of Nephro
logy, University of Naples, Italy.
C,unlike the other nondiuretic antihypertensivem,
exhibit natriuresis .Our purpose was to determine
whether this defect was mediated by C-dependent in
creased secretion of natriuretic PG. 18 patients
with arterial hypertension and normal renal func
tion were placed on costant intake of Na and phos
phorus and were randomized in 3 aroups: group 1, C;
group 2, C + indcnethacin(I); group 3, I. 1(0, 2(0
or 4(X5a/24h of C and/or l(Xen/24h of I were given
f or one week. In the control condition and in the
last day of treatment urine (U) PGE2 and PGI2 excre
tion, plasma aldosterone (PA), osnolar clearance and
clearance of PAN were determined; clearances of cre
atinine, sodium(CMa) and phosphorus (Ce) were measu
red daily. In group 1, cumulative Na balance in
one week was -151±21 and -162±23SE mEq at 2(X) and
4X/ 24h of C, respectively while was unchanged at
1(Xn'rg/24h of C.After 200, 4CQi/24h,but not 1(X)ng Of
C, U-PGE2 and U-PGI2 significantly increased while
filtration fraction fell due to a rise in CPAN;f I
nally, CNa was correlated with.Cp (p(O.Ol). PA de
creased after C (p<O.05) .In group 2 ,natriuresis dis
appeared even if PA decreased as in group 1. In
group 3, C was unchanged. Conclusions :a) natriure
sis by C is critically dependent upon increased syn
thesis of 2 and PGI2 but not upon PA;b)proximal
tubule is the main site of decreased Na reabsor
tion.
THYROID FUNCTION IN ACUTE RENAL FAILURE
N.G.De Santo,C.Carella,G.Capodicasa,G.Amato,F.Nuzzi
F.Sorrentino,V.De Simone,C.Giordano
University of Naples,Naples,Italy
This study was performed to characterize thyroid
function in acute renal failure( ARF ).
We studied 7 with ARE without critical ill-
ness( 4M and 3 F aged 17-45 years ),and studied
them on 3 occasions:A) during the anuric stage
3rd-4th day of anuria ),B) durina the diuretic
fase( 3rd-4th day from onset of diuresis ),C) 1
m6nths after BUN normalization.We evaluated:Total
Thyroxine( 1-4) ,Total Triodothyronine4 T-3) ,Free-
Reverse Triiodothyronine( FrT-3 ),Total Reverse
Triiodothyronine(rT-3),Thyroqlobulin( hTG ),
Thyroid Binding Globulin( TBG),and Thyroid Stimu-
lating Hormon( TSH ).In addition we evaluated the
TSH and 1-3 response to TRH( 400 ug I.V ).As con-
trol we used data in 15 normal subjects aged 17—50
years).
In A T-3 and T-4 were reduced( p 0.01 vs normal
T-4 correlated with plasma creatinine.FrT-3 was
increased ( p<O.Ol).IBG,TSH and hTG were within
normal limits.TSH response to IPH was blunted,T—3
response to TRH was normal.In B:T—3 was still
reduced( P.O.O1 vs normal ) and the TSH response
to TRH was was blunted.In C all data were within
normal limits.
The data demonstrate that also in APF hygotha-
lamic abnormalities occur and result in bioche-
nical hypothyroidism.
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THYROID STATUS IN UREMIC CHILDREN
N.G.De Santo,R.N.Fine,C.Carella,E.Leumann,S.Fine,
G.Amato,G.Capodicasa,F.Nuzzi ,C.Caoasso,B.Lama
F.Scoppa and C.Giordano
University of Naples,UCLA Los Angeles ,University of
Zurich,Santobono Hospital in Naples
In order to define the thyroid status in uremic
children we studied:a) 10 children with a 50-75%
reductioh in GFR,b) 13 children with ESRD,c) 10
children on HD,d) 13 children on CAPD,e) 4 children
on CCPD and f) 100 normal children aced 3-17 years.
We evaluated by RIA T-3,T-4,TSH,TBq,rT-3,FT-3,C-H.
hTG was measured by IRMA,FT-4 in lysophase and in
equilibrium dialysis.The association constant(kaT—4)
for TBG was measured in HD and CAPD.The TSH,BH and
T-3 response to TRH was also measured.
In normal children a negative relationship was
evident for FT-4,T-4,T-3 and TBG.The correlation
was positive for rT-3.Ne relationship was found for
FT-3.In uremia T-3 and T-4 were reduced( p 0.001 vs
control FT-4 was normal except in CAPD pts where
it is increased( p 0.05 vs normal ).TSH, hTO,GH,
FT 're normal .FT-4 was increased on CAPD( p 0.05
vs ooronl ) and it was in the normal range in a,b,
c.iT-4 was depressed in CAPD( p 0.01 vs normal
nc ).Anti-hTP was negative.The TSH response to
T° was delayed,a GH peak not present in normal was
found in uremia.T—3 response to TRH was normal.
The data indicate that uremic children are not
hypothyroid.They do only show hypothalamic-pituita-
ry abnormalities for which no hormonal treatment
is required.
PROSPECTIVE CONTROLLED THERAPEUTIC TRIAL WITH
DIAMINOOIPHENYLSULFONE—OAPSONE (DDS) IN PRIMITIVE
IGA NEPHROPATHY (I9AN).
P. Deteix, S. Colon, Ph. Leitienne, P. Cochat,
M. Laville, P. Zech, 3. Traeger.
Clinique de Nephrologie, hôpital Edouard—Herriot,
Lyon, France
IgAN has common features with dermatitis herpe—
tiformis (OH) IgA deposits in mesangium or dermis
circulating IgA immune complexes, IgA plasmocytes
found in abnormal high proportion in tonsils of
IgAN patients and jejunum of DH patients. A few
patients have IgAN and DH. DDS is very efficient
in DH. As there is no specific treatment of IgAN
DDS was tried in a double blind randomized trial.
16 patients who gave their informed consent
received for one year DOS, 100 mg/day (or placebo).
All had IgAN diagnosed on a kidney biopsy, disease
severity was light or moderate (creatininemia less
than 180 )Jmol/L. Patients with Henoch Schönlein
purpura, lupus, cirrhose were excluded. After a one
year regular survey iterative renal function tests
and biopsy were performed.
2 patients dropped from the study (1 on DOS),
material for iterative histology was inadequate
in 3 patients (2 on DOS). No important side effect
was observed. Blood pressure, proteinuria, renal
function, IgA blood level did not change in both
groups (8 DOS, 6 placebo). Hematuria disappeared
in 6 DOS patients and 1 ontro1 patient, that is
no significant (Yates' X 2,62). Changes in glome—
rular sclerosis, memangial deposits, glomerular
proliferation, interstitial sclerosis, arteriolar
deposits were no different in the two groups.
DOS is no efficient in IgAN in conditions of
our trial. Deeper knowledge of' pathogeny is still
necessary to find specific therapy for IgAN.
LONG TERM FUNCTIONAL IMPROVEMENT AFTER ACUTE RENAL
FAILURE WITH CIS—DICHLOROOIAMMINEPLATINUM (COOP).
P. Oeteix, S. Colon, T. Philip, N. Lefrancois,
C. Sellem, P. Zech, 3. Traeger.
Clinique de Nephrologie, hopital Edouard—Herriot,
Lyon, France
A 22 years old man has been observed for two
years and a half after toxic acute renal failure
(COOP).
Chemotherapy was given on november 1980 to treat
a non seminomatous testicular tumor. 6 courses with
vinblastine, actinomycin, bleomycin, chiorambucil
and COOP (115 mg/m2) were done. Creatininemia
normal before the 6th course was three weeks later
at 920 umol/L. Kidney biopsy showed only massive
tubular necrosis without any sign of regeneration.
Dialysis was necessary (once the week) until july
1982 with gradual decrease of predialytic
creatininemia. Continuous slow improvement is still
occuring as seen on the table.
Dialysis
Creatininemia
(umol/L)
Creatinine clearance
(ml/s/l.73 m2)
1981 1982 1983
12 1 12 1 12
90 964 801 481 434 366
0,33 0,90
Second biopsy (5/82) showed proximal tubular
atrophy with a thick tubular basement membrane.
There is no renal atrophy as seen on regularly
performed renal echogrmphy.
Long term delayed functional improvement is
possible after acute tubular necrosis with COOP.
Persistence of platinum in tubular cells, at very
low concentration, could explain the absence of
regeneration and the delay to get recovery.
• GLOMERULOTUBULAR FUNCTION IN CYCLOSPORIN A TREATED
RATS. A LITHIUM CLEARANCE, OCCLUSION TIME/TRANSIT
TIME AND MICROPUNCTURE STUDY.
H.Oieperink, P.P. Leyssac, H. Starklint & E. Kemp.
Laboratory of Nephropathology, Odense, Denmark.
A total of 120 rats treated sith CyA (dose range
0—50mg/kg) were investigated. In CyA treated rats
me found decreses in GFR and in absolute proximal
tubular reabsorption, while fractional proximal tu-
bular reabsorption was increased. After volume ex-
pansion (2% body weight) the GFR returned to normal
and so did absolute proximal tubular reabsorption,
while fractional proximal reabsorption remained ab-
normally high. Increased sodium clearance per se
was unable to normalize renal function. Intravenous
CyA immediately reduced GFR and absolute proximal
reabsorption. Blockade of luminal sodium exchange
with Amiloride did not increase lithium clearance.
Fractional proximal reabsorption in proximal convo-
luted tubule calculated from lithium and inulin
clearance was 69%, and when calculated from occlu-
sion time/transit time it was 68%. Proximal tubular
transit time was as mean 26 sec, and in several tu-
bules we found total reabsorption. The surface of
the kidneys showed groups of partially occluded and
fewer groups of dilated tubules, while most of the
tubules apeared normal. Proximal tubular hydrosta-
tic pressure was as mean 11 mmHg, which is a sub-
normal value. We found a positive correlation (p<
.ool) between GFR and fractional lithium clearance
in CyA treated rats, and a negative correlation in
controls. There was no correlation between renal
function and serum or blood CyA. Plasma renin con-
centration was elevated during CyA.
We conclude CyA nephrotoxicity to be due to de-
creased ultrafiltration pressure, most reasonably
secondary to a reversible spasm in the afferent
glomerular arteriole.
Year
Month
COOP
1
'III'
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IMPROVEMENT OF SEXUAL DYSFUNCTION IN MALES WITH
CHRONIC RENAL FAILtJRE(CRF)AFTER LISURIDE(A DOPAMINE
AGONIST)TREATMENT.
L.Ruilope, R.Garcia—Robles, J.Parada, J.M.Morales,
M.Praga, L.F.De Villa, B.Miranda, M.Sanchez-Garcia,
J.L.Rodicio.
1°Octubre & Ramón y Cajal Hospitals & Dept.Exptl.
Endocrinol. Universidad Complutense.Madrld.Spain.
Hyperprolactinemia(HPRL)has been considered
one of the possible pathogenic mechanisms of the di
minished sexual function in males with CRF.We stu-
died a group of 20 male patients(1O with HPRL),10
on hemodialysis and 10 on conservative treatment to
investigate whetheror not in CRF a deranged dopami—
nergic system leads to the appearance of HPRL which
in turn induces a diminution of sexual function.The
response of PRL to TRH, the response of FSH and LH
to LHRH and plasma testosterone levels were measu-
red before and after 4 weeks treatment with Lisuri-
de(O.025 mg/8h)a dopamine agonist.
When compared to 10 normotensive volunteers
the initial study revealed:higher levels of PRL in
CRF(p<0.01)with a poor response to TRH, no diffe-
rence of FSH and LH and lower testosterone levels
(p0.01).We observed a decrease(p<O.O1)of PRL and
an increase of testosterone(p< 0.O1)with Lisuride.
together with improvement of their sexual activity
in 8 patients(7 HPRL). The response of PRL to TRH
was augmented whilst FSH and LH did not change.Treat
ment with Lisuride for a year in 8 patients was
been well tolerated and clearly improved their se-
xual activity.There were no episodesof hypotension
These results suggest the existence of dopaminergic
modulation of sexual function in CRF and the possi-
bility of treatment with a well tolerated dopaminer
gic agonist whenever sexual dysfunction is an im-
portant complaint in CRF.
LOW CALCIUM DIET EFFECTS ON URINARY SATURA
TION/INHIBITION ACTIVITIES IN STONE FORME
E .Duranti , P .Conti ,M . Sasdelli.
Div.ne Nefrologia,Arezzo,Italia
20 primary renal calcium Stone Formers
(SF)were studied in comparison with 10 hoa
ithy Controls(C).In all we evaluated besid
es routine examinations,urinary Activity
Product Ratios(APR) of calcium oxalate(Ox),
brushite(Br)and monosodium urate(NaU)(Pak's
method),at first during a free-calcium diet
(FD)and then after a week of adherence on
a diet restricted(RD)in calcium(400mg per
day)and in NaC1(4gr per day).
RESULTS: C SF
APR FD RD FD RD P
OX 4.3+1.93.7+l.63.2+l,8+l.1
Br 2.4+1.6 1.9+0.9 1.7+1.0 1.6+0.8
NaU2.0+O.91.9+l.O1.B+1.2 1.7+1.9
— *
FPR <0.05
— r_..***__l _***_ **OX 7.1÷3.5 9.0÷2.8 6.7÷3.2 7.5+3.4
Br 3.1+1.44.1+1.2 2.4+l.7+O.8 cO.OOt
We conclude that the urinary saturation
inhibition indexes(APR/FPR)do not show any
statistical difference in SF and C during
a FD.A RD on the contrary decreases signif
icantly urinary saturation with respect to
calcium oxalate(APR Ox)in SF,but,above all,
increases inhibitory activities(FPR)in the
two groups.We confirm,therefore,the role
of a low calcium diet,in the therapeutic
approach and prophylaxis of calcium nephro
lithiasis.
EFFECTIVENESS OF ESSENTIAL AMINO ACIDS AND
KETO ANALOGUES IN UREMIC PATIENTS.
Di Landro D., Bertoli M., Ruffatti A,Urso M.
Naso A., Penn N., Pappani A., Gasparotto
M.L. , Romagnoli G.F. (Intr. by G. La Greca)
NephroTEVTTysis Unit - Civil Hospi
tal — Padova. Italy.
In 42 uremic patients fed a low protein
diet with plasma creatinine over 7mg/dl,
the Authors evaluated the effectiveness of
keto analogues (KA) and essential amino
acids (EAA) given p.os.
The patients received an unselected low pro
tein diet conteining 0.25 mg/kg/day of pro
teins, and 58 mg/Kg/day of EAA, 75 mg/Kg/
day of KA and 13.8 mg/Kg/day of hydroxime
thionine. Caloric intake was about 40 Cal/
Kg/day. Before and after the study anthro
pometric findings, N balance, BUN, p. crea
tinine, uric acid, serum inorganic phospha
te and calcium. NH2-COOH terminal PTH, un
nary excretion of urea, creatinine, uric
acid were evaluated. Plasma proteins evalu
ations and nerve conduction studies were
also performed. 4 weeks after treatment
with KA and EAA a neutral N balance as well
as an improvement in nutritional status and
a lower retention on uremic toxins was no
ticed. Furthermore, after 5 months of treat
ment a significant lowering of PTH and
plasma phosphate was observed.
EFFICACY OF CAPTOPRIL IN HYPERTENSIVE CHILDREN
WITH AND WITHOUT RENAL ARTERY STENOSIS
F. U. Eke, J. W. Balfe
Hospital for Sick Children, Toronto, Ontario,
Canada.
Sixteen children aged 4 months to 15 years
(mean 8.4 yrs.) with intractable hypertension were
treated with Captopril 4.2 mg/kg/24 hrs. (range
1.3 - 12 mg/kg/24 hrs.) over a period of 10 months
(range 2 weeks to 26 months).
Six of the children had hypertension secondary
to Renal Artery Stenosis (RAS) and most had renin
related hypertension with elevated plasma renin
(mean 30.97 ng/ml/sec.) before treatment with
Captopril . In all but one patient effective
blood pressure control was achieved, mean fall in
systolic pressure 52 rn/Hg.; in diastolic pressure
34 mm/Hg. There was no significant difference
(P0.46)*in serum creatinine level , pre-treatment
(mean 122 142 umol/l) and during treatment
(mean 148 146 umol/1). Two of the six children
with RAS developed a marked rise in serum
creatinine which fell to pre-treatment levels when
the drug was withdrawn. Captopril was restartod
in one with a smaller dose with good blood
pressure control and no rise in serum creatinine.
Transient skin rash was seen in 3 patients
(18%), which disappeared when the dose of
Captopril was lowered, and reversible neutropaenia
in one (6%). Proteinuria and hyperkalaemia were
not encountered.
Several reports have described deterioration
in renal function in patients treated with
Captopril. Our experience shows that it is a
valuable drug which can be safely used in
children both with or without renal artery
stenosi S.
* Student's 't' test
HYPERCIILOREMIA : A COMMON FINDING IN CRF
G.Enia,C.Catalano, C.Zoccali, D.Iellaino and Q.Maggi-
ore .Cefro di Fisiolcgia Clinica l C.N.R. e Divisiaie Nefro-
logica. Rio Calabria . ITALY.
Flyperdilcrmnic eciis is gmerally caider1 pm,iliar to
thbjlo-interstitial thseaeea in early OF, while m,mel orl
serum chloride is the es,El fiMirie in av.ed OF iri,ersjm-
tly of rmal disease. Sirre rasiy patimis seas to esc,e fresi
this pattern, wa retrcqectively siialyzed the ecid-base sis e —
lectrolyte stats of l6 stable OF sttjects.
Prevalmre of P,perdilararda ( Cl> iCE rmrl/l)v .' in pa
tirnts with nrxerate ( S.cr. la,-352 jxoi/l) to severe ( S.cr.
3O—?O4 riol/l )OF. awi 34% in t&se with asi stage OF (S.cr.
) 4 unol/l ). I'perchlorania r ears imrn in iailo
interstitial dises ( 4 )thsii in diric glmerulcnritis
4 ) or other types of re,al diseases. Hyperdilcranic patisii
is were ears ecidetic thai the sersothloranic at all stages of
OF ( fig. ). The did rrt differ for serum srxUun
potitsn, calcium, alkaline urea/crea
tinine ratio.
In clumia, : in csxitrast to the traditicnal view, Fpper —
dilorsinia is crzim in all stages of OF, it is rt peculiar to
titulo-interstitial diseases, it is iated with a more rise'-
ked red,tia'r in plasirsi bicarix,ate erzcmtrmtia.
to1 CO
5 Creatin in,
51 a43 317C' l's Cff,,r -'-nf niopes P - 1 OP 1,57
"-,-.rC:p1 C" ole.txons F 355 OF 1.153 p<.SQi
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM, BLOOD VOLUt& AND URIC
tID AND URINARY PROSTAGLANDINS AND KALLICREIN IN PREGNANCY
INDUCED HYPERTENSION. P. Fievet, E. Agnes, M. Hervé, A. Carayon,
1. Desailly, Jr de Frernont, A. Mimram, A. Fournier. (1) CI*J
MIENS; (2) h6p. Tenon, (3) Hop. Pitié, PARIS, (4) CHU MONTPEL—
LIER — FRANCE.
Plasma resin activity (PRA), plasma aldosterone (PA) CRIA]
1asma volume kallikrein [(L<) Esterasic method] and urinary
G:2, PCF2 , 6 keto PGFp and TBX [RIA] were measured in 24
patients with pregnancy induced hypertension (diastolic>9O nmnHg
after 20 weeks). According to the evolution of blood pressure to
bed rest,2 groups were distinguished permanent (PH) (17
patients) and labile hypertension (LH) (7 patients). Hypovolemia
(—14 and —7% respectively) was present in the 2 groups but PRA
significantly higher in LH than in PH and in the control group
of 16 patients (C), and sigrsificatly lower in PH than in C.
BUA was sigrrificatly higher in PH and LH than in C. Correlations
studies in PH showed (1) that BUA was negatively correlated to
PV (r=—0.7) and to PRA (r=—0.6), (2) that there was no correla—
Lion between PRA and PV, (3) that UK was correlated to U 6 keto
I'GFltL (rs.7), (4) that PRA was, independently from UK, negati—
vely correlated to U 6 keto PGF1,L (r=—0.6) and PGE2(ro—D.5).
conclusions (1) LH and PH represents 2 distinct forms of PIN
with different pathogenesis. (2) In PH, hypovolemia may explain
the increase of BUA and does not induce an appropriate stimula—
hon of the RAA system. (3) In PH, the correlation between UK
and PC is physiological and may be explained by the stimulation
bf the phosphalipase A2 by kallidin. (4) The negative correla—
ion between PRA and 6 keto PGF1.,,, is unphysiological and sug—
tests the role in PH of a substance which would simultaneously
decrease PRA and increase PGI2 production.
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SCHöNLEIN—HENOCH SYNDROME AND SOME COAGULATION PARA-
METERS AMONG CHILDREN
C. Fede, G. Bellinghieri*, C. Collura, V. Savica
Istituto di Petatria Medica Preventiva e Sociale,
Cattedra di Puericultura e Istituto Pluridisciplina
re di Clinics Medica e Terapia Medica Generale e
Speciale* — Università di Messina —.
Aim of the study sac to evaluate some coagulati-
on parameters in Schönlein—Henoch syndrome among o—
ur children population without any therapy,because
literature data, often, are no univocal.
PT,PTT,TT,fibrinogen,XIII factor,serum and urina
ry levels of FDP,platelets count,were measured on
27 children age ranging between 2 to 12 years with
Schönlein—Henoch syndrome.
The results of the study showed that
—FDP urinary levals were positive among 60% of exa-
mined subjects while the serum levels were positive
among Sg,25%
—XIII factor levels was increased among 33,33% of
subjects . -
—PT,PTT,TT were in normal range.
—Fibrinogen was decreased among 18,51%,while among
2q,62% was increased.
The data show th5-L the study of the coagulation
parameters is really important in Schönlein—Henoch
syndrome because the greater alterations are conne-
cted with more severe kidney injury even if someti-
mes these alterations are no constant; we think teat
are necessary other study to explain this behaviour
MICROCOMPUTER MONITORING OF CHRONIC RENAL FAILURE
J. Foote, M. Campbell, R. Dathan, C. Ranabaldo
(Intr. by M. Searle)
Royal South Hants Hospital, Southampton, UK.
The purpose of this study ias to evaluate the
role of the microcomputer in a renal clinic.
In a retro—spective stsdy of 50 patients, calcu-
lated creatinine clearance values (Ccr), simple
mathematical transformations of the plasma creatin-
inc (PCr), plasma urea (PU), and PCr were plotted
against time. It was possible to predict the pro-
gress of most patients by fitting least squares re-
gression lines to the data from an early stage of
their course. The predictions obtained using calcu-
lated Ccr were superior to those using transforma-
tions of PCr, but a significantly better performance
was provided when both forms of data were evaluated
in combination. The courses of a few patients were
predicted by an exponential rather than linear re-
gression and individual cases also benefitted from
the use of filtering techniques. shen all these
features were considered 80% of the patients followea
a predictable course.
The PU to PCi- ratio was found to be useful for
detecting intercurrent complications.
The microcomputer identifies the form of data
and selects the regression mode most appropriate to
each clinical case. A practical system has been
established which provides a graphic display to-
gether with the PU/PCr ratio and up to any 5 further
biochemical or clinical parameters including details
of therapy. This facilitates surveillance of the
natural history of the disease, allows the need for
dialysis and transplantation to be anticipated, warns
of any intercurrent complications and helps object-
ive assessment of the efficacy of treatment.
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URINARY PYROPHOSPHATE (PyPO4) AS A LITHOGENIC FACTOR IN CALCIUM
STONE FOAMERS, WORSENED BY CALCIUM RESTRICTION IN IDIOPATHIC
HYPERCALCIURIA. P Bataille, B Lacour, lB Roullet, H Atik, A. Pru—
na , A Fournier.1) CHU AMIENS,2) HSpital Necker— PARIS - FRANCE
Pyrophosphate ( PPi ) was measured before and after 4 days of
calcium restriction, by enzymatic method, in the 24 hours urines
together with phosphate in 12 controls and in 62 calcium stone
formers classified according to their calciuria into normocal—
ciuria (NC=12), dietary hypercalciuria (DH=27) and idiopathic
ypercalciuria (IH=14). Results
Free Ca Diet Ca A Diet PPO4 aflsr
Mean+SEM UPO4 UFPi iPPI UPO4 IJPPi UPPi Ca rest.
-
mmol/d mmol/d P04 mmol/d inmol/d P04 mmol/l
Control 26 43 1.5 22 30 1.2 0.94
RCa 30 30 1.1 29 28 1.1 O.9O
OH 33 29 .8 28 25 .9 O.8O
IH 33 27 .8 29 22 .7 O.8O
* significance of the difference between free and Ca restricted
diet p>.D5. § significance of the difference between the control
and Ca stone formers.
The table shows that comparatively to controls, UPPi is si-
gnificantly lower only in IH on free diet and after calcium res-
triction whereas the urinary PP1/P04 ratio is decreased on
free diet in each group of stone-formers comparatively to con-
trols. After calcium restriction, there is a significant decrea-
se of P04 and PPi urinary escretion only in IH. The values of
PP1 and P04 are correlated in control (p<.02) as well in stone
formers (p<.02), and like wise the changes of PP1 excretion
with those of P04 excretion induced by calcium restriction were
correlated in stone formers and in controls.
CONCLUSIONS : 1/ Low Pyrophosphate excretion is a lithogenicfac-
tor since the urinary PP1 /PD4 ratio is small in each subgroup
of Ca stone formers and since the absolute excretion of PPi is
smaller in the IH group. 2/ PP1 excretion is further decrea-
sed by calcium i.e. diary product restriction only in the IH
group,which suggest that supplement of P04 would be particula-
rly beneficial in this group.
INFLUENCE OF CHLORTHALIDONE ON SERUM AND URINARY
ELECTROLYTES IN UNCOMPLICATED MILD ESSENTIAL
HYPERTENSION.
R.M. Freeman, W.L. Lawton and A.E. Fitz.
University and VA Hospitals, Iowa City, IA, USA.
Ninety two patients with mild essential
hypertension received either chlorthalidone (50 mg
daily) or placebo. 24—hour urine and serum samples
were analyzed for calcium, phosphorus, magnesium,
sodium and potassium before and after 1 and 12
months of treatment. Results: 1) the 24—hour
urinary excretion of calcium decreased from 211 mg
to 124 mg (one month) and 157 mg (1 year) in
chiorthalidone treated patients and did not change
in those receiving placebo. The decrease in
urinary calcium was positively correlated with
baseline urinary calcium and inversely correlated
with % tubular reabsorption of phosphorus. Despite
decreases in urinary calcium excretion the serum
calcium did not change at 1 month and only a small
(9.65 to 9.85 mg/dl; p<.O5) change at one year was
noted. Hypercalcemia was uncommon with only 5 of
92 values greater than 10.5 mg/dl in chiorthal—
idone treated patients (3 of 92 values in placebo).
The highest value was 11.2 mg/dl. There was no
relationship between the decrease in urinary
calcium and the increase in serum calcium. Weight
loss and changes in plasma renin were not related
to changes in urinary calcium at one month. 2)
Serum magnesium was unchanged at one month but
showed a decrease at one year (1.60 to 1.53 mEq/L)
in treated patients. No relationship between
serum magnesium and plasma renin was observed.
While chlorthalidone has a potent effect on
urinary Ca excretion, its effect on serum Ca is
minor. Chlorthalidone is an unlikely explaizetion
for severe hypercalcemia in patients with
uncomplicated mild hypertension.
EVALUATION, BY MEANS OF ELECTROMYOGRAPHIC ANALYSIS,
OF THE EFFECTS OF CARNITINE ADMINISTRATION IN PATIENTS
WITH CHRONIC RENAL INSUFFICIENCY (CR1), WHO ARE UNDER-
GOING PERIODIC HEMODIALYSIS.
M. Frascarelli*, C. Alfarone*, L. Rocchi*, R. Bedini*,
N. Calvani***, S. DIddio***(Intr. by G.M. Vacha).
*Cattedra di neurofisiopatologia, UniversitA of Roma.
•*Servizio Emodialisi, Clinica Santo Volto, Roma
***Direzione Ricerche Cliniche Sigma—Tau, Roma
In the present study the effects of the administration
of Carnitine (2 g i .v. at the end of each dialysis) in a group
of 20 pta with CR1, subjected to repeated dialysis, were ana-
lyzed. 4 recordings were done for each subject: the first
apart from any treatment, the second after a month of treat—
ment with placebo, the third and fourth respectively fol-
lowing 1 and 6 months of carnitine administration at the end
of each dialysis treatment. In any case, controls were carried
out the day after dialysis, the period in which the muscle
would find itself with a very low Carnitine level due to the
plasmatic rebound. In each series of electroniyographic
evaluations the following were taken into consideration: a) for
the anterior tibial muscle, the trace under stress against
resistouce was derived using needle electrodes as well as
with those having a plaque surface, the electrcayographic
sipoal was analyzed with F.F.T. in order to obtain the
spectrum; b) for the ecternal popliteal sciatic nerve the
distal latency values and the maximum and minimum motor
conduction speed were derived from the pedidium nLlscle. The
evoked muscular potentials were evaluated using the following
parameters: amplitude, duration and number of the phases,
through averaging technique. The comparative evaluation evi-
denced a more correct distribution of the frequencies in the
power spectra and a major expressivity of muscular
strength after Carnitine administration.
• INFLUEICE OF PHOSPHATE RESTRICTION, KETO-
ACIDS AND VITAM1N-D ON THE PROGRESSION OF
CHRONIC RENAL FAILURE
P.T.Fröhling. K.Lindenau, R.Schmlcker
and K.Vetter
St. Josefe—Hospital Potsdam, GDR
In a prospective follow—up study,
The progression of chronic renal insuff i—
oiency was observed in 60 patients with
mild renal failure for more than 12 months
— 30 patients underwent vitamin-D—prophy—
laxis by a pharmacological dosis, and 30
remained without. In advanced renal failu-
re 30 patients received only a protein—
phosphate restricted diet, 30 patients vi-
tamin D alone, and in 30.oases vitamin D
and keto—acids were added to the diet. 20
patients without dietary treatment served
as control group. The regression between
1/creatinine : time served as control pa-
rameter.
Results
1. Phosphate restriction can delay the
progression of chronic renal failure.
2. Vitamiri—D—administration does not
deteriorate the renal function.
3. Keto—acids have an additive effect to
temporally improve the renal function
and delay the progression.
4. No relation between the calciuxn—phos—
phate—product and the progression of
renal failure was found.
5. Higher PTH-levels were combined with
a more rapid progression of renal
failure.
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TRILOSTANE FOR LONG TERM TREATMENT OF PRIMARY ALDOSTERONISM.
COVARISON WITH SPIRONOLACTONE AND AMILORID * THIAZIDE.
Cl. GALY, A. Fournier, M. Tolani, P. Fiévet. CHU AIIENS, FRANCE
Trilostane, an inhibitor of the 3 ci deshydrogenase of the
steroidogsnesis, has been given for the treatment of 4 cases
(2 men, 2 women, 22—57 years) of primary aldosteronism diagno-
sed on hypertension ( mean SEM of supine mean arterial pres-
sure (MAP) = 130 2 mmHg), hypol<aliemia (3,16 0,32 mmol/1)
and standing high plasma aldosterone ( 311 + 44 pg/mi ) and low
plasma renin activity (PRA = 0.96 + 0.6 ng/ml/h) ( placebo pe-
riod ). Maximal dose ( 840 + 120 m ) achieved a good blood
control ( MAP = 109 + 14 ) nd normalization of kaliemis
3.9 + 0.15 ), PAld( 207 35 ) and PRA ( 2.16 + 0.74 ). In—
lostane alone was p'jrsued 3 — 15 months. Clinical side effects
were : burning mouth in 2 cases leading to discontinuation in
1 case ; impotency and asthenia leading to discontinuation in
an other case. Because of hypertension escape lOll mg of ateno—
lol was given in a case after 6 months. Under maximal doses
plasma cortisol increase after synthetic ACTH ( 0.25 mg IM
was normal ( 1195 238 nmol/l ). Plasma testosterone was low
in the man with impotency but remained low after trilostane
discontinuation in spite of impotency recovery and was associa-
ted with normal LH. The other had normal testosterone and LH.
These 4 patients were also treated by spironolactone ( 250 +
50 m ) for 4 weeks which achieved normotension(MAP = 117 + 7)
and normokaliemia ( 4.13 0.3 ) but indjced impotency in the
same man and metrorragia in one woman. Amilonid alone in 1 pa-
tient ( 30 mg ) or in association ( 20 5 mg ) with hydrochlo-
rothiazide ( 50 mg ) in 2 cases achieved also normotension
112.3 3.4 ) and normokaliemia ( 3.7 ÷ 0.7 ) without side
effect.
CONCLUSIONS
1/ Trilostane is an effective drug to treat primary aldostero—
nism on a short term basis but long term escape of hyperten-
sion may occur. 2/ Clinical side effects appear more frequent
than with amilorid ÷ thiazide.
• IgA MESANGIAL DEPOSITS IN C3H/He.] MICE AFTER ORAL
IMMUNIZATION.
C. Genin, .].C. Sabatier and F.C. Berthoux , Service
de Néphrologie, HOpitai Nord, Saint—Etienne, France
in order to obtain an-experimental IgA Nephropa—
thy, we orally immunized C3H/He.] (He.]) mice which
art known to be high producer of IgA and we compa-
red them with C3H/eB (eB).iO He.] and 8 eB received
ferritin orally (20 mg by gastric intubation then
1 mg/mi of drinking water for 1 month). 9 He.] and
10 eB were not immunized and served as controls.
The serum level ofimmunoqlobulinff (Iq) was determi-
ned by radial immunodiffusion and the results were
expressed in % of the pooled control sera. IgA were
slightly higher in He.] than in eB before immuniza-
tion (104 % fl7 vs 97 + 46) and after immunization
(137 85 vs 107 59) contrasting with IgG and 1gM
which were slighty lower in He.] than in eB. The
serum level and class of antibodies (Ab) to fern—
tin were determined by E.L.I.S.P. IFgher titers of
specific IgG and 1gM than of lgA were detectable in
most cases buthey were very variable depending on
animals and there was no difference between the 2
strains. Deposits of Ig were studied in immunoflun—
rescence and scored from traces to +++÷. igA depo-
sits were detected in the mesangium before immuni-
zation in 3/9 He.] (+:l case, trHces : 2) vs 1/10 eB
(traces) p : MS and essentially after immunization
in 8/10 He.] (+-+. : 1, + : 5, traces : 2) vs 2/8 in
eB (+) p(O.O2. Mesangial deposits of IgG and 1gM
were present before immunization and did not in-
creased significantly after immunization. No pro—
teinuria or hematuria could be detected in mice witl
I9A deposits.
After oral immunization, both He.] and eB mice
produced specific Ab but He.] only presented signifi-
cant mesangial deposits of IgA. Thid strain appears
genetically more susceptible to develop I0A ON and
represents a good experimental model for this
disease.
EFFICIENCY OF HIGH DOSE STEROIDS AND PLASMA EXCHAN—
GES(P.E.)IN SEVERE MESANGIAL IqA GLOMERULONEPHRITIS
(IgA GN). C. Genin, .].C. Sabatier, P. Laurent,
R. Gonthier, B. Laurent, F.C. Berthoux, Service de
Nephrologie, Hôpitai Nord, Saint—Etienne, France.
21 out of 240 patients with IgA ON presented
known signs of severity. Group 1 includes 13 pa-
tients treated with steroIds PE in order to stop
the evolution to terminal chronic renal failure
(CRF). Groupe II includes 8 patients not—treated
with steroIds, not randomized but servinq as con-
trol. IqA ON was diagnosed from usual histological
data. The signs of severity were :— roteinuria
> 3q/d in 7 cases (6 with CRF) in group I vs 6
(2 with CRF) in group II ;— CR1 in 10 cases vs 3
— epithelial proliferation in 2 cases vs 0. Ste-
roIds were administered every other day in 3 puJses
of 750 mg Methyl Prednisolone followed by a single
injection of 5, 4, 3, 2 mg/Kg then tapered by 10 rr/d
every week. 7 patients have been treated by P.E.
in addition. This treatment was followed by non
steroldal anti—inflammatory agents (NSAI) for 1 year.
5/8 patients from control group II were treated by
NSAI only. All the patients had a normal blood
pressure with or without treatment. After at least
one year, urinary signs had disappeared or signifi-
cantly decreased in 6/13 cases from group I vs 1/8
from group II. Renal function in group I improved
in 1 case (initial serum creatinine 200 umol/l),
stabilized in 4 cases (creat.2OO : 3 cases, crest
200—500 : 1 case), and — worsened in 5 cases (crest
200—500) (3 patients are dialysed). The 3 patients
from group II with CRF (creat. 200—500) worsened
(2 are dialysed). From this comparative study, it
looks that steroIds associated or not to P.E. can
decrease significantly the urinary signs and sta-
bilize the renal function in 50 % of the cases,
contrasting with the irreversible and spontaneous
progression of CRF in cases with severe IgA ON.
• ADULT HEIGHT IN PEDIATRIC PATIENTS WITH
CHRONIC RENAL FAILURE (CRF)
G. Gilli, K. Schärer, 0. Mehis.
University Children's Hospital, Heidelberg
and Florence Nightingale Hospital, Düssel-
dorf, F.R.G.
Earlier findings suggested that adult
height (AH) of most pediatric patients
treated by hemodialysis (HD) or transplan-
tation (TP) is subnormal and that during
treatment relative height (expressed by SD
from mean normal) is worthening (Proc.EDTA
18:329,1981) . We have reexamined this pro-
blem with improved methodology in a group
of 41 pediatric pta followed longitudinal-
ly at different stages of CRF until AH was
attained. Cessation of growth was assessed
by repeated height measurements and con-
firmed by epiphyseal closure. Actual AH was
compared with values predicted from serial
determinations of bone maturation (Tanner's
method). At last observation 15 pta were
treated by MD, 9 by TP and 17 still con-
servatively (CT). Based on population spe-
cific standards, the distribution of AM
was skewed towards the lower centile bands,
but only 1/13 boys and 3/28 girls ended up
at heights <2 SD from means while 4 pta
exceeded the means. No significant dif-
ferences were found between sexes nor bet-
ween pts treated by MD, TP or CT. Mean age
when AH was reached was 18.6 yrs in boys
and 16.2 yrs in girls, i.e. close to nor-
mal means. Conclusion: contrary to expec-
tations final stunting is infrequent in pe-
diatric pts with CRF and the age at com-
pletion of growth is usually not delayed.
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THYROID DYSFUNCTION IN URENIC PATIENTS
C.Giordano,N.G.De Santo,C.Carella,V..Mioli,G .Bazzato
G.Amato,G.Capodicasa,A.Tarchini,U.Coli,F.Nuzzi,
V.Landini ,V.De Simone,C .Mottola,F. Capuano
University of Naples,University of Ancona,Umberto I
Hospital ,Mestre, Italy
In order to characterize thyroid dysfunction in
uemia we have studied the following groups of pta
A) 50 healthy controls,B) 14 pts with GRF of 60+16
mi/mm, C) 10 patients with a GFR of 30+8 ml/min,D)
15 pts with ESRD,E) 40 pta on HD,F)35 pta on CAPD
and measured by RIA T—3,T—4,TSH,FT—3,FT—4,TBG,GH
and hTG by IRNA.FT—4 was measured also by equili-
brium dialysis in order to measure the association
constant of 1—4 for TBG( KaT—4 ).The TSH,GH and T—3
response to an intravenous TRH load was also stu-
died in 15 patients of groups A,E and F and in all
pts of groups B,C,D.
In B,C,a,E,F T—3 and T—4 were reduced( p<O.OOl
vs A )and rT—3 increased( p<O.OO1 vs normal ).FT—3
GH and TBG were normai.TSH was increased( p<0.Ol vs
A)but still within normal limits.FT—4 was normal
with both methdos but KaT—4 was reduced ( p<O.Ol
vs A ) in F and normal in E.TSR response to TRH was
blunted in groups B—F,GH response evidentiated a
peak not present in A,T—3 response was normal.
Since FT—4 is normal,TRH half time is normal
in uremia,the data on blunted TSH response to TRH
should point to the existence of hypothalamic—pitui-
tary abnormalities associated with a low T—3 and
1—4 syndrome.The data exclude hormonal substitu-
tion for these patients.
ZINC KINETIC BEHAVIOR (ZKB) IN CHRONIC RENAL FAILU-
RE (CRF) PATIENTS
D.Grekas, P.Nikolaides, J.Tsakalides and A.Tourkan-
tonis, Univ. of Thessaloniki, 1st Med. dept.,
Hospital AHEPA, Thessaloniki, Greece
Few reports have dealt with ZKB in CRF patients.
This study was carried out on 10 normal subjects
and 28 patients divided in 3 groups:group CRF1(n=lO)
with moderale uremia, group CRF2 (n=10) with advan-
ced uremia and group HD (n=8 hemodialysis patients).
After a 10 hour overnight fast, each subject inge-
sted dose of zinc acetate containing 60mg of elemen.
tal zinc. Plasma zinc was measured by Atomic Absor-
ption spectrophotometer (Perkin Elmer 305A) at 0.5,
1,2,3,4 and 8 hours. Also, zinc concentration was
nieasured in 24 hours urine collection. The table
summarizes the study results,
Controls CRF1 CRF2 HD
a 237.5±20.6 206.2±51.8
b 2.25±0.5 2,75±0.5
135.0±12.9*
2.6± 0.3
148.7±15.5*
2.5± 0.5
c1142.2±203,41075.7±234.1 834.8±114.9* 909.1±67.3*
d 5.1± 0.7 5.7± 0.9 10.8± 2.9* 11.8± 3.8*
e 0.13±0.02 0.12±0.02 0.06± 0.02* 0.06±0.01*
f 0.71±0.19 0.42±0.12 0.21±0.06* 0.13±0.01*
a:Cmax, maximum concentration; bTmax time of Cmax
c: AUC, area under curve; d:T½, elimination half
life; e:Kel, elimination rate constant; f:UC, urine
concentration. *p<OOtfl (compared to controls).
Data analysis suggests the following conclusions:
1) Cmax and AUC, both decreased in CRF2 and HO pa-
tients shows significant impairement of zinc absor-
ption 2) Kel and T½alterations suggests reduced
ability in elimination rate and excretion of zinc
in uremic patients.
EFFPXS OF LW PIYFEIN DIETS Ct' CRETININE CLEARAN
CE (CPc1) P NO1MALS AND CH1IC UREZIICS.
G. Barsottj, E.Mnrelli, A.Giannoni, M.Lazzerj, R.
Baronti, G.Pozzetti, A.Fosso, S.Giovannettj.
Clinica dica l, tiniversità di Pisa, Italy.
Pts with chronic renal failure (CRF) show a line
ar decline of CRc1 with tire. High protein intake,
inducing hyperfiltration in the residual glcmeruliis regarded as a cause of this decline (Brenner'82
Therefore a change fran a free diet (PD) to a low
protein diet (LFo) is expected to induce a reduc-
tiori of Cl both in normals and in CRF pts.
The 24 h CPc1 was measured in 5 normal volun-
teers for 3 days on PD (protein intake: 1
.5 g/Kg/
day) and for 3 days on LPD (protein intake: 0.6 g/
Kg/day). It was 125.9+21.6 on PD and 107.7+18.5
rul/inin on LPD, respectively (p<0.CO1). —
In 11 CBF pts CRc1 was measured daily for 4
days during LPD, and for the following 3 days while
on artificial diet (AD) (0.3 g/Kg/day of protein of
vegetable nature, supplemented with essential amino
acids and ketoanalogues), and subsequently 1 nonth
later. CRcl decreased fran 10.6+2.9 to 9.1+3.1 ml!
ruin in the first 3 days of AD (p<O.CO1). The mean
rate of CRc1 was unchanged 1 nonth later, but 4 pts
shced a significant iriprovement of CPcl as canpa—
red to the initial 4 days control period.
These data confirm a direct relatioship between
protein intake and GFR and are consistent with the
hypethesis that the protection of the residual re
nal function exerted by AD (Barsotti et Al.,'81)
takes place through this mechanism.
• EFFECT OF ZINC TREATMENT (ZT) ON CELL MEDIATED IM-
MUNITY (CMI) ON CHRONIC RENAL FAILURE (CRF) PA-
TIENTS
D.Grekas, N. Tsakalos, Z.Giannopoulos and A. Tour-
kantonis, Univ. of Thessaloniki, 1st Med. dept.,
Hospital AHEPA, Thessaloniki, GREECE.
Several different mechanisms contribute to immu-
ne impairment in CR1 and the deficiencyof zinc may
be one of these. Oral elemental zinc was administe-
red as zinc acetate at the dose of 60 mg/day for 4
weeks. Delayed type hypersensitivity (0TH) skin
tests were performed with 4 antigens (multitestlMC,
INSTITUT MERIEUX):Streptococcus (SK), Tuberculin
(PPD), candida albirans (CA) and Trichophyton (TP).
Monocyte accessory cell function was tested by the
ability of these cells to promote autologousT-cell
colony formation (TcCF) in response to staph—pro-
tein -A (SpA).
Study patients were divided in group I of 6 pa-
tients with moderate uremia and group II of 7 pa-
tients with advanced uremia. Zinc plasma concent-
ration increased to all patients after ZT. The res-
ponse to skin testing after ZT indicated moderate
increase of 0TH in controls and group I and signi-
ficant increase (p<0.01) in group II.2/6 patients
of group I and 2/7 of group II, who were anergic
before ZT showed positive skin reactions (>2mm)
after ZT. Group I and II demostrated significant
impairment in TcCF before ZT (p<0.O1 and p<O.0O5
respectively), compared to normal controls. After
ZT both groups of patients showed a significant
increase (p<O.O1) in TcCF. It is suggested that ZT
is effective to (1) restore the anergy in all ure-
mic patients (2) increase the 0TH response in ad-
vanced uremia and (3) improve the (in vitro) im-
paired CMI in uremic patients.
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SKELETAL MUSCLE BUFFERS RESPONSE TO AN ACUr
TE ACID LOAD.
A.Guariglia,C.Antonucci ,U.Ai-ouini ,E.Coffcini ,S.Uel
Canale,E.Fiaccadori,F.Reni,P.Vitali and A.Borghetti
(Intr.by V.Cambi)
Istituto di Clinica Liedica e Nefrologia,Parrna,ITALY
Intracellular buffers are bel*ved to neutralize
more than one-half of an acutely infused mineral a=
cid,but still controversial is the partecipation of
soft tissues in this process.We aimed to investiga=
te the role of skeletal muscle in the cellular res
ponse to an acute acid load.
15 male Wistar rats(25O-400gr.b.wjwere anesthe=
tized and given NH4C1(O,3M;6mEq/Kg b.wjintraperito
neally. pCUv and HCO3v were determined at time 0
and 1 h.after the infusion.Then the white part of
the lateral portion of quadriceps femoris was exci=
sed and used for the determination of muscle bicar=
bonate(HCO3i)by means of TCO2method(Guariglial984).
Intracellular pH(pHi)was then calculated by the Hen
de'sort-Hasselbalch equation using PCO2v.lS rats we=
e usee as controls. A significant extracellular me
tabolic acidosis(HCO3v18,l2v.s.28±l,5,p.OOl)in ra
ts given NH4C1 was found;a significant intracellular
acidosis v.s.controls was also found(HCO3-j9,16±l,5
v.s.l3,8±l,4 p<.OOl;pHj6,84±O,08v.s.7,03±O,04p<.OOl)
Since PCO2values were unchanged(PCO2v5O±4v.s.51
3)and renal compensation is known to be uneffecti=
ye within our experimental time,an active role for
muscle buffer systems in the early phase of an acu=
te metabolic acidosis must be postulated.
ADVERSE EFEC OF BLW) PRRSSUBE ON RENAL AND RL'TINAL
PIJGMJSIS OF TYPE I DIABFI'ICS
Ch. Hasslacher and E. Ritz, DepartnEnt Internal
Medicine, Heidelberg, Germeny (FI3)
It is cc*mionly assumed that hypertension is a late
feature of clinically overt diabetic nephxopathy (ON)
i.e. proteinuria, in type I diab. In a retrospective
study on type I diab. we were able to show subtle
but signif. BR abnormalities also in the preproteinu-
tic stage. 52 consecutive non—proteinuric type I diab
who subsequently developed persistent proteinuria1)4 consec., albustix pos. urine) and 50 consec. pat
who did not develop prot. were analyzed. All pat. we-
re seen for a median of 10 tines per year. HR (phase
I and V) was measured after 5-10 nun. rest, sitting,
in a sep. roan by one of 3 nurses throughout 1966-
1982. Pat, were followed for a median of 12 years
(6-16). Median of 60 casual systolic HR measurements
in pat. who subsequently developed persistent prot.
was sig. (p0.05) higher (135 meflg, 116—210) than in
pat. who did not (124 rrmHg, 104-168). The syst. BR
difference was not explained by difference of age,
body weight and age at onset of duration of diabetes.
Sex ratio was similar in both groups. - In 16 pat.
(8 male, 8 female) proliferative retinopathy (pR) de-
veloped after a median of 3 y. (1-9) after beginning
of persisting proteinuria (pp). Canpared with pp diat
without pR develonent, pat. with pR had earlier on-
set of diabetes (median age 17 vs. 33 y.) and earlier
onset of pp (15 vs. 22 y. after onset of diab.), 44%
of diab. with pR had constant hypertension. A neg.
correl. was found between syst. and diast. RH and in-
terval between onset of pp and onset of pR (p<0.01).
- The study documents relation of hypertension to
both onset of proteinuria and proliferative retino-
pathy.
EVIDENCE FOR SELENIlPI—DEFICIENCY RELATED CARDID—
MYOPATHY IN LOW CLE; ANCE PATIENTS
C. Hampel, K.—H. Schaller, Th. Zahn and Li. Gessler
Institute für Nephrologie und Arbeitsmedizin der
Jniversitdt Erlangen — Ndrnberg ERG
Selenium (Se) is an essential trace element and
a component of glutathion—peroxidase, an enzyme
which prevents oxidative damage to various tissues
in eluding the myocardium. Several reports of Se
deficiency and cardiomyopathy have appeared in the
literature during the past years.
We investigated the possibility of Se deficiency in
patients with renal failure and whether such a de-
ficiency lead to cardiomyopathy. Plasma Se levels
were measured in 22 dialysis patients, 20 low—
clearance patients ([C), 21 patients suffering from
myocardial infarct without evidence of renal di-
sease and 20 healthy subjects. There was no signi-
ficant difference beteeen mean Se levels in con—
trols7.5uq/l± 3.242SEM), dialysis patiets
(63.09—3.198) and infarct patients (61.71—3.911).
Levels were significantly lower in [C (5l.O93.095,
p(O.OOl). In order to determine if Se deficiency
in these patients was dun hn a low protein diet-,
we looked at urea:creatininm ratios. We did not
find, that patients with high ratios (poor diet
compliance) had significantly higher Se levels
than patients with low ratios. In the LC group, no
correlation between Se levels and cardio—thoracic
ratio or hoernoglobin was seen. However, there was
a significant negative correlation between plasma
Se levels and Dl interval prolongation (p0.OOl).
In contrast, there was no correlation between
plasma calcium levels and [IT interval prolongation.
This disturbanceof myocardia]. repolarisation in
the presence of low Se levels is suggestive of a
Se deficiency related cardiomyopathy.
UPENIC PNEUMONITIS: PATHENE'TIC lIQORTANCE OF
IRDVE0LYTIC ENZENES
A. Heidland, W.H. Hon. E. Heidbreder, J. Haun-
schild, H. Heine, R. Sch.fen, G. Kiuger, U. Gilge
Departhents of Internal Medicine, Universities of
Urzburg and nreiburg, Institute of Anatany, Uni-
versity of Witten/Herdecke, FRG.
The pathogenesis of uramtc lung syndrome is not
completely understood. To get further insight into
the underlying mechanisms, ARF patients with adult
respiratory distress syndrane (ARDS) as well as
uramic rats without overhydration, hypertension,
hyperkalania and heart failure were investigated.
Methods: In rats urania was induced by bilateral
nephrectany or ureter ligation. Dmgs were studieS
by light and electron microscopy (EM). Various
parameters of protease-antiprotease systems were
determined in bronchoalveolar lavage (HAL) and in
the blood of men and rats.
Results: In acute uremic rats light microscopy re-
vealed the classic signs of beginning of ARDS with
interstitial and intraalveolar eSana, microatelec-
basis, round cell infiltration and hemorrhages. In
EM marked degradation of collagen, elastin and
proteoglycans was observed in the interstitial
space. Type II cells showed irregular multilunina-
ted bodies, the surfactant was desquamateS. In HAL
fluid (rats and patients) total proteolytic activi-
ty of seine proteases was markedly enhanced. Si-
multaneously in plasma C 3 complement, prekalli-krein, antithranbin III and plasminogen showed sig-
nifikant reductions.
Conclusion: Our investigations show that acute
uremia in rats and men is followed by protease ac-
tivation in the HAL fluid and various blood sy-
stems. This may be followed by interstitial edema
sad degradation of elastin, proteoglycans and
collagen in lungs.
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ORAL COMPLICATIONS IN HEMODIALYSIS PATIENTS.
Ingrid Hellstrom,Lars—Eric Lins,Birgitta Norstedt,
Eva Norstedt.Institute for Cariology,Dental School
and Department of Medicine,Division of Nephrology,
Karolinska Hospital ,Stockholm,Sweden.
Patients with severe renal failure present a com-
plicated medical picture,with manifestations from
a number of organ systems,including the oral cavity.
Modification of the diet and the use of drugs in re-
nal failure have multifacetted effects even in the
oral environment.
In an attempt to present clearly the association
between the medical characteristics of severe renal
failure and oral manifestations the medical and oral
status of 15 patients on hemodialysis,7 women and
8 men aged 21-67 years has been registered. The pa-
tients dietary history has been detailed and their
drug regimens charted. The dental status includes
occurrence of caries,erosion,hypoplasia,discoloured
teeth,and deposits(plaque and calculus). Periodontal
changes,including alveolar bone status have been re-
gistered and saliva analysis was carried out for Se—
cretion,buffering and lactobacillus count.
High caries prevalence,plaque,calculus and gingi-
vitis occurred in most of the patients. In a few
patients severe palatinal erosion was observed. De-
spite salivary disturbance in the form of diminished
secretion the majority of patients registered nor-
mal buffer capacity. Fewer than half the patients
had high lactobacillus counts.Severe radiographic
changes of the lamina dura and the underlying alveo-
lar bone were seen in all patients.
These results have confirmed the theoretically
predicted association between medical and oral com-
plications in severe renal failure and thus indicate
the need for special dental prophylaxis for this
patient category.
PERIPHERAL BLOOD MONOCYTE ACTIVATION IN
CHRONIC PROLIFERATIVE GLOMERUIONEPHRITI S
Z.Hrub W.ICopeá, Z.Szewczyk
Nephrologioa3. Dept., Medical AcademyWrocaw, Poland
Circulating adherent monocytes were
evaluated in vitro in attempt to estimate
their activity In chronic proliferative
glomerulonephritis/C.P.G,./ patIents /19
cases! and healthy donors /20 persons!.
Patients were free from overt infection
or other systemic diseases and had no
features of impaired renal function.
Monocytes isolation was performed by
density gradient centrifugation and adhe-
rence to glass. Thereafter expression of
their Fe receptor /FcR/ was measured by
rosette assay with IgG coated erythro—
cytes and metabolic activity established
by NBT test.
Both parameters tested showed signifi-
cant increase in C.P.G patients in respect
to healthy subjects. Moreover, elevation
of NBT values demonstrated herein was not
encountered in 76 individuals with other
glomerulopathies /minima]. change,membra—
nous,mesangial,mesarigjocapjflai'y and fo-
cal!.Associated enhancement of FoR and cell
metabolic activity point to monocyte acti-
vation in C.P.G. thus suggesting possibi-
lity of appreciable involvement of immune
mechanisms in pathogenesis of this glome—
rulopathy.
PLASMA AND CORPUSCLE ZINC(Zn) LEVELS IN UREMIC PATIENTS
S. Hosokawa, T. Imai, T. Nishio, T. Tomoyoshi, M. Nonaka,
K. Sawanishi, Senbai Hosp. Shiga Univ. Kyoto Univ. Kyoto, Japan
We examined total aerum protein (T. P), protein analysis, plasma
snd corpuscle Zn concentrations in four groups: (1) 20 normal
subjects (10 male, 10 tamale; 36±10 years) ; (2) 10 diabetic
nephropathy (DN) patients (5 male, 5 female, 42± 16 years) with
various renal function levels ; (3) 20 uremic patients without
hemodialysis (H. D) (BUN>70 mg/dl, serum creatinine>7.0 mgA.1,
creatinine clearance'(15 mI/mm) (11 male, 9 female, 46±20 years
and (4) 20 hemodialysis (H. D) patients without DN (10 male, 10
female, 44±16 years). We collected the blood before breakfast and
measured plasma and corpuscle Zn with flamelesa atomic absorption
spectrophotorneter. No patients received zinc supplements or blood
transfusion. Protain analysis was done by the electrophoresis. These
results are shown in the table.
Protein analysis showed almost the same pattern in each of the
four groups. We conclude that plasma Zn levels are significantly
higher in DN patients (group 2) than in the normal group (1)
deapite nearly equivalent T. P values. Corpuscle Zn levels are
significantly higher in DN patients (group 2) than in normals (group
1) and are highest in uremic patients (group 3). Comparison of
corpuscle Zn levels in HD patients (group 4) and normals (group 1)
revealed significantly higher levels in the HD group despite nearly
equivalent plasma Zn levels in these two groups.
1 2 3 4
(normal) (DN) (uremic) (HP)
T.P(g/dl)
Plasma Zn
(.ag,/dl)
Coruscle Zn
(ug/di)
P<0.01
6.8±0.4 6.4±0.6 5.8±0.4 6.4±0.4L._ L_P<0.05.....J
•P<O.0o1- -P<0.01—
97.9±16.7 134.0±18.2 64.2±8.6 99.7±17.7
.
1—P<0.05--—1 r-P<0.0l—r
1388133 1466±126 1718±198 1510±162P<0.o1
• CYCLOSPORIN A (CyA) & SHORT ISCHEHIA (Isch): A NEW
MODEL OF EXPERIMENTAL ACUTE RENAL FAILURE (ARF) IN
RATS.
A. laina, D. Herzog, S. Gavendo, S. Kapuler, I. Se-
rban, G. Schiby, & H.E. Eliahou.
Dept of Nephrology, Chaim Sheba Medical Center,
Tel-Hashomer, 52621, Israel.
The known nephrotoxic side-effect of CyA in man
is difficult to reproduce in experimental animals.
To determine whether a mild episode of Isch may be
a factor in the production of CyA toxicity, right
nephrectoniy was performed in 3 groups of Charles
River rats: I.Isch (Lt renal pedicle clamping) for
20 mm, followed by IP CyA 6Omg/kg/d; II. Isch 20
mm without treatment; III. Sham (no isch) followed
by CyA as in I. Rats sacrificed after 4 days.
CyA+Isch Isch alone Sham+CyA
Ser Creat. 1.4±0.3 1.06*0.3 0.83±0.1
Ccr
FENa%
FEK
FEH2O
n
136*15
0.94±0.14
1.07±0.1
-0.1±0.015
10
261±39
0.61±0.08
0.54±0.08
-0.04±0.005
6
318±24
1.17±0.08
0.85±0.07
-0.01±0.001
6
Means±SE. CcrCreatinine Clearance ul/min/lOOg t3W.
By analysis of variance: CyA+Isch group showed
lower Ccr(p<O.001), higher FENa(p(0.05) & FEK (<
0.003) and lower FEH2O(p<O.001) compared with Isch
alone. Ccr was same in Isch and i.n sham groups.
Histology showed more vacuolization of tubular epi-
thelial cells in the CyA+Isch than in Isch alone.
CONCLUSION: CyA following a short episode of
ischemia results in ARF in rats.
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DOES NUMBER OF BIRThS AFFECT SERUM CREATININE?
A. IAINA, M. Modan, A. Lusky
Sheba Medical Center, Tel Hashomer, Israel.
A representative population sample (n=909) of
women aged 40-70 was interviewed for number of
births and examined for serum creatinine, glucose
tolerance test, blood pressure and body mass index.
No. of Mean *s,d, ing/dl Serum Creatinine by Aget
Births 40-49 50-59 60-69
0 — 1 0.85±0,19(25) 0,85±0.17(36) 0.93±0.17(36)
2 - 6 0.86±0.17(278) 0.89±0.21(242) O.87±O.l7(1S5
7 0.73±0.14(31)" 0.87±0.19(63) O.85±0,22(43)#
t Numbers in parentheses represent number of women.
* pc0.05 compared with 0-1 6 2-6 births group.
# p=0.06 compared with 0-1 births group.
A significant overall negative correlation
(r=-O,l1; p<O.O5) between serum creatinine and
number of births was found, and was most prominent
in age groups 40-49 (r=-O.25; p<O.Ol) while for the
other two age groups it was not significant
(r=-0.O6 and -0.09), Serum creatinine increased
significantly with age in those with 0-1 births
(pc0.05), but not in the two groups with 2-6 or >7
births, No significant association between blood
pressure, glucose tolerance systolic and diastolic
blood pressure or body mass index and number of
births was found. We conclude that contrary to
prevailing notions multiparity was associated with
improved renal function as reflected by serum
creatinine. Multiparity seems to prevent the age
related increase in serum creatinine.
P—FIMBRIATED E. COLI AS ETIOLOGICAL AGENT OF
ACUTE PYELONEPHRITIS IN ADULTS.
S,H. JacobsoR, G. KNllenius2, L.E. LIns1
S.B. Svenson'
1/ Department of Medicine, Division of Nephrolog
Karolinska Hospital, Stockholm, Sweden
2/ National Bacteriological Laboratory,
Stockholm, Sweden
Bacterial attachment to urinary tract epithe—
hum is important in the pathogenesis of urinary
tract infection. Adhesion is mediated by P—fin—
briae that recognize a specific structure,
Gal(l — Gal 4, moiety of the P—blood group
antigens, on the target cells. P—fimbriated
E. coli have earlier been shown to be highly
associated with primary non—obstructive pyelo—
nephritis in children.
In the present study 28 consecutive female
patients, 15—62 years (mean age 32 years), with
acute pyelonephritis diagnosed on clinical signs,
were investigated for bacteriological etiology.
All patients had fever -38°C, significant bacteri-
uria (1OO.OOO bacteria/ml urine), increased
CRP and decreased renal concentrating capacity.
None of the patients showed gross anatomical
anomalies.
From three patients Gram—positive bacteria
(lOO.OOO bacteria/ml urine) were recovered.
The remaining 25 patients hadlOO.OOO E. cohi/mi
in their urine. Of these E. coli strains 19(76 2)
were found to be P—fimbriated.
In conclusion it appears that P—fimbriated
E. coli are important as causative agents of
acute pyelonephritis also in adults.
• THE EFFECTS OFd.-PROPRANOLOL AND CAPTOPRIL AGAINST
POST ISCHEMIC ACUTE RENAL FAILURE (ARF) IN RATS.
M.Ishigami, T.Maeda and S.Yabuki.* (Intr,by K.Ota)
KANTO OSAI HOSPITAL, KAWASAKI JAPAN.
TOHO UNIVERSITY, TOKYO JAPAN.*
We previously reported that d-isomer of propra-
nolol was effective in increasing glomerular
filtration following ischemia in animals but its
efficacy was not entirely protective. Therefore,
the purpose of this study was to test effective-
ness of a combination of t&propranolol and captop—
ru, a converting enzyme inhibitor could enhance
further the recovery of renal function following
ischemia than that of fL-propranolol was given
alone. This study was done in a rat model in which
the left renal artery was occluded for 45 mm. and
renal function was observed 24 hrs later. In the
untreated control animals (n=9), GFR measured 24
hrs after ischemic insult was 54t112t.(Imin/1OOg 8W.
In contrast, GFR in animals treated with either
d-propranolol (l6jjg/kg/min, n=7) or captopril (16
/kg/min, n=6) was 173'.t22 (this value was signi-
ficantly different from untreated control group)
and 1O2±16/min/1OOg 8W respectively.
The combined therapy (n=7) showed the further
improvement in GFR reaching to 3O6t352'min/1OOg
SW and its value was significantly better than cC-
propranolol alone treated group and six times
higher than untreated control group. This combined
therapy may be more useful in situation which
renal circulation is interrupted like renal trans-
plant and renal vascular surgery.
EFFECT OF KIDNEY TRANSPLANTATION ON HISTOLOGICALLY
PROVEN URAEMIC SKIN ALTERATIONS
H.G. Kachel, P. Altmeyer*,W. Fassbinder
Depts. Nephrol .and Oermatol .*,Univ.Hosp, ,Frankfurt,FRG
In a minority of patients with chronic renal
failure severe skin problems have been described.
However systematic macro- and microscopic dermato-
logical examinations of uraemic patients have not
been performed so far, We therefore performed an
extensive clinical and histological investigation
of the skin in 59 uraemic patients — 7 not yet dia
lyzed, 24 with regular dialysis treatment (ROT) for
2—3 years, and 28 with ROT for more than 8 years —
and zdditinnafly in 19 transplanted patients with
normal graft function. As shown in the table in
uraemic patients a marked xerodermia (Xo) and a
severe actinic elastosis (AE), and histologically
a distinct microangiopathy (MA) with swelling and
proliferation of endothelial cells and perivascu—
lar deposition of immunoglobul ins (I9G, IgA, 1gM,
C3) and fibrinogen was found. The incidence of all
skin alterations increased with time of uraemia.
In the transplanted group these lesions were ob-
served in a lower incidence and in a much more dis-
crete pattern. 6 patients with extensive skin alte-
rations during ROT were rebiops led 1 year after
kidney transplantation. In all these patients the
lesions tended to heal or disappeared completely.
We conclude that uraemia induces a particular skin
disease which is reversible by successful kidney
transplantation.
Incidence of skin alterations
no ROT 2/ 7(29%) 3/ 7( 43%) 3/ 7(43%)
ROT < 3 y 17/24(71%) 14/24( 58%) 17/24(71%)
ROT > 8 y
transplanted
26/28(93%)
l/l9( 5%)
28/28(100%)
5/l9( 26%)
25/28(89%)
3/19(16%)
patients
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POSTOPERATIVE CHANGE IN ECF AND GFR IN ABDOMINAL
SIJRGEE.Y
K.Kletter, R.Dudczak, R.Khosropour, H.Frischauf
1st Medical Department and Clinic of Anesthesia and
General Intensive Care, Vienna, Austria
Post— and intraoperatively considerable shifts of
body fluids are reported together with an unchanged
or decreasing renal function. Steady state methods
are not apt to determine GFR or the size of ECF
because of the quick-change of fluid transfer rater
between body compartments. Therefore this quantitie$
were studied by noncompartmental methods by Cr—SI—
EDTA in 12 patients who underwent abdominal surgery
receiving a high fluid infusion regime. Additionally
plasma volume (PT, 1—125 albumine), colloid osmotic
pressure (COP), cardiac index (CI) and mean arteria4
pressure (MAP) were documented.
Comparing an immediately pEe— and postoperative
period a marked increase in GFR, ECF and a slight
increase in CI was shown, whereas PV and COP de-
creased (table). MAP did not change significantly.
The changes were significantly correlated in a
positive manner for GFR and ECF and negative for
GPR and PV. No correlation was found of this
quantities in aspect to COP and CI.
The increase in GFR may be interpreted as a
physiologic response to the high infusion regime.
Possibly even the lack of an augmentation in GFR
would indicate an impaired renal function.
RELATIONSHIP BETWEEN THE RENIN-ANGIOTEN-
SIN ALDOSTERONESYSTEM /RAAS/ IN PATIENTS
WITH ESSENTIAL HYPERTENSION /EH/
F. Kokot, A. Wiçcek
Department of Nephrology, Silesian Schoo'
of Medicine, Katowice, Poland
103 patients with mild or moderately
severe EH and 33 healthy normotensive sub
jects were examined. In all subjects pla-
sma osmolality, plasma renin activity
/PRA/ and plasma level of vasopressin /AVP/
and aldosterona were estimated twice:
first after administration of a normal
salted diet /100-120 mmcl NaCI/d/ and a
8 hr recumbency end a second time after
3 daysof dietary sodium restriction
2Q mmol/d/ and 3—4 hr upright position.
Hypertensive patients irrespective from
the value of PRA showed similar levels of
plasma osmolalityaldosterone and AVP le-
vels as normotens.ve subjects. In contrast
to normals in hypertensive subjects no
correlation between plasma osmolality or
PRA and plasma AVP—levels were stated. In
spite of 'normal0 AVP—levels in blood pla
ama a significant correlation was found
between plasma AVP levels and systolic
blood pressure.
Conclusions: From the results obtained in
this study it follows that both PRA and
plasma osmolality are of secondary impor-
tance in the regulation of AVP—aecretion
in patients with EH, The importance of
AVP in the pathogonesis of hypertension
seems to be probable but not yet unanimo-
usly proved.
ENDOCRINE ABNORMALITIES IN PATIENTS WITH
ACTIVE NEPHROLITHIASIS IAN!
F, Kokot, Ki.ersztejn M,, Kuczera M,
Department of Nephrology, Silesian School
of Medicine, Katowice, Poland
In 76 patients with AN and 28 healthy
subjects serum calcitonin /CT/, glucagon
/Glu/, prolactin /PRO/ and 25-OH-D levels
were estimated during an i,v. calcium
load. All studies were performed under
standatzed dietary conditions,
In 2/3 of all patients one or more li—
thogenic factors were found. In patients
with AN i,v. calcium administration was
accompanied by a significant lower incre-
ase of serum CT and Glu and a decrease of
PRO levels. In addition in AN lower
25—OH—D levels were found than in normals
No significant correlation was found bet-
ween serum and urinary Ca, phosphate and
Mg and the above stated endocrine abnor-
malities. Also urinary excretion of oxa—
late, uric acid and hydroxyproline were
not related to the stated endocrine pro-
file in patients with AN, All endocrine
abnormalities wore more marked in women
than in man.
Conclusion: Factors other than the above
mentioned hormones seem to be involved
in the pathogeneis of AN.
RENAL RESPONSE TO ORTHOSTATISM IN HYPERTENSION
DEPENDANCE ON THE LEVEL OF BLOOD PRESSURE.
M. Labeeuw, N. Pozet, P. Zech, A. Hadj Afssa, M.
Vincent, J. Traeger.
Université Lyon I, Clinique de Nephrologie, INSERM
U 80, Lyon, France.
The changes (a) in GFR, plasma renin activity
(PRA) and sodium excretion (la) following 90 mm of
orthostatism (0) were studied In 18 controls (C)
and 32 age matched (38 4- 11 years) untreated hyper-
tensives (HP) (blood pressure, BP 171/106 ma Hg,
onset : 26 months) with values in recumbency (R)
identical to C for GFR (2.20 + 0.49 ml/s) ; PRA (37
+ 26 ng/l/min) and Na (2.54 + 1.10 microM/s). &
lere correlated (p<O,001) wiTh the values of their
respective parameters in R. Therefore, a were ex-
pressed as residual a (ra= observeda- expecteda
from the correlation in C), 0 decreases more GFR
(p<O.Ol) and Na (p<0.05) and increases less PRA
(p<0.Ol) in HP than in C (rank sum test). raGFR
and raPRA show no correlation with age, duration
of hypertension, Na or PRA in R, but are positively
correlated with BP (diastolic BP and raGFR R =
0.48, dBP and raPRA r 0.44, p<0.01). The increa
se in diastolic BP induced by 0 is negatively cor-
related with r.aGFR both in C and in HP (r = 0.36,
p<O.05) but is identical In C and HP (8.2 vs 9.9 ma
Hg) and cannot account for the difference in raGFR.
Although abnormally large in HP, raNa show no si-
gnificant correlation with BP and raFeNa in HP is
identical to that of controls.
These findings indicate either a direct action
of high BP on the renal response to 0 or reflect an
increased sensitivity of the renal vasculature to
catecholamines. They are consistant with the rever-
sal of these abnormalities when BP is reduced by
treatment.
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preoperative
GFR 1o7 + 7.7 mi/mm.
ECF 22.4÷ 0,9 1 BW
PT 3.40+ 0.17 1
COP 24 +3nsnHg
CI 3.1 + 0.3 1/mm m2
postoperative
141 + 13.3 mi/mm
26.5+ 1.5 1 BW
3.08÷ 0.17 1
20 -4- 3 mmHg
3.5 + 0.5 1/mm m2
LIMITED ASSISTENCE IN PLASMAPHERESIS TREATMENT
S. Landini, U. Coli, G. Bazzato
Nephrology and Dialysis Dept., Umberto I Hospital
Venice—Mestre, Italy.
Spontaneous membrane plasmapheresis by gravity
has appeared an easy, simple and no hardware techn
ique. Nevertheless this procedure implies continuo
us and active presence of nursing staff in the mul
tiple nianouvres of lowering and elevating the bag-
plasmafilter set. On the basis of our experience we
have tried to minimize the manual work by disegni-
ng an automatic system. This new model includes an
electric operating lever which alternatively lowe-
rs and elevates the collecting bag, connected to
the conventional plasinafilter. A single venous pun
cture allows the blood withdrawn phase with in-line
anticoagulant (ACD) infusion.
When an adequate volume of plasma has been separa—
ted, the whole system is automatically, by electr-
ic power, raised above the patient. Then the inlet
phase starts and the concentrated cells are reinfu
sed with replacement fluids. After the connection
to the system by venous puncture, the patient can
manage himself the procedure by pushing the button
of electric supporting arm, which leads to the ml
ct-outlet phase of plasmapheresis. In the meantime
the patient also handles the set up anticoagulant
or plasma infusion, acting on a three way stopcock.
By this model we are treating acute and chronic pa
tients of different pathologies (multiple myeloma,
LES, acute drugs intoxications etc.) requiring lim
ited nursing assistance. This new technique, for
its semplicity and ease of operation, minimizes
the costs as well medical and paramedical staff as
sistance. This device can promote a real diffusion
of spontaneous membrane plasmapheresis and allows
to the patient to perform a self care treatment.
• ACI.ffE RENAL FAILURE AND TUBULAR DAMAGE DUE TO
SEPSIS IN AN ANIMAL MODEL.
A.L.Linton, J.F.Walker, R.M.Lindsay and W.J.Sibbalc
University of Western Ontario, London, Canada.
Renal effects of sepsis in man range from
isolated tubular proteinuria to ATN and cortical
necrosis. The mechanisms are not understood, and
animal models using I.V. E.Coli or endotoxin are
suspect because they have not mimicked the early
haemodynamic changes of human sepsis — + cardiac
index (CI) and + systemic vascular resistance
(SVRI). We induced generalized sepsis in sheep
(n=lO) by caecal perforation, and produced a high
output, non—hypotensive state similar to that seen
in man.
CI PCWP C Cr FeNa
(L/min/ (mm Hg) (mL/s) (%)
U.Prot. Fe
(mg/mi) Lyso-
zyme
12 2.7 2.07 .186 1.65
11 1.9 0.50 .663 6.6
13 1.3 2.77 .619 16.6
Increased Fc lysozyme, and increased urinary pro-
tein excretion shown to be due to low molecular
weight proteins (<30,000 d) provide evidence of
tubular cell damage analagous to that seen in man.
Glomerular filtration rates (measured both by
creatinine clearances and DTPA clearances) had
halved 48 hours after the induction of sepsis.
Pathological examination of the kidneys revealed
normal glomeruli, no consistent changes in tubular
cells on light microscopy, negative immunofluores-
cence but structural changes in proximal tubular
cells on E.M. In this model, non-hypotensive sepsis
predictably produces damage to proximal tubular
cells, and accompanied by evidence of reduction of
GFR. Th model will be of value in evaluating the
effects of pharmacological intervention.
THE EFFECTS OF ACUTE PHYSICAL EXERCISE ON
ACIDOSIS AND SERUM LACTATE AND PYRUVATE
LEVELS IN UREMIC PATIENTS
J. Lindi, M. Rus, J. Drinovec
Clinic of Nephrology, University Clinical
Center, Ljubljana, Yugoslavia
Several disturbances of carbohydrate
metabolism (CHM) are well documented. We
intended to evaluate acute local exercise
test (LE)-hand grip and cycloergometric
submaximal exercise (SE) (Shephard et al.
1968). Thee groups were tested:patientS
with chronic renal insufficiency (CRI)with
mean serum creatinine concentration (MSCC)
685 ).lmol/l(N=ll), patients with chronic
renal insufficiency treated with hemodialy-
sis (HID) (N=ll) with MSCC at the beginning
of lID 1252 umol/l. Last group was tested
before(BHD) and after HD(AHD). Controls
(CG) were 10 healthy volunteers. The main
results are shown in a table.There was
significantly more pronounced acidosis in
CR1 and BHD. Index pyruvate/lactate(P/L)was
normal in ADH comparing to SlID and CR1.
P/L was also improved after SE in ADH, but
the values didn't reach statistical signi.
ficiant levels.
Our results are indicating that HD impro-
ves anaerobic CHM during physical exercise
probably due to correction of metabolic
aci'sis. CR1 BHD AHD CG
age(iears) 42,5 39,6 39,6 28,9Tof normal)83,4 96,2 86,. 112,4
P/L before SE 0,098 0,063 0,106 0,121(mmol/l)aft.SE 0,049 0,028 0,039 0,039P/L before LE 0,040 0,036 0,085 0,058(mmol/l)aft.LE 0,033 0,043 0,045 0,047
HCO3bfore SE 16 17 21 22
(mmol/l)aft SE 14 15 18 18
NEUTRAL STEROID NETABOLITES IN BODY FLUIDS
OF UREMICS AND ALLOGRAFT RECIPIENTS
Helga Ludwig—Koehn,A. Sziedat,H.V.Henning
Dept.of Nephrology,Univ.of Goettingen, FRG
Steroid metabolites enriched from urines,
hemofiltrates,CAPD dialysates and plasma of
loo patients and controls were identified
by gas chromatography—mass epectrometry and
quantified by capillary gas chromatography.
The elimination of androaterone and etiocho
lanolone in uremic body fluids was in the
lover normal range or significantly decrea-
sed and did not normalize after successful
transplantation.A significantly decreased
excretion of corticoid metabolitee was ob-
served in urines of uremica and allograft
recipients and in CAPD dialysates,but not
in hemofiltrates. 1 1—oxygenated androstano—
lones,degradation products of corticoste —
roids were found to be elevated in urines
of uremic patients and in hemofiltrates.
These substances in urine correlated sig —
nificantly with the serum creatinine levels
During a hemofiltration procedure the eli -
mination rates of corticoid metabolites and
11—oxygenated androstanolones dropped to 5o
% of the initial values.Preliminary measu —
rements indicate a nearly tenfold elevation
of steroid glucuronides in plasma of uremic
patients,A filtration with hemofilters of
plasma from controls and a uremic male yiel
ded only 5o% of the 11—oxygenated androsta—
nolones and no dehydroepiandoreterone from
the uremic plasma,while from the control
plasma all steroid conjugates were ultra—
ble.We assume in uremia disturbances of ste
roid metabolism possibly due to changes of
enzyme activities and protein binding.
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Baseline 49
24 hrs 5.3
28 hrs 6.9
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POTENTIAL ROLE OF POLYAMINES AS INHIBIRS OF
ERYTHPOPOIESIS IN THE ANAEMIA OF RENAL FAILURE
R.J.S._McGoninle, F. Husserl, J.D. Wallin,
O.M. Rennert, J.W. Fisher.
Queen Elizabeth Hompital, 'iirminrham,Enciard.
Tilace Medical School, New Orlea'is, U.S.A.
University of Oklahoma, Oklahoma City, U.S.A.
Patients with renal failure receiinr CAPD
o' PDT were studied to assess the relationship
of th polyamines, spermile, spermidine and
p+esree the seerit o' anaemia and decree
o' serm inhibition of ervhropoiesis. Seum
ervh—opoiein (Ep) was measred by RIA and
polvarnines were seas-red b- HPI. In "itro
erythopoiesis was assessed by eryt'roid
proe'itor cell (CFU-E, UFU—E)rrowt'l in foetal
ncise li"er and peripheral blood cultures.
Patients shoved a Wide rane in serum pol-
amine le'els which were hirher than in normal
muh-erts, however, they did not correlate with
serum Ep, plasma creatiine, haematocrit, or
decree of serum inhibition of' in vitro er'-thro—
poiemis. No difference in serum polyanitne
levels was found between CAPD and DT patiens,
aithouch CAPD patients had sirnificantly (p<.O5)
hiher haematocrit values. All 3 polvarnines
(1.O-.O nmol/ml) showed a si-nificant (more
than 50%) inhibition of RFU—E crowth in vitro in
the presence of both Ep and burst promotinr
activity, and to a lesser extent inhibited in
vitro CFtJ-E crowth. Thus, we have demonstrated
4he inhib±torT effect of spermine and its meta-
bolic precursors speridice and p'itrescine on in
'iro crowth of erythroid prorerlitor cells.
T-1oweve, ser'un polyazine levels did not
clinically correlate wi4 the severity of
anaemia or de'—ee of jnhihi tion of ervthro—
pniesis.
EARLY DIALYSIS MINIMIZES MORTALITY IN ACUTE RENAL
FAILURE (ARF) FROM LEPTOSPIROSIS. A STUDY OF 41
CASES.
R.Maiorca, S.Mombelloni, E.Movilli, C.Camerini.
Dept. of Nephrology,Spedali Civili,Brescia, Italy.
41 cases of ARF from leptospirosis (serov.
icterohaernorrhagiae) were studied from 1970 to
1982, mainly male (39/41), mean age 40 12.
30.6% contracted infection while working in
agriculture, 40.9% in leisure activities, 28.5%
in unascertainable occasions. 100% had fever, ARF
(63.4% anuric), icterus; 36.6% arrived under
shock, 43.9% had hemorrhages. In many cases,
evolution of hepatic and renal damage appeared to
be dissociated. Anuria mean duration was similar
(about 3 days) in patients with and without
shock. Platelets reduction below 100.000/cmm was
constant, but only one case showed evidence of
D.I.C. Many serum enzymatic activities were
moderately rised (GOT.GPT,AP, LDH, CPK, amylase).
All cases were treated with penicillin, 95% with
peritoneal dialysis (7 also had hemodialysis).
Overall mortality was 22%, related to hemorrhagic
(cerebral, adrenal) miocardic or hepatic causes.
No relationship was found between precocity of
antibiotic therapy, bilirubinernia, shock, and
mortality. But a close one was seen between
precocity of dialytic therapy and survival.
Mortality in patients dialysed at: 0-3, 3-6, 6-9
and over 9 days from initial symptoms was re-
spectively 0, 3.5, 25, 42.5% of the pts. at risk.
Dialysis seems to remove something(s) determinant
for pts. survival.
FISH OIL LOWERS TRIGLYCERIDES(TG) AND INCREASES
PLATELET N—3 FATTY ACIBS(FA) IN RENAL FAILURE
Maidment CGH*, Jones SF, Lea 7A
*Addenbz.ooke' 8 Hospital, Cambridge and
University of East Anglia, Norwich UK
Chronic renal failure(RF) is assooiated with
an increased risk of vascular disease. Disturb-
ance of lipid metabolism, especially hypertri—
glyceridaemia, may be a contributing factor. Pop-
ulations eating a diet rioh in fish have a low
serum TO, high platelet n—3 FA and a low incid-
ence of vascular disease.Dietary supplements of
fish oil have been shown to produce favourable
changes on blood lipids in normal subects. 6 RN
patients(P), stable on haemodialysis, and 6
healthy controls(C) were studied. Fasting plasma
lipids and platelet total NA were measured. All
subjects then ingested ll.3g fish oil (Maxepa)
per day in capsules without change in diet.After
4 weeks they were restudied. Plasma lipids were
measured using enzymatic spectrophotometric tech-
niques. Platelet NA were extracted from membranes
with chloroform/methanol. NA methyl esters were
prepared by acid transmethanolysis. After ax—
traction NA were analysed by gas chromatography.
TEST SUBJECT BEFORE AETER
N—3 iTmoles f) P 4.02(0.83) ** 7.17(1.25)
(20:5,22:5,22:6) C 5.22(0.54) ** 8.61(0.80)
(SD in parentheses, * = p <0.05, ** p< 0.01)
!i—3 PA increased markedly and TO fell In both
groups after Maxepa. N—3 FA were negatively
correlated with TO after 1raxepa (r5 —0.88, p=
< 0.01). Thus, fish oil may be of value in
managing lipid disturbance in RN.
RAPID PROGRESSIVE GLOMERULONEPHRITIS (RPGN)
CLINICAL COURSE AND PROGNOSIS WITH AND
WITHOUT SPECIFIC THERAPY
U.Metz. A.Daul, N.Graben
Div. of Renal and Hypertensive Diseases
Universltaetsklinikum. D-4300 Essen,FRG
Since 1971 we surveyed 21 patients with
nonautoantibody-induced biopsy proven RPGN.
12 of them were treated with an immunosup-
pressive combination therapy consisting of
cyclophosphamide, azathioprine and predni-
sone. 6 of these pts were additionally trea-
ted by plasmapheresis. 9 pts received no
specific treatment at all. 2 pts of the
plasmapheresis and 2 pts of the immunosupp.
treated group had an Impressive improvement
of renal function for several years. 3 pts
remained on hemodialysis or underwent dia-
lysis within a few months. 3 pts died from
pneumonia during immunosuppressive therapy.
Of the 9 untreated pts 4 had also a signi-
ficant and longlasting improvement of renal
functIon, 2 of these had been on dialysis
initially. Considering the unexpected good
results in the untreated group reports of
successful treatment of RPGN by plasma—
pheresis and/or immunosuppression should
be carefully evaluated.
Plasma TO
(mmol/1)
P 1.94(0.42) ** 1.45(0.21)
C 1.67(1.01) * 1.02(0.38)
PLASMA EXCHANGE IN GUILLAIN-BARR SYNDROME
(GBS)
G.J. Meyer, K.H. Kruse-Thams, K. Christiani
and W. Niedermayer
University Kiel, W.-Germany, Zentrum Konserv.
Medizin I, Abt. Nephrologie
We evaluated the natural history of GBS-
patients with conservative management (n=42)
versus treatment with (membrane-) plasmaphe-
resis therapy (PP) (n=8). The clinical data
of muscular paresis, respiratory vital capa-
city and EMGs in these two groups were com-
paired in adition to CSF cellularity, protein
contents, immunoglobulins and WBC changes
including lymphocyte stimulation (PE-IA) and
subpopulations (Okt4/Okt8).
In acute GBS PP enables an immediate, total
and persistent remission of the disease with
gradual normalisation of the humeral and cel-
lular abnormalities and the electromyographic
abnormalitis, while in chron. GBS the neuro-
logic damage is mainly due to morphologic
destruction of the nerve fibers with less
favorable results after treatment with PP.
PLASMA INTACT PTH 1—84, C—TERMINAL PTH
53—84, AND BONE HISTOLOGY IN PATIENTS WITH
CHRONIC RENAL FAILURE.
G. v. Mittelstaedt, H. J. Roth, N. Gretz,
J. Frank, U. Hellfritsch, S. Weissbach,and
N. Strauch,
Clinic of Nephrology, Klinikum Mannheirn,
University of Heidelberg, Mannheim and
RIA-Labor Dr. Lirobach, Heidelberg, FRG.
It was the aim of thLs study to assess
the value of intact PTH 1—84 as a prognos-
tic parameter of renal osteopathy.
In 30 patients with chronic renal failure
we measured the intact PTH 1—84 (modified
RIA from Immuno Nuclear Corp., Minnesota,
USA; normal range: 3—7 prnol/l), the C—
terminal PTH 53-84 (homologeous human PTII
RIA, routine in-house method; normal
range: 10—50 pmol/l), and the alkaline
phosphatase. In all patients a bone histo-
logy was available at the same time. The
degree of the renal osteopathy was deter—
rained in the groups ha, lIla and IlIb
(Delling).
In our patients the intact PT}I showed a
higher correlation to the alkaline phos—
phatase (r=0,53l) than the C—terminal PTH
(r=O,376). In contrast to the C—terminal
PTH—levels, increased intact PTH concen-
trations were associated with renal osteo-
pathy equivalent to secondary hyperpa—
rathyroidism in bone histology. Conclu-
sion: As the intact PTFI 1—84 is indepen-
dent of renal function and correlates with
bone histology, its measurement may lead
to a better estimate of the clinical state
of patients with renal osteopathy.
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LOCALIZATION OF DR ANTIGENS IN NORMAL HUMAN KID-
NEY: DR EXPRESSION ON VASCULAR ENDOTHELIAL CELLS
P.Arrizabalaga, E.Mirapeix, R.Vilella, A.Torras,
J.Andreu, A.Darnell, L.Revert.
Hospital Clinic. Barcelona. Spain.
DR antigens are widely distributed in cells
with immunological activity. In vitro, the human
endothelial cells are normally negative for DR
molecules. However,morphological studies on tissue
sections suggest that renal vascular endothelium
appears to express DR antigens. We have studied
the DR expression in normal human kidney.
We have obtained and used a mouse monoclonal
antibody directed against a monomorphic determi-
nant of DR (EDU—l) with indirect immunofluorescen—
ce (IF) technique on eleven specimens of normal
human tissue. Nuclear counterstaining with ethi—
dium bromide (SB) was used for cellular localiza-
tion. Tonsil sections and peripheral blood cells
were used as positive control. Monoclonal antibody
to non DR antigens (CRIS—l) and ascitic fluid
obtained by intraperitoneal of cells of Balb/c
NSA myeloma line were used as negative controls.
A constant pattern of IF (DR antigens) was
observed in all the specimens. We have observed
heavy IF in the renal interstitium and in the
glomerular capillaries. In addition, bright stai-
ning was observed in the mesangium. EB counterstai
fling showed DR antigens around endothelial cells
in glomerular capillaries and probably vascular
endothelial cells in intertubular capillaries.
This shows that in normal human kidney, the
DR antigens are localized in cellular structures.
This suggest that the renal endothelial cells
might play a fundamental role in transplant rejec-
tion as well as participate in local immunological
reactions.
ACUTE RENAL FAILURE COMPLICATING VIRAL HEPATITIS
IN THE ABSENCE OF SEVERE HEPATIC INSUFFICIENCY
J.Montoliu, A.Darnell, L.Revert.
Hospital Clinic. Barcelona. Spain.
Four patients (2 HBsAg positive), with acute
icteric viral hepatitis (VH) developed acute
renal failure (ARF) in the course of their ill-
ness and in the absence of other complications.
Their peak serum creatinines (4.7 to 10, mean
= 7 mg/dl) were reached either before or simulta-
neously with their maximum serum aminotransferase
values (1390 to 2730, mean = 2032 mU/mi). Apart
from VH no other factors responsible for precipi-
tating ARF could be identified. In the HBsAg
negative patients, serologies for infectious
mononucleosis, CMV infection and leptospirosis
were negative. In 2 patients liver biopsy showed
changes consistent with VH. Proteinuria was ab-
sent in all cases, making glomerulonephritis
unlikely. Urinary sodium excretion was uniformly
high (57 to 104, mean 76 mmol/L in random sam-
ples). Two patients required short courses of
dialysis. All cases recovered completely with
return of serum creatinines to normal values
after a mean of 25 days. After a normal serum
creatinine had been achieved, one case was lost
to follow—up and the other 3 maintain normal
renal function and liver function tests 7 months
(mean) following the initial episode.
Otherwise uncomplicated VH is a potential
cause of ARF, even in the absence of severe hepa—
tic insufficiency. The mechanism of ARF in VH
is unknown but vasoconstriction phenomena induced
by endotoxemia might contribute.
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THE CONSEQUENCES OF THE FINDING OF VESICOURETERAL
REFLUX(VUR)IN ADULTS.
J.M.Morales,L.M.Ruilope,M.Praga,C.Gomez.J .M.Marti—
nez,M.T.Ortuño,JM.Alcazar, I.Bello,J.L.Rodicio.
C.S.1 de Octubre. Madrid. Spain.
Uncertainty continues to persist regarding the
prognosis of VUR in adults. The data of 32 adults
patients(13m, 19 f,X age 27) have been revisited.
At presentation renal failure was present in 22 ca—
ses(68.7% range 1.8016 mg/dl) and proteinuria in
25(78% range 0.3 to 6 g/24h).The degree of proteinu
na fell into the nephrotic range in 5 patients but
was not accompanied by any of the serum markers of
the nephrotic syndrome.Both serum creatinine and
24 h proteinuria correlated closely(r=O.722,p<0,OO
).Arterial hypertension was present in 20(62.5%)
and a positive urine culture was found in 19(5-9.3%.
Thirty patients were followed for periods ranging
between 6 and 72 months. Sixteen patients entered
a dialysis program,half of them when first seen and
the remaining during the evolution. In the other
14 patients,10 underwent surgery of their vesicoure
teral reflux. Surgical outcome was good in every ca
se but renal failure progressed in 2 cases.In the
remaining 12(8 operated)renal function remained sta
ble. We found that the higher the initial creatini—
ne and proteinuria the worse the prognosis of renal
function. Arterial hypertension,urinary tract in-
fection, bilateral reflux, degree of reflux and th€
presence of HLA B12 and HLA Aw32 were not impor-
tant prognostic factors. CONCLUSION: The presence
of vesicoureteral reflux in adults constitutes an
ominous finding with more than half of the patients
entering a dialysis program during a follow-up of
less than 6 years. Although in some cases renal
function remain estable additional follow—up may
well prove to confirm our conclusion.
INTERSTITIAL FOAM CELLS IN NEPEROTIC SYNDROME
BELONG TO THE MONOCYTE/MACROPHAGE LINEAGE.
F. Nolasco, J. S. Cameron, R. Reuben, B. Hartley,
F. Carvalho, R. A. Coelho.
Guys Hospital, London, U.K. and Hospitals Civis
de Lisboa, Portugal.Interstitial foam cells have been described in
patients with the nephrotic syndrome, but their
origins are obscure; both tubular cells and
macrophages have been suggested as precursors. We
have studied 28 adult cases with a nephrotic
syndrome: 15 membranous, 4 MCGN, 2 FSGS, 3 minimal
changes and 4 SLE) of whom 10 had prominent inter-
stitial foam calls, using an indirect immunoper—
oxidase technique and a panel of monoclonal
antibodies (McIth). Anti—HLA--DR (DA2,M7O4)
reacted with peritubular and glomerular capillaries,
interstitial round or stellate cells, and with
variable intensity with epithelial tubular cells.
However, in 6 patients (5 idiopathic, 1 SLE) very
strong staining was noted in large interstitial
cells which had a foamy appearance, both on surface
membrane and cytoplasm. Further staining with
other McAbs revealed that these calls also
expressed a common leukocyte antigen (2D1 ), and a
macrophage marker (FMC 32+). Weak staining was
also noted with anti C3b receptor (TO5+) and
anti-helper/inducer T lymphocytes (Leu 3a+). No
staining was detected with anti—B cell antibody
(TO 15) NE cells (Leu 7), pan T lymphocyte(UCHT 1)
or T cytotoxic/suppressor call (UCHT 4) antibodies.
Thus interstitial foam cells express markers that
are characteristic of cells of the monocyte/
macrophage lineage. Although some interstitial
foam cells may have an epithelial cell origin,
in nephrotic patients they seem to be macrophages.
EVIDENCE FOR A COMMON MECHANISM OF HYPOZINCEMIA IN
CHRONIC RENAL FAILURE (CRF) AND FOLLOWING ACUTE
TISSUE INJURY
T.Mountokalakis, C.Pathouli, C.Platsakis, D.
Symvoulidou, S .Voudiklari
Second Medical Department, Athens University,
Athens, Greece.
To elucidate the mechanism by which serum Zn is
decreased in GRF, we determined serum levels of Zn,
albumin (Alb), 52—macroglobulin (n2—M) and trans—
ferrin (Tr) and urinary Zn excretion (UzV), in 12
non—dialyzed CRF patients. Values were compared
with those obtained on the first postoperative day
from 13 patients subjected to major abdominal sur-
gery. Twelve healthy subjects served as controls.
Serum Zn(mean±SEM) was significantly lower in both
CRF (65.6±5.2 g/dl) and surgical patients (69.1±
5.9 ig/dl) than in controls (93.8±6.2 ig/dl).Also
significantly lower than normal in both patient
groups were serum levels of Alb (3.72±0.21, 3.73±
0.20 and 4.69±O.28g/dl,respectively) and of Tr(203.2±
15.8, 224.5±17.9 and 355.9± 43.5 nig/dl), while se-
rum 2—M did not differ significanlty among the 3
groups (281.3±19.2, 243.0±20.7 and 227.2±21.9 mg/
dl). UZnV was significantly higher in both CRF
(577.7±78.6 ug/12h) and surgical patients (1043.2±
406.4 g/12h) than in controls (316.3± 88.5 lIg/24h).
The similar pattern of changes observed in CRF and
those induced by acute tissue injury suggests a
common mechanism of hypozincemia, related to chan-
ges in Zn—binding proteins and to increased urina-
ry Zn losses.
ADULT-ONSET MINIMAL CHANGE NEPHROTIC SYNDROME (MS):
TIMING OF RESPONSE, STABILITY OF REMISSION AND
LONG-TERM FOLLOW-UP.
F. Nolasco, J. S. Cameron, J. Hicks, C. S. Ogg,
D. G. Williams.
Renal Unit, Guy's Hospital, London, United Kingdom.
Recently, steroid treatment of nephrotic adults
without initial biopsy has been advocated. However,
the timing of response to steroids, stability of
remission and response to cyclophosphamide of
adults with MCNS are poorly documented. We
reviewed 89 patients with MCNS aged 15 to 62 years
at onset, followed up to 24 years ( = ?.5y).
Severe hypertension and renal impairment were more
frequent in older patients at onset. Initial
treatment with prednisone in 75 patients resulted
in remission of proteinuria in only 45 (60%) by
8 weeks and 55 (73%) by 16 weeks, but a further 3
went into remission later, 58 (77%) in all. Subse-
quently, of these 58, 24% had no relapse, 55%
relapsed infrequently and only 21% were frequent
relapsers. Cyclophosphamide (36 patients) was as
effective in inducing remission, and only 13
patients relapsed later, with an actuarial remi-
ssion estimate of 65% at five years. No influence
of age was detected on response to steroids or
cyclophosphainide, but younger patients were more
often relapsers. At most recent follow—up 59(66%)
of patients were in remission, 15 (17%) were dead,
and only 15 (17%) had active disease. The mortality
was confined to older patients, only 5/15 from
complications of their nephrotic syndrome; only one
patient died as a complication of treatment
(pulmonary edema from i.v. albumin). Thus, adults
with minimal change resemble similar children, but
are slower to respond to steroids, relapse less
frequently, and remain more often in long—term
remission after cyclophosphamide.
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• ALt0STEONE RESIONSE 10 r&)tXJIATION OF P(YTASSItI4 IN
PATIENTS IN DIALYSIS OR WITH ESSENTIAL HYPEUI'ENSION
K.Olgaard, E.Langhoff, E .Tvedegaard, S.Madsen, M.
Hanuier and J. Ladefoged.
Med.Dept. P, Rigshospitalet, Openhagen, Derinark.
The patogenesis of essential hypertension (EU) re-
mains unkncwn. The present investigation, therefore,
examined the influence of modulation of the distri-
bution of potassiun on the aldosterone response in
patients with untreated EH, patients on chronic
dialysis (anethric (AN) and non-nephrectatized (NN))
and in control patients (C) with no hypertension
and normal kidney function. Short-term infusion ofinsulin-glucose resulted in a transitory fall in
plasma K without a change in the total-K content of
the body. Plaena aldosterone, cortisol, renin acti-
vity, potassilrn and sodiun were measured during a3 h. infusion of insulin-glucose in all patients
and repeated in the EU and C groups after 2 weeks
of sodiun depletion by diuretics. In response to in-
fusion of insulin-glucose plaama aldosterone in-
creased significant (P < o.ool) with a mean of 41%
before and 116% after sodiun depletion in Eli pa—
tients in contrast to a significant fall (p< o.ool)
of 30% and 41%, respectively, in the C group. In
patients on chronic dialysis aldosterone increased
by 97% in the AN group and decreased by 110% in the
NN group. N3 significant changes were dexonstratedin plasma renin activity and plasma cortisol levels.
Thus the present investigation has dnstrated
an abnormal response of the adrenal glands to modu-
lation of potassiun in patients with EU, similar to
the response of aneric dialysis patients, while
the response of NN dialysis patients with varying
degrees of hypertension corresponded to that of
normal C patients. It is suggested that the abnormal
response in patients with EEl may be of importance
to the understanding of the pathogenesis of essenti-
el hypertension.
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NO MORE DEATHS WITH LEPTOSPIROSIS
M.Borghi,U.Bodini,B.COpercifli, F.Forzani
C.Gruttad'Auria,F.Pecchini, P.L.Romanini+,
C .Romano
Division of Nephrology,InfectiouS Disease
++ and Blood Bank+ — Hospital of Cremona —
Italy
Due to the nearness of three rivers and
to the plain land our Hospital takes care
of many leptospirosis cases,expecially am-
ong fishers but also in cow milkers. Some
of them,every year,present the Weil's syn-
drome and are defined serious by the blood
urea nitrogen(BUN)(>100 mg/dl),platelets( 70.000),total bilirubin(>15 mg/dl) and
arterial pressure(Max <90 mm/Hg) values.
Clinical picture besides jaundice,fever,
shock and haemorrhagic syndrome,is charac-
terized in many cases by "Herpes labialis"
may be important for the illness serious-
ness.
From 1980 the before treatment(perito—
neal dialysis only)was replaced by Scrib—
ner's shunt,plasmapheresis(3 every patient
),extracorporeal dialysis(5,9/pt) and pla-
telets infusions(mean 6 bags each contai—
fling 0,7 x 1011 platelets). Dialysis was
in regional heparinization and was made al
so twice a day to have BUN below 100 rng/di
Time preceding 1980 was characterized
by eight deaths from 15 treated cases. 11
following patients all recovered.
• EFFECTS OF ACUTE AND CHRONIC RANITIDINE ADMINISTRA-
•
TION ON RENAL FUNCTION AND PARATHYROID ACTIVITY IN
CHRONIC RENAL FAILURE.
N. Pozet, M. Labeeuw, A. Hadj Aissa, C. Bizollon,
P. Zi}f J. Traeger.
Clinique de Nephrologie, INSERM U 80, Universitê
Lyon I, Lyon, France.
The effects of Ranitidine (R) on the creatinine
clearance (Ccr), the urinary excretion of sodium
(Na), potassium (K), calcium (Ca), phosphorus (P),
cyclic AMP (AMP, nM % ml Ccr), the blood level of
parathormone (PTH, "C" terminal immunoassay) were
studied in 11 patients with renal failure (Ccr = 27
+ 18 ml/m, age : 53 + 11). These parameters were
tudied from 0 to 9Ominutes (period I) and from 90
to 180 m (period II) after an oral dose of R (150
mg) both before (study A) and after (study B) a
treatment by.R (300 mg/day/28 days). In study A,
Ccr decreases in period II (- 12 % p<.O5) with not
significant decreases in excretion of all electro-
lytes while PTH and AMP are unaffected. In study B,
Ccr and the excretion of K, Ca, P decrease signifi-
cantly (p<.O25) in period II with not significant
decreases for Na and no changes in PTH and AMP.
When identical periods are compared between studies
A and B no differences are evident for Ccr and ex-
cretion rates of electrolytes, but PTH values are
significantly lower in study B (2759 vs 2098,
p<.O5) while blood Ca (correlated for proteins)
and P, phosphate reabsorption and AMP excretion
show no significant changes. Plasma levels of R we-
re higher (p<.O1) in study B than in A, indicating
accumulation of the drug in renal failure. In con-
clusion 1) although hamful effects of R on-renal
function could be suspected for acute studies no
such effects are evident with chronic administra-
tion ; 2) chronic treatment by R decreases "C" ter-
minal. PTH without affecting other parameters of PTH
et :cvity.
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INFLUENCE OF Mi.UROSCUF'IC HbMPIUMIR IMH) ON RENAL
FUNCION IN IgA NEPHROPATY (IgAN).
M. Praga, V. G.Millet,L. M. Ruilope ,J Navas ,J M. Moral es,
J.M.Alcazar,I.Bello, J.L.Rodicio.— C.S.12 de Octubre
Madrid-Spain.
IgAN is a disorder characterized by outbreaks of
MH.The appearance of renal failure during MH has
been described as very unusual . During a period of
3 years we conducted a prospective study which per-
mitted us to investigate 29 episodes of MH in 21 pa-
tients. In 11 episodes(37.9%)(Group I), a derange-
ment of renal function was observed, characterized
by a significant increase (y0.5 mg/dT)of serum crea-
tinine(Crs) to values ranging 1.2—6.7 mg/dl(X 3 mg/
dl). In the remaining 18 episodes (Group II) no chan
ge was observed in Crs. The worsening of renal func-
tion was accompanied by a longer lasting of MH(4.8±
1.3 vs 3.5±1.5 days; pO.O5). Arterial hypertension
and edema were not present in any case whilst oil—
guria appeared in only one case of group I. A com-
plete recovery of renal function was observed in ev
ry case of group I, 1 to 2 months after the MH. Re-
nal tissue was obtained in 6 MH of group I and in
10 of group II. ihe most striking finding in group
I was the presence of erythrocitic casts occluding
the lumen in as much as 50% of the tubules coinci-
dental with severe impairment of renal function.
Cellular crescents were present in 3 cases of each
group but in less than 15% of the glomeruli. Fin-
dings of tubular necrosis were more frequent and
severe in biopsies of Group I. CONCLUSION: A worse
ning of renal function can often be observed during
MH in IgAN. Tubular damage and obstruction by red
cell casts my play a significant role in the appea-
rance of this reversible complication.
•
•
MAGNESIUM METABOLISM IN IDIOPATHIC Ca STONE FORMERS.
A Pruna, P Bataille, M Finet, P Leflon, A Demontis, Cl Galy, 3F
de Fremont, A Fournier. Service de nephrologie et Laboratoire de
Biochimie — CHU HSpital NORD — 80000 AMIENS. FRANCE.
Because of the suspected role of magnesium deficiency in cal-
cium stone former, plasma magnesium and urinary calcium and ma-
gnesium excretions were measured in 60 controls and 82 calcium
excretion stone forniers classified according to their calcium
excretion in 3 groups (norinocalciuric (NC), dietary hypercalciu_
na (a-I), and in idiopathic hypercalciuria (IN), this latter
group being defined by a calcium excretion>.D7mmol/kgn calcium
restricted diet (CaRD) of 400 mg/day). The measurements perfor-
med after 4 days of CaRD are summarized in the table
Mean + SEM UMQV(rnmoi/d) UCaV(ninol/d) UMg/UCa PMg(mmol/l)_
Controls
3.4 * .16 2.02 + .3 1.68 + .15 .84 + .01
(n=60) — - - —
NC
3.87+ .17 2.84 + .3 1.36 * .08 .82 + .09
(n=36) — - — —
DH
3.94* .3 3.78 + .4 1.04 + .13 .85 + .01
(n=17) — — — —
IH
4.26+ .28** 7.1 + 4*** .6 + .04***.79 + .01*(n=29 — — —
Comparison patients versus controls : p<.05,** p<.01,***p<.OO1
The table shows significant differences only for the IN group
which has significantly higher U Mg V, lower P Mg, but lower
U Mg/U Ca.
Conclusions 1/ The coexistence of a higher IJMgV and of a lower
P;.Ig in IH suggests that, there is a magnesium depletion in IH
due to a renal lcrik 01 Mg which might be explained, in these
patients with primarily increased intestinal calcium absorp-
tion, by a relative state of hypaparathyroidisin. 2/ The lower
UMgIUCa ratio may favor a higher propensity for calcium crystal.
lization suggesting that magnesium supplement may be of thera-
peutical interest specially in the IH group.
ABNORMAL Na,K COTRANSPORT IN RED CELLS OF
UREMIC PATIENTS.
F. Quarello, R. Boero, C. Guarena, C. Ro—
sati, G. Giraudo and G. Piccoli.
Medical Nephrology, University of Turin,
Turin, Italy.
Abnormally low Na,K cotransport fluxes
have been observed in erythrocytes (RBC)
from patients with essential hypertension
arid in some of their normotensive off-
springs, suggesting genetic transmission.
We studied the maximal rate of Na efflux
mediated by Na,K cotransport inRBC from 25
uremic patients (U)(7on hemodialysis, 7 on
hemofiltration, 11 on CAPD) and in 13 normal
subjects (N). The effect of incubation of RBC
from N with uremic plasma was also tested.
We observed a significant reduction of
the mean value of Na,K cotransport in U vs
N (O.19+.03 mMol Na/i RBC/h vs O.50±.07;
p.(.Ol). Na,K cotransport was low in 85 of
U vs lOl'o of N. This defect is not related
to primary renal disease, family history
of hypertension and modality of treatment.
Incubation with uremic plasma did not
inhibit Na,K cotransport.
Our results show that uremic patients
have a quite uniform suppression of RBC
Na,K cotransport, probably not dependent
on the presence of plasma inhibitors. Na,K
cotransport activity, although genetically
coded, can be modulated in uremia by
acquired factors.
GLUCOSILATION OF PROTEINS IN UREMIA
C.Quereda, J. Sabater, R. Marcn, R. Matesanz and
J.Ortuño.
Centro 'Rarn6n y Cajal". Madrid. Spain.
The effects of uremic abnormalities in
carbohidrate metabolism on the non—enzymatic
glycosilation of proteins have been mainly studied
in hemoglobin. Moreover, methods employed have been
chromatographic and so, potentially interfered by
carbamylated hemoglobin and by shortening of life-
span of RBC. To avoid these problems, we have
measured glycosilated hemoglobin (GHb)and plasmatic
glycosilated protein (POP) using a more specific
chemical method of glycosilation, the
thiobarbituric acid method, in 29 nondiabetic, non—
dialyzed patients with chronic renal failure (CRF)
and in 29 nondlabetic hemodialysed patients (MD).
Twenty six healthy subjects (N) and 19 nonuremic,
insul independent diabetic (D) were used as controls
In every group, glycosilated hemoglobin was also
determined with a conventional microcolumn
chromatographic method (Nb Al). CRF and 0 patients
showed similar values of GHb, HbA1, and POP, which
were higher than those of N group. Hemodialysis
induced a significant decrease in GHb and POP
levels although they remain raised when compared
with N. Hb Al values were similar in both uremic
groups. In the nonuremic groups (N and 0), there is
a linear correlation between methods used and
between glycosilated proteins and usual parameters
of glucidic control; this does not happen in uremic
patiens (CRF and Ho).
We conclude that there is an abnormal
glycosilation of proteins in uremia, nondependent
of carbamylation reactions, and partially
corrected by hemodialysis.
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• HYPEETENSION (UT) IN IgA-GLCMER(JIDNEPHRETIS
Rambausek, M., Waldherr, R., ilndrassy, K., Ritz,E.
Dpts. Internal. and Pathology, Heidelberg, FI3
IgA-GN is the nost cannon (25%) in our popula-
tion. Thus, UT due to IgA-GI is the rrost carson se-
caidary form of ff2. In the present analysis, BP in
75 biopsy-caifirnod IgA-(2' was related to clinical,
mniiunological and histol. features and compared
with BP nasuraints in the local population and
101 biopsy-confirmed non-IgA-GN. Prevalence of UT
was similar in IgA-G and non IgA-G (S-crea .1.5
22.4% in IgA—GN; 31.7 non—IgZ--GN; S—crea>1.5 94%
in IgA-G; 57.1 in non-IgA--GB). In IgA-G there was
a clear relation of HT to age (17.2% ITT, age< 30 y;
82.8> 30 y), but age could not be dissociated from
the confounding variable of renal function. Nacro-
hanaturia was a predictor of nornotension /MH in
43/46 of noniotensives (93.5%) and 3/46 (6.5%) of
hypertensives). There was no relation of hyperten-
sion to plasna IgA levels, IgA deposits in skinbiopsy, circulating IC. A relation was found bet-
ween liT and glamerular iniminhistology: of 29 UT pet
10 had pure mesangial (35%) and 19 mesangial and
capillary (65%) deposits. A high signif. relation
between liT and glcmerular sclerosis was observed
(UT 38% no sclerosis; nornotensives 78% no sclero-
sis; liT 62% daionstrable sclerosis; NT 22% dmion—
strable sclerosis). Sixrtilarly vascular lesions (hy-
alinosis) were absent in 21/46 NT and present in
28/29 ITT. IgA deposits were not seen in vessels
with the exception of the site in close proximity
to the glctnerulus. Of particular interest is the
later development of UT and renal failure in 5 of
25 initially nornotensive pat. with vascular le-
sions. The current observations underline the non—
benign character of IgA-G'T. Its relation to UT is
indistinguishable fran other GN and is related to
clinical and histological characteristics.
• ARE P—HEMOLYTIC STREPTOCOCCI INVOLVED IN THE
PATHOGENESIS OF MESANGIAL IgA-NEPHROPATHY?
S Rekola, A Bergstrand, H Bucht.
Karolinska Inst Dept of Tnt. Med Danderyds hos-
pital, Danderyd.Depts of Pathology and Renal
Medicine.Huddinge hospital, Sweden.
Of all renal biopsis in our area 1974—83, 187
patients fulifilled the criteria of Mesangial
IgA—nephropathy (Mes. IgAN). Appearent onset of
disease was of three kinds. 73 patients had
recurrent macroscopic hematuria in connection with
upper respiratory tract infections. 46 patients
had asymptomatic hematuria and/or proteinuria.
38 patients had a history of possible acute
glomerulonephritis in connection with upper
respiratory tract infection.
Since 1983 we have investigated patients with Mes.
IgAN in a prospective mannor. Among other tests we
have estimated antibody—titers against Strepto—
lysin 0 (ASO) and DNase B(ADNase B). Cultures for
isolation of )3—hemolytic streptccocci (13-HS) were
also taken.
Until now we have seen 92 patients prospectivly.
33 patients (36%) had growth of 3—HS in their
throats without signs of pharyngitis. )3—HS gr A
was seen only in 1 patient, gr C (17), gr C (7),
gr B (5), gr F (2) and unspecified (3). 2 patients
had 2 different strains. ASO—titers were not
elevated. 40 patients (43%) had an ADNase—titer .
BOO.
The findings of elevated ADNase—titers and high
number of positive throat cultures are far higher
than expected in the local population. In our
opinion there is a possibility of a pathogenetic
role of 3—HS in the Mem IgAN in our country. It
also seems that p—HS others than group A could
be of importance.
SODIUM (Na) LOADING AM]) URINARY PROSEAGLANDINS (Ris)
IN DIABETES INSIPIDUS (DI) RATS
M. Rathaus, N. Kariv, J. Bernhei,n
Department of Nephrology, Heir Hospital, Kfar Saba
and University of Tel Aviv, Israel
Current evidence suggests that the antidiuretic
hormone (ADH) and changes ui Na balance influence
renal PUs. To separate between these two mechanisms,
the effect of Na loading on PUs was studied in female
DI rats compared to female,age matched,heterozygote
Long Evans controls (C). Ten DI and 10 C had a normal
Na intake. In 10 DI 0.16% NaC1 solution was supplied
instead of water for either 8 days (n.5) or 14 days(n5). In 10 C a 0.80% Nail solution was used for the
same periods. Three urine collections were measured
for Na,K,RiE2 and RiP2 (RIA) in each rat. Resuitsi
Normal Na 8 days ** 14 days **
Na(mmol/d): C
DI
2.2±0.1
2.3±0.1
3.9±0.1 3.0±0.2
5.9±0.2
K (mrnol/d): C 3.1 4.5±O.1 3.4+0.2
RiE2(paol/d):
2(Oh/'c.u
DI
C
DI
C
DI
3.5 0.1
857 123
333 39
204 20
126±11
4.7 + 0.1
1630 20237 48
372 + 45
160+22
3.3 0.1
826 76
206 28
218 11
106+8
El? ratio: C 4.4 + 0.6 4.5 0.7 3.8 0.3
*
DI 2.7±0.6 2.8+0.3 1.9+0.2
=p 4..05, =p C.01 ,when compared to normal Na.
The above findings suggest that: a) a similar
pattern of PG excretion with Na loading is observed
in DI and C rats; b) the significant increase of FUR2
and RiFat 8 days suggests a role of ADH for this
increase,and c) the significantly low PGE2 and E/F
ratio in DI rats at 14 days suggests an adaptation of
the tubular production of His with prolonged Na load.
INVESTIGATIONS ON 24—HOUR URINES IN IDIOPATHIC
STONE FORMERS
Ch. Riess, B. Hess, U. Binswanger
Section of Nephrology, Department of Internal
Medicine, University of Zurich, Switzerland
Chemestries and activity products for calcium
oxalate were obtained from 24 hours urine collect-
ions in 43 idiopathic male calcium oxalate stone
formers. Results were compared with data of age
matched healthy blood doners.
urine excretion
mmol/24 hr stone formers controls
Calcium
Oxalate
Phosphate
Magnesium
Uric acid
6,3 + 2,9
0,39 0,14
28,5 - 10,9
4,0 + 1,7
3,1 1,2
7,3 + 2,2
0,40 0,15
36,4 10,8
5,5 + 1,7
2,8 + 1,2
activity poduct
acaaOx,mm *
4,O.lO_8
1,9.10_B
3,2 io_8
l,4.lO_8
mean + SD
*calculated by Nomograms f Robertson
No differences of the quantity of mineral in
the urine excreted during 24 hours and of the
activity product for calcium oxalate can be shown
between patients and controls. The pathophysiol-
ogic role and diagnostic meaning of the measure-
ments have to be questioned on the basis of these
findings.
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• MACROPHAGE FUNCTION IN PRIMARY AND SECONDARY GLOME
RtJLONEPHRITIS (GN).
D.Roccatello, R.Coppo, G.Martina, B.Basolo, C.Rol—
lino, D.Cordonnier*, G.Piccoli. Medical Nephrology
(prof. A.Vercellone) University of Turin, Italy
and * CHU Grenoble, France.
Experimental models suggest that the macrophage
function (MF) plays a capital role in the develop-
ment of some glomerulonephritis. We studied 78 pa-
tients: 17 membranous GN(MGN), 16 primary IgAGN
(pIgAGN), 8 membranoproliferative ON (MPGN), 6 Fo-
cal Glomerular Sclerosis (FGS), 2 GN with mesangial
1gM deposits (IgMGN), 11 lupus nephritis (LN),3po—
lyarteritis (F), 3 crioglobulinaemias (C), 5 Schön—
lein—Henoch ON (SH), 5 cirrhosis—associated GN(CGN)
Patients were analyzed for HF by measuring the
clearance of anti—Rh(D)—sensitized 51Cr—labelled
autologous erythrocytes, IgG and IgA immune corn—
plexes(IC) by Clq or conglutinin tests. In phase
of clinical activity a defective MF was found in
6i.7% of primary GN (7/il MGN, 8/10 pIgAGN, l/6
MPGN, 1/2 GSF, 1/2 IgMGN) and 77% of secondary GN
(8/9 LW, 1/1 F, 1/1 C, 2/1 SH, 2/3 CGN), whereas
only 3 of 26 patients studied during an inactive
phase had a prolonged immune clearance. IgAIC were
detected in 87% of patients with primary and second
ary IgAGN with defective HF. IgGIC were detected
in 25% of patients with primary GN and 140% of LN
who had a prolonged immune clearance.
A defective MF affects a conspicuous number of
patients with active nephritis. Circulating IC or
unidentified factors related to the active phase
of disease might blockade MF, favouring tissue de-
position.
• EARLY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE.
J.B. Rosman, P.M. terWee, G.Ph.M.Piers—Becht, W.J.
Sluiter, F. vander Woude, S. Meijer, A.J.M. Donker.
University Hospital, Department of Nephrology,
Groningen, The Netherlands.
In animal studies it has been noticed that diet-
ary protein (P) restriction delays the progression
of chronic renal insufficiency. A prospective,ran—
domized trail in man however, is still lacking.
Therefore, we started such a study in our nephrolo—
gic outpatient department in January, 1982.
199 patients with a creatinine clearance between
10 and 60 ml/min entered into the trial. Patients
with SLE, PAN and active Wegener's granulomatosis,
of with a lethal disease, were excluded in advance.
Patients were stratified for sex, age and renal in-
sufficiency. 105 patients were randomly assigned to
a P—restricted group (0.4—0.6 g per kg NW); 94 pa-
tients were assigned to a control group.
At randomization, mean 24 h urea excretion was
280 and 288 rnmol, respectively. At 18 months, these
values were 180 and 290 mmol/24 h (p<0.001). In
the P—restricted group, phosphate— and P—excretion
decreased. Serum phosphate fell in the P—restricted
group. Patients in this group ultimately used less
A1(OH)3. Serum albumin did not change.
Survival curves revealed a significantly better
survival of P—restricted patients. Moreover, it ap-
peared that median serum creatinine concentration
in the control group increased every month with
1.3% of the initial value (r0.90; p<O.O1). In the
P—restricted group, median serum creatinine remain-
ed constant during the whole observation period.
We conclude that moderate restriction of P is an
acceptable and effective regimen for delaying pro-
gression of functional deterioration in early renal
failure. Further analysis of our data might reveal
which renal disease benefit most from dietary mani-
pulation, i.e. P—restriction.
POLYCYSTIC KIDNEY DISEASE PREVALENCE IN A
POPULATION OF UREMIC PATIENTS.
G.F. Romagnoli, A. Bianco, F. Buzzi, P.L.
Cappellari, M. Bertoli, D. Di Landro, M.L.
Gasparotto, A. Naso, N. Penn, A. Ruffatti
M.L. Stoppa (Intr. by G. La Greca).
Hemodialysis Service, Hospital of Padova,
I ta ly.
The Authors evaluated polycystic kidney
disease prevalence in 1811 patients on re
gular dialysis in an italian country of
6500000 inhabitants. 148 patients (8.17%)
were affected by polycystic nephropaty and
features of heredity were present in 111
(75%) of them. In these patients, 81 fema
les and 67 males, mean age was 52.8 years
(range 33-75) and mean dialytic age was 7.8
years (range 1—14). The presenting features
occured at mean age of 40.19 years in fema
lea and 42.11 in males, were hypertension
in 35.8%, renal colic in 25.6%, macroscopic
hematuria in 25%, CRF in 17.5%, pain in
14.8%, UTI in 8.1%, heaviness in 7.4%, sto
nes in 5.4% and palpable abdominal mass in
4.7%. Mean time elapsed between diagnosis
and start of dialytic treatment was 10.13
years. During dialytic treatment, complica
tions were mainly related to vascular ac
cess (2.6±2.2 surgical procedures/patient),
to hematuria and infections which required
nephrectomy in 34 patients (22.9%) and bi
nephrectomy in 6 (4.5%). Hypertension was
detected in 40 patients (26.94%).
SSTRIF1CATION C'? H3 {0L2STRQL iN 'iH
PLASh1A U? PAr.LNTS WITH {kJNIC NAL?Ai LU.
U.Piskorzyii.ska, B.Putkowski, T.Eadzio,
A •Lanit I us.
Medical Academy, Gdaxsk, Poland.
Studies were carried cut as a part of
investiat ions aimed to clarify a ome
mechanisms responsible for lipid
metabolism disturbances in chronic renal
fai1ure..xperiments were done using blow
of 28, non—dialysed, patients with
advanced chronic renal failure/serum
cretinine 645 to 2740 umol/l/ and12
healthy people..strification of H'
cholesterol was measured in whole plasma
and in hii—density lipoproteins /ULJfraction during 5h incubtion at 37 .me
sparation of the free H cholesterol and
H'holestercl esters was carried out
using thin—layer thromatography.
kadioactivity of the separated fractions
were meaoured using a scintillation
couner.It was found that estrification
of H cholesterol is:
a/ significantly inhibited in whole
plasma of patients with chronic renal
failure, b/ at this same time it is
significantly higher in HDL fraction of
the uremic plasma.It is suggested that
the observed disturbances are due to the
inhibition of lecithin—cholesterol
acyltransferase activity in the uremic
plasma.
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ACTIVITY OF TISSUE NZYMS IN iRONIC
RENAL FAILUR&
13.Rutkowski, A.Szutowicz, J.Kabata,
M.Stpiexi, A.Manitiusedicel Academy, Gdañsk, Poland.
Studies were carried out as a part of
investigations aimed to clarify some
mechanisms responsible for carbohydrate
and lipid metabolism disturbances in
chronic renal failure.Muscle, fat tissue
and liver of rats with chronic renal
failure/induced by two—stage nephrecto'/
and of control animals were analysed for
the activity of several enzymes, among
them hexokinase, fructose—6—phosphate
kinase, lactate dehydrogenase and free
fatty acids synthetase.it was found that
the activity of hexokinase, fructose—6—
phosphate kinase and lactic dehydrogenase
was higher in muscles and fat tissue of
urernic rats, while fructose—6—phosphate
kinase activity in the liver of these
animals was lower than in controls.Liver
free fatty acids synthetase activity was
elevated in rats with chronic renal
failure.These reaults indicate that the
activity of certain enzymes, involved in
carbohydrate and lipid metabolism, is
not uniformly affected in different
tissues of uremic rwts.
DECREASED FUNCTION OF THE RETICULOENDOThELIAL SYSTEM
(RES) IN IDIOPATHIC GLOMERULONEPHRITIS (GN).
F.P.Schena,A.M.Fracasso,G.Fanfani,G.Mastrolitti. 2nd
Medical Clinic and Nuclear Medicine,Bari,Italy.
The atudy of the RES,disease activity and circula
ting immune complexes(CIC) were investigated in a
longitudinal study of 16 patients(pts)with primary
gn(membranous,5,membranoproliferative,6,and extra—
capillary,5).A total of 16 pairs of studies were
available for analysis.The mean interval between
studies for all pts was 3.5±1.2 months.The RES fun—
ction was evaluated in vivo by measuring the rate of
removal of 99Tc labelled human serum albumin milli—
microspherea(TCK9) and in vitro by studying the pha
gocytosis index in isolated peripheral monocytes
utilizing three testa:IgG—coated sheep red blood
cells,C3b—coated rabbit red blood cells and latex
phagocytosis. At the time of the first study the
clearance half times for TCK9 were significantly
very long(p<O.OO1).Decreased phagocytosis was pre-
sent for at least two tests in all pts.The degree of
RES dysfunction correlated significantly with both
clinical activity(p<O.05) and CIC(%Clq-BA;p<O.05).
In the follow—up study 11 pta with clinical improve
ment had concomitant improvement in RES function whi
le in 5 pta with clinical deterioration prolonged
TCK9 clearance anda low phagocytosis index persisted.
RES function changed concordantly with the change in
the clinical status in all cases(p<O.Ol). Longitudi-
nal analysis did not show concordance of changes in
RES function and CIC,The lack of concordance could
suggest that 'other factors may also contribute to
the modulation of RES dysfunction.
G000PASTIJRE—SYNDR(rIE FOLLOWIh( MYCOPLASA
PN1JMONTAE INFECTIONS.
H. Schaar, P. Fherle, P. Mahieu, P. Schepers
(Intr. by HJ.Sieberth)
Dept. of Tnternal !ert.icine II, Aechen, (ern.F.R.
Described was a disease in cows after infection
with mycoplasna hovirhinis, comparable the
(oodpasture-syndroaie. Our experirents result in
the statement, that arter infection with
nycoplasma pneur'oniae antibodies are rwoduced
against the cell nembrane, which also fit to the
human glornerular basement membrane. This could he
demonstrated by indirect innune fluorescenz and
by the solid phase radiointnunoassa". Coileren-
tary to this we investioatd 1? sera from
patients with Goodpasture—syndrone. These sera
had an impressive positive nyconlasr'a complenont
binding reaction and also showed a nro''th
inhibition for this rivcnpiasna species.
There is a cross raction betneen r'yconlasna
pneurloniae antibodies and human PB! antibodies,
so Goodpasture—svndrone ray bo Followed by an
infection through these microoranisr's.
IS THERE STILL APPLY FOR DIETARY TREAThENT IN
ADVANCED CHRONIC RENAL FAILURE?
R.Sohmioker,P.T.Frc3hling, K.Vetter, I .Kaschube,
HJClinkmann
Department of Internal Medicine, University of
Rostock and Research Clinic of Nutrition,
Potsdam—RehbrUoke, GDR
It was the aim of the study to asses the effect
of dietary treatment on rehabilitation rate in
patients with advanced chronic renal failure. 105
patiets with an average serum creatinine level10.3 — 2.2 rng/dl, whose protein intake was 0.4 g/
kg body weight/day, received as supplement to a
mixed protein—poor diet the aequivalent of I g
nitrogen/day in essential amino acids (EAA) (n=46)
or 0.5 g nitrogen/day in keto acids (1(A) (n=59).
Mean duration of treatment was 10 months (range
3 to 41). A significant improvement in metabolic
disturbances (nitrogen balance, serum transferrin,
urea, metabolic acidosis, calcium—phosphate meta-
bolism, PTH) was observed. After institution of
the therapy, all patients with a good compliance
had no relevant uremic symptoms. 21 patients (20%)
returned to full—time work and 69 (66%) to part—
time. 37 out of the 105 patients are dialyzed in
the meantime. A negative influence of dietary pre
treatment on the.long term follow up in regular
hemodialysis could not be found.
Our study demonstrated that a mixed protein—poor
diet supplemented by EAA or KA can safely improve
the rehabilitation without disadvantages for the
patients for the iimiinent regular hemodialysis.
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• CHARACTERIZATION OF MECHANISMS RESPONSIBLE FOR THE
UREMIC INSULIN RESISTANCE. IN VIVO AND IN VITRO
• EXPERIMENTS.
0. Schmitz, 0. Pedersen, E. Hjøllund,'B. Richelsen,
H. E. Hansen, H. Beck—Nielsen, H.
Kommunehospitalet and Amtssygehuset,
OK 8000 Aarhus C, Denmark.
The basis of insulin resistance common in uremia
is not clarified. The present study examines:
1) Insulin dose—responses in uremia; 2) adipocyte
insulin receptors and the effect of insulin on in-
tracellular processings in chronic renal failure.
1) A 3-step euglycemic clamp was done in 14 ure—
mic and 10 healthy subjects. Three rates of insulin
were infused each during 120 minutes: 0.5, 2.0 and
4.0 mU/kg/mm. The last 30 minutes glucose disposal
rates were consistently lowe in uremic than in
contrls (2.3 — O.3vs. 6.6 — 0.8;÷7.8 - 0.6 vs.13.2 - 1.1 and 9.6 — 0.7 vs. 15.5 - i.c mg/kg/mm.
All p < 0.001). Insulin levels were similar in the
two groups, but those required to elicithalf maxi—
al response were higher in uremics (83 — 5 vs. 54
- 8 uU/rnl, p < 0.01).
2) 125I-insulin binding, non—insulin and maximal
insulin stimulated i4C—D—glucose transport and con-
version of 14C—D—glucose to total lipids were iden-
tical in 8 uremics and matched controls. However,
insulin concentrations causing half maximal glucose
transport and lipogenesis were shifted 3 fold to
the right (p < 0.02), indicating a decreased sensi-
tivity to insulin.
In conclusion, uremic insulin resistance is the
result of severely depressed insulin action locali-
zed at postbinding cellular sites.
THE EFFECT OF BETA ADRENERGI C BLOCKADE ON RENAL
AUTOREGULATION IN A3 ISOLATED PENFUSED KIDNEY.
N. Rabinovitch, J. Shohat, 0. Boner, 3. Rosenfeld,
Nephrolo' Institute, Beilinson Ned.ical Center,
Petah Tikva, Israel.
Renal blood flow and GFR remain constant in
spite of wide changes in renal artery pressure.
The mechanism of this autoregulation is still
unclear.
In this study, the effect of beta adrenergic
blockade on the autoreguiation of renal flow was
examined in an isolated perfumed rat kidney model.
The left kidney was perfused in situ with an
oxygenated physiologic solution at 370C. Perfusion
pressure (i') was maintained at 60, 80, 100, 120,
140 and 160 mm Hg for 15 minutes • Rena]. perfusate
flow was measured by timed collection of the
effluent. The rats were allocated to 3 groups:
(1) 11 rats received no pretreatment (c), (2)
7 rats were pretreated during the 4 pre.-experi—
mental days with pindolol (PIN) in a dose of
1 mgcg/d., I?, (3) 5 rats were pretreated as
above using propranolol (PR) in a dose of 7 mg/
kg/d, IP. In the C group perfusate flow was
maintained at the same level in spite of siguifi—
cant changes in the PP. Similar changes in the
PP in the PIN group were associated with siguifi—
cant changes in the perfusate flow. However, in
the PR rats, a similar decrease in PP did, not
change the perfusate flow, whereas the perfusate
flow increased only when PP was elevated above
t40 mm Hg. PIN, a beta—adrenergic blocker with
intrinsic sympathomimetio activity, abolished
the autoregulation. PR, a non.-selective beta—
blocker with no intrinsic syinpathomimetic activity,
affected autoregulation only at hii pressures0
These results suggest that the sympathetic system
plays an important role in renal autoregulation.
MINOXIDIL IN TREATMENT-RESISTENT HYPERTEN-
SION AFTER RENAL AILOTRANSPLANTATION
J.Scholze,K.Precht ,H.—W.Buder,D.ScholzMedical Clinic (Charitê) ,Eumboldt—Univer—
sity,Berlin,GDRIn 5—lo% after renal allotranspiantation
hypertension is treatinent—resistent even
with two or threefold antihypertensive corn—
bination.Out of 255 transplanted patients
(pts) 16 pts remain hypertensive. 9 suffer-
ed from renal artery stenosis (RAS), in 3
pts the serum creatinine level was elevated.
The following results were obtained
with Minoxidil in combination with Propano—
101 (P)and Puosemid (F).Mean dosis:215 mg P,
235 mg F,23 mg(lo—5o rng/d) Minoxidil.
Parameter before 2week 6th,0 12non.
BP syat. 2o2x 2o 16o212X 152a22x 14925X
HP diast.122± 11 97± 7X 95±11X 9o±16X
tJV inl/d 1945±563X1658±378x2270±9o4 2071*377
UNa mmol/l 157±25 123± 52X 161123 15o673
Cr/umol/l l6683 163± 78 155± 53 164k 84
Urea—Numol/1 — 7,94,3 9,8*4,1 11i9,
PRA ,lig%AII/3ha,5±76 418±238X (Boucher)
x= p 0,05 (Wilcoxon test)
Side effects: ITypertrichosis in 15/16 pts,
fluid retention in 11/16 and in 2 pta pen—
card effusion. 2 were withdrawn: fluid re-
tention and hypertrichosis. 1 pt died in
consequence of infarction.
We conclude that Minoxidil in treatment—
"resistent" hypertension is high effective
in combination with F and P if operative
reconstruction or PTA of HAS are impossible.
EPIDEMIOLOGICAL DATA IN POPULATION OF 250 000 ON
MINIMAL CHANGE NEPHROTIC SYNDROME, (MC) IGA NEPHRO—
PATHY (IgAN), IDIOPATHIC MEMBRANOUS (IMN) AND MEM—
BRANOPROLIFERATIVE GLOMERULONEPI-IRITIS (MGPN).
P._Simon*, M.P. Ramée**, K.S. Ang*, G. Cam*
* La BeauchAe Hospital St—Brieuc, ** Lab, of Pa-
thology CHU Rennes, France.
Prevalence and incidence in a population on pri-
mary glomerulor,ephritis are rarely known. Between
April 1, 1975 and October 1, 1983, 217 cases of
primary glomerulonephritis were histologically
diagnosed in the nephrology center of a health dis-
trict with 250 000 inhabitants : 66 (30.5 %) of the
lesions were IgAN, 21 (9.6 %) were IMN (48 % of all
cases of MN), 18 (8.3 %) were MGPN and 14 (6.5 %)
were MC. All patients were born and lived in that
district. At the end of the period under review,
the prevalence was evaluated at 2.6/10 000 (IgAN),
0.8/10 000 (INN), 0.7/10 000 (MGPN) and 0.5/10 000
(MC). The incidence per year was evaluated at
3/100 000 (IgAN), 0.9/100 000 (IMN), 0.8/100 000
(MGPN) and 0.5/100 000 (MC). The disease began in
subjects under 35 years of age in 65 % (IgAN), 38 %
(IMN), 83 % (MGPN), 71 % (MC). Between April 1,
1980 and October 1, 1983, only 3 cases of MGPN were
diagnosed, against 15 cases for five years before.
At the end of the study, 28 of 119 patients had re-
nal failure ; IgAN : 22 cases ( 33 %), IMN 3 (14 %),
MGPN : 9 (50 %), MC : any case (0 %). Eleven of 28
were on hemodialysis ; IgAN : 6 cases (9 %), INN
1 (4.7 %), MGPN 4 (22 %).
This study brings epidemiological data unknown
to date in a French Country and shows how valuable
it would be from a socio—economic point of view if
these data were confirmed in others countries.
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PROTECTIVE EFFECT OF VERAPMIL :ON THE
ISCEAMIC ACUTE TUBULAR NECROSIS IN DOGS
Mohamed Sobh (M.D.) ,M.Mansour(P.H.D) ,M.Ghoneim(M.D)
Urology&Nephrology Center ,Mansoura University ,Egypt.
During renal ischaemia,there is increase in mit—
ochondrial calcium ion which could be responsible
for renal vasoconstriction and cellular necrosis(Sc
hrier,1983) .Verapainil decreases intracellular calc—
iuln ion by decreasing it's inward displacement dur-
ing the plateau phase of action potential.
In this work three groups of mongrel dogs had
been used.Each dog was anaesthetised by nembutal &
mechanically ventillated.Normal saline was pumbed
through a femoral vein catheter & the bleod pressure rno
nitored through a femoral artery catheter. Rightne-
phrectomy was done.Urine was collected through a ur-
eteric catheter.Left renal blood flow (RSF)was mea-
sered by an electromagnetic flow probe.In the first
siXity min.Complete renal artery clamping was
followed one hour after release by a significant re-
duction in:RBF,GFR,urine volum/min. (UV) , the tubular
cell necrosis(ATN)manifested by a significant incr-
ease in the urinary enzymes (Alkalin phosphatase,
L.D.H.and G.T.)kidney biopsy from experimental ki-
dney was compaired with that from the right kidney,
biopsies examined by light and electron microscopy.
In the second group following Verapamil 0.5 mg/kg.
I.Vbolus there was no renal hemodynamic or functi-
onal changes.In the thrid group pretreatment with
Verapamil prior to 60 mm isehemia caused a definit
protection againest tubular cell necrosis (abscent
increase in the urinary enzymes) .Beside there was
marked blunting of t.he expected decrease in the
RBF,GFR and UV.
This study showed that Verapamil can protect aga-
inst the ATN and ameliorate the expected increase in
the intrarenal vascular resistance following the 60
mm. renal ischaemia.
• FOLLOW UP STErID uSAGE IN RPPIDLY PFXRESS1VE
.
CRESCENTIC GIAYERUIflNEPHRITIS (RPCt2) SU(XESSFUILY
TREATED WITH PULSE MT1TIY1PREDNIS0IDNE (PMP) OR
PlASMA RE{ANGE (PX)
M.E. Stevens, J.M.Bone. Renal Unit Royal Liverpool
Hospital, U.K.
The poor imsethate prognosis usually associated
with RPCXE' may be halted or reversed by early
aggressive therapy with PMP or PX but the long term
outcone is uncertain.
Of 26 patients with RPE treated with V1P or PX
19 made a prctnpt initial response. Patients with
lupus nephritis, post streptococcal disease,
malignant hypertension and Goodpastures syndrcme
were not included in the study of follow up steroid
dosage. All patients were maintained on reducing
dosage Prednisolone (initially at 3Qrg/day) and
Azathioprine or Cyclophosphainide 2-3 ng/ kg/day.
Five patients showed progressive loss of renal
function within one year of starting treatment. In
4 of these patients, the dosage of Prednisolone had
been reduced to 20ng/day or less after 4 weeks. By
contrast, in 10 others for whctn data was available
Prednisolone was continued at a daily dosage of 30
mg/day for 6—8 weeks after PMP or PX and renal
function rnained stable or continued to improve.In
these stable patients the rate at which the dosage
of Prednisolone was reduced thereafter was lower
than in patients whose renal function deteriorate.
At one year he cumulative steroid dosage was 4.4—
1.1 and 2.8 — l.2g in the stable and relapsing
groups of patients respectively (Students t=2,68
p 0.02). Steroid side effects were infrequent and
not severe in both groups.
These data suggest that the follow up dosage of
Prednisolone may be critical in the first few
flDnths after starting PMP or PX.
• CIMETIDINE THE H2-RECEPTOR BLOCKER, EFFECT ON THE
RENAL AUTOREGULA1ION IN DOGS.
• Mohamed A. Sobh (M.D.), G.E. Plante (M.D.),
Urology & Nephrology Center, Mansoura University,
Mansoura, Egypt, and C.H.U. De Sherbrooke, Canada.
Histasin (H1, H2) receptors were reported to be
present in the kidney. Some cases of Acute Renal
Failure were reported to occur following Cimeti-
dine therapy. This work was designed to test for
the effect of Cimetidine infusion on the renal
hemodyriamics and its autorequlation.
Two groups of female mongrel dogs were
examined. Each dog was anaesthetized with nesibu—
tal and its respiration was controlled autom—
tically. Through a femoral vein catheter saline
containing the markers PAH and Inulin was pumped
3 ml/min. Through a fenioral artery catheter the
blood pressure was recorded. Through ureteric
catheters the urine was collected. A nylon tape
put around the aorta above the origin of the
renal arteries was used to decrease the mean
Renal Perfusion Pressure (RPP) from 100 to 85 to
75 mm Hg. The following parameters were measured,
RBF, GFR, UV, UNaV, Upo4V and FENS.
In the first group (control) the autoregula-
tion was found to be intact as the RBF and GFR
were kept constant in the face of a decreasing
RPP. In the second group Cimetidine infusion
1OM/niin caused 11% reduction in the RBF. Reduc-
tion of the RPP to 75 rinn Hg caused a significant
decrease in the RBF by 30% and the UV by 50%,
the GFR was stable.
This work demonstrates the depressive effect
of Cireetidine on the total RSF and its auto-
regulation.
L J;UNO8EGULATOPY ThEAD RUT /It, IN
ADULT NEPIffiOTIC 3Y3DRJJE INS!L.a1ay, E.Dulka, E,Magyarossy ,K . Szepesházy,
L.Kopper, Z.Negy. /Introduced by I.Taraba/
II.Dept.of Hed.nd .Dept.of Ptho1.
emme1vreis LIed.Univ. ,udepest, 2ungary
Results of 94 adult nephrotic patients with chr.
glonierulonephri tis /GN/ treoteci by immune regul-
atory drgs v!ere evalueted. atientm were group-
ed according to their renal histological findings
as follows 1.7 minimal chance /110 ri=13/j 2.1
minimal glomerler norrie1iT ,4GR n=lO/; 3.!
focal scierosing GE /iSGN n=0/; 4.! mesangial
proliferative C-IT /MPGN n20/; 5.! membre.no-
proliferative C-N /LICGN n=13/; membrenous C-N
/1.1011 n=30/. Treatment covered a 3—6 month p criod
containing prednisune and cptos+ tic dru;s:
0ncovinc±Pmuran÷yclophocphamide in the majority
of cases. Taking the amount of urinary proteine
excretion before El to one hundred percent,
mean proteinuria end PD cftr the end of
treatment are given in Table I
MC hOE ROGN NEC-N C-iCC-N C-IC-N
3+1 46÷15 114÷21 44+15 84+21 25±9Results show that a./ treat-cient of adult minimal
change $5 is also sccccessful,b./diiferentietion
of minimal glomeinlar abnormality from minimal
change seems to be reasonable according to the
expected percentage effectivity o± therapy,
c./hiotological diagnosis of memhranouo glomer—
ulopathy encountcr a high probability of effect-
iveness, d./a combination of cytostatic drom
seems to have a bettor result in the treatment
of NEC-N than some literary data, e./ protein—
uria in LEON or in NCGN wam rot influenced by
It in accordance to the literature.
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SEPTIC SHOCK AND ACUTE RENAL PAILURE:ANAIY
sIS OF FACTOR WHICH INFLUENCE THEIR EVOLU—
T ION.
,.M.Tabernero,J.A.Snchez Tomero,J.Martin,
J.?.Macias.
Serv.Nefrol.Hosp. Clinico • Salaxnarica. Spaine
Data concerning 64 patients with septic
shock and acute renal failure are analized
in order to elucidate the influence of di-
fferent factors, such as previously under-
lying arid associated diseases,localization
of the original septic focus,bacterial a—
genta,analytical data and therapeutic ma—
nagenient.
The mean overall mortality rate was
68,7% and reached 73% in patients over 65
years old.Multivariate statistical analy-
sis showed that some clinical conditions
such as oliguria(p<O, 02), cardiovascular
complications(p.<O,01) or high C.P.V.(pcD,03
were associated with a poor progriosis.The
prevalent agents responsible for septic
shock were gram(—) bacteria.The main loca-
lization was in urine.The survival rate
was higher in those patients with sepsis
originating in the urinary tract (pco,03).
The clinical outcome did not se'm to be
influenced significantly by the use of po—
livalent antibiotic therapy regarding the
classical combination of aininoglycoside
and B—Lactam antibiotics,as well as the
use of dopamine and steroids either alone
or in combination.Parenteral nutrition wit}
carbohydrates,lipids and aminoacids also
seemed to improve the suvival rate in the
elderly,even though the result were not
statistically significant.
HEMODYNAMIC AND IMMUNOLOGICAL FACTORS IN THE LATE
DEVELOPMENT OF HYPERTENSION IN HEYMANN NEPHRITIS
I. Tikkanen, A. Miettinen, T. TMrnroth,
F. Fyhrquist (Intr. by B. KuhlbBck)
Minerva Institute for Medical Research; Department
a-F Bacteriology and Irmiunology, University of
Helsinki; and IVth Department of Medicine, Helsinki
University Central Hospital, Helsinki, Finland.
Heynann nephritic (HN) rats under long-term
OOCA-NaC1 treatment develop hypertension with a
malignant course. In the present study, the effect
of a short-term 000A—NaCl load on the development
of hypertension in HN rats was studied.
HN rats were treated with DOCA-NaCl between
weeks 2 and 6 after the first irrrnunization with
brush border (RB) antigen. During that time, anti-
BB antibodies and iriniune deposits typical of mem-
branous nephropathy ensued, followed by protein-
uria. Hypertension developed in DOCA-NaCl treated
HN rats but not in rats with HN only, while DOCA-
NaCl load alone caused a moderate increase in
blood pressure (BP). After the cessation of DOCA-
NaC1 treatments, BP normalized.
Within one year, however, BP increased in HN
rats (135+2.3 rmiHg, mean-l-SEM, 119+1.3 in controls,
p<O.OOI) but even more in HN rats treated initially
with DOCA-NaC1 (147+4.7). At that time, hyperten-
sion correlated most clearly with glomeruloscler-
otic and tubulointerstitial changes.
The present study emphasizes the importance of
an interaction between herrtdynamic and inrnunologic-
al factors in the late developcent of hypertension
in HN rats. On the other hand, hemodynamic factors
may be increasingly involved in the long term
course c-F nephritie.
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FUNCTIONAL RENAL RESERVE MEASURED BY ANINOACID-
OR/AND DOPAMINE INFUSION.
P.M. ter Wee, J.B. Rosman, A.J.M. Donker.
University Hospital, Department of Nephrology,
Groningen, The Netherlands.
Both a meat meal and infusion of aminoacids in-
crease GFR in animals and in man. Another possibi-
lity to increase GFR is infusion of a low dose of
dopamine. In this study we have compared the ef-
fects of dopamine, without and with VaminR, on GFR,
ERPF and filtration fraction (FF).
Five groups of persons have been studied: heal-
thy volunteers (n8), healthy individuals after
uninephrectomy (n=9), renal patients with normal
GFR (n=l!), renal patients with moderately impaired
GFR (n9), and renal patients with severely impai-
red GFR (n7). GFR and ERPF were measured simulta-
neously with 1251—iothalamate and !311—hippurate,
respectively. Dosage of dopamine was 1.5—2.0 pg/kg!
mm for 2 h, dosage of VaminR 500 ml/6 h for 18 h.
Patients with impaired renal function revealed
a significantly lower FF. Dopamine increased GFR
especially in normals and in patients with normal
GFR. In all groups, FF fell (p40.0!). Infusion of
VaminR also resulted in an increase in GFR, which
was of comparable magnitude. FT however, tended to
increase (p(O.IO). The highest GFRs were measured
on the combination of VaminR and dopamine. Patients
with severely impaired renal function again did not
show any change. -It is concluded that the existence of functional
renal reserve can be determined by both dopamine
and infusion of an aminoacid solution. Dopamine
predominantly seems to act on the efferent, infu-
sion of VaminR on the afferent arteriole. Patients
with moderately to severely impaired renal function
already hyperfiltrate. In this situation neither
dopamine nor VaminR can induce a significant in-
crease in GFR.
FINE-NEEDLE ASPIRATICJ CY'IOIJJGY OF HEYMANN
NEPHRITIS
C. Gronhagen_Riska*, E.v.Willebrand**, I. Tikkanen*,
A.Miettinen*** & T.Tdrnroth* (Intr. by B.Kuhlbäck*)
Depts. of dicine*, Bacteriology and Ixrraviology***
and Thansplantation Laboratory**, University of
Helsinki, Helsinki, Finland.
No glomerular leukocyte response has been obser-
ved in Heymann neritis. On the other hand, little
is known about infiltrating leukocytes in the in-
terstitial reaction. This was studied by fine—need-
le aspiration of kidneys during different stages of
the disease. Rats (8+4 controls/group) were sacri-
ficed at 3 weeks (a) after intaunization and at 2(b) and 10 (c) weeks after a booster. IgG deposits
in GBM were observed in (a) and had increased, to-
gether with tubular deposits in (b) and (c).
Cells infiltrating renal tissue were determined
from fine-needle aspirate smears. Incrennt score(IS) indicates percentage of cells in kidney minus
percentage of peripheral blood white cells (Chin.
Intlalnol.InnTunopathol.17:309,198O). IS (mean+s.d.)
was high in inuainized rats, 4.8+2.5, compared with
controls, 2.9+1.2, P<0.01. Highest values were ob-
served in (b), 6/8 had IS >5.0. IS were also high
in (a) and greatest individual variations were seenin (c). IS increased from lymphocyte infiltration,
iinnunoperoxidase (IP) stains of smears indicated
predominant T-cell infiltration. Very high IS:s in
(b) and (c) were also associated with B-lynphoblast
infiltration. Subtypes will be further analyzed by
IP staining of frozen sections.
Results suggest T-cell dependent interstitial
inflanination in early and late stages of Heysann
nephritis. B-lyxnphOblast infiltration may suggest
local antibody production. Fine-needle aspirate
smears may prove a useful and simple way of eva-
luating Heyxnann nephritis.
HEP4OYNANIC EFFECT OF MAGNESII*i SLLFATE IN ECLPMSIA. M. Tolani,
A. Tondriaux, P. Fievet, P. Bataille, H. Dkhissi, A. Fournier.
Cl-U PMIENS, FRAl-CE.
We made a hernodynamic study with Swan Ganz catheter and ther
modilution technique before (T0) and 120 mm after T the I.V
injection of MgSO4 (priming dose of 4 g followed by 1 g at T90
mm) in 3 patients with eclampsia : patients (pt) 1 and 2 in
iianediate post—partum, with pulmonary oedema in pt 1 ; pt 3 at
her 27 th week with oliguria due an extracaptillary glomerulo_
nephritis. Results
MAP SVR CO SPP WP WB
Mean + SEM
d/s/cm5 1/mm nml-lg nm-lg ml
T0 133+6.80 1215+118 8.8+1.1 20+1.1 12+1 0
T1 105+3.7 1368÷127 6.4+0.7 15÷1 9÷1 30÷50
MAP : mean arterial pressure ; SVR : systematic vascular resis-
tance ; CO : cardiac output ; SPP : systolic pulmonary pressure
WP : wedge pressure ; WB : water balance.
In pt 1, a diuretic effect accured after 150 sin leading 6
hours later to a negative We, a greater decrease of Co and in
increase in SVR ; meanwhile pulmonary oedema cleared. In pt 2,
the diuretic effect occured only after tte 8 hours. In pt 3 no
increase in diuresis was observed until 500 sg of furosemide
was given.
Conclusions : 1/ In eclampsia with increased CO and normal SVR,
MgSO4 decreases BP by decreasing CO since there is no change in
SVR. 2/ The decrease in CO masks the systemic vasolating
effect. It is not due to a negative inotropic effect since ther
is no increase in WP. This implies a decrease in preload due
to increased venous compliance since no significant diuretic
effect observed during the first 150 mn. 3/ M9SO4. appears
to be a drug particulary suitable to treat eclampsia complica-
ted with pulmonary oedema since besides its anticonvulsive
properties, it lowers BP, increases venous compliance and may
increase diuresis.
acyl—carnitine. After 4 sos of suspension the muscle
carnitine values returned to the typical levels of
dialysed pts, that is below normal. In conclusion we
suggest ti-rat high doses of CAR in haemodialysed pts
(1—2 g/i.v.) can be administered for not excessively
prolonged periods (4—5 mos), and then they thi1d be recliced
In fact, we cannot exclude that some paradoxical i-'per.
triglyceridaemja reported in the literature after lcng-
term CAR treatment could be due to the high inmcle levels
of acyl-carnIthe that are shifted towards the sthesis
of triglycerides rather than towards oxidation.
CORONARY ARTERIAL DISEASE IN RABBITS WITH
CHRONIC RENAL FAILURE
E.Tvedegaard, E. Falk, M. Nielsen (Intr.
by J.H. Thaysen).
Medical Department P, Rigshospitalet,
Copenhagen, Denmark
Chronic renal failure(CRF) has been
proposed to accelerate the arteriosclero-
tic process. We have studied the coronary
arteries in rabbits after 9 months dura-
tion of surgically induced CRF. Compared
to controls the CRF rabbits had 5l—Cr—EDTA
clearance reduced to 25%, se—creatinine
was increased by 3oo%, se—Ca by 42%, se—P
by 56% and a moderate hyperlipidemia was
present.
Coronary arterial changes were found in
all of the CRF rabbits. In the intiina fo-
cal proliferations of smooth muscle cells
were seen without accumulation of calcium
or lipids. In the media both degenerative
and proliferative changes occurred and
calcium deposits were frequent. No eviden-
ce of increased lipid content was found.
Angiography and systematic histological
examination revealed no obstructions ex-
ceeding 5o% of the lumen. Similar morpho-
logical changes were found in other syste-
mic arteries.
In the non—cholesterol-fed rabbit CRF
thus induces proliferative changes of the
coronary arteries. The factor(s) initiat-
ing smooth muscle proliferation during
CRF remains to be identified.
COMPARISON OF DIHYDROTACHYSTEROL (DHT) AND DIHYDRO-
TACHYSTEROL COMBINED WITH 24,25 DIHYDROXYVITAMIN D
(2+,25 DHCC) THERAPY IN THE TREATMENT OF RENAL
OSTEODYSTROPHY IN CHILDRE.
R. van Diemen-Steenvoorde , R.A.M.G. Donckerwolcke
.
Bosch, W.J. Visser, J.A. Rayrnakers, S.A. Duursma.
Department of Paediatrics and Research Group for
bone metabolism, University of Utrecht, Utrecht,
the Netherlands.
9 Patients, aged 5 to 15 years undergoing
chronic haemodialysis were treated subsequently witl
DHT and DHT combined with 2+,25 DHCC. Biochemical
parameters (serum calcium, phosphate, alkaline and
acid phosphatase, iPTH, vitamin D metabolites
levels), radiological findings (skeletal X—ray
changes, measurements of bone mineral content (BMC)
by dual photon absorptiometry of lumbar spine,
femoral neck and femoral shaft) and quantitative
bone histomorphometry were used to evaluate treat-
ment results.
During treatment with 2,25 DHCC (25 pg/day) a
significant decrease in serum DHT2 levels was do-
cumented, no alterations of serum iPTH were noticed
and raised 2k,25 DHCC values were found. A moderate
increase in bone density at the metaphysis was
shown on X—rays of the wrist, an increase of BMC
was found in the lumbar spine and the femoral neck
and a decrease of osteoclastic surfaces on repeated
bone biopsies was found following 2,25 DHCC treat-
men t.
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SERUM AND MUSCLE CARNITIT4E IN HAEMODIALYSED
PATIENTS AFTER TREATMENT (18 MONTHS) AND AFTER
SUSPENSION (4 MONTHS) OF L—CARNITINE
G.M. Vacha, G. Giorcelli, M. Corsi, S. D'Iddio
Divisione di Nefrologia e Dialisi, Ospedale Mauri—
ziano Umberto I, Torino, Italy
Four haemodialysed patients (pta) (mean age 61+7
years; mean dialytic age: 28±4 months (sos) treated
for at least 18 mos with L—carnitine (CAR) (2 g/i.v.
at the end of each dialysis) have been selected. A
first muscle biopsy was performed simultaneously wi
suspension of CAR treatment and a second biopsy aften
4 mos. Blood samples (pre— and post—dialysis) were
taken once a week during the 4 sos of suspension.
The results of blood analysis showed that ser'un CAF
was about 10 times higher with respect to the normal
values (463+235 pM/i versus 45±6 pM/i) at the moment
of CAR interruption. During the suspension, a adual
reduction in the values was observed and normality was
reached after 14 weeks. Treatment with CAR induced
"super normal" values in all carnitjne fractia inthe
muscle and particularly an important increase in the
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NEPHDPATHIA EPIDfl'IICA IS ENDEMIC IN WESTERN
EUIOPE. C. van Ypersele de Strihou, J.M.
Vandenbroucke, G. van der Groen, J. De Sniyter,
University of Louvain Medical School, Brussels,
Institute of Tropical Medicine, ntwerp,University of Leuven Medical School, Rega
Institute, Leuven.
The newly isolated Hantaan virus (HV) causes
Korean henorrhagic fever and nephropathia epide—
mica (NE). These diseases were thought to be
confined to the Far East and to Northern and
Eastern Europe. The availability of adequate
serological techniques for the determination of
anti-NV antibodies has alloced us to diagnose HV
related renal disease (HVRRD) in Western Europe.
We diagnosed 3 cases of HVRRD in personnel
working in a research laboratory. Further investi
gation of asyxnptonatic personnel working in this
and in other laboratories of the sane cair?us led
to the discovery of a high prevalence of elevated
anti-NV antibodies. The infection was traced to a
colony of laboratory rats.
Subsequently, we have observed five riore cases of
HVRPD in subjects unrelated to the University
canpus. The NV was identified in small wild
rodents, Clethrioncmys glareolus. More recently
we have confirned the extension of the disease in
northern (Laon and Lille) and eastern (Besançon)
France. A similar case has been reported in the
neighbourhood of Paris. The syirptonatology and
the spontaneous resolution of renal failure are
typical of NE.
Our data denonstrate that HVRRD is endemic in
Western Europe and should be considered in
unexplained acute renal failure preceded by highfever and acute lumbar pain. In addition they
suggest that laboratory rats should be screened
for the NV.
WEGENER'S GRANULOMATOSIS: 3 PATIENTS TREA-
TED WITH CYTOTOXIC AGENTS AND MEMBRANE PP
P. Zabel, G. E. Leimenstoll, H.-U. Gutsche
G.-J. Meyer, W. Niedermayer
Department of Nephrology, University of
Kiel, Kiel, West-Germany
Humoral immune mechanism play a major
role in the pathogenesis of Wegener's Gra
nulomatosis (WG). Thus, treatment of this
disease with PP appears to be effective.
3 patients with acute WG were treated witi
membrane PP in addition to conventional
therapy (cyclophosphamide and methylpred-
nisolone). The clinical course and the
immunological status were studied (immune
complexes, iinmunoglobuline and complement
factors).
All patients had pulmonary effusions and
infiltrations and were anuric. A complete
remission of the pulmonary involvement was
achieved within a few days of treatment,
however the renal function improved only
in 1 patient. 2 patients developed ERF.
With PP therapy several factors of the
complement cascade were found diminished,
immune complexes disappeared completely.
The clinical improvement was well corre-
lated with the immediate PP therapy as
soon as histological diagnosis was con-
firmed.
ALTERATION OF THE COURSE OF CHRONIC RENAL FAILURE
.
(CRF) BY DIETARY PROTEIN RESTRICTION (PR)
A.J. Williams, S.E. Bennett, G.I. Russell,
J. Walls, Area Renal Unit, Leicester General
Hospital, Leicester. U.K.
Dietary PR in CRF will alleviate uraemic
symptoms and has been shown to effect the
progression of renal failure although the mechan—
ism and indicators for PR remain undetermined.
Over a 6 yr period 47 pts (18 F, 29 N) with
various renal diseases were given a diet contain-
ing 0.6Gm/Kg protein SW and approx. 20 mMol
phosphorous per day. Renal function and dietetic
adherence (urea: creatinine (U/C) ratio) was
monitored regularly. The mean age of pts was
44.5+2.1 yrs (range 17-69) and the mean period of
observation was 17.4+2.24 mons. (range 3-62). Mean
serum creatinine was 780.3+37.8 uMol/L (range
399-1570) at atart of PR and the progression of
renal function was determined by the slope of the
reciprocal creatinine plot.
A significant change (p <0.001) in the
reciprocal creatinine slope was seen in 41 pts
(83%) together with a decrease in U/C ratio
0.047+0.002 to 0.039+0.002 (p<O.OO1). Six
patients failed to show any improvement. There
was no difference in BP or serum phosphate pre or
post diet. No evidence of malnutrition as
evidenced by changes in albumin, transferrin or
body weight occurred. No correlation was found
between age, sex, aetiology or initial S.
creatinine and the change in the reciprocal
creatinine slope.
Dietary PR appears a safe method of slowing the
progress of renal function in the majority of pts
with CRF. There appear to be no simple predictors
of response or non-response or at what stage such
dietary manipulation should be introduced.
EFFECTS OF DIETARY PROTEIN RESTRICTION ON
THE COURSE OF EARLY RENAL FAILURE
G. Zekar (Intr. by I. Taraba)
B.A.Z. County Hospital, 1st Medical Dept.
Miskoic, Hungary
TWO groups of patients With histo-
logically proved glomerulonephritis (GN)
and CRF were studied. Group 1 comprised
28 patients With Sfl endogenous creatinine
clearance (Ckr) of 66 ml/min,daily protein
excretion (DPE) of 1.7 g. These patients
were kept 8 to 18 months on a diet contain-
ing about 40 kcal/kg and 1 g/kg of protein.
Phosphorous and calcium intake were not
limited. Group 2 had 32 patients with a
mean Ckr of 60 ml/min and DPE of 1.8 g.
They had followed no specific dietary
regimen for 6 to 14 months. Their dietary
calorie and protein intakes averaged 30
kcal/kg and 70 g, respectively. At the
end of the observation period Ckr values
of group 1 averaged 74 mi/mm, the DPE
amounted 1.1 g. Values for group 2
averaged 53 ml/min and 1.9 g respectively.
Moderate dietary restriction of protein
alone results in improving Ckr values and
a decreased protein excretion in early
stages of CRF in patients with GN.
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ALDOSTRONE—RENIN AXIS IS CERTAIN RENAL DISORDERS
IN RELATION TO HYPERTENSI('4.
M.A.ZANATY, M.O.EL-h'AlEG, M.L. SHAHWAN, A.MUSTAFA,
M .BAVR;
FacaUj o MedLcne, ZtgazLg. Egypt.
This work was designed to Study renin angio-
tensin—aldosterone system, in certain renal dis-
orders namely chronic renal failure(C.R.F)
and nephrotic syndrome (N.S.)and essential hyper-
tension to find out any derangement that may ass-
ociate these disorders. The study included 61
subjects classified as, 23 C.R.F. 13 N.S., 12
essential hyperension patients and 13 normal
subjects as a control. estimation of plasma renin
activity (P.R.A.) and serum aldosteron, with B.U.
C.C. and S. Na. and S.K. level, P.R.A. & aldost—
erone and serum K. levels were found to be sig—
nificantly$ in C.R.c. with / normal serum Na. In
N.S. group showed significant I in P.R.A. and ald-
osterone with significant in S. Na and normal K
level. In the group of essential hypertension,only
serum aldosterone level was sinificantly incre-
ased. In C.R.F. it seems that low S.Na. may
lead to excessive renin secretion together with
hyperkalemia which enhance aldosterone secreation.
Also renin secretion may be autonomous or due to
failure of sympathatic control mechanism. In N.S.
group hypereninemia and hyponatremia stimulate
aldosterone secretion secondry to hypovolemia. In
essential hypertention group the hyperaldoste—
ronemia may be attributed to increased sensitivi-
ty of superarenal Cortex to minimal changes in
renin—angiotension system as well as decreased
clearance of aldosterone.
DECREASED VIABILITY OP FETAL RAT
REPATOCYTES IN HtJMA.N UREMIC SERUM
K. Zoellner, C. Hel].mann, U. Otting,
C. Noack, J. Gross
University Children's Hospital,
Berlin, German Democratic Republic
Petal rat hepatocytes (h.) were used
as experimental model to study the in-
fluence of uremia toxins on liver meta-.
bolism during development. H. were pre-
pared by W. HUHN a.o. (Biol. Neonate
44, 153—57, 1983). The influence of ure—
mb serum on the Ii. was studied using
the trypan—blue exclusion method (t.e.
m.) and the LDH—release (LDH—r.).
Results: 1) Viability rates of 85 %(t.e.m.) and of 67 % (LDH—r.) were found
2 hours after preparation of the h.
2) The viability of h. was decreased
by the addition of serum of healthy
persons by using the t.e.m. (pc 0,05),
but not by LDH—r., in according to PBS.
3) In comparison to PBS as well as to
normal' serum the uremia serum strongly
decreased the viability of h. in the
t.e.m. and the LDH—r. (e.g. viability
after 30 mm incubation, measured by
t.e.m.: normal serum 85 %, uremia serum
62 %, p<O,01).
Conclusions: Fetal rat hepatocytes seem
to be a useful experimental model to
study the influence 'of uremic serum
on liver cells during development. The
viability of h. is clearly decreased
by uremic serum.
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RERPPR?JSAL OF THE DIAGNOSTIC CRITERIA OF PRIMPRY
AUJOSTENISM (PA)
Abdelhamid,S. ,Vecsei* ,P. ,Fiegel,P. ,Walb,D. ,christl,
H.L. ,Gottschalk,F. (Intr. by D.Walb)
Deutsche Klinflc für DiagIx)stik Wiesbaden, *ph_
kologisches Institut UniversitEt Heideiberg, GFR
Norirokalemia, normaly reactive plasma-renin are
coniron and urinary-aldosterone-18-glucurcnide (Ald-
1 8-Gluc) are frequently found to be normal in PA.
Stimulation-and suppressiontests (renin ,aldoster-
one) are major procedures for screening purposes in
hypertensive population. Hence the diagnostic value
of urinary free-aldosterone (f-Aid), tetrahydro-
aldosterone (Th-P,id) as well as 18-OH-corticoste-
rone (1 8-OH-B) in plasma and urine were studied in:
30 patients with PA (16 adenomas, 14 hyperplasia)
and in 274 patients with essential hypertension.
The steroids were estimated using RIA after ex-
traction and chromatography. Discrimination analy-
sis was used as statistical nethod for interpreta-
tion of the results. TH-Ald exihibited the best
discriminating paraneter followed by 18-OH-B and
f-Aid and Ald-18-Gluc. In 6 cases with PA the ele-
vation of 18-OH-B preceded that of aldosterone.
lb distinguish adenona from hyperplasia urinary
steroids did not show clear cut difference between
the groups. Plasma-i 8-OH-B revealed to be the best
paramater but there was an overlap of the values
in few cases. In corrparison to adrenal venography
and adrenal venous sairpling for aldosterone (nost
precise method) computer trography (CT) proovedto be reliable in localizing tunors.
Conclusion: lepeated urinary studies of Th-Ald
and 18-OH-B revealed to be most reliable in scree-
fling and diagnosing PA. This simplifies office
screening for PA. 18-OH-B can be an early marker of
PA and is of significant value in diagnosing adeno-
mas.
N-ACETYL-BETA-D-GLIJCOSAMINIDASE IN THE DIAGNOSIS
OF REJECTION
J. Arnfred, E. Morterisen & H. E. Hansen
Medical Department C and Department of Clinical
Chemistry, Aarhus Kommunehospital, Aarhus,Denmark
Measurement of N—acetyl-beta—D—glucosaminidase
(NAG) in urine has been proposed as a simple test
to indicate rejection in renal transplants.
NAG excretion in urine was measured daily in
24 consecutive recipients of cadaveric renal
transplants for 21-79 (mean 40) days after trans-
plantation. 13 patients had azathioprine and
prednisone treatment 9 were treated with ciclo-
sporine A and low—dose prednisone.
After separation on a G 25 sephadex column
NAG in urine was measured by photometry at 405 nm.
Ciclosporine A in blood was measured by a radio—
immunoassay.
In the 24 patients 12 rejection episodes were
observed, 5 occured during the oliguric period,
the patients still being on dialysis treatment,
7 took place after cessation of graftoliguria.
Regression analysis demonstrated a low diagno-
stic sensitivity (58%) and a low diagnostic speci-
ficity (37%) of increases in NAG excretion as an
indicator of rejection. In 8 of 16 patients
studied, intravenous urography was followed by a
significant increase in NAG excretion.
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SOMATOSENSORY EVOKED POTENTIALS (SSEPs) IN UREMIA
A. Albertazzi, B.D1 Paolo, P. CappellI, L.Varanese,
E. Di Stefano*.
Nephrology & Neurology* Depts; University of Chieti
Italy
Abnormalities of conduction velocities have been
described in uremics through the evaluation of pro—
pagational properties of an afferent input along
the related central sensory pathways.
In 26 pta (8 on RDT) we determined SSEPs by the
elicitation of sensory—motor velocities of median,
peroneal and sural nerves and simultaneously peak
latencies and interpeak times.
Lower limb peripheral conduction was more
frequently abnormal than that of upper limb, the
distal segment being involved to a greater degree.
Since central propagation was more impaired during
lower (11 out 27 cases) that during upper limb (1
out 27 pta) stimulation and the intracranial
propagation time was occasionally prolonged, we
could hypothesize a defective impulse conduction
predominantly at the spinal level.
Our neurophysiological data seems to confirm a
defective neural conduction in uremia in agreement
with central—peripheral distal axonopathy (a reva-
luation of dying back neuropathy). An abnormal
impulse propagation was also rarely found in
proximal districts of peripheral fibres as well as
along the intracranial sensory pathways.
SSEPs represent a powerful new tool to quantify
the existence of uremic neurological lesions.
IMMUNFIXATION OF URINE PROTEINS
K.Bauer, J.Zazkornik and P.Schmidt
+ .Institute for Clinical Chemistry and La-
boratory Medicine, University of Vienna,
Au s tr i a
First Medical University Clinical Vienna,
Austria
Differentiation of proteinuria in gb—
merular and tubular types is of consider-
able interest for clinical nephrobogy.
Quantitation of 62—microglobulin is one
approach to this problem, being impaired
by extreme unstability of this protein at
acid pH.
Immunofixation in agarose gels is a sen-
sitive and reliable tool for qualitative
identification of proteins in various body
fluids; with carefully standardized tech-
nique semiquantitative estimations are al-
so possible with limitations. Antibodies
against serum—albumin, transferrin and
immunogiobul ins (heavy—chin—specific)pre—
cipitate with serum proteins of different
molecular weight as markers of glomerular
damage, whereas antibodies against a— and
137—microgbobul in and "urine—microglobul ins"
iaentify typical markers of tubular damage
Typical example are demonstrated, in-
cluding variation of the patterns during
time course after renal transplantation.
By means of this method, valuable additio-
nal information is available concerning
source of proteinuria in unclear cases.
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IS THE NONINVASIVE MEASUREMENT OF RENAL
CLEARANCE OF LOW MOLECULAR WEIGHT PROTEINS
POSSIBLE? PRELIMINARY RESULTS IN MAN
C.Bianchi,C.Donadio,G.Tramonti,P.Lorusso,
R. Guzzardi
Cattedra di Nefrologia Medica,Clinica Me—
dica2 ,Fisioiogia Clinica C .N.R,University
of Pisa,Pisa,Italy
Many low molecular weight proteins (cal-
citonin,insuiin,lysozyTne,etc.) are removed
from the blood by the kidney where they
are accumulated.The measurement of renal
clearance of such molecules necessitates
renal vein catheterization.We are now ap-
plying a new noninvasive method for the
measurement of the renal ci of Aprotinin
(Ap) ,a small protein m.w.6500,labelled
with Tc99m.Ap-Tc99m is largely and stably
accumulated in the kidney with minimal uri-
nary excretion.Renal ci of Ap (and of other
small proteins with similar renal handling)
can be determined during continucis venous
infusion of Ap—Tc99in as:
=t2 P(t)dt
where:K is the increase of the radioacti'-
vity over each kidney measured by external
counting and corrected for tissue attenua—
tion,and P is the plasma concentration of
Ap-Tc99m.We have studied 6 subjects with
normal renal function and 1 patient with
renal failure.In normal subjects renal ci
of Ap-Tc99rn was about 40% of the GFR.In the
patient with renal failure renal ci of Ap-
Tc99m and GFR were similar.This method
could give noninvasiveiy the unilateral
renal ci of low molecular weight proteins
handled by the kidney.
EVALUATION OF THE SEVERITY OF UREMIA BY A
SIMPLE CHROMATOGRAPHIC PROCEDURE.
N. Cerulli, L.Politi, A.D'Angelo, A.Stra
niero, R. Scandurra.
Surgical Nephrology and Institute of Bio
chemistry University of Rome, Italy.
In uremia increasing amounts of compo
unds, not excreted by the kidney are sto
red in the blood. The unique way to eva=
luate the severity of uremia is to measu
re the blood concentration and the clea=
rance of urea and creatinine. Very recen
tly we have developed a simple chromato=
graphic method on a Biogel P2 column (1.6
x83cm) eluted with 50mM NH4HCO3 pH8 (30m1
/hr) and monitored at 254nm, which has a
high degree of reproducibility and can be
used to evaluate the severity of uremia.
As a matter of fact the elution profile
of 2ml of deproteinezed serum from a nor=
mal subject is quite flat whereas that of
O,25ml of urine is composed by many peaks
with a well definited height. In the eiu=
tion profile of a uremic serum the peaks
height increases, increasing the severity
of uremia, whereas in the elution profile
of urine, the peaks height progressively
decreases. This simple procedure permits
a wider evaluation of uremia and is then
proposed in addition to the one offered
by the serum analyses.
• THE BONE SCAN (Bs) IN PATIENTS WITH ALUMI—
NIIJM ASSOCIATED BONE DISEASE (AABD).
J.Botella.,JL.Gallego.,J.Fernandez.,D.sanz-
Guajardo.,A de Miguel.,J.Ramos.,P.Lorenz.,
R.Enriquez. ,C.Sanz—Moreno.—Univ.Autonoma.,
Clinica Puerta de Hierro.,Madrid. ,Spain.
The interpretation of the BS in patients
under RDT is still unclear. We have analy-.
zed the BS of 6o patients and isolated a
group of 39 with a BS pattern of (i) absent
or diminished tracer deposit in bone and
(2) increased soft—tissue deposit.
A comparation of the data of these pati-
ents with thpse of the other 21 yields: Hi-
gher serum Al (88.63 vs 39.58
pg/l, p(O.OOl), lower serum PTH (4.72 4.3.O(
vs 15.09 ng/ml, p.(O.OOl), longer ti-
me in RDT (149.33 436.07 vs 30.24
months, p<O.05), and more clinical and ra-
diological signs of osteomalacia.
Desferrioxamina therapy (1 g at each di-
alysis session) was given to 32 of these
39 patients. After 6 months the described
BS pattern persisted in only 11 patients
(p<O.Ol, serum Al had fIlerto 3.01 4
16.30 (p<ojooi) and PPM rose to 6.28
(p(o.o5). There was also a marked clinical
and radiological improvement of osteomala—
cia. The non—treated group showed no signi-
ficant clinical, analytical, radiological
nor BS changes.
e conclude that the BS pattern descri-
bed corresponds to AABD and reverts with
DF'O therapy and the lowering of the serum
Aluminium.
REPLACEMENT OF RENAL VEIN RENIN SAMPLING (RVRS )WLTH
RENAL SCINTIGRAPI-W (PS) IN THE CHOISE OF TREATMENT
FOR RENOVASCULAR HYPERTENSION (RVH).
C.Chiarini,E.Degli Esposti,M.Dondi,N.Monetti,A.San—
toro ,A. Sturani ,A. Zuccalà,P . Zucchelli.
Dept.of Nephrolor, Malpighi Hospital ,Bologna, Italy
RVH represents a prognostic problem since the majority of the tests used to detect it are unrelia —
ble and unconfortable. We report our results of a
very simple test, PS, as a prognostic test in compa
rison with RVRS. For PS the operative criteria were
the renal hypoperfusion index, the functional per —
cent contribution of each kidney and pathological
visual data. For RVRS the criteria was the lateralj
zation of renin secretion. 30 patients were operat-
ed before 1981 on the basis of RVRS. 93% of the pa-
tients benefitted from surgery: PS was positive in
89% and RVRS in 85% of the patients. After 1981, 32
patients were operated on the basis of PS and RVRS
was not performed. 96% of the patients beriefitted
from surgery and PS was positive in 91% of pati —
ents. Moreover PS was very useful in the follow—up
of operated patients showing the pattern of renal
perfusion.
In conclusion, we propose to substitute RVRS,
which is an unconfortable and complicated test,with
PS, which is a simple and comfortable test.
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PARATHYROID SCINTIGRAPHY WITH A DOUBLE TRACER
TECHNIQUE IN THE FOLLOW—UP OF HYPERPARATI4YROIDISM
IN UREMIC PATIENTS UNDERGOING HEMODIALYSIS.
M.De Luca,N .Borsato° ,F .Susanna,P.Calzavara,G.Ferlin
C.Cascone.
Renal Unit,Nuclear Medicine Service°,General Hospi—
tal,Castelfranco Veneto,Italy.
In order to confirm the sensibility of parathy—
roid scintigraphy with a double—tracer technique,
since surgery is obviously less frequent in secon-
dary than in primary hyperparathyroidism,the.same
physician applied it twice in 15-18 months in 14
patients,8 males .and 6 feniales,aged 19—61 years,on
dialysis since 2-12 years.Five patients were on
treatment with Vit.D. The findings were always re-
ferred to serum Ca,P,Alkaline Phosphatase,PTH and
x-ray film of bone.The second time we performed
also ultrasonography of the neck with a 7.5 MHz
transducer.
In 7 cases the scintigraphic patterns were super—.
imposed and also the other parameters.In 6 patients
we found new enlarged parathyroid glands but not
significant changes of laboratory and skeletal fin—
dings(that could be reveal,if confirmed by surgery,
the capacity of scintigraphy to detect the hyper—
function of glands before time to clinical and labo
ratory setting).In one case, treated with Vit.D,
we documented a reduction of enlarged glands (from
3 to 1)and contemporary decrease of serum PTH and
improvement of skeletal x—ray pattern.
The scintigraphic and ultrasound findings agreed in
7 cases.In 6 cases only scintigraphy was positive,
in one only ultrasonography.
In 3 patients submitted to parathyroidectonly loca-
tion of glands was in agreement with scintigraphic
patterns.
Therefore this techniquemay be useful not only for
a better approach to surgery,but also in the follow
up of the uremic osteodistrophy.
C-REACTIVE PROTEIN(CRP)AS INFECTION MAR-
KER IN CHRONIC PENAL FAILURE
K.Dalhoff,J.Otte,E.Schulz,K.Sack
Med. Hochschule,Luebeck , FRG
Early recognition of serious infection
in oat.with chronic renal failure remains
a major diagnostic mroblem.We studied the
usefulness of csuantitatively measured CRP
as infection marker in this grour' of pat.
In 40 nat.undergoina chronic haemodia-
lvsis basic analysis of CRP(laserneohelo-
metrv) ,ESR,WBC and e'nhoremis were perfor-
med.CPP-controls were made in cases of
clinically susnected infection and in the
early ohase after renal transolantatlon.
Whereas the ESP was markedly elevated
in all pat.,CRP in basic analysis was
slightly increased in 2O/40(6—3Omg/l)and
considerably increased in 8/40(>3Onig/l),
the latter resulting from concomittant
diseases with notably elevated CRP as ost—
eomvelitis,chronic liver disease,M.Bechte-
rew etc.There was no correlation to the
creatinine levels as narameter for dialv—
tic effectivity.Controls always showed
significantly increasing CRP-levels in sy-
stemic bacterial infection(n=6) ,whereas
no increase was seen in local bacterial
and in viral infection(n=1O),including
icase of CMV-nneumonia.CRP was elevated
too in rejection episodes following renal
transplantation (n=6).
CRP,indenendent of dialysis or uremia,
oroved to be useful as infection marker
in chronic renal failure.Nevertheless,one
must be aware of individual basic levels
for correct interoretation of elevated le-
vels in case of acute illness.
YOCARDIAL STUDIES IN HEMODIALYSIS (ND) PATIENTS.
R.Dudczak, iC.Derfier, K.Kletter, }I.Frischauf,
L.Marosi, P.Schmidt, J.Zazgornik
I.Med.Univ.Klinik, Vienna, Austria
Myocardial perfusion with Ti 201 after dipyrida—
mol was evaluated in 33 patients on RD treatment
(: age: 52 yr, ND: 33yr).In addition radionuclide—
angiography was done at rest in 31 patients and re-
peated in 13 after isometric exercise. All patients
studied showed no signs of congestive heart failure
53% of the patients had abnormal Tl 201 scinti—
grams, whereas coronary artery disease (CAD) was
underestimated from clinical symptoms alone (33%).
The incidence of an abnormal TI 201 finding in-
creased with the duration of ND treatment. However,
in the symptomatic patients angina appeared already
in the first or second year of HD therapy. 39% of
patients with abnormal Ti 201 findings died within
a year following the scintigraphic examination.
From 15 patients with normal Tl 201 scans 26% died.
Mortality rate was above that as reported in
asymptomatic or mildly symptomatic patients with
CAD, averaging 7.7%/year. The main cause of death
were cardiovascular complications in patients with
abnormal Ti 201 findings. Left ventricular ejection
fraction (LVEF) was within the normal range in all
patients. Thus in our patients LVEF appeared not as
an important prognostic characteristic. However,
left ventricular function can be impaired following
exercise. After exercise LVEF decreased in patients
with normal as well with abnormal Ti 201 findings,
more pronounced in the latter. Thus, uremic
compounds may contribute, besides CAD, to altera-
tions in ventricular performance, possibly detori—
ating the influences of ischemia on the myocardium.
Thus, nuclear medicine procedures, may add to
the diagnostic performance, which may have
prognostic_implications.
PROSPECTIVE PROTOCOL FOR URETEROPELVIC
JUNCTION OBSTRUCTION IN CHILDREN
N. Hall, A. Piepsz, F. Collier, F. Janssen,
N. Perlmutter (Intr. by P. Vereerstraeten)
Free University of Brussels, Belgium
A retrospective study, concerning 40 chil-
dren with ureteropelvic junction stenosis was
done to analyse the influence of the renal
function criteria on the therapeutic decision.
Renal function was measured with the isotopic
separate glomerular filtration rate of the
99 m Tc—DTPA complex using a scintillation
camera and the integration of data by a mini-
computer as described in previous papers.
Comparison of radiological data and SGFR shows
that parenchymal thickness and caliceal dila-
tation are not good criteria to appreciate the
renal function.
Our prospective attitude (specially for ante—
natal diagnosis of hydronephrosis)is now
based on individual evaluation including
— the symptomatology — the ultrasonic findings
— the separate glomerul filtration rate and
the drainage function by means of the total
transit time and furosemide test before and
after micturation.
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ASYMP'IOWiTIC REJ)TPION PFrER RAL TRANSPLANTATIC1'
IN CICIOSPOPJNE TREATED AND ANURIC RB2IPIENTS.
DIAOSTIC IMPORI'ANCE OF FINE NEEDlE ASPIRATION
BIOPSY (flB).J. }yer, D. Sellin
Transplant Unit, dical University LUbeck (F1).
39 consecutive recipients of a cadaveric kidney
received ciclosporine and low dose steroids. In
24 patients (62 %) anuria (nEan period 11.3 days)
occurred after transplantation. Clinical observa-
tion as veil as blood and urine analysis vere per-
forced as normally. In particular ultrasound (US)
and FNAB vere done in 4 - 5 days intervals. None
of the 24 patients shod clinical syltptorns of
acute rejection (AR) during anuria. Changing in
US-findings was moderate in one case only. ENAB
alone was able to reveal diagnosis of AR in 3
patients. In 2 cases antirejection therapy was em-ployed successfully. One graft, hovever, was lost
because of a falsely *interpretation of FNAB. Using
conventional inminosuppression diagnosis af AR in
anuric patients generally was supported by the
classic syisptoms of fever, local discomfort, and
veakness. Svelling of the organ additionally was
documented by US. Ciclosporine seems to prevent
very effectively AR but seems to prevent equally
the appearance of the classic rejection sysptorna—
thology including US-f indings, at least in our
experience. When avoiding the more precarious true
cut biopsy, ve believe FNAB to be a most isportant
method to prove diagnosis af AR in the anuric
patient.
* negative
VOLUME EXPANSION IN UREMIA : A TEST FOR DETECTION 01
UREMIC MYOCARDIOPA THY AND AN INDICATION FOR THERA-
PEUTIC MANAGEMENT.
R. Schmitt, D. Schohn, P. Olier, H. Jahn
Service de Néphrologie, CHU de Strasbourg, France.
If it is of interest to study the possible caus
involved in .uremic myocardiopathy, it is also of
great interest for the clinician to can evaluate t1
cardiac function in uremic patients, which may be
helpful for the therapeutic management.
In this order we use a simple and reliable test:
a volume expansion (EXP) by means of 1 liter saline
0.9% infused in 1 hour. Before the infusion a right
heart macrocatheterization is done and is maintainei
till the end of the EXP. Following hemodynamic para-
meters are monitored : arterial pressure, heart ra-
te, right atrial pressure (RAP), pulmonary wedge
pressure (PWP), cardiac output and stroke index (SI)
We establish the cardiac function curves by plot turf
the SI against the Th values at the start and at
the end of the EXP. These curves and the calculated
ratioSI/,PWP ( end diastolic compliance) allow
to appreciate the patient's cardiac function :1) Ma-
re steeper the curve, more higher the SI/4PWP, mo
better the patient tolerates the EXP and it is possi
ble to treat him by administration of NaCl. 2)More
flattened the- curve, more lower is SI/oPWP, which
means a decreased compliance and a possible impair-
ment of the myocardium. But it is also important to
evaluate at what part of the function curve one is
situated at the beginning of the EXP. With a low mi
tial SI and a low SI/PWp there is a definite myo-
cardial impairment. If the initial SI is high one
can imply a high cardiac output state and it is not
possible to decide if there is a functionnal distur-
bance (upper limit of the function curve) or a real
myocardial impairment. Here the administration of
NaC1 is contra indicated as B blocker treatment and
inotropic drugs can be indicated.
KIDNEY SCINTIGRAPHY IN DIABETIC PATIEFS
S. Ilié, M. Bogiáevié, S. Atitiá, V. Stefanovié
Institute of Nephrology and Hemodialysis,FacUltY
of edicine, Ni, Yugoslavia
995
Dynamic kidney scintigraphy and Tc—DTPA
clearance studies were performed in 30 patients
with diabetic disease lasting over lo years. Two
groups of patients were investigated: 16 patients
without proteinuria and with normal serum
creatinine and 14 with manifested diabetic
nephropathy assertained with proteinuria and
increased serum creatinine level. Six parameters
of computerized curves were analysed and compared
with the corresponding paramers found in control
group of 2o hesithy persons. Tc—DTPA clearance
was determined from one blood sample, taken at
180 sin.
In diabetic patients without proteinuria a
statistically significant decrease of the second
segront- nlcpc (p ooS) ':'as fnnrL 'ther oaramete'a
of dynamic curve were unchanged. 10 the econd
group of abetic patients, renograms were
apiated. Tc— DTPA clearance was significantlly
reduced in both groups (Cl DTPA control=1l7±l2
mi/sin; Cl DTPA diabetic=87±6 sham, p o.ool;
Cl DTPA diabetic with nephropathy=36+17 al/sin,
p o.ool).
This study showed significant reduction of
glomerular filtration rate in diabetic patients
both with diabetic nephropsthy and diabetic
without clinical signs of nephropathy but lasting
over ho years.
CRITICAL ASSESSMENT OF THE VALUE OF RENAL
GRAFT ULTRASONOGRAPHY
V. Koandrle, 0. Mareková, I. Skála,
V. Prat, J. Jirka, I. Reneltová
Institute for Clinical and Experimental
Medicine, Prague, Czechoslovakia
The authors review over 1200 ultraso—
nographies /US/ of 245 transplant reci-
pients. They assess the value of US in
differential diagnosis and stress the use
of appropriate instrumentarium. In the
early postoperative period small 3.5-5 MHz
transducers with sector field of view are
preferable, whereas in the later period
transducers with rectangular field of
view permitting a more accurate determi-
nation of graft length, have proved most
useful.
US provides accurate information on
graft size, shape and position, allows
early detection of starting rejection as
compared with normal findings at previous
US and e:cludes dilatation of urinary
pathways. Further, US documents blood and
urine accumulation if graft rupture and!
or urinary fistula are present. It helps
to identify and monitor pathologic focal
findings /haematomas, abscesses, lympho—
celes/ and is a reliable guide in their
puncturing.
US has become an essential ancillary
diagnostic technique after renal trans-
plantation.
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THE ESTIMATION OF URINARY EXCRETION OF
ZINC /Zn/, CALCIUM /Ca/ AND MAGNEciIUN /Mg/
AFTER LOADING HYDROCHLOROTHIAZIDE /HT/ IN
PATIENTS WITH UROLITHIASIS.
Kosicka T., Musialik D.
/Intr. by J. Knapowski/
Dept. mt. Med. Poznati, Poland
The urinary excretion of Zn before and
after a single orally administration of HT
in patients with urolith.iasis was determi-
ned.
The fractional excretion of Zn, Mg and
Ca were performed by atomic absorption
/Perkin—Elmer 400/ in 12 patients with cal•
ciuxn urolithiasis and 10 healthy subjects
before and after orally administration
100 mg HT.
The basal urinary excretion of Zn and
M were significantly lower in patients,
but urinary Ca excretion didn't differ inboth groups.
fter PT administration the urinary
excretion of Zn, Mg and Ca didn't changein control group; in patients urinary Zn
excretion was significantly increased, but
urinary Ca and Mg excretion didn't differ
in comparison to basal values. The urinary
Ca and Mg excretion after PT administra-
tion were significantly lower in patients.
Urinary Zn excretion didn't differ signif I-
cantly in both groups and obtained values
as in control group.
The increased urinary excretion of Zr
after thiazide suggested the usefulness of
PT administration in, prevention of calcium
nephrolithiasis.
HIGH RESOLUTION REAL-TIME SONOGRAPHY AND QUANTITA-
TIVE FLOW ULTRASOUNfl MEASUREMENTS OF ARTERIOVENOUS
FISTULAS.
L.Marosi ,H.Ehringer,M.Hirschl ,P.Schmidt,J.Zazgornjk.
R. Koppensteiner,E.Minar
In 26 patients (17 rnen,9 women, average age:38.9
years 17 - 78 years ) in maintenence hemodialysis
investigations of Cimino-Brescia-Shunts with high-.
resolution-real-time-scan (Biosound;8 MHz trans-
4ucer)was performed.This technique provides infor-
station regarding vascular wall alteration e.g. it's
pathological changes and also is beneficial for the
patients in an atraumatic way.
In addition measurement of the shuntvolume was made
in 39 patients treated by chronic haemodialysis
with Cimino—shunt, using a multichannel pulsed
Doppler Ultrasound instrument, at defined points of
measurements (supplying brachial artery, venous
lrainage 5 cm proximal of the anastomosis). The
quantitative measurement became possible, because
of the symmetrical flow at these points of measure-
ments. The average shunt-volume was 7.4 ml/sec.All
these patients were suited for dialysis and had no
cardial problems.The femoral artery, the common
carotid artery and the brachial artery of 10
patients were also measured. The average flow of
these arteries was on low-normal level. The systo—
lic maximal flow was significant lower than by
healthy persons. In the common carotid artery this
change depended on the shunt volume.
DIAGNOSTIC VALUE OF URINARY CYTOLOGY IN PATIENTS
WITH ANALGESIC NEPHROPATHY (AN), PRESENTING WITH
A MALIGNANT URO-EPITHELIAL TUMOR (MUT)
W. Lornoy, I. Becaus, J. Martens, V. Morelle,
E. Fonteyne, L. Thienpont, J. Mestdagh
O.L.Vrouwziekenhuis, 9300 Aalst, Belgium
A higher incidence of MUT is reported in
patients with AN.
—
We studied 21 patients (m age 63.8y) with AN
in which 22 MUT of the upper urinary tract were
detected in 16 patients a renal pelvic tumor,
in 2 a ureteral tumor, in 2 a tumor of both and
in one a bilateral tumor of the renal pelvis.
All had a transitional cell carcinoma.
A positive urinary cytology was detected in
12 MUT : 8 times in a MUT grade II, 4 times in a
grade III, but none in a grade I. A negative uri-
nary cytology was present in 10 MUT 5 times in
a grade I, 3 times in a grade II and 2 times in
a grade III. In the tumors grade II and III with
negative cytology, complete obstruction of the
pyelo—ureteral tract was demonstrated. In 5
patients a positive urinary cytology was the
first sign of the presence of a MUT.
Conclusion the sensitivity of urinary cyto-
logy (54.5%) was rather low, due to complete ob-
struction of the urinary tract and the presence
of MUT grade I. However this method is non-inva-
sive and led to the discovery of a MIJT in 22.7%
of these patients. Moreover a positive cytology
was obtained in all cases of MUT grade II and III
without obstruction. In view of these results,
regular examination of urinary cytology, as well
as complementary investigations, are recommended
in patients with AN.
DOPPLER ULIIJ'LSONILfESi iOR EVALUALI-
NG ARTERIAL FUNCTIONAL RESERVE OF PAL
MAR ARCH AFTER DRUG INDUCED STIMULA-
TION.
G. Rizzuto, S. Greco, S. Scida, R. Sisca, C. Cuzzo-
crea,M. M . Mauro, A. Antonelli.
Nephrology Department USL 16 Crotone ITALIA.
Aim of present study is the proposal of simple
test for evaluating by Dopplersonography some of
rapid changes induced byTNG 0.30mg and Nifedipi
ne(N FD) lOmg(both perlingually)on perypheral arte -
rial system.8 male healthy subjects aged 20 to3Owe
re examined by directional CW Doppler with recor
•ding of average instantaneous velocity at paperspe
•ed of mm5/sec.The investigation was done on par-
ticular vascular district i.e.palmar arch wose phy-
sical pecularities(re si stance ,inductance, capacitan
ce)are comparable to electric reactive circuit.The
diagrams of velocityobtained on radial artery after
modified Allen's test at standard time of ten sec.we
-re examined maesuring theOverShooting(OS)(at the
apex of curve of the overflow phase)and theSettlin
Time(ST)i.e.the time employed for going back to
nitial level.The study aas done in double blind f a-
5hion. OS=5.836-0.63mm(p(O. O2)ST=12. 143'- 0,74
alO'N FD(p(0. 05)05=3. 625tO. 62mm(p=N S)ST= 10.
545"O. 57"(p=NS)a5'TNG. OS=2 - 8750. 34mm. ST=
10.523"tO.52"placebo.The above data show an in
-crement of OSand an exsion ofST afterNFD confi
-rming a more efficacious perypheral action of cal-
cium antagonists than nitrates.This prelyminay stu
-dy gives us the possibility of utilizing the Doppler
test for estimating the funct.reserve of vasc.syst.
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VALUE OF URINARY RED CELLS MORPHOLOGY IN DIAGNOSIS
INVESTIGATION OF NEPHROPATHIES.
C. Michel, J.F Ygout, P. Ronco, B. Viron, A. Olame
F. Mignon.
Tenon Hospital — Paris, France.
Morphology of urinary red cells (R.C.) were
examined to determine the value of dysmorphic ery—
throcytes in glomerulonephritis diagnosis speci-
ficity, sensibility and prediction of histologic
lesions.
Urine samples from 79 patients with haematuria
defined as more than 10.000 urinary R.C. per inn,
were examined with a phase contrast microscopy
within 1 hour of collection, without centrifuga—
tion. A percutaneous renal biopsy was performed in
order to classify the histologic injury in all pa-
tients.
Dysmorphic R.C. were seen in the urine speci-
men of 54 patients. All had histologically proven
glomerulonephritis. Ther percentage of dysmorphic
R.C. varied from 1 to 80% of total R.C. Non dys—
morphic R.C. were seen in the other 25 patients
17 had proven glomerulonephritis and 8 had other
parenchymal lesions than glomerulonephritis (tu-
bular, interstitial or vascular). All types of
glomerular lesions are represented, but no histo-
logical type was correlated neither with the pre-
sence or not of dysmorphic R.C, nor with the ran-
ge of percentage of dysmorphic R.C.
With this procedure, the presence, even in
small percentage of dysmorphic R.C., is pathogno—
conic of glomerular lesions, but doesn't presume
any kind of histological variety. False negative
are possible. Further studies are indicated to
identify factors responsible for the variable
percentage of distorded R.C. seen in case of gb—
inerular lesions : the histologic variety doesn't
appear prominent.
THE vitLL)Iry (F CORRECTION FACtORS IN THE ANALYSIS
OF lONISal) CALCIUM.
N.J. NiLo1aa,is, A.M. De Fancisco, E. Gaiger,
1.11..!. Goodsoip, R.S.C. Rod1er, M.K, rd.
Department of Medicine, University of Newcastle
upon lyne, Newcastle upon lyne, England.
Measurement 01 ionised calcium is an accepted
nCtiaxi of dote inin.g free blood caIcin. It is
LneWn tat .XL4ea ilk pIt, WL.i. Sg..,
.en anC a coircutioR tiLu as
.ecn ie;eLupd and applied. In this stody welociced.at tb accracy ui tiiC correction actor or an
ICA I analyser.
For paired assays perforited on serum, one
sample was analysed immediately aiter venesection(actual value) and the other was stored in a capped
syringe at roem temperature for 2 and 6 hours.
Whole blood w9 stored at ro tnperatore for 6
hours and at 4 C for 24 hours. The stored samples(oath corrected and uncorrected for pH) were
cnpared with the actual result. The taole records
tuc nu.oer of measurements (in percent) which dif-
fered fr,ss tue actual resatt oy more than 2 stan-
dard dviatioas for the precision of the measure-
ment (—0.02 amok/i). Tue actuni. calcium 4ipatietits
was l.l0Z).ll ntmol/l and the pH was 7.41—0.04
Time
_____
iemp No.of
ptS
% Changes at
ph Actual pH 7.40
Serum
Blood
2 us's
6 hrs
6 Airs
24 Ers
Room
Room
Room
4°C
2o
30
31
2u
10% 50%
46% 53%
3d% 71%
50% 77%
This study shows that uncorrected values are
more accurate than corrected values and that
following correction a high percentage of values
will fall outside 2 BA) of the actual result.
ISOTOPIC RkNOGRAPHY AND AC6TE RENAL FAILURE
.MydlIk,J.Zimdek,I. Pokorn4,.Taká
flrth Med.Clin.,Dept.Nucl.Med.,Paculty
Hosp.Koice ,Czechoslovakia
Renographic exatniristion was performed
in 80 patients in various stages of acute
renal failure of various origiri.Renogra—
phic picture in the oligo—anuric stage was
dependent on the length of duration,on the
character of functional and morpholo'ic
renal changes and to some extent on the
etioloical factcrs.It was independent on
the presence of hypertension.The most fre-
quent type of the renographic curve in the
oligo—anuric stage was the "obstructive"
one which became gradually normalized and
as the lest element was normalized the
third phase.In the patients with long
lasting oligo—anuric stage and with rever-
sible functional and morphological changes
the curves showing afunction were found
wbich,however,hecarne normalized during
convalescence.To the rapidly pro,gressive
plooerulonephritis /Goodpasture s syndro-
me,' the "afurictional" or "isostenuric" ty-
pe of the curve was found in isotopic re—
nogram,which did not change during the
course of i'Llness.The importance of the
dynamic examination of the isotopic re—
nogram is pointed out in individual stages
of acute renal failure which makes possib—
le to evaluate the improvement of the tu-
bular function of the kidrtey.In the diffe—
rencial diagnosis of renal failure the re—
noFraphic examination can differentiate
chronic renal fnilure,one—sided obstruc-
tive uropathy and partly enables to disco-
ver the cause of the acute renal failure.
DIFFERENTLY CHARGED HUMAN SERUM ALBUMIN FOR
DIAGNOSTIC USE IN RENAL DISEASES.
Th. Ockhuizen, M. Haas and D. de Zeeuw. (Intr. by
G. K. van der Hem). Univ. Hosp. Groningen. The
Netherlands.
Loss of charge—selectivity of the glomerular
basement membrane (GBM) is thought to contribute to
the urinary protein loss in certain renal diseases.
The aim of our study was to device a method to
quantitate in humans loss of charge—selectivity of
tjIsGBM.i?r this purpose differently labelled( I & I) endogenous human serum albumin (HSA)
of identical Stokes radius but of different charge
is need5 We explored three methods
I. Two I—labelled fractions of native HSA,
differing in one p1 (iso electric point) unit were
obtained by column iso electric focussing. However,
a re—distribution to the original p1 spectrum
range 4.5—5.6) was observed after adding both "I—
HSA fractions separately to normal human serum (EMS).
This phenomenon appeared to be due to the interact-
ion with Cl ions and negatively charged fatty acids.
IL Extensive experiments to change HSA in charge
by non—covalent binding of fatty acids did not yield
stable, modified HSA.
III Under well—defined experimental conditions HSA
was succinylated. lodinization of this anionic HSA
yielded a fraction with a p1 of 4.7, which was
stable in NHS at p1 4.5. Cationization of HSA with
ethylene diamine gave after iodinization a p1 of
7. , which was stable in NHS at a p1 range of 7.0—6.0.
Molecular weight determinations of the native and
chemically modified HSA did not show significant
differences.
In conclusion, we were able to prepare HSA
fractions with the same Stokes radius but with
different charge.
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METHODOLOGICAL VARIATIONS IN THE SELECTIVITY INDEX
(SI) OF URINARY PROTEINS. D.de Zeeuw, M.Haas, J.
Mulder, S.Meijer, GK.vd Hem, Th.Ockhuizen. Univ.
Hospital Groningen and Lab, of Public Health
Leeuwarden, The Netherlands.
A reliable determination of a defect in size—se-
lectivity of the glomerular basement membrane(GBM)
will be of clinical importance in diagnosing and
treating patients with different renal diseases.
Renal clearances(Cl) of endogenous proteins are
frequently used. We evaluated the effect of three
inimuno—chemical techniques on the outcome of the
SI (Cl—albumin/Cl—IgG) in 34 patients with varying
proteinuria(3—15g/day) : radial inimuno diffusion
(RID), electro inimuno diffusion(EID), and nephelo—
metry (NEPH).
The SI values from RID data correlated poorly
with those from EID data(r=O.33). Similar results
were found for RID versus NEPH(r=O.22), and EID
versus NEPH(r=O.OO). Comparing the renal Cl of al-
bumin measured by these methods, good correlations
were found. IgG—Cl, however, correlated poorly,
predominantly due to a distinct discrepancy between
RID, EID, and NEPH with respect to urinary IgG—
concentrations. Isoelectric focussing and two—di-
mensional electrophoresis (viz, charge and molecu—
lar weight) of blood and urine samples followed by
immuno—specific staining on nitrocellulose blots,
showed interindividual variations in size and char-
ge of urinary IgG. Preliminary results show that
in—vitro modification of the charge of urinary IgG
changed the concentration measured.
In conclusion, measurement of size—selectivity of
the GBM using renal clearances of albumin and IgG
fluctuated with the iinmuno—cheinical method employed
predominantly due to the physico—chemical proper-
ties of IgG. Whether RID, EID or NEPH is to be the
method of choice has yet to be evaluated.
DETERMINATION OF GLOMERULAR FILTRATION RATE (GFR)
IN MAR BY SINGLE INJECTION OF DTPA 99mTc AND TWO
PLASMA SAMPLES.
Palla R., Tuoni M., Sbrana A., Bianchi R.*
Clinica Medica 2, *Servjzjo di Medicina Nucleare
Università di Pisa, PISA, Italy.
The evaluation of GFR is important in the follow
up of nephropatic patients. The radioisotopic me-
thods of determining GFR by single injection (SI)of
tracers are noninvasive and well accepted; on the
contrary, the method of continuous infusion of tra-
cer until infusion rate is equal to excretion rate
is time consuming and difficult to perform in a cli
nical setting. However, the SI methods is approxi-
mate in the extrapolating the logarithmic curve ba-
ck to zero time to derive P (0); therefore, to im-
prove the method, we measured in 28 pts. with well
preserved or reduced GFR, total DTPA 99mTc plasma
clearance after S.I. and serial blood sampling,
using a 2 compartment open model and exponential
curve stripping which give accurate analytical so-
lution (Cli), and tracer clearance from one pool s
stem and two plasma samples (Cl2) at 90 and 120 mi-
nutes after 5.1. From comparison of Cli and C12 re—
suits is possible to calculate the equation for the
regression line and obtain the correct value for
Cl2 from regression equation:
y = B . a a = 0.914552 b = 1.171493
In conclusion: the measurement of GFR by one pool
system lead to an overestimation of GFR; two pool
system is not suitable for the need of serial blood
sampling; from the comparison of the two methods we
obtained a suitable method for clinical routine exa
mination which allow us to measure with good preci-
sion GFR after single injection and two blood sam-
ples after 90 and 120 minutes from tracer injection.
THE CONSEQUENCES OF UNINEPHRECTOMY (UNX): STUDY OF
LIVING RELATED DONORS (LRD). R.C. Pabico,
S. Sandroni, B.A. McKenna, R.B. Freeman. Univ. of
Rochester, Rochester, N.Y., USA.
Compensatory functional hypertrophy in LRD is
achieved in 2—4 weeks post unx (Kidney mt 8:166,
1975). Glomerular filtration rate (GFR) and effec-
tive renal plasma flow (ERPF) rose by 37% and 55%
respectively, from pre unx. We are concerned with
the potential adverse effects of long—term hyper—
perfusion of the remaining nephrons. 17 LRD (14
men, 3 women; current ages: 37—81), 5-11 years
post unx (mean—8.5 yrs) recently underwent com-
plete history and physical examination; blood
count and chemical analyses; urinalyses; urinary
protein excretion (UprotV) and creatinine clear-
ance (Ccreat). Only the 81 yr old had medical
problems (respiratory infection, peptic ulcer);
the rest were in good health. 5 had minimal hyper-
tension (150—170/90—100); 2 had UprotV greater
than 250 mg/day (630, 260). The mean current
Ccreat/pre unx Ccreat was 0.69 unchanged
from the early post unx/pre unx value. 7 LRD who
underwent renal hemodynamic and tubular function
studies pre unx and 2-4 weeks post unx, underwent
the same studies recently:
Pre UNX 2—4 wks 7—10 yrs
(1 Kidney) Post unx Post unx
GFR(ml/min/1.73m2) 55±5 76±5* 78±6*
ERPF " 270± 17 426±40* 354±42*
FF(GFR/ERPF) O.2±.O1 O.18±.O1 O.22±.02
TmPAH(mg/min/1.73m2) 45±2 59±4* 66±5*
TmPAH/GFR O.83±.05 O.80±.O5 O.84±.06
p <.05 compared to pre unx
Thus, after almost a decade post unx, hypertension
and proteinuria are seldom seen in LRD. Renal
excretory function is stable. Glomerulotubular
balance is preserved.
MEASUREMENT OF SERUM "MARKERS" OF MUSCLE (SKELETAL
AND MYOCARDIAL) TISSUE IN TJREMICS IN REGULAR DYALI-
TIC TREATMENT (RDT): EFFECT OP THE SINGLE DIALYSIS.
0. Giampietro, G. Buzzigoli, N. Cern, N. Neni, M.G
Del Chicca, D. Ciociaro, A. Clerico, R. Palla.
C.N.R. Clinical Physiology Institute, II Medical
Clinic of the University, Pis, ITALY.
A rise of some enzymes following hemodialysis in
RDT uremics has been reported, although the signif I
cance and causal are uncertain.In 25 RDT uremics(21
males, 4 females, age 29—74 yrs, mean duration of
dialytic treatment: 4 yrs) we measured myoglobin(M)
levels by RIA and circulating activities of creati—
nekinase (CK) and its myocardial isoenzyme CK—MB,
lactic dehydrogenase (LDH), aiphahydroxybutirric de
hydrogenase (HBDH), glutainic oxaloacetate transami—
nase (GOT) with enzymatic methods at 37 C, before
(BD) and after (AD) dialysis. We found very eleva-
ted mean BD M levels which became clearly higher AD
(230±23 vs 266±27 ng/ml, M±SEM). Enzymatic activi-
ties, which were within normal limits both RD and A
D, became all significantly higher AD (LDH: 151±78
vs 220±30 OIL; HBDH: 66±7 vs 94±11 OIL; GOT: 13±2vs
17.4±3 OIL, M±SEM), except CR which was unaffected
by dialysis (72±10 vs 73±10 U/L, M±SEM). CR—NB was
practically undetectable in all patients.
These results suggest that an injury of muscle
(skeletal, not myocardial) mass, likely due to ra-
pid changes of electrolytes, osmolality and pH oc-
curs during dialysis. As a consequence of these ra
pid metabolic changes, a muscle release of serum
muscle "markers" follows.
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ULTRA$OUND(US) AND RADIONUCLIDES(RN) IN
THE DIAGNOSIS OF CYSTS AND TUMOURS OF
THE KIDNEY
M.Polepakovi4.S.Dikova L.Grevska and
N.Simova. Thtr.by G. Masir).
Depts. 0 nephrology end nuclear med. ,Ned—
ical Faculty,U.of Skopje,Yugoslevia.
1000 patients suspected of renal diseases
were investigated by US.
Patients with adult polycystic disease
(51 case),simple renal cysty(26),multiple
renal cysts(l5), hydronephrosis(lol) and
renal tuxuours(l6) were investigatod.Some
patients have renal feilure(ARP or CR?).
The results of US were compared with IVU,
radionuclides(dynamio renal imaging with
99 To—rn DTPA and static functional imaging
with 99 Tc—rn DMSA) and renal angiography.
US can provide information despite the
complete absence of renal function.The me-
thod is non invasive and should be the fi-
rst choice of investigations in patients
suspected to have renal cysts or tumours.
US is extremly useful in the investigation
of children and in pregnancy.
RN are valuable as an initial investiga-
tion in patients with cysts and turnours
and ARF. RN may identify unusual sites of
functioning renal tissue.
US and RN have a special place in the
evaluation of patients who are allergic to
radio contrast media. Both methods are co-
mplementary in the investigation of renal
cysts and tumours.
NEUROMUSCULAR REACTION TO PAIRED STIMULI
(NMRPS) IN CHILDREN WITH CHRONIC RENAL
FAILURE (CRF)
B. Reitter, K. Schärer, S. Wacker.
University Children's Hospital, Heidelberg,
F.R.G.
Children develop signs of uremic poly-
neuropathy (UPN) only rarely. Earlier stu-
dies using motor nerve conduction velocity
(mNCV) have yielded inconsistent results.
We have initiated a new double pulse stimu-
lation method (NMRPS) able to detect prima-
ry axonal degeneration which is the histo-
pathological lesion in UPN. After a first
neuromuscular response the delay (D) up to
a second (conditioned) action potential and
its amplitude (A) are determined. Pairs of
supramaxinal stimuli are applied to the
peroneal nerve by surface electrodes and
the responses recorded by using electronic
processing devices (Medelec MS 6 system).
81 children at different stages of CRF were
examined by NMRPS and mNCV. Results: On
conservative treatment (n=45) A was signi-
ficantly depressed at different stimulus
intervals when serum creatinine was .3 mg%.
In children on regular hemodialysis (HD,
n=24) D values were prolonged before HD
sessions but returned to normal afterwards.
The changes in HD patients were correlated
with residual urine volume/24 hrs and crea—
tinine clearance, but not with dialysis in-
dex. After transplantation (n21) A was
again related to GFR.In conclusion NMRPS is
a suitable, well tolerated method to detect
early subclinical UPN in children. The de-
gree of electrophysiological changes is de-
termined mainly by residual renal function.
NEUHOPHYSIOLOGIC ASSESSMENT(NA) OF THE PRO-
XIMAL PAET OF THE PERIPHERY NERVES IN
URAEMIC NEUROPATHY (UN)
M.Polenakovió ,R.Ljapev,N.Ivariovski and
G.Masin.Depts of nephrology and neurology,
Medical Faculty,U.of SkopjeYugoslavia.
In 41 patients with chronic renal failu-
re of which 23 on haemodyalisis and 18 on
conservative treatment were done NA on the
proximal segment of the periphery nerves of
lower extremities to detect UN. The invest-
igations included the conduction velocity
of P wave(VF) and latency of F wave(LF)for
n.peroneus and n.tibialis as well as condu-
ction velocity of H reflex(VH) and latency
of H reflex(LH).50 healthy persons served
as a control group.Results are shown in the
table.
Perametres CRF Control P
VF—P in/s 51.1 53.9 p<0.l
VF—T rn/s 49.3 53.7 p<-O.0l
LF—P ms 40.7 42.0 n.s.
LF—T ms 43.1 40.4 n,s.
VH rn/s 47.8 57.8 pO.OOl
LH ma 36.5 30.3 p<0,00l
Our results were pathologic in 37 to 40%
for F wave and in 90% for H reflex in pati.
ents with CRF.We conclude that the damage
of motor and sensory neurons were localiz-
ed also to the proximal part of the periph-
ery nerves and not only to the distal one
as it has been considered so far.Our inve-
stigations suggest that UN is a result of
the influence of toxic metabolic substances
on neurons.The used methods are non invasi-
ve and gives the possibility of a complex
analysis of both motor and sensory neurons.
VALUES OP COMPLEMENT AND PROPERDIN FACTOR B IN
THE NORMAL PREGNANCY AND PREGNANT WOMEN WITH
E P H GESTOSIS DISEASE.
•1B. Rosic,
Clinical Hospital, Belgrade, Beigrad,
Jugoslavia.
Authors made investigations on complement
C3, C4, as well as on properdin factor B (PFB)
using nephelometry methods (Beckman Immuno-
chemistry analyser).
Determination C3, C4 PFB levels was performedin 20 control subjects and in 60 patients of
endemic nephropathy.
Preganant women were tested during the while
gravidity (in months and trimesters). The
average result for C3 in first trimester was
1.551 g/L, in the second l,824g/L and in the
third 2,046g/L. C4 results were first trimester
0.106g/L, second - 0,l24g/L, and third - O,l4Sg/L,
and at last for PFB I — 0,153, II - 0,i46 and
III — 0,l3Og/L.
Under statistical treatment (using Takey —
Snedecor test) those results have shown the
significant difference between first and third
trimester for complement C3. for I and II and as
well as for II and III there is no difference for
C4 and PFB.
The final result is that EPH gestosis make
significant differences only in complement C3.
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DETERMINATIONS OF NUCLEOTIDES IN ERtTROCYTES IN
THE PATIENTS FROM ENDEMIC NEPHROPATW.
D. Rosi, T. )Jaumovi, M. StamenkovLd',
N. Despotovic, .7. Rosi, M. Vidanovi&
City Clinical Hospital, Beograd.
We determined nucleotides in the erytrocytes
with the same two groups. For sample preparation
we used special technique described by Schmidt and
Thanausser. For analysing nucleotide we had
recourse to an automatic amino acid analyser with
integrator, printer and special in detector for
short wavelengths.
As can be noticed determination were carried
out for monophosphates and for adenosine di—
phosphates as well as for adenosine triphosphates.
Slightly increments were noticed for uridine
monphosphate, guanidine monophosphate, cytosine
monphosphates and for adenosine monophosphate.
Imidine monophosphates was decreased. Adenosine
monophosphates was significantly increased while
adenosine triphosphate was considerably
decreased.
TUMOR MARKERS IN THE ENDEMIC NEPHROPATHY
AND DIAGNOSTICS OF MALIGN DISEASES OF THE
URINARY TRACT
M. Salatié, A. Hali1baié, S. Trnaevié, S. Lolin
Clinic Internal, Tuzla - Yugoslavia
Carcinoembryonic antigen (CEA) and alpha-feto-
protein (AFP) plasma levels in thirty three patients
with different stages of the endemic nephropathy,
ten with a combination of papillocarcinoma of the
urothelium and the endemic nephropathy and eight
with the adenocarcinoma of kidney parenchyma were
determined by radioimmunological methods as a me
ans to assess their diagnostic value in these disea-
ses. Ten middle-aged blood donors served as a con-
trol group.
Not a singLe group of our patients showed a stati-
stically signiicant difference in CEA and AFP plasma
levels when dompared to either the normal control
values or levls in the actual diseases.
Our resuls exclude the significance of plasma
CEA and AFP determination in the diagnostics of the
above mentioned diseases, a finding that agrees
with the observation of some other investigators. A
significant elevation of plasma concentration of the-
se antigens in any one stage of the endemic nephro—
pathy was neither observed.
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DETERMINATIONS OF IZOENZYMES L 0 H IN
THE PATIENTS SUFFERING FROM ENDEMIC NEPHROPATHY
.7. Rosic, T. Naumovi, M. Stainenkovid',
N. Despotovid M. Bozoviz, H. Vidanovic
Institute Medical Biochemistry, Pharmaceutical
Faculty, Belgrad, .Tugoslavia.
Izoenzymes L D H was determined in 30 healthy
persons and in 40 patients with endemic nephropa—
thy.
Technique — separations and determinations of
izoenzymes L D H were carried out in agrose gel.
In the control group value for L 0 H1was
32,8% and in the sick group Only 40,7%. That
izoenzymes L 0 H1 was increased in patients.
L 0 H in control group was 44,1% and in sick
group only 29,0%.
L D H3 in control group was 19,3%, and in
sick group 16.6%.
L 0 H4 in the healthy group was 3,6% and in
the sick group 10,8% so significant increment
exist in the second group.
In the control group we could not find
measurable amount of LDH5 whereas in the sick
group the value was only 2%.
VALUE OF HCGI3 MEASUREMENTS IN BLOOD AS A PREGNANCY
TEST IN WOMEN ON MAINTENANCE HEMODIALYSIS.
A.Schwarz, K.-G.Post, F.Keller, M.Molzahn. *
Medical Department, Klinikuxn Steglitz, Berlin.
We investigated hCGI3 content in the blood of 19
non—pregnant women and 4 men. This is the diagno-
stic pregnancy test for hemodialysis patients,
since urine tests are not performable or mislea-
ding in patients with renal insufficiency. Blood
samples were taken 3 times before and after dialy-
sis at an interval of 1 week. Measurements were
done by RIA (hCGi3-RIA-Kit Serono). - The median
hCGB values were 9 mIU/ml (0—116) in 7 menstruatinç
women, 6 (0—25) in 11 postmenopausal women, and
0 (0-7) in 4 men. In all 3 groups, the median hCGB
values were less than 10 mIU/ml, i.e., below the
upper normal limit. HCGB levels of the 3 groups
(menstruating women, postmenopausal women, and men)
showed no statistically significant difference
(H-test of Kruskal and Wallis). However, the indi-
vidual measurements varied considerably, exhibiting
an elevation in 32% (tenfold elevation in 2 cases).
Only women had increased hCGB values. In 2 women,
the elevated hCGt3 normalized after renal transplan-
tation. We conclude that, even in the blood of
non-pregnant women on hemodialysis, elevated hCGB
values may be found which erroneously indicate an
intact pregnancy of 3 to 5 weeks duration or a non-
intact pregnancy (e.g., impending abortion or
extrauterine gravidity). Assuming a pregnancy by
elevated hcGB in blood, at least 2 control measure-
ments must be done in order to confirm or exclude
the rapid increase of hCGB in blood indicative of
an intact pregnancy.
*(Intr. by M. Molzahn)
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DIAGNOSTIC AND PREDICTIVE VALUE OP ThE RENAL
RADIONUCLIU€ PERPUSION INDEX IN ThE EARLY
POST TRANSPLANT PERIOD
T.Zwas, 0. Simansky, E.T. Jacob
Sheba Hospital, Ramat Gan, Israel
356 radioisotopic scans with Tc-99m=DTPA were
performed in 88 renal transplants and the
perfusion index was calculated. The perfusion index
is the ratio of radioisotopic counts in the
ipsilateral iliac artery and in the graft. Four
groups of patients were defined depending on the
graft function during the first week and the
outcome at six weeks.
The results of all of the perfusion indices
were graphed and the median value for each group
was plotted for different post transplant periods.
There was a statistically valid difference between
all of the groups for all of the periods.
Successful grafts had a lower median than did failed
grafts. 177 studies were performed within three day
prior to a rejection episode. The rejection episode
was correctly diagnosised by a perfusion index
greater than 200 in 64%. 31 patients were diagnosed
as suffering from only ATN. The perfusion index was
less than 200 in only 43%. The radioisotopic scan
was able to diagnosise a number of uromechanical and
vascular complications correctly.
We conclude that the radioisotopic examination
has moderate ability to contribute to the assessment
of the quality of the graft. It can indicate the
eventual outcome with some measure of accuracy.
The radioisotopic scan is helpful in diagnosing
gross uromechanical or vascular pathology, however,
the perfusion index is unable to differentiate
between ATN and rejection with sufficient sensitivity
to be of practical value in the management of the
graft during the initial anuric period.
DYNAMIC ECG AND ECHOCARDIOGRAPF-IY UNI-BI—DIMENSIONAL
IN EVALUATING CARDIAC ARRHYTHMIAS OF UREMICS ON ROT
F.Susanna,O.Totis°,M.DeLuca,P. Simoncello°,P.Calza=
vara,C.Cascone. Renal Unit,Cardiology Opt°.
General Hospital,Castelfranco Veneto,Italy.
Twenty—seven patients,aged 20-66 years(mean 43),
on RDTsince 6—68 months(mean 55),all with acetate
buffer,were studied in order to detect the inciden=
ce of cardiac arrhythmias ma period of 48 hours
registration dynamic ECG (Holter).The results were
related to anamnestic parameters,laboratory reperts
ECG,chest—x-ray,echocardi ography uni —bi —dimensional
in order to find risk factors for cardio—vascular
diseases.
Supra—ventricular arrhythmias were found in 8
c4ses;ventricular extrasistoles in 9 (33%) and 5
of them presented 3°—4° Lown's degree in some phase
of the 48 h registration.Ventricular arrhythmias
increased during and/or after dialysis in 3 cases.
We compared the five patients with 30_40 Lown
degree ventricular arrhythmias to the other popu=
lation for all the studied parameters,with curren
tly used statistical analysis tests(t—student, 2).
Highly significant correlation was found with eft
veriiricular hypokinesia and decreased ejection fra=
ction C 60%);slight but no significant correlation
with history of hypertension.
Our experience suggests that uremics on ROT pre=
senting important ventricular arrhythmias are affec
ted by myocardiopathy.In contrast with previous —
reports,in our population age,degree of anemia,dis=
lipidemia,HDL-Col,PTH,electro]yte disturbances and
ultrafiltration rate during dialysis do not seem
to be responsible for severe ventricular arrhy=
thmias.Moreoveor,dialysis treatment does not play
a major pathogenetic role in determining disrhy=
thmias,but it could enhance the degree of an ar=
rhythmia in a pre-existing cardiomyopathy.
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STANDARDIZED ASSAY FOR 22Na—EFFLUX RATE CONSTANT.
T. Tapper, J.F. Jilderda, G.K. van der Hem and
D. de Zeeuw.
University Hospital, Groningen, The Netherlands.
Numerous reports have been published on the
diagnostic value of cell 22Na—efflux rate constant
(Na—ERC) in hypertensive, uremic and dialysis pa-
tients. However, the inter—study mean normal values
vary: 0.29 to 0.50 h. Variation in methods is in
part responsible for conflicting data. This urged
us to develop a 22Na—ERC assay of cells in plasma
with a high degree of standardization, achieved by
the mechanization of the manual procedures.
loaded erythrocytes are separated from wash medium
with silicone oil (sg:I.04) by centrifugation in
syringes. The packed cells are automatically pres-
sed out of the syringe into plasma. The suspension
is divided over 4 microtubes, and incubated at
37°C during 15',30' and 45', respectively. In the
presence of a semi fluid gel, cells and plasma are
separated by centrifugation. Both are assayed for
radioactivity.
22Na—efflux rate (mean +
inter—assay
(n4)
SD) (h')
intra—assay(n8)
normals
(n"13)
Total 0.52+0.01 0.54+0.04 0.47+0.06
Ouabain—
sensitiva
—
0.32+0.01 0.33+0.04 0.32+0.04
Furosemide—
sensitivity 0.055+0.010 0.05+0.01 0.023+0.022
In conclusion, this standardized, high capaci-
ty method allows accurate measurement of different
ERC's with high reproducibility.
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COMPARISON OF HISTONORPHOMETRY AND COMPUTED
TOMOGRAPHY IN QUANTITATING TRABECULAR BONE
IN DIALYSIS AND TRANSPLANT PATIENTS.
I2LLE'" Lorenzo,J.M. Glez Posadas (intr
by F. Valderrabano).
S. of Nephrology.Htal. Oral. y Clinico.Htal
V. de Candelaria. Tenerife. Spain.
A method for the assessment of Tra
becular Bone Mass (TBM) by Computed Tomogra
phy (CT) at L4 vertebral body was designed.
•After repositioning of a dog a coefficient
of variation (Cv) of 2.21% was seen.When 4
normal individuals were studies twice with
an interval of 1 week the CV was 2,76%.In
29 normal individuals an age related bone
loss was seen(r=O,7S;p(O,Ol).In 9 Chronic
Hemodialysis patients (CHP) and in 4 succes
fully transplanted patients (TP) the TBM
assessed by CT and the histomorphometry of
the iliac crest were compared.A good corre
lation between TBM by CT and % Total Bone
Volume (1EV) (r=O,d5;pCO,Ol) and % Minera
lized Bone Volume (MBV) (r=O,B4;p(O,O1) in
the iliac crest was found.In S of 6 patiens
with decreased TBM a low TBV and MBV wee
aeen.Two patients showed a high TBM and
they were the cases with a high TBV and NBV
No special IBM pattern was seen in Osteoma
lacia(n=S) or Osteitie Fibroem (n=ll). The
noninvasive assessment of IBM by CI in the
axial skeleton allows a reliable characte
rization of trabecular bone and can be an
iportant help in the follow—up of CUP & IP.
THE RELATIVE CLEARANCE (C) OP 99mTc_DMSA: A NEW
APPROACH TO MEASURE DYSFUNCTION OP PROXIMAL RENAL
TUBULES.
W.H.J. van Luijk, S. Meijer, W.J. Sluiter, A.J.M.
Donker and D.A. Piers.
State University, Groningen1 The Netherlands.
Renal scintigraphy with 99mTcDMEA in pts with
proximal tubulopathy (PT) yields a low uptake in
renal cortex with high urinary esretion. To gyalu—
ate this finding C studies with mTc_DMSA, 1I_
thalamate and 11I—hippurate were performed. Simul-
taneously, relative C of S2—microglobulin (2—M)
and lysozyme (LYSO) were determined. 9Tc—DMSA was
given in a dose of 0.06—0.36 mg divided in a pri-
ming and a sustaining dose for continuous infusion.
20 Pts with PT and 17 controls with various non—
tubular diseases were investigated. All PT pts had
an elevated relative C of 52—M.
In PT pta relative C of 99mTc_DMSA amounted to
15—33%, whereas in the control pta values of 6—14%
were established. Analysis of DV of 99mTc_DMSA
versus filtered load showed that the Tm for 99mTc_
DMSA was not exceeded. The mean renal excretions
were 29% in PT and 9% in control pts. In 10 PT pts
with GFR>4O ml/min C of S2—M, LYSO and 99mTc_DMSA
were 26—95, 2—29 and 15—33%, respectively. Analysis
of UV/GFR versus serum level of 62—M and LYSO
showed thst the Tm's were exceeded with slopes of
1.20 and 0.33, respectively.
Thus: 1. simultaneous determination of GFR,
ERPF and proximal tubular function with radiophar—
maceuticals is possible; 2. a relative C of 9YmTc
DMSA > 14% points to tubular dysfunction; 3. the
renal handling of 99mTc_DNSA resembles more LYSO
than $2-M.
USEFULNESS OF 99mIcPYRDPHOSPHATE BONE SCINTIGRAPHY
IN THE SURVEY OF DIALYSIS OSTEODYSTROPHY.
J—L. Vanherweghen, A. Sohoutens, P. Bergman,
N. Dhaene, M. Goldman, H. Fuss, P. Kinnaert.
Erasme Hospital, University of Brussels, Belgium.
The possible contribution of 99mTcPyrophoephate
(Tc-PP) bone scintigraphy in the evaluation of
iialyeis osteodystrophy was investigated by semi—
quantifying the To—PP uptake by the skeleton using
Fogelman's score (FSO to 12).
a)In hemodialyeed(HD)—patients ,FS correlated
with the bone calcium accretion rate measured after
147CaC12 injection(r=.8C,p<.O1,n11).
b)FS remained stable in RD—patients after 6
months of treatment with 1(OH) vit D3(from 5.7±0.7
to 5.2±D.6,n12) as compared to a significant in-
crease in a randomized group of untreated HD—
patiente(fron 6.2±0.9 to 7.9t0,9,n9,p<.OO1).
c)Ien of 33 HD—patients treated by 1(OH)D3 deve-
loped hypercalcenia during the first month of
treatnent.Ihey had a lover FS than the 23 patients
who tolerated the treatment(3.9±1.O vs 8.0±0.9,
v.001).
d)Higher iocrease in serum Al levels after des—
ferrioxemine(DFO) was associated with lower FS(FS<
5:AAl 100 ug/l—n=7— vs FS>5:AA1 28 pg/l—n=17—;p<.
OO1).In 2 cases of Al bone intoxication, a high
uptake of Tc—PP by soft tissues was found and FS
was low(1—2).After DFO therapy Ic—PP—soft tissues
uptake disappeared and FS increased to 8—9 with a
strong increase in bone calcium accretion rate.
In conclusion,patterns of Ic—PP bone scintigra—
phy correlated well with calcium bone turn—over and
this technique could thus be proposed 1)tc evaluate
the degree of activity of oeteodymtrophy 2)to de-
tect patients at risk for vitamin B intoxication
and 3)to screen patients with impairment of bone
mineralization such as Al intoxication.
SONCGRRPHIC DIRCNOSIS OF RtNRL VEIN THROMBOSIS IN THE NtPHROTIC
SYNDROME
3. Verbanck, B. Segsert, L. Rutgeerte, 0. Verleden, F. Verhelst.
Oepsrtment of Internsl Medicine,
H. Hart Hospital,
Roeselsre, Belgius
R sonography wee performed in a 26 year old man with the
nephrotic syndrome due to membranous nephropsthy, in an attempt
to look for the presence of renal vein thrombosis.
Sonography was performed using a real-time 3.5 MHz linear
and sector transducer (type ROR. KranzbUhler). The cortical
echodensity of both kidneys was increased and the cortico-
meduliary contrast was enhanced. The right kidney was 11,S cm
long, but the left kidney was markedly enlarged and measured
13,5 cm. On careful transverse sonogrsphy of the upper abdomen
a dilated left renal vein was visuslimed, containing a sharply
delineated echodense thrombus. The diagnosis of left renal
vein thrombosis was confirmed by phlebogrsphy, showing exten-
sive left renal collateral circulation.
Due to its excellent ability to wisualise retroperitonesl
wssculsr structures in non—obese patients, sonogrsphy can
docueent renal vein thrombosis in patients with the nephrotic
syndroee.
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KIDNEY LYP1PHO1R DIGNO5IS BY SDNOGRAPHICRLLY GUIDED RSPIRATION
3. \Jerbanck, 6. Segaert, F. Verheist, 3. Tytgat, V. Tanghe.
Heilig Hart Hospital, Roeselare, Belgium.
Rn abdominal real—time sonography (3.5 6Hz AUR KranzbUhler)
was performed in 4 patients. Renal symptomatology was absent
in two of them. One other patient presented with macroscopic
hematuria and one with bilateral lumbar pain. Urinary output
was noimal in all patients. However, various degrees of renal
failure were noted; serum creatinine values were 1
.6, 2.5,
3.0 and 13.0 mg% respectively.
At sonography, the renal cortex was diffusely enlarged in
3 patients. The renal architecture was completely disturbed by
a diffuse parenchyrnal infiltrative disease, presenting as
numerous, small, poorly echogenic tissue clumps. In the fourth
patient, a poorly echogenic 'swollen' appearance of the left
kidney lower pole was observed, leading to a moderate pyelo_
caliceal dilatation. A fine needle (24 gauge) kidney puncture
was performed under sonographic control without complications
in all 4 patients. Cytologic analysis of the aspirate revealed
in all patients lymphomatous kidney invasion (1 centrocytic,
1 centroblastic, 1 centrocytic—centroblastic and 1 undifferen-
tiated non-Hodgkin lymphoma). After cytostatic treatment,
normalisation of the renal sonographic appearance and the
serum creatinine levels was observed.
In conclusion, renal lymphomatous invasion is easily dia-
gnosed by sonography. Guided fine needle kidney aspiration
allows pathologic classification which diverts cytostatic
therapy. 1'loreover, serial ultrasound examinations help to
establish the therapeutic response.
• EVAi.TllTIOU OF THE INTACT HOdIIONE ASSAY IN THE
.
STUDE OF PARATHYROIO AUTOGRAFT FUNCTION
. C. H. Pie epirig)ie, A.J. Parnhan, J. H. Farndon.
H. WiLcjnsori
Dept. of Nephrolo' and. Clinical Biochernistxy,
Freenan Hospital, and Dept. of Surgexy, Royal
Victoria Infirear, Newcastle upon Qyne.
Total parathyroidectonr with autotransplant -
ation of paratkrrroid tissue into the forearm is
now a well established procedure in refractoiy
hyperparat1y-roidism secondaiy to renal disease.
Previous studies of autograft function have used a
radioinaiunoassay (ETA) for paratlrroid hormone(PIN) measuring the biologically inactive C—tern
inal fragment which has a long half life in renalfailure.
We have studied 6 haernodialysis patients with
parathyroid autotransplants using a RIA for the
biologically active intact PIN and conpared
results with the C—terminal assay findings. In 5
patients the C—terminal assay gave differences
between the graft and non-graft arms of 30% pre-
and 20% post-dialysis whereas corresponding
differences with the intact PIN assay were 59%
arid 43%. In the sixth patient, who probably has
residual parathyroid tissue in the neck, the C-
terminal assay showed no difference in the arias
and the intact Pm assay a difference of 15%.
This study suggests that particularly in pat-ients with renal failure, the Rh for intact PTH
is of greater value in the localisation of para-
thyroid tissue than the C-terminal assay and may
be of value in distinguishing between overactivihy
of the graft and residual paratlrroid tissue in
the neck when hyperparathyroidism persists after
paratJmJroidectoay and autotransplazitation.
ELISA FOR DETECTION OF ANTI-GLOMERULAR BASE-
MENT MEMBRANE ANTIBODIES . INFLUENCE OF
VARIOUS MICROTITER.PLATES ON ASSAY. SENSITIVITY.
M. Weber, H. Köhler, M. Manns, K.-H. Meyer zum BUschenfelde
(introduced by D. Hoeffler), University of Mainz, FRG
Demonstration of antibodies (AB) against antigens (AG) of
glomerular basement membrane (GBM) is possible by various
methods including indirect immunofluorescence, gel diffusion,
passive hemagglutination and radioimmunoassay. Recently,
ELISA methods have also been reported. We describe an anti-
GBM-AB ELISA with special reference to the influence of
microtiter-plates on assay-sensitivity.
Human GBM was prepared according to Westberg and Michael
(1970). A collagenase digest of GBM (5GBM) was used to coat
suitable microtiter-plates. Sera were added and allowed to react.
Bound immunoglobulins were then detected using rabbit
anti-hu-lgG-AP. Enzymatic activity was measured using p-nitro-
phenyl-phosphate and absorbance was read at 405 nm. Various
sorts of microtiter-plates were tested according to their influence
on assay-sensitivity. Optimal conditions for each step were
determined.Specifity and reproducibility were tested.
Anti-GBM-AB were detected in 10 sera from patients with
Goodpasture's syndrome but not in sera obtained from patients
with other types of glomerulonephritis (41), SLE (14), Sharp-
syndrome (4), Wegener's granulomatosis (3), primary biliary
cirrhosis (15), chronic active hepatitis (20), rheumatoid arthritis
RhF pos. (10) and RhF neg. (10) or healthy blood donors (178).
Absorption of positive sera with sGBM prior to coating resulted
in a fall of absorbance values under the cutt-off value of the
assay. Sensitivity of the assay was best, when using PVC plates
with flat wells. When using other materials (lmmulon, Nunc-
Ion-delta, Polystyrene) or wells with U or V forms, AB recogni-
tion was worse. Carbonat-buffer, pH 9.6, proved to be the best
coating buffer. Background-reduction was obtained using Tween
and/or BSA in various steps of the assay or by removing lgG
contamination of sGBM by affinity chromatography. Reprodu-
cibility was high. The assay proved to be more sensitive than the
immunofluorescence method.
The ELISA may be used in detecting anti-GBM-AB associated
glomerulonephritis and in estimating titers of circulating AB in
patients under therapy. Furthermore, the E LISA may be used
in studies aiming at characterisation of the GBM antigens.
CHANGES IN BODY COMPOSITION OF CHRONIC
UREMIC PATIENTS DURING MAINTENANCE HEMO—
DIALYSIS AND AFTER KIDNEY TRANSPLANTATION
'árum1 I., Osongor, J., L6csey, L.
Szabó, T. and Kakuk, Gy.
let Department of Medicine and Central
Research Laboratory, Univ.Ided.SchooJ.
Bebrecen, Hungary
Repeated body composition analyses
were carried out in 41 chronic uremic
patients with the multiple isotope method
of Bauer ot al./1975/ in order to help
the individual dialysis strategy and
dietetic treatment.
Total body water /TBW/, extracellular
fluid volume, plasme volume and exchange-
able sodium were determined. Total blood
volume, red blood cell mass, intracellu-
lar and interstitial fluid volumes were
derived from the directly measured com-
partments. Lean body mass, total body fat
and exchangeable potassium were estimated
on the ground of TBW values.
It was found that the patients had had
a significant extracellular, a slight
intracellular overhydration and a likely
pathologic water content of fat tissue at
the start of dialysis treatment. The
overhydration was reduced — but not
ceased — on maintenance hemodialysis.Some
patients on maintenance hemodialysis for
several years have developed an increase
in total body fat and intracellular fluid
volume while the same increase could be
observed in all patients after succesfu].
kidney transplantation.
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PLASMA FIBRONECTIN AND FIBRINOGEN LEVELS IN NEPHRO-
TIC SYNDROME AND AFTER RENAL TRANSPLANTATION
W.Graninger, J.Zazgornik, E.Minar, K.Pirich,
P.Schmidt, P.Balcke
I.Medjcal Clinic, University of Vienna, Austria
Fibronectin (FN) is an opsonic protein produced
mainly by fibroblasts and vascular endothelial
cells. Diminished plasma levels of this protein
were reported in patients (pts) with chronic renal
failure.The aim of this study was to investigate
the behaviour of plasma FN and fibrinogen (FGEN)
levels, and the relationship of these proteins in
pts. with nephrotic syndrome (N.S.)and after renal
transplantation (R.T.).
In 9 pts.with N.S.and in 38 R.T.pts.the plasma FM
and FOEN were investigated.Plasma FM levels were
measured by turbidimetric immunoassay,FGEN using
immunodiffusion method. In R.T.pts.additionally oçi-
antitrypsin -macroglobulin, antithrombin III,C 1—
inactivator ad(.)-antiplasmin levels were estimated
FM FGEN
Normal values (N=100) 325+ 70 iig/dl ; 256 75 mg/dl
N.S. (N=9) 614+264 pg/dl; 801 +263 mg/dl
R.T.pts. (N'38) 385+100 ig/dl; 458 +135 mg/dl
The plasma FN levels were elevated in 7, The FGEN
in 8 out of the 9 investigated pts.with N.S.A posi-
tive correlation was found between FN and FGEN
(pzO.01),cholesterol (p.O.O1) and proteinuria (p
0.05). In R.T.pts.the plasma FM level was increased
in 14 (37 p.c.), while the FGEN concentration was
increased in 20 (53 p.c. )out of the 38 cases. A
positive correlation was found between FM and FGEM
(p&0.001) and'X2—antiplasmin (pcO.O01 ).
Conclusions:The plasma FN is elevated in N.S. The
positive correlations between FM, FGEN and —
antiplasmin indicate that elevated FM may be a
additional factor responsible for hypercoagulabili-
ty in N.S. and in some pts. after R.T.
Abstracts 531
ONCE DAILY VANCOMYCIN AND GENTAMICIM IN THE
TREATMENT OF CAPD PERITONITIS
L.D. Gruer, D. Mu, J.H. Thrney, J. Curiey,
T.J. Lockinrton, J. Michael.
Renal Unit, Queen Elizabeth Hospital,
Uirmincam, En—land.
In a t'id o 75 episodes o CAPD
peritonitis we found 96% of the bacterial
ioiaes to h sensitive to a combination of
"ancom"nin ('i) and tobramvcjn CT). 52/38
rorec"ti"e episodes of peritonitis were
cured by the addition of V (l5mrji) and T
(Sm—/i) to each bar of dielvsate. Sustained
se—un T le'eis ran-ed from 3.1 - rn—/i
which we considered potentially ottoxic. We
therefore studied a re'ime in w"jch larrer
doses of V (omr/l) and rentar,inin (2OmR/i)
were added to the o'rernit'ht dialyaate
After 8 hours one of these antibiotics was
coninued in the iiht of bacteriology for
10 da's. 28 of 31 coneecuti"e episodes of
peritonitis were cured by this renine. Serum
-entamicin ie"els ranned from 1.6 to n/l,
1e'els which we consider safe. This re—joe
is effecti-e, simpler and cheaper.
GRANULATED DRY CHEMICALS FOR HAEMODIALYSATE.
Tetsuzo Agishi, Iwakazu Kaneko, Kazuo Era,
Toshiaki Suzuki, Kazuo Ota and Takeshi Suzuki5.
Kidney Center, Tokyo Women's Medical College,
Tokyo and Tomita Pharmaceutical Co., Ltd.,
Naruto5, Japan.
Dry Chemicals have practical advantages over
concentrated solution type chemicals in preparing
dialysate for haemodialysis. Modern technology
has enabled to produce granulated dry chemicals
which contain all components necessary for haemo—
dialysis and instantaneously dissolve in 38°C warm
water even to prepare 35 times concentrated solu-
tion type dialysate. Although a wide variety of
dry chemicals with different prescriptions can be
theoretically produced, two types of dry chemicals
using either acetate or bicarbonate as buffer have
been routinely applied in clinical haeinodialysis
without any particular problems. Granulated dry
chemicals is produced in such a manner as a con-
centrated solution including each electrolyte com-
ponent is either sprayed out in hot air through a
pressurizing nozzle to be dried or sprayed over a
hot rotating drum to form dry pile which is subse-
quently crashed into the granules. Each portion
of the granules contains a fixed proportion of the
composition because of this production procedure.
The advantages of the granulated dry chemicals
for haemodiaiysate over concentrated solution type
are as follows: no concentration due to evapora-
tion, no caramelization, negligible change in pH,
a small volume, lightness (less than one third of
solution type), easy transportation, easy storage,
inexpensiveness and more adequate for home dialy-
sis.
iS COMPUTERIZATION OF SMALL HAEMOVIALVSi.S
UNITS FEASI8LE ?
P. Ae.bLocheii., V. Scfco'uiexe..t, 0. FeL&y (lnt&. by
1.-P. Wauiev).
HôpLta2 e.antonaL, Fn_Lbowig, SwLtzei&cvid
Re.c.ervt avid wtwie deve2opme.nt o kLrietLc mode.-
£..Lng Lvi datjo-L4 theicapy aA weLL a the. e.no-'imouA
amowtt o cia-ta jc6ty moxe. and riioLe. -the. u4e. o
compuAz'i -Ln dLa.Ly4L4 wiLto. We. .th'te.,çone. de.veio-
pe.d a p-'iognani 'uvinLrig on a pe.'uovia.L mocompute.'i.
tha.t handLe 156 ci eet.t .type o Ltenu taling
Ln-to ace.owtt Loto'cLc2aL, c&vvLeitL, tee.knLe.aL, La-
botoity avid a-tnie.n-t da,ta. Abowt 100.000 da-ta
£wui..zked by owi 4moLlL c.e.n-tvi (40 patLent6) weM
4-to/Le.d duLng the. -LX4t yewL.
The. pliog'w.m coniwte.d -Lvi a way ha-t Lt Ls
e.xcJ_uLueLy mariage.d by riwreo arid phy3-LcJan4.
Leaitnng tLnie. ha4 rio.t e.ce.ede.d one. hoWL.
Fa4t ae.ce.&o o cia-ta, cia-ta giaphLea-e. d-iopLo.y
wth on. u/2howt pn.e.vLouA mathema-t,Le.c2 -t&an4 o'una-
tiLoni (n.e.ue.ne., Loga-'tLthtn, e.-tc.) avid a ce.'c-taLvi de.-
gn.e.e o automatLc cia-ta e.va&ccttLon (n.e.e.ognii2/on o
cia-ta gniI4Lcant.t vaito$2ovi) 4e.em -to £ntpn.Ove. pa-
tLe.n-t' 4 C 'c.a.L c.a.n.e.. The. awtoma-tLv. e.xe.e.wtLon o
uan..Louo !urietAc mode.thtg4 (un.ea, he.patLne.) ha2 had
n,Lca.L -LncLde.nce.4 on d&tLy4Ls
-tLme., dLetaity
pn.e4cJlpton, etc.
Te.chvicctL Jjnpiwvemejqt arid pn.ice. Loweji.Lng -Lvi -the.
raLcitocompaWt LeLd peiunLt -the de.ve2opme.nt o
powvi1L p)wg-tain4 oLLowng optLmo2 patLent'4 cLL-
vvLcctL managemeivt. TheL't we 4howLd no LongeJi be.
/te4e)we.d to -ônpo-t-tani.t cLLnLcctL ce.n-tex.
PTH IN THE ELDERLY ON REGULAR DIALYSIS TREATMENT.
A. Albertazzi, B. Di Paolo, P. Cappeili, M. Evange—
lista, M. Maccarone.
Institute of Nephrology, University of Chieti,Italy
In the last years an increasing number of
elderly patients entered in a regular dialysis
treatment (RDT). We evaluated the severity of hyper
parathyroidism, a complication which can shorten
dialysis survival, in these patients in respect to
younger ones.
We compared a group of 7 patients (1st), more
than 60 years old (66.85±14.811) on RDT from 16.71±
15.33 months with a residual renal function of 1.21
mi/mm and diuresis of 150±117.914 mi/2hh to a
group of 13 younger patients (lInd) (1111.07±13.12
years) on RDT from 36.69±30.16 months with a
residual renal function of 1.814±0.88 mi/mm and
diuresis of 223.07±91.37 ml/214h concerning: PTH—N
terminal, F, Ca, alkaline phosphatase (AP).
1st group presented a significantly lower PTH
(2.91±1.1411 vs 6.62±2.87 rig/mi), P (14.33±0.68 vs
6.02±0.811 mg%), and AP (88.0±15.83 vs 157.69±62.21
U/l). In both groups PTH resulted directly
correlatable with P whereas not with dialysis
duration.
In elderly patients on RDT secondary hyperpara—
t.hyroidism appears of lower degree probably due to
a better control of P perhaps also through a
reduced dietary phosphate intake considering that
older people eat less.
532 Abstracts
1INICAL AND SEROLOGICAL COURSE OF HEPATITIS B
VIRUS (HBV) INFECTION IN HEMODIALYSIS PATIENTS (HD).
A. Albertazzi, G. Del Rosso, B. Di Paolo, C. Spisni,
P. Palmieri.
Institute of Nephrology — Univ. of Chieti, Italy.
In HO there is a high risk of contracting HR. We
analyzed during the last five years the serological
markers of HB infection (HBsAg, HBsAb, HBcAb, HBeAg
HBeAb), the clinical manifestation and liver
function tests (LFT) of each HD. We divided the pts
in contagious (HBsAg-s- only or HBsAg+ associated
with HBeAg+) and non contagious-immune (HBsAb+ only
or HBsAb÷ associated with HBeAb-s-).
In the first control (1979) the infectious
population consisted of 145,8% while the non
infectious—immune pts were 141,6%. During the last
control (1983) the infectious pts represented 18,9%
while 614,9% resulted non infectious—immune. Only in
two series of controls we evidenced the absence of
exposure to HBV (18,5% in 1980 and 10,8% in 1982):
these were pts whom had undertaken dialysis since
no more than 3 months. Only in 1979—1980 we had
cases of clinically evident HB. All the remaining
pta developed non symptomatic, anicteric HB
evidenced exclusively by the LFT alterations and
the appearance of the above mentioned serological
markers which rapidly undergo seroconversion to
immunity.
In Dialysis Centers where prevention and/or iso-
lation measures cannot be taken the HBV could beco-
me 'attenuated" as demonstrated clinically by the
subclinical HB course and serologically by the acti
ye immunity.
DENTAL MANAGEMENT OF TME CHRONIC
MEMODIALYSIS PATIENT
M. Alberth,L.L5csey
Dept.of Stomatology and I.Dept.of Medicine
University Medical School
Debrecen, Hungary
A chronic hemodialysis program for ren.-
al diseases has been initiated at the
Dialysis Centre of the I.Dept.of Medicine
of the Debrecen Medical School since 1971.
The patients regular dental screening and
treatment commenced in January 1962. The
average age of the 46 patients receiving
dental treatment was 38 years /23 males
and 23 females!. Our two year results re-
vealed that the oral hygiene of these
patients is worse than that of the average
population. In 44 cases out of 46 we found
serious aenemia, calculus formation andgingivitis. In each case we found an atro-
phy of the alveolar bone and pocket form—
ation.We regard this symptom to be cardin-.
al in uremic hemodialysis patients. As a
co:i3equence, there's a pathologic mobi-
lity of the teeth which is proportional
to the bone resorption. Though not very
typical we found 10 cases with clicking
of the temporomandibular joint arid pain-
fulness of the joint and its surroundings.
Owing to the increased tendency to caries
and the parodontal disease the majority of
patients lost most of their teeth untimely
Because of this special care should be
taken while performing the restoration. We
emphasize the need for special dental
care of hemodialysis patients.
"UREMIC NERVOUS DISEASE" AND HEPATITIS B (HB) INFEC
TION IN ROT PATIENTS: A CLINICAL PARADOX
A. Albertazzi, G. Del Rosso, B. Di Paolo, 0. Viola,
M. Maccarone.
Institute of Nephrology, University of Chieti,Italy
Although HB is recognized as a problem of hemo—
dialysis Centers, there is little current informa-
tion In regards to concomitant peripheral and cen-
tral nerve disfunction.
We analyzed liver function tests, serological
markers for HB infection (HB5Ag, HB5Ab, HBcAb,HBeAg
HBeAb), and neurophysiological parameters: Electro—
myography (EMG: Opponens Pllicis Muscle), Motor
Nerve Conduction Velocity (MMCV: Ext. Pop. Nerve),
Sensory Nerve Conduction Velocity (SNCV: Ext. Pop.
Nerve), and Somatosensitive Evoked Potentials
(SSEPs: Ext. Pop. Nerve).
Despite natural progression of neuropathy, we
evidenced an improved MNCV and SNCV (p(.OO1) in
the ten HBsAg + pts versus randomly picked HBsAg —
pta. The nerve conduction impulse resulted
significantly accelerated within the tracts knee-L3
and L3—Cz'. There was no change for EMG and P2a—P3a
waves. Furthermore, in the HBsAg ÷ and concomitant
HBeAg + pta (indicating a persisting viral
replication) the above results were more eclatant.
We propose that intracellular viral replication,
stimulating proteins synthesis, might induce a
perspicuous protein outflow along the peripheral
fibers, therefore playing a relevant role in this
clinical paradox.
A SIMPLE TECHNIC\L APROPCH TO BUFFEIED BIC?RB0NATE
HAHIIODIALYSIS.
L.Alciturri,J.Cacón,A.Ya2iez,J.Espinosa,J.'llleria
N. Eskubi.
Clinica Nefrol6gica Bilbaina.—BILBAD-SPAIN.
Ca Precipitation, sofisticated machinery and Co2
ration to undesirable levels,represents an obstacle
to develop an haeriodialysis program with bicarbonate
We recomand a sixiple technic to avoid this inconveni
ents.— Material and nethods :PVC container (1000 1.)
open top ,Watson Marlow nonitors and blood pumps ,We1
tec micropoirit dialyzers,pH mater Kornik 168,Atomic
absortion espectophot. Perkin Elmar 460.- It is esen
cial to iTantein the pH level below 7.60 to avoid the
precipitation of Ca and M3 then using bicarbonateinsted acetate.— We use as estabilizer LPCTIC Ac. —
(85%) intermidiatly.Once the dialysate is prepared
the pH is 7.37±0.02 having added 250cc of lactic Ac
forl000 1. solution.At the first hour the pH is —
7.47±0.02.At the second hour pH is 7.64±0.03,preci_
pitation starts to avoid this we add at this stage
thelO% of the initial cuantity of lactic Ac(25cc)in
nediatly we obtein pH=7.48.At the final of four hc&r
HI) the pH is7 .55 without having any tipe of precipi
tation.— Sumiiary: 1st.—We denostrate that bicarbona-
te concentrate in an open PVC container si unstable
during a 4h.HD,to avoid this,is necessary to add lac
tic Ac in various stages.2nd—The use of open PVC con
tainers allows the Co2 generated in the reaction go
out to the open air avoiding high levels of this gas
in the dialysate liaiid and at the sane tine in blo
od.With the risk that this accident could report in
patients with severe respiratory problems.3ed.—We a
port a sinple technic easy to manage thatwith three
1000 l.containers permits us to haenodialyze at le-
ast 30 patients daily with bicarbonate at a very low
cost,with all the advantages that this treatnent -
brings with it.
CONVERSION TECHNIQUE OF AN EXTERNM SHUNT INTO AN
INTERNAL A-V FISTULA. NINE YEARS EXPERIENCE IN AN
HENODIALYSIS CENTER.
AUTORES. L.Alciturri; N.Legarreta; L. Rodriguez;
J.A. Chacn; J. Espinosa; T.Ruiz; A.Garcia—Alfageme.
Clinica Nefrologica.— Bilbao — Spain.
During the last nine years we have been using
this technique of transforming the external A—V
Shunt into an internal fistula, in end stage uremic
patients who requiere to begin the hemodialysis with
urgency. We started using the Buselmeier shunt and
the preliminany results were reported at the E.D.T.
A. XIII congress (Hamburg 1976).
We are now using with the same results the "Short
Shunt', a modality of scribner shunt wich is placed
in the forearm vessel (radial artery cefalic vein),
to start the hemodialysis program.After obtained a
good 'maturation" of the vein, the device is removed
and an internal A—V fistula is performed with same
vessels.
At present this technique has been used in more
than 160 cases. We have analized one hundred of
these consecutive cases with the following results:
in 77% of them this was the permament vascular
access for more than four months. There were
problems with the new fistula in 15% of the cases
wich were solved after a period of rest. Tj
8% the fistula were definitely lost, 4% of them due
to bad manipulation of the external shunt, previous
to its conversion. This results indicate that the
method is valid, since for the mayority of the cases
it was the definite solution. At present we
recommend early removal of the shunt in case of
any problem.
"THE QUALITATIVE INFLUENCE OF DIFUSION (D) UPON
CARDIOVASCULAR SYSTEM DURING HEMODIALYSIS (ED)".
M.S.Anco;S.A.Draibe;M.A.Saragoca;HAjzen;OLpmo,
Nephrology Division. Escola Paulista de Medicina.
So Paulo (SP), Brasil.
It is well known that D impairs the circulatory
adaptation to ultrafiltration (UF) during HD blun-
ting the response of total peripheral resistance
(TPR) to a drop in cardiac output (CO). If a quanti
tative effect of D is involved it could be expected
better TPR responses when U is reduced as in the
low—flow ED. Therefore, the changes in CO, mean
pulmonary artery pressure (MPAP), mean arterial
pressure (MAP), heart rate (HR), total plasma pro-
tein concentration (TP) were measured in 10 chro-
nic uremic patients during a high UF rate concentio
nal HD (CVHD) and a high UF rate low—flow ED (LFHD
using a Polyacrylonitrile membrane. Dialysate flow
was 500 and 34 ml/min respectively. Blood flow was
maintained between 250—300 ml/min in both. Over a 2
+hours period the UF volume was 2800—240 ml during
CVHD and 276O35O ml during LFHD (SEM). The crea—
tinine clearences (CrCl ml/min) and the percent
changes in the TP and hemodynamic parameters are
shown below:
CrC]. A%TP %MAP L%HR A%CI A%TPR A%MPAP
CHVD 987 +19.8* _24.2* +12.9* —25.3* +5.9 _45.l*
LFHD 374 +13.6* —19.9* — 0.6
-17.8 +5.3 _47.2*
*p<0.O5 from the basal levels.
The smaller increase of TP during LFHD compared
to CVHD can only be due to a better plasma refil-
ling rate. TPR responses to changes in CO was the
same and no correlation was found between indices
of efficiency of ND and the changes in TPR in both
procedures. These data suggest a qualitative rather
than a quantitative action of D impairing cardiovas
cular responses during ND.
MAINTAINED URINE FLOW IN HAEMODIALYSED PATIENTS MAY
PROTECT AGAINST HYPERP.LUMINAEMIA
P. Altmann, K. Butter, J.Cunningham, F.Goodwin,
F.Marsh.
The London Hospital, London, England.
Aluminium (Al) from contaminated dialysate and!
or Al containing phosphate binders is an important
cause of disease in dialysis patients.
We have measured serum Al every 4 months in i09
patients and tap water Al monthly. Significant
correlations were found between serum Al and time
on dialysis, exposure to tap water Al and oral Al
(Table). Because there was better correlation bet-
ween Al exposure and serum Al in patients with low
(<lOOml!d, Gp A) urine output than higher (Gp B),
we examined the relationship between urine volume
and serum Al. A highly significant correlation was
found between serum Al and urine volume. This could
not be explained by any influence of dialysis dur-
ation on urine volume. Furthermore phosphate binder
requirement was not related to urine volume.
Months on Tap water Oral Al Urine Vol
dialvis (ba) Al (log) (log) (log)
Al(log)
All pta
r=0.35
p<0.O01
r=0.24
p<0.O5
r=0.51
p<0.O01
r—O.58
p<0.001
Al(log)
Gp A
r=0.42
p<0.Ol
r=0.28
p<0.OS
Al(log)
Gp B
r=O.17
p<0.S
r=0.03
p>O.S
r—0.57
p<O.O0l
These results suggest that maintained urine flow
may protect against aluminium intoxication. However
it is, as yet, unclear whether aluminium excretion
at these very low GFRs is related to GFR itself
or to urine volume.
NON INFECTIOUS COMPLICATIONS IN SUBCLAVIP
VEIN CATHETERIZATION.
Attardi A. Somigli L]. Salvadori M. Di Paolo
N. Sodi A. (member EDTA).
Dept. of Nephro1oy, Florence, Italy.
Percutaneous subclavian vein catheteri-
zation actually is emploied frequently as
a short lasting vascular access for hemo—
dialysis.In our dialysis center we perfor-
med 240 subclavipn catheterizations during
the last two years.Here we show 4 differerv
non infectious, serious complications which
advised us to employ caution i%1performing
such cathe-terizations.In the 1 case we had
an intrapleural hemorrhage whi recovered
with surgical therapy.In the 2 case we haá
a pericardial hemorrhage caused by a right
atrial puncture.Again a surgical therapy
was necessary.The other 2 patients who cu-
red spontaneously had respectively a pneu—
mothorax and a blood mediastinic effusion.
Our experience suggests that the hemorrha-
gic risks are freQuently encountered,The
following cautions seems particu:Lerly use—
ful.It is necessary to avoid strict and to
much stre±ght metal guides.Likewise to much
long and straight catheters have to be a—
void.1t is also mandatory to perform a dia
lysis with low heparin doses and to pos-tpo.
ne dialytic treatment if to many difficul-
ties or excessive pain have been encounte-
red during the catheter insertion.
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SMALL BOWEL OBSTRUCTION IN INTERMITTENT
PERITONEAL DIALYSIS
J. Golomb, M. Blum, G. Peer, A. Aviram
Rokach (Hadassah) Hospital, Tel-Aviv, Israel
Acute intestinal obstruction without concomi-
tant peritonitis is not a frequent complication
of maintenance peritoneal dialysis. It is most
always relieved by surgical exploration and pen-
toneal thickening with adhesions are found.
We report of 3 cases encountered during one
year, in whom the typical clinical and radiolo-
gical signs of small bowel obstruction were
manifested. None had a previous history of
abdominal surgery. In two, the episode occurred
within 3 weeks from the insertion of Tenckhoff
catheter. In the third case, the ileus occurred
following recurrent episodes of peritonitis.
All 3 cases were conservatively treated by
bowel decompression via nasogastric tube combined
with administration of Gastrographin. Within
1 - 3 days the clinical manifestations receded
and X-rays became normal.
We think that small bowel obstruction in
peritoneal dialysis patients is more common than
previously reported. Management can be conserva-
tive if the patient is properly monitored.
THE INHIBITION OF PLASMA ALDOSTERONE SEC-
RETION INDUCED BY HEPARIN, NOT MEDIATED
BY SERUM POTASSIUM CONCENTRATION.
Baba, M., Ishida, Y., Akiba, T., Nakagawa,S.,
Shiigai, T. and Takeuchi, J.
Tokyo Medical and Dental University Medical Dept.
Tokyo Japan
The decrease of plasma aldosterone concentration(PAC) after hemodialysis(HD) is said to be medi-
ated by serum potassium concentration. On the
other hand, heparin-induced inhibition of PAC has
been reported elsewhere. In order to clarify the
contributing mechanism of PAC inhibition during
HD, the followings were studied.
PAC of 6 patients on chronic HD were determined
before and after HD with and without heparin. The
change 5y heparin infusion alone was also studied
in 5 uremics on the day off HD. Heparin-free HD
was performed with use of gabexate mesilate.
The results of PAC and plasma renin activity(PRA) were as below. Angiotensin I and II were
changed in accordance with PAC and PRA. There
were no significant difference in ACTH, serum so-
dium and potassium concentrations between HD with
and without heparin.
heparin-free HD with heparin infusion
HD heparin alone
PAC before 75.2+46.2 58.7+38.8 51.8+43.6
after 70.1+44.9 36.726.3* 45543.4**
PRA before 6.03+7.05 4.55+4.30 4.23 +5.51
after l1.414.4 9.628.75**I 4.18±4.88
PAC:ng/lOOml, PRA:nglml.h, *:p<Q.OS,**:p<O.Ol
***:p< 0.025
The results indicate that the inhibition of PAC
during HD is caused by heparin and that it is not
mediated by serum potassium concentrations.
EFFECT OF NALOXONE ON TESTOSTERONE SECRETION
IN DIALYSIS PATIENTS
R. Lazebnik, G. Peer, A. Aviram
Rokach (Hadassah) Hospital, Tel-Aviv, Israel
An inhibitory effect of brain opiates system
has been postulated to have a role in states of
hypogonadism. Opiates blockade by naloxone
stimulates gonadotropins and testosterone secre-
tion in normal males. Ureniic males have hypo-
gonadism and impotence, usually unimproved by
dialysis. The basic defect seems to be an impair-
ment in testicular androgen biosynthesis.
The effect of acute administration of i.v.
naloxone (0.03 mg/Kg) on plasma levels of testo-
sterone was studied in 6 normal males and 6 hemo-
dialysis patients, both at age range of 23 - 43
years. Patients were on dialysis for 3 - 6 years,
all were impotents with low plasma testosterone.
Naloxone caused a rise of plasma testosterone,
within 2 hours, from 552 64 to 671 90
nanogr/dl in normal males. In the dialysis
patients the elevation was from 256 + 125 to
583 + 266 in the same time.
Although further studies are necessary, it
seems that opiate-inhibitors may have a place in
the treatment of uremic hypogonadism.
THE CHANGES OF LACTATE DEHYDROGENASE
PATTERNS IN THE SERA AND URINES OF THE
PATZENTS WITH ENDEMIC NEPHROPATWt
N Winterhelter,F_Baic,S Jadri
Institute of physiology and biocbemistr
Ned ic1 Faculty,Sarajevo,
Institute of physiology Medical Faculty
Tuzia ,Yugoslavia
The investigation of total activity
nd of the aistribution of relative acti-
vities of lactate dehydrogenase /LDH/ iso-
enzymes were carried out in dialysed and
on—dialed,patients in different stadi—
a of endemic nepbropatby In the majority
of cases total LDH activity was increased
in the sera,and in all subjects it was in
creased in the urine This was interpreted
as the consequence of increased anaeroby
in affected tissue.
Electrophoretic analyses of LDH isoen—
sy'mes revealed also the subfractionation
of the isozymes,but additional fractions
ware enzyiaatially active Experimental
3ata led to the conclusion that additic.Aa
zones were the result of the formation of
the complexes between 1DH isozymes and ot-
her serum proteins.
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PHAGOCYTOSIS AND BACTERICIDAL CAPACITY OF
POLYMORPHONUCLEAR NEUTROPHILS /PMN/ IN
PATIENTS ON INTERMITTENT PERITONEAL DIA-
LYSIS /IPO/.
H.Wysocki, E.wierusz-4ysocka. R.Czarnecki
K.EQczyk. A.Szczepaniak
Academy of Medicine, Pozna,'i, Poland
It was postulated that PMN migration
into peritoneal cavity occurs in selecti-
ve manner and at first involves the cells
of higher functional quality bearing the
receptors for Fc fragment of I9G.
Therefore phagocytosis and PMN becte—
ricidal capacity were evaluated in pen—
toneal fluid and peripheral blood simul-
taneously. The studies were done in 15
patients with uremia on IPL) using the
fluorochrome microassay. The phagocytosis
of PMN obtained from peritoneal fluid was
similar to those isolated from peripheral
blood, whereas bactericidal capacity of
peritoneal PMN was much hi9her, It was
even higher than that noticed in blood of
healthy persons.
The obtained results confirm our con-
cept of the selective PNN migration into
peritoneal cavity. They may also suggest
that rni9rating PNN additionaly undergo
stimulation, probably by factors origins—
ting from peritoneal cavity being the
reot focus of sterile inflammation.
uLNEFICI#L EFFECT OF INTERMITTENT PERITO-
NEAL UIALYbIS /IPU/ Tr<EATMENT UN THREE
PATH..AY OF PLATELETS /Pl/ .GGEGATION /A,
M.Komarnicki, I.Pietrzok, K.6czyk,R.Czarnucki, M.Zozulirsko, K.Antoniewicz.
Academy or Medicine, Poznai, Poland.
Uremic changes in P1A mechanisms are
still under study. .e tried to compare
th influence of IPO and hemodialysis/HO/
on P1A, depending upon: 1—AUP, II—prosta—
landins/PG/, Ill-neither AUP nor P0, in
39 uremic patients and 57 healthy persons.
e determined: P1A—I— ADP—induced/Uorn/
and plasma aggregating activity /Piv/—Caen
hichel; P1A—Il— malonylodialdehyde /MDA/
content in Fl after stimulation with ara—
chidonic ocid/tuart/, P1A—III—influenced
by thrombin. .ie checked also the correla-
tion of the P1A—I,II,III with plasma crc—
atinine /Pcr/ and guanidines /MG,GSA/
concentrations.
Results indicate near normal values /73
of PIA—I—ADP in patients treated by
IPO /G5t8inm/ contrasting with those on HO
/42i5mm/ whereas the PAA remained decre-
ased in both IPU and HO /normals—50*3,IPU
—22±5, HD—21±4nlm/. Similarly, P1A-Il me-
asured by ML)A were 15±lnM in normals, 12
*2nN in IPO, RU showed still decreased
values /7±j.nh/. AlSO. P1A—Ill depicted
values comparable with normals /36±3mm/
on IPU /34±Ymm/ and .40 /25±4mm/. P1A—I
well correlatee inversely with MG whereas
this is the case in P1A—Il with GSA in HO
only. P1A—Ill correlates with Per too.
,.e conclude, IPO is more useful for
amelioration of P1A in uremia, than RD.
THE INFLUENCE OF FUROSEMIDE /F/ AND SODIUM
MITROPRUSSIDE /Na-NP/ ON ULTRAFILTRATION
AND EXCRETION OF SODIUM AND POTASSIUM
DURING PERITONEAL DIALYSIS
A.crzegorzewska. T.Grala, K.Bczyk,
J.Alexiewicz
Department of Nephrology, Academy ofMedicine. Pozna,, Poland
The purpose of our study is the evalu—
ation of the influence of intraperitoneal
administration of F /40 mg/lI and Na—NP/5 my/lI on ultrafiltration and sodium
and potassium excretions during isotonic
and hypertonic peritoncal dialyses in
uroemic patients.
Na—NP added to the slightly hypertonic
dialysate /12 patients! increased signifi-
cantly ultrafiltration /from 2,8 2,4 to
5.4 3.2 mI/h/ky bw/ as well as excretion
of sodium [From 5,5 1,4 to 16.5 7,0
mEq/h/ and potassium /from 4,1 to
5,8 2,0 mEq/h/. The addition of F to the
moderately hypertonic dialysatc /1 pa-
tients! caused the increace in pcnitoneal
/from 14.7 b. to 23,t 11, sEq/h! end
renal /from 1,2 0,7 to 2,0 1.3 mEq/h/
excretion of sodium. The potassium excre-
tion with urine also increased /from O,i
0,2 to 0,9 0,2 sEq/h! however, its
peritoneal removal and ultrafiltration
volume did not change significantly.
.e conclude and Na—NP actiurla may in-dicate a poesiiility of their utilization
for improvement of peritoneal diOlysib
efficacy without relative hypernetraerua
concowitnt th hih ultrafiltration.
VITAMIN C AGGRAVATES SECONDARY HYPEROXAL-
AEMIA IN CHRONIC HAEMODTALYSIS PATIENTS
P. Baicke , P. Schmidt, J . Zazgornik ,H .Kops a,
A. Haub ens t o c k
I.Med.Clinic ,University of Vienna,Austria
VitaminC supplementation is recommend-
ed in chronic haemodialysis patients.Since
ascorbic acid is a metabolic precursor of
oxalic acid,we studied the effect of vita—
minC administration on plasma oxalic acid
levels.In 9 chronic haemodialysis patients
Ig vitaminC was given intravenously after
each dialysis session.Mean plasma oxalic
acid level(normal range l6,8+6,o pmol/1)
rose from 79,6+18,Ipmol/l toI9I,l+29,6
umol/l within 2 weeks(mean increase 24oc,
t9,78,p4O,00!).After 3 weeks the level
was 2o6,3+39,9imol/l,after 4 weeks 21o,5
+27,2 pmol/l.When vitaminC supplementation
was discontinued plasma oxalic acid levels
fell approximately to the pretreatment va-
lues within 2 weeks.Plasma oxalic acid—
creatinine ratios—evaluated to exclude dif
ferences in dialysis efficiency—showed a
similar behaviour.
Our data show that secondary hyperoxalaem
ia,as a consequence of renal insufficiencl
is aggravated when vitarninC is given.It is
likely that aggravation of hyperoxalaemia
causes an enhancement of calcium oxalate
deposits,found in a high percentage of
dialysis patients in kidney,myocardium,
pancreas,bones,cartilage and joints.
VitaminC supplementation should therefore
be restricted to the minimal dosage neces-
sary to correct vitaminC deficiency.
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• DESFERRIOXAMINE (oFo) TREATMENT FOR ALUMINIUM (AL)
AND IRON (Fe) OVERLOAD IN UREMICS WITH HAEMODIALYSIS
(Ho) ORHAEMOFILTRATION (HF)
C.A.Baldamus, H.Schmidt, E.-H.Scheuermann, E.Werner
J.P.Kaltwasser, W.Schoeppe
Depts.Nephrology and Hematology, Univ.Frankfurt/FRG
Although DFO is the treatment of choice in Al and
Fe overload, comparative pharmakokinetics and effec-
tivity of Al and Fe removal during HO and HF remain
to be investigated. Therefore Al, Fe (atoniicabsorp—
tion photometry) and DFO Clearances (Cl; mi/mm) and
distribution volumes (V; %BW) weredetermined in5pa—
tients each undergoing HO (1i hrs; Gambro GF I2OH)
and HF (29 1 ultrafiltrate; Gambro HF 303). Small
Ganibro filters (GU 1700) were applied pre and post
treatment device to measure plasma water concentra-
tion of urea (U), DEC and chelated Fe and Al for
calculation of clearances and mass balances (error
<l5°). DEC (0.03 g/kg BW) was given i.v. two days
prior to HD or HF.
HO HF HO HF
Fe 58 105 0.36 1.00
Al 80 105 0.50 1.00 38
Depending on initial Al and Fe concentrations
the maximal amount removed per HF was Al : mg
and Fe: 19 mg.
At the applied clearance rates, kinetics of
OFO, chelated Al and Fe indicate a single compart-
ment distribution volume,slightly smaller than
total body water (VU = 61 BW). Fe as well as Al
chelated by OFO are cleared more effectively by
HF than by HO.
DELAYED HYPOTENSIVE RESPONSE TO DIALYSIS IN HYPER-
TENSIVE PATIENTS WITH END—STAGE RENAL DISEASE (RD)
D.C. Bathe, A. von Riotte, and G. Lang. (Intro.
by F. Schwartz).
Univ. of Illinois, West Side VA, Chicago, IL, USA
The blood pressure (BP) profile during and fol-
lowing hemodialysis was investigated in 10 pa-
tients with RD. HP was non—invasively monitored
at 15 minute intervals for 24 hr. using an automa-
tic portable recorder (Del Mar Avionics, CA).
During the 4 hrs of dialysis (D), systolic BP did
not change (from 179±7.0 to 178±1.9 mmHg) while
diastolic fell only slightly (from 101±3.7 to
92±1.0 mmflg) despite a weight loss of 2.6±0.3 kg.
A progressive decrease in systolic and diastolic
BP was observed after D reaching its lowest value
5 hours following completion of the procedure
(146±5.5/75±3.2 mmHg), p<O.Ol. Thereafter, systol-
ic and diastolic BP remained below 150 and 90 mmHg
respectively, throughout the remaining 15 hrs of
monitoring. BP during sleep (147±1.7/77±.9 mmHg)
was not different than during daily routine
(147±2.0/78±1 mmHg). The lack of change in BP
during D and its delayed fall after D was ob-
served both in patients with high plasma renin
activity (PEA) (8.4±2.4 ng/ml/hr) and in patients
with low or normal PEA (0.9±0.2 ng/ml/hr). We
conclude 1) in patients with RD, there is a de-
layed hypotensive response occurring several hours
following D. 2) Vasopressor mechanism(s) other
than the renin anglotensin system must be acti-
vated during D to attenuate the fall in HP second-
ary to fluid removal by D. 3) The vasopressor
mechanism(s) which sustain BP during D are attenu-
ated following 8 allowing the BP to fall towards
normotensive levels. Regardless of the mecha-
nism(s), our data suggests that antihypertensive
therapy is not needed in the 24 hrs following D.
ORAL l.25(OI-4)2D3 VERSUS ORAL CALCIUM CARBONATE ON
}-1YPERPARATHYROIDISM OF HAEMODIALYSIS PATIENTS
J.D.Barata, A.Famos,J.R.Santos (intr.by J.Moreira)Clnica de Doencas Renais — Lisbon
To compare the effects of l.25(OH)O3 with oral car
bonate supplements on iPTH—C, AlkaYine phosphatase
(AF) and Bone X—RAY, 35 patients on Regular Haemo—
dialysis (Hd) with high levels of iPTI-4—C and main-
tained normal levels of total plasma calcium (Ca t)
and phosphorus (P) for 6 to 18 months were selected
and retrospectively studied.
24 patients were on l.25(OH)203 — GROUP I (GI)— and
11 patients only on oral Calcium Carbonate supple-
ments—GROUP II (GIl). There was no difference in Cat
values between the two Groups and they were identi-
cal concerning sexe, age and years of Hd.
AF levels were analysed on % of normal values.
The levels of iPTH—C showed a non significant ten—
denc to low in GI and a significant increase
p(O.005 in Gil. AF levels decreased in both groups
P(O.OOl and X—RAY only improved in GI.
We concluded that for the same normal levels of Cat
l.25(OH)2D3 may have a direct action on Parathormo—
ne release and AF percentual levels decreased inde—
pendentely of iPTH—C levels.
IS A REVERSIBLE CONDITION THE IMPAIRED ULTP.AFILTRA
TION IN CAPD PTS?
—
G. Bazzato, U. Coli, S. Landini, A. Fracasso, P. Mo
rachiello, F. Righetto, F. Scanferla. —
Nephrology and Dialysis Opt., Umberto I Hospital
Venice-Mestre, Italy.
Among 72 uremic patients (pts) who entered our
CAPD program, 11 (15%) of them developed a reducti-
on or loss of the ultrafiltration (UF) capacity of
the peritoneal membrane (PM) after a mean period of
27,2 mos treatment, showing a progressive water and
salt retention (mean BW increase of 7,21+0,6 Kg).
They were treated by administering IV high dose of
Furosemide (F) (15 mg/Kg/day), while daily urine ye
lume, UF, Na, urea, creatinine, phosphorus, uric ac
id removal with dialysate, and protein losses were
evaluated. 7 pts resulted "responders" to F with an
increase in urine output from 380+154 to 1270+475
mi/day and in Na excretion from 32+10 to 110+28 mEq
/day. In the meantime in all these pts a daily decr
ease of BW was observed (mean 1.20±0,28 Kg/day). We
noted also a progressive increase in UF capacity of
PM from 288+123 to 1220+154 ml/day, while solutes
removal with dialysate remained unchanged. The oth-
er 4 pts "not responders" to F showed a scanty resi
dual renal function and hemofiltration (HF) was ins
tituted. In the following days we noted an increase
in the UF of the PM from 460+192 to 1215+202 ml/24h
associated with an increase in Na removal from 61+8
to 158+20 mEq/24h. We think that both these therape
utic modalities, normalizing PM hydration and water
and electrolyte balance, play an important role for
ultrafiltration in CAPD patients. In fact in case
of altered hydration status it may be normalized ei
ther by forced diuresis of residual urine output or
by conventional HF, leading to a complete recovery
of PM UF capacity.
Cl Cl/C1U V
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DOUBLE-BAG SYSTEM (D-BS) FOR HANDICAPPED CAPD PATI
ENTS.
G. Bazzato, U. Coli, S. Landini, A. Fracasso, P. Mo
rachiello, F. Righetto, F. Scanferla.
Nephrology and Dialysis Dept., Umberto I Hospital
Venice—Mestre.
Since 1978 we are using D-BS for CAPD with satis
factory results in terms of incidence of peritonit-
is and pta compliance, for the absence of wearing
bag during dwell time. Furthermore CAPD represents
the first option for our uremic pts entering dialy-
sis program. To match the multiple needs of subjec-
ts (old, diabetic, arthritic, blind) with physical
handicaps in bag exchange procedure, we have design
ed a proper modification in D—BS connecting procedu
re (FIG).
This matter consists of a diaphragm, to be perforat
ed in the sticking manouvre, which maintains, by a
folding cover protection, needle sterility.
Before its inserction a luer cap is lock to a bran-
ch of the Y shaped adapter in order to keep in line
the axis of the whole system.
The connection is performed by driving the needle
through the resealable rubber closures. To give a
further help to the pt also a manual miniaturized
nachine, for progressive penetration by screwing ma
nouvre, has been provided. D—BS, besides to be effe
ctive in prevention of peritonitis and Pt rehabilit
tion, by this substantial technical improvement at
lows us to admit to our CAPD program handicapped pe
bple and makes this procedure a therapeutic approa-
ch for unselected uremic oooulation.
ff!J BEFORE
AFTER
ACQUIRED KIDNEY CYSTS AMONG HAEMODIALYZED
PATIENTS: NEW DIALYTIC PATHOLOGY ?
C. Bellinghieri,V. Savica,N. Ilacqua,C. Liosi,F.
Torre,F. Consolo
Istituto Pluridisciplinare di Clinica Medica e Tera
pia Medica Generale e Speciale, UniversitA di Mes—
ama, Italia
We studied with sonography 80 patients to follow
the kidney anatosopathologic injury evolution among
our haemodialyzed population and to continue our
follow up on incidence of acquired renal cysts du-
ring haemodialytic treatment.
All our patients (16—80 yrs) with no Cystic chro
nic nephropaties were under dialytic treatment for
a period between 4 to 110 months. They were exami-
ned by renal time echography with linear sound; hae
matocrit,cholesterol and triglicerides were under
control too.
Our data showed an higher incidence (44%) of sin
gle and/or multiple mono and/or bilateral acquired
cysts without side preference.
The statistical examination showed no relation-
ship with haematochemical parameters.
This high incidence of acquired renal cysts a—
mong haemodialytic population suggest that is real—
ly important to continue the studies to eventually
confirm this new dialytic pathology and to investi-
gate its connection with other parameters.
CARDIAC CALCIFICATIONS AND LONGTERM HEMODIALYSIS
U.Becker, G. Leimenstoll, W. Niedermayer
Department of Nephrology, University of Kiel,
Kiel, West-Germany
Osteodystrophy, soft tissue - and arterial
calcification are often seen in patients under-
going hernodialysts. The evidence of cardiac cal-
cifications is seldom been studied, though these
patients have a high risk for endocarditis.
Studied 2—dimensional by ultrasound - in these
patients - calcifications of the mitral valve
or annulus were detected in 26,3%, of the aortic
cusps in 8,8% and combined in 5,3%. There were
no correlations to biochemical changes or medical
treatment.
In epidemiologic studies especially mitral or
submitral calcifications are known in only
about 3% of all patients by echocardiograrnm.
The clinical significance is that those patients
have higher risk for endocarditis, mitral
regurgitation and dysrhythniias.
Therefore the 2—dimensional—ultrasonic investi-
gation 1st extrenily helpfull to control patients
with renal insuffiziency especially because
pericardial effusion can be detected by the
same method.
13—THALASSEMIC TRAIT AMONG HAEMODIALYZED PATIENTS IN
SOUTHERN ITALY COUNTRIES
A.Casuscelli di Tocco,G._Bellinghieri,F.Gioffre,
V.Savic,A.Sofi,F.Torr,V.Farina,A.Mallamac',A.
Reggio,F.Consolo'
Servizio di Nefrologia e Dialisi Ospedale Civile
Vibo Valentia e Istituto Pluridiaciplinare di Clini—
ca Medica e Terapia Medica Generale e Speciale'
Università di Messina
We performed an epidemiologic atudy in southern
Italy countries (Sicily, Calabria) where 13—thalassemic
trait is frequent,to evaluate the incidence of this
status among our haemodialyzed population.
959 patients,undergoing periodic haemodialysis,we
re studied by Hb electrophoresis technique.
The results showed an incidence of Jl—thajassemjc
trait(8,00%) and sickle cells trait(O,30%) among our
haemodialyzed population.We noted that this higher
incidence was registered around the Measina straits
area(11%);on the other hand in Reggio Calabria area
we found 6,2% .We,then,compared VCM,Hb,Ht and blood
transfusion necessity between 13—thalassemic and nor-
mals haemodialyzed patients:VCM and Hb were lower
among 13—thalassemic dialyzed patients than normals
dialyzed,while Ht and blood transfusion necessity we
re no significative.Our data showed that in southern
Italy countries(Sicily and Calabria) there is an
high incidence of 13—thalassemic trait also among hae
modialyzed people with more severe anaemia than oth-
er haemodialyzed population.In fact their ipoprolife
rative anaemia is worsened by ipocromic microcitic
anaemia of 13—thalaasemic subjects.
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TRANSPLANTATION IN CAPD TREATED PATIENTS
S. Benarbia, J.F. Brocard, A. Prutchansky, M.
Pocheville, G. Benoit, B. Charpentier, 0. Fries
Service de Néphrologie, HOpital Paul Brousse,
Faculté de Médecine Paris-Sud, 94800 Villejuif -
France
It has been suggested that the risk of infec-
tions after renal transplantation (RT) could be
increased in CAPD treated patients, especialy if
the incidence of peritonitis was high. From april
1979 (i.e. when CAPD started in our country), until
decembre 1983, 419 transplantation were performed
in our center. 17 of these patients were on a
CAPD programm : 9 women, 8 men : mean age 35.2
years (21-64 years) ; mean length of pre RI treat-
ment 13.5 months (1.5 to 45 months). Peritonitis
had occured in 14/17, with 3.2 peritonitis/patient
incidence. In 2 patients, peritonitis were observed
8 and 10 days before RT ; the peritoneal catheter
was removed during transplantation in these 2 pa-
tients, and was left in situ in the 15 others for
4-16 weeks after RI. Amid 6 post RI oliguric renal
failure, CAPD was employed in 5 patients, without
trouble. CAPD related complications occured in
only one case with a mild ascites for 12 days ; no
peritonitis were observed.
Conclusions : CAPD does not increase the inci-
dence of post RI complications and may be proposed
as the first method of dialysis before renal trans-
plantation.
SYMPATHETIC NERVOUS SYSTEM FUNCTION IN NORMOTENSIVE
CHRONIC HEMODIALYZED PATIENTS
D. Bernardi°, L. Bernini°, S. Ghione+, E. Nesti°,
A. Brandinelli Geri°, D.A. Urti°, I. Bonechi°.
(Intr. by R. Palla).
o Ospedale S. Fliniato, Pisa, Italy.
+ C.N.R. Clinical Physiology Institute, University
of Pisa, Italy.
The compensatory function of the sympathetic
nervous system (SNS) in fourteen normotensive ure-
mic patients on hemodialytic treatment just before
and just after a regular hemodialysis session was
studied by determining arterial plasma norepine-
phrine (NE) and epinephrine (E) before and after
postural activation.
Plasma NE and E levels resulted higher than in
normal subjects in every case. Before the dialysis
a strong direct correlation was detected between
the postural changes of plasma NE levels ( LI-plasma
NE) and the concomitant changes of mean blood pres-
sure ( LI-mBP). After dialysis: standing induced a
significant decrease of mBP, the relationship be-
tween LI-plasma NE and LI-mBP was absent and a si-
gnificant inverse correlation was found between the
postural changes of plasma E levels and LI-mBP. No
differences was detected between LI-plasma NE va-
lues before and after dialysis.,
In conclusion: 1) only before dialysis a strong
dipendence between sympathetic activity and pressu-
re response to orthostasis is present; 2) the basal
enhanced activity of SNS is unable to increase ef-
fectively in dialysis-induced hypotension.
A TRIAL OF INTRAPERITONEAL VERSUS INTRAVENOUS
ANTIBIOTICS IN THE TREATMENT OF CAPD PERITONITIS.
Bennett-Jones D.N., Eaton A. ,Taube D.,Wass V.,
Mawson P., Neild G.E. ,Rudge C.,Cameron J.S.,
Williams D.G.,Ogg C.S. GUYS Hospital, London UK
A randomised trial was conducted to compare
intraperitoneal (IP) with intravenous anti-
biotics (IV) in the treatment of CAPD peritoni-
tis. Forty five patients had 75 episodes of
peritonitis, defined as abdominal pain with
cloudy dialysate (>100 leucocytes/il). Peritoni-
tis in 39 episodes was treated with IP vancomy—
cm (20 mg/i) and tobramycin (4mg/i), while 36
episodes were treated with IV vancomycth
(0.5-1.0 G depending on bodyweight) and tobramy-
cm (1 mg/kg with monitoring of blood levels)
changing to appropriate oral antibiotics,
determined by culture and sensitivities, on day
4. Staph epidermidis was the commonest organ-
ism cultured (45%). Overall 90% of the patients
treated with IP antibiotics were cured (defined
by no recurrence within 28 days), whereas only
64% of those given IV antibiotics were cured
(p<O.O2)
In those episodes due to a tobramycin—
resistant organism we showed that IV vancomyci.n
is less successful than IP vancomycin (p<0.OS)
whereas we were unable to show a similar
difference for tobramycin when the organism
was vancomycmn resistant. The lower success
rate using IV antibiotics may therefore be due
to failure of vancomycmn given by this route,
rather than tobramycin.
LIPIDS AND AIjIPOP1I'EINS AS CRDICWASCULR RISK
FACIORS IN HNDDIALYSIS PATIENTS:A Ca>JTVSIAL
IOLE?
F.Bergesio,M.Salvadori,R.Ciuti,M.Bandinelli,A.Sa-
re.Iiocenti,E.Bertcni,V.Frizzi,A.Sodj.
Nephrology and Dialysis Units of S.Giovanni di Dio
arid S.M.Nuova Hospitals,
Florence, Italy.
In order to elucidate the clinical seaming of
lipids ,apolipoproteins, and other cardiovascular
risk factors in uremic patients (pts) ,123 pta on
naintenance heircdialysis (M.H.) were studied and
separeted into two groups according to the presen-
ce or absence of atherosclerotic vascular disease(A.v.D.) ,elicited either before or after the begin-
ning of dialisys. The pts, selected for having no
causes known to affect lipid netabolism,were then
evaluated for total cholesterol (I) ,Triglyceride,
HDL-cholesterol,apoprotein-A(apo-A) ,apoprotein-B
apo-B) ,HDL-Cholestorol/iC ,apY-A/apo—B, ¶L/apo—B
ratios, and for age,tirre on dialysis, body weight,
blood pressure,hematccrit and parathyyroid hortrone.
Neither lipidswith apolipoproteins ,nor the
three ratios exaxnined,did significantly separate
the A.V.D. group fron the control cne.?nong the ii-
pids,apo—A,although not significant,showed to be
the xrore relyable index for AVD.The only significa-
nt difference was found to be dialytic age ,lower in
the AVD group(p<O, 05) .Lipids and apolipoproteins,
contrary to normal subjects,do not seem to be a use
full neans in discriminating NH pta with AVD,and
then to represent important risk factors.
Perhaps other factors in pta on NH nay play a
sore iirportant role as cardiovascular risk factors.
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DESFERRIOXAMINE (D.F.O.) INFUSION TEST
MAY PREDICT BONE ALUMINIUM (Al) DEPOSITS IN
HEMODLALYZED (H.p.) PATIENTS
Y.BERLAND*, S.CHARHON**,M.GRANVUILLEMIN*,M.OLMER*
*Service de Nphrologie, Hop. Conception Marseille
**Inserm 1J234 Lyon FRANCE.
It has been shown that DFO infusion carried Out lfl
RD patients with osteomalacia. (OM) promote a peak
serum aluminium (S.Al) which was correlated with
the bone Al content (Milliner, et al Detroit 1983).
In order, to determine if DFO infusion test can
predict those patients with bone Al deposits from
patients without, we performed in 19 HD patients
a 6 g DFO infusion for 2 hrs during 4 hrs dialysis.
S.Al levels were determined before starting dialy-
sis (Ti) and repeated 48 hrs later (T2). A tran—
siliac bone biopsy was performed in each patients.
Al. staining procedure (aurine tricarboxylic acid)
localized bone Al deposits mainly at the interface
between osteoid and mineralized bone in 8 patients
(Al+) and did not in ii patients (Al—). In the Al+
group, 4 patients had histological evidence of low
turnover OM, 4 patients had a predominant hyper—
parathyroidism (H.P.T.). In the Al— group, 11 pa-
tients had HPT bone lesions (associated with OH in
only one case). Baseline S.Al did not allow to
discriminate reliably those patients with bone Al
deposits from patients without because of a large
distribution of the values. In contrast, 7 out of
8 Al+ patients had S.Al at 12 higher than 200IJg /1
(mean + SD:352.1 + i77.1jg/l).Whereas only 1 Al—
patient reached this critical value at T2 (143.5 +
38.1) (p<O.O5). These results suggest :1/DFO test
may predict those patients presenting bone Al de—
posits.2/Nethertheless a bone biopsy is still man-
datory to diagnose the type of bone lesions in Al+
patients since various types of bone disease were
associated with Al deposits.
LUND-ILR!! STUDY OF DIABETIC RETINOPATHY(DR)IN PERt-
TONEAL DIALYSIS(PD)PATIENTS.
fi.Feriani,M.Pedrotti,S.Biasioli,D.Borin,A.Brendolar
S.Chiaramonte,A.Fabris,C.Ronco,G.La Greca
Dept.of Nephrology,St.Bortolo Hospital,Vicenza-Ital
To verify if early PD could slow the progressior
of microangiopathy in diabetic pts with CRF,retini
fluorescein angiography(FA)was performed in 7 pts(i
males,5females;mean age 48.3 yrs;type 1=5 pts,type
11=2 pts),shortly before the beginning of PD(mean
serum creatinine 6.5±l.2mg%).Severe DR,both ischemi
and oedematous,was present in 14/14 examined eyes;
Laser-therapy(LT)was applied in 6 eyes.FA was repe
ted in each pt(5 CAPD,2 IPD)every 6 months:2 eyes
were followed for 24 months,2 for 18, 6 for 12, 2
for 6.Over these periods,the FA picture never prese
nted significant deteriorations,while 2 pts got wor
se for other diabetic complications(cataract,etc.).
These FA findings were retrospectively compared witi
those of 5 uremic diabetic pts on conservative trea
tment,cornparable for age,serum creatinine and DR:a
year later,in 8/10 examined eyes the retinic pictu-
re got worse.Early PD seems to be able,at least,to
slow DR.Whether this effect depends on the dialysis
itself and/or on the better metabolic control is
still unclear.The absence of worsening in the 6 LI-
treated eyes could be ascribed to LI itself or to
LI joined with early PD and improved metabolic con-
trol.Even in the latter case,LT,if early employed
together with PD,allow•s to get satisfactory results
ONE YEAR NUTRITIONAL EVALUATION OF CAPD PATIENTS.
S.Bertoli,R.Galato,D.Scorza,G.Barbiano di Belgiojo-
so,C.Rovati ,L.Radaelli ,L.Minetti.
Renal Unit,Niguarda Ca'Granda Hospital, Milan,Italy
In order to evaluate the nutritional status of
CAPD patients (pts), 20 pts have been studied by em-
ploying simple indexes of protein methabolism. The
pts were on CAPD from 3-6 mounths at the beginning
of the study. Age ranged from 55 to 78 years, mean
weight was Kg 68±11.8. At the beginning and after 12
iionths the following parameters have been evaluated:
Blood Urea Nitrogen (BUN GIL), Albumin (A G/L),Urea
Generation Rate (UGR 8/day), Protein Catabolic Rate
(PCR G/Kg/day), Total Protein Loss (TPL 8/day) ,Crea-
tinine Generation Rate (CGR mg/day), Dietary Prote-
mm (DPI G/Kg/day) and Caloric Intake (KCa1/Kg/day)
the last through a dietetic investigation performed
for 3 days. The results are reported in the table.
BUN UGR PCR TPL CGR DPI NB (DPI-PCR)
I
.57+6.7+ 0.93±9.4±16 1.1 +21.7+
2 2.1 .2 2.6 .2 .24 .7
II
.61± 5.9-i- 0.91+ 8.9÷ 13.7+ 1.04+ +17 +
.18 2 .17 1.8 .3 .23 .6
ns ns ns ns p(0.O5 ns ns
DPI, UGR and PCR are reduced but not significan-
tly. Nevertheless the nitrogen balance (NB) seems
still slightly positive. There was a significant re
duction of CGR, which is correlated to the varia-
tion of NB.
Our results confirm that CGR represents a relia-
ble index of CAPD pts nutritional status. The fin-
of a positive NB with time does not imply that
I,IWD pts are not exposeu to muscle wasting.
O AND L LACTATE (LI) PLASMA LEVELS AND AC1DBASE 8A
LANCE DURING LI HEMOFILIRATION (HF).
M.Feridrrj ,S.Biasioli,M.Pandjn,D.Borin,A.Brendolan
Chiarwsonte,A. Fabris,C .Ronco,M.Irevisan,G.La Greca
Dept.of Nephroiogy,St.Bortolo Hospital ,Vicenza-IIALY
The base balance(BB)in post-dilutional,middle ef
ficiency HF(ultrafiltraterange:l3—2lml/min)was stu
died iii 6 pts.L-LT concentration in reinfusionf1ud
was 4OmM/L.Blood samples(before and after the fil-
ter)were taken during the session(O,30,l2Omin,encl)
and 1 hr later;ultrafiltrate(UF)samples were taken
at the same times as the blood ones and from the fi
nal UF whole volume.The measurements of pH,pCO21Cc
(ILiJO2),TCO2(Corning965),L and D—LT(enzymatic me—
thod),iiiade in each sample allowed the following re—
iiarks:1)The total BBCtotal LI actually infused-(UF
LI + TCO2UF)3was positive after a single session
(l55+44m1/L).l3ut the weekly BB(buffer gain/weekwith
i-IF - Hgeneration/week)is apparently equilibrated,
while definitely negative if organic anions—lost ir
the bE-are considered(piruvate,acetoacetate,etc).2)
During the dialytic session,L—LI blood concentratio
rises(up to a maximum of l2.6mM/L),therefore the ma
ximum LI turnover rate is exceeded(2.26 versus the
normal 0.77mM/L).Ihe amount of LI infused(4OmM/L)ne
eded for a slightly negative BB,may alter LI metabc
lism,theoretically allowing an accumulation of it:
?.04+0.48nlM/L(NV=O.5-lmM/L),lhr later the session.
3)D-LT is present and accumulates in blood(before
the filter)(O°=O3;end=O.93;lhr later=O.63mM/L)and
it disappears as a slow metabolism substance.Wtir
a L into D conversion,due to L-LT high levels exists
and what it may result in,is still unknown.
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SINGLE NEEDLE PLASMAPHERESIS : COMPARATIVE STUDY OF
FOUR TYPES OF FILTERS.
Billiouw J.M., Vanholder R., Vermaercke N., De
Cubber A., Ringoir S.
Dept. Nephrology, University Gent, Belgium.
The present study evaluates the performance in
single needle plasmapheresis of 4 different filters
the Plasmaflo Asahi 0.1 m2 (n=21), the Plasmaflo
Asahi 0.5 m2 (n=26), the Hemaplex Dideco (n"16) and
the Capillary Plasma Separator Travenol (n=17). An
exchange volume of + 3 liters per session was ob-
tained in each grou.
The duration (D) per session, mean transmembrane
pressure (TMP) and plasmafiltration capacity (PFC)
were evaluated (table I).
Table I. Plasmaflo Plasmaflo Hemaplex
Asahi Asahi Dideco
0.1 m2 0.5 m2
Capillary
Plasma
Separator
Travenol
92.1 +
4.9
46.9 +
3.5
0.86
0 125.0 +
mean + SEN 4.7 —
TMP (iimHg) 70.9
mean + SEM 7.0
PFC (?ñl/ 0.40
mm Ng.min.
The highest plasmafiltration capacity per time unit
was obtained with the Plasmaflo Asahi 0.5 m2, the
results being intermediate with the Hemaplex Dide-
co and the Capillary Plasma Separator Travenol
In a second part of this study the extraction
ratio's of immunoglobulines (E, G, M and A) were
calculated as procentual changes from the beginninç
to •the end of the procedure. The highest extraction
ratio's were obtained with the Plasmaflo Asahi 0.5
IgE : 60,6 %, IgG : 59,6 %, 1gM : 60,9 % and IgA
63,2 %. The lowest ratio's were obtained with the
Hemaplex Dideco IgE : 35,6 %, IgO : 49 %, 1gM
42,9 % and IgA : 47,5 %.
PERSONAL TECHNIQUE IN SURGICAL TREATMENT OF TRUE
ANEURYSM IN ESRD PATIENTS WITH ARTERIO-VENOUS FIS-
TULA (AVF) FOR HEMODIALYSIS.
U. Bonalumi, G.A. Simoni, D. Friedman, E. Borzone
and F. Griffanti (Intr. by G. Gurreri)
Patologia Chirurgica I, Università di Genova, Italy
True aneurysm is a frequent complication in ESRD
patients who have AVF for hemodialysis. Operation
is indicated only when aneurysm is so large or so
adherent to skin as to risk the rupture. Operation
should aim at reducing the caliber of aneurysm,
maintaining the AVF functioning and utilizing the
corrected aneurysmal tract for puncture.
Ten patients, submitted to hemodialysis from a
minimum of 4 to a maximum of 8 years, with simple
or double aneurysms at distal forearm, underwent
operation which entails a skin incision parallel to
dilated vein. Aneurysm is completely isolated from
currounding tissue, excess vascular tissue is resec
ted on the side of the vein wall in such a way to
perform a lateral vascular anastomosis and to have
aneurysm corrected.
Operation resulted early complication free in
all patients. Forty days after surgery aneurysm re-
lapsed in a subject: it was corrected again with
resection of a small stenotic vein tract.
The utilization of such surgical technique makes
it possible to puncture the previously aneurysmatic
vein because the vascular surface exposed to the
trauma of the needle inserted for hemodialysis is
integer and not involved in the postvascular suture
healing process.
REDUCTION OF SILICONE PARTICLE LOAD IN HEMODIALYSIS
J.Bommer, E.Pernicka, J.Kessler, E.Ritz'LRambaUsek
• DFjiiETht Internal Medicine and Max-Planck-Instit.
fUr Kernphysik, Heidelberg, FRG
Deposition of silicone particles in viscera of
hemodialysis patients is a well recognized longterm
hazard of hemodialysis. Previous estimates of sili-
cone loads using chloroform extraction assessed on-
ly soluble silicone oligomers and gave low figures
(5o ug/5 h hemodialysis)(Leong,NEJM 1982). To eva-
luate spallation with different tubings and pumps,
we used an in vitro system and measured particle
counts and silicone with atomic absorption spectro-
metry. In a recirculation system (3oo ml saline
with a MD roller pump, Fresenius Co.) and silicone
tubing (ID 8 mm,wall thickness 1.8mm) using 25 rpm
28o ml/min, silicone particle release was assessed
at various occlusion forces (5-22 kp).Silicone par-
ticles were counted microscopically after quick fil
tration (Millipore) of an aliquot.Silicone in the
recirculation fluid was quantitated by measuring
silion (Si) using flameless atomic absorption spec-
trometry (serial dilutions, internal standard) .When
occlusion forces were reduced from 22 to 5 kp,the
roller pump by sifferent spring coila,silicone par-
ticle release per 5 h decreased from 5.6 o.9xlo9
to 3.9 * l.lxlo9 particles. In parallel,the silico-
ne amount in the recirculation fluid decreased from
1.6 to o.24 mg. By the adjustment of the occlusion
pressure the calculated annual Si load in hemodia-
lysia patients can be reduced from 25o mg to 36 ing
per year. Non-elastic deformation of silicone tu-
bing with hysteresis was seen in high, but much less
in low pressure. We conclude that reduction of occ-
lusion pressure effectively reduces spallation of
silicone tubing.
• INITIAL EXPERIENCE WITH HEMASITE VASCULAR ACCESS
• DEVICE (Hd) FOR MAINTENANCE HEMODIALYSIS
U. Bonalumi, G.A. Simoni, D. Friedman, E. Borzone
and F. Griffanti (Intr. by G. Gurreri)
Patologia Chirurgica I, Università di Genova, Italy
Eleven patients undergoing chronic hemodialysis
with unsuitable peripheral vessels for standard ar—
teriovenous fistula, received the Hd. There were 8
females and 3 males with a mean age of 55 years
(range 43—73). Mean follow—up was 7 months (1-13).
Under local anesthesia the Hd was placed in the up-
per arm between the brachial artery and the brachial
vein in a straight fashion by a double end to side
anastomosis with 6/0 monofilament suture.
One fistula thrombosed on two successive times
because of important hypotension episodes. In both
cases thrombectoniy was successful utilizing a Fogar
ty catheter through the device at the first, and
through the arterial suture line, at the second epi
sode. Another fistula thrombosed 45 days after ope-
ration and was successfully declotted by surgery.
Two patients died with still functioning Hd because
of causes not related to the presence of the device
Mean flow through the Hd was 730 + 91 mi/mm (6 ca-
ses) and 1088 + 235 ml/min (5 cases) at operation
and 4 months after, respectively. The devices are
still being used with enthusiastic acceptance by
the patients.
In conclusion the main advantage of the Hd is the
Dossibility of performing hemodialysis without need
les, maintaining the potential longevity of graft
fistulas. Main disadvantage is its high cost.
Abstracts
100.7 +
4.8 —
24.3 +
6.0
1.34
120.6 +
17.6
—
45.9 +
3.5
0.70
COr.:iLICATIONS CF PITE1MITTENT PERITONEAL
TIALYSIS /IPD/
y. Bores, F.r1ge1, T.Tóth
Department of Medicine, Tunty Hospital,
Keposvr, Hungary
Porty—t-;o patients with chronic renal
failure were treated with IPD during the
lest five years. Over this period 3192
IPP trestrnents were administered. The
mean time of treatment of one patient
was 7 months. A large number of patient
using commercial aoluticns /Peridisol,
iluman/ developed severe abdominal pain.
The occlusion of Tenckhoff or "repl—e
csth" catheter wee observed on 24 pati-
ents in 36 occasions. 7 patients
developed intreabdominal haemorrhage.
Perforation of vesice urinarie by
abdominal catheter occured in one patient
2ernle abdominalis wa observed on 3
patients who were treated over a period
more tbsn ten months. One patient
developed hiatus hernia. 24 patients had
a totol of 49 episodes of peritonitis.
The overall incideflce of tia complicati-
on vies one episode every 4 treatment
months. 2he organisms causing peritonitis
in 62 per cent of cases v'ere Gren nedeti—
ye bec:erie. The peritonitis of 29
epiaodes in 15 patients :'ecovered. Ii 3
a transfer to heemodialysis was
I 1dicaed hecsuae ol' sIbtesiones. ne
!sd due to perionit±s.
::poproeinso:ia :'ith gencralzed a"sm'
as chacrY in o pr ceit c p.enta.
- e'ectrolytT i '2 ceacs,
t-e lipid chsn-sa in 5 patla is wereohe'.
VASCULAR ACCESS FOR HEMODIALYSIS (HO)
OR PLASMA EXCHANGE (PE)
EXPERIENCE WITH PERCUTANEOUS CATHETER IN CHILDREN
F.BOUISSOU, M.REMEZY, C.WOOD, Ph.BARTHE
Med. Inf. C — CHU PURPAN — TOULOUSE — FRANCE
Per cutaneous vascular access with catheters is
now well established in adult patients. Few data
concern children. We report our experience in 23
pediatric patients (mean age By range 9m—16y).
This technique had been indicated in combination
with a single needle device (alternative clamp) for
RD (13 cases) or PE (10 cases). Insertion was per-
formed according to the SEDLINGER modified technique
(local or general anesthesia).
Size catheters was adapted to the age (VYGON
0:1 to 2mm
Three types of vascular access were used.
JUGULAR Vein 3
removal at
each seas.
6 40 days
(m= 19 d.)
.Few complication occurred (One partial pneumothora>
2 surinfections).Venous blood flow was good in most
cases
Percutaneous vascular access is useful and safe
in children ; it allows RD session in emergency,
it is faster than peritoneal dialysis, and gives
time for a CIMINO fistula. In very young children
general anesthesia is recommanded for the insertion
with X.Ray control, and jugular vein access is
easier than subclavian vein. Femoral access could
be reserved for a single session or when failure of
others accesses.
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MAY DESFERRIOXAMINE THERAPY WORSEN SECONDA-
RY HYPERPARATHYROIDISM 9.
J.Botella.,JL Gallego.,J.Fernandez.,D.Sanz-
Guajardo.,A de Miguel.,J.flamos. ,P.Lorenz.,
F.Berisa.,M.Salya.—TJniv. Autonoma Madrid.
Clinica Puerta de Hierro. ,Madrid.,Spain.
Patients with Aluminium Associated Bone
Disease (AABD) show almost normal serum PT!
levels; it has been described that DFO the-
rapy may worsen secondary hyperparathyroi—
dism in these cases.
We have studied 32 patients with high
serum Al (95.25 pg/l) and clinical,
radiological and bone scan signs of AABD.
All were treated with DFO, 1 g at each dia-
lysis session for 6 months. The control
group comprised 28 patients with lower se-
rum Al level (16.ol 4.52.62 pg/i) and with
no clinical nor radiological signs of AA]3D
though in 7 cases the bone scan was sugges
tive.
The treated group improved clinically
radiologically and in the bone scan, but
PTH rose from t.() to 6.28 ng/
ml (p(o.05). PTH was not 5ignificantly
changed in the controls (12.96 l7.3O vs
16.70 4.2O.2L ng/ml). In neither group were
there significant changes in Ca, P or Alk.
phos. Soft tissue calcificatjoris were simi
lar in both groups (7/32 vs 6/2P). Serum
Al fell in the treated groun to 35.01 4.
16.30 (p<O.OOl).
—
We conclude that DFO at the doses used
improves AABD and rises serum PTH, but
does not worsen the clinical, analytical
or radiological data of secondary hyperna—
rathyroidism.
MICROSURGERY, VIDEO—TAPE DEMONSTRATION, BRESCIA
AND CININO ARTERIOVENOUS FISTULA (A.V.F.) FOR
SMALL CHILDREN.
P. Bourquelot.
I-Iôpital Saint—Joseph, Paris, France.
Video—recording (through the microscope) is a
very impressive and efficient way of teaching how
microsurgery is useful to the creation of distal
A.V.F. at wrist in very small children.
Preoperative check—up, including phlebography
is briefly shown. The surgical microscope, the
microsurgical instruments and ligatures are des-
cribed. Emphasis is given to the importance of
experimental microsurgical training. Important
points of the surgical procedure are made clear
avoidance of spasm of the vessels whose diameter
is about one millimeter, confection of a long
side to end anastomosis with four non—interrupted
sutures, immediate verification of the permeabi-
lity with a Doppler apparatus.
42 distal A.V.F. have been created in 33
children weighing less than 10 kg 6 fistulas
thrombosed immediately, 17 fistulas have been
used for chronic hemodialysis until secondary
thrombosis or renal transplantation or death
occured (mean permeability 16 months), 16
fistulas are still on use since 6 to 57 months
(mean : 27 months), 3 fistulas are not yet on
use.
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OPSONIC DEFICIENCY IN SERA OF PATIENIS UN HAEMO—
DIALYSIS DETECTED BY LUMINOL DEPENDENT
CHEMILUMINESCENCE (CL)
S.P. Bramwell, E. Tonner, D.L. McWhinnie,
J.A. Bradley, J.D. Briggs
Western Infirmary, Glasgow U.K.
Cellular and humoral immune medianisms have been
inter6ively investigatel in patients with chronic
renal failure (CRF). Less attention has been
focused on non-specific host defence mechanisms
although these are recognised as beirg vital for an
adeluate response to the common pathogenic organism
encountered by these patients. CL has recently
been dribei as a sensitive means of assessing
serum opsonic activity and phagocytic function of
polymorphs (PMN). We have used this technique to
study peripheral blood PMN of 24 non-infected
patients with CRF (14 on hasnodialysis (HD), 10 on
CAPD) and 24 normal age-sex matched controls.
Under standardised conditions 10 PMN from either
patient or control were reacted with zymosan
particles previously cpsonised in either autologous
or heterologous serum and the CL measured over 15
mins. Results are expressed as average counts/mi n/15 mis. S.D. Usirg autologous serum-opsonised
zymosan, HO cells produced significantly less CL
than their matched controls (HD 123±57 control 174
p <0.01) but CAPU cells did not differ from
control values (CAPD 135±72 vs control 171±43
p >0.05). When sera from patients was used for
opsonisation, control cell CL was depressed by MD
serum (122±47 p<0.O1) but not by CAPO serum (144±
69 p>O.05). Control serum ertiancei CL in both HO
cells (160±62 p <0.05) and CAPD cells (mean 177±79
p<0.02) to normal control levels suggestir that
cells from CRF patients are cap&1e of normal func-
tion. The cpsonic defici ency denonstratel may
relate to the susceptibility of dialysis patients
to infection.
CELLULOSE ACETATE HAEMODIALYSERS ENHANCE
VASCULAR STABILITY DURING SHORT DURATION
ACETATE HAEMODIALYSIS (AHD).
B. Branaer .6. Deschodt ,R. Oulés ,C. Granol—
1 eras, D. Trei sss&de ,S. Shal don.
Dept. of Nephrology. CHRU NIMES FRANCE.
Previously during recirculation of blood
with cuprophan(Cu) vascular stability(VS)
was present during 30mm prior to dialyis.
Now, we have prospectively compared the
response of 7 stable ESRD patients during
Cu l.2m3dialysis with 1 cellulose acetate
1.4m1dialysis(Ca).The dialyses were 1 week
apart. A Monitral system with controlled
linear UF was used with dialysate Na 138.5
acetate 35.0,Ca 1.8 meq/L. UF rate was 0.4
L/hr. and dialysis lasted 3hrs.Cardiac
Index(CI)(IG.dye dilution) was measured at
end of 30 mm. recirculation prior to
dialysis and at end of dialysis prior to
wash—back.Mean arterial pressure (MAP)was
measured with a Dinamap. Total peripheral
resistance was calculated from TPRI=MAPx
B0/CI,Systolic index SICI/HR. Results are
shown Xchange(A> from pre to post dialysis
X MAP SI HR TPRI
Cu —13.3 0.6 26.3 —31.5
Ca —4.7 —10.7 23.1 — 9.7
ns 2.<0.05 ns 2.<0.05
The improved vascular stability with Ca
compared to Cu occurred during dialysis
but not before with recirculation (30mm).
This suggests a tardive rather than an
immediate mechanism, such as compliment
activation. But does not exclude a
secondary action of compliment on another
pathway.
EFFECTS OF HEMODIALYSIS AND APHERESIS ON LYMPHOCYTE
CELL CYCLE.
B.Brando, G.Busnach, L.S.Belli,A.Dal Col, M.L.Perri-
no, L. Minetti.
Renal Unit, Niguarda-CaGranda Hosp. Milano, Italy.
Peripheral blood lymphocytes were analyzed for
cell cycle state innediately before and after 20
hemodialysis and 29 apheresis procedures. Relative
DNA content was measured by propidium iodide incor-
poration in polyamine-Triton X-lOO buffer and flow
cytometry. Activated cells outside the G0 resting
phase were identified as the S÷G2M population and
their percentage was calculated. Pre/post seance
percent variation of S÷G2M cells was considered.
Hemolytic complement (CM50) was measured as well.
After hemodialysis on Cuprophan membranes a repro-
ducible post-seance reduction (-25.9%+ 10) occurred.
On the contrary, a trend towards an increased S+G2M
population was an almost invariable finding after
apheresis (÷34% -'-20). The highest increments were
observed in autoimmune diseases and in myelomas
with hyperviscosity. The effect of apheresis was si-
milar both with membrane and with centrifugation
techniques. Our data indicate a different behavio-
ur of lymphocyte activation patterns after extra-
corporeal circulation and plasma modification. In
hemodialysis complement activation occurs with re-
distribution of polymorphs and lymphocytes. In a-
pheresis procedures, the abnormal plasma removal
may reduce a negative feedback on lymphocytes, thus
leading to an increased amount of activated cells
in peripheral blood.
THE BLOOD LINES HAVE TO BE CONSIDERED IN THE 810—
COMPATIBILITY STUDY DURING ACETATE HEMoOIALYsIs(A}1;
B. Branger, D.Treissêde,R.Oulès, JP. Balducchi,
F. Michel, R. Rey, M. Treille.
Nephrology Department CHRU ,Nimes,France
Biochemistry Department CHRU, Montpellier, France.
Most of the studies of biocompatibility have been
done with only regard to the dialyser membrane com-
position. A possible role of blood lines (DL) was
neglected because of small area in contact with the
blood (about 3% of dialyser area). This one year
prospective study evaluated in 12 patients (6males,
6 females, mean age 51 years) the effects of two
different blood lines (O,036m2), other dialysis pa-
rameters beeing unchanged (cuprophan membranes 1,2
m2), as follow a first 3 months period with poly—
vinil chloride (PVC)BL, then 3 months with polyure-
thane extruded PVC (PE)BL, then again 3 months PVC
BL and 3 months PE BL. Following measures were ma-
de monthly white blood cells (WBC), neutrophils
(pn) and eosinophils(eo)counts, complement fractiois
(CH5O,C3,C4) at dialysis time O,3Omn,l8Omn. IgE
and thromboxane at time 0 and l8Omn. All values
were calculated with a correction for hemoconcentra
tion and expressed as percentage of change from to
initial values (, %).
Comparison of periods were made by using the Wilco—
xon test for paired observations. The table show
the significant results.
PVC PE PVC PB
—60.2 —50.9++ —57.0 —53.1+
—76.7 —65.5++ —65.3 —61.0+
—73.0 —63.2+ —68.3 —60.3+
observations, +2(ö.O2 ++2d.O.Ol
BL Period
Ah % WBC
O—3Omn
eo
For paired
PB versus PVC
In conclusion, the use of PB DL during AHD induces
less leucopenia than PVC DL and therefore should b€
considered when studying AHD biocompatibility.
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• SYSIOLIC TIME INERVAIS HEFORE ND FER HE'4O-
.
DIALYSISJ. Braun, H. Ruçpredht, U. Gef3ler
University Insitute of Nephrology, NUrnberg, F
Noninvasive measurement of systolic time inter-
vals is an acceptable method to predict changes inhemdynainics as caused by henrxlialysis (HD).
investigated 108 dialysis patients, age 54 12,
directly before and after hentxiialysis.
The fo1ldng parameters were measured by FG and
phcnocardiogram: heart rate (HR), pre-ejectiori-
period (PEP) left—ventricular—ejection—time(LVr). Fran this data we calculated ejection-
fraction (EF) using Gerrads fornula (EF = 1,125
— 1,25 x PEP/LVFT).
Change in EF was correlated to predialytic EF
and to predialytic cardio—thoracic-ratio (CYrR).
We found, that if the predialytic EF> 55%, post—
dialytic EF decreased by alut 10%. Iiever if
predialytic EF<55%, postdialytic EF increased by5%. The higher the CrR the ler the decrease of
EF during HD. In patients with a CrR0,55, EFfell fran 64% to 61%, hcQever in patients with
CI'R<0,4, EF fell fran 67% to 44%. Patients with
a low dR have a significantly higher increase of
HR (23,4 h/mm), than patients with a high dIR
(13,9 b/mimi) after HI).
There is a negative correlation between change
in EF and weight loss during HD in patients with a
predialytic EF> 55%. HcMever in patients with
EF<55% we found a positive correlation between
the ts..v parameters.
We conclude that measurement of systolic time
intervals can be useful in predicting ideal weight
of certain dialysis patients.
A NEW AUTOSTERILIZING CONNECTION SYSTE
FOR CAPD.
U.Buoncristianj ,P.Bianchio ,M.Cozzari ,N.Di
PaoloW,C.Carobi.
Dialysis Units,Perugia E Siena*— Institute
of Infectious Discases,Perugia — Italy
In order to reduce peritonitis inciden-
ce in CAPD patients we set up a new connec
tion system consisting of a) a small
prosthesis fixed on the catheter (a short
tube closed with a clamp at the end near
the catheter and with a cap at the free
end,fillod with disinfectant between the
exchanges); b) a long transfer set ending
in two sterilization chambers at the two
extremities to be connected with the bag
and the prosthesis respectively,and the en
tire system filled with disinfectant aftcr
the connection. We tested the efficiency
of the system in vitro,contaminatjng the
two connection sites with Pseudomonas Aeru
ginosa(8x1o9 baeteria),staphylococcus Au—
reus(2.lxjOlO bacteria) and Candida Albi—
cans(2.1x108 mycetes). No growth was obser
ved in any of the tests with the disinfec—
tant,whereas a regular growth was observed
in the control tests using only a washing
with the dialysis solution. Thus,on the ba
sis of such good in vitro results,and in
view of the advantage of eliminating the
need of wearing the bag,we began an in vi—
vo trial which is underway and has shown
encouraging preliminary results.
TRANSPORT OF PROTEINS ACROSS THE PERITO—
NEAL MESOTHELIU IN VITRO
A.Brehorowicz, J. Knapowski
ept.of Pathoohysiology,Medicrl Academy,
Poznati,Pola-rid
It is proposed thot proteins are trans
ported across the peritoneal mesothelium
b pinoc'vtosis.To find out factors deter—
mining this process we performed studies
on the monolayer mesentery mesotheliuxn ob
tamed from rahbits.Effect of cytochola-
sin B/5ug/ml/,colchicmne/1O1ol/1I.vera—
parnil/1O—5'bl/l/,calciurn ionophore A23187
/1O—5ol/l/ and local anaesthetic hupiva—
caine/O.25no1/l/ on the transmesothelial
transport of albumin was evaluoted.
Cytochalasin B and colchicine decrea-
sed transepithelial transport of albumin
by 33% and 54% despite simultaneous in-
crease of the rnesothelial permeability to
small and rnicdle molecules.
Pinocytonis within the mesothelial
cells seems to be dependent on the defi-
ned intracellular calcium concentration
as both increase of the intracellular cal
cium with A231A7 and decrease of the in-
tracellular calcium with verapemil inhihi
ted transport of albumin by 26% and 27%.
Bupivacaine acting both as the cytoske
letal poison and cnlciwi channel blocker
decreased transmesothelial transport of
albumin by
It seems possibly,that substances in-
fluencing function of the mesothelial cy—
toskeleton and/or changing intracellular
calcium concentration within the mesothe—
Hal cells may diminish the loss of pro-
teins during peritoneal dialysis.
LONG ThOM CLINICAL,fETABOLIC AND LOCISTIC
RESULTS WITH DAILY HECYCLED BICARBONATE
DIALYSIS WITH POLYACPILON1TRILE iEBRANES.
U.buoncristiani,L.Ciombjnj,N.Djpaolo*,tj.
ROaiol0÷,i.Cozzari,C.Carohi.
Dialysis Units, Perugia_Siena*,Città di Ca
stello,Ascolj Pieer:o+, Italy.
Eight patients previously on standard
hernodialysis have been treated for 12u—810
days(meac 390) with a new schedule consi—
sting of daily short sessions(9U rnin.),u—
siru a rew portable kidney recyclinr at
high flow(lOo—10oml,mir.) 2o—2 liters of
a solution containing bicarbonate as buf-
fer and no K .1olyacrilonitrile membranes
were used and a mean blood flow of 275m1/
sin was obtained through a double lumen
coaxial sim1e needle. Long term results
are even better than the already good
short—term results. The most important are:
significant reduction of the middle molecules and increase of hematocrit;pil and UCO3
almost stable in the normal range;easy con
trol of dry weiFht and excellent intradia—
lytic tolerance in spite of the high 4
weight (l.5kg,hour);normalizatjon of blooo
pressure in hypertensive and hypotensive
patients;norrnalization of platelet functi-
on and improvement of clectromyogram;signi
ficant increase of general well—being,ap—
petite and muscular strength.Particularly
appreciated is the semplicity and portabi-
lity of the machine,and the short schedule
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CPPD PERITONITIS: 10 OR 21 DAYS TREATMENT?
P.Altmann, K.Butter, J.Cunningham, P.Drew,
F.Goodwin, F.Marsh.
The London Hospital, London, England.
Home CAPD patients who presented with uncomplic-
ated peritoneal infection, having been free from
peritonitis for 1 month, were randomly allocated to
21 or 10 days treatment with vancomycin (V) and
gentainicin (G). Over 7 months 49 episodes of inf-
ection occurred in 31 patients out of a population
of 80. Dialysate cultures were positive in 51.8%;
of these Staph. epidermidis accounted for 40%,
Acinetobacter 10%, Pseudomonas 10%.
At presentation V (500mg iv) and C (lOmg/l dial-
ysate in alternate bags) were given. At 48h, acc-
ording to bacterial sensitivity, V (lSmg/l dial-
ysate) or G were continued; both were continued for
"sterile" peritonitis.
All patients responded clinically. 28 episodes
were treated for 10 days: 6 (21.4%) were followed
by further peritonitis within 28 days of the end of
treatment. 21 episodes were treated for 21 days: 7
(33%) likewise developed peritonitis. The differ-
ence was not significant. 5 patients, all of whom
had received at least one 21 day course of G, dev-
eloped clinical evidence of vestibular damage; none
of those patients who had received only 10 day
courses of treatment developed this. The study was
therefore terminated.
We conclude that treatment of CAPD peritonitis
with vancomycin and gentamicin is effective but
potentially toxic. Although further study is nec-
essary, 10 day courses are adequate and, more
important, safer.
INTERNAL 3UGULAR VEIN (LIV) CANULATION WITH 2
SILASTIC CATHETERS (CT): A SAFE VASCULAR
ACCESS FOR HAEMODIALYSIS1O-ID)
B Canaud, 33 Béraud, H 3oyeux , C 1Mion.
Divisions Nephrology and Surgery , University
Hospital, Montpellier, France.
In spite of recent progress, blood access for HD re-
mains a problem in many patients with acute (ARF) or
end stage renal failure (ESRF). To overcome the limita-
tions of subclavian CT, we developed a technique using
2 silastic CT implanted in LIV. The radiopaque CT were
30 cm long, 2 mm ID/3.3 mm OD, with an intravascular
segment perforated with 6 side holes on distal 5 cm.
After canulating one LIV (Seldinger technique) through
a small skin incision (.5 cm), the 2 CT were successi-
vely inserted into the vein lumen through Desilet intro-
ducer with one CT (venous return) placed 4 cm deeper
than the other. The extravascular segments were then
tunnelled subcutaneously 7 cm below the internal 1/3
of clavicle. CT were fitted with luer lock adaptors.
Since November 1982, 79 CT were used in 79 patients
(53.3+14.5 y.o.; 40 M, 30 F) for a mean duration of 43
daysrpatient (range 1-269 days). 18 dialyses (average)
were carried out during each period of canula insertion
for a total of 1434 sessions. Indications were: ARF 25
pts; ESRF: start of treatment:26; HD pts with fistula
problems:15; complications of CAPD:13. CT filled with
heparin at end of HD were easily declotted at begining
of next session. Blood flow was 219+20 mI/mm (SD),
recirculation 6+2% and correlated positively with ve-
nous return pressure (slope: .51; r=.94). Only 2 compli-
cations were observed: 1 incomplete intravascular
thrombosis proven by phlebography, treated with local
urokinase infusion; 1 skin exit infection with septicemia
cured with ATB without CT removal. Ely-CT offers a
convenient alternative to conventional vascular connec-
tions and can safely be used even in long term HD.
UREMIC METABOLISM DURING HIGH EFFICIENCY ON LINE
HEMOFILTRATION (HEHF)
S.David,V.Cambi,M.E.Ferrari,R.Barsni,G.Savazzj,L.A
risi ,R.LugariV.Nico1otti(A.Gnudi*C.Buzjo.
Cattedra di Nefrologia,*Cattedra di Endocrinologia.
University of Parma, Italy.
HEHF with 32 1 of substitution solutions was car
ned out in 4 clinically stable patients on hemodi-
alysis(HD).Comparative studies were performed dur-
ing HD and 3 mts after the start of HEHF.Urea gen-
eration rate(GUN)was evaluated by kinetic methods.
Carbohydrate metabolism was studied by i.v.glucose
tolerance test.Growth hormone(CH)and Glucagone(G),
insulin counteracting hormones,were evaluated by Ar
ginine(A)test ,and Prolactine(PRL)was also dosed.Pe—
ripheral neuropathy was studied by motor nerve con-
duction velocity(MNCV)tests.High molecular weight
solutes(500—1500)(MM)were measured in serum,dialysa
te and ultrafiltrate by G15 Sephadex chromatograph)i
HEHF didn't modified GUN.In both studied periods
an equally reduced glucose disappearance Constant
was obssrved,without any difference in insulin re—
lease.GH was higher in HEHF(pO,05)either in basal
condition or after A infusion.High plasma G levels
were detected in both MD and HEHF,irresponsive to
A testMNCV increased in HEHF(p(0,05)as well as MM
serum concentrations significantly fell.Increased
GH and reduced PRL in HEHF may be explained by a
more effective dopaminergic activity in HEHF.
In conclusion HEHF improves the performances of
autonomic and peripheral nerve system.
DECREASING THE INFECTION RAT.E IN HAEMODIALYSIS:
A BACTERIOLOGICAL SURVEY.
JB Cannata, R Cimadevilla, E Suarez, A Moreno,
V Cuesta, V Peral, J Herrera.
Hospital General de Asturias Universidad de Oviedc
Oviedo, Spain
Infectioris(INF)are still an important cause of
morbidity and, mortality in haemodialysis(HD). As
our HO unit had a high staphylococcal(Staph) INF
rate:O.5 INF/pt/year(y) (92% of all our INF/y) and
66% of our deaths/y ,we decided to improve our
working scheme implementing morestrict norms" and
carrying out serial epidemiological(EPD) studies
amongst pts and staff to evaluate the new policy.
The main changes were: scrubbing hands and arms
in theatre fashion for pts and staff, vascular
access(VA) punctured once local antiseptic dried—
out, eating prohibited in HO unit, no treatment of
Staph carriers.
During the EPO controls we took 535 samples from
nose,nails and VA. The criterion to diagnosis INF
did not change throughout the 48 months study
taking 452 haemocultures and 595 samples from the
above mentioned areas because of suspected INF in
the 62 studied pts.
One year after implementing thestrict norms"
the rate of Staph INF/pt/y decreased to O.l9(p 001)
and the number of carriers also decreased. Three y
after the'strict norms" the rate was 0.07 compar-
able to our home HD pts(O.O6). The incidence of
non—Staph INF remained low troughout the study and
there were no death due to any kind of INF with
the new strategy applied last three y.
Our results stress the need to maintain "strict
working norms" to avoid the risk of spreading
bacterial contaminations and INF in HO units.
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BLOOD PRESSURE (BP) CONTROL DURING HAEMODIALYSIS
(I-ID) AND CAPD. A COMPARATIVE STUDY IN PATIENTS(pts)
HAVING BOTH FORMS OF TREATMENT SEQUENTIALLY.
JB Cannata CG Isles, JD Briggs, BJR Junor.
Hospital General de Asturias? Oviedo, Spain.
!stern Jnfirmary.MRC, Glasgow, Scotland.
Several authors have suggested that CAPD permits
better BP control than HD but to our knowledge
there are no comparative studies in pts who under-
went both forms of treatment. Pts with hypertensicil
(HPT) and end—stage renal failure (ESRF) treated by
HD for a minimum of 6 months(m)and then by CAPO for
a further 12 m were elegible for the study. Nine pt
satisfied these criteria.
BP was recorded sitting or lying,in HD by the
nursing staff and in CAPD by th pts themselves. HD
pts underwent 12 hours dialysis/week,CAPD pts had 4
2 litres exchange daily. Anti-HPT drugs were given
dhen HD plus ultrafiltration or CAPD with hyper-
tonic dialysate failed to mantain a diastolic BP
<95 mmHg. The mean ( SE)of the first 7 BP read-
ings for each month of both periods were compared
using paired t—tests. In order to validate the
comparison of BP taken by different means,BP read-
ings of nurses,CAPD pts and one of the authors were
compared finding good agreement among these 3 sets
of readings.
After 1 m of CAPD there was a significant fall
of systolic(p<OO1)and diastolic(p<OO5)BP,this fall
was niantained over the subsequent m. This better BP
control on CAPD was achieved despite withdrawal or
reduction of anti-HPT therapy in all pts. While the
pts body weight remained stable during HD,after 6
m of CAPD there was a significant weight gain.
This results suggest: In ESRF the presence of
severe HPT should probably influence the choice of
treatment in favour of.CAPD rather than HO.
ALLPUNIUM GASTROIPrESTINAt. ABSoRpTIoN IS IT ROOIJLATED BY TUE
IRoN-ABSORI'IVE M52HNISM ?
JR Cannata, E Suarez, V Cuesta, B Rodriguez, A Sanz-Medel,
V Peral, J Herrera, 3 Perez ILanderal.
Hospital General de Psturias. Facultad de Ciencjas Quimicas.Universidad de Oviedo. Oviedo. Spain.
It has been recently reported that a number Of smtals(lead,
cadmium,cobalt( could be absorbed by the iron-absorptive
itechanism. Thus, an iron (Fe) deficiencies, increased aziount of
then s.ould be absorbed. On the other hand ,aluminiuni(Al) gastro-
intestinal absorption has been proved bit Its irechanism is
still unknown.
Therefore, the aim of this study was to investigate whether
haenrxuialysis(Ho) patients(pts) with low, normal and high Fe
stores have similar or different patterns of Al absorption.
We studied 30 HO pts dialyzed with the saire schedule using
low-Al dialysate. Pa the table shows we f coned 3 groups (G)
according to their serum ferritin(S Ferr) levels. During 7 days;(Period I) all pts received Fe sulphate and Al hydroxjde(Al(OH)3)in the dose they were currently having to keep serum phosphorous(P) between 1.5—1.8 rnnol/l. At the end of Period I all pts were
stopped the oral Fe and during further 7 days all received the
sane dose of Al(OH)3 (2.8 g/day) (Period II).
As the table shows, in all groups the change of dose irent a
significant increase of Al(OH) intake being the highest (p.0a(X)5)
in 0 III(Hlgh S Ferr). Neverthless, this group was the on1y wto
did riot show any ssçortant increase of serum Al fran Period I
to Period II. When we ccaared the rate:Al(Clj)3 doss/Serum Al we
found no significant (HO) changes in 01 ai8fi aa ihIy
significant result(piO.w2) in G III dasonstrating that despite
a significant increase in Al(Cft) intake in all groups, CIII wasthe only who did not have a proprtional increase in serum Al.Period I Period II
sr i CI Gil CIII CI CII CIIIerr (ng/ <10) 102—250 >250 <ICE) 102-250 >250
(Mean) (48) (149) (464) (48) (149) (464)82
Al (OH)3/ Al (p) MS MS n.W2 MS MS o.022Serum P (rmrol/1) 1.7 1.66 1.46 —— ——
In Period II the sern Al values frcm GI and Gil were
statiscally different to those of C III (p<O.025).
hence,from our results we could think that the"canioni path-
way of itetal absorption" is also indicated in Al absorption.
If so,pts with repleted Fe stores would have less chance to
absorb Al and thus the levels of S Ferr might be a gcoi index
to predict Al absorption and may be Al)0fl) necessities. This
would also explain partially the wide rang of individual
variations in Al gastro—intestirial absorption.
. ASSFSSXM 'on-: BI-IJEFIT OF aLie4Gt ALLrIINIUM ivososrot-:SQ(EDULE 04 liNf\FJ4IA AND SERUM PIKPIIOJS (P) C0VWL.
35 Cannata, E Suarez, C Rodriguez, V Cuesta, V Peral,J Herrera.Servicio do Nefrologia. Hospital General de Mturias.
UDiversidad de Oviedo. Oviedo. Spain.
Even t!mgh there is increasing evidence that aluminium (Al)
could influence anaemia, little has been said ait the role of
Al (OH) on erythropoiesis by its absorption and further taie
marrow toxicity or by its likely interaction with iron(Fe) into
the gastro—intesttha-l tract.
We therefore ,progressively evaluated in an increasing nun*mr
of patients (pts) on hammidialysis (HD) the binder efficacy of
changing the Al (OH) administration policy by stopping the breakfast dose (using it once or twice daily instead of thricely),
likewise its likely influence on the control of anaemia.
During the whole study we maintained the sane dialysis strategy
using low-Al dialysate and the sate restrictive blond trans-
fusion (Br) policy. All pta received fasting oral Fe sulphate.
This abstract sumnarises the results fran the first 27 pts
included (pilot group) *e caidletad 2 years follow-up after the
change, likewise the progressive results fran the whole Ho unit
according sore pts adhere to the new schema.
In the pilot group the significant Al(C*() reduction(p'cO.02)
fran v.9±4 to 5.6±3 tablets/day did not uddify the serum P
control (1.640.3 to 1.640.4). Nevertheless,the haaicgicbin(Hb)
increased fr&i 8.0+2 to 9443 remaining stable thra4*ait the
seid year and the nunr (N) of ur reqaireaants decreasedfran 3,19 to 1.22 units/pt/year. At the end of this period only
27% of these pta had serum Al values higher than 2.5 uisol/l.
The main results fran the whole HI) unit are suimiarisod in the
table showing the henef it achieved in control of anaemia accord
ing to the progressive adherence of pta to the new policy. The
N of Al (OH)3 tablets/day decreased fran 8 (yearl-2) to 4.7 (year 6)
years 1 2 3 4 5 6N of pta in the ND unit 27 30 39 42 45 57Cunulative % of pta 0 % 0 % 23% 43% 60% 102%new schedule
Serum P (Imiol/l) 17404 lfr'04 1,6404 17305 1,7404 1,7405
Hammiglobin (g/dl) 7.4+2 7.4+2 7.9±2 8.6±3 8,4±3 8.6+3
ST (units/pt/year) —— 2.6 2.8 1.8 1.7
I BT3CX) ml packer) red cells 4 Begining of theor 5(5) ml whole blood, pilot group.(Air results support the hypathesis that Al could interfere
the erythropoiesis and stress the necessity of reassessing P
binders tailoring the dose according to the different proteinintake patterns,
EXIT SITE INFECTIONS IN PATIENTS ON CAP)).
A. Cantaluppi , C.Castelnovo ,A.Scalaniogna, L. Guerra,
G.Graziani ,C.Ponticelli.
Div. of Nephrology,Ospedale Maggiore,Milano,Italy,
Twenty—six episodes of exit site infection,defi—
ned as purulent discharge from the exit mite with
positive culture,were diagnosed in 24 out of 68 pts
(24 F and 44 M,mean age 54±15 years) treated by
CAPD for 19±12 months with two—cuff Tenckhoff cathe
ters.The rate of infection was 1/49.5 pt—months:
Staph. aureus was isolated in 18 cases,Staph. epi—
dermidis in 6,Pseudomonas aeruginosa and Serratia
marcescens in 1.
In 14 episodes infection was cured within 15—20 days
by the daily topical application of antibiotics (RI
famin)assocjated (6 cases)with oral antibiotics(Rj—
fampin ,600mg/day).
In 10 cases,in which the previous therapy failed to
eradicate the infection within 20 days,the outer Da
cron cuff was removed and general antibiotics were
started(Cefazoljne and/or Rifampin).In 8 cases infe
ction was cured,but in the remaining 2 cases the ca
theter had to be removed.
Finally,in 2 cases the diagnosis of exit site infe-
ction was made in occasion of a peritonitis episode
due to the same organism responsible for the exit site
infectj.on:in both cases catheters had to be removed.
In conclusjon,exjt site infections represent a
frequent cause of morbidity in CAPD pts,which can
require removal of catheter in about 15% of pts.
546 Abstracts
CLINICAL AND LASORATORIAL FEATURES OF
PRURITUS AMONG 220 PATIENTS UNDERGOING
MAINTENANCE HEMODIALYSIS.
J.Pinto;P.Leitao; I .Rodrigues;A.Vaz;J.Vinhas;
J.Silva;L.Aguilar and F.Carrera.
NMC—Centro Medico Nacional. Renal Unit.
Lisbon. PORTUGAL.
'F he present survey was undertaken to investi-
gate the prevalence, severity and character
of pruritus among 220 patients undergoingHD and his relationship with laooratorial
data. We did not considerer patients with
less than four months of Hi) and all of them
were examiiiated by a dermatologist.
The X2 statistic was used to test for signifi-
cant differences in proportion and Student's
t test were used to compare population means.
Only 37(17%) refer uncomfortable pruritus.
Arilong this group 26(70%) had generalized
?ruritus ar..d ll(3C%) had localized. 7(l%)
u(oi%j moderate. i43b%) constan
and 2.3(62%) occasional.
w ccrrelate the different clinical presenta—
iom of pruritus with age, sex, durationf ), BUN,Ca,Phos,Alk.Phoc,CaxP, PTH and
the presence of Xerosis. \'e found a signifi-
cant correlation (p 0.03) with the presence
of Xerosis and constant pruritus. The others
biochemical parameters did not differ statisti-
cally with regard to clinical forms of pruri—
tus.
AUT0N0lJ EUH0PATHY IN .HEi0OI[LY3I3
PATIENT3 (Hp): BHC.lriLEI23 Id THE
INTElDIAL(TIC PH.3E.
P. lacovoni, 0. alcagni, .lorosetti,0. Gerrnan, .. :.:eloni, :1. 3onfiglio, P.
Fortezza and J.U. asciani.linica hirur<iea, II (Jniversitä diHoma
Uthough an inadenuate reflex control
of the oardiovascular function secondary
to autonomic deficit is known to be pre —
sent in HP, the nature of the autonomic de
ficit is still controversial. ihjle seTe—
raE observations concerning the dialytic
phase are reported, informations coricer —nj the intel-dialytic phase are scanty.
19 non diabetic HP, on chronic hemodialy—
cia vere studied. Baroreflex stinmüation
was applied by —45° diving and +70° til-
ting of a tilting bed developped hr the
authors, and by the Slalsalva manoeuvre,
while a continuous EOG was recorded end
the arterial pressure was monitored with
an automatic device. .liean Valsalva ratio(R..,ax/:i Un) was 1.48 + 0.18 3D. The
diving — tilting test showed the following
findings: P13 — 3 12 D mm Hg;
H +11 ÷ 7 L/niii. The data suggest
that a parasympathetic inhibition prevai-
ling on the adreno—sympathetie activation
is responsible for the baroreflex stimla—
tion in the interdialytic phase.
CHANGES IN BODY COMPARTMENTS ON DIFFERENT TYPES
OF HEMODIALYSIS
M.GarcIa, M.Carrera, C.Piera, R.Deulofeu, X.Com—
pany, J.M Pons, J.Montoliu, J.Setoain, L.Revert
Hospital Clinic. Barcelona. Spain.
The aim of this study was to evaluate plasma
volume (PV), extracellular volume (ECV) and intra
cellular volume (ICy) in "conventional' hemodialy—
sis (HD) and hypertonic HD.
Thirteen patients were studied. Seven patients
weighing 65.55+9.44 Kg were on conventional HO
3x4 hrs/week with a dialysate containing 138
mEq/L of Na and having an osmolarity of 305 mOsm/
L. Other 6 patients weighing 58.85+5.26 Kg had
been for a 1 month on a stable regimen of hyperto
nic ND 3x3 hrs/week using a dialysate with 130
mEq/L of Na and 295 mOsm/L and perfusing 342
mEq of C1Na during the first hour of HD.
125One ur before HD, the spaces oç RIHSA— I
(Pv), SO4Na (initial ECV) and H 0 (total
water) were détermined. The plasma al7bumin was
meagred hourly and at the end of HD the space
of SONa2 (final ECV) was again tested. ICV=To—
tal water — initial ECV.
In conventional HD with a weight loss of 1900+
+387 g, PV and ECV diminished 14.5+6.4 and 19.2+
respectively and ICV increased 1.7±3.3%,
showing that weight loss was exclusively due
to ECV with a subsequent hyperhydration of ICy.
In hypertonic HO with a weight loss of 1866±668
g PV, ECV and ICV decreased 5.4÷4.5, 10.4÷7.4
and 3.4±3.8% respectively, indicating that weight
loss was due to ECV in 54% and to ICV in 46%.
IN contraposition to conventional HD, the
use of hypertonic methods in HO allows dehydra-
tion of the intracellular compartment and main-
tains better the PV during HD.Iaotopic tehcniques
were useful for evaluating the distribution of
weight loss.
IIPVNT OF HISTOLOGICAL OSTEITIS FIBl)SA IN
PINTS TREATED BY CONTINWUS ANBITLATORY
PEBITONEAL DIALYSIS (cAPD) 'OR TWO YEARS.
M.J.D. Caeeidv, LA. Ellis, J. P. Owen, L. Sellars
H. Wilkinson, M.K. Ward and D.N.S. Kerr
tniveraity of Newcastle, Newcastle upon Tyne, LI.
17 patients who had been treated for end—stage
renal failure by CAPD and who had not been on
maintenance haemodialyeis prior to this were
atud.ied. All patients were on CAPD for over 2
years and had paired trans—iliac bone biopsies
close to the onset of CAPD and at 22 months or
over (range 22—29 months). Whilst on CAPD mean
serun ion.tsed and total caloiun rose and mean
serun phosphat. and calciun x phosphate productfell. Nean aerun magneei.a rose to above the nor
mel range and remained elevated, over the 2 year
period. Serum aluminium recorded 6 monthly in 15
of the patients ranged between 15 g/l and 56 ug/L
At the onset of CAPD secondary hyperparathyroid.tem
(2°HP) was detectable radiologically (erosions) in
29%, aerologica].ly (parethyroid horace.) in 59%
and histologically in 7 of cases. examination
of paired bone biopsiea0show.d improvement in the
histological grade of 2 HP in 11 patients, it
remained static in 6 and deteriorated in only 1.
Paired osteoclast counts fell (p =<0.01) and thedegre, of fibrosis decreased (p =<O.05). A
greater number of patients taking I ohydroxychole—
calciferol for 6 month. or more improved (5 out
of 6 v 6 out of ii). We conclude that treatment
CAPD resulted, in improvement of the degree of
2 HP in our patients and that this was more
evident in those also receiving 1 c'hydzoxychole-
calciferol. Whether th. persistent hypemanoe—
aemia present in these patients had any effect in
suppressing parathyroid homone secretion remains
to be established.
COMPUTERIZED PROGRAMME TO COMPARE TOLERANCE OF RDT
PATIENTS TO DIFFERENT DIALYSIS SCHEDULES
F.Lonati, B.Pea and A.Castellani. Nephrology and
Dialysis Unit, Umberto I Hospital, Brescia, Italy.
In the attempt to compare rapidly,easily,andwitt
ductility the tolerance to different dialysis sche-
dules we have carried out a computerised program ap
plicable to a personal computer (RAM:256 MBytes).
The following data were collected for each dialy
sis,subjected to automatic quality control and then
compacted and recorded:pre dialysis and minimal bin
od pressure (BP),pre and post dialysis body weight
(BW),clinical acciderits,number of symptomatic hypo—
tensions (SH),the time of appearance of the first
SH,the saline and/or hypertonic sodium chloride bo—
lus injected.
The data recorded and the ones matematically de—
ducted(mean BP,ABW,BP and so on)can be quickly cal
led for a single patient or for a choosen group,for
a selected period or for the total period of each
scheduie,and then elaborated.
In a few seconds it is possible for each parame—
ter:i)to get graphic trend visualisation;2)to calcu
late the mean,standard deviation, % frequency;3)to
compare different periods (T test,T test for paired
data,,2 test);4)to research linear correlationa bet
weeri the different parameters with visualisation of
regression line and points scattering;5)to evaluate
the changes of frequency during the time by the use
of cumulative sum technique (CUSUM).
A first application was done to analyse the sub-
stitution of bicarbonate(B)in place of acetate(A)in
18 patients with frequent SH in a standard dialysis
schedule.The patientm were studied in A for a mean
of 6 months and when long term stabilisation was ob
served they were swichted to B for a mean of 13 mon
the Stdiliaation was observed after 30 B.No significant
differences were observed for all analysed parame-
ters when stabilisation periods were compared.
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PHYSICAL FITNESS (PF) AND THE METABOLIC PROFILE(MP)
OF TWO SELECTED GROUPS OF DIALYSIS PATIENTS.
D.C. Cattran, F. Thome, S.S.J\ Fenton, W. Geisler,
G. Steiner, J. Harrison, 0. Javit.
Department of Medicine, University of Toronto,
Toronto, Ontario.
We compared 31 patients PF and NP prior to
starting an exercise program. Age, smoking, and
alcohol history were similar in the 17 hemodialysis
(HD) and 14 continuous ambulatory peritoneal
dialysis (CAPD) patients. Differences were sex
ratio: ND CM/F 15/2), CAPD (N/F 4/10) and treathient
duration HD (7O5O mo.) vs. CAPD (2ll5 so.).
Nutritional intake, total body nitrogen and
potassium and anthropornetric measurements were
similar in the HD and CAPD group. Biochemical
parameters were similar aside from a higher hemo-
globin in the CAPD patients but red cell mass in
mls/kg was equal.
Predicted maximum oxygen consumption stratified
for age and sex was equal in the 2 groups and was
55% of normal with fully 00% of the patients in the
very unfit to poor category. RBC mass and Vo2max
closely correlated (r=O.76).
The lipid profile in the standard CAPD condition
with dianeal in was markedly different from both
dianeal out and the ND population. Cholesterol(CH)
and triglycerides (TG) were 50% higher and had a
strong positive correlation with a high fasting
(221 pmoles/L) and 2 hour p.c. (330 pmoles/L)
insulin values (despite normal blood sugars). The
total apo—B fraction was 90% higher than normal in
CAPD and increased with time on CAPD but was normal
and did not change in RD.
Poor PF is seen in both HD and CAPD. The lipid
profile in CAPD has more atherogenic potential than
HD and may worsen with time on treatment. A
regular exercise program may benefit both the PF
and MP of both groups.
PERITONEAL CATHETER PATHOLOGY: EXPERIENCE OF 4
YEARS.
P.L.Cavaili, G.Viglino, R.Cottino, F.Goia (Intr.
by V.Grivet).
U.S.S.L. 65 — Ospedale S.Lazzaro
Aiba, Italy.
We intend checking the survival and the compli-
cations in 49 Tenckhoff peritoneal catheters in a
period of 4 years. Forty—five of them were inser-
ted in our Unit, 10 by surgical team of our Hospi-
tal and 35 by our nephroiogist team.
The estimate of peritoneal catheter survival
inserted by us, uses a life table approach.
Early catheter failure were 7 (15.55%) and the
probability of working after 24 months is 0.70.
The longest survival is 29 months (still functio-
ning).
We observed these complications: 3 obstructions
(13.64%), 6 displacements (27.27%), 4 tunnel in-
fections (18.18%), 3 cuff erosions (13.64%), 5
fluid leakage (22.73%), 1 breakage (4.5%). In
5 cases replacement of a new catheter was needed.
The measures adopted in order to prevent and
treat these complications will be described.
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PLASMAPHERESIS AND CHARCOAL PERFUSION IN
SEVERE HEPATIC FAILURE
C. Cavicchioni, I.R.Marino, G.De Luca ,G.Alfano*
DeFartment of Surgery and DepartrnentofMedicine*
Catholic University of Sacred Heart, Roma,Italy
The authors describe their experience about
the combined treatment with plasmapheresis
failure. They treated a group of seven patients
suffering from coma IV with both procedures used
in series in extracorporeal circuit. They were
given daily treatments wich lasted four hours
heach. There was a total of 34 extracorporeal
treatments. In one case,therapy had been inter-
rupt ed because of recurring episodes of hypoten-
sion. There was an improvement in the state of
consciousness in six of the patients. The authors
found no significant changes in the BCAA/AAA
ratio,wich had been unbalanced at the begining
of treatment in all patients. Using plasmaperfu—
sion,they did'nt found significant changes in
coa't1ation parameters. Even though data are
still too few in number to be able statistics,they
do show that the two methods can be well inte-
grated and that the effectiveness of each can be
imoroved upon with combined use. Results of this
experience,however,still enough to make consider
these extracorporeal devices among first choice
methods in the temporary treatment of hepatic
coma.
RISK FACTORS OF AORTIC(AO) AND CORONARY(CO) ATHLXU-
SCLEROSIS IN A GROUP OF CHRONICALLY HEMODIALYZED
PATIENTS(CHD): A CLINICAL AND AUTOPSIC STUDY.
A.Chachati, C.Dechenne,G.Rorive,G.Lennes,J.P.GOdOn.
State University of Liege, Belgium.
Because of the difficulty in evaluating AD and
CO atherosclerosis with clinical data only, we
dealt with autopsic evaluations of these lesions ir
54 CHD patients and in 21 end stage renal disease
patients who died during the first month of hemodia
lysis (ESRD).We estimated the AD and CO atheroscle-
rosis observed at autopsy in these two groups in a
semi-quantitative manner(severity scored 1-5).In ll
CHD group the degree of AD atherosclerosis apprecia
ted by the score is significantly correlated with
age(p(D,O1 Kendall coefficient correlation),with
mean blood pressure(BP)(p(D,O1)and left ventricular
hypertrophy(LVH)(p(O,O1)considered before the begin
ning of the treatment with hemodialysis,with obesi-
ty (p(O,O5)and with phosphatase alkaline level
(p(O,O1).No significant correlation was observed
with sex,uricemia,glycemia,triglycerides and cho-
lesterol levels.The degree of CO atherosclerosis
was only significantly correlated with age(p('O,Ol),
BP(p(O,O1)LVH(p(O,O1)and obesity(p(O,O1).We obser-
ved no difference in the degree of AO and CO athe-
rosclerosis between the CHD and ESRD groups. This
was explained in our study by the similarity of
most of the risk factors. On the basis of this au—
topsic study, we conclude that AO and CO atheros-
clerosis in CHD patients depend on the classical
risk factors, particularly hypertension which exer-
cise its deleterious influence before the beginning
of treatment with heniodialysis and that the techni-
que of hemodialysis per se is not an important risk
factor in atherosclerosis.
DIAGNOSTIC ERRORS DISCOVERED AT AUTOPSY OF 54 CHRO
NIC HEMODIALYZED(CHD) PATIENTS.
A.Chachati ,C.Dechenne,J.P.Godon.
State University of Liege, Belgium.
Studies on cardiovascular morbidity and on athe—
rosclerosis in CHD patients are often based on mor
tality data obtained from clinical records.To ap-
preciate the error caused by such an inference,we
studied the clinical and autopsy data of 54 CHD pa
tients and 259 autopsied controls.The causes of
death diagnosed before autopsy were compared with
those established after autopsy.The clinically
diagnosed cause of death was thereby confirmed as
correct in 46% of the cases in the CHD group as
compared to 61% in the control one,and as erro-
neous or not known in 54% and 39% respectively
(X2 4,52-p(O,O5).In the CHD group,death observed
t autopsy was related to cardiovascular disease
in 61% of the cases(with only 13% secondary to
atherosclerotic disease,while 17% to pericarditis,
15% to non ischemic heart failure,2% to dissecting
aneurysm,7% to cerebral hemorrhage and 7% to endo-
carditis),to infectious disease in 13%, to diges-
tive tract disease in 9% and to others. Most of
the clinical errors in the CHD group are due to
misdiagnosed pericarditis(6/9),non ischemic heart
failure(4/8)and cerebral hemorrhage(2/4).These er-
rors were interpreted as secondary to an overesti-
mation of ideal body weight or a pcor control of
biological parameters.The survival analysis ap-
plied to the overall population of CHD gave results
which in fact were not much different from those
given by EDTA. Our results showed that autopsies
are still needed in CHD patients where a reliable
diagnosis is required and that studies based on
mortality data without necropsies should be con-
sidered carefully.
HISTOMORPHOMETRIC BONE CHANGES FOLLOWING THERAPY OF
ALUMINIUM—RELATED OSTEOMALACIA WITH DESFERRIOXAMINE,
S.A. Charhon, M. Beruard, P.M. Chavassieux, M,C.
Chapuy, P.J. Meunier.
INSERN U 234, Lyon, France.
Brown et al,(Lancet,1982,ij,343—345) reported 2
patients with aluminium (Al) related osteomalacia
(ON) treated successfully with Desferrioxamine (DFO
infusions. Since this, only few cases have been re-
ported. We report herein the iliac bone histomorpbe-
metric changes observed after 8 months of therapy
with the association of DFO (6 grams IV once aweek),
l,25(OH)2D3 (mean: O.65pg/d) and 24,25(OH)2D3 (6,5
pg/d) in a 35 year old hemodialyzed woman with frac-
turing Al related ON. After 2 months of therapy, th€
bone pain gradually resolved, the strength improved
and the patient could walk again. Serum alkaline
phosphatase levels rose from 7,1 to 16,3 Bodansky
units and IPTH (C terminal assay) increased from 13
to 22.4 mU/mi after 8 months of therapy. Histomor—
phometric bone changes were characterized by a mar-
ked reduction in the osteoid volume (from 41,1 to
17.7%), in the osteoid surfaces (from 95.6 to 66.l)
and in the thickness index of osteoid seams (from
43.0 to 26.7 ; normal:17.5±2,5), The trabecular
double labelled surfaces were markedly increased and
the calcification rate rose from 0.10 to 0.90 jmitd;
normal: 0.72 In contrast with the initial
findings, bone Al deposits were mainly localized
far away from the mineralization fronts.In addition,
there was a dramatic increase in resorption surf ace
from 1.1 to 12.5% as well as in the size and the
number of osteoclasts revealing a severe hyperpara—
thyroidism. In conclusion (1) DFO associated with
vitamin D metabolites appears to be a rapid and
effective treatment of Al related ON allowing the
resumption of an active mineralization process.
(2) this effect is associated with a marked increase
in bone turnover.
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• CARPAL TUNNEL SYNDROME,SHOULDER PAIN AND AMYLOID DE
POSITS IN LONG-TERM HE-1ODIALYSIS PATIENTS.
B.Charra,E.Calemard,M.Uzan,J.C.Terrat,T.Vanel and
C. Laurent.
Centre de rein artificiel de Tassin,69160 Tassin(F)
Carpal tunnel syndrome(CTS)and shoulder pain(SP)are
commonly observed in long-term hemodialysis(hd)pati
ents(pts) but up to now it has remained unclear we-
ther these two facts are related or not.
Among 110 pts treated by hd since more than 8 ye
ars in our institution,52 were operated on one(24
pts) or both(28 pts) sides of a median nerve entrap
ment.Operated or not,all pts received the same amou
nt of hd as expressed in total hours(l4000+4000)or
in number of sessions(1400+400).
Among 58 pts not or not yet operated on(GROUP 1)23%
complained of SP.
The 52 operated pts divided in two subgroups:-38pts
(GROUP IIa)showed during surgery(performed without
a tourniquet) typical yellowish granulations which
proved to be amyloid deposits,SP occured in 95% of
them.
-l4pts
(GROUP IIb)at contrast rarely showed granulations
and never were positive for amyloid deposits ,only
20%of them complained of SP.
The distribution of CTS and SP cannot(p0.00l)be
reasonnably explained by chance;the amyloid deposit
may represent the pathological link in this associ-
ation.
None of the contemplated factors(age,primary renal
disease,tobacco addiction,blood-access history,blo—
od pressure status ,parathyroidectomy,hematocrit,whi•
te blood cell count,infection rate,globulin level)
so far explains why some pts get and some others
are free of this widespread complication of long-
term hemodialysis treatment.
CONCOMITANT REMOVAL OF ALUMINIUM (Al) AND IRON (Fe)
BY HEMODIALYDIS AND HEMOFILTRATION AFTER DESFERRIO—
XAMINE (DFO) INTRAVENOUS (IV) INFUSION.
C.Ciancioni,J.LPoignet ,C.Naret,S.Delons,Y.Nsuras,
P.Allain,N.K.Man.
Centre M8dical E.Rist, Hopital Necker, Paris
Pharmacologie, CHU, Angers, France
In six anuric hemodialysed patients, Al and Fe
mass transferts (N) were determined 48 hours after
40 and 80 mg/kg body weight DFO IV infusion. All
patients were Al overloaded (x±SEM:78.7±28.3 ug/g
wet bone tissue) and 2 had high ferritin plasma le-
vels (x: l954 vs l'47 ng/ml—FP1 vsFP2)
Hemodialysis ( 150 1 batch dialysate) and hemo—
filtration (18 1 substitution fluid) were performed
using a high permeable membrane (Bio-Hospal 3000S).
Al and Fe were measured by inductively coupled plas
na emission spectrometry in plasma, fresh and used
dialysate, substitution fluid and hemofiltrate, be-
fore and after each session.
—Al and Fe mass transferts (x:mg/session) are
shown in the table;
HEMODIALYSIS HEMOFILTRATION
DFO (mg/kg) O 80 40 80
N Al (n06) 1.28 1.65 1.08 1.17
N Fe (FP1,nn2) 2.91 5.68 l.8'4 9.81
N Fe (FP2,nrk) 2.90 2.59 0.57 0.95
These data suggest that:
l_LO mg/kg DFO is the adequate dose for Al removal.
2-Fe removal is dose related in high ferritin plas-
ma concentration patients.
3—In Al overloaded patients with high ferritin plas-
ma concentration, 80 mg/kg DFO IV infusion, is
the most efficent dose for concomitant Al and Fe
removal.
BODY WEIGHT (BW) PROGRESSION DURING CHRONIC RENAL
FAILURE (CRE) AN) REGULAR DIALISYS TREAThIENT (RET).
Cianciaruso B,Capuano A,Calderaro V,Marcuccio F,Au-
ciello A,Iandolo R,Bonanno D,Dal Canton A,Usberti
M,and Andreucci WE.
Dpt of Nephrology,2 Fac. of Medicine,Naples,Italy
A negative progression of BW has been reported
in end-stage CRF and during RDT. In order to assess
the progression of BW starting from a pre-uremic
stage of CRF we evaluated BW and the Ponderal Index
(P1 = height/3./W) in 38 adult non diabetic patie-
nts from an average two years before and two years
after the beginning of RET. Actual BW (Act-BW) was
the mean of the post-dialisys weights of the last
month,BW at the beginning of RET (lstSit_BW) was
the pre-dialisys BW at 1St dialisys sitting,pre-
Uremic BW (pre-U BW) was the weight registered on
average two years before RDT. The results show that
in all patients lstSit_BW was signifcantly lower
than pre-U BW (p<O.OOl) and that 1S Sit-PI was si-
gnificantly higher than pre-U P1 (p<O.OO1). lstSit
-BW,in all patients,was not significantly different
from Act-BW. The patients with the highest BW loss
during RET had the highest BW loss before starting
RET (20% of pre-U BW). Pre-U P1 in this group was
lower (p<O.1) than in the other patients ,meanin-
g a higher percentage of body fat (BF) in this
group. In conclusion the results show that: a)most
of the weight loss occurs in end-stage GRE prior
to RET, b)weight loss is mainly due to the reduc-
tion in BF, c)the weight loss is not recovered by
dialisys.
• HEMOFILTRATION WITHOUT SUBSTITUTION FLUID (nwsF).
G.Civati, C.Guastoni, A.Perego,U.Teatjnj, L.Minettj
Renal Unit, Niguarda Ca'Granda Hospital,Milano,Italy
High Efficiency Hemofiltration (HEHF) —2 L of ul-
trafiltrate (UF)/kg dry body weight/week — is probe
bly the best way to replace renal function because
gets highest clearances of solutes among a wide ran
ge of toxic solutes. Nevertheless the need of large
amounts of reliable sobstjtutjon fluid makes this
technique too expensive.
Our aim was to get in vivo performances nearly
good as in HEHF by regenerating patient's UF. For
this end we dialyzed on the average 180 mi/mm of
[IF through a 4 sq.m. higly permeable membrane, then
reinfusing the purified fluid into the venous line.
Iwo patients have been treating for over 6 months.
Hemofilters were reused for 3 times; dialyzers for
25 times at least.
Average clearances of several experiments were:
urea 190+9; creatinjne 189+15; Inulin 70+3; B2—mi—
croglobulin 171-2 nil/mm. Subjective well being and
cardiovascular stability were maintained. No pyroge
nic reactions were recorded.
HWSF can be a safe, effective and comparatively
cheap method to treat uremic illness. Benefits of
HEHF could be maintained on long term in spite of a
smaller Inulin clearance. Furthermore neither sub-
stitution fluid bags nor balancing monitors are re-
quired.
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T-CELL ACTIVATION BY A SINGLE HAEMODIALYSIS SESSION
P. YOUINOU, J. CLEDES, D. TANDE, J.P. HERVE D.
TOLLU, and P.M. LYDNYARD.
University Hospital Medical School, F. 29279 BREST
CEDEX, FRANCE.
Patients undergoing maintenance haemodialysis dis
play a cell—mediated immune deficiency, the patho—
genicity of which is still a matter of controversy.
Consequantly, the effect of a single haemodialysis
session needs some further experimental work.
We enumerated T, T helper and T suppressor/cytoto—
xic cells in 12 patients on long—term maintenance
haemodialysis (9M/3F), ranging in age from 24 to
69 yrs (mean 42.2) and in dialysis time from 3 tc
100 months (naan : 49.3). In addition, we counted
T activated cells, i.e.T cells expressing receptor
for interleukin 2 (IL—2). All the enumeration were
done, using monoclonal antibodies, just prior to
and 30 mm. after a dialysis session. The compari-
son between the results before and after the ses-
sion made the WILOOXON paired test. The data is
given in the table below.
OKT3 OKT4 OKT8 4/8 IL—2
42.7 22.4 1.9
(55—72) (35—60) (18—28) (1.4—2.4) (1.16)
n =14 n 12 n = 12 n = 12 n 9
After 63.3 39.4 24.1 1.7 9.6
(40—73) (30—50) (l8—44Y(O.9—3.3) (2—25Y4
n = 14 n = 12 n = 12 n = 12 n = 9
Geometric means and ranges + 0.01 ++ 0.00 1.
The two relevant points are the increase of OKT8 +
ye cells and the T—cell activation by the dialysis
session. It should be interesting to know whether
or not the activated cells were suppressor T cells.
FACIORS AFFECTING PARTICULATE CONTAMINATION OF
UNUSED CAPD FLUID
I.Couper, B.Junor, I.Henderson, J.Dobbie, L.Wilson
Renal Units, Glasgow Royal and Western Infirmaries
Glasgow, U.K.
A study was undertaken to evaluate factors
which might affect the particulate content (more
than 2 microns) of unused CAPD fluid. An electr-
onic particle counter (Coulter ZB) was employed.
Samples of unused isotonic and hypertonic
dialysate (Fresenius and Pravenol) were found to
conform to the British Pharmacopoeial limits for
parenteral products ad were unaffected by
heating of bags to 37 C for up to 6 hours or by
the addition of standard medications including
insulin and sodium bicarbonate.
Review of standard procedures in our own and
several other CAPD Units revealed that up to 1.5ml
of antiseptic solution might enter the dialysate
during bag changing and we assessed the effect of
addition of severel commonly used disinfectants on
particle counts. Aqueous and alcoholic povidone
iodine solutions,alcoholic benzalkonium chloride
and 70% methylated spirits produced increases of
less than 10—fold whereas aqueous and alcoholic
chlorhexidine solutions and 100% methylated
spirits induced large increases often greater than
30-fold. Scanning electron microscopy revealed
these probably to be of plastic origin.
We conclude that regular use of antiseptic
sprays during CAPD bag changing will expose the
peritoneum to a higher level of particulate con-
tamination and that the use of 100% methylated
spirits or chiorhexidine solutions (aqueous or
alcoholic) should be discontinued until data from
animal studies becomes available.
NON—INVASIVE EVALUATION OF CARDIAC FUNCTION IN
DIALYSIS PATIENTS.
G. Costanza*, G. Lo Piccolo, P. Gambino*,
F. Di Giovanna*, A. Stalteri.
Nephrology and Dialysis Service, *cardjology Ser-
vice, Ospedali Civili Riuniti of Sciacca, Sciacca,
Italy.
To investigate the existence of urelnic (dilata—
tive) cardiomiopathy (CMD), left ventricular (LV)
function was evaluated by non—&nvasive methods on
fourteen selected maintenance dialysis patients,
age range 19—45 years (mean 35), on regular treat-
ment for between 12 and 24 months, non ipertensi—
ye nor affected by other cardiopathy or sistemic
diseases; TM echocardiographic data were evalua-
ted by computer with digitizer.
Three pts. (21%) had completely normal echocar—
diogram; in seven pts. (50%) LV end—diastolic dia-
meter (LVEDD) was abnormally increased; four pts.
(28%) had abnormally high LV sistolic diameter;
LVEDD and cardiac output appear correlated (r=O.69
p<0.Ol). Mean circumferential shortening rate,
fractional shortening, E—point septal separation
appear abnormal only in two pts. (14%); two pts.
had asimmetrical non—obstructive septal hypertro—
phy.
The results showed no evidence for CMD, left
ventricles normal or dilatate with normal contrac-
tility, i.e. pattern of high—output or hyperdina—
mic state; pathogenesis of asiminetrical septal
hypertrophy, tipical of hypertrofic cardiomiopa—
thy, remain obscure.
VA'C0MYCIN PHARMACOKINETICS IN CHRONIC HEMO-
DIALYSIS PATIENTS.
G. Dunn, J.V. Anandan, C. Cruz, B. Zarowitz,
K. Krane, N.W. Levin. Henry Ford Hospital and
Wayne State University, Detroit, MI., USA.
Because of its prolonged serum half life
and poor dializability Vancomycin (V) is an
ideal treatment for gram positive infections,
especially staphylococcal, in chronic hemo—
dialysis (CH) patients. Because few studies
have been done on the appropriate dosing
regimen for V in this clinical setting, the
pharmacokinetics of V for CH patients was
studied so that appropriate dosing regimens
could be developed. Ten bacteremic but other-
wise stable CH patient (M:F 6:4) mean age
(53±10 yrs) on a regimen of 9-12 hrs/week
hemodialysis (H) with high efficiency
dialyzers were studied. One week after an
initial dose of 1 gm of V a similar dose was
infused over 1 hour at the beginning of H.
Serum V levels were measured at the end of
1,2,4,8,48,72 and 160 hrs. The Iv] vs time
data was fitted to a two compartment, open
pharmacokinetic model and the following were
calculated: elimination rate constant (Ke);
half life (Tfl; volume of distribution (Vd);
and total body clearance (Cl) (values are mean
1
N Ke (hr ) T (hr) Vd L/ko Cl mi/mm
10 0.003±0.0013 252±73 0.98±0.34 3.64±1.75
Correlation coefficients between peak level of
V and dosing based on lean body wt. and total
body wt were (r=.33 and 0.06 respectively).
The data indicate that weekly doses of 17
mg/kg/lean body wt will be therapeutic in most
hemodialysis patients. This respresents cost
effective therapy in hemodialysis patients.
Before 64.9 5.5
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iN VITu PEtNEA&ILITY OF PAfIETAL
PERITONEUM TO URIC ACID
K.Czyzeviska, A.Grzeyorzewska, K.bt?czyk,
J.KnapOwSl(i
Academy of Medicine, Poznari, Poland
poor correlation betveen serum uric
acid concentration and its peritoneal
excretion has previously been established
in our clinical studies. To elucidate
this effect a series of experiments in
vitro on isolated peritoneal membrane
was carried out.
Rabbit parietal peritoneuni was used as
the suitable model. In three groups of
experiments /n 30/ lasting up tu 135
sin uric acid transfer from the vascular
to the mesothelial side of the membrane
was determined against the concentration
gradient of 5, 10 and 20 mg/dl. amples
were taken in 15 mirt intervals.
Clear—cut positive correlation between
the gradient and the flux of uric acid
was observed. Nowever. the quantities of
uric acid which were determined on the
mesothelial side varied somewhat under
the same conditions of experiments. mdi—
catini that individual differences in
permeability of the membrane also e*ist.
in confrontation with tho results ob-
taind previously with patients aubmitted
to the peritoneal dialysis a conclusion
can cc drawn that the uric acid perito—
neal transport is modified by other
factors which arc omitted in studies.
oerformed in vitro.
• EFFECt'S OF BIiX)D—DIPLYZER INTERACTION (SHAM-
DIALYSIS) ON H4DDYNAMICS AND CY.)Ü'GF} TENSION IN
1ALThY ?N
A. Danielssai, U. Feyschuss, J. Bergstrdtn.Cpth of Renal ?dicine and Clinical Physiology,
Karolinska Inst., HucUinge Univ. Hasp.; Ruddinge,
Sweden
Several side—effects of standard hemodialysis
are not easily explained by diffusion of sub-
stances fron blood to dialysate and vice versa.
Bbcod—nmatibrane interaction may have profound
biological effects, such as transient leucopenia,
ccisplement activation and increase in pulmonary
vascular resistance (an effect observed in the
sheep by Lindsay et al. 1983). We have developed
a model for the study of bioctpatibility pro-
bleits in healthy man. Blood front a catheteter in
a fextoral vein was pumped through a cuprophane
capillary dialyzer (Gantro 120 M) to a cubital
vein at the rate of 200 ml/min for 150 mm. the
dialyzer had been rinsed with saline and the
dialyzate ports occluded. A Swan-Ganz catheteter
was used for measurement of cardiac output (Q)(thernodilution) and pulmonary arterial pressure(PAP). Bradhical arterial pressure (HAP), l.ter
limb vascular resistance(LVR) (pletysnography),
catedholaminés, white cells () '2 and Pa)2
ware ala measured repeatedly before and during
the procL lare. decreased with minimum at 20
mm. of hiood-trane contact, returning to
base-line within 60 mm. 2 also decreased after
20-30 mm. ever, PAP retained unchanged as did
HAP, 0 and p.ilse rate nor did LVR and peripheral
resistance change consistently. ir results sho.q
that in spite of transient leucopenia and fall in
P02, presumably due to -aggregation, ulnonary
vascular resistance is not influenced in healthy
man.
EFFECT OF CHRONIC MAINTENANCE HEMODIALYSIS (MD) ON
CARDIAC FUNCTION
C.D'Agostino,C.Manno,E.Squiccjmarro,M.stella,M.vir—
gilio,F.P.Schena. 2nd Medical Clinic,Bari and Divi-
sion of Nephrology,Acquaviva delle Fond
Cardiovascular diseases are one of the most fre-
quent causes of mortality and morbidity in patients
(pts)on HD.We studied 60 pts ageing 55+13 years,3O
normotensive(N)and 30 hypertensive(H)on conventional
acetate HD for 34+29 months.We carried out 1)24 hour
dynamic ECG Halter recording(HR) on the day of dia]
sis,2)systo—dyastolic and mean blood pressure monitc
ring, 3)M—Mode and two dimensional echocardiography,
4)evaluation of hematic Na,K,Ca,Mg,EUN,creatinjne,
total and MDL cholesterol,pO2,pCO2,pH,HCO3,Osatura-
tion,bases excess,Hb,pre and post HD,5)determinatiai
of loss of weight during MD and interdialytic ponde-
ral increment.In 95% of pts(N=45%,H=55%)there were
alteration of the HR:26%(N=33%,H=67%)showed severe
hyperkinetic arrhythmias ; 8.3% (H=100%) had severe hyj
kinetic arrhythnias and 8.3%(H=100Z) had transient
ischemias. Parameters 2,3,4 and 5 did not differ sig
nificantly in the two groups of N and H. During the
dialytic session and in the immediate post HD period
(2h),arrhythmias or signs of ischemia appeared in
35% of pts(N=47%,H=53%).Parameters 2,3,4and 5 did
not differ significantly between thia group and the
remaining pts.In conclusion,HD may worsen a prexist-
ing cardiopathy or bring to the fore latent cardio-
vascular damage;the identification of the actual pa
thogenetic factors involved deserves further inve-
stigations.
• IMPAIRED REGULATION OF 8-ADRENOCEPTORS (R)
IN PATIENTS ON MAINTENANCE HAEMODIALYSIS.
A.Daul, A.M.Khalifa, N.Graben, O.-E.Brodde
Med.Kljnik & Poliklinik,ljnjv. Essen,F.R.G.
In patients on maintenance haemodialysis
(MUD) reduced sympathetic activity is often
observed. To study whether this may be due
to a decrease in B-R responsiveness, proper-
ties of 82-R in lymphQçytes of MUD-patients
were assessed by (±)-15iodocyanopindoloI
binding. In 39 MUD-patIents the mean B2-R
number was not different from that in 55
healthy volunteers; lymphocyte cAMP respon-
ses to isoprenaline (1PM, 0.1-100 tiM) and
NaF (10 and 5OmM),however.were significant-
ly reduced. Furthermore, infusion of IPN
(1;2 and 4pg/min for 5mm each)produced in
control markedly higher increases in heart
rate and plasma renin activity than in MUD-
patients.Dynamlc exercise on a bicycle(80%
of maximum heart rate) for 15mm caused in
10 healthy volunteers increases in plasma
catecholamines (CA) from 0.47±0.1 to 1.83±
O.2ng/ml; concomitantly lymphocyte 132—R
number increased by 80%.In contrast,Jn MHD-
patients exercise induced smaller CA-in-
creases (from 0.73±0.2 to 1.65±0.3 ng/ml)
and did not affect 132-R number. It is con-
cluded t1Tt in MUD-patients I-R responsive-
ness is reduced. Since B-R number is not
altered, this reduced responsiveness is due
to a post—receptor defect.In addition, J3—R
regulation seems to be impaired in MHD-pa-
tients as indicated by the lack of exercise
to affect B-R number.Reduced B-R responsi-
veness and impaired B—R regulation may con—
tribute to the reduction In sympathetic
ctivity in MHD—patients.
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A MICROCOMPUTER MODEL TO PLAN RENAL SERVICES
R.N. Davies, A. Polak,
University of Southampton, Southampton, England.
In many countries there is an unmet demand for
treatment for end—stage renal failure, particularly
amongst older patients. A model of the treatment
system is needed to explore the implications of
meeting this demand and of giving different
priorities to the available treatments.
The discrete event simulation which runs on a
microcomputer, is adaptable and easy to use. It
describes renal unit activities realistically,
including haemodialysis, continuous ambulatory
peritoneal dialysis (C.A.P.D.), transplantation
and the use of hospital and day patient beds. It
provides output on the computer screen throughout
each simulation run and saves data for further
analysis and costing.
A simple demonstration based on local and
published data gives five year predictions of the
resource needs that would arise from a decision to
admit 50 patients a year, all aged over 55 years.
It shows the inpatient bed occupancy and costs
rising less steeply in an integrated C.A.P.D. and
transplantation programme than if C.A.P.D. alone
were used. The numbers of patients show no signs
of levelling off in either policy.
This theoretical example gives an indication of
the model's value in planning the services of a
renal unit.
CAUSES OF RENAL FAILURE AND PATIENT OUTCOMES IN
A NORTHEASTERN U.S.A. PATIENT SERIES.
N. Deane, R.J. Wineman
Manhattan Kidney Center
New York, U.S.A.
In the USA a pilot study of the EDTA data col-
lection and analytical methodology was conducted.
The study purposes were to test the applicability
of EDTA techniques in a U.S. environment and to
obtain data on features of U.S. renal disease which
could be compared to European experience. Of note
were differences in distributions of causes of
renal disease by race and age, and the large number
of cases of heroin nephropathy in young black
patients.
Data were collected from records of over 1000
patients from two dialysis centers in a large urban
area in the Northeastern U.S. A modification of the
EDTA data form was made to provide a code for
patient race.Through the cooperation of Dr. Anthony
Wing, analyses were made by the EDTA Registry staff
and computer system. Initial findings are based on
1981 data,currently being updated to provide trends
through 1983.
Selected results follow: heroin nephropathy is
the primary cause of end stage renal disease (ESRD)
in younger Blacks (37.7%), Glomerulonephritis is
the leading cause of ESRD in Whites (26.9%) and
Hispanics (20.4%) under 45. In the older patients
(>45), for Whites the leading cause of ESRD was
renal vascular disease (RVD) (15.4%) with diabetes
and cystic disease second (13.2%). For Blacks, RVD
(26.4%) led other causes with diabetes (14.6%)
second. In older Hispanics, diabetes (37.3%) was
primary with RVD (18.2%) second. The primary cause
of death of all ages, sex and races of ESRD pa-
tients was cardiovascular. In this patient series
survival of Whites and Blacks was similar with
Hispanics showing better survival beyond 3 years.
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PREMATURE VENTRICULAR CONTRACTIONS (PVC'S): A POOR
PROGNOSTIC SIGN IN ESRD PATIENTS.
N. Deane, I. Kronzon, I.C. Berman, R.J. Wineman,
M.A. Garvey.
Manhattan Kidney Center
New York, U.S.A.
The electrocardiograms (514) performed over a
2 year period (April 1980 to August 1982) on 232
ambulatory ESRD patients were analyzed. Routine 12
lead ECG's were performed while the patients were
not on dialysis treatment. The tracings were
interpreted by one cardiologist.
The 10 most common ECG findings listed as per-
cent of frequency of occurrence in the patient
population were: Left ventricular hypertrophy—58%,
nonspecific ST—T wave abnormalities—39%, 1' A—V
block—l9%, left atrial enlargement—l8%, normal—l7%,
sinus tachycardia—l6%, PVC's'l4%, sinus bradycardia
—9%, premature atrial contractions (PAC's)—9% and
peaked T waves suggestive of hyperkalemia—9%.
The frequency of these findings was checked in
78 patients that expired by 12/83 or 133 patients
that survived through that date. 21 patients were
lost to follow up. The moat dramatic change found
was in the frequency of PVC's (expired—24% vs sur-
vivors —10%, P <.01). Even when patients were div-
ided into 7 different groups (AGE 1<40 years,II 40-
55 years, 111>55 years, ON DIALYSIS IV 0—12 months
V 13—36 months, VI 37—60 months and VII>60 months)
PVC's were uniformly more common in patients that
expired versus those that survived through 12/83.
Various ECG abnormalities were found to occur
together in patients at a higher frequency than
expected, but the only such finding showing Stat-
istical significance was the combination of PVC's
and PAC's (13 observed vs 3 expected, P <.05).
In conclusion, a statistical analysis of random
ECG's in ESRD patients demonstrates that PVC's may
be a poor prognostic sign.
REGIONAL ANTICOAGULATION CITRATE CALCIUN IN AN HEMO
DIALYZED PATIENT WITH P "3OUS D17RAL HEMATOMA".COM—
PARISON WITH THE RESUL'Z OF 25 HEMODIALY1D PATIENTS
WITH THE SANE ANTICOAGULATION.
E.DECHELETTE, P.Y.HENHAMOU, F. KUENTZ,P.VIALTEL,
P.ZAOUI ; C.H.U. GRENOBLE • FRANCE
Mr. G... born in 1919 was undergoing hemodialvsis
since March, 1979 for a chronic interstitial nephro
pathy caused by a complex urological problem. Pen—
toneal dialysis had become impossible by numerous
abdominal suraeres. Failures of different arterio
veinous fistulas lead to put a Thomas shunt on right.
femoral vessels in May,1981, which permeability nec
ded anti E vitamin druqs. Hemodiavsis was undergone
,ithout problems thrice weekly (4 each dialysis)
until 9.9.1983 when a "Sous dural hematoma' occured
on the right side with cerebral lesions underneath.
Neurosurgeons forbade any heparinisation for 3 weeks
and any efficient anticoagulation for 3 more weeks.
Thomas shunt nnueekly became complicated with throm
bosis. Hemodialvsis was managed for 9 weeks by the
means of iuqular or subclavier central veinous cathe
terS.
Regional anticoagulation of the dialysis circuit
was obtained by infuon of Trisodic Citrat, coun-
terbalanced by Calcium Chloride. In this way, pa-
tient's coagulation time was maintained overcoagu—
lable during 3 weeks, then isocoagulable during
3 weeks • A femorosaphen arterio—veinous fistula was
created on 10.28. 1983 at the left thigh. Five
months later, hemodialysis is managed by this £ is—
tula with heparin, neurological condition, clinical
and paraclinical (CAT. Scan, electroencephalography)
is normal. We report the results of citrate dialysis
and we compare them to those of 25 dialysis (12
patients) undergone with the same protocol.
Advantages and disadvantages of this method aDe
analysed.
ALli.1INIlJl BURDEN IN CHRONIC HMODIALYSIS AND HEMOFILTRATION
MAINLY DEPENDS UPON PHOSPHATE BINDERS, NOT UPON THE PROCEDURE.
3.F. de Frémont, P. Führer, P. Lefion, Ph. Morinhtre, C. Lam-
brey, Z Abduimassih, V. Tahiri, H. Dkhissi. Cl-lu AMIENS — FRANC!
In 14 patients dialysed 3 times a week with a dialysate alu-
minium < .3 umol/l and in 14 patients hemofiltrated at the rate
of 40 ÷ 5 liters a week and receiving a substitution fluid with
an aluminium concentration of .3 + .1 umol/l, plasma aluminium
(PAl) was measured by inductively coupled plasma emission spec—
trometry before and 44 h after IV administration of desferrio-
xamine (Deaf) a chelating agent of Al. Furthermore, all have
had a bone biopsy for measurement of aluminium. 24 of these pa-
tients had taken Al(OH)3 and the total dose previously prescri-
bed was 2204 + 325 g in HO and 2890 + 1050 in HF (NS). Duration
on HO was 24 + 4 months and that on HF 30 + 4 so (NS). PAl
mean + SEM ) before Desf was 1.5 + .4 umol/l in HO and
2.2 + .6 umol/l in HF (NS). PAl increase after Desf (PAl Desf
was 2.25 ÷ .47 Jmol/l in HO and 2.66 t 0.5 1jmol/l in HF (NS).
Bone aluminium content was 0.67 .0.5 fimol/l in HO and 0.64 +
0.1 1jmol/l of fresh bone in HF (NS) i.e. significantly (P<.O1)
higher than in 7 non uremic cadavers C 0.07 PAl Des?
and bone aluminium were significantly ( p < .001 ) correlated
to Al(OH)3 total dose (r = 0.81 and 0.64 respectively ). Alu-
minium balance during an hemofiltration procedure rangeo from
- 22 and 1.81jmol and is inversely correlated to prehemofiltra-
tion PAl ( but not to quantities of ultrafiltration and subs-
titution ) so that it becomes negative when PAl exceed .5urnol/l
CONCLUSIONS
1/ Aluminium burden in patients on HO and HF minimally esposed
to parenteral aluminium intoxication is mainly dependent upon
previous administration of Al(OH)3, and therefore is compara-
ble in HO and HF when the total dose of Al(OH)3 is comparable.
2/ The procedure of HFper se does not expose to greater risk
of aluminium intoxication than HO provided the control of hy—
perphosphatemia without Al(OH)3 is the same.
• OHAIGES IN LE?P VENTRILULAR (Lv) ANATOMY DUEING
REMODIALYSIS (HD),00NTItIuOUS AMBULATORY PEBII'ONEAL
DIALYSIS (CP.PD) AND AFFER trENAL TRANSPLANTATION.
A. Deligiannis,E.PaakalidOu,G.Sakelariou,V.Vargeme—
zls ,P.Geleris,th.PapadimitriOu.
From the 2nd Prop. Dept. of Medicine,Aristotelian
University of Thessaloniki ,Greece.
Te changes in LV anatomy undergoing HD, CAPD
and after successful renal transplantation (Er) in
50 patients with end—stage renal disease were eva-
luated by h—mode echocardiography.No patient had
symptoms of other systemic disease,severe hyperte—
ntion,oardiac failure or pericarditis during the
atudy.Each group (HD,CAPD,RI) consisted of 10 pa—
tients.Measurements were performed in all patients
within one month after initiation of HO and APD or
before RT,as well as after 20—24 months of each prc
cedure.The following parameters were calculated;LV
end—diastolic (LVDd) and end—systolic (Lvdd) dime—
nmion,septal (s) and LV posterior wall (Pd) thick—
ness,aorta (Ao) and left atrium (LA) dimension,LV
nd—diastoiic volume (LVVd) and LV mass.From the
results we can see that:a.In patients on HD,LVVd
increased by 15.5% (from 140.2±25.8 cm5 to 161.6±
30.5,p(0.05),LV mass increased by 24.5% (208.8±38.4
gr to 259.5*37.7,p0.05),while the other parameters
did not change significantly.b.On OAPD,LVVd decrea-
sed by 6.7% (149.2*38.6 to 139.2*34,5,NS) and LV
mass by i6.3 (213.5*43.5 to 178.7*24.8,p40.05),whi
le no significant difference was observed in the
other parameters.c.After RT,LVinasdecreaeed by 20.7,i
(202.7±56.6 to I60.7*37.5,p0.05) and LVVd by 6.6
(140.5*52.7 to 131.2±31.6,N3),while the other para-.
meters did not show significant changes.
In conclusion, this study indicates that RD deteri
orate LV volume and rnass,while CAPU and successful
renal transplantation improve LV hypertropny in ch-
ronic uremic patients with stable cardiac function.
EVALUATION OF SHORT TIME HEMODIAFILTRATION (HOF)
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iF d Frémont P Foguer M Tolani R Oemontis NI< Man A Four—
nier .(1) Cl-lu AMIENS (2) Hap Necker PARIS — FRANCE
Hernofiltration (HF) with only 10 liters of substitution
fluid (SF) allows long term survival of uraemic patients with
good clinical fitness but with disquieting levels of small and
middle molecules. In order to improve these biological parame-
ters without increasing the time of treatment, HDF was psrfors1
by adding a simultaneous dialysis to the 1010? SF. To assess
separately the efficimocy of the 2 procedures, the blood ente-
red successively into the hemofilter and the dialyaer. Within 2
hours, 10 1 of SF was administred and 30 1 of an acetate dialy—
sate was delivered. 3 patients with a residual clearance <0.5
mi/mn were successively treated by short HIF during 3 months.
During I-OF the mass transfer per run by dialysis and HF wasj_
dialysis filtration
mass transfer 30 liters 10 liters SF
urea carol 375 368
creatinine carol 11 15
phosphate nsnol 10 15
aluminium umol 3.2 5.6
middle molecule b4 — 2mg 42 90
The biological results compared at the end of each period
improved after 3 months of HDF : blood urea and plasma creati—
nine, phosphate alumlliJm and middle molecule b4 — 2 decreased
respectively by 38%, 17%, 3%, 39% and 17%.
Coiclusions : 1/ The mass transfer of urea and creatinine are
comparable with the 2 procedures whereas mass transfer of alumi-
nium phosphate and b4 — 2 seems slightly greater with HF (10 1
of SF) than with a dialysis against 30 1 of dialysate. 2/ Addi-
tion of simultaneous dialysis with oily 30 1 of dialysate to 10
1 HF improves levels of small and middle molecules within 3
months. 3/ Short HOF is an other mean to improve the adequacy of
the treatment of terminal uraemia with the advantage over the
increase of ultrafiltration volume of a lower cost sincefime on
machine a-cd SF volume are not increased.
BLOOD PRESSURE RESPONSE TO HEMODIALYSIS TREATBENT(HD)
E.Degli Esposti,A.Sturani,A.Santoro,E.Trombetti,C.
Chiarini ,A.Zuccalà,P.Zucchelli.
Dept. of Nephro1ogy,Malpigri Hospital ,Bologna, Italy.
In order to evaluate the mechanism(s)by which HD
normalizes blood pressure,8 hypertensive uremic pts
were studied irorcediately before and after 3 months
of chronic RD. The following pannateres were evaluat
ed in both periods :mean arterial pressure(MAP),heart
rate(HR),plasma renin activity(PRA),plasma noradre—
naline(NA),exchangeable sodium(ES),the acute respon
se of MAP to 50 mg of captopril ,and the barorecep—
tor reflex sensitivity index(BRS1).The BRSI was eva
luated during phase IV of an invasive Valsalva mano
ecrrre. (*p at least <0.05) BEFORE
MA.? rim Hg
HR beats/mm
PRA ng/ml/h
NA ng/l
ES ircEq/Kg LBM
MAP(C)nis Hg
BRSI msec/rurrr Hg
120 3.4
85
2.4± 0.9
325
55.1± 2.5
— 7.8± 1.6
5.3± 0.3
ER
103 2.4*
75 1.8*
2.1± 0.6
248
54.4±1.6
— 11.6±1.6
9.8±2.2
Our results, suanarized in the table, show that:
3 months of HD normalizes blood pressure without si
grificant1y affecting ES. The pressor role of renin
is the sane in the two periods tested. A siiifi —
cant reduction in HR and a tendency in NA to decrea
Se are observed. This reduction in sympathetic tone
may be related to the concomitant improvement in ba
roreceptor function as suggested by the tendency of
BRSI to increase.
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SENSITISATION TO ETHYLENEOXIDE THROUGH DIALYSIS.
Krister Delia, M.D., Lars Belin, M.D., and Urban
Wass, M.Sc.
Departments of Nephrology and Allergology, University
of Göteborg, Sweden
Allergic reactions during hemodialysis treatment
have been described and ethyleneoxide (EO) used to ste—
rilise the equipment has been incriminated. EO is a
very reactive chemical, and residues in the blood path
of the dialysis system may react with plasmaproteins to
become a hapten.
A 43 years old male with renal failure because of
CGN developed wheals, nasal stuffiness and bronchospasm
after a change from a parallel flow to a capillary fil-
ter after 3 years on hemodialysis. IgE—antibodies to a
conjugate of EO and HSA were demonstrated in the blood
by RAST and in the skin by a skin prick test. The con-
jugate was prepared by bubbling EO through a solution
of HSA. Retrospective mapping of the levels of the IgE
antibody to EQ was possible in stored plasma sanples.
Detectable levels were seen soon after RRT with hemo—
dialysis was started. As the syntoms coincided with
the change to a capillary filter this suggests that the
patient became exposed to Larger amounts of allergen.
The syntoms disappeared when use of parallel flow fil-
ters was resumed. All fellow patients in the ward and 2
blood donors were screened for IgEEO antibodies with a
negative result.
In order to reduce the risk of developing EQ—allergy
we suggest that the following measures be considered:
proper selection of plastic materials in the filters
and tubings, careful degassing after sterilisation,
proper packaging to permit diffusion of EO and adequate
rinsing of the system prior to use. The construction
per se of the capillary filter may predispose to a
greater retention of EQ. Diagnosis of this disorder is
possible using a skin prick test and RAST with EQ—pro-
tein conjugate as a test antigen.
A NEW METHOD FOR INSERTION OF INDWELLING
PERITONEAL DIALYSIS CATHETER (PC).
N.Di Paolo and Buoncristiani.(Introd. by A.Sodi)
Nephrology Depart. Regional Hospitals of Siena and
Perugia. ITALY.
To eliminate the disconfort caused by surgical
methods and the riks involved using the Trocar, for
1 year we have used a new technique for insertion
of PC.We devised a steel instrument,vaguely
resembling a rinoscope,composed of 2 semicones
either 6 or 7.5 cm long with rounded tip.The andie's
are connected by a screw to permit dilatation of
semicones.After a local anesthesia,an introducer
needle is inserted into peritoneal cavity.A guide—
wire is passed throught the needle which is then
withdrawn and instrument is placed around the guide
and gently pushed up to peritoneal cavity.The guide
is now removed and sqmezing the handles of the
instrument we introduce PC up to 2 cm beyond the
first dacron cuff.Once PC is in place,the instrument
is removed and a subcutaneous tunnel may be made.
There is a possibility that the needle may perforate
an intestinal loop,but experimenting on dogs we
observer that,in this case,the instrument will
pressdown the loop without piercing,and when the
guide is withdrawu,it remains in abdominal cavity
and PC will assume the correct position.We have
used this method for 25 patients.14 were new cases
while 11 underwent PC repositioning.For all patients
this new method proved to be excellent with no
leakage and PC were utilized after only 24 hours.
We emphasize the brief time for PC insertion,the
minimum disconfort and semplicity of the technique.
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THE HEMOSTATIC FUNCTION IN PATIENTS ON AMBULATORY
PERITONEAL DIALYSIS (CAPD) AND HEMODIALYSIS (HD).
N.Di Paolo, U.Buoncristiani,G.Fanetti,M.De Mia and
E.Gaggiotti.(Introd. by A.Sodi)Nephrology and
Dialysis Departm. of Regional Hospitals of Siena
and Perugia. ITALY.
In order to compare the hemostatic function in 14
CAPD patients with that of 11 HO patients after at
least two years of treBtment,the following paramers
were determined :Prothrombin time,Activated Partial
Tromboplastin time,Prekallicreain, C1lnactivator,
Fibrinogen Activity and Fibrinogen like Antigen,
Fibrinogen Degradation Products,Antithrombin III,
Plasmiriogen,Alfa-2-Antiplasmine,Alfa-2-MaCrO -
globuline,Platelet Count and Aggregation with ADP,
ADR and Fibrinogen.For three consecutive days the
CAPD patients were examined while, the HD group was
tested before and after HD and both 2 and 6 hours
after dialysis.The results were submitted to
statistical elaboration and showed differences in
hemostasis in CAPD and HO patients.The marked
increase in Fibrinogen like Antigen was more
noticeble in HD patients.This increase provokes in
turn an increase in the fibrinolytic (a rise in
Plasminogen) and anti-fibronolytic (a rise in Alfa—
2- Antiplasmine) processed which are more evident
in CAPD group.
Antithrombin III is higher in CAPD patients while
the Platelets aggregation parameters are higher in
D. Our data show a better response of CAPD to the
Irombophilic state compared with HD patients.
INFLUENCE OF MIDDLE—MOLECULAR—MASS SOLU—
TES (MMs) ON ERYTHROID COLONY GROUTH IN
VITRO
Lj. Djukanov, L. Biljanovi6, J. Petro-
Radrnilov
Institute for Kidney Diseases, Clinical
City Hospital, Institute for Medical Re-
search, ++Institute for Biological Rese-
arch, Beograd, Yugoslavia
Pre—dialysis sera of the patients on
regular hemodialysis were subjected to
molecular sieving chromatography on Sephe
dex G—15 column. Elution profile displays
five distinct fractions in the range of
middle molecular mass. In order to inves-
tigate the biologic activity of MMS 'ie
studied their influence on erythroid co-
lony formin cells (CPU-.E) using normal
ODE mouse marrow cells. Second and 5th
fraction of MNS produced a significant
inhibition of CFU—E and this effect was
dependent of the concentration of MIIS in
the culture. The remaining fractions of
NIIS had no effect on erythroid colony
growth in vitro.
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OSMOTIC FRAGILITY OF EAYTHROCYTES (ABC), CELL DE
FORMABILITY, AND SECONDARY HYPERPARATHYROIDISM
(2°HPT) IN HEMODIALYSIS (HD) PATIENTS
D.Docci, F.Turci, G.SalvI (Intr. by S.Stefoni)
Servizio di Nefrologia a Dialisi,
Ospedale M.Bufalini, Cesena, Italia
Since PTH has been shown to increase calcium
influx into human R8C in vitro,it may be hypothe
sized that excess blood levels of PTH could be in
part responsible for the altered mechanical prope
rties of ROC in uremia.To test this possibility,
the osmotic fragility and deformability of R9C we
re measured in 32 RD pts and correlated with 2°
HPT.l6 healthy subjects acted as controls.The coc
centration of NaC1 at which 50% of ARC were lysed
(MOF)was significantly higher in HO pta then in
controls(O.485+O.025 vs O.4l3-MTJ.0l5).RBC deforma
bility,measurad as ROC flow rate(VRBC)through nu
clepore membrane,was significantly reducad(28.04÷
18.77 vs 92.64+13.82ml/min).No significant corre
lations were found between either the MOE or the
VRBC and the hewetochemical indices of' 2°HFT.Fur
thar,no differences were found between pts with
normal alk.phosph. and pts with high elk.phosph.,
as well as between patients with normal radiogra
phs and pta with X—ray evidence of 2°HPT.3 parath
yroidectornized pta had the MOF end VADC in the ma
me range as other HD pts.Lastly,effective treetme
nt of 2°HPT by either phermecolopical means or mu
rgical removal was not associated with e consensu
al improvement in ABC function.Therefore,the ABC
is probably not a target organ for PTH in uremia.
This observation is of interest em to the search
for the link between 2°HPT and anemia of uremia.
ACUTE CHANGES IN T LVMPH0CVTES (LII) SUBSETS TNVUCEV
SY HEMOVIALVS1S ((IV).
F. CoLeait-t, F.Mascwt-t-LemoneC . T-L ternctvu, L .Ve Vttet
R.WevM.V,a(1ntJt.bg' P.Vent'iaeten).
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0KT8÷ceUs (/nsn3) 649÷15 404÷32 <.001
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pIuzsma ca-techotzmlnei.,.
Thws, In covrt'uvs-t to a (p-'wbabLy "-tebound") gka-
nuLoeyo4-L, HV I oUoved by a decnease In -the
nwnbvr. o tofaJ. T Ly (OKT3÷), rnoJn-1y Oi -the
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AUhough these change-,sappea't Independent o the
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,esa-Ln tO be dnte'tm-Lned.
LO&-TERM RIGHT AThIAL CATHErERISATION-NEW APPROACH
10 DIFFICULT CIRCULAIDRY ACCESS - 3 YEARS EXPERIENCE
PK DonnellY, DMA Francis, A Heaton, N Hoenich,
MK Ward, R Wilkinson, G Proud, RMR Taylor.
Renal Unit, University of Newcastleupon Tyne, England
Successful treatment of patients by hawnodialysis
depends upon effective long—term access to the circ-
ulation. Of 226 patients treated at this centre for
end—stage renal failure over the last 3 years, 18
(8%) have had major difficulties inmaintaining circul-
atory access. These 18 patients (mean age 47.8, range
17—68 years) had 63 (3,5/patient) vascular access
procedures (shunts, fisulas, PTFE or vein grafts),
which failed for a variety of reasons (thraribosis,
high or low output cardiac failure, atherosclerosis)
All patients were either unsuitable for or had failed
on CAPD and 7 had one or more renal transplants
which had failed. long—term central venous access
was achieved by insertion of a silastic catheter in-
to the right atrium via a jugular vein. Using a
single needle technique (flow rate 2OLknl/min, recirc-
ulation 12%), 2392 dialyses have been successfully
performed and patients have been maintained for 1—
42 months (mean 10.9).
Ccinplications: Infection - 3 catheters were
replaced following recurrent exit site infection.
Thranbosis - 2 catheters were rnoved and one
successfully declotted following spontaneous catheter
thrcmbosis. Routine catheter heparinisation andoral
Dipyridamole therapy has since eliminated this problen
None of the patients has lost access nor died as a
result of catheter—related problans. One pateint has
successfully undergone renal transplantation having
used a catheter as his sole means of access for 12 months
Whilst not recannended as a routine first-line of
vascular access, long—term central venous catheter-
isation has proved safe and effective in treating
patients for whan conventional access has failed.
• hAISEI) SEJWM NICKEL CONCENTRATIONS IN CHRONIC RENAL
.
FAILURE (CEF).
M, Drazxjiows<y, S.M. Channori, I.S. Parkinson,
M.K. Wend, D.N.S. Kerr.
Department of Medici e, Royal Victoria Infirmaxy,
Ne'.vcastle upon Tyne, England.Sern nickel concentrations were measured in
normal subjects and patients with CRF by l'iiazieless
atomic absorption spectrophotometry using serum
oased catiiratioii standards. The limit of
detection was 0.6 ,ng/i.
In 1 noraL suojects the median serum nickel
concentration was 1.0 ,ug/1, rauge< o.6—,.o ,ug/i.Increased concentrations of serum nickel were
found in 31 CBF patients treated conservatively(p<O.Ol). The median va1e was 1.6 tg/1, range
<0.6-3.6 )i'. InC serun creatinine range in these
patients was 135—1116 anol/l.
No correlation was found between serum nickel
and serum creatinine concentrations, (Speazmants
rank correlation coefficient r5='O.lO, p'O.O5) or
oetween serum nickel and seium albumin concen—
trations (z'=O.O1, p'O.O5).
In 13 patients on continuous ambulatory pent—
ones]. dialysis (CAPO) the median serum nickel
concentration was 8.o ig/1, range 5.4—11.4 pg,t1,
a significant increase (p.<O.O1) over both normal
subjects and CR1? patients.
In 10 liaexnodialysed patients post—dialysis serum
nickel concentrations (median 8.6 pg/I, range
4.8-.20.O pg/i) were significantly higher (p"cO.OOl)
than pre—dialysis values (median 7.6 ,pg/l, range
3.2—15.6 pg/l).
Analysis of nickel in tap water, deiouised water
and dialysis fluid showed the highest concentra-
tions to be present in the dialysis fluid(2—3 ug,/lWe concLude that serum nickel is elevated in
patients with CRF and those treated by hamno—
dialysis or GAPD.
o'. ce-eta-eao e ace-fwte
be-Low (means ÷SEM) and
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QUANTITATIVE MEASUREMENT OF PLASMA DNA AND
HEMOD1ALYSIS
3.M. Dueymes, G.3. Fournié, 3. Lule,
3.P. Pourrat, 3.3. Conté, Unite INSERM 269,
CHU Purpan, 31059 TOULOUSE Cedex, FRANCE
Hemodialysis is responsible for the release of high
amounts of DNA in blood. Until now, the origin of cir-
culating DNA in this situation was not known. To study
this phenomenon, a new method suitable for the quanti-
tative measurement of 0.05 to 20 ng of DNA in 10
l plasma samples was used. Plasma DNA was evaluated:
'(1) before, during (30, 60, 90, 120, 180 mn) and after
dialysis in 20 patients dialysed on cuprophane (CU)
or polyacrylonitrile (PAN) membrane ; (2) before and
after the artificial kidney ; (3) during in vitro studies
in which artificial kidney was perfused using blood
from normal donors (fresh or 7 days old). Other parame-
ters (leukocyte counts, complement, C3activated f rag-
ments) known to be useful for the evaluation of the
biocompatibility of dialysis membranes were also evalua-
ted. Results were the following : (1) circulating DNA
increases in time whatever the nature of the membrane
but significantly more with CU. No correlation was
found between the transient neutropenia observed
at 30 mn with CU and DNA level ; (2) during all the
time of hemodialysis, results found before and after
the artificial kidney clearly showed a decrease in leuko-
cyte counts and an increase in DNA levels, variations
significantly correlated ; (3) in vitro studies, no varia-
tion of leukocyte counts and DNA levels was found with
fresh donor blood, while a progressive decrease in leukocy-
te count associated with an increase of DNA levels
were observed with 7 days old blood. In conclusion
(1) during hemodialysis high amounts of DNA are released
from leukocytes damaged in artificial kidney ; (2) quanti-
tative measurement of DNA in patients under hemodialysis
is a new tool to study the biocompatibility of dialysis
membranes.
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OBSTPIJCTIVE UROPATI-IY AS A CAUSE OF RENAL
FA ILURE AMONG DIAL YSIS PATI ENTSLt.,Professor of medicine,in
Shams university,Cairo,Egypt.
In a study of the etiology of chronic
renal failure among 170 dialysis patients
in a dialysis center in Cairo over the
last 3 years,obstructive uropathy due to
Bilharzial ureteric strictures was found
in 26% of cases. In 9% urinary calculi
were present in association with the
t3ilharzial ureteric strictures.The over-
all incidence of urinary calculi in this
group of dialysis patients was 15. It
is concluded that obstructive uropathy
due to ilharzial ureteric strictures is
an important cause of end—stage renal
failure in Egypt. The incidence of urin-
ary calculi among dialysis patients in
this study is much higher than that of
European centers.
• . S:.I ND REIAL
__
IN REGULAR DIALYSIS TEEATTIENT (EDT)V J.Erben, B.Hajkova,Ei.Pantucek, L.Kubes.
First iIedical Clinic,2atholoy Departuent
University Hospital Hradec Krlové,
Czechoslovakia
Fluorides (F) in plasma (P),urine (U)
and dry bone tissue (B) were estimated
using a P—ion selective electrode in fol-
lowing groups: 20 control persons (OF),
11 waiting (CHRI) and 40 patients on
maintenance haemodialysis (EDT). The in-
crease of PP (CP:2.4÷1.4,CHRI:6.4+2.5,
RDT:12.3+4.5 umol/lYand BF (CP:5.1e31
CHRI:99.9÷31 .2, RDT:339.1÷150.6 umoi7g)
significantly correlated with the decre-
ase of GPR still before RDT, duration of
RDT,number of dialyses (in all: pO.OO1),
with the maximum in completely anuric
patients (379.7jl53umol/g ). The increa-
se in F retention was intensified becau
of absorption of considerable amount of
P/dialysis (tap water P leve.:40—50umol/L
postdialysis P increase 21Q').Developmerrt
of bone fluorose known to develop withBP
over lSOumol/g1 was not found in any of
40 trepanobioptic samples. No correlatii
was found between laboratory findings of
renal osteopathy and F, but no patient
had spontaneous fractures for as long as
10 years using fluoridated water.
We conclude that P might have protec-
tive effect against renal osteopathy pro-
gression also in high retention values.
THE EFFECT OF DIALYSAJE JEMPERATURE ON HEMODIALYSIS
LEUKOPENIA.
G.Enia, C.Catalano, G.Creazzo, F.Zaccuri, A.Mundo,
D.Iellaino and Q.Maggiore. Centro di Fisiologia Cli-
nica del C.N.R. e Divisione Nefrologica. Reggio Ca—
labria. Italy
Leukopenia ( L ) occurring early during HD is
considered to result from alternative pathway Corn —
plement activation by the cellulose membrane. We in
vestigated if lID L can be attenuated by lowering
the dialysate temperature ( T ).
With a cross over study we assessed in 6 patient
the effect aiv of II) carried out with unwarmed (24.3°
+2.7 °C ) and warmed ( 36.8÷ .5°C) dialymate. T
was monitored through thermocouple needles( Ellab
inserted in the blood and dialysate circuits. Du —
ring the procedure with unwarmed dialysate, blood
was warmed before reentering into the patient by
immersing a specially designed venous line in a
thermostatic bath.
Maximal fall in WBC count ( after 15' )averaged
76.0% SD 6.4 during warm dialysis, 39.7% 15.3
during unwarmed dialysis ( p<.CO1; paired t tt ).The
lower dialysate T reduced by 11+50 4% the dialy—
zer urea clearance. In additional studies on the
same patients with dialysate T from 34°C to 38°C
we found that the WBC fall ( at 15' )bore a high-
ly significant relationship with dialysate T (r=
—
.68, p(.col ; Spearnmo ral test). In conclusion the
use of unwarmed dialysate markedly reduces the de-
gree of dialysis induced L, likely because it cau—
sea a lesser degree of Complement activation.
ThE INEFFECTIVENESS OF ANGIOTENSIN II FOR THE VASCULAR
STABILITY IN HAEMOFILTRATION AND HAEMODIALYSIS
W.Ernst, C.A.Baldamus, P.B.Bechstein, W.Fassbinder,
D.Ganten*, F.Oppermann, E.—H.Scheuermann, W.Schoeppe
Dept. Nephrol. Univ. Ilosp.,Frankfurt, and Dept.
Pharmacol*, Univ.Hosp., Heidelberg, West—Germany
Improved haemodynamic stability during haemofiltration
(HF) is a well recognized phenomenon caused by a more ade-
quate sympathetic response to volume removal and consequent
lY an increase in total peripheral resistance. This phy-
siological response to volume removal is not seen during hae-
modialysis (HO). Thecontribution of the renin—angiotensin-
system (RAS) during HD or HF to blood pressure stability has
not been clarified so far. Therefore, the response of plas-
rnareninactivity (PRA), angiotensin II and plasrnanoradrena—
lin (PNA)concentration wes measured after 3Omin.of extra—
corporeal circulation (EC) and after 4hoursof HO and HF in 8
patients with identical small Solute removal, sodium loss
and bodyweight reduction. Under heth procedures blood
pressure was registrated every 15 minutes.
MAP(mmHG) PNA(ng/L) PRA(U/L) All (fMol/L)
EZ 9-9±18 469258 13.8± 7, 14.5± 8.7
HD240 91±23 481±217 19.3±12 48.5±13.2_._
EZ 96±17 462±129 15.3± 9 13.7± 4.9 *
HF2401 98±22 558±108* 20.8± 7 29.8±l5.4i
*=p<O.O5; <0.01 (paired t—test), =
During HO and HF, an identical increase in PRA is seen,
whereas the corresponding rise in angiotensin Il(A Ii)
is significantly smaller in HF than inHD in contrast
of the haemodynamic stability in HF (see MAP). A sig-
nificant increase of PNA was only observed during
HF. These findings show the importance of an in-
tact sympathetic system for vascular stabil ity du-
ring volume depleting procedures, whereas A H seems
to be of no importance. It remains open, whether
the significantly smaller increase of A II during HF
is only due to a higher clearance rate
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FIBRONECTIN(FN), PREALBuMIN(PA) AND RETINOL
BINDING PROTEIN(RBP) LEVELS IN PATIENTS VITH
CHRONIC RENAL PAILURE UNDERGOING ERMODIALYdIS
(CRF—i-ID) AND IN PATIRETS APTER SUCCESSPUL RENAL
TRAN3PLANT(RP).
H. Espinel, J. Joven, NJ. Rodrigo, A.Olmos,
R.JardI, S. Schwartz.
Hospital Valle de Hebr6n de Barcelona. Spain,
Reports are few on REP concentrations in CEF
HD and its relationship with hypervitaminosis A
observed in these patients. REP, which is usua-
lly bound to PA, is normally filtered through
the renal glomeruli and reabsorbed in the proxi
mel tubuli cells, where it is thought to be me-
tabolized. The aim of this study was to investi
gate the relative importance of this catabolic
pathway. At the same time, PN was studied as a
nigh molecular weight protein which was thought
to remain uninfluenced by dialysis. FN, PA and
REP were measured by specific single radial inn
uncdiffusion plaques in 3 age—matched groups of
15 males(control, CRP—i-ID and RT) receiving no
vitamin A supplement. Values expressed in mean1
S.D. CONTROL CNN—RD NT
?N(mgjdl) 314±62 355j71 304±67
RBP( " ) 5.5j1.1 23j2.9* 1O.1j5.4
3O.95.7 4O.27.3**3O.7j8.3
. p(O.0001 respect to control and RT.**p(O.OO1
respect to control and p(O.005 respect to RT.
Our data show elevated REP levels in CNN—Hi),
with significant decrease in the NT group. dimi
lar findings have been reported for vitamin A
levels. Our observations suggest that 1)eleva—
ted RIP levels can be caused by a loss of func-
tional renal mass, and 2)increased REP concen-
trations are a possible cause of increased vita
mm A levels in patients with CNN—Hi). However,
follow up of the sane patient through CRF—HD
and NT would be necessary to confirm it.
HATMODIALYSIS INDUCED HYPOXEMIA.
S Fawcett. NA Hoenich. DNS Kerr.
Department of Medicine,University of Newcastle/Tyne
Rapid falls in arterial oxygen levels (Pa02) are
associated with haemodialysis treatment. To
elucidate the mechanism of this phenomena, and to
assess the role of membrane type and dialysate
composition, eight patients receiving maintenance
haemodialysis were studied with different membrane
(Cuprophan, polyacrylonitrile (PAN15) and
dialysate (40 mmol/L acetate; 30 mmol/L acetate;
bicarbonate) combinations. Blood and expired
gas determinations as well as carbon monoxide
diffusing capacity (DLCO) serum acetate levels
and white blood cell counts were performed.
Pa02 fell with both Cuprophan and PAN15
membranes when used with acetate, although falls
with PAN15 were reduced significantly. Bicarbonate
further reduced but failed to totally eliminate
hypoxia.
Hypoventilation was observed for all membrane
dialysate combinations. Respiratory exchange
ratio decreased by 25% with both membranes when
used with acetate, due to a decrease in lung CO2
excretion. DLCO fell by 40% for Cuprophan
compared with 14% for PAN when using acetate.
In contrast with PAN, patients dialysing with
Cuprophan demonstrated a widening alveolar-
arterial oxygen difference.
These findings indicate that hypoxemia during
dialysis is due to both hypoventilation and
pulmonary dysfunction induced by leucopenia and
suggest that the use of biocompatible membranes
with bicarbonate based dialysate is the most
optimal treatment particularly for patients with
a diminished cardio pulmonary reserve.
COMPUTED TOMOGRAPHY AND PHOTON ABSORPTIOME
TRY: EVALUATION OF BONE MASS IN HAEMODIALY
ZED PATIENTS
A.Farine11i,L.PerazziniRL.Bedani,B.Bsgni*
Division of Nephrology
Health Physics Department*
U.S.L.31 - Ferrara - Italy
The bone mass evaluation is useful to
correct diagnosis and follow up of uremic
osteodystrophy.
We studied 15 haemodialyzed patients (a
ge 46.4÷8;6 male,9 female) by means of two
noninvasive methods. CT (computed tomogra-
phy) scans of distal radius at 33% and 10%
of ulna length were performed three times
at 12 months intervals.On occasion of the
third tomographic study BMC (bone mineral
content) of the same bone sections by means
of photon absorptiometry was obtained. The
duration of haemodialysis at the time of
the first CT bone mass evaluation was 31+
28 months.
The follow up of bone mineral assessment
by CT demonstrated a progressive decrease
of mineral content. The results obtained by
means of the two methods showed a good
correlation at 33% but not at 10% sections.
The analysis of 10% cross—section seems
influenced by repositioning errors and so
it results poorly reproducible.
VIBRETIOR SINSCRY THRSHOLD (vsT) AS A GUIDE TO
ADEQUACY CF DIALYSIS
T. C. Feest and W. Trounson
Royal Devon & Jxeter Hospital, Exeter, UK.
Neasurement of VST with a biothesiometer is a
rapid non—invasive repreducible method of studying
sensory nerve function: it is abnormal in uraemia
and is corrected by transplantation. Serial
measurements of VOl at the medial malleolus were
made in 75 dialysis patients. Age corrected data
was analysed by non—parametric multiple regression
and Wilcoxon tests. Factors affecting VOl, and
effects of treatment changes were studied.
Older dialysis patients show greater increase
of VOl from expected than younger ones (p<O.OO1).
Mean VST is worse if urine volume is below 150 ml
daily (p<O.05) but some anepbric patients have near
normal VST after ten years dialysis. VOl is not
related to plasma creatinine in the whole group but
each of 13 patients studied twice weekly for the
first three months of dialysis had a fail in VOl
which related to a fall in plasma creatinine
(p0.05). VOl is not related to duration of
dialysis, deterioration from first to send year
being due to decline in urine outrut. VOl improved
in seven patients changed from hmemodialysis (HD)
to CAPD (p<O.05), more so in those with no residual
renal function, and tended to deteriorate in seven
patients changed from CAPD to ND.
Six patients changed from 4 to 5 two litre CAPD
exchanges daily in a cross over study (estimatedincrease in middle molecule clearance io.). vs'r
improvement was not significant. VST deteriorated
in three patients changed from CAPD to alternate
day intermittent PD, and in three CAPD patients on
discharge from hospital.
VOl is a useful monitor of adequacy of dialysis,
and can aid individual prescription of dialysis.
HIGH HYPERGLYCEMIAS IN DIABETIC PATIENTS UNDER CHRO-
NIC HEMODIALYSIS — C. Ferreira, L. Oliveira, R. Paz.
R. Martins and J. Pratas.
ClInica Eurodial — Leiria — Portugal
Hemodialysis changes the natural history of certain di-
seases, causes a new pathology, helps confirming theses and so-
metimes questisns concepts otherwise considered unquestionable,
such as that of the hyperosmotic coma development mechanism in
diabetic patients.
In three diabetic patients under heniodialysis, who, for
different reasons, had abandoned the insulin therapy, we have
registered hyperglycemias higher than 800 mg nine times, seven
of which in routine pre—dialysis tests, with the patients sho-
wing no special symptoms, besides thirst and an eacessive gain
of weight, and the other two when they showed lethargy asd dis-
comfort.
Shswing no osmotic diuresis, these patients were found
hyperhydrated ( thirst o flow of water out of the intracellular
space) and is hyponatremia, what prevented the development of
the typical neuroisgic signs of hyperosmolarity, what is a su-
bject of discussion in this work.
The anomalies we found agree to a certain extent with
other recent descriptions; their correction by means of hemodia-
lysis and the return to the insulis therapy is defended ax the
simplest avd safest method in the ambulatory treatment of such
cases, mainly if there is an eoceusive hyperhydration and a nor-
mal natremia, but the dialyser fluid must have a low concentra—
tien of sodium.
EFFECT OF DIALYSATH CO8SOSITION ON BLOOD VOLUTiIE
DURING DIALYSIS WITHOUT NP7T ULTRAFILTRATION
S.J.Flemirg, R.N.Greenwood, W. R.Cattell
Dept of Nephrology, St Bartholomew's Hospital,
London, United Kingdom
There is disagreement as to the effect of
change in plasma osmolality/LNa) on
intercompartmental fluid movement. We have
studied fluid shifts into and out of the
vascular compartment occurring in 7 patients
subjected to 90 mine dialysis without net
ultrafiltration, using high (Na 154 nmnol/l),
normal (Na 140 mrnol/l) and low (Na 126 mmol/l)
dialysate concentration. Change in blood volume
(By) was considered to occur solely as a result
of water hjft and thus was monitored by direct
measurement of blood water content
(go, H20/ml blood).
This study, performed without use of
radioisotope measurements and hence free from
their inherent inaccuracies, showed that
alterations in plasma ommolality due to urea
removal did not alter By. By contrast, osmolal
changes induced by alterations in plasma Na and
associated anions caused significant (paired
i—test, p<0.05) changes in By. Interestingly,
the reduction in BV produced by low sodium
dialysate is greater than the increase produced
with high sodium dialysate. This supports the
idea that water moves more readily out of the
vascular compartment than in the reverse
direction.
GLUCOSE AND NON-GLUCOSE SOLUTE TRANSFERS
AND ULTRAFILTRATION DURING CAPD
Laura W. Fleming, W.K. Stewart
University Department of Medicine, Dundee
Scotland
Patients on CAPD with loss of ultra-
filtration (UF) capacity have benefited
from treatment with an empty peritoneum
overnight. UP volume and total osmolar,
glucose and sodium absorption per bag have
been calculated in order to elucidate the
transfers occurring. Patients with good
and poor UP could not be differentiated by
peritoneal dialysate osmolar or glucose
concentrations after either short or long
dwells. Calculated osmolar gains per bag
were significantly higher in patients with
poor UP, but only small differences were
seen in calculated glucose absorption per
bag, comparing patients with good and poor
UP. UP volume per bag correlated very
closely with calculated net osmolar gain
per bag (r = -0.92). Good UP was
characterised by glucose absorption
exceeding osmolar absorption, implying non—
glucose solute loss from patient to
dialysate. Poor UP was characterised by
osmolar absorption exceeding glucose
absorption per bag, implying absorption of
non—glucose solute from the dialysate.
This pattern was most marked during long
overnight dwells, when net osmolar gain
could exceed glucose gain by 180 mOsm.
Patients with poor UP differ from those
with good UF more in their absorption of
non—glucose solutes than in their
absorption of glucose.
DEEP FREEZE FRESERVED SAPHENOUS VEIN ALLOGRAFTS
FOR HEMODIALYSIS
AUTORES: A. Garcia—Alfageme; L.Rodriguez; A. Gar-
cia Alonso; J. Espinosa; J.A.Chac6n; T.Ruiz; A.
Yafiez.
Clinica Nefrologica.— Bilbao — Spain.
For the last two years we have been studying
the performance of safenous vein allografts as A—V
fistula for hemodialisis. These grafts are -
preserved at very low temperature (—70°) and have
been used in 11 patients; in 4 of them in loop
position in the forearm, in other 4 in straight
configuration, and in 3 as a by—pass to
reconstruct nonfunctioning A—V fistulas.
Results. In 3 cases the grafts clotted in the
early post—operative period (poor venous runoff).
The remaining 8 grafts have been well
functioning with a patency average of six months.
There have been complications related with the
dialysispunctures; two cases presented endotelial
fibrous hiperplasia at the venous anastomosis
leve, wich needed surgical repair. There has not
been any infection.
The evolution of the vein wall has been
estudied by means of biopsias taken in
reoperations. No rejection data has been found,
and after 8 months evolution, the vein wai.l
presents hialinic infiltration, wich preservation
of the rest of the wall.It is concluded that this graft is a good
alternative to others grafts, cheap and readily
available for hemodilysis.
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POLYMORPHONUCLEAR LEUKOCYTES (PMN)
FUNCTION IN CHILDREN ON HEMOFILTRATION
(HF).
L.Ghio°,A.M.Plebani,M.Picca° ,M.Giani° ,A..
Biolchini ,E. Viola, C. Maccarinelli ,A. Edefonti
M.Bardare1. ( Intr. by L. Minetti)
Pediatric Dialysis Unit,University of Milan
First Pediatric Clinic,University of Milan
PMN abnormalities were reported in patients on
chronic renal insufficiency and hemodialysis .Data
are lacking for HF .The PMN function (chemotaxis,
phagocytosis and killing of Candida Albicans (CA))
was studied in 8 pediatric patients (4.5-16.2 -16.
2 years) treated with HF for 17.7±7.18 months.
Blood was obtained before and after a mean of 5
hours of HF .6 out of 8 patients showed a depressed
chemotactic response (mean preHF:43.68±22.93%;
mean postHF :41.32±21 .84%.The pre and postHF
sara were able to depress PMN function of normal
subjects (mean preHF:46,57+19,48%;mean postHF
43,08±20,27%) and this depression took place even
after a preincubation of the sera at 56° for 30 mi
nutes.Pre and post treatment phagocytosis and
killing of CA were normal in all patients .ln conclu
sion, only chemotactic function was impaired in
children on HF. This defect in probably due to a
serum inhibitory lat -stable factor ,not complete
ly removed by HF.
• NITROGEN BALANCE (Nb):AN ADEQUATE TREA
.
TMENT PRESCRIPTION INDEX IN CHILDREN ON
HEMOFILTRATION (HF).
M .Giani, M.Picca,A. Saccaggi,R .Galato, A.Betti-
nelli, C. Funari, L .Ghio
,
A. Edefonti (Intr .by.L .Mi-
nettt).
Pediatric Dialysis Unit,University of Milan.
Low pretreatment BUN levels have been used as
a good index of treatment adequacy in patients on
end stage renal failure. An adequate pretreatment
BUN but unsatisfactory Nb and growth velocity we-
re found in 3 out of 12 children (12+3yrs,24.7±
2.4 kg) on HF treatment. HF was prescribed using
urea kinetic model.Urea generation rate (Cu) ,pro-
tein catabolic rate(PCR) and Nb were assessed in
each child after the first year of HF (T[D) and after
another year (Ts) following the increase of plasma
water cleared/week (Cpw/week).Assessment of die
tary protein intake was performed in children on
an unrestricted diet by 10 day records every 2 mon
ths.Growth rate(GR) was recorded according to
Tanner.
Results:
Cpw/week BUN Nb GR
ml/min/ 1. 73sm mg /dl mg/kg/day cm/year
T° 8.6+0.7 100t25 34±25 3.1-i-0.7
T. 10±0.5 90±19 174±54 3.8±0.9
It is concluded that a treatment prescription ad-
dressed only to a low BUN target may be inadequa-
te in pediatric patients; Nb is otherwise a more
appropriate index,as suggested by the improvement
growth rate.
INFLUENCE OF VARYING(BLOOD)IONIZED CALCIUM
(Ca)ON BLOOD METABOLIC PARAMETERS OF
OSTEODISTROPHY IN CHRONIC HPLEMODIALYSIS
Rivetti V.,M.Baruffaldi, P.Ghiringhelli, F.
Pee chini
Hospital Division of Nephrology,Cremona,
Italy
++Dialysis(HD)Ca cycle(ust after,24 an
d 48 hrs after)was valued in 60 patients a
ad successively varied in several ways: ea
ch of seven groups(6 to 9 persons),continu
ed to assume aluminium hydroxide(3.-6 g/day
),but had a specific change of osteodistro
phy treatment.After three months Cacycle
was checked again.Phosphorus(P),total cal—
cium(Catot),alkaline phosphatase(AP),proti
demia and parathormone(?TH)were also studi
ed before and after the period.
Results include changes(p.O,O5)of Ca
when oral calcium supplements carried off
(from 1,27±0,07 to 1,19±0,05 rnmol/l at 48
hrs),3 mEq/l,instead of 4,calciuin dialysis
fluid iristituted(from 1,51±0,12 to 1,36±0,
13 just after HD),vit.D withdrawn(frorn 1,3
1O,O6 to 1,23±0,03 at 24 hrs:p<O,O1) and
calcifediol added(from 1,62±0,13 to 1,50±
0,06 just after HD).Metabolic(P,CatOt,AP,
FPH)changes appeared only when Ca cycle
was troubled: only one group treated with
oral calcium supplements had no variation
of Ca after vit.D added but an increase
of P(from 5,08±0,57 to 6,O7±0,6O.Ca cycl
e appears as an index of bone metabolism.
PLASMA CALCIIJM—OXALATE PRODTJCT(sCa.Ox)IN PATIENTS
(pts)ON CHRONIC HEMODIALYSIS(RDT).
G.Vagelli ,S.Lupetti ,G.Pratesi ,G.Calabrese,M.Gonella
Service of Nephrology and Dialysis,Casale Morif.,Ins
titute of Medical Clinic I,Uriiversity of Pisa;Italy.
As Ca—Ox deposits have been reported to determine
severe lesions in many organs of ROT pts,sCa.Ox was
studied in 20 normals and 26 pta before and after
dialysis(BTJ,AD).All pts received piridoxine after
each dialysis;the dialysate Ca level was mmol/l 2.
sOx was determined by a specific enzimatic method
(mean normal value ol/l 2l.9+4.9SD),sCa by atomic
absorption spectrophotometry(mean normal value mmol/
1 2.49+O.153D).
aOx BD and AD(mean value emol/1 63.6+10.3 and 37.8
+6.8SD,respectively)wss significantly higher than in
normal(p<O.OOl,in both caaes).The mean sCa BD(mmol/.
2.37+O.16SD)wae slightly lower than normal;it increa
sed AD(mean value mmol/l 3.O5+O.19SD)reaulting signi
ficantly higher than its predialysis and normal va
lue(pO.0Ol,in both cases).In all pts sCa.Ox RD and
AD(mean value 151.1+28.2 and ll5.5÷22.5SD,respective
ly)was significantly higher than normal(mean value
54.7÷13.1SD)(p<O.OO1,ifl both cases).
Despite sOx is reduced by RDT and piridoxine add
nistration,aa previously reported,theae procedures
are not sufficient to reduce sOx in a way as to pre
vent oxalosis induced by Ca—Ox deposits.As these oc
cur when sCa.Ox is exceeded,other therapeutic approa
ches are suggested in an attempt to decreaae this
product in EDT pts.
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ACUTE RENAL FAILURE (A.R.F.) IN HIGH RISKS PA-
TIENTS : IS CONTINUOUS PERITONEAL DIALYSIS (C.P.O)
AN EFFICIENT ALTERNATIVE TO ITERATIVE HEMODIALY—
SIS (H.D.) ?
R.Gonthier, J.C.Sabatiér, C.Genin, J.Toulon et
F.C.Berthoux, Service de Néphroloqie, Hôpital Nord
Saint—Etienne, France.
Our experience with CAPO in the treatment of
chronic renal failure, led us to use this tech-
nique in treating high—risks patients with ARF.
From 80 to 83, we treated with CPD 25 patients
presenting many factors of severity known to wor-
sen the prognosis, and in the same period 17 pa-
tients with iterative HO but less critically ill.
ARF causes were similar in both groups. We defined
8 factors of severity : Age>70 ; post operative
ARF ; external bleeding and/or severe anemia
(hernoqlobinernia <75 q/l) ; septicemia or septic
shock ; intensive steroid and/or immunosuppressive
therapy ; prolonged shock (MAP<70 mm Hg); Acute
respiratory distress syndrome requiring mechani-
cal ventilation ; and severe hyperhydratation
(A weight>15 %). Their mean number is 2,2 for
CPD patients versus 1,2 for HO patients. More
precisely, 4 factors Jere more frequent in CPL
patients Ag>7O (CPO 8/25, HD 1/17) ; bleeding
or anemia (CPD 15/25, HO 2/17) ; steroId or im-
munosuppressive therapy (CPD 8/25, HO 3/17) ; sep—
ticemis (Cr0 11/25, HO 2/17). In both groups we
achieved a low mortality ; (4/25 (16 %) in CPO
vs 3/17 (18 %) in HO. Renal recovery was similar
in both groups but seems to be delayed in the CPO
subgroup. This comparative study indicates that
CPD is a valuable alternative to HO in high—risks
patients and validates our a priori choice of CPD
for the most severely ill patients.
THE EFFECT OF CAPD ON WHOLE BODY PROTEIN TURNOVER.
F.HJ. Goodsiiip, S. Lloyd, M.B. Clague, M.K. Ward,
H. Wilkinson, D.N.S. Kerr.
Department of Medicine, koyal Victoria Infirmary,
Newcastle upon Tyne, England.
xpeiments both in vitro and in vivo, in nan
and animals, est that protein turnover is de-
creased in urmuja, However little is known about
the effect of dialysis upon whole body protein
turnover. We have therefore measured whole uody
protein turnover in 5 patients with chronic renal
failure in the niontli prior to the onset of CAPI) and
after 3 months treatment. This w done using a
primed constant infusion of l—t—-C Leucixie with
measuroment of 14C Leucine specific activity once
isotopic equilibrium had been attained. The results
for these studies aregiven (valuesareg.g.day±sEM).
Turnover Breakdown Synthesis Balance
Pre—dialysis 2.39±O.23l.64).23 2.O2).25O.38±o.O5
After 3 mths
on CAPD 2.44).45l.69±0.l8 2.15±0.170.46±0.02
At the sane time a full nutritional assesmnent
including the measurenent of skinfold thickness,
total body potassium, post absorptive aiino acids,
dietary intake, albumen, transferrin, complement
and inimunoglooulins was undertaken. No significant
differences were found between either group for
these paraneters.
Whole body protein turnover, synthesis andbalance increased but these changes did not reach
statistical significance. However from the combined
variance of lie groups involved we have estimated
that it would uc necessary to study 20 patients to
be 90% certain of avoiding a type two statistical
error when looking for a 20% difference in protein
turnover with 95% confidence.
• THE CARDIOVASCULAR AND METABOLIC EFFECTS
OF MIXTURES OF ACETATE AND SUCCINATE: A
• POTENTIAL IMPROVEMENT IN DIALYSATE SOLU-
TIONS.
F.M. Gonzalez, P.L. Kirkendol, 3.E. Pearson and E.
Reisin.
Louisiana State U. Med. Center, New Orleans, LA,
USA.
We have reported that succinate (SUC) produces
substantially fewer cardiovascular (Cv) effects than
does acetate (AC); HCO3 regeneration after SUC, how-
ever, occurs too slowly to be used alone in dialysis. The
present study determined CV and metabolic effects of
mixtures containing AC/SUC at a ratio of 25:75%,
50:50%, or 75:25%. For the CV studies, each mixture
was infused into anesthetized dogs at doses of 0.125,
0.25, 0.5, and 1.0 mEq/kgfmin for 10 mm at each dose
level. The effects on BP, HR, CV, CO dp/dt, and TPR
were determined after each infusion period. In the
metabolic studies, each mixture was infused at a rate
of 0.25 mEqfkg/min for 1 hr in acutely nephrectomized
dogs. Blood pH, hematocrit, NAP, K, CL-, and HCO3-
were determined every 20 mm. The effects on HCO3
regeneration show that 25:75% AC/SUC is similar to
100% SUC and the 75:25% AC/SUC was similar to 100%
AC. The 50:50% mixture offers the advantages of rapid
but less marked and more sustained HCO3 production.
Corresponding pH changes in all mixtures followed
HCO3 levels with increases in NA+, and decreases in
CL-, but no change in K level or HCT. BP, HR, and
dp/dt were not affected. Gradual CO (from 3.5 to 6
L/min) and TPR increases were noted. CV changes in
all combinations closely resembled those previously
reported for SUC alone. Because the addition of SUC
seems to reduce the untoward CV changes seen with
AC, the ratio of AC:SUC should be based on metabolic
considerations only. Present date suggest that a
50:50% AC/SUC mixture is the best combination for
optimal metabolic and CV effects in dialysis.
SEVERE STAPHYLOCOCCUS INFECTIONS IN HEMO-
DIALYSIS PATIENTS TREATED WITH VANCOMYCIN
S.Srugies, R.Windeck, E.Rosenthal, N.Graben
Div. of Renal and Hypertensive Diseases and
Institute of Microbiology,
Universltaetsklinikum, 0—4300 Essen, FRG
During a period of 12 months in 18 patients
on chron. hemodialysis 20 episodes of bac-
teremia or septicemia were abserved, of
which 14 were caused by staphylococci. In
10 cases staph. aureus, in 4 cases staph.
epidermidis was cultured from blood samples.
6 proven and 3 presumable av—fistula infec-
tions were the source of staph. aureus sep—
ticemia. 5 av-catheter related infections
were caused by staph. epiderm.(3x) and staph.
aureus (2x). Severe complications (shunt
rupture, endocarditis, osteomyolytis, brain
abscess) occured in 2 patients with staph.
aureus septicemia. 9 episodes of staph, in-
fections were successfully treated with van-
comycin with singie or repeated doses of
1000 mg i.v. per week.
Staph, invasion from blood access sites is
still the most frequent cause of bacteremia
in dialysis patients. Nearly all these in-
fections can be controlled by a single dose
of vancomycin, Vancomycin is known to be
highly effective against staph, strains.
Because of its extremely long half life It
can be given conveniently as a single dose
of 1000 mg iv/week in dialysis patients.
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SUBCLAVIAN VEIN STENOSES AND ARTERIO-VENOUS
FISTULAE (A.V.F.)
A. Mouton, A. Granier, P. Bourquelot.
Hôpital Saint Joseph, Paris, France.
36 central venous stenoses have been observed
in 30 patients on hemodialysis (6 patients had
bilateral stenoses) between 1980 and 1983.
Predisposing factors were observed in 16 pa-
tients : breast's cancer surgery (2), percutaneous
subclavian vein catheterization (10), pace—maker
endo-cardiac lead (2), intravenous chemotherapy
(2)
The site of the stenosis was the subclavian
vein (32) or the brachiocephalic vein (4)
The stenosis was complete (20), partial (14)
or incertain (2)
The diagnosis was made before creation of an
A.V.F. (10) by systematic phiebography or digital
substraction angiography, or after creation of
an A.V.F. in case of development of a subcutaneous
venous vascularization (10) or development of a
major aedema of the arm (16) which imposed the
ligature of the A.V.F. (14) or the surgical treat-
ment of the subclavian stenosis (2)
In 50 per cent of the cases, subclavian venous
stenosis makes an A.V.F. impossible in the consi-
dered upper limb. Digital substraction angiogra—
phy makes the diagnosis easily.
SPONTANEOUS KIDNEY RUPTURE DURING
HEMODIALYSIS
M. Haberal, Z. Once, Y. Ozogul, 0. Gokce,
V. Mavi, S. Dedemen, N. Bilgin.
Hacettepe Univ. Hosp. TX. Center, Ankara,
Turkey.
Spontaneous kidney rupture is seen very
rarely in patients on hemodialysis as com-
pared to transplant patients. We encounter-
ed only 2 cases of kidney rupture out of
650 (0.3%) patients at our hemodialysis
center, where since 1982, has provided
27,860 sessions of dialysis. The 2 patients
that experienced kidney rupture were males,
aged 19 & 31, with both being hypertensive.
The patients displayed symptoms of light
abdominal pain during dialysis (speed of
the blood flow was at 250ml/per mm. with
5000 units of heparin, using a plate dia—
lyser 11.5), and post—dialysis both had
acute abdominal complaints. Exploratory
laparatomy was performed, to find the right
kidney ruptured in both patients. Because
of their history of hypertension, bilateral
nephrectomies were performed.
These 2 cases showed that in hemodialy—
sis patients, acute abdominal symptoms can
be warning signals of a forthcoming kidney
rupture. The treatment without a doubt is
exploratory laparatomy, followed by a neph-
rectomy, and in the case of a hypertensive
patient, a bilateral nephrec€omy can be
performed.
This experience shows that in hemo—
dialysis, eventhough it is a rare
occurance, kidney rupture can and does
happen.
DRUG COMPLIANCE IN HEMODIALYZED PATIENTS
Grossi C., Geusa A.L.(*), Montemurro N.E.
Servizio di Nefrologia e Dialisi, USL TA/3,
Martina Franca, Italy
(*) Centro Emodialitico .Jonico sri, Taranto, Italy
We have controlled the drug compliance of
hemodialyzed patients. In a 250 days period we
have directly given all interdialytic therapy to
51 patients undergoing chronic hemodialysis. We
have given to patients all medicines necessary for
a period varying from 5 to 10 days; the patients
were invited to ask us for more medicines as soon
as they had finished them. The quantity of
medicines was carefully registered and patients
were not reminded if they were late in requesting
the next dose. Compliance has been calculated by
percentage difference between prescribed drugs and
the ones really distributed, obtained from the
registered data. We daily prescribed to patients
from 0 to 15 quantities of medicines each
(tablets drug—spoons or ampules). The average was
3.8 4•• Drus were classified in Al(OH)1,
anti—hypertensive cardiotonics, vitamins &
minerals, psycho—rugs, miscellaneous. General
compliance was 60%: 52,520 prescribed units versus
31,510 requested units. Amongst the different drug
categories, the highest compliance was seen in
Al(OH) and psycho—drugs, though there was no
statisfically significant difference. Also, no
significant difference was seen amongst the
different drug—types (capsules, pills,
soluble—pills, ampules). Statistically significant
differences have been found between the compliance
of drugs taken during meal—times (71%) and drugs
taken ?ar from meal-€imes (40%). Finally,a highly
significant inverse correlation (pO,Ol) was found
between compliance and number of daily assumed
medicines. No correlation was found between
compliance and school grade of patients.
Conclusions:
1) minimize the number of daily drug
administrations; using, if possible,
"retard" drugs;
2) if possible, administer the main part of the
therapy during dialysis treatment;
3) if possible, tie the hour of therapy to
ritual and ripetitive events (such as meals,
teeth—cleaning,etc.)
HEMODIALYSIS WITHOUT HEPARINIZATION
B. Oxen, G. Gursoy, N. Bilgin, N. Haberal
Turkish Transplantation & Burn Foundation
Dialysis Center, Ankara, Turkey.
Between January 1st and December 31st,
1983, 269 patients received 14,940
sessions of hemodialysis at 4 hours each
at our center.
As our standard procedure, the patients
were given 100/kg units of heparin at once
and then continued at 1250 units per hour.
Patients with pericarditis, early post-
operative stage, or hemorrhage complica-
tions receive regional heparinization. 11
of the 269 patients (6 males, 5 females)
that presented one or more of the above
complications were dialysed without he-
parinization. When the speed of the blood
flow was kept at above 250ml/per minute,
there were no coagulatory problems en-
countered.
Of the 269 patients, 10 who were on the
regular dialysis program without compli-
cations were used as a control group. As
a result, we found that there were no
significant differences between the hepar-
inized and non—heparinized group either in
complications related to coagulation or in
the BUN, Creatinine, K and Na blood levels.
We can conclude by saying that if the
speed of the blood flow is kept at above
250ml/per minOte, we can safely dialyse
the patient with complications without
heparinization.
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CABBONE DIOXIDE AND VENTILATORY REGULATION DURING
ACETATE (UDA) AND BICARBONATE (HDB) HEMODIALYSIS
A. Mahiout, H. Hampi, M. Kessel
Klinikum Charlottenburg, Nephrology
Freie Universitdt Berlin, FRG
A study was performed to evaluate the pulmonary
regulation during hemodialysis with respect to a
quantitative description of the CO2 inputs and
outputs in the dialyzed patient.
The effect of the dialysate composition was
investigated by comparing HDA and HDB with the
same Cuprophan dialyzer type in 10 patients under-
going maintenance hemodialysis. Blood gas and
ventilatory changes were measured to evaluate
(a) the total arterial C02—concentration (TCO2)
(b) the transport of CO2 across the dialyzer mem-
brane, (c) the pulmonary CO2—excretion and (d) the
alveolar—arterial p02—gradient (AaDO2).
During HDA 2.7 mmol/min CO2 was eliminated
through the dialyzer. The respiratory rate de-
creased to approximately three quarters of the
predialysis value, and the lung CO2—expiration
rate was lowered by 2.8 0.6 mmol/min. In con-
trast, no ventilatory changes were observed du-
ring HDB, and this is expected due to an insig-
nificant C02-uptake of 0.5 mmol/min. Total arte-
rial C02—concentration increased in HDB from 20.4
to 23.7 0.1 mmol/l, but was constant in HDA.
HDA and HDB produced no significant change in
AaDO2, but the decrease in the ventilation rate
during HDA accounted for 80 % of the fall in the
alveolar p2 A°2 in contrast to HDB, where no
decrease in A02 was observed.
Hence, extra—pulmonary C02—excretion during
hemodialysis plays the predominant role in the
change of the ventilatory function. AaDO2 re-
mained unchanged in both dialysis procedures.
Membrane—blood phenomena can be excluded as a cau
for the observed pulmonary chanqes.
KINETICS OF DIETHYLHEXYL PHTHALATE RELEASE INTO
BLOOD PERFUSTS FROM PVC HEMQ2IALYSIS TUBINS
D.B. Haughy3' , D. Breutzmann1,3G. HemphillA. Collins ' , and P. Keshavish(Intr. by C.M. Kjllstrand)
Hennepi County and Metroplitan MedicalCenters , and Univ. of Minnesota , Mpls., U.S.A.
High performance liquid chromatographic and
gas chromatographic—MS techniques were developed
to determine the type and quantity of phthalate
ester plasticizers in polyvinyichioride (PVC)
hemodlalysis tubings. Diet hyihexyl phthalate(DEHP) was the major phthalate ester (22—35% by
weight) identified in 11 unlined and 1 poly-
urethane lined manufacturers' PVC hemodialysis
tubings. The time course of DEHP release into
blood perfusates from PVC tubing was studied by
recirculating dog blood at 37CC for 4 hours in a
closed loop system. Diethyihexyl phthalate
concentrations in plasma were determined by a
specific and sensitive gas chroinatographic—MS
technique. The release of DEEP from hemo—
dialysis tubing was zero—order with respect to
time for up to 4 hours and was independent of
the type of tubing studied. Serum concentra—
tion of DEHP at the end of 4 hours of recircu—
lation ranged from 43.9 to 50.5 ug/mi. The
present study demonstrated that 1) DEHP was
released at a similar rate from several different
types of PVC hemodialysis tubing, 2)
co—extrusion of PVC tubing with an Inner poly-
urethane lining did not prevent or retard the
release of DEHP into blood perfusates, and
3) the amount of DEHP released into blood per—
fusates was independent of the type of PVC
tubing and the Content of diethylhexyl phthalate
in PVC tubing from several different manufactur-
ers. (Supported by FDA contract 223—83—5000)
ERYTHROCYTE GLUCOSE—6—PHOSPHATE DEHYOROGENASE
IN CHRONIC RENAL FAILURE
Dr.E.HasanoUlu, Dr.M.dztUrk, Dr.S.Eldelek lioUlu
Erciyes University Kayseri — TURKEY
Erythrocyte glucose—6-.phosphate dehydro —
genase (G6PD) activity was measured in 16 non—
dialyzed patients with Chronic Uraemia, 15
patients on regular haemodialysis and 18 healthy
control subjects. In non—dialysed uraemic
patients G6PD values were significantly higher
than controls (P < 0.01) Haenlodialysed patients
demonstrated the highest G6PD values of all
groups,being significantly higher than in cont-
rols (P <0.001) and ron—dialysed (P <0.01).
G6PD activity wao positively correlated to
serum creatinin in uraemic patients (rs r 0.65,
P <0.001) In haeniodialysed group G6PD activity
was correlated to the reticulocyte (rs 0.58,
P <0.001).
These results indicate that a younger mean
red cell age is responsible for the increased
G6PD activity in dialysed patients.
EFF1CT OF CAPD ON THE HYPEI&LIPIDAEMIA OF CLRONIC
RhNAL FAILURE.
A. Heaton, S. lisdali, J.M. Ramos, J, McGuuk,LK. Ward, D.N.S. Kerr.
Department of Medicine, Royal Victoria IIufJ.ZLary,
Newcastle upon Tyne, England.
CAPO LLaS been reported to accentuate the hyper—
lipidaamia of uvaamia. e have prospectively
studied serum iipiLis and lipoprotein fractions in
50 patIents (iiLean age 40 yoars) starting CAPD andfollowed thi for up to 3 years. A detailed assess-
mcut of sequential dieLaly ciiaiugcs was made in 20
patients.
Mean total triglyceride (ta) rose by 25% fron
2.04±0.12 o 2.40O.25 (p<O.05) wituin u mouths
on CAPD, due mainly to a rise in tue VLDL fraction,
out did not change therealter. Cholesterol (Chol)
rose during CAPi) iron .,3±0.2o at start to
6.61±0.2/ at 12 months (p.0.Ol) and 7.40±0.bO at
3() mouths (p<0,Ol). All Ciuol—fractions contribut-
ed to this rise particularly LOL—Chol, uLt MDL—
Cnoi aLso rose significantly (10%) during CAPD.
Mean dietary calorie intake jell uy 280 kcai inthe
first 12 mouths on CAPD due to a hall iii carbohy-
drate and fat intake, but protein intake increased
frets l.Ou to 1.15 g/kg. Cholesterol intake also
rose out the poiyunsaturated:saturated fat ratio
was unchanged at 0.21. Peritoneal glucose absorp-
tion provided a mean of 480 kcai/day.
Lipid changes in CAPI) may be partly due to
peritoneal glucose aosorption but also due to
marked dietary ciuan,,e. The changes observed do not
confer an unequivocally increased atherogenic
risk on CtPD patients.
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SPONTANEOUS ARTERIOVENOUS HEMOFILTRATION (SAVH) IN
PATIENTS WITH ACUTE RENAL FAILURE (ARF)
W. Heinker, W. KreuBer, C. Krier, H.O. Just, L. Röh
DFmiT of Urology, Anaesthesiology and Nephro-
logy, University of Heidelberg, FRG.
In recent years, SAVH has been applied in patients
with fluid overload. In the present study SAVH was
used in patients with ARF; blood-access was achieved
with a Scribner Shunt providing higher blood flow.
Since 1982 25 patients with ARF were studied during
a total of 1.000 treatment days. ARF was induced
post—operatively. 20/25 patients were artificially
ventilated. Abdominal (12), heart (7), head (3) surg
SAVH was performed with an Asahi hemofilter type
PAN 150 under anticoagulation with 20—25000 IU hepa-
rin i.v./d. Under ICU-conditions filtration rates
of 8-11 l/d (blood pressure>120 mmHg) and 4 — 8 lId
(BP.( 120) were reached resp.. Filtrate was substitu-
ted by sterile Ringer lactate solution and high Ca-
loric parenteral fluids (3000—4000 kcal/d). At fil-
tration below 10 l/d additional hemodialysis was ne
cessary. 20/25 patients died from extrarenal causes:
infection (8), cardiovascular complication (7), res
piratory failure (5). No serious bleeding or shunt—
infection has been observed, but clotting of the
filter often occured. SAVH seems to be highly effec
tive and of great advantage in patients with ARF.
Carpal tunel syndrome (CTS), cystic bone lesions
(CBL), Rheumatic manifestations (RM) and acquired
amyloTdosis (A) in chronic hemodialysis (ND) an
epidemiological study in 134 patients
J.P HERVE, Y. PENNEC, J CLEDES1, Ph. LGUY,
H.P. GUILLODO, P. Y0UINOU , B. BOURBICOT
+ Service de Naphrologie (Prof. J. CLEDES),
++ Clinique Pasteur (Dr S. HERMAN),
+++ Département d'Immunologie (Dr P• YOTJINOU).
The observation of a 52 yr old HD patient died from
acquired systemic A (CTS, bilateral shoulder pains,
histologically—proven amyloid CBL and CTS) prompted
us to set up an epidemiological survey of 134 pati-
entS in 2 liD centres. The average age and the time
of dialysis of the patients were 5! + 17 yrs and
62 + 47 mths, respectively, 13 patients (10 ) 5 N
8 F draw our attention : the clinical data is sum—
murized in the table below.
N %
CTS 10 80
CTS+RN 9 69
CTS+CBL 8 61
CTS +CBL+RM 8 61
A was demonstrated in 4 of out 6 surgically.trated
patients. The HD duration was far longer (p(10 ) in
presumably A + ye (140.5 + 36,8 mths) than in A—ye
(57.6 + 45.2 mths) patients, whilst the age were
comparable. We are not able to show any relation
ship between presumably A and the type of nephro-'
pathy, aluminium or parathormon level. It is worth
suggesting that patients on maintenance ND display
systemic A unique pattern, including CTS, CEL and
RN.
GROWTH OF MICRO-ORGANISMS IN USED AND UNUSED CAPD
FLUID. I.S.Henderson, G.V.Orange and A.C.T.Leung
(lntr. b A.C.Kennedy).
Departrents of Bacteriology and Nephrology,
Glasgow Royal Infirmary, U.K.
Peritonitis remains the most important
complication of CAPD. Dialysis fluid, which
contains high concentrations of glucose, should
provide a good culture medium for organisms.
The ability of both used and unused isotonic
CAPO fluid to support the growth of a range of
micro-organisms isolated from previous episodes of
peritonitis was investigated. Unused fluid and
samples of PD fluid from 4 patients were inoculated
with standard concentrations of Staph.aureus, Staph.
epidermidis, E.coli, Strep.viridi Landida
a Ibicaniid a diphthêi baci iTii and were
incubated at 37°C. The number of organisms
present at 3, 6, 12 and 24 hours was estimated
using the technique of Miles and Misra.
We demonstrated that organisms grew well in
used CAPD fluid and that there was no appreciable
difference in the pattern of organisms growth in
samples from different patients. E.coli and
staphylococci grew very slowly in unused PD fluid.
The other test organisms failed to grow but no
bactericidal effect was demonstrated.
The addition of albumin (10 g/l) and
neutralisation of pH from 5.1 to 7.1 produced no
major differences in the ability of unused CAPD
fluid to support the growth of organisms.
We conclude that used CAPD fluid provides an
excellent growth medium for many micro—organisms.
Unused PD fluid does not. The factors responsible
will be further elucidated.
A COMPARISON OF DOUBLE PUMP SINGLE NEEDLE SYSTEMS:
NA Hoenich. N Downing. S Pearson. C Woffindin.
MX Ward.
Department of Medicine.UniverSity of Newcastle/TynE
Mechanical "tidal flow' systems of single needle
dialysis utilising two pumps offer significant
advantages compared with similar single pump
systems in terms of blood flow attainment and
ultrafiltration control. They have recently
become available from a number of haemodialysis
equipment manufacturers who offer them as an
option on their proportionating systems. Use of
such systems, while preferred by the patients, is
associated with mixing of arterial and venous
blood in the extracorporeal circuit (recirculation
which can compromise the efficiency of dialysis.
Five recently developed systems have been
studied and compared using the same group of
patients to assess recirculation.
Bellco BL 760F(4)
Recirculation (%) at
200 ml/'nin
Urea Creatinine
7.4 2.8 7.7 2.9
Cobe (5) 10.9 3.3 9.8 2.1
Gambro BMM1O—4(4) 8.7 2.2 9.9 2.6
Extracorporeal SPS (7) 9.0 1.4 9.8 1.2
Hospal BSM2 (4) 10.0 2.7 10.4 2.2
Mean SEN shown I
Figures in parenthe sea refer to observations
Recirculation, at the manufacturers recommended
system settings differed. The dependence of
recirculation on system settings was investigated
and under optimum operating conditions the
efficiency of dialysis was comparable with that
obtained, using conventional two needle access.
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HAEMODIALYSIS INDUCED HEADACHE
H.Holzer, H.Pogglitsch,K.Marugc ,F. Sterz,
E. Ziak
Medical University Clinic, Graz,Austria
In 125 patients on chronic haemodia—
lysis treatment (HDT) clinical data and
dialysis technique were compared with the
incidence of headache (H) during H1T.
Patients with÷H were younger (H 39—l5yea
without H 51 - 14 years) and showd
higher blood pressure (÷H 164/91 — 20/10
TnnHg; without H 149/87 — 19/lommHg).
Despite lower pressure women developed
twice as frequent H. Laboratory data did
not show any correlation to the occurence
of H. Furtheron a significant influence
of the dialyser (p o,ool ) and the
frequency of HDT ( p<o,00l ) was
observed. H episodes occured only in 19%
of the HDT of the H patients using a
plate dialyser whereas, in 34% using 2
various types of capillaries respectively
In patients on HDT 3 (2) times/week H
episodes were observed in 18% (25%) after
a long dialysis intervall compared with
9% (lo%) after a short intervall. In 27
patients cerebral blood flow (CBF ml/loog
/rain) was measured quantitatively by the
intravenous Xenon 133 method before and
after HDT. In patients with H CBF was
significant (p<o,oo5) hgher before
(87 — 21) and after (89 — 23) HDT
compred with the H free÷patients before
(76 — 17) and after (70 - 15) HDT. The
occurence of H in HDT is in part a
consequence of hypertension, anaemia,
emotional stress and thrombocyte lesion,
in part a summation of all together.
FACIORS CONTRIBUTING 10 PERIti9ITIS IN CPD
L .Hortling,M.v.Bonsdorff ,E.Honkanen ,A. -R.Kala.
IVth Dept. of Medicine,Helsinki University Central
Hospital, Helsinki ,Finland.
During 1983 40 episodes of peritonitis in 29
C7'.PD patients were registered.In patients with
diabetes nEllitus one peritonitis episode per 4,4
rtonths,and in patients with terminal uremia of
other reasons one episode per 5,4 nonths ,were re—
corded.Using the Tenckhoff dialysis catheter one
peritonitis episode per 4,2 ienths (144 nonths of
treatnt) and the Gore-Tex catheter one perito-
nitis episode per 10,3 nonths (62 nsnths of treat-
rnt) were observed.The distribution of the number
of peritonitis episodes between the patients was
as follows:no episode 9 patients,one episode 7
patients, two episodes 8 patients ,three episodes4 patients and five episodes 1 patient.
The following factors associated with peritoni-
tis in CPPD patients were observethremval of con-
necting tube 6 patients, surgical procedure 7patients,leakage or noves-rnt of catheter 8 pati-
ents ,Ixor hygiene 10 patients, skin infection at
the root of the catheter 2 patients ,error in per—
formance of the dialysis procedure 2 patients,
other infections 3 patients and no reason 3 pati-
ents .The microbial isolates were those expected,
25 episodes of gram-,11 episodes of gram— and one
episode of fungal peritonitis,two negative cultu-
res were recorded.The above nntioned findings
show that factors contributing to peritonitis in
CPPD patients ny be found and corrected in order
to avoid further peritonitis episodes.
RELEASE OF GRANULOCYTE PROTEINASES DURING
HEMODIALYSIS
W.H. Hörl, R.M. Schafer, A. Heidland
Departments of Medicine, Universities of Freiburg and
Wurzburg, FRG
Attempts were mode to evaluate the possible role of
neutral proteinases of polymorphonuclear leukocytes
(PMNs) on intradialytic protein catabolism of patients
undergoing regular hemodialysis therapy. We report here
the results obtained in 70 chronically uremic patients,
aged 48,8+1.4 years, undergoing hemodialysis for 39,4+3,5
months. Blood constituents were determined as follows:
creatinine 12.9+0.4 mg/dl, BUN 82.3+3.2 mg/dl, hemoglo-
bin 8.4÷0.2 g/dl.
The cytochemical test of Klessen was used to evaluate
the activity of neutrophilic PMN leukocyte proteases.Pro
teolytic activity is revealed by a ring-shaped area around
each neutrophil due to erythrocyte hemolysis and plasma
protein degradation. Halo formation was reduced in blood
smears of all patients with end-stage renal disease under
going RDT. Concomintant to the development of leukope
nia, a maximal increase of the plasma levels of the gra-
nulocytic elastase in complex with alpha1.proteinase in-
hibitor was observed 3 h after starting herrodialysis
(÷409%; p > 0.001). 33 patients showed ory lOW concen-
trations of granulocyte elastase whereas 37 patients had
values higher than 400 ng/ml and 13 patients higher than
800 ng/ml (normal value 60 ng/ml).Maximal elastase-s1Pl
concentrations higher than 2.700 were seen in 2 patients.
Significantly enhanced elastase values were determined
in diabetic patients, no differences were observed in pa-
tients with chronic glomerulonephritis, pyelonephritis or
polycystic kidney degeneration. However, plasma prote-
inase activity measured with azocasein as a substrate de-
creased during hemodialysis therapy (0.127+0.019 vs.
0.037+0.007 U/mg; -71%; p < 0.001).
Granulocyte elastase could be released during hemodialy-
sis due to the contact of blood cells with the blood lines
and/or the dialyzer membrane.
• CHANGES IN COPPER (Cu) AND ZINC (Zn) IN CHRONICHEMODIALYSIS (HO.) PATIENTS
• S. Hosokawa, T. Imai, T. Nishio, T. Okumura, K.
Senbai Hos., Shiga Univ., Kyoto Univ. Kyoto, Japan
We studied the behavior of Cu and Zn during H.D. We examined
65 chronic renal failure patients (40 males, 25 females, average
age 39 16 years) who were undergoing 5-hour HO, 3 times a
week, by various kinds of dialyzers. Serum Cu, Zn and total
protein (TSP) levels were measured before (Cu(b), Zn(b), TP
(b)) and after (Cu(a), Zn(a), TP(a)) dialysis. Ultrafiltrate fluid(UF) was obtained by ECUM method at 5 minutes after the
beginning of HD and the concentrations of Cu and Zn in UF
(Cu uf, Zn uf) were measured. At 30 minutes after the beginning
of HD, we examined serum Cu, Zn and TP (Cu(in), Zn(in) TP
(in)) in the blood and Cu, Zn (Cu Din Zn Din) in the dialysate
at the inflow site of the dialyzer, and also, serum Cu(out), Zn
(out) and TP(out) in the blood and Cu(o out), Zn(D out) in
the dialysate at the outflow site of the dialyzer. Cu and Zn con-
centrations were determined by atomic absorption spectrometry
(Hitachi KK Japan). In our patients, we got the following results
(Cu(b) 98sg/dQ; Cu(a) 120; Cu(uf) 6-3; Cu(pin) 2.7; CU(D out)
3.3; Zn(b) 78; Zn(s) 91.2; Zn(uf) 8.2; Zn(in) 79.4; Zn(out) 81;
Zn(Din) 108; Zn(Dout) 9.8 ,ug/dQ; TP(b) 6.24 g/dQ; TP(a)
7.01; TP(in) 6.3; TP(out) 6.90 g/dQ. The dialyzer membrane
contains Cu and Zn. However, when the dialyzer was washed
by 500 mQ normal saline, Zn was removed, while Cu (150 sg/5
hr, 1 m2) was liberated from the membrane during HD. Cu uf
and Zn uf were diffusible through the membrane.
T.P(out) T.P(a) . Zn(out)
TP(in) and-f(b)exPresses hemoconcentrat1on.-2.) and
Cu(out) . Cu(oout) Zn(Dout)expresses diffusion. — . and— - expressesu(in) Cu(oin) Zn(Dln)
semoconcentration and diffusion. We reached the following
oncluions:
1) Serum Cu concentrations increased significantly (P<0.01)
from 78 before HD to 120 pg/dQ after HD by hemoconcentra-
tion and liberation from the membrane.
2) Serum Zn concentrations increased significantly (P<0.Ol)
from 78 before HD to 91 .sg/dQ after HD by hemoconcentra-
tion.
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SEXUAL FUNCTIONING IN KIDNEY DISEASE PATIENTS
BEFORE AND DURING DIALYSIS TREATMENT
S.11i6, M.Milenkovid,S. Kostid, V. Ignjatovie,
V. Stefanovid
Institute of Nephrology and Hemodialysis,Faculty
of Medicine ,Mental Health Center, Faculty of Me-
dicine , NiB, Yugoslavia
Sexual functioning was analysed and compared in
the same patients before the institution of renal
failure, in the pre—dialysia period and during
maintenance hemodialysis. Thirty—two patients were
studied, 25 males and 7 females. The mean age of
the examinees was 44 9.5 years, duration of
hemodialysis treatment was 41 + 19 months.
The number of patients with sexual problems
during maintenance hemodialysis was significantly
increased compared to the period without renal
failure (c=o.294) and the pre-dialysis period
(co.256). A statistical ysignificant decrease of
sexual interst on dialysis compared to the period
of3halth (x = 22.oo) and pre—dialysis period
(x = 12.3o) was found. The frequency of sexual
lutercouces decreased compared to the peiod of
heclth(x =l7.4o)and pre—dialysis period(x =lo.7o)
It is conluded that sexual functioning becomes
worse in end—stage kidney disease patients on
hemodialysis, compared to the period of health
and progressive renal failure. Kidney transplants—
tion is the best way to improve sexual function
of those patients.
HYPER1STROGRREMIA IN MALRR 41711 CHRONIC RENAL
FAILURE UNDiiRGOING HEMOIUALYSIS (cRF—HD).
J.Joven, E.Espinel, A.Olmos, ,J.Rubis—Prat, R.
Cataln, R.GalaDd, J.Castellanos, S.Masdeu.
Hospital Valle de Hebr6n de Barcelona, Spain.
Recent studies have reported raised plasma
estradiol(E2) levels in male survivors of myo—
cardial infarction, suggesting that hyperestro—
genemia may constitute a separate coronary risk
factor(cRF*). Cardiovascular morbidity and mor-
tality in patients with CEF—ED as well as dis-
turbances of goziadal function are very common.
Plasma levels of sexual hormones and choleste—
rol(C) in the high density lipoproteims(HDL)
and subfractioris(HDL2,HDL3) were investigated
in 18 males with CEP—UD and compared to a care-
fully age—matched control group(CG). E2, tea—
tosterone(T) and progesterone(P) were determi-
ned by specific R.I.A.8. HDL—C, HDL2—C and
FIDL3—C were measured after selective precipita-
tion procedures. 112 levels were significantly
higher in patients(50j3.8 n/L, mean±S.E.M.)
than in the CG(35.9j4 ng/L)(p 0.025). T and P
levels(20.2j1.3 and 1.5±0.2 nmol/L respective-
ly) in patients were similar to those of Cl
(24.1±4.2 and 1.47±0.1 ninol/L). HDL—C was 34.3
1.7 ing/di in patients and 46.9±2 in CG(p 0.025
HDL2—C was 10.2±1.2 in patients and 17±1.6 in
CG(p 0.01). Our results suggest that hyperestro
genemia, whose mechanism of production is uncer
tam in these patients, could constitute a se-
parate CRF*, since the low JiDL—C and HDL2—C
found in them are not correlated with 112 chan-
ges. However it is necessary to bear in mind
that our assumption can be masked by other CRi
frequently associated ( hypertension, glucose
intolerance, etc...).
HAEMODIALYSIS AND HAEMOFILTRATION EFFECT
ON INCREASED VALUES OF SERUM LIPIDS IN PA-
TIENTS WITH CHRONIC RENAL INSUFFICIENCY
B. JEREN-STRU3I, M. PREJAC, T. JEREN, I. BEUS,
M. ANTO, B. KOVARBAIC
MILITARY HOSPITAL, Zagreb, Yugoslavia
While studyino the biochemical parameters in PS.
tients treated by haemodialysis, we' ye noticed lipid
patholoqical values, a hyperlipidemia of type IV, ac—
cordina to Frederickson.
—The Table shows medium x values of lipid tot. I,
trialicerice II, cholesterol III and phospholipid IV, exa-
mined over the period of 36 months in 30 patients
treated by haemodialysls and 20 patients treated by
heemofiltratian.
Heemodialysis Heemofiltration
X0 X36 P x0 '36 P
1 12,5 9,7 <0,001 8,4 10,3 <0,01
II 5,2 3,4 <0,001 2,7 3,5 <0,05
III 6,2 5,4 <0,05 4,3 5,2 <0,01
IV 3,3 2,7 <0,05 2,4 2,9 <0,01
The lenath of haemcidialysis treatment influen-
ces the proGression of hyperlipidemia, while haemofil—
tration reduces the lipids. The LPL—values tend to in-
crease with haemodiafiltration (after 45 mm. x =
63,5 31,8, at period end = 75,2 35,3), which
incirectly shows the elimination or reduction of the
LPL inhibitor. Cardiovascular incidents are less fre-
quent when reducing hyperlipidemia; in other words
one of the factors that intensify atherosclerosis and
fasten its course ie. prooressmon in uremia patients,
is eliminated.
THE AETTOLCGY OF SCLEROSING PERITONITIS
F J H Junor, J D Brigs, M Ncitosh, I Cooper,
Western Infirmary, Glasgow, Scotland
Scierosing peritonitis (Sc?) Ic a serious and
often fatal complication of continuous ambulatory
peritoneal dialysis (CAPD). Eight of 514 pationts
on CAPD using Fresenius equipment (Gpi) develcped
ScF. No cases occurred in 143 patients using
Travenol fluid (Gp2) or in a similar number of
patients using Fresenius equipment in another
hospital over the same period of time (Gp3). The
only difference in technique wan the use of
chiorhexidine in alcohol as a sterilising spray in
Gp as opposed to iodine containing solutions in
Gps 2 and 3. Investigations revealed that up to
1m1 of spray solution could be introduced into the
abdomen at each exchange using Fresenius equipment
Chlorhexidine can precipitate lactate in solution
and when ml of chlorhexidine solution was added
to CAPD fluid a siiificant increase (up to loo x)
in the particle count in both Fresenius and
Travenol fluid occurred. This was confirmed by
scanning electron microscopy of a 2u filter
through which the fluid was passed. The effect
was not observed with iodine containing solutions.
The possibility of an allergic reaction is raised
by the finding of over 90% eosinophils in
non—infected peritoneal effluent in one patient
shortly before the djaiomis of ScP was
established.
Chlorhexidine ist used to spray the
connectors in North America or Germany where ScP
has not been reported but is extensively used in
France where most previous cases have occurred.
Animal experiments are in progress to confirm the
role of chlorhexidine in the development of ScP.
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ANTIBIOTIC TREATbIENT OF PERITONITIS IN
INTERMITTENT PERITONEAL DIALYSIS ( IPD
H. J. Kolmos ( intr. by F. Petersen ).Statens Seruminstitut and Dpt. of Nephro—
logy, Odense University Hospital, Denmark.
Treatment of infective peritonitis,
consisting of peritoneal lavage with intra.
peritoneal and universal administration of
antibiotics for up to 4 weeks, was evalua-
ted in 97 consecutive cases registered
among 66 patients treated with IPD over a
three—year period. Cephalothin was used in
the initial phase, but when the results of
culture and sensitivity testing became
available treatment was preferably changed
to more narrow—spectred agents of similar
low toxicity, e. g. ampicillin and methi-
cillin. Potentially toxic agents, such as
gentamicin and vancomycin, were only used
for multiply resistant strains and could
be restricted to 13 per cent of the cases.
The overall continuance rate was 9o per
cent. Relapse of peritonitis occurred in
10 per cent of the cases and was associa-
ted with a treatment duration shorter than
2 weeks. In 15 per cent of the cases the
dialysis catheters had to be changed,main_
ly because of irreversible one—way ob-
struction. Deaths attributable to perito-
nitis occurred in 3 cases. Side effects of
antibiotic treatment were registered in 13
per cent of the cases, the most common one
being self-limiting diarrhoea.
MAMMDGft4PHIC FINDINGS IN CHRONIC HAEMODIALYZED
PATIENTS
H. Kopsa, B. Sommer, J. Zazgornik, P. Schmidt,
P. Hajek, P. Balcke, N. Gritzmann
1st Med.Clinic, L.Boltzmann Institute for Radiol.
Tumor Diagnostics, Univ. of Vienna, Austria
Breast examination by mammography was prospecti-
vely done in 12 female patients on ROT, aged from
37 to 74 years. Basic renal disease was glomerulo—
nephritis in 6, interstitial nephritis in 4,Alports
syndrome in 1 and tuberous sclerosis in 1 case. The
period of chronic renal insufficiency varied from
2 to 25 years.Duration of chronic dialysis was 27,3
months on average (5—78). In all cases laboratory
findings of secondary hyperparathyroidism were evi-
dent. No patient was diabetic in the dialysis and
control group.Dialyses were performed 2 to 3 times
per week. Gynaecologic history,physical examination
ard X-ray of the breast have been done. A Siemens
maimnographic unit with Kodak low dose screens and
films was used.
Results: Localisation of painless calcifications
were arteries in 7 cases,the parenchyma in 10 cases
and the tubular duct system in 4 cases.Calcium de-
posits were dominantly scattered. In 1 case calci—
fications were associated with multiple fibroadeno-
mas. Fequency of arterial calcifications was evi-
dently higher when compared with 100 controls of
normal renal function. In all but 1 case calcifica-
tions occured in both breasts, no inflammation was
seen. In 2 cases density of the parenchyma was in-
creased. Premalignant or malignant structures were
not found.
We conclude that in patients on RDT calcifica—
tions in the breast are a cormnon finding and are
possibly due to secondary hyperparathyroidsm.
Initial clinical evaluation of the Cross-Over
Double Pump (COOP) Single Needle system.
IK.F. Kopp, R. Pfab, T. Pankiewicz, G. Schätzle-
Schuler, A. SUcker.
II. Med. Klinik, Techn. U. MUnchen, West Germany.
In view of the complexity and operational
problems of existing Single Needle (SN) devices,
a fully automatic, seifregulating SN-system has
been developed. It eliminates all extra operational
steps except a conventional speed setting of the
continuously running blood pump. The maximum pump
speed is monitored by the maximum blood flow avai-
lable for extracorporeal circulation from the
cannulated vessel. Obligatory ultrafiltration has
been eliminated through use of a continuously
running venous return pump. Autoregulation of the
venous return pump by the blood compartment pres-
sure of the dialyser allows to keep TMP at any
desired pressure level between 0 and 200 mm Hg.
Use of high flux dialysers in the diafiltration
mode is thereby feasable.
To date a total of 124 routine 4 to 5 hour
dialysis treatments have been completed in four
different patients. Maximum extracorporeal blood
flow rates of 240 ÷ 15 el/Mm were obtained with
14 G V catheters. Measured recirculation, using
urea dilution studies was less than 10 %. Dialysis
efficiency was exactly proportional to measured
extracorporeal blood flow rates and dialyser
clearance as in double needle dialysis.
In conclusion, the initial clinical evaluation
of a newly designed autoregulatory Cross-Over
Double Pump Single-Needle—system showed operational
simplicity and clinical efficacy comparable to
double needle dialysis.
J.tEJ)IATE POST OPERATIVE IIANAGEN1tIJT OF PAHATHIROIDEC
TOM! (Frx) IN HEMODIALYSEI) PATIENTS (HP).
Z. Korzets ,B.Spitz,R.Jedeiken,J.Bernheim,J.Bernheim.
Depts of Nephrology and Intensive Care Unit, Heir
Hspital, Kfar Saba, Israel.
PTX remains the treatment of choice in severe hyper
parathyroidism(HPr)in HP.No firm guidelines exist for
the management of imnediate postoperative period. To
standarize it, we reviewed the records of 14 HP who
underwent successful PIX.The following I*rametera were
studied every 4h during the first 36h after FIX: (1)
clinical and ECG signs of hypocalcaemia(HC)and hyper
kalemia(HK)(2)seruin Ca,K.Routine laboratory measure
ments were performed daily for 7d. A central venous
line was introduced at operation. Ca infuion(Ca lv)
(2.4mg elemental Ca/mn)was begun when Ca decreased
by 1O%.Oral Ca and vit D were begun within 12h.Pati
ants were maintained on a lov(28G)protein—low IC diet.
Hemodialysis(HD)was delayed for as long as possible.
In 6,a transient increase in Ca appeared within 6h;in
11,IIC developed within 24h.Of the 11,7 showed anabru
pt decline of Ca within 8—16h.These data ware corre
lated to preoperative parameters(Ca,K,P,Alk.Phos iFISI)
The most severe HC developed in those HP longest onHD
with the highest Alk.Fhos.(p(O.O1).No correlation was
found with preoperative PTh,gland size or weight. HIC
occured in 12(to 7.4 meq/l),within 12h, necessitating
conservative therapy in 8,peritoneal dialysis(PD)in 3,
H]) in 1 HP who developed intraoperative wound bleeding.
Ca lv was continued until Ca stabilized on oral thera
py.We conclude that: (a)the most rapid and lowest Ca
decline occurs within 8—12h in HP with the most severe
HPT,(b)Ca IV should coesnence upon a 1C/. decrease of Ca,(c)oral Ca and vit B should be given as soon as possi
ble (within 12h),(d)to prevent bleeding H]) should not
be performed within the first 48h,(e)HK is frequent
and may require PD.
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TRETTHENT OF flN OVERIOD BY DESFERRIOXAMINE (DFO)
IN PATIETS ON CHiIC NDWIlLYSIS (CHD) WITH
TBNSFUSION DEPENDENT ANEMIA.
J.Kovarik,H.Graf,H. Irschik,W.Waloszczuk,V.Meisinger
W.Linkesch,H. K. Sturiinvoll,W.F.Pinggera
tjniv.of Vienna,Austria
To maximize the biological half tire, 3Crng/kg
body weight DFO were given after the end of hato-dialysis (ND) in 5 patients with transfusion depen-
dent anenia. Iron renoval during the subsequent HI)
and the increase of iron excretion by the stool af-
ter DEO was measured by atanic absorption spectro-
scopy. Negative iron balance by the artificial kid-
ney was calculated using a Newton Cotes type proce-
dure of numerical integration. We investigated the
function (Q+Qf) C over the duration of ND
treainent,which equals the total amount of iron re-
moval during HD,which was found to be 21,8±6,9mg,
whereas cuniaulative iron loss via the feces was
36,5±14,6 mg.Hence, total iron removal was calcu-
lated to be on average 50 to 60 mg after admini-
stration of a single dose of DFO.
long term treant resulted in a significant de-
crease of serum ferritin levels fran 2309±295 ng
WHO/ml to 715±177 ng WHO/ml (p(O,CO1) after a
period of 36±5 months.
We conclude, that DFO in a dosage of 30 mg/kg body
weight given at the end of ND is able to reinve
more than 5oa eq iron/month if it is administered
folling each ND. long term results indicate,that
a negative iron balance is possible despite no
significant change of transfusion frequency if not
more than 2 units of blood (Soo eq iron) are ad-
ministered within one month.
RECONSTRUCTIVE SURGERY FOR A-V FISTULAS IN
PATIENTS ON HEMODIALYSIS.
Z.Kraev,Ch.Kumanov,Tch.Slavov,Z.Kirjakov,
L. Donovsky, J. Janev, P. Pantchev.
Medical Academy,Scientific Institute of Ne-
phrology,Urology,Hernodialysis and Transplan
tation, Center for Hemodialysis.
We accept for reconstructive operations
upon the A-V fistulas for hemodialysis
the creation of a new A—V an astomosis bet-
ween artery or artery and vein from the
previously constructed A—V fistula.
The reconstructive A—V anastomosis we
distrubte on three group: 1. Reanastomosis
between the same artery and vein above the
previous anastomosis; 2. New anastoniosis
between the sane artery and a new vein;3.
New anastomosis between the new artery and
the same vein.
For the period of 4 years we performed
81 reconstructive operation for A—V fistu—
las. From the first group — 58, second gro
up - 21 and the third group - 2.
The coutinuity of usage in 93,6% of the
operations is one year and in 83,3%—3 years
SECONDARY VASCULAR ACCESS SURGERY IN PATI-
ENTS ON HEMODIALYSIS WITH PTFE GRAFTS
Z. Kraev, Z.Kirjakov, I.Stantchev.
Medical Academy, Center for Hemodialysis,
Sofia, Bulgaria.
The PTFE grafts were used as a secondary
access method for hemodialysis. During a
period of 30 months 41 GORE TEX grafts we-
re implanted in 37 patients on regular he-
modialysis. 19 of the grafts were placed
in the lower arm, 22 in the thigh. 40 of
the grafts were curved.
The most common complications were as
follows:early thrombosis 4 grafts; late
thrombosis 5. In 4 patients revision of a
venous anastomosis was performed. Pseudo—
anaurism :formation was occured in 2 pati
ents. Local infection in 3 case.
The cumulative patency rate of the
grafts in our patients is 72,5% after 1
year and 64,5% after 2 years.
EFFECTS OF OVER ONE YEAR ENDURANCE
TRAINING AT THE ANAEROBIC THRESHOLD IN
HEMODIALYSIS PATIENTS
R. Krause, I. Bennhold - Krankenhaus Moabit
III. Med.Depart. & Inst.f.Sportsmedicine,
Berlin, FRG
The most effective adaption of the
cardiocirculatory system,the neuromuscular
function and the cellular metabolism is
found both In sportsmen and in untrained
healthy people by an Individually dosed
extensive endurance training program at
the anaerobic threshold (4 mmol/l blood—
lactate). 6 RD—patients (25—55 ys) were
trained twice weekly by bicycle—ergometer
(50—100 watts 15—25 mm.), i patient in
intervall-running also. Maximal spiro-
ergometric controls were taken before and
after 3- to 6—months. Results: 1. Maximal
work load, max. breathing capacity and
max. oxygen uptake rose significantly.
2. 1 patient improved to normal levels.
3. The physical capacity does not necessa-
rily correspond to the Hgb. 4. Inspite
of the increase of training load exercise
heart-rate and syst. blood pressure
decreased significantly. 5. 1 patient
lost his claudicatio of the right calf
and his symptomatic hypotension during
RD-treatment.
This improvement we refer to an increase
in the volume and the aerobic encymes of
the mitochondrla, and of the myoglobin and
glycogen contents in skelet-muscle.
Biopsies have already proved these effects
of extensive endurance training in un-
trained healthy people and in well-trained
athlets.
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PSYCHOLOGICAL PROFILE OF PATITS TREAThD BY
CAPD.
°KROtiII A. ,°°AIT—SLIMAIii B. ,IIASgANI If. ,DRIF Le.
°Servioe de ? phrologie—IIopia1 KOL}A (AL HiH
°°Rdaniaation—Ilonital iustapha —ALHR
Because of the increasing nunnber of patients
awaiting hoaodialysis treatnant,eighteen
-
applicants were ken charge of between Jsn.151983 and Dec.315 1983 for a treatment by C.PD.
Ten of these atieuts wore mubitted to
psychaiogical consultations by a oaycholgist
neteber of the nedical team.
Thu,tho various sychological teots endinterviows enabled the c-dioal tean to iolte
the :atients resenting ychopatLologiu ci
rob1ems likely to have a negative effect on tnc
treat-ont.3O od the patients thus aroved to be totally
dependent on their relatives for their care.
This seeced to inhibit in the-n any tendency
towards autonomy and. self—relanoe attitudes,
which would norsally garantee a more effective
CAPD treatent.
Taking into account the socio—oultural
environment prevailing in our country,it seemed
reasonable to predict that the condition of some
:oatients eight decline due to the high degree
of dependency they were held in Lecause of too
caring attitudes shown by their fa2ily entourage
The results reachet,then,through our
psychological investigation shows the cossibility?
to detereino,on the one hand,the restrictive
c-eoots that may be involved in the CAPD said
one the other hand,the incidence of the disease
und ita treat ant on the atients'osychic
deveio.:nent.
EFFECT OF DIALYSATE SODIUM ON TI DOPAMINE
/DA/, ADRENALINE/A! AND NORADRENALINE /NA/
CONCENTRATION IN HEMODIALYSIS/ITD/ PATIENTS.
A.Ksiazek, J.Solski. Division of Nephrolog
School of Medicine. Lublin, Poland
The different sodium concentration of
dialysates were used to test the hypothesi$
that the abnormality of the sympathetic ac-
tivity in RD patients may cause sodium con-
c entratiOn.Both conventional dialysate/Na—
l3lnEq/l/ arid /Na—l48mEq/l/ were used.NA,A,
DA in blood concentration and cold pressor
test /CD! were examined in 8 normotensive
patients without antihypertensive drugs.
Table I. Conventional 1-lemodialysis
Di4aie p.sCt po.+ CD p.s CD po.t CD
x SU *131)
NA Z24 O t 2B 2.56 32 330 24Pk- 13 A 95 50 l54
DA 70 (7 l4' 67 I? (4
NA 34, 4 35* o 314 S6 366 Ii
Na-448 A 132±23 (±2A 136±36* IY±32.DA 106±20' I± 8 I0V±2I ii6t
'hJle II. Ultrafiltration
befoseFfD aftHU
Datysate p.s CD putt CD p.-e CO po.± Cl)pgm g±D
MA 224 44 300 (lax 34L t 8 836± I)6
Na-45 A %± aa 29±1 68t qo_ II3±724 549iM 4141542 419±94
Na- A s es t $2 il 39
DA lift 246 23± 36 Ui t l5è III 2.3to the valuere—in rererences or pre
'4-in references between diai.Pa—131andi-iaIdie results obtained sugest that increas—ing of sodiumi concentration i dialysate
aause the increasing of catecholamines le—
vel in piasa as well as lack of stiula—dion frou tbe part of syrpathetic activity
under the cold pressor test.
METABOLISM OF MINERALES, VITAMIN D, GLUCOSE AND
SOME HORMONES IN CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS / CAPD.
L. Janicks, A. Esiazek, Z. Twardowski, F.Kokot
Clinic of Neohrology, Lublin, POLAND.
The effects of CAPD on calcitonin/CT, insulin!
IRI/, glucose after dynamic stimulation/parathy—
reid hormone/PTH/, Vit D and mineral metabolism
were evaluated in 6 patients. The studies were
performed before treatment and 3,6 months after
the start of CAPD. All the hormones were
measured by radioimmunoassay.
Predialysis values 3rnos.on CAPD
x+SD x+SD
CT pg/mi 211 + 179 273 184
6mos on CAPD
x+SD
478+ 417
IRImU/l 27 + 18 46.8 + 241 47.2 4- 19.8
PTHng/mi 4.2 1.8
25/OH/D 5.6 + 1.5
ng/mi —
5.3 + 2.0
12.1 + 4.0
4.1± 1.7
12.9 ÷ 3.4
Ca mmol/i 1.8 0.4 2.0+ 0.2 2.2 + 0.1
<
Mgmmol/l 1.4 + 0.6 2.59 + 0.4 2.2+0.4
p < 0.05
Pmmol/l 2.9 0.7 1.9 0.4
p<O.O5
1.8 0.4
p<O.05
Fasting glucose was unchanged after 6 months
of CAPD treatment. We measured glucose response
after dynamic stimulation! L-Dopa, IRI. We
have also found the response of CT and IRI to
physiological stimuli. The results will be
discussed.
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CONTRIBUTION OF HEMOFILTFATION(HF) TN TREATMENT OF
PORPHYRIA CUTANEA TARDA (POT') IN A} HEMODIALY7,ED
PATIENT.
'.KUENTZ, S. DECHELETTE, C. ARVIEUX, PY. BENHANOU
BASTRENTA C.H.U. GRENOBLE FRANCE
Appearance of a blister dermatosis ]ike 1iT in 1 to
4 % of hemodiyzed paterts presents therapeutic
problems.
He report the case of a 43 yeard—old patient, under
going hemodiaiyss for 9 years, who developped seve
re POT witi ever infection, oedemes, face and hand
eain, disfiguring the patient and leading his to
suicidal incas. Uroporphyrin (un) was as high as
100 times the normal value, no was ferritin, plasma
tic aluminium = 2 up/mI, no immune disorders (par—
ticularlv no antiebiderrric antibodies). Convention
nal treatments (nn solace exposure, no photosensbi
lizinq drugs, synthetic aetipaludism drugs, no let-
ting off PVC dialysis tubulures, conventionnal dia-
lysis, six plasmatic exchanges') did not have any
positive effects.
flennofiltration : 20 liters thrice weekly on modified
cuprophar. membrane induced improvement skin condi
tion became better, blood U° level fe from 32O0w
/i before 1st HF to 78 nq/1 before 14 treatment1
(Ni = 0 — 30 up/i'). This successfuil result was
maintained duing 18 months.
We discuss (a) type of artificial membranes(polya—
mide membranes gived much worse results) (h) clea-
rance of uroporhvrins in relation with size of the
noiecuies and modes of treatment.
We cunclude that these preliminary results show the
eneficia1 contrition of HF in this pathology.
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CARPAL TUNNEL SYNDROME IN 10 YEAR HOME—DIALYSIS
PATIENTS
B. Lafforgue, 3.P. Juquel, B. Utzinger, P. Raymond
C. Bony
AURA, Centre d'Entrainement Hémodialyse Domicile,
PARIS, FRANCE
Out of 36 home—dialysis patients —24 male, 12 fe-
male— with an over iO year duration of chronic
dialysis (range 120—180 months) 16 patients (44%)
reported symptoms of carnal tunnel syndrome (C.T.
S.), 9 male, 7 female, mean age at beginning of
chronic dialysis was 43 (range 48—61). Cause of
renal failure was : glomerulonephritis : 8 (50 %),
polycystic kidney desease : 4 (25 %), hyperten-
sion : 2 (12,5 %), other 2 (12,5 %). C.T.S.
was bilateral in 10 patients, either simultane-
ously, either 1 to 4 years later. 2 patients had
only right symptoms and 4 only left ones. There
was no special relation between C.T.S. and the
site of vascular access. Pain, numbness and pares-
thesiae localized in some or all of the first 4
digits, often awakening them at night, were pre-
sent in all patients. In 2 cases symptoms disap-
peared, one without treatment (now 5 years ago),
one after 2 local injections of a long acting
corticosterold (now 3 years ago). However most of
the patients had such injections (1 to 4) without
great success. So 21 surgical decompressions of
the carpal tunnel were performed in 12 patients,
9 bilateully (3 during the same operation). Mean
age at that time was 57 (range 34—68) after
duration of chronic dialysis of 133 months
(range 92—180). They all had prompt relief of
pain and paresthesiae immediately after surgery.
There was no recurrence of such symptoms even 6
years after operations.
ONCOTIC AND OSMOTIC PRESSURE IN PLASMA OF
PATIENTS ON HEMODIALYSIS WITH FALL OF
BLOOD PRESSURE DURING DIALYSIS
R.M.Lederle, D.Klaus, R.Lemke, D.Antoni
Stätische Kliniken, Dortmund, FRG
Hypovolemia due to high ultrafiltration,
changes of peripheral vascular resistance,
variability in the reactions of barorecep-
tor.-reflex and norepinephrine-secretion,
and hypoosmolality are known causes for
marked fall of BP during hemodialysis (HD).
In 15 pntients on chronic HD, who showeda
systolic mean fall of BP from 140 to 82 mm
Hg during dialysis (group B), ws investi-
gated the reactions of oncotic and osmotic
pressure and the catecholamines norepinerh-
rifle, adrenalin and dopamin. 13 patients
on chronic HD with constant BP during dia-
lysis served as a control group (group A).
Results: At the time of BP-fall the onco-
tic pressure in group B increased signifi-
cantly more (increase +10% of initial val-
ues) than in group A (+3,5%). In group B
osmotic pressure also fell to a greater
extent (-5,9%) than in group A (-2,1%). In
both groups concentrations of norepineph-
rine reacted equally (slight decrease of
-8,8 and -6,9% respectively). The weight
decreases did not differ (-3,1 versus -2,9
U. The high increase of oncotic pressure
in group B is due to a decrease in intra-
vascular volume, the rate of replenishing
being delayed due to the also greater fall
of osmotic pressure. The control of oncot,ic
and osmotic pressure in patients with fre-
quent symptomatic BP-falls could be useful
for in-term corrections of intravascular
volume.
BLOOD ACCESS AND LONG TERM HENODIALYSIS
0. LAURENT, M. UZAN, E. CALEMARD, B. CHARRA
Centre de Rein Artificiel de Tassin - 69160 Tassin
France.
Blood access experience on 83 hemodialysed pa-
tients treated for more than 10 years (21 more than
15 years) in the same unit is reported.
Among the 83 patients, 67 are still alive on
dialysis, 3 were transplanted and 13 died. They were,
are on a long hemodialysis schedule, using self punc
ture (90 % of patients) in the same sites.
Out of the 78 Scribners shunts for the old ti-
mers, to maintain a blood access it has been neces-
sary to build 142 artério-veinous fistula (126 real
ly used), 28 Thomas's shunts and 2 vascular grafts.
All over the 1114 patient-years of the study
no death was due to the blood access complications
or failure. Among the 67 patients still alive on
hemodialysis, 56 use an artërio-veinous fistula
anjil a Thomas's shunt. The actuarial patency curvE
of the artério-veinous fistula pointsout that 50 %
are still used after 8 years. The correspondant
figure of the Thomas's shunt is 3.5 jea;s.
We shall discuss how long dialysis, autonomy
of patients and repeated puncture in the same sites
respectively account for the long arterio-veinous
fistula patency rate obtained. We shall justify our
selection of Thomas's shunt as a second choice.
We shall conclude that problems of blood access
do not represent for us a limitation to a very long
term hemodialysis.
ACETATE-(AC—D) VERSUS BICARBONATE DIALYSIS (BC—D)
IN CRITICALLY ILL PATIENTS. A COMPARATIVE STUDY.
K.M.L.Leunissen,S.J.Hoorntje,H.A.Fiers,W.T.Dekkers,
A.W.Mulder, Catharina hospital, the Netherlands.
Haemodynamic instability is the major problem
during haemodialysis of critically ill patients.The
use of acetate in the dialysate could enhance this
phenomenon. We compared 12 pairs of randomly per-
formed recirculation Ac—D and Bc—D in 9 such pa-
tients, using the Bellco Unimat delivery system.
All other variables were kept strictly comparable.
Decreasing mean arterial pressure (MAP),cardiac
output (CO) and left ventricular stroke work index
(LVSWI) in Ac—O are impressive, whereas Bc—D didn't
show important alterations. (Table)
hr D MAP tnmHg CO lJmii LVSWI u 2 mNg p02
+1,799,0
+0,9101,3
+ 1 86,2
+0,8103,3
mmHg
5,8 ,
0JAc90,2±3.9IBc88.4±5
)fAPmniHg
9,7+1,3
9.2+1,31 C0
69,4+4.9
68,1+7,9
%LVSWI
30.2
30,8
26,1
31,2
JAc —14,1 4,1
2IBc—1.4±2.3
—19,1 +4,5
-3+4,1
2,7 6,3
-5,5+6,4
1JAc -1 1,7 + 2.7.21,6 6.324
18c41,5±2$-3,5+4.72,1+7.429,3
.p<O,O5 *:p<O,O2 x:p
+ 2,5 83,6
+0,796,8
<0,01
+ 4,5
+4,0
Haemodynamic instability during Ac—D must be a
consequence of an impair ment of cardiac perf or—
mance,since the LVSWI decreased significantly where.
as the heart rate,the systemic vascular resistance
and the cardiac filling pressure changes were not
significantly different.Since peak arterial acetate
levels were below the maximum utilization rate,the
cardiodepressive effect of acetate most probably is
secondary to hypoxaemia, hypocapnia and incomplete
correction of the acidosis. The stable haemodynamic
state during Bc—D makes this procedure a first
choice in treating critically ill renal failure
patients.
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BIOCOMPATIBILITY (COMPLEMENT AClIVATION) DURING
HAEMODIALYSIS.
D Levett. C Woffindin, NA Hoenich. G Bird. DNS Ker
D€partment of Medicine,University of Newcastle/Tyne
Two groups of ten patients receiving maintenance
haemodialysis for chronic renal failure were
dialysed with Cuprophan(CU) and polyacrylonitrile
(PAN15) membranes, each used with dialysate
containing either acetate (40 mmol/l) or bicarb-
onate (35 mmol/l) . Factor B (haemolytic RID and
crossed IEP) , C3 (laser nephelometry and crossed
IEP), C3a (RIA) and CH5O were measured on samples
taken pre—dialysis and at 15 and 60 minutes during
dialysis. Analysis of variance demonstrated no
effect of dialysate on complement levels, allowing
results to be pooled.
An intermembrane comparison demonstrates a
significant rise at lS(p<O.OOS) and 60 (p<O.O5)
minutes for C3a levels. CU shows increases of 398%
and 416% and PAN15 increases of 107% and 115% at
15 and 60 minutes respectively compared to pre—
dialysis values. Factor B conversion shows a fall
of 15% for Cuprophan compared with 5% for PANI5 at
60 minutes (p<O.O5) . This trend was reversed for
C3 levels measured by laser nephelometry where a
fall of 13% for PANI5 compared with 2% for
Cuprophan (p<O.Ol) was observed at 60 minutes.
Other measured parameters failed to demonstrate anl
significant intermembrane differences possibly due
to a lack of technique sensitivity and specificity.
These results suggest that routine laboratory
methods for measurement of complement levels may
not be suitable for the quantification of
differences in complement activation induced by
haemodialysis membranes and these differences are
best demonstrated by the more sensitive RIA
technique.
ThE EFFECT OF ULTRAFILTRATION (HF) AND DIALYSATE
COMPOSITION ON HAEMODIALYSIS ASSOCIATED ACUTE
PULMONARY HYPERTENSION (APH) AND HYPOXIA.
R.M.Lindsay, J.F.Walker, W.J.Sibbald, A.L.Linton.
University of Western Ontario, London, Canada.
Studies in sheep have shown that blood exposed
to dialysis membrane causes leucopenia, APH and
consequent hypoxia. Sequential HF/dialysis or the
use of bicarbonate dialysate rather than acetate
has resulted in greater vascular stability and
less hypoxia during dialysis in humans. During
dialysis with cuprophan HFAK in 5 sheep, we
examined the effects of isolated HF, bicarbonate
(B) or acetate (A) dialysate on the pulmonary
artery response and its related hypoxia. Mean
pulmonary artery pressures (mm Hg) and Pa02 during
the first 30 minutes of exposure of blood to the
membrane were as follows:
MEAN PAP
0 5
TIME (
10
mine)
15 30
16 42 40 31 23
16 28 39 30 26
17 27 38 32 36
Changes in PaO2 mirrored the degree of APH through
out. HF induced a greater rise in mean PAP at 5
minutes than either B or A, suggesting that the
presence of dialysate may reduce the severity of
the response, perhaps by removal of a dialysable
substance. The degree of hypoxia and APH was not
affected by the composition of the dialysate.
GLYCEROL AS OSMY7IC AGEI' IN PERI)NEL DIALYSIS
B. Lindholxn, A. tlsnielsson, B. Gunnarsson,
A. Traneus, A. Werynski, R.E. Dolkart, J.Bergstr1L
Karolinska Institute, Dept of Renal Medicine,
Huddinge University Hospital, Stockholm, Sweden
The potential clinical role of glycerol as an
osnotic agent for PD was evaluated by ccsnparing
acute tolerance, osnotic efficiency, peritoneal
transport of solutes and short—term metabolic ef-fects of PD solutions containing either glycerol
(0.85, 1.4 and 2.5%) or glucose (1.36, 2.27 and
3.86%) in 24 single dwell studies (6 hrs) in 4 non—
diabetic CAPD-patients. Radioisotopically tagged
albumin was added to the dialysate and the rate of
fluid transfer was determined by the dilution prin-
ciple after repeated dialysate (10) and plasma (3)
samples, which also included determinations of gly-
cerol, glucose, osmolality, electrolytes, urea,
creatinine and total proteins. In spite of higher
initial osnolality and higher initial ultrafiltra-
tion (UP) in the glycerol solutions net HF after 6
hrs was less than with glucose. Diffusive mass
transfer of creatinine and total proteins through
the peritoneum increased significantly when glyce-
rol was used. Peak glycerol levels in plasma were
0.5 - 5 mrol/l. No side effects were observed. Addi-
tional studies in diabetic CPPD—patients showed de-
creased insulin reiirements.
We conclude that the use of glycerol instead of
glucose in PD solutions offers no advantages in
terms of improved OF or in lowering the caloric
load. Our findings suggest that glycerol may in-
crease the peritoneal permeability. This may lead
to an increased absorption of the osmotic agent
and an increase of the caloric load per ml of HF
volume. Its potential value in diabetics and as an
auxiliary osmotic agent in amino acid solutions,
however, justifies further studies.
HEMODIALYSIS IN DOGS WITH A HEPARIN COATED HOLLOW
FIBER DIALYZER.
L—E Line, N—B Hjelte, 0. Larm, R. Larsson, P. Olssor
Department of Medicine, Division of Nephrology,
Karolinska Hospital, IRD Biomaterial AD, Department
of Experimental Surgery, Karolinska Hospital, Stock
holm and Swedish University of Agricultural Scien-
ces, Uppsala, Sweden.
Hemodialysis requires systemic heparinization
to prevent clotting in the extracorporeal system,
but administration of heparin is associated with
bleeding complications and long term side-effects
i.e. osteoporosis.
In an attempt to exclude systemic heparin we
prepared a hemodialysis set (C—DAK 3500, Cordis Dow
and PVC tubings) with a covalently bonded heparin
coating,which exhibits thromboresistant properties
with regard to platelets and plasma coagulation.
The surface heparinization procedure did not affect
the ultrafiltration coefficient or in vitro dialys—
ance of urea, sodium chloride or uric acid.
Hemodialysis was performed in non—uremic dogs
for three hours using a Gambro AK 5 monitor. With
the heparin costed equipment a constant blood flow
of 205 24 mi/mm was easily maintained. There was
no increase in whole blood coagulation time, no
measurable heparin release from the surface, no
increase in FPA concentration in plasma— indicating
insignificant conversion of fibrinogen to fibrin—
and no change in platelet count. Heparin coated
dialyzers were complete clean after rinsing with
saline.
It is evident that a stable heparin coating on
inherently thrombogenic materials enables extra—
corporeal circulation in absence of systemic anti—
coagulation treatment and without measurable
activation of the hemostatic mechanism.
1J.F.
BIcarbonate
Acetate
U.F.
Bicarbonate
Acetate
PaO2
96
104
100
85 81 92 90
108 90 96 107
98 84 102 104
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A METHOD FOR ACCURATE INFERENCE OF BLOOD SOLUTE
CONCENTRATION FROM MEASUREMENTS OF DIALYSATE
CONCENTRATION
Dorm 0. Lobdell, (Intr. by Prof. H.J. Gurland).
6e Laboratories, Inc., Denver, U.S.A.
A technique has been developed for inferring
the blood concentration of a dialysable solute
from measurements of the dialysate concentration.
The fundamental requirement of the system is
that the measurements be made in a time duration
which permits the assumption of steady values of
the blood concentration, blood flow rate, and
membrane clearance.
The method is dependent upon the ability to
accurately measure and maintain dialysate flows
and inlet solute concentrations. In a great
many cases of interest the solute is absent in
the inflowing dialysate. The anticipated effect
of ultrafiltration is included in the analysis.
A direct measure of the dialyzer clearance is
provided. This feature may well have applica-
tion in reuse.
The presented technique is well adapted to
microprocessor controls and would be accomplished
on line.
EFFECTS OF ACETATE AND BICARBONATE HAEMODIALYSIS
ON PLASMA CALCIUM FRACTIONS.
G. Lo Piccolo , A. Stalteri.
Nephrology and Dialysis Service, Ospedali Civili
Riuniti of Sciacca, Sciacca, Italy.
Plasma calcium fractions (PCF) are reported to
increase differently during haemodialysis; pre-
vious studies, however, were performed using ace-
tate haemodialysis.
To evaluate the effects of bicarbonate—dialy-
sis (BD) in comparison with acetate—dialysis (AD)
on PCF, we measure total (TCa), ionized (iCa),
complexed (cCa) and protein—bound calcium (PbCa),
pH and total protein content before and after
20 four—hour AD and 20 four—hour BD, using for
both dialysate with 1.75+0.05 mmol/l of calcium;
ultrafiltration was similar for both groups.
After dialysis, TCa values are slightly, but
not significantly, higher in BD than in AD; PbCa
values, corrected for the change in total protein
content, are significantly higher in BD than in
AD (p<O.ool); iCa and cCa showed no significant
difference between AD and BO. Finally, pH values
are significantly higher in BO than in AD
(p< 0.001).
We conclude that BD is associate with increa-
sed binding of calcium per gram of protein; this
phenomen suggests an increase in anionic protein
binding sites that might be related to greater
increase of pH observed in 80.
PSYCHOLOGIC INVZTIGATIONS IN HAEMODIALY—
ZED A1D TRANSPLANTED PATIENTS
L.L6csey,L.Balogh,E.T6th and I.Wóruni
I.Dept.Ied.Univ.Med.Debrecen ,Hungary +The authors have studied the level of Al
PTH,BUN and oreetinin in the serum of 94
dialyzed and 15 transplanted pts,end sear-
ched for correlation with their payobolog
cal atete.In the case of each pta the Lee—
ry—teat,TAT,PPT test,tbe Taylor questlona—
ry,the Beck's depression scale and an ana-
lytical interview were made.Conaidering
their reaults,tbey found that the psychol
gical status of their pta was worth than
their physical statua.The anxiety level was
increased as a consequence of the feeling
that their disease is uncurable and of the
fact that they are completely dependent on
the the macbinary and treatment.The inter-
personal adaptability of the pta and their
emotional control decreased.The pta became
at the same time querulent towards their
milieu and also more dependent from it.The
pta turned more en more towards their "ego"
while they became also socially more intro
verted.At the same time they idealized the
ir own self—image as being extroverted,e—
nergic,dominent and helpful.It was found
that this attitude was also maintained by
the complaisance of their social aurroun—
ding.The vigilance—concentration tests we-
re aignicant1y worthened in pta with hi-
gher Al ,PTH,BUN and creatinin levels.
The authors underly the advantages and
the usefulness of the individual and grouppsychotherapy in the treatment of the abo-
ve mentioned pta.
HOW TO ASSESS THE ADEQUACY OF DI&LYSIS
STH& TEOY
V. I3rtovi, F. Lopot, A. V1ek
Charles Univ. Med. School, Department of
Medicine, Prague—Strahov, Czechoslovakia
The main concern of renal replacement
therapy is to substitute the regulatory
function of the natural organ, i.e. to
keep "le milieu intdrieur" stable with
sufficiently low catabolites levelH. To
assess the adequacy of a dialytic strate-
gy, it is necessary to take into consider.
ation not only concentration of cataboli—tes in body fluids and the protein catabo-
lic rate but also the cycling in the body
chemistries and fluids.
A new criterion based on urea kinetics wadevised, it accounts for the mean blood
urea concentration as well as for its
cycling.
Results of the clinical application of
the criterion have confirmed the theore-
tically obtained conclusions: The mean
value of the criterion was 70+7 in a
group of 30 patients dialysed 6 hours
twice weekly and 55±E in 28 patients din—
lysed 4 hours three times weekly under
identical conditions. The difference was
statistically significant. Differences
in clinical condition between these groups
were also established, The mean criterial
value for 15 CAPD patients was 20, mdi—
eating physiological superiority of this
method over intermittent heemodialysis.
COMPARISON OF THE EFFECT ON BLOOD PRESSURE (BP) OF
HEMODIALYSIS (HO) VERSUS CONTINUOUS AMBULATORY
PERITONEAL DIALYSIS (CAPD)
F. Louis, P. Ruedin, H. Favre.
Department of medicine, Geneva, Switzerland.
Several observations showed that BP is better
controlled in CAPD than in HO patients.
This study has been designed to understand the
potential differences between the two methods in
regard to BP control. Thus, 10 HD patients have
been matched with 10 CAPD patients for sex (18
males, 2 females), age (58,9 1,2 years — HO;
57,8 3,5 years — CAPO) and duration of the
treatment (24 3 months: both methods). On HD, BP
fell from 153 5/93 6 mmHg to 143 6/85 2
mmHg after 24 months. 20 % of patients remained
normotensive, 30 % were poorly controlled with
antihypertensive therapy and SO % did no longer
required antihypertensive drugs after a mean
duration of treatment of 15 1,5 months.
Throughout this period body weight (BW) remained
stable (0,21 * 0,09 kg). On CAPD, BP fell from 169
3/97 4 mmHg to 130 0,6/84 2 mml-Ig
(p <0,001). 40 % of patients were initially
normotensive and remained so, 50 % were free of
antihypertensive drugs after a mean of 6 0,4
months on CAPD, and 10 % required antihypertensive
drugs all along the period of observation. There
was a non significant gain in 8W (1,4 0,8 kg).
CAPD controls BP better and faster than HO
independently of the 8W. This observation favours
the hypothesis that hypertension in end stage
renal disease patients may be due to a circulating
substance of middle molecular weight that is
better removed by CAPD than HO.
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EFFECT BLOOD PRESSURE (BP) OF HEMODIALYSIS (HO)
AND CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
(CAPO) : LONGITUDINAL STUDY:
F. Louis, P. Ruedin, H. Favre.
Oepartement of medicine, Geneva, Switzerland.
BP often presents serious therapeutic problems
in the management of end stage renal disease
(ESRO) patients. To further evaluate the
respective effects of HO and CAPO on BP, seven
patients (6 males, one female) aged from 32 to 4t
years (mean 37 2,1 years) undergoing first HO
(18 2 months) and then transferred to CAPD (17,E
3,4 months) were studied.
BP, proteins, body weight (BW) and electrolytes
were measured monthly for each patient throughout
the two periods of treatment. During HO period,
average BP was 165 * 7/105 3 mmHg and fell to
130 4/80 2 mmHg (p <0,001) on CAPO.
When started an HO, 20 % of the patients were
normotensive and remained so, whereas 80 % were
hypertensive and received throughout the HO period
antihypertensive drugs. In 60 % of the latter
patients, hypertensive medication has been
withdrawn or tapered 4 0,6 months after their
transfer to CAPD. Proteins (HO : 2,0 0,3 g/l
vs CAPD : A 1,8 0,2 g/l) and OW ( HO :A 0,3
0,02 kg vs CAPD : 1,2 0,8 kg) were similar
during both HD and CAPD periods as well as plasma
electrolytes.
The better control of 8P achieved on CAPD was
independent of 8W.
This longitudinal study of patients submitted
to both procedures indicates that CAPD could be
proposed to patients in whom BP remains
uncontrolled after 18 months on I-ID.
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ANAPHYLATOXIN FORMATION AND LEtJCOCINETIC
DURING HEMODIALYSIS (HO): EFFECT OF
DIFFERENT AREAS BY CELLULOSIC MEMBRANS
A. Mahiout, J.J. Sanchez, H. Hampi and
N. Kesael. Klinikum Charlottenburg,
Nephrology, Freie Universitt Berlin, FRG
Measurable complement activation re-
sults in the formation of both C3a and C5a
anaphylatoxins and decreases of the arter-
ial leucocyts concentration, which was ob-
served in 10 patients undergoing — intra—
individual maintenance RD with different
inembran areas; 1.2 m2 and 0.3 m2 area.
Specific radloismunoassay measurements
show that the patients displayed different
plasma levels of C3a and C5a antigens by
different cellulosic membran areas after
initiating HD. During HD, C3a plasmalevels rose in the venous site (outflow)
to a peak of 10 times from the initial
value (390±105 ng/dl) in patients with
1.2 m2 dialyser, in contrast to 2 times
with 0.3 2 dialyser. C5a antigen was also
detected in outflow, the initial levels
(30±10 ng/dl) were not so elevated as the
C3a but the difference between the large
and the small surface warm also detectable.
Consequently the dialyser with reduced sur-
face does not develop increases in C3a and
C5a arterial levale. The reduction of the
arterial leucopenie appearance time to
approximatly 50% could be reached reducing
the membran surface area to the fourth
proportion
These observations provide direct evidence
that anaphylatoxins formation and decreases
of the arterial leucocyts concentration
are dependent of the surface foreing area
by cellulosic membrans.
ACQUIRED RENAL CYSTS IN ROT—PATIENTS HAVE
NO INFLUENCE ON HEMOGLOBIN LEVEL.
B.S. Lee, W. Hust, H. Mann.
Department of Internal Medicine II,
Technical University of Aachen,
Aachen, G.F.R.
In ill RDT—patients without hereditary
polycystic kidneey disease cyst formation
has been investigated by ultrasonic exa-
mination. Incidence and volume of cysts
were the same in the right and in
the left kidney. They were not correlated
with sex, age or primary renal disease of
the patients. There was a significant po-
sitive correlation between the duration
of ROT and number of cysts. There was no
correlation between number and volume of
cysts and hemoglobin concentration (hema—
tocrit). It is concluded that renal cyst
formation in ROT-patients has no influ-
ence on hemoglobin concentration and that
clinical relevance of these cysts only
comprises hematuria, retroperitoneal he-
morrhage, infection, stone formation and
malignant degeneration.
DIALYSIS SYMPTOMS AND METABOLIC PARAMETERS DURING
DIFFERENT F\)RMS OF RENAL REPLACEMENT THERAPY.
M Surian,F_Malberti,P Cosci,U Corradi,G Colussi*,E
Os Ferrari,L Minetti*.
Renal Lnits,Lodi and Niguarda—Cà Granda MilanHospitals, Italy.
In order to evaluate hemodynamic tolerance 8 pa
tients with high incidence of symptoms in acetate
dialysis(A) were treated for 3-6 mos respectively
by single pass bicarbonate(E) and recirculating bi
carbonate(R) dialysis and by high ultrafiltration
rate(>l5oml/min) hemofiltration(HF) .1y body weight
hourly percent weight loss,presession mean arteri
al blood pressure(MAP) and plasma osmolality were
similar during each treatment. Plasma osmolality at
the end of the run was higher in R(309+5.8 mOsm/kg
U20) than in A(295+6, p(O.O2),B(293±7, pO.O2) and
HF(3Ol±5. MAP decreased more in A(27±12 mmHg) than
in 5(14,7÷7, p<O.05),R(l2±lO, pO.O2) and HF(ll-f8,5
p<O.02). but MAP drop was similar in B,R and HF. Iii
ring B,R and HF PCO2 and PD2 did not change,whilo
pH(respectively pre and post,B:7,38+O,03 and 7.L6±
0,03, p<O,00l; R7.354o,OL and 7.h340.O4, p(O.OO5;
HF;7,35÷O.O2 and 7.39+0.01, p'CO,05) and HCO(B:2l÷
2.7 and 27±2,p<O.OOl; R:18.4±2 and 23±3.2,pZO.02;
UF:18±2 and 18.5±1.3 m/l) increased. In A P02
(from '.5+lO to 79.5±9.7 mmHg,p<O.O5', PD02(from
35.6±2.3 to 3OL+4.2 mmHg,p<O.05) and HCO3(from
19.5±2.2 to 16,9+3,p<0,05) decreaaed,pll unchanged
and acrun acetate levels at the end of the run in
creased to 10.1÷4.4 mil/l. In comparison with A2the
treatment with B,R and HF significantlv(p<O.OOl) re
duced the incidence of hvpotension(A:29.8;B:9;R:8;
HF: 10%) ,vomiting (A: 17.2; B: 1; H: 4; HF: i%) and headache(A:16.2;B:3;S:4;FlF:l./). In conclusion:in symptoma
tic patients during A,the treatment with B,R and HF
prevents hypoxemia and hypocapnia and improves tole
rance to fluid removal.
MEASUREMENT OF INDIVIDUAL RATE OF METABOLISM OF
ACETATE (RMA) IN REGULAR DIALYSIS TREATMENT (RDT)
H. Mann, P. Maukner, S. Stiller
Dept. Internal Medicine II, Technical University of
Aachen, GFR
Reduced RMA is considered as the cause of symptoma-
tic hypotension and negative inotropic effects in
ROT. In order to evaluate the individual RMA, in 100
patients on low—flow dialysis (Qb 150—200 ml/min, Qd
300—400 ml/min, dialysis time 4—8 hours, mean 5.8
hours) blood acetate concentrations have been
measured.
Method: The concentration profile of acetate imme-
diately after the termination of a dialysis session
was measured by an enzymatic method From these data
and the concentration in the dialysate and the
dialysate flow rate, RMA and the distribution volume
of acetate (VA) was calculated. During dialysis pH
and pCO2 were measured in hourly intervals.
Results: Interindividual acetate concentrations (CA)
were between 1.5 and 6 mmol/l at the end of the dia-
lysis session. In this range we observed a first
order kinetic: RMA = R CA. The calculated distribu-
tion volume of acetate is about that of the extra-
cellular volume. Values for R were between 1 and 4
1/mm. Maximum possible rate of metabolism could
not be derived from these data. PH and the concen-
tration of bicarbonate showed a steady increase,
pCO2 after a small initial drop, was nearly
constant. Despite this and the low concentrations of
acetate 25 % of the patients had a washed—out
feeling after the session and hypotension could not
be avoided completely.
Conclusion: The disadvantage of acetate overload in
high—flux dialysis can be avoided by the adaption of
the dialyser clearance to the individual RMA. Mea-
surement of RMA is a further step towards individua-
lisation of RDT.
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THE EFFECT OF CHRONIC HEMODIALYSIS ON BLOOD
COAGULATION PROTEINS.
C.Mannhalter,H.Kopsa,J.Zazgornik,P.Schmidt,
E.Deutsch.
1.Department of Medicine, University of
Vienna, Vienna, AUSTRIA.
We studied the effect of chronic hemo-
dialysis on factor XII, prekallikrein, high
molecular weight kininogen and factor XI,
the so called contact phase factors. The
clotting activity and the antigen concen-
tration were significantly lower in these
patients than in normal controls. The mean
values in our patient group versus a normal
control group were for F XII 94%, normal
115%; PK 83%, normal 120%; HMWK 81%, normal
105%; F XI 70%, normal 85%. A possible ex-
planation for the low concentrations could
be a continuous loss of these proteins to
the dialysis membrane, which cannot be com-
pensated by synthesis. We succeeded to
firstly demonstrate adsorption of F XI from
plasma to cellulose acetate in vitro.
Secondly, we could show a slight reduction
of circulating factor XI in two patients
during one dialysis procedure. This was
demonstrated by measuring F XI clotting
activity in the dialyzed patient blood
after the removal of heparin. And thirdly,
125I-factor XI bound to the hollow fiber
membranes of an artificial kidney during a
simulated dialysis with whole blood.
Therefore, a continuous loss of the con-
tact phase factor during long time dialysis
treatment due to adsorption to the membrane
appears likely.
FIVE YEARS OF SELP—CARE' DIALYSI$ NITH
VOLUNTARY PARERS.
P.Martinelli, H. Salvadori, A. Sodi (Member of
EDTA).
Department of Nephrolor USL IO/D Fl,
Florence, Italy.
Our Hospital has organized from 1979 a.
particular kind of self—care dialysis
where the assistance is not given by
Hospital nurse staff,but it is assured,
without expence,by volunteers who are
engaged in public assistance organizations
and who are instructed in our Department.
Over 6000 dialysis have been performed
up today and the patients,who used this
service,have clinical conditions,bioche—
mical behaviour and degree of rehabilita,—
tion similar to our home dialysis patients.
In this long period of time we tested the
security of this type of dialysis centre,
which is a very low cost one.The dialysis
emergencies have been exceptional end
always controlled only by volunteers.
The availability of the volunteers,whose
number has constantly increased,has never
been a problem.
This experience induces us to increase
the activity of our self—care centre and
it may be an example for those communities
which may have volunteers organizations
able to cooperate with Hospitals.
BIOC0MPATIBILITY 0E4DIFFERENT MEMBRANES(M)
IN ACETATE(A)AND BICARBONATE(B) DIALYSIS(D)
11. Martens ,C . Budde , S. Gopp inger , K . Ress
G.Wulle,G.M[iller,K.Jaschonek,K.Rother,
U.Reinhardt,H.Liebich,T.Risler
Med. Univ. Hosp. Tubingen ,Heidelberg; ERG
Biocompatibility(Bio) is a major drawback
in classical Cuprophane(CU) DM.Neser Mare
said to have major advantages.Thus we com-
pared CU to polymethylmethacrylste(PPIA),po—
lyacrylnitrile(PAN)and polysulfon(PS) M in—
traindividually in 8 patients undergoing
regular D for ESRD.
Using RD WBC fell significantly to 33%
in CU(p.0.00l),to 85% in PMA(p.0.0l),to 91%
in PAN(pcO.05)and to 85% in PS(pD.00l)after
20' and reached initial values in CU,PAN and
PS after 200',while it stayed at 71% in PMA.
In AD CU and PMA induced similar changes in
NBC as in BD.Opposite WBC did not change in
PAN and PS.
To correlate these findings to alveolar
0 exchange we measured CU diffusion capaci—
ty(DC).DC decreased initially to 74% in CU
(pcfl.flD?),tn 905 in PMA(nU.fl5)and to 8C
in PAN(p0.02),shi1e it was unchanged in PS
using BD.After 200'DC reached initial values
in PAN and PMA,while it was unchanged in CU
and dropt to 92% in PS(p0.02).In AD DC fell
to 76% in CU(p0.001),to 84% in PS(p0.002)
and 83% in PAN(p0.0l).After 200'DC reached
initial levels in CU and PS,ahile in PMA DC
decreased to PAN levels(p.0.003).
Results on additional Bio parameters as
complement and lymphocyte differentiation
(using monocl.antibodies) are still pending..
We conclude that newer N have advantages
in Bio,but still have drawbacks partly de-
pending on the dialysate buffer used.
CN -THBLOBULIN LEVELS DURING HE43DIALYSIS
REFLECT THE BItMPATIBILITY OF THE DI1LYSER?
A.Martin-Malo, F.Velasco, P3,ndres, L.G.Burdiel, E.
ndres, D.Castillo, A.Torres and P.Aljarna.C. S. "Reina Sofia°. University of Cordoba. SIain.
The interaction between blood and dialyser indu-
ces platelet activation which results fran defici-
ent maubrane biocanpatftility. Since systanic anti—
coagulation does not modify the plasma levels of -
thranboglobelin (-'P3), this platelet specific pro-tein is a reliable guide to platelet activity dur-
ing hatialysis (HD). We have therefore related
plasma -'1 concentrations with another well known
index of biocaipatibility such as neutrophil count
changes during HD.
Nine stable regular HI) patients sequentially tre
ated with cuprophan (CU), ethylene-vinyl-alcohol
(EvL) and polyacrylonitrile (2N—69) meabrane dia-
lysers were studied. plasma levels (alA) and
neutrophil counts were determined at 0, 15, and 60
sin fran the start of HD in the arterial line asll as at 15 mm in the venous line.
CU induced a profound neutropenia at 15 mm (16%
of starting value) which was associated with a sig-
nificant increase in plasma -'I3 (+11%; p<O.005).
During HI) with EVJL there was a moderate decrease
in neutrophil count (59% of starting value) and -¶t levels rose slightly (±7%; p(O.OS). With AN—69
meabrane there were no significant changes in neu—
trophil count and -'1 concentrations reaained ste-
ady (+2%; NS). Considering CU and EVL data as a
whole, the decrease in neutrophil counts correlated
with the rise in (r=—0.87; p(0.00l).
We conclude that the degree of platelet activa-
tion during HD estimated by plasma -T levels de—
perds on the type of manbrane and it is a useful
marker of blood canpatibility of the dialyser.
AN IMPROVEMENT FOR VASCULAR ACCESSES SURVEY:
NON—COMPUTERIZED ANGIOGRAPHY WITH BONE SUBTRACTION
J.P. MASSELOT, P. COUMIAN, J.M. BERTHELOT,
A. LEFEBVRE, J.M. IDATTE (Intr. by D. KLEINKNECHT)
A.U.R.A., 5, rue du Bessin, 75015 PARIS
Between 1982 and 1984, 100 angiographies have
been performed for arterio—venous fistulas (A.V.F.)
in 82 out of 148 center haemodialysis patients.
Results were:
— 24 normal functionning A.V.F. : angiograms were
useful to nurses, making needle insertion easier
— 39 juxta—snastomosis stenosis
— 10 stenosis on the course of the vein
— 27 proximal graft—vein anastomosis atenosis: in
these cases 12 were located on the main axillary
vein.
Major difficulties were encountered by opacifi—
cation of main proximal veins,i.e. axillary and
subclavian. Added to our non—seriographic X—ray
generator, a duplication system with bone subtrac-
tion allowed us to emphasize contrast: first radio-
graphy is done prior to contrast medium injection,
second one during injection in the A.V.F. or graft
of 30 to 50 ml of ioxaglic acid: superposition of
both, negative and positive copy results in the
disappearance of common structures i.e. bones,
showing a better contrast of the veins. This
simple method seems to be worth using, specially
since 50% of patients with arterio—verious grafts
and 30% of those who needed subclavian vein cathe-
terization show a stenosis at one year.
HIGH EFFICIENCY CONTINUOUS ARTERO—VENOUS HEMOFILTRA
TION (CAVHF) IN PATIENTS ON INTENSIVE THERAPY.
F. Mastrangelo, S. Rizzelli, L. Alfonso, M. Napoli,
C. CorlianB, M. Aprile, V. De Blasi, A.M. Montinaro
Department of Nephrology and Dialysis. V. Fazzi
Hospital, Lecce, Italy.
The CAVHF is a new technique suggested for the
treatment of patients on intensive therapy suf Ia
ring from renal failure or other diseases requiring
a depurstive therapy.
17 patients with acute renal failure, n° 13 with e
xogenous poisonings, n 2 with inadequate secretion
of ADH and n° 2 with left ventricular heart failure
were treated.
The depurative value (waste—molecules clearances
and depurative capacity) is satisfactory. An increa
se of clearances and QF has been reached by high
blood flows, a combined pre and post—dilution te
chnique and a negative pressure system. A of
1000 mi/h. has been achived: this value is higher
than that obtained with other intermittent traditio
nal techniques. The biocompatibility of the system
(studies on red—cells, withe—cells, platelets and
C3) is satisfactory considering the long period of
treatment (4.4 4 days of continuous extracorpo
real circulation.
The clinical effects are favourable: it has been de
monstrated a more physiological control of biochemi
cal indexes, water and electrolyte balance, acid—ba
se balance and protein catabolism (also by the easy
use of the total parenteral nutrition). Likewise a
good good vascular tolerance has been obtained also
in patients with more serious impairments.
DYNAMIC ELECTROCARDIOGRAPHY (dECG) IN EXTRACORPO—
REAL DIALYSIS (HD).
F. Mastrangelo, A. Galati, M. Accogli, F. Caggetta,
V. Nuzzo, M. Aprile, S. Rizzelli, C. Corlianô.
Department of Nephrology and Dialysis. "V. Fazzi"
Hospital, Lecce, Italy.
It has been reported that heart rythm disorders
take place during HD sessions. At present, reseat
ches with dECG including observations of the inter—
dialytic period are lacking.
66 dialyzed patients have been studied by Holter re
cordings of 48 hours for each patient. 23 patients
(34,8%) did not show epysodes of arrhytmias. Heart
rythm disorders are shown in 43 patients: supraven
tricular arrhytmiaa (SA)(44%), ventricular arrh
tmias (VA)(18,6%) and an asmociation of two types
(SAVA)(37%). Hypokinetic arrhytmias have been poin
ted out in 4 patients and ischemic disorders in 8.
A statistical evaluation of the following indexem
was performed: sex, age, arterial pressure, time
spent on dialysis, serum Ca++, K+ and Na+ levels, a
cid—base bmlmnce, p02, pCO2, Htc, PTH, interdial
tic body weight increase, echocardiographic anal
sis of the left ventricle (LV) (normal, hypertrophy,
dilatation). The HO session causes changes in mci
dence (but not in types) of the arrhytmias. From
this point of view, the SA show a lower incidence
(5,2%) than AV (50%) and SAVA (75% VA, 25% SA).
The responsible factors are the changes in serum
levels, age, ischemia and the use of acetate dial
sis.
FAVOURABLE EFFECTS OF BICARBONATE—DIALYSIS (HD—Bic)
ON THE PHOSPHOROUS (P) BODY POOL IN URAEMICS.
F. Mastrangelo, S. Rizzelli, V. De Blast, C. Corlia
no, L. Alfonso, M. Napoli, N. Aprile, A.M.Montinaro
Department of Nephrology and Dialysis. "V. Fazzi
Hospital, Lecce, Italy.
It has been demonstrated during a longitudinal
study on 35 patients that the HD—Bic causes lower
serum P levels than acetate—dialysis (HO—Ac). In or
der to explain this phenomenon, following studies
have been performed: i)A venous infusion of stan
dard P solution has been given to 20 patients du
ring a period of 3 hours; 2) Afterwards, 10 pati
enta were undergone HD—Ac and 10 patients HD—Bic;
3) Finally, the curve of increase in serum P le-
vels was calculated during the 4 hours subsequent
the dialytic session. The HD—Bic causes lower va-
lues of P pool (t<.Ol), total space (tc.Ol), cellu
lar space (to.Ol) and cellular P clearance. It has
been also demonstrated a greater P depuration du-
ring HD—Bic because there is a significant differen
ce in the P measured in dialysate as regards the be
dy pool. Finally, the increase in serum P levels du
ring the 4 hours subsequent the dialytic session is
significantly higher in HO—Ac.
These data show that HD—Bic improves the body pool
in the uraemics: the better correction of metabolic
acidosis and the absence of acetate metabolism are
two factors responsible for these phenomena.
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HIGH EFFICIENCY HAEMODIALYSIS (h.e.HD).
Abstracts
F. Mastrangelo, S. Rizzelli, M. Napoli, C. Corlia—
nh, L. Alfonso, V. De Blasi, M. Aprile,A.M. Montina
ro.
Department of Nephrology and Dialysis. "V. Fazzi"
Hospital, Lecce, Italy.
It has been calculated in the last years that
the optimal goal should be the greatest removal of
the uraemic toxins performed in a limited period of
time. It has been also affirmed that these goals
cannot be obtained either with traditional short
dialysis or with efficient short dialysis (problem
of the vascular stability).
In recent years (1975 — 1983) we have performed a
program of h.e.HD characterized by 1) short (10.5 —
12 hours a week) dialysis time (td), 2) shortened
dialytic interval (s), 3) high and personalized dim
lyzers surfaces (Sj5lyzer/S0y ratio 0.8 — 1.2).
High efficiency has been attributed on the basis of
Dialysis Index (D1) that was 1.3 — 1.7 (short HD
= 1). The study was performed on 113 patients whose
57% complained of vascular stability disorders:
this trouble has been corrected by bicarbonate dia
lysis performed extensively. The favourable dm1
cal results are the following:
1) Very good compliance (diet freedom, short times
of' the dialytic sessions).
2) Low mortality.
3) Very poor incidence of ischemic cardiopathy or
heart death.
U?P.J :CrIRAToRY II'JCT1c:3 i:' P,i3: -
AiTi3IOTICS INDICACJD?.
H. :a-tesanz, L. Orofino, .i. Anaya, d.M. .sccbar,
d.M. HernncIez, A. Fernndez, L. Orte, J. Ortudo.
Contro. Iaia6n y Cajal. Lidrid.
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8 episodes of upper respiratory irxdection with
orma1torax X—ray and, absence of amigdalitis in
patients were treated. with amoxicilin (A, n=29) 50C
mg/8 h x 7 days, or :lscebo (P:iaotose, n=29) in a
aouble blind. study. The auration of symptoms (rinor
rhea, sore throat, cough, expectoration, fever ann
mialgias) was ua1itiiiod i: patasats—day. Eothgroups were sinilar ir. initial symatoes/atier.t(i,79 vs 3,72), time on i, albunin and }b. to dia
betic patients were iiinludcd. Two P patacnts left
the treatcent becauae ":astric intolerance".
Total duration of zynrtoas was 3igrificatively
less in A group (337 vs 423,5 p6., c<O,00!) ac well
aa with rinorrhea (< C,o1), expectoration (p(C,col),
and sore throat (pC,01) without diferences in
cough, s'alnias nor fever duration. There were no
severe cornplictions, nit evolation niter 7 day wa
considered ur.satisaactory in A and P p. tients(< 0,C0l). :10 iiiforences were found in and,
oat 1 body weight, blood pressure ann cardao—tao
ranic index between the start and. inc ena of the
atudy.
..rly antibiotic therapy an upper rsa.irtcry ifections of : natiets accounts 1-or a qaicker res
lu-iior. of symptoms nrobar.iy becauo of reve.tion
of bacterial ovrinfection, and ahould he conside—
ran na -the tretcnt 01 choice.
4) Good control of the arterial pressure levels,a—
naemia and neuropathy.
• STANDARD METHODS FOR MICROBIOLOGICAL ASSESSMENT
OF ELECTROLYTE SOLUTION PREPARED ON LINE (ES) FOR
HEMOFILTReTION (HF)
H.U. Mayr, F. Stec*, C. Mion*
Department of Nephrology, Hospital St. Josef, Re-
gensburg, W-Germany
*Department of Nephrology, University hospital,
Montpel 1 ier, France
The quality assurance of ES requires micro-
biological standard methods. We assayed microbio-
logical methods on their reliability and suita-
bility in clinical routine conditions during HF.
Preliminary in vitro comparison (n=3O) of the
agar pour plate method with the membrane filtra-
tion technique (ME) using .22/.45 pm pore—sized
disc filters (F) showed that 4O? of pseudomonas
aerug. and 3l° of staphylococcus coag. neg. had
not been detected by ME. Under simulated HF
conditions counts of bacteria showed a better
recovery of 139 on .45 pm than on .22 pm F (n=88).
The continuous flow of the total volume of ES
through F in 300 HF's revealed <1 —<300 colony—
-forming units/3O 1 in 95?f of the samples.
All LAL standard endotoxin tests of ES remained
negative despite a maximum rise of 1.3 C in
patients' body temperature.
Conclusions: 1) number of pseudomonas aerug.
and staphylococcus coag. neg. is underestimated
by MF.
2) In HF conditions MF shows a better recov-
ery on.45 pm F than on.22 pm F.
3) The continuous flow MF is a suitable method
for assessing routinely the bacterial content
in ES during HF.
4) Patients' body temperature seems to be
more sensitive than the LAL pyrogen test.
PSYCHOLOGICAL FACTORS IN HEMODIALYSIS PATIENTS
N. Milenkovid, S. hid, S. Kostid
Mental Health Center, Faculty of Medicine;
Institute of nephrology and Hemodialysis, Faculty
of Medicine, N18, Yugoslavia.
Fdychological factors in end-stage kidney
disease patients on hemodialysis were intented
to be find out by explorative study. Inventory
Cornell Index (CI-N4) was administrated to 38
patients (M—29, F—9).
Validity scales sugests high confidence degree
of res'klts. Patients shows moderate degree of
neuroticism. There are significant elevations of
hypochondriacal and depressive tendencies.
These characteristics may be comprehened as
secondary established neurotic disordes in
relation to kidney disease and hemodialysis.
Thise explanation doesn't seem to be completely.
We suppose inclination to psychosomatic tupe of
reaction to stress in these patients has been
existing before evolution of kidney disease. In
etiology of kidney disease evolution,
psychological factors, predisposition for
disorders in ANS, for psychosomatic disorders,
should be considered.
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BEHAVIOUR OF PHOSPHORUS (P) AND CALCIUM (Ca)IN SERUM
4ND OF PARATHORMONE (PTH) AND CALCITONIN (CT) IN
PLASMA AFTER CEASING TO ADMINISTER PHSOPHATE-
BINDERS CONTAINING ALUMINIUM TO DIALYSIS PATIENTS.
E.Minar, J.Zazgornik, R.Dudczak
I.Medical Clinic, University of Vienna, Austria
In recent years many papers have been published
on the importance of aluminium accumulation after
long-term treatment with aluminium containing phos-
phate binders. The continuous intake of such medi-
cation can cause severe side effects. A total of 37
chronic hemodialysed patients (Opts) (mean age:45.8
years; mean duration of dialysis treatment: 30
months) received medication without aluminium-con-
taining phosphate binders for 4 weeks. We investi-
gated the influence of this period on concentration
of Ca and P in serum and jPTH and CT in plasma. PTH
(Antibody Wellcome Labs., AS 211/41) and CT(Immuno-
Nuclear Corp.) were determined radioimmunologically.
Bovine PTH was used as tracer—Inolex 1515 COOl ,Wil—
son, USA-, and human PTH (MRC 75/549) as the stan-
dard. Before starting of treatment the plasma con-
centration of iPTH and CT was pathologically in-
creased in all patients.A significant increase(p<
0.0025) of the average concentration of P was obser-
ved in the total group (2.11 + 0.57 —.. 2.46 -I- 0.60
mmol/l), but in 38% of the patients this increase
was very small, with a maximum of 0.2 mmol/l. The
concentrations of serum Ca (2.11 ÷ 0.23 - 2.10 +
0.26 mmol/l)and of IPTH (2.19 + 1.57-. 2.64 + 2.27
ng/ml)and CT (290.1 + 188.3-. Th0.9 + 170.0 pg/ml)
in plasma did not chnge significantTy in
the total group during the period without phosphate
binders. Our results suggest that the continuous
prescription of aluminium containing phosphate bin-
ding medication seems not necessary in chronic
hemodialysed patients.
SUPPRESSOR CELL ACTIVITY IN HEMODIALYSIS PATIENTS
E.Mirapeix, J.Montoliu, C.Sutrez, J.López—Pedret,
L.Revert
Hospital Clinic. Barcelona. Spain.
Peripheral blood lymphocytes from 18 normal
individuals and 14 patients on regular hemodialy—
sis were incubated with two different concentra-
tions of Con A (10 jig and 4Opg of Con A/million
cells). Irradiated and non irradiated cells were
then tested in their capacity to suppress a stan-
dard MLC. The proliferative response to Phytohema
glutinin, Pokeweed mitogen and Concanavalin A,
was also determined. Suppressor cell activity
(SCA) of non irradiated cells in hemodialysis
patients was similar to that of control, both
at Con A concentrations of 10 and 40 pg/b cells
while irradiated cells of hemodialysis patients
showed a suppressor cell activity significantly
lower th0n controls, at Con A concentration of
40 pg/b cells (25.78%±lB.86 vs 46.O5%±9.79,
p <0.001). The proliferative response of lympho-
cytes from hemodislysis patients to the three
mitogens, did not show any difference when compa-
red with normal controls.
The normal proliferative response of lymphocy—
tee from hemodialysis patients to mitogens and
the normal suppressor cell activity of non irra-
diated cells, suggest normal T cell function.
The abnormal suppressor cell activity in irradia-
ted cells indicate that the radiorresistant popu-
lation has a functional defect. The cell respond
bbs of this suppressor defect probably belongs
to the monocyte/macrophage population because
of its relative radiorresistance as compared
to the radiosensitivity of the T suppressor cell.
EFFECT OF COMBINATION THERAPY WITH CIMETIDINE AND
PIRENZEPINE ON PLASMA PARATHYROID HORMONE (PTH) AND
CALCITONIN (CT) LEVELS IN HEMODIALYSED PATIENTS
E.Minar, J.Zazgornik,R.Dudczak,S.Panzer,P.Schmidt
I.Medical Clinic, University of Vienna, Austria
Several authors reported a decrease of circula-
ting levels of immunoreactive (i) PTH with cimeti-
dine (C) in patients with secondary uremic hyper—
parathyroidism. In a short-term trial on chronic
hemodialysed patients (Dpts) there was also found
a significant decrease of i PTH after i.v.adminis-
tration of the muscarine receptor antagonist piren-
zepine (P). None of these two drugs could, however,
normalize the elevated PTH levels in Dpts.We there-
fore evaluated the effects of an oral combination
therapy with C and P on plasma PTH and CT levels in
24 Opts (mean age: 50 years; mean duration of dia-
lysis treatment:23 months). Serum concentration of
PTH (Antibody Wellcome Labs., AS 211/41) and of CT
(Immuno-Nuclear Corp.) was determined radioimmuno-
logically. Bovine PTH was used as tracer-Inolex
1515 COOl, Wilson, USA-, and human PTH (MRC 75/549)
as the standard.Before starting of treatment the
plasma concentration of iPTH and CT was pathologi-
cally increased in all patients. As compared to the
pre-treatment plasma levels of PTH and CT, there
were no significant changes of their plasma concen-
trations during a 4-week administration of 800 mg C
or 100 mg P daily, and the concentrations also did
not change significantly during the following 4
weeks of combination therapy with C and P in the
above mentioned dosage. Serum concentrations of cal
cium and phosphate and the activity of the alka-
line phosphatase showed no significant changes
either. Therefore we suggest that this therapeutic
approach cannot be considered for the treatment of
uremic hyperparathyroidism.
ADRENERGIC CONTROL OF SERUM POTASSIUM IN CHRONIC
RENAL FAILURE: EFFECT OF SALBUTAMOL
J.Montoliu, L.Andreu, J.López—Pedret, L.Revert
Hospital Clinic. Barcelona. Spain.
Beta adrenergic receptors modulate intracellu-
lar potassiua (K) uptake in chronic renal failure
(CRF) (Proc EDTA 19: 756,1982; 20: 572,1983).
To further investigate the effect of specific
beta—2 stimulation on K metabolism, we gave salbu—
tamol (S), 0.5 mg i.v. in 10 sin to a group of
12 essentially anuric nondiabetic patients with
CRF on maintenance hemodialysis (ND), 72 hr after
their last HO. Thirty sin after the S injection,
the patient's serum K dropped from a mean preinjec
tion value of 5.5+0.7 mmol/L (+SD) to a mean final
value of 4.4±0.7 mmol/L (mean decrement in serum
K 1.1 mmol/L, p 0.001). Individual changes in
serum K ranged from —0.7 to —1.8 mmol/L. Serum
insulin and glucose also increased (23.1+9.6 to
67.7±41.9 iU/ml and 90.1±10.9 to 128.1±25.4 mg/dL
respectively, p<O.Ol for both), but the increment
in serum insulin and the decrement in serum K
were not correlated. The S injection was generally
well tolerated.
Thus, S has a rapid and significant K lowering
effect in CRF,which is probably mediated by direct
beta 2 adrenergic facilitation of intracellular
K uptake. However, an increase in insulin secre-
tion could also intervene. Salbutamol might be
useful in the acute treatment of hyperkalemia
in CRF.
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CARPAL TUNNEL SYNDROME (CTS) WITH LOCAL AND ARTI—
CULAR AMYLOID DEPOSITS IN HEMODIALYSIS (HD) PA-
TIENTS
E.Bergada, J.Montoliu, J.Bonal, R.SubIas, J.Ldpez
Pedret, L.Revert
Hospital Clinic. Barcelona. Spain.
From July 1981 until December 1983, 24 CTS
were diagnosed in 15 out of a total 364 HD pa-
tients, which represents a 4.1% incidence. None
of these 15 patients has amyloidosis as a cause
of their renal failure or suffers from an amyloi—
dogenic disease. Of the 24 cases of CTS, 9 were
bilateral, 6 unilateral and 2 of the latter were
contralateral to the vascular access site. In
17 cases, surgical decompression of the carpal
tunnel was performed. Histopathology was availa-
ble in 15 cases. In 9 of them amyloid deposits
were demonstrated by positive birrefringence
to Congo Red stain. Two patients with bilateral
CTS had also polyarthargia and intermittent syno—
vial effusions. In both of them, amyloid deposits
were demonstrated as well by synovial biopsy.
Therefore: 1. Four percent of our HD patients
develop CTS. 2. In these patients 60% of the
histopathologic studies of the carpal tunnel
demonstrate amyloid deposits, and 3. Some pa-
tients with CTS develop articular amyloidosis.
CHEMILUMINESCENCE DETERMINATION OF PERITO—
NEAL DIALYSIS FLUID OPSONIZING ACTIVITY
R.Mori, L.TrioJ.o, S.Lippa, P.De Sole
Universit Cattolica del Sacro Cuore, Rome,
Italy.
Opsonizing activity of dialysis fluid,
after an 8 hour dwell tinie, has been mea-
sured. The peritoneal effluents were obtai-
ned from 5 uninfected CAPD patients. Opso—
nization was performed by incubating 25mg
of zymosan with different amounts of dialy-
sis fluid (20—8Oml) at room temperature for
2 hours. Opsonization process was studied
by means of its ability to induce chemilu—
minescence response from normal human poly—
morphonuclear leukocytes (1).
The 2 hour loss of opsonizing activi-
ty in CAPD patients is equivalent to a
clearance of 05—l0ml/2h of plasma (100—
—200 opsonizing doses at 50%).
This quantity seems to be very small in
respect to the amount of total protein lost
(5—lOg/21lh) Our result is in accord with
that obtained by Verbrugh et al.(2) who
found peritoneal fluid opsonizing activity,
in respect to S. epidermidis, 100—fold 10—
war than that of normal serum.
1) Mon R. , Triolo L. , Ceriatj F. , Lippa S.
Oradei A. , De Sole P. : Life Support Sys—
tems 1 (Suppi. 1), 1983, 1511—157
2) Verbrugh HA. , Keane WF. , Hoidal JR.
Freiberg MR., Elliot GR., Peterson PK..
J. Infect. Diseases 1117, 1983, 1018—1029
DESFERRIOXAMINE INDUCED ALUMINIUM REMOVAL
IN HEMODIALYSIS
J.Bonal, J.Montoliu, J.López—Pedret, E.Bergada,
L.Andreu, M.Bachs, L.Revert.
Hospital Clinic. Barcelona. Spain.
Aluminium removal in hemodialysis (HD) de-
pends on the effective concentration gradient
between dialysate aluminium and the free diffusi
ble plasma aluminium concentration.
This study evaluates if the use of high flux
membranes and the type of dialysis bath influen-
ces aluminium removal. Ten dialysis patients,
with safe plasma aluminium levels were studied
Plasma aluminium (pAl) was measured by atomic
absorption spectrophotometry. We evaluated the
change in pAl, free diffusible pAl fraction,
dialysate Al and Dialysance of Al before and
48 hrs after infusion of 2 g Desferrioxamine
(DFO). All measurements were performed in aceta-
te vs bicarbonate HO using Cuprophane vs acrylo—
nitrile—AN—69 membranes. Preinfusion pAl was
70±7 pg/L and rose to 143+34 ug/L post DFO.
Free diffusible fraction rose from 19% to 24—53%
(mean 37.5%) post DFO. Dialysate Al was constant
at 13+1 g/L in both acetate and bicarbonate
baths. Al Dialysance was zero in baseline condi-
tions and rose to 1.1 jl/min post DFO. There
was no significant changes neither between HD
with acetate or bicarbonate nor using cuprophane
or acrylonitrile membranes. The free diffusible
fraction correlated significantly with pAl le-
vels reached post DFO (r=0.79 p<O.0l) indepen-
dently of the type of membrane used.
We conclude that Al removal post DFO depends
on the pAl reached. The use of high flux membra-
nes such as AN—69, does not improve Al removal
in vivo.
COMPARISON OF RENAL OSTEODYSTROPHY DURING CHRONIC 1-IEMODIALYSIS
AND HEMOFILTRATION. P Morinière, 3F de Frémont, P Fohrer, JL Se—
bert, H Dkhissi, Z Abdulmassih, Y Tahiri, A Fournier. CHU AMIENS
in 15 aptients on chronic hernodialysis (HO) and in 11 patients
on chronic hemofiltration (HF). HD and HF was performed with low
aluminium concentration (<.3umol/l)in the dialysate or in the
reinfusion fluid. The duration of treatment, and total dose of
previously prescribed Al (OH)3 or CaCO3 were comparable. No one
were taking 1 OH vitamin 0. 1-listochemical staining showed traces
of aluminium in only 1 patient of each
Mean (or range) Normal HO I-F
Qateoclast count/im? <.4 1.34 1.04
Usteoblastic surface % of total surface <11 11.6 8.4
Osteoid thickness index (OH) 13—26 12 14
Apposition rate u/day 0.5—1 O.85** 0.51
Mineralization front % osteoid surface >53 44 40
Plasma calcium mmol/l 2.2-2.6 2.37 2.37
Plasma phosphate mmol/1 .8—1.3 1.8O 2.06
Plasma bicarbonate rncnol/l 24—28 21.5** 24.5
Alkaline phosphatase IU <170 169** 137
Plasma aluminium ,umol/l <.3 1.5 2.2
Plasma PTH 44—68 pg/ml 80—220 1939 2320
rlasma 25 OH vitamin U ng/ml 16—30 24* 15
Plasma 1.25(0-1)2 vitamin U pg/al 20—40 36** 16
Plasma 24.25(OH)2 vitamin 0 ng/ml 1—3 0.65 0.63
Comparison HO versus HF : p<.1O **p<O5
Conclusio,s 1/ Moderate hyperparathyroidism exists in all pa-
tient except 3 and its severity is comparable in HD and HF in
spite of lower P 1.25(011)20 in HF. 2/ Florid osteomalacia with
increased DII is absent in all patients but mild osteomalacia
with decreased mineralization is more frequent in HF and is asso-
ciated in this group with lower alkaline phosphatase and lower
P 1.25(OH)2D. 3/ Lower P 1.25(OH)D in HF may be explained by
slightly higher P P04 and lower P 25 OH 0 partially due to
difference in vitamin 0 supplement.
1 f OH VITAMIN 03 INCREASES PLASMA ALUMINIUM IN HEMOOIALVZEO PA—
a TIENTS TAKING Al(O-l)3. P Moriniere, V Tahiri, A Leflon, M Nerve,V z Abdj].msssjh, R Demontis, A Fournier. Service dv Néphrologie at
taboratoire ds Biochimie, CNU AMIENS, FRANX.
Ten stable patients on chronic hsmodislysis taking a constant
thee of Al(OH)3 (mean÷So = 2÷lg/day) were given 1 pg/day of 1 K
OH vitamin 03 (1J03) for 4 weeks and ware observed 3 weeks befo-
re and 2 weeks after 103 administration. Before the first dia-
lysis of each week, their plasma concentration (P) of calcium
(Cs), phosphate (P04), protein and aluminium (Al) ware measured.
PAl was measured by inductively coupled emssion spmctrometry
(normal <0.3pm/l). Their dialysste aluminium was <.3 uM thanks
to reverse osmosis. Results
Before ts03 During 1.cD3 After b(03Mean +SCM
—
— 3 weeks 4 weeks 2 weeks —
PAl umol/l 1.18+.26 1.52+.3* 1.92÷.025
PCa(corrected)esiol/l 2.37÷.03 2.62+.0S 2.5 +.115
PPO4 smiol/i 1.92.03 2.Olw.07 2.02;.03
wpcoS, wwp<0.01=significance of ths com7arison before versus
djring 1A03 ; § p<.05, §5 p<0.01=significance of the comparison
diring versus after D3.
PAl increases significantly with 10H 03 and remains elevated
at even higher levels for 2 weeks after 1C3 discontinuation.
However, in the 3 patients for whom PAl was measured 2 months
after 1413 discontinuation (while their dome of Al(OH)3 was kept
constant), PAl returned to its basal value. PCa increased signi-
ficantly withad 03 but returned to basal value within the 15
dsys after 1KD3 discontinuation. PPO4 remained constant throu-
ghout the study.
Conclusions 1.0H 03 induces a significant rise in Pl which
persists 2 weeks after its discontinuation. This may be esplai—
ned by either an increase of Al intestinal absorption and/or a
decrease in Al tissue storage capacity and should lead to close
monitoring of PAl during vitamin 0 therapy.
EVALUATION OF THE HYPOTHALANIC PITUITARY ADRENAL
AXIS TN PATIENTS ON CHRONIC HEMODIALYSIS (CHD):
EFFECTS OF INSULIN INDUCED HYPOGLYCEMIA (1111) AND
ACTH—RELEASING FACTOR (ACTH—RF)
N.Kallivretakie, C.Platsakis, S.Voudiclarie,
T.Mountokalakis, N.Liog, E.Poener, G.Tolis
Hippokration General Hospital, Athens, Greece,
Salk Institut, La Jolla, Ca,USA and McGill Univer-
sity, Montreal, Canada.
Patients on CHD often exhibit dysfunction of the
hypothalamic—pituitary axis. Diminished suppressi-
bility of pituitary corticotropes to glucocorti—
coida is comoon and not infrequently ITH elicits
abnormal cortisol stimulation. The latter is not
clear whether ia due to hypothalamic or pituitary
dysfunction. To elucidate this, we assessed adrenal
responsiveness to TIll (a hypothalamic stimulus) and
to ACTH—RF (a pituitary secretagogue) in 9 patients
on CHD.ACTH—RFwaa given i.v.in a bolus of lpg/kgr.
IIM was elicited with cryatalline Zinc Ineuline at
a dose of 0.1 i.u. per kg BW. All patients exhibi-
ted clinical and biochemical evidence of hypoglyce-
mia. ACTM—RF elicited no stress response. Plasma
cor-tisollevela ranged between 19—39 pg/dl (x:27.3)
the day of the TTH end 18—38 pg/dl (x:23.l) the day
of the ACTH—RF teat. Following hR the mean respon-
se was 15 ug/dl (range 1—25), whereas after ACTM—
RF it was 29 ug/dl (range 8—37) (pCO.O5). An exag-
gerated response (peak levels > 64 iig/dl) was seen
in 1 of 9 patients tested with hIM and in 6 of 9
tested with ACTH—RF. The above data indicate that
in patients on CHD the anterior pituitary cortico—
tropea may show altered secretory capacity not on
account of pituitary but of hypothalamic limita—
tions and demonstrate that ACTH—RF can replace TIM
in the evaluation of the pituitary—adrenal axis.
SPECIFICITY OF GHRH AND ACTR—RH INDUCED PITUITARY
RESPONSES IN HEMODIALYSED PATIENTS
G.Tolia, A.Margioria, N.Ling, H.Guyda, C.Platsakis,
N.Kallivretakia, T.Tillis, S.Voudiklaria, T.Mounto—kalakis
McGill University, Salk Institute, Mt Sinai Hospi-
tal and Hippokrateion Hospital, GREECE
Patients on henodielymis (1W) often exhibit
aberrant responses of ACTH and OH to TEN. In order
to assess the specificity and efficacy of ACTH—RH
and GHHH we administered in 9 patients on HD and
measured ACTH and OH in blood obtained at 20 mm
intervals for 2hrs. ACTH levels were normal and
showed a 25—300 percent rime after ACTH—RH but not
CHRH. OH levels were normal in I of 9 patients and
showed a 30—600 % increment after GHRH but not
ACTH—RH. Either peptide was given at a dose of
lug/Kg i.v. In those patients with not marked GH
response to 01-IRS we alsb measured it after hypo-
glycemia. The results obtained with the latter
were similar to those after GHRH.
Above data establish the efficacy of ACTS—RH
and GHRH as specific secretagogues in the evalua-
tion of anterior pituitary function in uremic
patients on hemodialysis.
IRON REMOVAL BY DEFEROXANINE (DF) DURING MEMO-
DIALYSIS (MD): IN VITRO STUDIES
O.E. Nuller-Wiefel, U. Vorderbrugge, K. SchArer.
Univeraity Children's Hospital Heidelberg, F.R.G.
DF is increasingly used in polytrenefuaed MD
patients to diminish toxic iron (Fe) overload. The
beat way to apply the chelating agent ia still un-
known. We investigated Fe removal (Fax) by HD in a
standardized model using pooled human plasma and a
hollow-fiber dialyaer MTS C) without transmembrane
pressure by meaauring 9Fe activity in plasma and
dialysate after addition of OF (lg/l plasma) as a
bolus given from 24 to 0 bra before MO or as a
4 bra infusion during the whole HO procedure. Fe
was determined repeatedly during HO. At very high
plasma Fe Fe' 2500 jimol/l) 59Fe was eliminated
almost completely within the first hour after start
of MO both with and without OF. At a normal Fe (18
imol/l) only 1.7% of initial Fe content could be
removed without OF. By applying OF the following
mean Fax was obtained: 4% by infusion during HO,
and 14, 82 and 100% after a bnlus at start of,
2 bra and 24 bra before MD, respectively. Fex was
not increased by addition of aacorbic acid (0.5
gil) nor decreased by transferrin (1.Og/l) . Memo—
filtration was more effective in removing Fe than
HO. Radioactive counts of the dialysate were
higheat at 3 mm after start of HO and reached a
minimum after 2 hre. Oata suggest that for Fex no
chelating agent is required in the case of high
Fe' such as found in acute Fe intoxication. How-
ever, at normal or slightly elevated Fe' as found
in Fe overloaded uremic children, a specific chela—
tor is needed. The chelating action of OF requires
more time than previoualy thought; therefore, it
seems to be logical to apply OF at least 24 bra
before MO is started in vivo.
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A NEW DIALYZER FOR THE CONTINUOUS MONITORING OF PATIENT' S
DEPURATION DURING HENODIALYSIS
6. Nunaretto, A. Bonadonna, Ospedale P. Cosma, Camposa.piero
Italy, C.Sa.a , Inphardiai Laboratories, Viadana, Italy.
Monitoring in hemodialysis (Ho) has always been limited to
estracorporeal circuit, while few attention have been paid to
the patient's depurative status. To make possible the monitoring
of the concentration of some .etabolites in the patient's blood
during the HO session, a new dialyzer has been developed by
Inphardial S.p.a. The dialyzer has a housing divided in two
parallel compartments. One co,part.ent contains a bundle of
cuprophan fibers having a surface of 1.1 sq.m. and the other
contains only 300 high permeability fibers. The dialysate fl,ows
only through the main compartment. 91% of the blood flows
through the fibers 0f the main compartment and is cleared by
dialysis; 3% flows through the other fibers which can be
considered a small hemofilter. A filtrate can be easily
collected from the second compartment and continuously analyzed.
Our hypothesis is that the ultrafiltrate can be representative
of solute concentration in the patient' a blood. During 161 HD
sessions (27 patients) urea, potassium and creatinine were
determined in samples of arterial blood and filtrate collected
simultanesously at 10th sin and every 40 mis. The data confirm
that ultrafiltrate is highly predictive of solute plasma
concentration, whatever the hematocrit or protein plasma
concentration. The concentration in the filtrate is always
higher than that in the blood and the ratio of blood
concentration and filtrate concentration is 0.90 for urea, 0.88
for creatinine and 0.91 for potassium. The standard deviation of
such ratio is about 3%. In conclusion this simple and
inexspensive dialyzer can be used whenever the assessment of the
depurative status of the patient is needed (acutely ill pts,
severely anemic pts, home dialysis pts, HbsAG positive patients)
THE 'MISSING LINK" — AN INTERMEDIATE SIZE HICKMAN
CATHETER FOR HEMODIALYSIS ACCESS IN LARGER
CHILDREN
I.E. Nevins (Intr. by C.M. K,jellstrand).
University of Minnesota, Minneapolis, Mn., USA.
Silastic right atrial Hickman catheters (HC)
have provided ininediate, safe and reliable
hemodialysis access in infants and small children
(Kidney Int. 24;694). Extension of this approach
to larger children is hampered by the maximum
blood flow available (about 50 ml/min). Between
September 1982 and March 1984, 23 larger (0.0. —
3.7 osi; 1.0. - 2.0 on) HC were placed for dialysis
access in 19 children (4—23 kg). The catheters
were in place a total of 1390 days (range 2—379)
and used for 551 dialyses (range 1—156). With
unipuncture equipment and parallel—plate
dialyzers, blood flows up to 100 el/sin were
achieved. All venous pressures remained below 350
no Hg. Since initially measured recirculation
ranged from 4—33%, stroke volumes were adjusted to
produce a recirculation of less than 15%. There
were no dialysis—related deaths, no
thrornbo—enbolic problems, and 14 patients (74%)
were free of all catheter complications. Seven
catheters required surgical revision. Infectious
complications, included 2 wound infections and 2
episodes of sepsis, all responded to appropriate
antibiotics and only 1 FC required removal.
This experience is very similar to earlier
studies of both smaller (1.0. — 1.6 nsi) and larger
(I.D. — 2.6 nm; Am. 3. Surg. 145;571) HC for
dialysis. Benefits include; ease of placement,
immediate use, low incidence of complications,
and simplicity of maintenance. This new HC
compliments the existing catheters and extends
these benefits directly to children between 10
and 25 kg who require hemodialysis.
FUNCPION RATES OF VASCULAR ACCESS IN DIABRTIC
PATIENIS
Ne.iweiler, W., ring, K., Bczrrner, J., Ritz, E.
Dept. Nerology and Surgery, thsiv. of Heidelberg,
Germany (Fl)
Vascular access has been said to be the AchiUes
heel of htodialysis in diabetic patients. To furthej
evaluate vascular access in diabetic patients, we
retrospectively analyzed fistula survival and fistu-
la cc*nplications in 60 non-diabetic center dialysis
patients and 25 diabetic dialysis patients (8 type I
17 type II). Median age in non—diabetics was 49.3
years, range 25—71, and in diabetics 56.7 years,
range 32-73. Diabetics required store vascular pros-
theses (Gore-Tex 6/25 vs. 1/60 in controls) and had
a similar frequency of brachial fistula (2/25 vs. 3/
60). The priaary fistula failure rate (closure with-
in 8 weeks postop) was 6/25 in diabetics (2/7 in
type I) and 10/60 in controls; the difference was
not significant. 6/25 of diabetics (2/7 of type I)
required revision of the first fistula because of
thranbosis. Actuarial survival of the first fistula
which functioned for 8 weeks was 0.83 in diabetics(vs. 0.93 in controls) after 6 nocnths; 0.83 in dia-betics (vs. 0.88 in controls)at 12 nonths and 0.59
in diabetics (vs. 0.62 in diabetics) after 120
xronths.
The data indicates that diabetics have higher rates
of primary fistula failure and initially scewhat
faster decay of fistula function. However, when vas-
cular access has been established, further fistula
ccmnplications are no store frequent than in non—
diabetics. The observations indicates that in con-
trast to previous statnmnents vascular access is
rarely the limiting factor for hnmtodialysis india
betic patients.
COMPARATIVE STUDY OF CEREBRAL BLOOD FLOW
(CBF) IN ACETATE (HDA) AND BICARBONATE
DIALYSIS (11DB)
U. Neyer, E. Wöss, H. Fritzsche (intr. byB. Watschinger)
Depts. of mt. Medicine, Nuclear Medicine
Landeskrankenhaus Feldkirch, Austria
Symptoms of cerebral dysfunction (head-
aches, ERG—disturbances) are observed more
frequently during HDA than during 11DB
(p<h,O5) and for that a decrease of CRF
due to a fall of arterial pCO2 during F-IDA
was suggested by many authors.
We measured CBF (ml/100 g/min) by the
Intravenous Xenon—133 method in 10 pa-
tients before and after HDA and 11DB re-
spectively. To reach conmarable data CBF
values were corrected to a normal hemo—
ilobin (160 g/l) and a PaCO2 of 40 mm 11g.
In spite of the exspected decrease of
from 34,1 + 3,2 to 28,7 + 4,5
(p<O,005) during HDA we observed a signi-
ficant increase of CBF from 56,1 + 10,1
to 79,1 18,3 (p<O,005) in the right
hemisphere and from 54,9 + 11,1 to
69,8 + 17,3 (p<O,05) In the left hemi-
sphere in correlation to a significant
rise in heart rate from 72 + 11,8 to
92 17,9 (p(0,005), whereas neither CBF
nor heart rate showed significant changes
during 11DB.
Therefore a decrease of CBF seems not
to be the suggested reason of cerebral
dysfunction during HDA.
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• ANAPHYLAC'IDID REACTIONS TO HAEMODLALYSIS ARE DUE
TO ETHY1EE OXIDE HYPERSENSITIVITY
A Nicholls, L Grammer, N Roberts, S Patterson
N Platte
Royal Devon & Exeter Hospital, Exeter, U.K.;
Northwestern University Medical School, Chicago,
U.S.A.; Royal Hallanshire Hospital, Sheffield, UK
Anaphylactoid reactions to dialysis occurred
in 16 regular haemodialysis patients within a
minute of the return of blood from a new dispo-
sable dialyser. Several patients suffered re-
peated stereotyped attacks, the illness varying
in severity from urticaria, sneezing and watering
of the eyes to severe bronchospasm and cardio-
vascular collapse, with most patients having
multiple anaphylactic symptoms. Various types
of dialyser construction and membrane were invol-
ved, but all were ethylene oxide (ETO) sterilised
so we hypothesised an allergic reaction to ETO
(or conjugate thereof) as the cause of these
reactions.
Serum samples were collected from reactors
and from comparable haemodi.alysis patients with
no anaphylactoid symptoms as controls. Total
IgE and IgE specific to albumin exposed to ETO
(ETO—HsA) were measured by polystyrene tube
radioinssunoassay, and total antibody binding
to EW—HSA by modified Farr assay. IgE to E'IO—
HSA was found in 6 of 7 reactors, hut in only 1
of 6 controls (p<O.05). Reactors had 2.5
6.0 (SD) n'ml ET—HSA bound to IgE, while
controls had 0.2— 7.8 (SD) ng/ml (p<O.05, log
transformed data). No significant differences
were found in total IgE or total antibody
binding to E'IOISA.
These results suggest that anaphylactoid
reactions are due to immediate 'type hyper-
sensitivity to ethylene oxide.
IS DIETARY LIPID-LOWERING TREATMENT MANDATORY IN
SHORT HAEMODIALYSIS REGIMEN?
P.L. Oe, J.A. Schouten, C. Popp—Snijders, J.M.
Luitingh-van der Veen, C. Mulder and J. van der
Meulen.
Free University Hospital, Amsterdam, The Netherlands
For shortening dialysis time to 10 hr/wk protein
restriction to 50 g/d is mandatory. More calories
should then be provided by fat and carbohydrate,
which may have an adverse effect on lipoproteins.
Therefore, a study on lipoprotein profile was done.
Serum levels of total cholesterol (TC), triglyc-
erides (TO), HDL cholesterol (HDL chol) and the HDL
chol/TC ratio were determined in 32 patients (17
men and 15 women) on short dialysis treatment. The
linoleic acid content (% C18:2) of adipose tissue
and the body mass index (BMI) were also determined.
The energy % polyunsaturated fats/energy % saturat-
ed fats (P/S ratio) was assessed by the 21 hr
recall method.
In all patients the P/S ratio showed a highly
significant positive correlation (r=D.7lL, p<O.O01)
with % Cl8:2 in adipose tissue. Eighteen patients
showed normal TG (<2.0 mol/l) and 14 patients el-
evated TO. In patients with elevated TG the HDL
chol/TC ratio was significantly lower (p<O.01).
These patients showed a significant positive corre-
lation between % C18:2 in adipose tissue and HDL
chol/TC ratio (r=O.53L, p<0.05) and a significant
negative correlation between BMI and HDL chol/TC
ratio (r0.576, p<O.05).
Our data indicate a) that shortening dialysis
time has a limited adverse effect on lipoprotein
profile and b) that in case of hyperlipidaernia in-
creased use of polyunsaturated fat in the diet and
weight reduction may have a beneficial effect.
THE EFFECTS OF LONG TERM CAPD ON PERITONEAL
CLEARANCE AND ULTRAFILTRATION.
N.I. Nikolakakis, R.S.C. Rodger, T.H.J. Goodship,
R. Ashcroft, H. Wilkinson, M.K. Ward.
Department of Medicine, University of Newcastle
upon Tyne, koyal Victoria Infirmary, Newcastle upon
Tyne, r0g1and.Loss of ultrafiltration and peritoneal clearance
are major caspLications associated with CAPD. We
have studied the effect of time on Ch'IPD upon ultra-
filtration and peritonea]. clearance.
Two groups of 15 patients were studied using (and
had only used) lactate based CAPO dialysis fluid.
One group was on APD for less tLan one year
(6.5*4.5 months) and the other for over 3 years
(43±8 months). The groups were matched for age
(45±16 years) and incidence of peritonitis (1
episode per 18 patient months).
Ultrafiltration was assessed fran net weighed
fluid loss d.iring a four hour exchange with 2 L of
hypertonic CAPU dialysis fluid (3.86% dextrose).
Peritoneal clearance was measured during this 4
hour period.
kesults for the 2 groups are shn:
Ultraii1tretiou Clearance mi/mm
Under
Over 3
1 year
years
1102±157)
991±217)
NS •°7.9±1.2) NS
(Values are xnean±SD) NS = Not significant
There were no significant differences oetweeu
the two groups. Percentage absorption of glucose,
calculated fran d.ialysate glucose was not different
in the two groups (53±11% against 4d)%).
This study suggests that there is no loss 01
ultrafiltration or peritoneal clearance with long
tent CAPD.
HEMODYNAMIC EFFECTS OF HIGH FLOW GRAFT A-V
FISTULA IN CANINE MODEL.
H.K. Oh, N.W. Levin, C. Cruz, J.B. Lakier.
Henry Ford Hospital, Detroit, MI., USA.
High output cardiac failure in chronic
hemodialysis patients occurs more freauently
when high flow access sites are placed
proximally in an extremity. We have studied
in dogs the effects of high flow graft AV
fistulae (mean flow 641 ml/min or 30% of
cardiac output) on the following cardiac
function parameters: mean arterial pressure
(MAP mm/Hg) cardiac output (CO L/min) Toal
peripheral resistance (TPR dynes sec/cm
and right and left ventricular systolic work
indices (R and LVSWI g/meter/M2) before (A)
immediately after (B) and 7 days post
operatively (C). The results are expressed as
mean SD.
CO TPR RVSWI LVSWI
1.9±0.5 2262±983 1.3±1.1 29±9
3.1±0.8 1675±878 1.7±1.1 38±10
3.2±0.9 1407±535 3.7±1.6 30±8
0.005 < 0.005 <0.01 NS
We conclude that larger shunts have greater
flows and greater RVSWI. In this model the
larger flow is compensated by a greater CO
and a drop in TPR without significant change
im MAP. In patients with compromised
myocardial function the increased flow may be
an important factor in precipitating
congestive heart failure particularly when
the shunts are large.
N=12
A
B
C
(AvsC)
MAP
76±16
87±19
71±14
NS
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HOSPITAL INFECTION CONTROL AND CARRIERS
OF STAPHYLOCOCCUS AUREUS IN A HEMODIALY-
SIS UNIT.
Ohgke,H. M.Tolon, H.Magnussen
Medical University of Luebeck, GFR
36 patients and the staff of a
hemodialysis unit were followed micro-
biologically (dermal, pharyngeal and
nasal cultures). Carriage of S.aureus
among patients (12 persistent and
8 intermittent carriers) was more
frequent than among staff. Cutaneous
colonization showed highest density
in persistent carriers. Phage-typingdid not reveal any cross—contamination
or cross-colonization inside the hemo—
dialysis unit although isolation measu-
res were not practised. Two persistent
carriers with heavy dermal colonization
underwent renal transplantation under
conventional conditions of operating-
room hygiene and recovered without
infection. This result and a bacteremic
episode in one of the intermittent
carriers clearly indicated that improve-
ments in infection control are to
be particularly concentrated to the
safe handling of vascular accesses.
For the assessment of S.aureus carriers
nasal cultures are sufficient as nasal
cultures are more often positive than
pharyngeal cultures.
REDUCED OSMDTIC HEX)LYSIS & IMPROVEMENT OF ANEMIA
.
BY LARGE DOSE VITAMIN—E (Vit E) SUPPLEMENTATION IN
REGULAR HEMODIALYSIS PATIENTS
K. Ono,
Ono Geka clinic, Fukuoka, Japan 812
It is known that the rate of heialysis is sig-
nificantly greater in Vit E deficient RBC in
comparison with controls. This study was performed
to clarify the effect of Vit E(alpha—tocopherol)
supplementation on plasma & RBc levels of Vit E,
osnetic fragility of RBC and anemia in dialysis
patients. We have analysed the plasma & RBc levels
of Vit E, Hct, and oslmDtic fragility of RBC in 15
regular henedialysis patients, before and after
treatment with Vit E, 600 mg daily for 30 days.
Other 15 unsupplemented dialysis patients were
served as controls.
In patients receiving Vit E, mean osnolarities of
begining and end of henolysis decreased from
102.8±0.9 to 98.9±0.7 and 72.1±1.1 to 67.4±0.8
nlDsnVL respectively.
In conclusion, the oral supplementatio of Vit E
could be of clinical benefit in correcting anemia
in regular dialysis patients by reducing the
fragility of RBC.
WES CMCEONIN HAVE A FOLE IN TREP.NT CF
DThLYSIS AND KIDNEY TR PL1NI'ED PATIENTS?
K. Olgaard, L.Nielsen, E.Langhoff, H.Daugaard, M.
Egfjord arid S. Madsen.
Med. Dept. P, Rigshospitalet, Copenhagen,Dennark.
The iysio1ogical importance of Calcitonin re-
mains unclarified. However, a toxic effect of PTh
in urania has become well docunented. The present
investigation, therefore, studied whether Calcita—
nm, as a possible Pm antagonist, could affect
sane of the disabeling syisptc*1s of patients on
long teni harodialysis,which in general do rot re-
spond to conventional therapy. Five patients, one
with severe pruritus and four with severe pareste-
sia of the lower limbs and feet, all dialys&1 for
several years and all unsuccessfully treated by
conventional means, were treated by i .v. infusion
of Calcitonin (lao I.V. three tiras a week) for
six nonths. The pruritus disappeared and the par-
estesia vanished to such an extend that all pati-
ents could wear shoes arid were able again to walk.
In the kidney transplanted patients focal osteo-
necrosis is a major problen. The sysptans developin a relative fixed pattern: pain and after weeks
to nonths focal uptake on bone scintiscans and
later appearance of focal osteonecrosis on x—ray.
I\O kidney transplanted patients with normal kid-
ney function developed pain in right hip and right
elbow with uptake on the bone scintiscan, but nor-
mal x-ray. During six xnths of treathient with Cal-
citonin lao I.v. three times a week the pain dis-
appeared, the uptake on bone scintigraphy disappear-
ed arid no focal osteonecroses appeared on x-ray.
We conclude from this preliminary study that the
clinical improvenent of these dialysis arid kidney
transplanted patients was so striking that the
present results may suggest a role for Calcitoninin the future treathient of such patients.
IN VITRO EVALUATION OF TRAVENOL ULTRAVIOLET SYSTEM.
G.Orange, I.S.Henderson, A.C.T.Leung (Intr. by A.C.
Kennedy).
Departments of Bacteriology and Nephrology,
Glasgow Royal Infirmary, U.K.
The limitation of chemical sterilisatjon of
CAPD connectors has prompted the development of
physical sterilisation techniques such as tte I-lot
Wire (Du Pont) and the Travenol Ultraviolet system.
There has been very little published data on
the in vitro efficacy of the Travenol U—V system
despite its increasing use in clinical practice.
The present study set out to evaluate the
bactericidal properties of this system against a
range of organisms isolated from previous
episodes of CAPD associated peritonitis.
Organisms used included E.coli, g.aureus,
.epidermidis, pviridans a diphthoroid
bacillus and Candida albicans.
Unused Travenol connector spikes were
contaminated with known numbers of bacteria and
irradiated with ultraviolet light using the
Travenol system as recommended by the manufacturers
The connector spike was then immersed in a
broth culture medium and incubated at 37°C in order
to culture any surviving micro—organisms.
The system appears to be a satisfactory method
of sterilising the connector spike in most cases
and can be recommended as an effective sterilising
agent on the basis of this in vitro assessment.
Vit E dose Vit
600 mg pre 10.67±0.9
post 20.37±1.6
-_______
p<0.Ol
E (mcg/ml) (mean SEM)
--
0.57±0.05 26.1±1.0
1.56±0.11 28.1±1.2
p<0.Ol p<0.05
None pre 9.73±0.8
post 10.05±0.8
MS
0.45±0.07 30.3±1.1
0.45±0.06 29.6±1.0
NS NS
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Isc}!:Ic CHMr3S PRLVPTI0N BY Pb'DIALY5IS PROPRA—
NO1OL ADMI4ISTRATI0N.
L.Orte; ii. iIatesanz; L. Orofino; A. Fernandez; J.
G. Revalderi a; J.L. Palma; C. Quereda and J. Ortu—
no.
Centro Ramón y Cajal. Madrid. Spain.
Death rate from cardiac arrest of unknown etiol
r, in chronic hemodialysis oatients (CH?), is high
—; possible causes as cardiac arrhytnias and jache
sic changes are quite common during hemodialysis
session (}D). The purpose of this study was to eva
luate the hypothetical preventive role of predialy—
sic Propranolol (PR) administration on the inciien
cc of these problems.
After a design of intradialysis plasca PR profi-.
le, measured by srectroflucrometry (RAD 1978), we
study 10 CHF, 3 of them with antecedents of angina
and receiving isosorbide tiiritrate at the time of
study. Continuous KG and 3? monitoring (lolter sys
ten—24 ilourrs) was perfornied. in these patients wit-hout R and after giving PR p.o. 1 hour before ID).
ctopic activity was classified according bewn cri
teria. Isohenic changes were defined when a desoen—
ding ST—T level more than 1 mm was aresent. There
was not found correlation between the severity of
IKG changes nd plasma Fit levels, dtrafiltration
volume, mean blood pressure and cardiac rate durino
}D. actopio activity was not modified when ?R was
iiven, while ischemic changes dissapeared in all
3 cases detected bassaily.
Plasma PR levels were not aignificatively modi-
fied, during fl) and they 1id not correlate with md
dence nd severity of afrhytmias, even when PR was
given juet before liD. iredialysis administratior
seems to revent iachemic ch:.r.ms i.uring liD, with-
out concomitant undesirable side effects like hyno
tension.
THE HOLE OF DESFERRIOXAMINE AS A CHRONIC THERAPY
IN THE PATIENTS ON REGULAR DIALYTIC TREATMENT.
C.Canavese, A.Pacitti, i4.D'Amicone, M.Salomone,
P.Stratta and A.Vercellone.
Cattedra di Nefrologia, Molinette, Torino—Italia
Following previous reports, we have treated
with Desferrjoxamine (DFO) 16 uremic patients
(pts) on regular dialytic treatment (ROT) for Al
(8) and Fe (8) overload (mean: 10 months/pts).
DFO 50 mg/Kg/week was infused during the first
week hemodjalysis (HD) or hemofiltration (HF) in
patients with encephalopathy (2), osteomalacic
fracturing osteopathy (2), positive DFO—test (4),
ferritin 2000 ng/ml and transferrin saturation
770/(6), hemocrornatosis with liLA A3(l pulmonary
oxyfication) Al (atomic absorption), Fe,Cu,Zn,
and Mg kinetics was monitored.
A relationship was found between Al—Fe removal
and serum peaks after DFO infusion both in RD (p,'
0,05) and HF (p<0,001), and DFO doses (RD pO,O5;
HF p<0,001). Al losses increase of 72% in both RD
and HF by doubling DFO doses. The HF/RD losses
ratio was 1.82 (DFO 3 gr) and 1.8 (DFO 6 gr).
Cu,Zn and Mg kinetics did not change after DFO;
Ferrjtjn and trsnsferrin saturation Slowly decrea-
sed. Encephalopathy halteu, but seizures recurred
after 1 year; bone pain decreased and Vit D
tnanagement became easier, but rsdiological lesions
were unchanged. Transient dyscromatopia was seen
(2), reversed after UFO stop.
DFO could be evaluated as a chronic therapy for
RUT patients, but low doses snd prolonged follow—
—up are needed.
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EFFECTS OF CARDIOSELECTIVE ( ) AND NONSELECTIVE
(BOTH AND ) ADRENERGIC BLOCKADE ON SERUM
P(YTASSIfM IN P.TIENTS WITH CHRONIC RENAL FAILURE
UNDERGOING HAEMODIALYSIS.
N. dzder, A.Aksoy, b'. Dó!rtlemez, H. Drtlemez.
Medical School of Gazi University, Internal
Medicine Clinic, Ankara, Turkey.
It has been shown that -adrenergic blockadeif nonselective, causes significant elevation in
serum potassium (K). It is thought that this in-
crease is due to inhibition of intracellular K
uptake and with cardioselctive adrenergic block-
ade this does not occur. To confirm this concept
we gave pindolol lO-l5mg daily for 15 days to 13
patients, and metoprolol 200-300mg daily for 15
days to 12 patients. All the patients were given
a diet containing constant K and non of them had
hepatic dysfunction and diabetes mellitus. All of
them had chronic renal failure and all were under
haemodialysis program. Pindolol caused a signif i-
cant increase in serum K (from 5.56 to 6.72meq/lt)
(p 0.005) .Though there was a decrease in intra-
cellular K values it was not significant,probably
because we evaluated only 4 out of =3 patients.
This point needs to be studied and clarified.
Metoprolol did not cause a significant difference
in serum ic levels (from 5.78 to 5.74meq/lt).Both
inetoprolol and pinolol group did not show signif-
icant changes in plasma aldosterone, serum insu-
lin and blood glucose levels. Both of them
decreased heart rate and arterial blood pressure.
Although number of cases are limited, our
results suggest that cardioselective blockade
should be the choice of 8adrenergic blockade
in cases of chronic renal disease.
POST—DILUTIONAL HEMOFILTRATION WITH INTERMITTENT
PRE—DILUTION FOR PATIENTS AT BLEEDING RISK.
A.Pecitti, C.Canaveae, V.Calitri, G.Mangiarotti,
G.P.Segoloni and A.Vercellone.
Cattedra di Wefrologia—Molinette—Turin,Italy.
Intermittent flushing of filters during post—
dilutional hemofiltration (HF) could substantially
decrease the higher heparln requirements of HF.
Ten patients on chronic HF (gravimetric moni-
tors, hollow fibers filtera)were monitored: along
one standard seasion(A)= hepsrin loading doses-
continuous infusion; and one (B) session=every 30'
flushing of filters by 250cc of bags fluid on
pre—dilution, stopping ultrafiltration (UF) and
blood arrival (30'); then, restarting UF and
allowing the monitor to automatically reset the
patient weight (150"). Heparin, 500 UI, was infu-
sed when clotting time was4'.
Less heparin was needed in B (1456+93 UI) than
in A (5975±1619 UI)(p.0Ol).Efficiency was unmo-
dified (UF rate:ll0±18 vs 115÷15 cc/sin; Urea
clearance: 110.1+42 vs 101.2 cc/min).End—session
PT,PTT,TT,AT III did not change in 13 in contrast
to A(p< .02—.00l).Plateleta counts and acti—
vation(PF4,B—TG,TBX),kinins and lysis showed com-
parable variations.Blood viscosity increased less
in B(p<'.Ol).
Local hesodilution decreases HF heparin need
without affecting efficiency and biocompatibility,
as confirmed by clinical experience on 3 AHF pts
(39 sessions) and 4 diabetic pts.( 300 sessions).
This schedule has actually stressed in our
experience the HF r6le as a first choice treatment
for high risk patients.
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...VALIJATIUN IF ALYbAT. SIAjILI1Y IN FIVE UFFb.N1
3ICAid0NAT UXALYdIS 8D) dYT..:.1s,
A. Perez Garcia, F Ana, P. Torrabadefla, R. Jo—frê, E. Junco, F. Valderrano.
Hospital Pro,,jncja]. de Madrid, Spain.
Fjt,e different systems of [30 were studied in or—
der' to evaluate calcium car3onate precipitation in
dialysate ia). c1, pC02, (2 1, ionic and total Ca
were measured avery hour in anaerobic samples of 0
obtained f rem different locations in the dialysato
proportional system, during 7—6 sessions. (real or
sham).
The dialysis systems were: 1/Drake .fjllock 7.0L1i
Oicaroriate solution ready 1350). 2/Bellco Uri3jnat,
3L 723 3GR 3/Gentry 2 Ax, Bicaronate powder 'te
be dissolved .3PU). 4/J/C Travenol R Datch tank
system,with single pass3F0). 5/Travenol rdP H,
batch tank system rucirculating sinlw pass, SF0.
Ca and Bicarbonate in 0 before the dialyser ware
always lower than that theoretically expected.lith
C3PD, levels of Ca were exponentially related to
P2 and (p02 2,21 e 0.4 Ca T and 8.67
-0.02 Ce Ie , r= 0.95 p(0.0l). Ca conccntration
was layered by pH> 7.5 and pCO2 .( 25 nmtHg indu-.
cing the risk of nenative Ca balance in patients.
Mach mac of tyj 1, 2 and 3 achieved a mearured Ca
levels of 3.25 mqJl without using a hijh quantity
of acid u?fer or an excess of CX)2. In typo 4 and
5 machines, a satisfatory Ca concen ration is ob-
tained only by keeping a large amount of 0 in the
tank ut all time. In type 5 machines Ca presipita-.
tion induced by massive C02 losses may occur more
readily due to recirculation of 0 • -xcesive apita—
tion must be avoided when proparinp a JJ solution
types 3, 4 and s). Heating and de—aerating waterbefore mixing gave bsttor 0 stability. sugjest
that iicaronstc 0 should be periodically monito-
red throuh analyses of' Ca, pH or pCO2.
LEUKOPENIA AND HYPOXEMIA DURING HEMODIALY—
SIS WITH CUPROPHAN MEMBRANES (CPM) IN A PA-
TIENT WITH HEREDITARY ANGIONEUROTIC EDEMA
WANE), MEMBRANOPROLIFERATIVE GLOMERULONE—
PHRITIS (MPGN) AND WITHOUT MEASURABLE COM-
PLEMENT ACTIVITIES.
R.Perricone,I.Taccone_Gallucci*, F.Antonelli,
C.De Carolis,L.Fontana,V.Mazzarella**, C.
Me1oni*, M.Morosetti* and C.U.Casciani*.
VI Clinica Medica, I University of' Rome.
* Clinica Chirurgica, II University of Rome.
** Istituto C.N.R. L'Aquila — Italy.
We studied complement activities, white
blood cell number (WBC), P02 and acid—base
balance during a single hemodialysis with
CPM in a patient with i-LANE, MPGM C3NeF positive
and without measurable complement activities.
While before, during and after the dialysis
procedure plasma complement activities (to-
tal—hemolytic complement, classical and al-
ternative CO convertase activities) were un—
measurable and no 3 conversion to COb occu—
red, profound leukopenia and hypoxemia were
found within 20 mm from the initiation of
heinodialysis (from 8,500 to 1,800 W1X and from
101.8 to 86 mmHg respectively). The falls of
WBC and of PG were not associated with any
improvement in acidosis and loss of carbon
dioxide.
Our data demonstrate that complement acti—
tion is not the only possible mechanism re-
sponsible for early leukopenia (and hypoxe-.
mia) during dialysis with CPM.
SEPTIC 0STEOAR'RITIS (SQA) IN PERIODIC HEMODIALT—
sls (11])).—
M Perez Prez, L GonzSO.ez Rodriguez, JA Sobrado
1A Courel, S Cigarrdn. ( Intr. by J Alvarez Orande)
Seco. )fefrologa. Hospital Xeral de Vigo. Spain.
Among a group of 50 patients undergoing } over
an observation period of 6 years (x=37.5 months)we
observed 73 bacteremic episodes (0,46 epis./pat./
year). The diagnosis of BOA was made in 4 of them
(2 men,2 women) with an average of 42.5 years (ran
ge, 29 to 58), and 27 months(range, 13 to 37) afterinitiation 1fl. The time from onset of simptoms to
diagnosis was 4—6 days in 3 oases and 30 in the
rest. All patients were bearer of an internal arte
riovenous fis'tula without signs of impairment. Two
patients had had hepatitis type B one of whom had
become persistent HBSAg carrier, and 3 had respi-
ratory infectious problems • There was renal osteo—
dystrophy in one case • Both lciees, sacroiliac and
wrist were the joints involved. The rest case was
an osteontyelitis 1)—li.
Two patein'ts died during the septic state. One
of two remaining patients died too 4 months later
due to a new sepsis by the same agent. In all ca'-
see there were enough facts suggesting hematogenous
dissemination by Gram—possitive micro—organisms:
S • aureus (3 oases) and B. pneuznoniae. Surgical
treatment was required in one oaae.
C0CLt.3I0I: 1. BOA in H]) patients is a severe corn
plication, as bacterial endooarditis or septic lung
embolisms 2. SOA in these patients can involve unu
sual sites 3. Gram—possitive ( speoial],y S. aureu)
are the organisms that most frequently cause SOA
4. Hepatitis type B and obronic respiratory disease
may be predisposing factors 5. Early recognition
of BOA and differential diagnosis with renal csteo
dystrophy ia required to avoid this potencially
serious complication.
SUBCLAVIAN VENOUS STENOSES: A COMPLICATION OF
TEMPORARY SUBCLAVIAN CATHETER HAEMODIALYSIS.
J. Petersen, 0. Davis, C. Cho and R. Feldman.
Stanford University and Veterans Administration
Medical Center, Palo Alto, CA, USA.
Maintenance of vascular access continues to be
a major problem in haemodialysls patients. When
permanent access becomes nonfunctional, subclavian
venous (SCV) cannulation has become a widely used
method of temporary dialysis with few reports of
significant morbidity from the technique.
We observed 3 cases of SCV stenosis in 6
patients (8 SCV5) who underwent haemodialysis via
SCV catheters. A standard aseptic infraclavicular
technique was used for insertion and catheters
remained in place for 1-35 days. In these 3
patients the symptoms affected the arm with the
permanent vascular access. The symptoms developed
3-6 months after the catheter was removed and
included massive refractory arm oedema requiring
contralateral placement of a graft (1), mild arm
oedema and vartcosities (1) and upper arm
varicosities (1). In affected extremities an SCV
catheter was in place for at least 15 days while
the ipsilateral permanent access was temporarily
nonfunctional. Development of SCV stenosis was
not related to infection. Contrast venography
of 8 SCVs revealed 80% narrowing (1), 50%
narrowing (2) and normal (5).
We conclude that SCV stenosis may be a frequent
:omplication of subclavian cannulation which can
contribute to significant morbidity. Symptoms
only develop with ipsilateral graft placement so
that contralateral graft placement may be
preferred following SCV cannulation.
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IMPROVEMENT OF SERUM F ERRITIN(SF)LEVEI
IN CHILDREN UNDERGOING HEMOFILTRATION
(HF)
M.Picca, A.Bettinelli, M .Giani, V. Cecchetti, L.
Ghio ,A.Saccaggi, M. Taddei, A. Edefonti.
Pediatric Dial3náis Unit ,University of Milan(Intr.
by L .Minetti)
Iron balance is abnormal in most of the patients
on chronic hemodialysis(HD) ,that results frequen-
tly in iron overload,as confirmed by high values of
SF .We studied SF ,every 6 mths ,in 9 children(meaii
age 11.5÷3yrs)treated first with HD for 12 mths
and afterwards with HF for the same period.HF was
prescribed by urea kinetic model.The relationship
between SF ,the number of blood transfusions and
other laboratory variables was examined in HD
and HF respectively.The main results are summa-
rized in the table:
SF(ng/ml) BUN(mg/dl) Gu(mg/mth)
HD 239.2+230.4 130±34.04 4.06+0.8
HF 139.7±172.8 112+24.17 3.39+0.86
p 40.05 <0.05 <0.05
Pretreatment BUN,Gu and SF decreased signifi
c antly in HF .The change of SF significantly cor-
related with pretreatment BUN(peO .O1)and Gu(p
O.Ochanges.No correlation was observed betwe
en SF ,the number of transfusions and the other
laboratory variables tested.In conclusion,a more
effective treatment modality,as indicated by the
decrease of pretreatment BUN and Gu,could impro
ye iron metabolism.
hIPH ALU'IUIUM SUNK CONTUNT (All) is o'r PFOrJLTA op
OSTEOALACIC (OK) AIY'UC CSTKOI1YKTROPHY (pp)
T.Piz;re1l,Q.aior,F.Bucci°,P.Nal1ant0,
K.Co ,-n' mi00 ,O.•;lrin°"
Cenrro iaiologis Clinic0 ,Cfl ,Rgtn lahri, ItalyClelr A'o) cats olugira ,Oome tdversit;y , Lk -dy'
Lahor' u' o To icolop,i,t,1. S .. ,00en, italy0
Al ough several obverv-.tio'a point out to high
AU) i'. 0900,uata on Alh in CO with prevalent Cstei—
Us F'ibros0 (Or) are lacidog.
Tn 17 cu ecu'ive dialyzed pta quantitative bone
histolopy and All welt deter eined on he same hone
senirer. I: Our pt- with resorhing surface end ost&
OCI astic index in the 'oreel range ,aa well as absen-
ce of earrov Cibrosis All ass II 'vg/Kg ash hone (ran
ge P3—lOP mg/Kg) .Ir U. pta with prevalent OFOS Al,b
was 56.5±33.0 nrg/Kg.In the latter groun the higher
Alb valuev'were asocjted with the more severe 9F
alnhougbor the whole,no correlation was found he—
tweer AU, cml the indexes of OFDO.Alb correlated
with serum Al (r-O.77,p<fl.Olj.Such correlation ills—
appeared if the four uts without overt OF were ad-
ded for the sralysis.In the two pta with primary Ox-
iosim Alb was 9 ar-id 35 mg/Kg ash hone,respectivelv.
In ore pt, with 01930 particulary severe and Aib 96
mg/Kg Clinical signs of OFDO disapneared after pars-
thyroidectomy (PTx).
From this prospective study we conclude that high
Aib is not peculiar of 0090 and can coewsist with
OFDO as well as primary Oxalosis in uremic stage.
High Alb levels do not interfere with PTx henefcral
effects.
EVALUATION OF SATELLITE (LIMITJu us MINIMAL CARE)
DIALYSIS UNITS.
DrGPincherle, Jmnc Lvans, A Iturst, P Mancini,J Whithy.
DHSS, London, England.
A team of a doctor, a nurse, an economist and
two administrators evaluated the working and costs
of 8 Satellite Dialysis Units. Information quest-
ionnaires, site visits and follow up queries if nec
essarv. The units were planned to operate under
widely differing operational policies so that the
different facilities, staffing and siting all
oroved successful in their different ways. Staffing
ranged from 10.8 hours of trained nursing time per
patient to less than 1 hour though in the latter
un-it this was supplemented by P hours per patient
per week of "house keeper' time. Annual costs per
patient ranged from £7,000 to £12,000 hut most
,nits' costs were between £8,000 and £9,000 at
1982 —83 prices: these figures compare with esti-
mates for hospital dialysis costs of £10,100—
511,700, for home dialysis of £6,900—7,500 and for
CAPD of £5,900 - £6,600.
The main factors affecting costs were patient
dependency and dialyser re—use policy, annual staff
costs per patient were less than £2,000 for uflits
taking fully independent patients only, rising to
over £+,000 for a unit including some very depend-
ent patients. The two units who reused dialysers
up to 6 times had annual consumable costs of around
£3,000 per patient, the four untts who did not re-
use had consumahles costs ranging from £3,600 to
£6,300. We conclude that Satellite Dialysis Units
provide a useful way of extending the range of
options for the treatment of end stage renal fail-
ure, especially for patients without help at home
or with unsuctable housing, at a cost which can he
as low as for hone dialysis.
• PHOSPHOROUS KINETICS DURING HEMODIALYSIS AND HEMO-
FILTRATION
H. Pogglitsch, W. Petek, E. Ziak, F. Sterz, H.
Hoizer,
Dept. of Internal Medicir and Institute of Medical
Biochemistry, University of Graz, Austria,
In order to find out the most effective property
for eliminating phosphorous (P) during hemodialysis
(HO) or hemofiltration (HF), we compared the effi-
ciency of 11 hemodialyzers and investigated various
models of hemodialysis technique. The results can
be summerized as follows: - 1. The P excretion du-
ring HD depends primarily on the properties of the
hemodialyzer (surface, membran characteristics
etc.). Under constant conditions (blood flow 200 ml
1mm.) the plasma phosphorous concentration (C0)
fell continuously by 16 + 2% or 31 + 3%, respeti-
vely, using less or moreeffective ialyzers. -2.
Higher lots of P are eliminated by HD (1.225 + 0.37
g) than by HF (0.717 + 0.25 g) in the case ofcom-
parable C (1.92 + O.mmol/l, 1.91 + 0.75 mniol/l,
respectivly). - . The in-vivo-cleaFance of P (K5
differs considerably from the real blood clearandê
(K ) and from the plasma clearance (K ). The reason
threfore may be sought in the very shall diffusi-
bility of P between plasma and red blood cells as
well as in the high transfer resistance of P be-
tween ICV and ECV. - 4. Within 12 ours after HD the
C reaches by about 70% of the initial concentra-
ton at the beginning of HD. The increase is caused
by the P-shift from the ICV into the plasma volume
and influenced by many factors (initial P level,
metabolic status of the patient, hyperparathyroid-
ism etc.). The rebound follows an exponential curve
in contrast to the generation rate curve of urea.
- 5. It can be imagined that the patterns of C0
during HDis regulated actively to a certain degree.
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NO NEED FOR ANTIBIOTIC PROPHYLAXIS AGAIEST
A-V .FISTULAE ENDARTHERITIS.
P.Ponce,P.llorejra, M.Costa(Intr.by A.Coelho)
Cuf Hospital. Lisbon,Portugal
The Arterio-Venous Fistulae(AVF)endoti-je
hum submitted to constant high pressure
flow and turbulence has the potential risk
of being colonized during episodes of bac
teremia.
To assess the need for perioperative an
tibiotic prophylaxis 22 chronic hemodialy
sic patients with C-B AVF were prospecti
velly studied after undergoing 45 conseciitives procedures(38 dental extractions or
instrumentation with gengival bleeding,6
urinary tract catheterizations,l colonosco
py)mostly for pre-transplant work-up.
Blood cultures were drawn 24 to 48h af
ter the procedure,and febrile reactions
and/or local signs of infection in the vas
cular access searched for 3 months.
In all the cases the blood cultures were
negative,and no clinical endartheritis fol
lowed these commonly bacteremic producing
situations. During the time of the study
(9 mo.) 2 cases of AVF infection not rela
ted to any previous procedure occured in
the Dialysis Unit.Ue concluded that the risk of AVF Infection is low in this clinical cet,ancl anti
biotic prophylaxis not cost-effective.
COMPUTER CONTROLLED DIALYSISJ.S. Pr1 and P. i.
Norfolk and Norwich Hospital,
Norwich, England.
Utilising a microprocessor controlled
artificial kidney machine we have demcnstrpte
the ability to set up and moottor the kidney
machine from a reocte centre? computer.
We have developed a variety of prograrree for1. extracting water from the patient2. controlling the rode e.g. sequential
ultrafi1tratior and dialysis
varying dialyate sodiur concentration
throughout dialysis.
The programmes con be used by the ncphrologiet
to prescribe the conditions governing a patient's
dialysis at any time prior to the treatment
commenning.
These developments have enabled us to conr'ol
accurately and relily the dialycis from the
central computer and to monitor the progress ofthe dialysis. They ml?] facilitate our ability
to maintain a high Standard of dialysis treat-
ment in peripherally placed units with minimally
trained staff.
ACETATE INIDLERANCE IN CHRONICALLY HEMODIALYSED
PAflENTS (CHoP)
M. Prud'home, P. Vinay, B. Vinet, N. Lvei1lé, C.
St—Louis, L. Laplerre, Y. Piette, A. Gougoux (Intr.
by E. Junco).
Hôpital Notre—Dame and Universitg de Montra1,
Montra1, Canada.
In order to define an "acetate intolerant" popula-
tion in CHOP, the computerized medical records of the
211 patients henodialyzed (HD) mere then 10 times
with acetate in our unit between 1974 and 1984 were
studied. Total W2, urea, creatinine and body wt pre
and post HO were analyzed. The patients were divided
in three groups according to their acid—base response
to HO. For each patient, the increment of plasma CO2
post—HO (daD2) was plotted as a function of the (1)2
pre—HD. This provides an intercept value (A) where
the metabolic generation of bicarbonate equals the
losses due to HO (d (1)2=0). This parameter is
directly dependent upon the metabolism of acetate.
Patients of group I (n175) had a A=20n1 and MO2(+)
or (—); group II (n18) had A"16mM andd W2(+); group
III (n=18) had A=l5niM and C02(—); Thus patients of
group III were clearly unable to generate bicarbonate
from acetate at an appropriate rate and their acido—
sf5 worsen per—HO. The study of this group reveals
that 1) less than 101 of CHOP were "acetate into-
lerant" 2) women are affected mere than men (14/4) 3)
that this syndrome occurs at the first ND and 4) is
not due to the duration or quality of 1D 5)that these
patients are mere acidotic than those of group I but
not group II. Blood acetate are measured in order to
validate the discrimination procedure described
above, and to examine the effect of bicarbonate admi-
nistration on acetate metabolism.
EVALUATrOM OP E08 Ci'FP WTTH ACUTe' R"PL
AILURE (ARF)
I.Radmilovi(,Lj .mjuJanovi', O.?adlovi',
Lj .RadovanOvid,m.wumarmc, '.LOi', .drd • Od,D.Vujid, J. TnnreaovstH
Institute for Kidney Oimoames ard 4eta}-oljc
Dlsorders,Chinical TnFritml OF fit",
Peograd ,Yuaolarj
Fetween l96 and 1993 we treated OO pm—
tiepts (rt) yjth AF disnosed a ecute tii
hular necromie. Tbp ratierte 'ere divided
into 10 etiolonic grourm iti' different
mortahit' ("t) 1) oFstetrjc—rot a'ortjop
233 pt (Mt 18m) and post rartu 40 rt (Mt
25%); 2) surgic 54 rt (Mt 44) ; 3)traurnmt—
Ic 28 pt (Mt 43%); 4)rancreatitis 10 rt(Mt
58%) ; 5) hepatorepal 5vndron'e 23 nt (Mt 39%
6) intoxication 59 r't (Mt 25%); 7) alimentar
intoxication 28 pt (Mt 25%); 8) sereJ 35 rt (Mt
23%); 9) havorrhaglc fever 24 nt (Mt 29%); ifl)ot—
h 56 pt (Mt 43%). The nst co!mr cauwem of
death a'ere shock, infection ard irrever-
sible CNS damaqe. 521 mt yere treated by
early, intensive dialysis: 504 by pen—
toneal, 17 by hetnodialysis, 88 hr both
and 87 pt were on conservative management.
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• PROTEIN BINDING OF ALU1INIDM IN NORMAL VOLtNTEERS
AND IN PATIENTS WITH CHRONIC RENAL FAILuRE (cia')
*H. Channon,**A.W. Skillen,*N.K, Ward,
*D.N.S. Kerr. Departments of Medicine* and
Clinical Biochemistry**, Royal Victoria Infirmary,
Newcastle upon Tyne, NE1 4LP, ENGLAND.
titrafiltration of sern through YN1O membranes
in a stirred cell pressurieed by CO2 in air
showed that the protein bound aluminium in 30
normel oiunteers was 41—7 (x=54) and in 30 CRF
patients 53_816 (=7().
When serum from S normsl v'lunteers and 15 CBF
patients were studied by ge filtration on Sepha—orl S—00 using Esrle' med4tn, pE 7.4, as a
buffer, the aluminium wee eluted as a single neck
ooincident with the traneferrin peak. Gel filtrat-
ion of commercially avaiD'ble human traneferrin 5
ag/mi (Behringwerke) aM albi&n 5 mg/mi (Hoechst)
before and after spiking '4th 2'0 31g/i aluxninlun
showed that aluminium binds strongly to trane—
ferrin bwt not to albumin. The transferrin itself
contained O0 g/l aluminium but the sibumin only
7 ng/1. The aluminium could not be removed from
transferrmn by dialysis or iñtrafiltration, even
tn the presence of 200 mg/I desferrioxamine. Gel
filtration of serum from 3 patients after dee—
ferrioxemine infusion sho'zed a second aluminium
peek which was non-protein bound and presumably
mobilised from tissues. This peek was eluted in
the same position as an aluminium deeferrioxamine
marker on this column. Gel filtration can not be
used for qumntitativ studies as the gel matrix
absorbs aluminium from the buffer. This aluminium
can subsequently be taken un by the serum or des—
ferrioxamine passing through the column.
We conclude that the majority of the aluminium
in serum of normal volunteers and CEP patients is
tightly bound to transferrmn and can not be
removed by dialysis or deaferrioxamine.
I.V.VANCOMYCIN FOR STAPHYLOCOCCUS PERI-
TONITIS DURING CAPD.
P. Rawer, K.E. Seim, H. Breithaupt,
G. SchUtterle. Center of Internal Medi-
cine University Giel3en, FRG
About 70 % of the episodes of perito-
nitis in CAPD are due to gram-positive
bacteria, staphylococci causing 2/3 of
the cases. The risk of dialysate-conta-
reination during application of drugs in-
to the dialysate-bag, reduced activity of
antibiotics in the dialysate, increasing
frequency of isoxazolyl-penicillin re-
sistant strains and the requirement for
daily i.v.-application of conventionally
used antibiotics prompted us to study the
pharmacokinetics of vancomycin after
i.v.-application. Serum-, urine- and dia-
lysate—concentration of vancomycin were
measured by HPLC and bioassay; elimina-
tion half-life, volume of distribution,
peritoneal— and renal—clearance were
calculated in eight patients, seven with
staphylococcal and one with "aseptic"
peritonitis during CAPD. Vancomycin pene-
trates well into the dialysate and effec-
tive dialysate- and serum-concentration
are achieved after i.v. -application.
Therapy was effective in six patients,
in two patients a sinus tract infection
made the removal of the Tenckhoff cathe-
ter necessary. On the basis of our data,
we recommend a loading dose of 1.0 g
vancomycin i.v., followed by 0.5 g every
48 hours for a safe and effective treat-
ment of gram-positive peritonitis during
CAPD.
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LEFT VENTRICULAR FUNCTION IN PATIENTS ON REGULAR
HEMODIALYSIS AT REST AND DURING EXERCISE TESTS.
C.Raidis,M.Papadimitriou, S .Giouticas,E.Basayannis,
P.Geleris and P.Metaxas
2nd Prop. Dept. of Medicine,Aristotelian Univ. of
Thessaloniki, Greece
Left ventricular function (LVF) was studied in
31 sready state chronic uraemic patients (24 male)
on regular hemodialysis (ROT) at rest and during e-
xersice tests,i.e.Leg raising (LR),Isonietric hand-
ling exersice (H) and supine bicycle exersice (B.E)
y noninvasive methods (Echocardiography,phonocar-
diography,carotid pulse tracing) between 2 sessions
of hemodiaiysis.Two groups of pts were identified:
A. Group I (G1,12 pts) with low % shortening of LV
short axis (% ED((3O%) and
B. Group 2 (G2,l9 pts) with normal %D (>30%)
Roth groups showed LV dilatation (EDV>112+8cm
p<O.005) and significant hypertrophy (LV mass>159+
+7gr,p<O .005) .Nevertheless,Gl shwed greater hyper-
trophy (LV mass/EDV=i,75+l4gr/cm ,p 0.005),c9mbined
with lower Cardiac IndexLt.1 and 5.1 L/min M ) and
higher peripheral resistances (2,458 and ],981 dynes)
at rest and during the exersice tests respectively.
Isometric relaxation time (IRT) was also found ab
normal in Gi (IRT 62msec at rest,74msec at H,
p<0.005).The above suggest that Gl patients were
in latent left ventricular failure (LVF).Correla
tion of %dD with age,time on ROT and biochemical
profile showed that Gi pts were older and for ion
ger period of time on ROT and had higher blood ure-
aiserum potassium and lower hemoglobin levels du-
ring the last 2 years. In conciusion,LVF in pts on
ROT shows a progressive adaptation characterised
by increasing LV work with normal LV contractility.
Except of other parameters poor biochemical control
ietnt may progressively lead towards heart
EXPERIMEIITAL PI½STEURISATICI OF CAPD CNEC1DPS.
D.J. Read, S. Foulkes, F. Parsons.
st.James's University Hospital, Leeds, England.
Skin organisms are recovered in up to 70% of
CP,PD peritonitis episodes, the likely portal of
entry being the bag/transfer set connection. We
investigated the efficacy of pagteurisation of
connectors contaminated with 10 staphylococci in
a sterile in vitro system Ean enpty 2 litre bag(the per itoneal cavity) sealed to a Travenol
system II R transfer set and sterilised by gairms
irradiationi designed to sisulate overnight CAPD
conditions M.th a morning bag changed Contamin-
ated connectors were incubated at 32 C for 8 hours
after which a 2 litre bag of 1.36% dialysis fluid
was run through to the0"peritoneal cavity" and
beth reincubated at 37 C for 4 hours. Organisms
in heavy growth were reproducibly recovered from
both fluid arid connector bit from neiher when the
connector was iimrsed in water at 75 C for 5
minutes either before or after the 8 hour incuba-
tion. Separate e,c)eriments with similarly
contaminated connectors, varying beth teirperatur8
and time of inirson, established a momentary 70 C
as the minin'wn required0for conpiete staphylo—
coccal eradication; 65 C requiring 10 minutes for
an equal effect. Intraluminal theuocouples
showed raising the connector to 70 C required
sean of 168 seconds ith intiersion water at 71 C
and 61 seconds at 77 C. Heat is a ample
effective method of eradicating skin organisms
from the connector and is cheaper than available
alternatives. Clinical trials are currently in
progress.
• ALTERNATIVE VASCULAR ACCESS IN PATIENTS LACKING
.
VEINS FOR STANDARD AV FISTULAE
W. P. Reed, P. D. Light, J. H. Sadler, E. Ramos
University of Maryland, Baltimore, U.S.A.
Since July 1981, we have used two unconven-
tional devices as means to reestablish hemodialysis
in patients lacking adequate upper and forearm
veins. The Hemasite polytetrafluoroethylene
fistula with external titanium port (37 patients)
and the Hickman central venous catheter (30 pa-
tients) can both provide immediate function when
standard access fails. Both devices also have a
potential for infection because they protrude
through the skin. We have found the Heinasite to be
more convenient to use and care for, but to be far
costlier ($3000 vs $40), more difficult to insert
(2 hr vs 30 mm) and remove, and more frequently
associated with major infections. Nearly half of
the Hemasite devices have now required removal for
infection. As a result, long term function has
been substantially less with the Hemasite device
than with the Hickman.
Hemas ite
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BONE MINERAL LOSS DURING CENTRE AND HOME HAEMO-
DIALYSIS. INFLUENCE OF VITAMIN 0 METABOLITES AND
PARATHYROID HORMONE IN SERUM.
H. Rickers, M. Christensen, C. Christiansen (Intr.
by V.P. Petersen).
Departments of Clinical Physiology and Nephrology,
Aalborg Hospital, Aalborg; and Department of Clini-
cal Chemistry, Glostrup Hospital, University of
Copenhagen, Glostrup, Denmark.
Serial measurements of the bone mineral content
(BMC) were made in 27 consecutive patients on chro-
nic haemodialysis (MD) for a mean of 4.8 years
(3.0—6.5 years) in order to select the patients
with a rapid BMC loss during MD. Mean BMC fell con-
stantly at about 4%/year with no difference between
patients on centre (n=14) and home (n=l3) MD, but
the variation in BMC loss was pronounced. Mean se-
rum values of 250HD (normal) , 24,25(OH) D (decrea-
sed to half the normal level) and l,25(B)2D (seve-
rely decreased and almost nondetectable) were simi-
lar in the patients with a BMC loss (> lO%/
3 years, n=l3) and slow BMC loss V lO%/3 years,
n=14). The "rapid losers" had a significantly high-
er serum level of parathyroid hormone (about twice
as high) than the "slow losers", whereas thn two
groups did not differ in serum concentrations of
calcium, phoCphate or alkaline phosphatase. Nor did
the two groups differ in loss of estimated lean
body mass during MD.
These findings point to the importance of fac-
tors other than impaired vitamin D metabolism in
the pathogenesis of renal osteodystrophy.
LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN HEMOOIALVSIS (HO) AND HE-
MOFILTRATION (HF). CCWARISON WITH UNFRACTIOtED HEPARIN (UFH).
H Rensud .1 Diévsl P Morinière Z Abdulmsssih F Tou1emondeH
Dkhissi A Fourniert •CHO AMIENS,**Instltut CHOAY, PARIS.
In the first study made in 28 uremic patients with hemorrha-
gic risk (3 recently bleeding gastric ulcus, 2 retroperitoneal
hematoma,1 bleeding colitis,12 surgical operations) CV 222, a
LMWH of 4500, was used during 105 HO snd 17 HF runs at various
priming doses (33,75,100AXAU/kg) followed by continuous infusion
of 1000AXAU/h. No massive coagulation in the blood lines nor
bleeding at the surgical wound, at the ulcus seen by fibroscopy
just after the run or in the drainage tubes was observed. Anti
Xa activity (AXa) and Activated Partial Thrombin Time (APTT) we-
re measured in 14 patients receiving the various doses of CV 222
and in 3 patients receiving low doses of UFH (priming dose of 33
lu/kg followed by an infusion of 500 lU/h) CV 222 at the dose
of 33AXaU/kg induces the same AXa as UFH but without increasing
APTT. In the second study made in 20 uremic patients (11H0,9HF)
without hemorrhagic risk the standard administration of UFH was
a priming dosa of 60+30 lU/kg with a continuous infusion of 1000
lU/h during 4 hours. In order to cvaluate the necessity of the
continuous infusion, CV 222 was administered as priming doses
follo9ed or not by a continuous infusion of 1000 AXaU/h. Priming
doses of 150—300 of CV 222 induced at 4 hours of the run an AXa
activity about half of that obtained with addition of conti-
nuous infusion but greater than that induced by usual doses of
UFH and sufficient to prevent infraclinical coagulation as evi-
denced by a slight increase of FPA (5.7ng/ml for a normal<3.5).
APTT induced at 2 and 4 hours by CV 222 were always much shorter
than that induced by usual doses of UFH. CONCLUSIONS 1/ CV 222
at the dose of 33AXaU/kg followed by continuous infusion prevent
clinically evident coagulation with a lower hemorrhagic risk
than low dose of IJFH since it does not increase APTI, and allows
therefore safe dialysis in patient with hemorrhagic risk. 2/ Sin
gle priming doses of 150 or 300 AXAu/kg present single and ef-
ficient adnristration of CV 222 in patients without hemorrhagic
risk.
LF—LIMITED DEHYDRATION DURING CONTINUOUS
ARTERIAL—VENOUS HEMOFILTRATION (CAVH).
A,F'abris,S.Biasioli,M.Feriani,G. La Greca.
Dopt.cf Nephrolcgy,S.Dortolo H.,VicenzalTA
A study of a patient on CAVH in conditio
n of marked dehydration due to excessive
ultrafiltration er sthsequerLtly with rein
fusion fluid, shows that everL in absence of
an adequate monitoring or care,the dehydra
tion of the patient on AVH is seif—limite
d avoiding dangerous cornplications.The stu
dy of henutocrit,total protein,oncotic and
hydrostatic pressures at the inlet and out
let of the filter,blood flows and filtrati
on fractions showed that even slight modi-
fications of these parameters consequent
to ultrafiltration process and weight loss
are able to reduce the total transrnemhrane
pressure(ir this case from 5OmrnHg to 12 mm
Hg)ad the ultrafiltration rate(11.5 to 0.5
mi/rn'), Very smal] forces are operating in
CAVH making the kinetic of ultrafiltration
different Prom any other extracorporeal
treatment.F'actors generally negligible as
protein concentration,play an important ro
le in the uitrafi]tration production.
After 12 hr's of ultrafiltration the patie-
nt showed a marked reduction of the ultra-
filtration rate due to a decrease in 'flF.
After replacement fluid UF rate returned
up to 10 mi/ni' thanks to an increase in
TM? due to plasma dilution and rise in B?.
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CLINICAL EXPERIENCE WITH CONTINUOUS ARTERIAL-VENOUS
HEMOFILTRATION (C.A.V.H.).
C .Ronco,S .Biasioli ,A.Brendolan,D.Borin,S.Chiaramont
M.Feriani,A.Fabris,L.Bragantini,G.La Greca.
Oepartment of Nephrology, Vicenza Hospital, Italy.
Technical problems or clinical complications may
contraindicate hemo or peritoneal dialysis.Fluid o-
verload may sometimes be refractory to diuretic tre
atment. For these reasons 25 patients have been tre
ated with C.A.V.H. as alternative to HO or PO.(6 pt
=Congestive hart failure,lS pt=Acute renal failure
with polytraumatism or severe cardiovascular insta-
bility secondary to abdominal or thoracic surgery,
1 pt=ascites+hyponatremia,3 pt=ultrafiltration loss
during CAPO).In patients without vascular access,fe
moral artery and vein cannulation was performed.
Blood flows ranged 35-110 mi/rn with an ultrafiltra
tion rate ranging 5—15 ml/m.A standard Kramer's kit
for C.A.V.H. was utilized. The treatment duration
ranged 6 hrs-7 days.In some patients a replacement
solution was administered in order to maintain the
Nitrogen and fluid balance.BUN was maintained gene-
rally below 100 mg/dl thanks the parenteral hyper-
alimentation. Even in absence of treatment related
complications,l4 patients died during or after the
treatment.The severe catabolic patients were swtced
to hemodialysis as soon as possible. Particular crn'e
as taken to the factors affecting the ultrafiltra-
tion rate in order to obtain the best performance
of the system. Filtration Fraction was assumed as
efficiency index during the treatment. In presence
of reduced ultrafiltration the evaluation of ciotled
fibers and clotting time was performed.
NEW HEMODIALYSIS: SURFACE 5 m2. Q0 500 mi/mm.
NEW SCHEDULES: 2 HOURS 3 DAYS/WEEK, 3 HOURS 2 DAYS/
WEEK, 6 HOURS 1 DAY/WEEK.
E. Rotellar, E. Martinez, R. Lubelza, J. Barrios,
R. Simó, J.F. Mulero, M.D. Perez, S. Bandres, J.
PiRol.
Clinics Renal, Barcelona, Spain.
With our device of 5 m2 surface with 500 ml/min
blood flow and 1000 ml/min dialysate flow, we have
dialyzed 25 patients without residual renal func-
tion and following an .i'restricted diet for only
6 hours per week in a period ranging from 2 years
to 1 year.
The clinical and biochemical results are the
same as for conventional dialysis.
Possible schedules:
a) 3 days x 2 hours. With this group we must use
bicarbonate dialysate in place of acetate in
order to avoid a sudden rise in the level of
acetate in the blood, with associated symptoms.
b) 2 days x 3 hours. Here we must use bicarbonate
dialysate and increase the potassium content
from 1.5 mEq/l to 2.7 mEq/l to prevent excess-
ive hypopotassemia. We also raised the level
of dialyaate glucose in order to prevent the
sudden dialysis Syndrome.
c) 1 day x 6 hours. For these patients we also use
dialysate with bicarbonate, with higher levels
of potassium and glucose.
Eith these different dialysates the patients do
not feel discomfort and they prefer this new hemo—
dialysis program because the schedules allow them
to lead more complete personal, social and working
lives.
The reduction in costs of the treatment is con-
siderable.
HEMOPERFUSION/HEMODIALYSIS IN THE TREATMENT OF
ACUTE THEOPHYLLIN POISONING
G. Rongved and L. Westlie
Dialysis department, Central Hospital,
'Fredrikstad, Norway.
Treatment of theophyllin overdosage with
hemodialysia and or hemoperfusion is accepted
as necessary in the most severe cases.
We treated a 63 year old woman who had an initial
theophyllin concentration of 1000 mikromol/l with
resin hemoperfusion (Extracorporeal XAO—4). The
theophyllin concentration before and after the
filter was found to approach each other in a
linear pattern, and it was possible to predict
the time of saturation of the filter. This
happend after 2 hours and the treatment was then
changed to hemodialysis and charcoal hemoperfusion
in series. This combination was highly efficient
in removing theophyllin and no saturation occured
during the rest of the treatment. Theophyllin
clearance fell from 200 mi/mm to 28 ml/min in
2 hours using resin hemoperfusion and from 196
mi/sin to 177 mi/mm using the combinAtion of
dialysis and charcoal hemoperfusion. Despite this
theoretical successful treatment the patient died
24 hours later with normal theophyllin
concentration but severe cerebral damage.
Conclusion: Severe theophylline poisoning should
be treated with a combination of hemodialysis
and charcoal hemoperfusion in series.
IRON PERIT0NEAL BALANCE AND SERUM FERRITIN IN PA-
TIENTS UNDERGOING C.A.P.D.
.]. ROTTEMBOURG, 3.Y MASCART, H. MEHAMHA, ].P. CLA—
VEL, M.C. JAUDON. Depts of Nephrology mnd Bioche-
mistry Hopital de la PhIL, PARIS — FRANCE.
In order to evaluate if CAPD induces an iron
deficiency and if patients required iron replace-
ment therapy (IRT) 22 patients (11 males, 11 fema-
les, mean age 56l6 years old) unergoing CAPD
treatment for a mean period of 17—10 months were
investigated.l5 of these patients have never recei-
ved any transfusion and 7 none within four months
before the study. No patient received IRT. Patients
were studied twice to four times at ten days inter-
val. Studies included hemoglobin, serum iron (SI)
transferrin, and ferritin levels. Peritoneal iron
excretion (PIE) and protein losses (PL) were stu-
died on 24 hours drainage volume. In 12 different
batches, iron levels in the inflow dialysate were
o.o6too2 Mmol/l. Mean results of 60 studies were
Ub 9.7—1.5 g%, SI l37:t4.4 Mmol/l,+transferrin 2.3
to.6 g/l ith a saturation of 25.7-11.8% and fer—
ritin 190—110 g/m1 (normal range 20 — 250 n/ml).
Mean PL were 9—4 q/da" and mean PIE was l4.B—B.4
umol/day. Iron excretion through urine out—put was
negligeable. In 5 patients with liver deficiency SI
was÷lower 8.Bt2 j.ijsol/1 (p0.Ol) with a lower PIE
6.9—5 jaol/day. During a peritonitis episode iron
excretion remained stable ll.6 6.5 tnol/day)
while the PL increased (15—5 g/day). A low iron
store was found i only three patients wish a low
ferritin level 35—8 ng/ml and a low PIE 8—4 umol/
day. Iron stores were normal in 19 subjects. The
study demonstrates that iron absorption from the
dialysate is negligeable but that iron losses
through the effluent could expose on a long term
treatment by CAPD to iron depletion. IRT is manda-
tory in patients with low ferritin levels.
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• VISUAL FUNCTION, BLOOD PRESSURE (BR) AND BLOOD GLU
COSE LEVELS (BGL) IN DIABETICS ON CARD.
• J.ROTTEMBOURG, P.BELLIO, K.MAIGA, F.
M.LEGRAIN. Hopital de la RulE. PARIS — FRANCE.
Over the last five years, 46 insulin dependent dia-
betic patients 24 males, 22 females mean age
52,3 13 yrs) were treated by CARD. At start of
CAPD extrarenal complications were severe including
retinopathy in all cases (6 blinds) hypertenslion
(94%) coronary (41%) or vascular (59%) diseases.
In 36 pta insulin was injected through the intrape-
ritoneal route, four times per day. Survival rates
were 85%, 63%, 57% at 1,2 and 3 yrs respectively.
The technique success rate at two yrs was 78% in i9
pta under 50 yrs mean age 39) and only 50% in 27'
pts after 50 yrs mean age 61). Visual acuity (VA)
was asseased at start and every six months. In the
younger age group (under 50 yrs) at start VA was
severely impaired (20/100 to 2O/'O) in 22 eyes and
moderately impaired () 20/50) in 16 eyes. During
CAPD, after a mean period of 18 months VA improved
in 10 eyes, stabilized in 21 worsened in 7. In the
older age group (over 50 yrs) 40 eyes could be stu.
died during a following period of at least a year
at start 26 eyes were severely impaired and .14 eyes
moderately impaired. VA improved in only 3 eyes,
stabilized in 26 and worsened in 11. BP was easily
controlled : systolic pressure decreased from 173
42 at start to 149 30 and 146 + 32 mmHg at j. and
2 yrs. 43 pts received antihypertensive drugs at
start, i4 at one yr and 3 out of 14 at 2 yrs. Dia-
betes too was easily controlled with fasting BGL at
+7.5 — 3.5 mmol/l and post prandial BGL at 8.5 — 3.5
mmolil. CARD offers to juvenile diabetics excellent
control of Br, the best control of BGL and the pos
sibility of VA improvement. In the older age group
CAPD offers to many diabetics the unique opportuni-
ty to be treated at home.
PERITONITIS (P) IN CONTINUOUS AMBULATORY
PERITONEAL DIALYSIS (CAPD) PATIENTS EVALUATION
OF INITIAL AMBULATORY TREATMENT WITH
CO—TRIMOXAZOLE (Co—I)
P. Ruedin, F. Louis, H. Favre.
Department of medicine, Geneva, Switzerland
Management of P in CAPO patients is still
controversial. Initial ambulatory treatment with
Co—I was evaluated in 32 patients, dialyzed with
an acetate bath (Hausmann, Switzerland),
presenting 79 episodes of P during a total CAPD
duration of 643 months, that is a 1,47
year—patient rate. Throughout the study, 28 % of
patients had no P, 59 % 1 to 5 P and 13 % had core
than 5 P. With the exception of 2 patients who
required hospitalization for fungal peritonitis
(total 15 days), all cases were ambulatorily
treated. 86 % episodes of P (68) were treated
initially with Co—T added to the dialyzate. 54,4 %
of these P (37) were cured, whereas the remaining
patients did not improve and then were given
appropriate antibiotics. In the responders, we
found the following bacteriology : exogenous germs
78 %, gram—negative bacilli 6 % and unknown germs
16 %. The non—responders presented a higher
percentage of gram negative bacteria 23 %
Escherichia coli, Pseudomonas aeruginosa,
Klebsiella pneumoniae, Proteus morganii and
unknown germs 10 %. Polyresistant germs and/or
fungus were found only in patients who received
antibiotics as first choice. In addition 3
patients on gentamicin developed long—lasting side
effects.
We conclude that initial treatment with Co—T
presents the following advantages : a) No
development of bacterial polyresistance. b) No
major side effects. c) Reasonable efficiency.
d) Inexpensive cost.
COMPARATIVE EFFECTS OF ACETATE AND BICARBONATE
HEMODIALYSIS ON LEFT VENTRICULAR PERFORMANCE
M. A. Ruder, M. A. Alpert, J. Van Stone,
(Introduced by Z. J. Twardowski)
University of Missouri-Columbia, Missouri, U.S.A.
To assess the comparative effects of hemodialy-
sis (ND) with acetate (AC) and bicarbonate (BIC)
base on left ventricular (LV) performance we per-
formed M-mode echocardiography on 36 patients
prior to and immediately following 4 hour main-
tenance hemodialysis (ND). Patients were ini-
tially dialyzed with the alternate base. Frac-
tional shortening (FS, %) was used to assess sys-
tolic LV function, and the peak systolic pressure/
end—systolic volume ratio (PSP/ESV) was sed to
assess LV contractility. In patients with low
pre-dialysis FS and PSP/ESV (n=1O), ND with BIC
increased mean FS from 23 1 to 35 2%
(p<O.0005) and increased the mean PSP/ESV from
1.67 0.10 to 2.68 0.11 (p<O.0005), whereas
ND with acetate increased mean FS from 22 1 to
29 * 2% (p<O.025) and increased the mean PSP/ESV
from 1.65 0.10 to 2.25 0.08 (p<O.05). In
patients with normal pre—dialysis FS and PSP/ESV
(n=26), ND with BIC increased mean FS from 36
1 to 40 1% (p<O.005) and increased the mean
PSP/ESV ratio from 2.96 0.24 to 4.78 0.31
(p<O.005), whereas ND with AC resulted in no
significant change in either hemodynamic vari-
able. Mean FS and mean PSP/ESV values obtained
after HD with BIC were significantly higher than
those obtained after ND with AC. We conclude
that ND with BIC produces a comparatively
greater improvement in LV systolic performance
due at least in part to an improvement in LV
contractility.
HAEMODIALYSIS WITH PROSTACYCLIN (EP0PROSTEN0L)ALONE
.
PB Rylance,MP Gordge,H Ireland,DA Lane,MJ weston
Renal Unit, King's College Hospital,LOfldOn SE5, UK
and Haematology Dept, Charing Cross Hospital,W6,UK
Heparinisation and platelet activation during
haemodialysis (HO) may exacerbate bleeding in a
patient at risk. Reversible platelet inactivation
by prostacyclin (PGI.) infusion offers the possibi-
lity of HD with plaèlet protection and without
heparin.
In 8 stable HD patients PGI2 (5ng/kg/min) was
pre—infused for 15 mm and dose titrated against
blood pressure (2.5—lOng/kg/mm) during a 4-hr di-
alysis without heparin, which was well tolerated.
In contrast to heparin-only HD performed in the
same patients, during PGI2-only HO there was a
small but not significant fall in activated whole
blood clotting time and activated partial thrombo—
plastin time fell from 35 to 30 sec (p<O.O5).
Platelet count fell by 9% (p<O.OOS) though this
as not significantly different from heparin HD.
8-thromboglobulin, a marker of platelet activation
was lower than during heparin HO, and was signif i—
cantly elevated above pre—dialysis levels only at
4 hrs, while Platelet Factor 4 remained unchanged
during PGI2—only HO. There was no significant
elevation of factor Vill—related antigen suggesting
endothelial protection. Whole blood platelet
aggregation was inhibited by 74%. Fibrinopeptide A
(FPA), an indicator of fibrin formation, however,
was markedly elevated during PGI2-only HO in 3
patients fibrin formation required the addition of
low dose heparin. In a separate study, combining
PGI2 with heparin prevented FPA generation with
reduced levels of heparinisation.
In conclusion PGI2—only HD gives platelet and
endothelial protection in comparison with heparin-
only HD, though the addition of small doses of
heparin is required to prevent fibrin formation.
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LOW MOLECULAR WEIGHT HEPARIN AS AN LTERNATIVE TO
UNFRACTIONATED HEPARIN DURING HAEMODIALYSIS
PB Rylance, Gordge,H Ireland, DA Lane, NJ Weston
Renal Unit, King's College Hospital,London, SE5, UK
and Haematology Dept. Charing Cross Hospital,W6, UK
Low molecular weight heparin (LH) is said to
have antithrombotic action with less risk of
haemorrhage, and to activate platelets less than
unfractionated heparin (UH).
We have compared LH fraction (Choay) with UN
(Leo) in 10 chronic haemodialysis (HO) patients
dialysed with 50 anti Xa U/kg boluses of each hepa—
rjn at the start of successive dialyses and moni-
tored for 120 mi UH prolonged activated whole
blood clotting time (aWBCT) at 15 mm to 149% (pre—
dialysis 100%) while LH produced no significant
prolongation. Activated partial thromboplastin time
(APTT) was prolonged to 395% by UN and to 134% with
LH (p<O.O0]) with equivalent anti Xa heparin levels
Platelet count fell at 15 mm both with UH (88.2%)
and LH (85.3%) but more so with LH at 60 & 120 mm
(p<0.O5)—thromboglobu1in, a marker of platelet
activation, rose progressively with both LH and UN
though elevation of Platelet Factor 4 was less with
LH (p<o.OS) possibly in part due to reduced
displacement from endothelium by LH. Factor VIII—
related antigen rose progressively with UN to 126%
but with LH there was a small rise only at 120 mm
(107%) , possibly reflecting reduced release from
endothelium. Fibrinopeptide A levels, a marker of
fibrin production, were consistently higher with
LH suggesting that higher anti Xa levels of LH are
required for effective anticoagulation.
Though the platelet count and 6-thromboglobulin
results during ND have not enabled us to demon-
strate reduced activation of platelets by LH, the
lack of prolongation of aWBCT and small prolonga-
tion of APTT may reflect reduced risk of bleeding.
INCREASED REMOVAL OF MIDDLE MOLECULES FOR THE
IMPROVEMENT OF SYMPTOMATIC HYPOTENSION DURING
HEMODIALYSIS
A. Saito, H. Naito, Y. Yainashita
Shinseikai Dai—Ichi Hospital, Nagoya, Kohnan Hospi-
tal, Kobe, and Yokohama Clinic, Yokohama, Japan
Symptomatic hypotension during hemodialysis
improves with conduction of hemofiltration.
Whether this results from the increased removal for
middle molecules or other factors is not clearly
understood. Using a new dialyser with remarkably
higher clearance for middle molecules compared to
conventional dialyzers, the frequency of hypoten—
sion was compared with conventional one. The new
dialyzer is Terumo TAF—lOW (regenerated cellulose
with a cut—off point of 35,000 dalton. The dialy—
sance for vitamin B12 is superior to Asahi PAN—l5
(PAN). In the gel chromatography with Sephadex G—
15 conducted for ultrafiltrate, the order of
removal for middle molecular fraction b (MW:l,000—
3,000) is TAF—lOW, PAN—15, B—l (PMMA) and TE—1OW
(regenerated cellulose).
Twenty patients who develops symptomatic
hypotension during hemodialysis too often with
Terumo YE—lOW made with the same material of the
same membrane area with TAF—lOW were transferred to
dialysis with TAF—lOW. Other dialysis condition
was unchanged. The frequency of hypoteasion of
systric blood pressure lower than 80 mmHg during
dialysis for each 3 months with the two dialyzers
was examined. The percentages of symptomatic
hypotension for TE—lOW 30.2 6.9% and one for TAF—
lOW, 12.3 5.6%.
Symptomatic hypotension was improved with intro-
duction of a new dialyzer of the same material and
area as conventional ones and of a significantly
higher removal for middle molecules (MW:l,000—
3,000).
SIGNIFICANCE OF HYPOXEMIA DURING ACETATE DIALYSIS.
Salvadeo A.; Segagni S.; Galli F.; Villa G. ; P09-
gio F.; Piazza V.; Bovio G.; Picardi L.; Groso-
ii M.*; Petrella E.*
Dialysis Dept., Fond. "Clinica del Lavoro", Pavia
* BELLCO Laboratories, Mirandola, Italy.
Some Authors hold hypoxemia during acetate
dialysis (AD) to be associated with peripheral
tissue hypoxia leading to intradialysis vascular
instability. A previous study showed that hypoxemia
follows hypoventilation mediated by CO2 loss across
the dialyzer (3O ml/min/sqm). Here we verified
how Pa02 decrease affects 02 transport and consump-
ti on.
Nine patients were studied during three AD. The
following were evaluated at dialysis start, after
30' and then hourly: Pa02 behavior (nunHg), satura-
tion Hb02%, 02 content (volume/lOO ml), Hb (gr/dl),
oxygen consumption (O2 - ml/min/sqm) and external
ventilation (E — l/min/sqm).
CO2 loss across the dialyzer and consequent
Pa02 drop (83÷9.7 to 75.2+8) does not cause
reduced Hb02% saturation, which remains constantly
around 93%. absorbed from alveolar air remains
constant even with reduced E, as seen by the
increased O2 /E ratio (39.2÷10.4 to 49.2+9.9).
Our clinical results indicate that reduced yE
and Pa02 do not affect 2 transport and consump-
tion; V02 and respiratory quotient do not change
significantly.
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REMOVAL OF ERYTHROPOIESIS INHIBITING FACTOR AND
IMPROVEMENT OF UREMIC ANEMIA BY PROTEIN-PERMEATING-
HEMODIAFILTRATION
A. Saito, H. Ogawa, I. Takagi, T.G. Chung
Shinseikai Dai—Ichi Hospital, Nagoya, Japan
Although inhibitor of erythropoiesis was under-
stood as small molecules, some authors recently
report large molecular fraction as the inhibitor.
In this study, ultrafiltrate obtained with a
protein—permeable filter (p—p—filter) was fraction-
ated to identify inhibitor of erythropoiesis.
Also, effect on anemia was examined by conducting
hemodiafiltration (HDF) with a p—p—filter as well
as with a conventional filter.
Sera of twenty dialyzed patients were added to
normal human bone marrow cell culture to make the
concentration at 10% and the effects on erythroid
colony—forming units (CFU—E) formation were investi-
gated. Furthermore, gel chromatography were
carried out on Sephadex G—l5 column for the ultra—
filtrate obtained from 5 patients treated byKuraray
C—2F of a p—p—filter filtering l2g of albumin per
HDF. Inhibition of CFU—E formation was examined
for each of 7 fractins obtained. Ten patients
receiving HDF with conventional filters (Hospal RP—
6 or Toray Bl—L) were transferred to HDF with C—2F
and data of pre—treatment and three—month after
treatment was compared.
85% of serum of 20 dialyzed patients inhibited
CFU—E formation. Significant inhibition of CFU—E
gormation was observed by gel chromatography in the
largest molecular weight fraction a (M.W. > 5,000)
of the ultrafiltrate. 10 patients of HDF, erythro—
cyte count, hematocrit and hemoglobin were signifi-
cantly higher with p—p—filter than with conventional
filters.
Improvement of anemia with a p—p—filter consid-
ered to be resulted from an increased removal of
inhibitor of erythropoiesis.
• NITRATES INDUCED ANENIA IN HOME DIALYSIS
• PATIENTS.
SrlvadoriM. Martinelli F. Comparini L.
Bondini S. Piccinini N. Sodi A. (momberEDTA
Dept. of Nephrology—Florence—Italy
Ten out of 40 home dialysis patients
suddenly showed a serious and, unusual sue—
mia.All these patients lived in Florence
and surroundig country and used charcoal
filters end softeners for the tap water
treatment.No unusual anemia. was shown by
other 15 home dialysis patients who used
demineralized water and by 120 patients in
hospital dialytic treatment who equally u-
sed demineralized water.All the 25 home
dialysis patients, affected or not by unu-
sual snemia,who used softeners showed me—
temoglobinemia and IIeinz bodies in the
blood.These are certain signs of I-lb oxida—
tion.Tap water's analysis were performed
and we found a dangerous nitrates excess
in all the town and surrounding country.
Chioramine and other oxidating compounds
were not found in any case.The softeners
were changed with demineralizators and the
clinical problem was solved.We obtained
a prompt increases of Ht,which in few mon.-
ths far overvielmed the preceedings stan—
dard values in all the patients.VJe think
that the increasing environmental degrada-
tion causes so a water pollution that also
strwtyof atbioW may be dange—
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• EFFECT OF EOSINOPHILIA ON THE HETEROGENEITY OF THE
ANTICOAGULANT RESPONSE TO HEPARIN IN ROT PATIENTS.
A. Santoro , E.Troithetti ,M.Casadei—Maldini ,A.Mazzuca,
E.Degli Esposti ,A.Sturani,A.Zuccalà,C.Chiarifli,P.
Zucchelli.
Dept. of Nephrology ,Malpighi Hospital, Bologna, Italy.
Plasma heparin concentration (HC),antithrombin
III (AT—Ill) ,plateiet factor 4 can be responsible
for the heterogeneity of anticoagulant response to
heparin in ROT pts.In order to determine whether the
presence of eosinophilia may be another factor in
interindividuaJ- variability to heparin response, we
studied 2 groups of ROT pts.Group 1 consisted of 7
pts with an eosinophil count greater than 500/me3
and group 2 of 7 pta with a normal peripheral eosi-
nophil count.All pts received,prior to dialysis, a
bolus dose of 70 U/Kg of heparin and HC,AT—III,acti
vated partial thromboplastin time(APTT)were measur-
ed at intervals to determine both heparin effect in
dex(HEI)and pharmacokinetic parameters as volume di
stribution,ha1f—1ife(t)) and clearance of heparin.
Prior to dialysis AT-Ill and APTT were similar in
group 1 and 2 (respectively AT—Ill 87.1 vs 88.5%;
APTT 31.7 vs 28.5 sec). There was no statistical
difference in heparin t1/2 (group 1 83.8±46.3 mm;
group 2 70.5±35.6 mm), but 1-El was significantly
lower in group 1 than in group 2 (206+117 vs 523+
244 sec/U/mi, p <0.001). These results indicate
that BUT pts with eosinophilia have a diminished
sensitivity to heparmn.This hyposensitivity might
be related to dialysis—induced eosmnophils' degranu
lation,with release of a major basic protein that
neutralizes heparin.
TREATMENT OF ACUTE TRILINE POISONING BY PL
ASMAPHERESIS AND HEMOPERFUSION.
P. Imperiali , E . Duranti.
Div.ne Nefrologia,AreZzo,Italia
TriUne cleaners contain various substa
nces such as chlorpropane,beflZefle and thri
chloroethylene,the principal component,whi
ch when intentionally or accidentally inge
sted,can cause serious and often deadly co
'nplicatiofls.
During the last year,three pts.were ada
itted to our hospital because of suicidal
acute triune poisoning;of these,two had be
en treated by a single plasmapheresis sessi
on and one by a combined plasmapheresis and
hemoperfusion session.
All recovered,but while the first two
pts.(females ranging in age from 17—23yra)
developed during the follow up a clinical
picture of hepatic necris;the last(a man
aged 28yrs),though having a history of her
oin abuse and HbSAg carrier,did not have
any complication with a quick achievement
of well—being.
In conclusion,the early treatment of ac
ute triune poisonings by plasmapheresis
appears to be a safe and effective procedu
re,but the combination of plasmapheresis
and hemoperfusion seems to increase the fa
vorable effectsand to accelerate the clini
cal recovery,preventing any toxic complica
tion.
• SODIUM Ac1CrATE, AN ARPERIAL VASODIL2YEOR: HEMODYNAMIC
.
EFFECIS IN NURMAL 1)3GB.
Monoel A.Saragoca;Angela M.A. Bessa;Rogrio A.Mulina.-
ri Sergio A. Draibe;Arlur B. Ribeixo;Oswaldo L. Rarmos.
Nephrologv—Hymertension Division.
Escx)ia Paulista de Medicina. So Paulo, Brasil.
The herrodynamic effects of sodium acetate (S1i)
have been inplicated in the hypotension during he-
rtndialysis. Its vasodilator action has been carac-
terized by mean arterial pressure (MAP) and total pe
riferal resistence (TPR) reductions, and cardiac
output(CO) incrnt, but its site of action is not
yet defined. To define if the action is artciolar
or venular dilatation or both, we studied 9 normal
dogs, infusing 4 graded doses of SP(.O34 to .300
rriEqjKg/min) .We determined MAP, 0) and TPR to confirm
the vasodilator effect, arid to evaluate the site of
action, also determined CPV,NTT' arid NPAP .From control
to the highest dose, MAP significantly increased
(106.9±4.5 to l19.9±6.4rrrnHg;p<.Ol),0D increased(l.5
to 3.43±.38l/inin;p<.0l) and TPR decreased (81.2
to 40.3±5.9AU;p<.0l). These were associated
with significant increases in CPV(206.78±23.48 to
247.1lr26.35m1;p<.Ol) and MPPP(14.3±.9 to 22.3±1.4
rrrnq;p<.Ol) and decrease in M'I'P(8.72±.76 to 4.56±
S3sec;p< .01). Our data show that marked increasein 0) and MAP, albeit reduction in TPR are induced
by SA. The increment in CPV and MPAP are consistent
with arteriolar vasodilatation and may be responsi-
ble for syrpathetic reflex activity, leading to
reduction in MIT, which denotes hyperkinetic circu-lation. The finding of increase in MAP, sugests a
stirrmiatory effect of BA itself accounting in part
for hyperkinetic circulation.
COMPARISON AMONG ACETATE HEMODIALYSIS , HEMO
FILTRATION AND BICARBONATE HEMODIALYSIS IN
THE TREATMENT OF PATIENTS WITH HIGH VASCUL
AR INSTABILITY.
M.Sasdelli,E.Vagnoli,D.BiZZaPri,P.ImPeriali
E . Duranti.
Div.ne Nefrologia,ArezzO,Italia
Six pts.(age from 44 to 63 yrs)with high
vascular istability,on maintenance hemodial
ysis for 5yrs(2—ll),were studied with the a
im of comparing the clinical and biochemic-
al effects of three different dialytic teco
iques.All pts. had been observed for simila
r periods(6-l2 months):the irst period on
acetate hemodialysis(AH)(lm cuprophan,dialy
sate=l4OmEq/l sodium);the second period on
postdilution hemofiltration(HF) (hemofilter
l.2m polyamide,fluid removed=26 1/session,
replacement fluid=l4OmEq/1 sodium);the thi-
rd eriod on bicarbonate hemodialysis(BH)
(lm cuprophan ,dialysate=39mmol bicarbonate)
For similar fluid removal amounts the in
cidence per session of symptomatic hypotens
ion episodes was 1.3±0.7 on AH,O.9+O.5 on
HF and 0.6±0.2 on BH.The fluid replacement
per session was 345±406ml on AH,244-f274m1
on HF and 176±238ml on BH.We did not find a
ny significant variation for biochemical pa
rameters during the three periods.
In conclusion,BH showes the less inciden
Ce of intradialytic complications in pts.
with high vascular instability.
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8—ENDORPFIIN SEHIJM LEVELS AND PAN DIALYZERS
V. Savica,G. Sellinghieri,S. Rotondo,I. Padovano,
G. Cost,F. Consolo
Istituto Pluridisciplinare di Clinica Medica e Tera
pia Medica Generale e Speciale, Istituto di Farma—
cologia1°, liniversità di Messina, Italia
We performed to study the role of dialyzers on
fI—endorphin serum levels,a protocol utilizing two
different membranes (cuprophan and PAN) among 8 pa-
tients, 4 males and 4 females, undergoing periodic
haemodialysis between 36 to 120 months.
We measured 13—endorphin and angiotensin serum le
vels before and after a four weeks cycle either
with cuprophan or with PAN dialyzers; every group
was himself control.
Our results showed that 8—endorphin serum levels
increased during the haemodialytic cycle with mem-
brane while decreased during PAN cycle withouth any
angiotensin serum levels increase. These data show
that the PAN dialyzers allow a 13—endorfin loss
through the membrane probably for its high cut—off;
we consider this important for a better management
of the orrnonal status among haemodialyzed people.
CUPROPHAN (Cp) IS NOT THE RESPONSIBLE ANTIGEN FOR
OIALYSIS—EOSINOPHILIA
E.—H.Scheuermann, I.Hauser, W.Ernst, W.Fassbinder
Dept.Nephrol., Univ.Hosp., Frankfurt, West-Germany
In about 2O?of patients undergoing regular dialysis
treatment (RDT) adverse immunologic reactions like eosi-
nophilia (Eo>500/mm3), IgE elevation (>20 lU/al) and -
more rarely— anaphylactic reactions are known to occur.
These symptoms have been attributed to single use of
ethyleneoxidesterilizedCp dialyzersby various authors.
To evaluatethepossibleroleofCpasirmiiunisingantigen
we conducted an open cross—over study, where Cpwas re-
placed by dialyzerswithan ethylen—vinylalcohol (eval)
membrane. The chemical properties of this recently deve-
loped membrane are completely different from those of Cp
and in addition the quantity of substances leachable from
it are less. Eval membrane is also said to be more biocom—
patible. lipatients (age 21-69y) dialysingon Cpmembra—
ne for 2—lI years participated in the study. Aftera con-
trol period (CP I) of 1 month dialysing on Cpmembrane the
patients were switched to eval for 3 months, followed by
arother control period mi Cp (CP II). Reuse was never per-
formed. To recognize t.he patients hypersensitivity status,
Eo and IgEwere determined weekly and datas upon compatibi—
lityof treatment were inquired at the end of each HD. Du—
ringCp I 9patients showed apersistenteosinophilia (
SD: 804±364) 10 elevated IgE (24l±326),8 patients showed
both symptoms. Afterchangeto eval, no influence on eosi-
nophilia (71,5±456) and gE (247±280) could be detected
and no improveme,tco dialysis dependent symptomswere
observed. During Cp II again no differences were
found.
We conclude, that Cp is not the responsible an-
tigen inciting the described immunologic reactions.
It remains open, whether the much smaller amounts
of various substances, which are still leachable
even from the eva) membrane, represent the respon-
sible antigens for the described phenomena.
DOUBLE SILICONE RUBBER IN—DWELLING VENOUS CATHETERS:
A NEW MODALITY FOR HEMOACCESS
H. Schanzer, S. Kaplan, S. Glabman, J. Bosch,
L. Nardi, L. Burrows.
The Mount Sinai Medical Center
New York City, U.S.A.
A variety of hemoaccesses are currently used for
hemodialysis. This report presents our experience
using double lumen silicone rubber in—dwelling cen-
tral venous catheters with a subcutaneous dacron
cuff. 15 catheters were placed in 15 patients through
venous cutdowns. A 10 cm subcutaneous tunnel was
created leaving the dacron cuff 2 cm from the ex-
ternal exit. 3 double lumen Hickman catheters [lumen
dia. (l.d.).6 mm], 10 Raaf catheters (l.d. 1 mm),
and 2 hemo-Raaf catheters (l.d. 2 mm) were used.
8 catheters were placed in the external and 7 cathe-
ters in the internal jugular vein. The tip of the
catheter was positioned fluoroscopically in either
the sueprior vena cava or the right atrium. The
double lumen Hickman catheters were used in l2hemo—
dialysis treatments. Mean blood flow (m b.f.) of
these treatments was 214.58 27.09 mi/mm. 77
treatments were done with the Raaf catheters with a
rn b.f. of 189.16 24.19 mi/mm. One of these ca-
theters thrombosed after the first treatment and
could not be used further. 28 treatments were done
using the hemo-Raaf catheter with a m b.f. of 247.32
7.87 mi/mm. Clearance and recirculation studies
demonstrate the efficiency of this hemoaccess. In
conclusion, these catheters offer a new, efficient,
painless modality for hemoaccess. The hemo-Raaf ca-
theter, having the largest lumen,provides moreeffi—
cient dialysis. The major advantages of this moda-
lity include the simplicity of the introduction, the
lack of serious complications, no sacrifice of major
arteries, no need for venopuncture and the poten-
tial for use in acute and chronic hemodialysis.
ROLE OF CONVECTIVE TRANSPORT IN HAEMODIALYSIS (Ho)
WITH HIGHLY PERMEABLE MEMBRANES (HPM)
M. Schmidt, C.A. Baldamus, W. Schoeppe
Dept.Nephrol .Univ.Hosp. Frankfurt, West—GermanyClinical benefits so faronlyseen in treatment modes
based on convective transport have recently also been re-
ported forHD with HPM. Differences to standard Cupropha-
ne HD have mainly been attributed to improved membrane bio-
compatibility. tbwever, the question arises,whethercon-
vection is rot the con-mon basis for improved symptomatology,
as it is believed for haemo- and haemodia-filtration.
To test this hypothesis, the contribution of diffusive
and convective transport to solute removal were invest i-
gatedatdifferent ultrafiltration rates (UFR) ,using asone
example for HPM thepolysulfonecapillarydialyserF6O. In
—vitrosoluteclearancesKs(inletQB=200ml/min, inlet
Q0=500m1/min) were (ml/min):
Urea Creatinine Inul in Myoglobin
K5 (UFR=O) 187 170 77 43
Ks (UFRIOOm1/min 197 191 134 85
Pressure profiles withinthedevice clearlyshow
f ilt ra t ion and backf ilt rat ion (d ialysate to blood) even at
zero net UFR, explaining the high clearances for largemole
Cu1es.
P.
B,in
= 83 mbar
'Bput
= 54 mbar
B,inDput = 3° mbar
BputD,in = —26 mbar
From these results, it is conceivable that clinical
benefits in haemodialysis with highly permeable
membranes are just a consequence of convective
transport.
.O,.,
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EFFECTIVE TREATMENT OF TJRAEMIC PRURITIJS
(UP) BY HAEMOPERFUSION (HP) IN PATIENTS
ON RDT
P.Schmidt, P.Balcke,L.Wagner,J .Zazgoraik
I .Med. Clinic,University of Vienna,Austria
Generalized pruritus is a common and se-
vere symptom in patients on RDT.Antihista—
minic drugs,parathyroidectomy and ultra-
violet phototherapy are of limited value
in the treatment of UP.Assuming that accu-
mulating uraemic substances could be in-
volved in the pathogenesis of UP a thera-
peutic trial with HP was done.
Between June 1981 and January 1984 in 10
chronic dialysis patients with UP resis-
tant to conventional therapy a total of 24
HPs (x 2.6 (1—6) per patient) were per—
formed.HP—procedures were done during dia—
lyss session for 3 hours each, a HAEMOC—
COL — cartridge being mounted between the
blood outlet of the dialyzer and the pa-
tient's venous blood line.
In 9 out of 10 cases UP disappeared or
markedly improved. Symptom—free intervals
lasted from a few days up to several
months.Recurrence of UP responded well to
HP in most instances.
From the data it is concluded that in UP
resistant to conventional treatment HP can
be recommended as an effective therapeutic
procedure. Efficacy of HP is possibly due
to the elimination of some uraemic toxins
not sufficiently removed by haemodialysis
treatment.
INTRAMUSCULAR IRON REPLENISHMENT AND REPLACEMENT
COMBINED WITH TESTOSTERONE ENANTHATE IN MAINTENANCE
HMODIALYSIS PATIENTS.
A. Schustak, D. Meshiah, Z. Waiss, L. Gotloib.
Dept. of Nephrology and Kornach Lab, for
Experimental Nephrology, Central Emek Hospital,
Afula - Israel.
Sixteen chronic uremics who showed exhausted
bone marrow iron stores and mean hematocrite values
of 20,9&4,2% at the time of starting maintenance
hemodialysis (HD) were treated by means of intra-
muscular iron dextran (IMD) (400 mg/month) for six
months. By the end of this replenishment period,
stainable bone marrow iron was observed and mean
hematocrite values increased to 27,24,9%
(P O,0O1). At this time, 200 nig. of IMD/month
and testosterone enanthate (1,5g/month) were
prescribed for the whole follow-up period (up to
8years). The observed mean hematocrite val'
'were up to 46,1'1,6%. Major side effects were not
observed.
The process of slow iron reabsorption from the
intramuscular injection site (up to 4 weeks) also
implies splitting of iron from dextran, therefore
preventing bone marrow deposits of iron dextran
complexes which make iron unavailable for
erytropoiesis. High doses of testosterone
enanthate can normalize hematocrite values of
maintenance hemodialysis patients with replenished
bone marrow iron stores.
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USE OF LOW MOLECULAR WEIGHT HEPARIN IN HAEMODIALYSIS
I.Schrader, 3. Rieger, H.MUschen, P,Kraj,er,
W.Stibbe, H.K'dstering, F.Scheler
University Hospital,Robert-Koch-Str.40, 34 G6ttingen, FRG.
Low molecular weight (1MW) heparin has been compared to
standard, unfractionated (UI') heparin in haemodialysis and
haemofiltration. In particular necessary doses and effects
on coagulation system and lipoprotein lipase (LI'L) were
investigated. At low doses the amount or 1MW heparin
required to produce a similiar bland heparin level to UI'
heparin was half that of the UF heparin dose, At higher
doses the blood heparin level rose sore rapidly with UI'
than with 1MW heparin.HighTy significant differences were
found in PTT and thrombin time between UI' and 1MW heparin.
I'TT was increased by 120 sec on average using UI' heparin,
whereas 1MW heparin only produced an increase of 5-7 sec
Throsbin time was increased by 230-250 sec under UI' heparin
and 5-8 sec under 1MW heparin. No significant differences
wece found in factor VIII activity and fibrin monomers
ruling out a difference in the activation of the
coagulation system by both heparins. Similarly there were
no changes in Quick's test, fibrinogen, antithrombin lii,
plasminogen, and 4'2-antiplasmin.LMW heparin alto produced
a significant smaller activation of IPI. resulting in a
reduced release of free fatty acids (FFA>.This must be
considered as an advantage of 1MW heparin since FFA are
involved in the development of arteriosclerosis, platelet
aggregation and displacement of protein bound drugs in
these patients.
In conclusion: On account of it slight influence on FIT
and thrombin time while retaining its antithrombotic
effectiveness it is probable that the bleeding risk with
1MW heparin will be reduced Further advantages of 1MW
heparin over U? heparin are to b found in the sadler
effect on platelets and fibrinclysis. LMW heparir would
appear to be indicated in dialysis patients with bleeding
risk, with diabetic retinopathy , on anticoagulant or
antiplatelet therapy and in those with thromcytobopenia.
MORBIDITY OF PATIENTS WITH ANALGESIC-ASSOCIATED
NEPHROPATHY AND END-STAGE RENAL FAILURE
SchwarzA, Pommer W, Keller F, Kuehn-Freitag C,
Offermann G, Molzahn M. (Intr. by M. Molzahn)
Department of Medicine, Steglitz Medical Complex,
West Berlin/FRG
In addition to special personality features,pa-
tients with analgesic-associated nephropathy (AAN)
also differ from other patients in state of mor-
bidity. In a cross—sectional study cf our hemodia-
lysis center (n=144), we examined a group of 48 pa-
tients with AAN (33%) and compared several aspects
of their morbidity with the remaining patient
group. Both groups were also matched for age and
duration of hemodialysis.
The results revealed statistically significant
differences between the patient group with AAN and
patients with other renal diseases (pats.with AAN
vs. controls, p<O.O5) with respect to myocardial
infarction (25% vs. 7%), angina pectoris (63% vs.
32%) , atrial fibrillation (21% vs. 4%) , arterio-
sclerosis obliterans of the lower extremities (52%
vs. 33%) , anemia (mean hemoglobin value 8.38+1.88
vs. 9.16+2.16g/dl), renal osteodystrophy (radio-.
logic signs, 67% vs. 41%; bone pain and myopathic
signs, 28% vs. 8%), carpal tunnel syndrome (23% vs.
7%) , peptic ulcers and erosive gastritis (54% vs.
23%) , colonic diverticula (15% vs. 4%) , and hemor-
rhoids (67% vs. 28%) . No statistically significant
differences were established with regard to hyper-
tension, peripheral polyneuropathy, tuberculosis
during hemodialysis, apoplectic insult, signs of
heart failure on chest film, ECC alterations, and
angiodysplasia.
We conclude that, even when matched for age and
duration of hemodialysis,morbidity is higher in AAN
patients than in those with other renal diseases.
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•HERPETIC VIRUSES INFECTION PREVALENCE IN REGULAR
.HEMODIALYSIS POPULATION (H). CONPARATIVE EVA-
LUATION WITH COILEMENT FIXATION (CF), INDIRECT
IlI1UNOFLUORESCENCE (IF), ELISA (EL).
Scolari F.,Nanca N.*,Sandrini S.,Cristinelli L.,
Prati E.,Turano A.*,Maiorca R.
Dept of Nephrology and *Inst. of Flicrobiology,-
Spedali Civili and University, Brescia, Italy.
Presence and titres of IgG(G) and IgM(M)
antibodies (Ab) anti-cytomegalo (CMV-G,M), herpes
simplex (HSV.G,M) and varicella-zoster (VZV.G,M)
viruses were evaluated with CF, IF, EL, in 50
patients on H. Anti-Hepstein Barr IgG (HBV.G
were also measured with IF in 26 patients.
The % of pts with "quantifiable' Ab and
titres geometric means were: CMV.G. : FC 30%-li,
IF 92%-161, EL 88%-2238; HSV.G: FC 76%-16, IF
100%-446, EL 94%-4160; VZV.G: FC 4%-Il, IF
60%-go, EL 58%-1795; EBV.G: IF 92%; Ct.IV.M: IF
10%, EL 10%; HSV.fl: IF 6%, EL 8%; VZV.r1: IF 0, EL
0. In 24 asymptoriiatic pts. a second serum was
tested: seroconversion was ascertained at 3
(12.5%) for anti-CMV, 2 for anti HSV (8.3%) 1 for
VZV (4.1%).
Conclusions. When tested with sensible methods
the prevalence in H pts. of CMV, HSV and EBV
infections nears 100%, VZV 60%. High levels of
IgG-spec.Ab and presence of 1gM-spec Ab and sero-
conversion in 6—10% of cases, all suggest con-
tinuous antigenic stimulation. Active infection
from CMV, HSV and EBV after renal transplantation
seems almost always to be a secondary infection.
.
EVALUATION BY MULTIPLE LINEAR REGRESSION ANALYSIS
OF THE ROLE OF BIOCHEMICAL AND HORMONAL FACTORS ON
THE BONE HISTOMORPHOMETRY OF UREMIC PATIENTS.
3L Sebert I Grégoire MA Hervé H Dkhissi M Gara-
bédian'A Fournier*CHU AMIENS_**HSp Necker,PARIS.
20 uremjc patients had bone biopsy coupled with
extensive plasma analysis. These patients had been
on hemodialysis or hemofiltration for 10—70 months.
Other treatments included Al(OH)3 in 17 patients
with a total cumulative dose of 100-6400 g, oral
calcium (.5—6 g/day) in 17, 25 OH D (5—30 Jg/day)
in 6, 1,L0H 0 (1 g/day) in 1. 18 patients had in-
creased osteoid surfaces, but none had increased
osteoid thickness and only 6 had increased osteo—
blastic surfaces (OBL.S). Osteoclast number was in-
creased in 16 and appositional rate (App.R) was de-
creased in 11. Multiple linear regression analysis
was used to evaluate the link between histomorpho—
metric parameters (and each of the studied plasma
parameters) (PTH, 1,25(OH)2 0, 25 OH 0, 24,25 (OH)2
D, Ca, P04, Bicarbonates, Mg, Al) when the influen-
ce of the others was suppressed by keeping constant
their plasma concentrations. Significant correla-
tions were found between 1) PTH and : OBL.S.
(r=.82, p< .001), osteoclast number (r=.74, p<.001)
2) 1.25 (OH)2 0 and 0BL.S. (r=.49, p<.05), Label-
led surfaces (LS) (r=.71, p<.0O1), App.R. (r.81,
p< .001), Bone formation Rate (BFR) (r=.59, p<.01),
3) Plasma P04 and : 06L.S (r.73, p<.O01), LS (r=
.39? p< .05), App.R. (r=.49, p<.01), BFR (r=.51, p
< .01). The results suggest that in uremic patients
PTH stimulates both osteoblastic and osteoclastic
populations but had no effect on osteoblastic acti-
vity which is mainly dependent on plasma 1,25 (0H)2
0 and P04 concentrations.
ORAL TREATI€NT OF CAPD PERIIDNITIS
N. Searle, G. Venkat Raman.
Wessex Regional Renal Unit, St Marys' Hospital,
Portsmouth, UK.
The efficacy of oral treatment with Cephradine
was compared to that of intra-peritoneal
Cefuroxime iq patients with CAPD peritonitis.
All patients presenting with peritonitis in a
one year period were eligible for the study.
Sixty-five episodes occurred in a group of 66patients over a period of +O2 patient months of
treatment. Seven were excluded (reasons to be
given) and 58 episodes were studied. Clinical
criteria divided this cohort into IN and OUT
patient treatment groups. After + rapid lavage
cycles the patients CAPD regimen was continued.
Within each group treatment was Cephradine SOOmgs
IN stat, SOOmgs orally + times daily, or
Cefuroxime 75Omgs IN stat, Y75mgs intra-
peritoneally/2L. cycle. Treatment was for 7 days.
Thirty-eight episodes were treated as OUT
patients and 20 as IN patients. Success of OUT
patient treatment was 58% and of IN patient treat-
ment was 65% (NS). Combined data from each group
showed Cephradine to be successful treatment in
66% of episodes and Cefuroxime in 55% (NS). Data
will be uresented to indicate equal severity of
episodes and effectiveness of treatment. Data on
culture results and sensitivities will be given.
Positive culture rate was 86%. Antibiotics
failed in 25% of cases overall, producing a cath-
eter loss rate of 1.26 patient months.
This treatment is simple, inexpensive and oro—
duces good compliance and avoids the possibility
of re—infection via the intra—peritoneal route.
We conclude that CAPD peritonitis can be effective.
ly treated as an IN or OUT patient with oral
Cephradine.
AN UNEXPECTED PHARMACOKINETIC PHENOMENON
OBSERVED IN DIALYSIS PATIENTS
K.—U.Seiler, M.Bröcker, D.Proppe*, II.Medi-
cal Clinic of Internal Medicine, *Dept.of
Nephrology, University of Kiel (FRG)
(introduced by W.Niedermayer)
In patients with end—stage renal insuffi-
ciency one would expect the rate of elimi
nation of a metabolically eliminated drug
to be unchanged whereas the concentration
of the metabolite should increase if its
excretion is only possible via the kidneys.
In our study of the pharmacokinetics of the
antirheumatic drug clobuzarit (c)- a so-cal-
led disease-modifying drug - which is com-
pletely metabolized into its glucuronide
and there upon liminated exclusively by
the renals, we observed in unusual pharmaco—
kinetic behaviour in dialysis patients:the
half-life of c was extended threefold com-
pared with the values in patients with a
normal renal function (3.5 days). The glu—
curonide of c was detectable in these pa-
tients as apposed to healthy controls. The
concentration of this metabolite constitut-
ed up to 30% of the concentration of c and
decreased parallel to the concentration of
C.- This phenomenon might be explained by a
regeneration of c due to enzymatic hydro-
lysis of theglucuronide conjugates in the
plasma by —glucuronidase. This hypothesis
was strongly supported by our further en-
zyme kinetic results. In these experi-
ments an enzymatic hydrolysis of the glu-
curonide conjugates in the plasma of these
dialysis patients could be demonstrated.
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NON-A, NON—B HEPATITIS (NANBEEP) IN }IEMODIALYSIS
PATIENTS (HDP). INCIDENCE, CLINICAL COURSE AND
RELATIONSHIP WITH BLOOD TRANSFUSIONS.
N. Simon ', A.N. Couroucd C. Jacobs '.
Centre Pasteur—Vallery--Radot * and CNTS ** Paris —
France.
The incidence and clinical course of NANBHep we-
re followed up prospectively over a five year pe-
riod in 158 HOP treated in one Centre and whose cu-
mulative time on treatment was 4610 patients (pts)—
months (mean/pt : 29 months, range : 1—60). Pts we-
re free of liver dysfunction at admission and of
hepatitis B during their time on treatment in the
Centre. 35 pts (22 %) developed NANBHep diagnosed
upon a significant rise of ALT levels together with
a concomitant elevation of S'nucleotidase and alka-
line phosphatase levels, in the absence of any
otherwise detectable toxic or viral cause. The an-
nual incidence rate of NANBHep ranged between 7,3
and 15,1 %. — Clinical symptoms were recorded in 17
pts (48 %). — In 29 pts (83 7) the disease followed
a protracted course with fluctuating ALT levels re-
corded for more than 6 months. No overt sign of he—
patocellular damage was noted. The yearly incidence
rate of NANBHep was higher during each of the five
year observation periods in pts who received more
than 0,5 blood units per month, than in those who
were less transfused. The influence of multiple
transfusions on the development of NANBHep was fur-
thermore analyzed in the 137 pts dialyzed in the
Centre for at least 6 months : NANBHep affected 50
% of the 22 pts who had received at least 8 blood
units within 6 consecutive months (range 8—31 unit
vs 21 of the 115 pta who received 0 to 7 units
over a similar period of time (X:11,4 p<O.OO1).
NANBHep in 1-IDP presents as a paucisymptomatic long
lasting liver disease, possibly mediated via blood
transfusions and whose remote clinical consequences
remain to be evaluated.
TENCKHOFF CATHETER (TC) VERSUS LIFECATHR
PERITONEAL IMPLANT (LPO. RESULTS OF A TWO
YEARS PROSECTIVE sy• 2 1A SIingneyer , B ranger , Oulès , M Marques , B
Canaud, A Balmès , C Mion 2 3A.LD.E.R. , Divisions of Nephrology and Surgery
University Hospital, Montpellier-NImes, France.
From 3an 82 to Dec 83, 64 TC (double dacron cuff)
and 57 LPI were implanted in 104 pts receiving either
IPD or CAPD. Cumulative treatment duration was: 58.1
and 36.5 yrs for TC and LPI respectively. A comparison
of the main complications observed with TC versus LPI
showed the following incidences (% values): dialysate
leaks 11 Vs 35; exit site infection 9.4 Vs 17.5; one way
obstruction 20.3 Vs 17.5; pain during dialysate infusion
20.3 Vs 0. IC surgical revision restored a satisfactory
dialysate drainage in 9 cases of one way obstruction
and relieved pain in 3 cases while one way obstruction
necessitated the removal of 8 LPI as revision was not
possible with this prosthesis. The incidence of peritoni-
tis was (number of episodes/pt treatment yr, IC Vs
LPI): 1/4.3 Vs 1/2.15 in IPD and 1/1.4 Vs 1/1.1 in
CAPD. In March 1984, 36 TC and 35 LPI were still
functionning; 11 IC and 10 LPI had been removed for
poor drainage, skin exit infection or pain; 17 IC and
12 LPI were lost because of patient death (11+6), tran-
splantation (1+2) or remission (2+2). Actuarial survival
at 16 months was 78% and 72% for IC and LPI respec-
tively. In conclusion, the main benefits of LPI were
pain suppression (particularly in IPD patients) and a
shortened drainage duration. However, these benefits
were partially offset by a higher incidence of post
operative dialysate leaks leading to an increased
frequency of skin exit infection and eventually to
peritoneal infection. Improving LPI design to facilitate
tight closure of the peritoneal cavity at time of LPI
implantation, should reduce these complications.
METABOLIC PROFILES IN CAPD DIABETIC PATIENTS
D.Spotti, G.Slaviero,°A.Cantaluppi, L.Monti, °C.Ca—
stelnovo, P.Micossi, G.Pozza.
Scientific Institute H.S.Raffaele, University of
Milan — °Department of Nephrology, Milan — Italy
24 hours metabolic profiles for blocd glucose
(BC), free insulin (Fl), lactate (La), butyrrate(Bu)
rxi glycerol (Gy) were carried out in 4 insulin-de—
oerrient diabetics who hed been in CAPD for more tham
6 months(group 1), in 4 noridiabetic uremic patients
aatched for age, sex arid duration of CAPD (group 2);
n 6 insulin-dependent diabetics treated with conti.
riuous subcutaneous insulin infusion (CSII)(group 3).
piring the study 4 daily dialysis exchanges with 7.5
/dl dextrose concentration were performed; insulin
in group I was aided to the bags.
'4BG was higher in group I than in group 2 and than
tn 6 normal subjects (p<O.Ol), but not different
from group 3. Mean Fl levels were higher in groups!
2 arid 3 than in the control group (p.O.OOl).In CAPD
patients (groups 1—2) plasma La and Gy levels were
higher (p<O.OOI arid p<O.OO5 respectively) arid Bu
Zevels were lower (p(O.OI) than io group 3 arid in
hormal subjects. BC was well controlled in CAPD
diabetic patients by intraperitoneal insulin edmini-
tration. Hyperinsulinemia in CAPD non diabetic pa—
ients reflects a continuous stimulus to insulin
secretion due to the glucose contained in the bags
pnd accounts for the low levels of Bu; high 0y le-
vels suggest conversely an increase of peripheral
Zypolisis in CAPD patients. The lactate absorbed
(rom the dialysis fluid may contribute to the highe
evels during CAPD.
STUDIES ON BACTERIOLOGICAL FILTERS (F) USED IN
CAPD
1 1 2A Slingenyer , F Stec , C Mion
A.I.D.E.. , Division of Nephrology, University
Hospital , Montpellier, France.Proliferation of bacteria on membrane of F used in
connecting devices (CD) for CAPD could contaminate
dialysis fluid with pyrogens (P) resulting eventually in
peritonitis. To investigate this possibility, we started a
prospective study of 100 F in 17 CAPD pts. The study
protocol include* 1/ P testing with Limulus assay
(LAL) (Pyrogent , Malinckrodt; detection level 12
pg/mI); 2/ F culture (C) done by infusion of liquid
Schaedler medium in F housing followed by incubation
at 37°C for 2-16 days. Protocol was done at time of
CD change realised by a nurse at the training centre
after either 14.3±3.3 days of use (group I: 50 F) or
28.3+4 days (group II: 50 F). LAL was found negative in
all samples tested. There were 37 positive C with 2
organisms in 8 and 1 organism in 29. Organisms were
isolated in F upstream chamber only in 29 cases and
from both upstream+dowstream chambers in 12 cases
associated with infectious peritonitis. Negative C were
more common in group I (70%) than in group II (56%).
Organisms were: Gram pos 77%; Gram neg 11.5%;
yeasts 11.5%. The most common organisms were:
Bacillus sp 19; Staph epid 6; Enterococcus sp 5; yeasts
3. In conclusion, positive C were found in 37% of F and
were not associated with P release in dialysis fluid.
The lack of P release in the presence of positive C
may be explained by a predominance of Gram positive
bacteria and/or by a limited load of Gram negative
bacteria. These results suggest the proven benefits of
using a filter in CAPD (ie. reduced incidence of peri-
tonitis) are not offset by the risk of dialysis fluid con-
tamination with P and that F use in CAPD is a safe
procedure.
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• THE BIOCARBONR VASCULAR ACCESS DEVICE FOR HAEMODIA—
.
LYSIS.
PJH Smits, DHE Lichtendahl, MJH Slooff.
University Hospital Groningen,Dept.of Surgery, head
Prof .Dr.P.J.Kuij jer.
The biocarbon access device is a promising tool
in secondary access surgery. Its main advantage ly-
ing in the fact that punctures, often the cause of
complications, can be omitted. This report compiles
our first experience with this new access deice.
From July 1982 until March 1984 16 Biocarbon shunts
were implanted in 11 patients (5 diabetics). Ages
ranged from 37—68 years. Mean dialysis period was
48 months (range 12—74 months). The mean number f
preceeding access operations was 8 (range 4—16). 13
straight grafts were placed in the upper arm and 3
loop grafts in the groin. No operative related mor-
tality was observed in this series. Mean follow up
time of all patients was 9 months (range 2—20
months) 6 thrombotic episodes were observed in 5
grafts. 5 could be solved by simple thrombectomy.
But at last 4 grafts had to be replaced because of
irreversibility of the thrombosis. Infection was
not a major problem and was observed in only I
graft and was treated by replacement of the biocar—
bon device. A steal syndrome was observed in one
graft although a successful banding of the arterial
anastomosis was performed this patient died a few
days later because of a myocardial infarction. This
initial experience with the Biocarbon shunt in se-
condary access surgery was favorable. Handling and
placement of the device was not difficult and pa-
tients and nurse compliance after extensive in-
struction was excellent.
TRASVENOUS SERIAL-XEROANGI OGRAPHY( TSXA) FOR
AV-FISTULAS IN HEMODIALYSIS PATIENTS.
R.Squerzanti,E.De Paoli Vitali,A.Farineili,
P.Mannella'G. HeneaR. Galeotti* (Italy)
Divisione di Nefrologia—Arcispedale S.Anna
*Istituto di Radiologia—Università,Ferrara
The survival improvment of uremics on ROT
may be limited by adverse anatomical condi-
tions of vascular access such as in elder,
in diabetic patients,eventuaily in polycys-
tic kidney and in several surgical revi—
sions.Previously, invasive angiography has
been relied upo for diagnosis of vascular
access compiications.In order to avoid the
side effects of the invasive fistulography,
an interesting technique more recent was
presented:the non invasive TSXA.Beautiful
pictures of AV-fistulas,of bone and soft
tissues are obteined,using Xerox 128—Casset
te changer,if 5Oml of contrast medium(370
mg I/ml)was injected(20m1/sec),by pig tail
catheter,in femoral or in controlateral an
tecuhital fosea vein.Indications for angio-
graphy in 20 HD-patients(mean age 57±l2yrs)
:pseudoaneurysm(25%) ,inadequate arterial
flow(20%),infection(20%),thrombosis(lO%).
In all cases TSXA shows angiographic pat-
terns of pathological lesions without side-
effects.Furthermore this method wich demos-
trates representative findings of perive—
nous fibrosis and of soft tissue infection,
may be specially helpful for surgica
procedures.
USE OF T1-E POLYACRYLONITRILE MEMBRANE IN
BIOFILTRATION TECHNIQUE
G.Splendiami,W.Valentini ,V.Aibano,R.Bamabei,
M. Tancredi.
Cattedra di Nefrologia Medica,Università de
LAquila,Italy
The polyacrylonitrile(PAN) membrane PN69 has
shown increased ultrafiltration with similar or
slightly better dialysis properties than cuprophan
expecially in the middle molecular weight range.
The introduction of the new PAN membrane AN69S
with high ultrafiltration and high diffusive clea-
rances offers the potential advantage of shorten-
ing treatment time. We have carried out a corrpara—
tive study on hemodetoxication performance aid
bioconpatibility(Bc) between AN69 end AN69S. Five
patients have been treated by AN69 dialyzer (3 hrs
thrice/wk) for 3 months. In 2 of them the MD was
performed with Biofiltration(BF) technique (3 it
of substitution fluid with Na l45Cl 45,HCO 100
mEq/i administred in the postdilution mode). Blood
biochcmistries,urea and creatinine clearances.
hemogasenalysis and Bc features wore evaiuatd.
The removal of middle molecules was determimated
by 1-PLO. The results showed that AN69S offers a
removal of smell and middle molecules better than
that of AN69. The Bc of the new membrane was corn—
parable with that of PN69. The use of BF improved
the corection of the acidosis afsr 24 and.48 Hrs.
In conclusion AN69S membrane used fey jD or DF
inrr-ies the detoxicatiori porii li s of PAN.
DOES CDRREXTI0N OF HYZINCA OF DIPLYSED PPTIENPS
INCREPSE lCTIVTY OF ZINC-DEPEMDENr TAUOENZT?
Stasinler, G., Klooker, P., Ectarner, J., Ritz, E.
Dept. mt. Med., University of Heidelberg, F1
It is controversial whether hypozincemia in uremicpatients reflects translocation of Zn into the intra-
cellular compartment (as in acute iase reactions) oi
true tissue level Zn deficiency. In veterinarian me-
dicine arid in humans (Kasarski, 1rn.J.Ciin.Nutr. 33,
2609,1980) the resçonse of serum alkaline phosjthata—
se (AP), a Zn-dependent metalloenzyme,to Zn reple-
tion is an accepted procedure to detect Zn deficien-
cy. In the present study, 28 hdialysis patients
without liver or bone disease with the lowernost pre-
dialytic Zn level (atomic absorption spectrophotc*ae-
try) were either given Zn supplementation in the dia
lysate (4(X) ig/l) or dialysed against no Zn. Plasma
Zn (2A), total serum P2 and the hepatic isoenzyne
(EP) respectively were measured 3 tines prior to,
once weekly during (6 weeks) and 2 weeks after Zn in
the dialysate. The acute effects of Zn administra-
tion via the dialysate were studied by measuring P2
before and after 3 dialysis each in the first week
of Zn. Plasma Zn in the run-in period was 0.76+0.11
rrg/l,increased to 0.95+0.1 in the + Zn and rerined
at 0.82+0.07 in the CX) group. Baseline P2 was 109+
24 IU. Mean intradialytic increase of P2 was +13.5%
in CD and +8% in +Zn group, presumably reflecting
hencccncentration. During Zn repletion, median P2 in
creased from 109+24 to 112+25 in i-Zn and from 109 to
113 in CX). P2 dreased inTh/14 of +Zn and 5/14 ofCD. It is concluded that Zn repletion via dialysate
with documented increase of serum Zn levels in ini-
tially hypezincemic dialysis patients causes no con-
sistent increase of P2 either acutely or chronical-
ly, thus causing doubt on existence of tissue Zn de-
ficiency.
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MYOGLOBIN: A POTENTIAL UREMIC TOXIN
V. Stefanovi, S.Strahinji, P. Miljkovi,
N. Leió, S.Kostiô
Institute of Nephrology, Faculty of Medicine, NiB
Yugoslavia
The aim of this work was to establish the level
of se.um myoglobin in different stages of chronic
renal failure (CRF) and the effect of herno— and
peritoneal dialysis upon its concentration.Twenty—
five patients with CRF of different etiologes,l2o
patients on maintenance hemodialysis, 5 acute
renal failure patients and 7 grafted patients were
studied.
An increase in serum myoglobin was found in
patients with an important reduction of GFR.Acute
renal failure patients without apparent
rabdomyolysis had also increased serum myoglobin
level. -Patients on maintenance hemodialysis had a
serum ayoglobin of 392±18 ng/ml, and urine
myoglobin of 236±20 ng/ml.Anephric patient and
patients with a low urine output had the highest
myoglobin level. Serum myoglobin before and after
hemodialysis did not changed. Cuprophane membrane
was found impermeable to myoglobin. Peritoneal
dialysis could remove an important portion of serui
ayoglobin. Comparison of pre— and post—peritoneal
dialysis serum myoglobin suggesta, beaidea blood,
some other importsnt poois of myoglobin. In
cadaver graft recipients an increased serum
myoglobin was found only in two patients with
markedly decreased renal function.
.
CARDIOVPSc'ULRR RtSK FACIO AND SURVIVAL IN HEM])IA-
LYZ DIABEI'IC PJTIENIS
Strumpf, C., Katz, F., Wing, T., Ritz, E.
Department Internal Med., Heidelberg (FI3) and
St. Thanas' Hospital, london (UK)
Survival of diabetics (D) on hdialysis (HI)) conti-
nues to be werse than that of non-D pat., primarilybecause of increased cardiovascular (CV) mortality.
In the present study in 17 German hiodialysis center
all urenic D (n=2(X); 69 type I; 117 type II, 14 non—
classified) entering HI) between 1976 and 1982 were
analyzed. Age/sex-matched non-D controls entering RD
at the same time were chosen fran available records.
History of hypertension, angina pectoris and ampsta-
tion; RR, LVH (EKG), vision, fundoscopy, poises,
heart size (X-ray), S-cholesterol at entry were eva-
luated. Actuarial survival at 12 in. was 74% in D(89.1 in Co) and at 3 y. 47% in I) (75.1 in Co). Docu-
merited history of hypertension for 5 years was a
strong predictor of cardiovascular death (odds ratio
2.4 and 3.4 in type I and II rsp.: 0.9 in Co). RR <
160 mg at entry diminished CV risk (OR 0.3 in type
I and II rsp.; 0.4 in Co); conversely,RR>160 xnnlg
increased OR (3.7 and 4.0 in type I andiirsp.; Co
2.5). Impaired vision did not adversely affect CV
risk in type I (OR 0.4) - no parallelism between mi-
cro- and macrovascular risk in type I — but in type
II (4.0). Absent perierai poises increased OR in
Co (5.2) nore than in type I (2.1) or II (1.5). Hy—
percholesterolenia and snoking had no dttistrable
effect on CV. Concanitant history of hypertension
and hypertension >160 mHg at itry irreased OR to
5.0 in type I and 6.2 in type II I), but nich less so
in Co (2.1). It is concluded that hypertension is
nore detrimental in D than non-I) on HD and is the
single nost important CV risk factor in I) on HI).
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THE APPEARANCE of DEPRESSIVE REACTIONS in
REtAON to PERSONAL! STRUCTURE of PATITS
on BCDIALYSIS
Lj. Nilo.avljevi6, V. £trahiti6, J. Zdravkoviã
Mental Care Center and Inst. of N.phrolo and
Henodiai.ysis, Ni', Yngoal via
During the reaearoh work done on 30 dialye.d
patients, two hypotheses were proposed. One was
that patients with the combination of introvert
character and high neurosis would react more
oftn depressively than thom. whose character
was extrovert and wb,o were less n*urotic. The
other one wag that depressive react ions appeared
in tha begining stages of dialysis, during the
first six months. -
m.nchov'a two-dimensional scale for -personalityi
estit and Hamilton's scale for depression
meaauraent were used.
The research work showed the results sup-
porting the two hypothesis stated, that I.
that introvert, neurotic characters were more
pron. to depression during the first six months
of dialysis than the othsr characters of
diel.ys.d patients.
- PROPIIYLAXIS OF HEPATITIS B IN A DIALYSIS CENTER
S.Sua,R.Pantovié,B.Dumovié,D.Cibin
Clinic of Nephrology,Military Medical Academy,
Beograd,Yugoslavia
Together with strict isolation of HBAg positive
patients,aingle use of dialyser from Gambro,rigo—
rous general hygienic measures we have applied
in the last 5 years Aunativ(Human immunoglobulin
anti—hepatitis B,Kabl AB,Stockholm) as a preven-
tive meaure.The prophylaxi.s was applied in 80
patients applying intramuscularly Aunativ 1250 IU
every three months.It was given also to staff
working in rooms for HB5Ag positive patients as
a preventive measure.Howevar,ln the case of acci-
dental innoculati on,especially conjunctival inno—
cu].ation the staff was given Aunatlv within first
hour or i8 hours latest.After a month the same
dose of Aunati.v 1250 IU was repeated.Slde effects
in the form of local reactlon,general reaction and
hypersensitive reactions were very rarely found,
being not more than 9% in our patlents.After se-
veral hours or 2—3 days they completely disappe—
ared.Shock after Aunativ application was not ob—
served.We consider that together with application
of general preventive measures Aunativ has a great
Importance in prevention of acut hepatitis B.
With such measures within the last 5 years in our
hemodialysis center no case of acute hepatitis B
was detected in our staff and patients.
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ArfIU0iJIS AGAINSf IN PAT1iNTS
AND STAFF 01? T:IL TLICIAL K1DiJY UNIT
A. zepielowsKi, I. Szeecsyk, u. Adaniioc, U.
Imbs, Is. 1asiak, W. Weyde
Ueportmeiit of Neplirology ,•,iedicul Acadesy—roclaw
and beportaent of Virusolugy State institute of
nygiene—WarszaWa PoluiidIn 7 curonicaily dialised ,utients, 5 per—
eons of the artificial kidney unit staff and
persons working at the goiieral vaid, nti—C.V
antibodies litre by iC tost has been stated. The
presence at antibouies zinc been stated in 5j of
patients, 6O ci' artificial kidney unit staff
and in of general waru tff.
in patients the rate of anli—C.V antibodies
apjeorance increased according to the prolonga-
tion of dialysotherapy. It was essentially with
the quantity of transfused blood /p(U,02/, riot
with the duration of dialysotherapy connected.
An essential correlation between the FC test si—
zo and the quantity of transfused blood /pO,u2/
has been stated. Dn a one and a half year obser-
vation the anti—Cr.IV aiitibudies in one half of
the seroriegutive patients nave been eta ted being
evidente of the prinary CN infection. in a
quarter of sero,ositive patients at least a four
fold increase of FC test has been observed being
an evidence of secundary infection. iioth, pritea—
ry and secundary infection have osen essentially
connected with blood transfusion /p<O,U2/.
In artificial kidney unj I staff the C test
ws stated to be cunsiderably higher than in the
general send staff. No any temporary trend has
been showu. in a group of 22 persoiis of arliii—
cml lzidnoy unit stl1 b3jug under .ne and a
sear observation, one person bus developou tire
CV I nbc lion. Thus a oore prove lent C. :v juice—
ti on nag iii the erlificiul kidney unit aiu[i
tlruti in the cnet'uL ward staff can be sttod.
PLATELET LIFE SPAN IN UREMIA
.
H. Tanaka, K. Urninioto, N. Izumi, K. Nishimoto, T.
Maekawa, T. Kishimoto, M. Maekawa (Intr. by S.
Nakagawa).
Dept. of Urology, Tadaoka Municipal Hospital
Osaka, Japan
Although platelet dysfunction in uremia is well
known, how the platelet is damaged has yet to be
determined. In this study, platelet life span was
measured in uremic patients undergoing different
treatments.
Platelet cyclo—oxygenase is completely and irre-
versibly blocked by oral administration of acetyl—
salicylic acid (ASA) . Platelets formed after the
disappearance of the effect of ASA have normal
ability of cyclo—oxygenase. The serial measure-
ments of malondialdehide converted from arachidonic
acid through peroxide by cyclo—oxygenase indicate
the time necessary to restore it to the pre—ASA
value. It can be regarded as platelet regeneration
time and indirect platelet life span. Malondialde—
hide was measured by modified Stuart's method.
Platelet life span was 10.3+1.0 days for healthy
volunteers (N=7), 6.7±1.0 daysfor hemodialysis
patients (N=l3), 8.0±1.5 days for CAPO patients
(N6), 5.0 & 4.9 days for non—dialyzed uremic
patients (N2), respectively. The former three
groups had statistically significant differences.
These results indicate that platelet life span
in uremia was significantly shorter than that in
healthy volunteers which is improved by blood puri-
fication. CAPD patients had the longest platelet
life span among uremic patients. It is suggested
that 2 to 3 times a week of extracorporeal circula-
tion in hemodialysis affect platelet life span and
that CAPD is better from the aspect of platelet
function.
IN VIVO VITAMIN Bi 2 MASS TRANSFER STJDIE IN A CU-
P1)PHAN STAMDARD DIALYZER SHC PRmXTIINANCE OF DIF-
FUSIVE SOLUTE REfJVAL IN THE MIDDLE MOLB2ULAR RANGE
W. Szpirt, P. Gimsing and B. Nielsen, Dept. of Neph
Hvidovre Hasp., Nedical Dept. C, Gentofte Hosp.,
University of Copenhagen, Copenhagen, Denmark.
The cormnnly accepted theory of convective trans
port in the middle molecular weight range, introdu-
ced by Babb & Scribner, is based on the in vitro
studies, where vit. B12 was used as a marker. In vi
vo studies were difficult due to B12 plasma binding
proteins. We have succeeded to saturate 90 - 95 %
of B12 binders by giving 1 mg cold B12 i. v. 15 mi-
nutes before 5 — 8 uCi of 57Co Bi 2 as a tracer was
introduced at the dialysis start. All plasma counts
ware corrected for the bound tracer fraction, which
can amount up to 50 % of the total count as the
free B12 is removed during consecutive dialyses.
Furthermore a method for collecting B1 2 frc the
dialysate was developed by elution through a XAD 2
resin column. Clearance measurements were perfor-
med as prescribed in NIH 77.1294 and our studies
of 2 flat plate and 1 hollow fibre type Cuprophan
dialyzers suprisingly showed no influence of ultra-
filtration on B12 renoval, whereas highly positive
correlation to blood flow was observed. We conclu-
de, that plasma protein polarisation could be res-
ponsible for these findings, as they were not al-
tered by dialyzers geaitry, which could be expec-
ted if masking of the membrane on the support was
the reason. Furthermore in vivo B1 2 sieving coef-
ficients obtained during sequens dialysis differ
significantly frcn the in vitro measured, thus it
should be avoided to extrapolate in vitro dialyzer
performance to clinical conditions. The theoreti-
cal mathematical expressions of clearance give
overestimated values, which are not in agreement
with the actual observations - Dialysate clearance
results should then be prefered.
AATIBODY—DLPENDENT /ADCC/ AND SPONTANEOUS
/NK/ CELL—IiIEDIAThD CYTOTOXICITY IN
REGULARLY DIALSED PATIENTh ITH CHRONIC
NAL FAILURE /CRF/.
I.Taraba and I.Lng
Serameiweis University Budapest, Hungary
Cell mediated cytotoxicity may play a
role in the immunological defense mecha-
nism. Therefore we investigated the ADCC
and NK activity of 19 patients with CRF
treated regularly either with hemodialysis
/HD/ or peritoneal dialysis /PD/. 30 he-
althy individuals served as control group.
ADCC was investigated by the method of
Perlmann and Perlmann. NK activity was
evaluated according to the niethod of
Jondal and Pross.
The postdialytic ADCC and NK activities
were significantly higher than the corres-
ponding predialytic values in both groups.
Comparing th predialytic ADCC activity of
the P /30,4—9.4/ arid the H]) treated group
/15,7—1,7/, the difference was significant
The PD treated group's activity did not
diffe from the average of the controls
/30,4—2,5/. There was also a significant
difference in the predialitic values of
the N activity of PD treated group +
/25,3—5,9/ and H]) treated group /12,3—1,01
It is likely that the cellular defense
mechanism is more effective in PD treated
CRF patients than in the H]) treated group.
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• DIRECT INTERACTION BETWEEN POLYNORPHONUCLEAR NEIl—
TROPHILS (PMN) AND CUPROPHAN MEMBRANES IN A PLASMA
—FREE MODEL OF DIALYSIS.
C.Tetta, A.Jeantet, G.Camussi, A.Thea, L.Gremo, P.
F.Martini, R.Ragni and A.Vercellone (Intr.by A.Ver
cellone).
Laboratorio di Immunopatologia, Cattedra di Nefro—
logia, Divisione di Nefrologia e Dialisi, Ospedale
S.G.Battista—Molinette, Torino (Italy).
The role of activated complement components has
been established in the pathogenesis of the neutro
penia associated with hemodialysis (ND) using dia—
lysers with cuprophan membranes. However, comple-
ment activation may be not the only factor respon-
sible for this phenomenon. The release of media—
tors(platelet—activating factor(PAF) ,PMN cationic
proteins(CP) and leucotrienes)is known to occur
when PMN are incubated in vitro with cuprophan mern
branes.
In this study, purified,plasma—free human PMN
in Tris—Tyrode's buffer, pH 7.2, with 0.25% bovine
serum albumin were circulated for 1 hr through a
hollow fiber dialyser with cuprophan membranes in
the presence of standard dialysate fluid (at 37°C).
At different time intervals, we studied: 1) the ki
netics of PMN aggregation by aggregometry,2) the
presence of PMN aggregates in the dialyser capilla
ries,3) the release of PAF,PMN CP,lactoferrin,lyso
zyme and lactic dehydrogenase,4) the binding of
PMN CP, lactoferrin and lysozyme to the dialyser
membranes. As early as 10 mm after the start of
the circulation,PNN were stimulated by the cupro—
phan membranes as they released mediators with a
high PMN aggregating activity. Numerous PMN aggre-
gates were observed to be entrapped in the dialy—
ser capillaries and to be firmly attached to the
membranes.
BONE SC1N1IGRAPHV(&S)A1V ALUMINUM TOXIC1TV(ATxL).
C.TLe2eman4,F.Co!2a'vt,R.Wen4,J.SmeyeA4V. Ve'bee!en'
M.V'xt(Ivit&.by P.Vveetxaeten).
H5pLtDl B'wgmann and AZ°,Bu44e4,BeLgA.wn.
VuJtJng £at yea-,we ct44e44ed The A ta,tw6 o
owt haJnocUo2y4L4 patLevt6 (NV pt6) by a iiowtLne de-
e&o,amLne Lnw)1on tei(VFO te4) :4e/wJn M. wa
mea4wted by ameLei,.4 atoriiLc ab4otptLon 4pecThopIw-
tomeJcy b ote(bA)and 48 (v ae)pAL)a 50 rng/!zg
VFO £n4Lon and The dLe,'tenee(Af Lnc'Lement)wa4
eaLauLated; pkf and Af -Lnctemen-t have been 4 howvt to
eoJvtt.,fate wLth bone AL eonten,t. In a piTevLouA 4tady
£n a £axge NV pojw1LatLon we oand a wea!z £nve'4e
eon te2a.tLon betiA'een BS(FogeLman'4aote,FS)and pAL
and AL LncAeinent(2n<.O5) .To eoniSAm The LnLaenee
o A.LTx on BS we p1to4pee,tLveLy 4tuctLed The evo!u-
tLon o FS and VFO -te, £n 24 NV pt a,t a one- yean.
£ntexvaLThtee pts had been &L e6wLLy Theated by
VFO dwzLng The 4Thdy ion. 4yn1ptomatie AL bone cU4ea-
4e;The AL 4ta-tu4 had £rapitoved Ln 4 oThens,p'wbahLy
a a eovveqaence °6 AL(OH)3 Lncthe 1teductLon whLLe
Lt had won ened £n 14 and temaJ.ned unehanged Ln The
3 oThen.O)e oand an -Lnv,te eo'ute&ttLon between
The voJuLo.tLon(t)o FS avid epAL(2n<.O1,it-.S62)and
AL Lnc mevvt(2ct<.O1,'t- .549) .FwThekmoite,a n.Loe o
pAL wa 6LgLieavttLy 44ocLctted wth a decAea4e o
FS)ahL 4quwe te,t,2a<.OO1,4ee Tab'e)
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COMPARISON OF BLOOD GASES MID ACID—BASE
PARAJETERS IN BLOOD AND UITRAFILTRATE
H.Thieler,H.Baufeld, W.Preibsoh,L. Senf
Medical Soliool,Erfurt, GDR
Introduced by K.Preoht
With the use of small ultrafilters in
front of and behind dialyzers for conti-
nuous monitoring of substances the questi.
on arises,whether ultrafiltrate also
reflects the blood gases and blood acid—
base status.
In 10 chronic dialysis patients during
isolated ultrafiltration using hollow f
bre artificial kidneys (cellulose acetate
membrane) blood from the arterial line
and ultrafiltrate from the dialyzer was
drawn at the same time,both under anaero—
bical conditions.An automatic blood gas
analyzer was used for the tests (AVL 940/
Graz). blood ultrafiltrate
P0 (kPa) 11.8 0.9 13.1 1.3PC 2 (kPa) 4.9 0.3 5.1 0.3
pH 7.49 0.02 7.44 0.04
H (nmol/l) 32.8 1.8 36,1 2.9
BE (xnmol/l) 4.0 1.7 1.3 1.8
BB 49.4 1.4 43.0 1.
HCO3 " 26.9 1,8 25.2 1.
TOO " 28.0 1.8 26.4 t 1.7
ifferences between parameters in
blood and ultrafiltrate can partly be ex-
plained by the absence of proteins in u1—
trafiltrate (plasma water).
There ist a parallelism of blood and
ultrafiltrate values of P0,PcO2,pH,H',
Standard
,
xcess,Buffer
Bases and Total C02.So it seems possible
to infer the blood status from ultrafil—
trate measurements — using correction
factors for some parameters.
BONE SCAN(BS)IN VIALYSIS(NV)PATIENTS(PL6) :RELATION
TO NVPERPARATHVROIVISM(HPTN)ANV AL TOXICITY(ALTx).
C.LcieLeman4,R.CUen4,F.CoUWut,J.Smeyvi4l.Van Noo,
G.Ve Roy,P.Be&gmann,V. Veithee2enM.V'aiua(InTh.by P.
Vtjteen4Thaeten).
HôpLtaL Bwgmann and AZ,B/tw44,BeLgAunI.
BS oyten 4how4 Lncea.4ed iAotope upta!ze -Ln NVpt bwt exact &LgnL7SLcance /eniaLn4 debwted.To c-
WvmLne -the po44LbLe Ln7&tenee o NPTH and ALTx on
99m-TcBS,4e'uLm PIN and AL LeveL4 beo'te(bAL)and 48
hito a7tvL(pAL)a dee-'w,carnLne Ln4Lon(VFO,50rng/fzg)
we&e rnea4wted at The -thne o BS.Miong aLL The 4tu-
d-Led ptA (g'toup 1,n=37)we dentLLed AL £ntox,Lea.ted
(ALl,g/tottp 2,n—24)and non-ALl pto)g/wup 3,n=13)thLs
wa done on The ba.oLo o The VFO-Lnduced 4e/Lum AL
LncAea4e(AL,22Oiig/L -Ln g/toup 2,<150 Ln 3)w(vLch £-6
lznown -to eonjteLa-te wLth bone AL eonten-t.ThL cLa4 -
4L{eaLLon wa4 eoniJtmed by 4pee-LLe 4taJJvLng o
bone tL64te 4peeiJlen4 son. AL Ln The l6p o goup
I and 5 o gtoup 3 Ln whom Lt was pvto'uned.B4 wene
4eo'ted 4einL-qaantLtatLveLy(Fogefran'4 4COJte,FS).
Paxa,ne,te)t noniaL g'toup 2 goup 3 2 v 3
FS 4 5.1(1-12) 6.5(3-12) N.S
FSE2)n pt6) 6 0
bAL (gIL) . 1 88.4+20,5 39.4'-12.9 p.0O1
pAL (p.IL) 486.641.3 138.820.5 p<.OO1
tAL (g/L) 380.2T36.2 99.412.1 p<.OO1
PIN (pg/rnfl 65—630 1258101 1243121 MS
SAP (lUlL) 65-230 453.3186.1 350.591.2 MS
FS wa eonAeZa.ted dLkecLLy wi..th PTH -Ln each
gkOLLp)2n<.OOI -Ln 1 and 2,<.O5 Ln 3)and Lnvekhe2y
wLth pAL and AAL Ln g'oap 1(2n<.05).AL Leue-L4 we/te
not eonjte,Lceted with PIN no aikaLLne pho6pha.ta4e
(SAP) ,no-te waite SAP wLth FS.
In eoncLwsLon,BS and PIN axe no-t d exev,t £n
ALl and non-ALl pt4;howeveit ALTx deoJtecAe4 FS and
vvty Low FSL2)4eeJn ven4 MLgge6tLve o ALT.HPTN £4
a44oe-La-ted wLth ghex FS,whateva't The AL 4ta,tu4.
iJwJLea4ed! anchartgeddecxea4ed
ox txalzaLLne pho4phata4e.
Thws,an agxavatLon o AL ove'iLoad(a.e44ed by
VFO teot)-Ln tiP pt4 £6 a64oca-ted wLth a Lowex-Lng
o,S FS and
-LnveMeLy.
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• REV BLOOD CELLS INDICES (RBC I) AND AL TOXICITV(Tx(
.
IN HAEMOVIALVSIS PATIENTS (I-iD PL6).
C.Tnans, L.KcL&via, F. CofaAL,R.0n4,J.Snleyve4°,V.
Vvtbeen,M.V'.axt(lvtt'l. by P.Ve&traeten).
HöpLLa.L B'wgmann and AZ°,Biru&seL,BeLgium.
MAaitociyLLe, hypoclhiwrn.Lc. anatimLa Ls a atWe o
/eveke At. Tx.To deLeoL a po.LbLe LnLLenc.e ot AL
on RBC I Ln a geneaL HP popwLct-tLon,we pkoetLve-
Ly tadLed -the evotLon o -these pcurwnete&4 -n 30
HP pts a-t a 6 to 12 rnon-th 'wa. VwrJng the ta-
dy,3 p-ts were eAsLt.y tMated by de/LocJ1vLne
(VFO) o'r AL bone dLsea.se; the 27 o.thees einALnedkee o AL Tx. 4ymptorivs.Pts who deveLoped 4y5-tentC
LneeLLon,bt.eecUng o& had 4u/Lge'Ly,-Jon Ok v-tcJn.Ln4
de1LeLenay we're excltaded. Howeve'r,-tiranwe€on wa
S-tLLL peit,o-'tmed when haemetocir- (HeL) eLt < 25%
(0-3 anLts panNed RBC/mon-th) .AL a-tLtd wa-s asessed
by a 'VFO'teíit:svwr,i At was nieaswred (atoln-tc
absonptLon specJjtomet&y) beoke (BAt) and 48 I-yr-s
ate'r (PAL) a s-tngeL 50 nip/lag VFO Ln(wsLon and ;the
d.Leirence wa caLcLuLALed (PAL). AL LeveLs we're no-t
aavreLctted wAth Hct, haemogLomLn (Kgb), MCV, MCH
and MCI-IC bwt the vwtAa-tLon (z) Oj PAL and PAL
duALng the pkospee-tAve s-tady was -Lnve'r-seLy co/r-'re-
La-ted wih iMCV (Zcz<.01) and INCH )2c<.O01); AMCV
and sMCH we're aLso covteta-ted toge-thvr (2o<.OOl).
FtALhe.'rnio're, pLs wLth PAL> 180 vg/t had a toweir MCH
than the o-the'r-o (28.2÷0.5 vs 30.4÷0.6, p.O5)
wmLch 1aLed -to be the case o'e MCV (87.4÷2.3 vs
91.9÷1.5, NS).
TIese nd-Lngs suggest Lha;t At -LnmLbLt-i Hgb syn-
thasLs even Ln HP pts wLthowt AL Tx syrnp-toms. At.io,
-Ln -the absence o L'ion d Ls-Lency, a atL -Ln MCV
and MCI-I Ln a given pt rnu-t 'raLie the posbtty
o At ove.rtoad.
MILD ALUMINIUM BURDEN INDUCED BY Al (OH)3 DECREASES
BONE FORMATION IN UREMIC PATIENTS.
MTolani, P Morinière, IL Sebert, MA Hervt, P Leflon
A Fournier. CHU AMIENS — FRANCE.
20 urernic patients on chronic hemodialysis (HO or
hemofiltration (HF) had bone biopsy for histomorpho—
metry and aluminium (Al) content determination, cou-
pled with extensive plasma analysis. These patients
had been on HO or HF for 10—17 months, The Al con-
centration (HF) fluids had besn repeatedly found
less than .3 and .6 uM/l, respectively. Other treat—
tnents included Al (OH)3 in 17 patients with a
total cumulative dose of 103-6400 g, oral calcium
.5—6 g/day) in 17, 25 OH 0 (5—30 ug/day) in 6, 1.DH
p (1 1jg/dsy) in 1. 18 patients had increased osteoid
surfaces (OS), but none had increased osteoid thick-
ness and only 6 had increased osteoblastic surfaces
(OBL.5). Dateoclaat number was increased in 16 and
àppoaitionnal rate (App.R.) was decreased in 11. All
patients had Al overload with increased bone Al
content and 17/20 had increased plasma Al, Only 2
had histochemical traces of aluminium. Using multi-
ple linear regression analysis, which allowed to
suppress the influence of all other simultaneously
studied plasma parameters (PTH, 1,25 (OH)2 0, 25 OH
0, 24, 25 (OH)2 D, Ca, P04, Bicarbonates, Mg) by
keeping constant their plasma concentration, signifi
cant correlations were found between plasma or bone
Al and OS (r=.63, p<.OO1), OBL.S (r=—.62, p<.01),
Labelled surfaces (r=—.39, p<.O5), App.R (r=—.39, p<
.05)), Bone Formation Rate (r=—.4O, p<.D5).
Conclusions The results suggest that mild Al over-
load, not severe enough to cause osteomalacia,de—
creasej'osteoblastjc population and activity, and
reducebone formation in uremic patients.
EVALUATION OF THE FACTORS POSSIBLY INFLUENCING THE PLASMA ALUMI-
NIUM INCREASE INDUCED BY Al(OH)3 LOAD.
M._Tolani, Ph. Morinière, A. Fournier, M.A. HervS, J.F. de FrS—
mont, P. Leflon. CHU 4MIENS, HOpital Lariboisière, PARIS—FRANCE
Al(OH)3 administration was discontinued for 7 days in 7 pa-
tients on hemodialysis and 11 patients on hemofiltration. Then,
their predialysis plasma concentrations (P) of aluminium (Al)
(inductively coupled plasma emission spectrometry), phosphate
(P04), calcium (Ca), bicarbonate, magnesium (Mg) and PTH44.68
were measured before and after a load of Al(OH)3 of 24 g in 2
days. Their P 1.25(OH)2D was also measured before the load. The
load induced a significant (p<.D1) increase in PAl (-.54umol/l)
and decrease in PPO4 (-O.56pmol/ll. Although the decrease in
PPTH was not significant, the changes of PAl and PPTH were nega
tively correlated (r—O.66). Multiple regression analysis (MRA)
was performed in order to assess the link of potential influen-
tial parameters on the percent increase of PAl such as PTH, P
1.25(OH)2D, PBicsrbonate + Mg and duration of treatment, age,
sex, body weight. Significant link was found with decreasing
influence with PTH (negative), P04 (positive), djration of
treatment (negative) and PBicarbonate (negative). No link was
found with the other factors and when the above analysis was mw
de again keeping P 1.25(OH)2D constant, the previous results ww
re not affected. MRA was also performed in order to assess the
link between the above parameters and the basal values of PAl.
Significant link with decreasing influence was found with PTH
(positive), P04 (negative), b5.:arbonate (negative), djration of
treatment (positive). ND link was found with the other factors
CONCLUSIONS
1/ Basal PAl which probably reflects aluminium release from
tissues, seems to be increased by PTH and duration of treatment
and decreased by hyperphosphatemia and alkalosis. 2/ PAl per-
cent increase from basal value during an Al(OH)3 load seems on
the contrary to be decreased by PTH and duration of treatment
and increased by hypmrphosphatemia and seems to be similary
decreased by alkalosis. 3/ P 1.25 (OH)2 0 does not seem the
influence PAl.
DESFERRIOXAMINE TEST PREDICTS BONE ALUMINIUM BURDEN IN UREMIC *
PATIENTS BUT NOT HISTOLOGICAL OSTEOMALACIA. M TolaniP Morinière
F Van de Vyver P Fohrer,P Leflon*,JF de FrSmont", IL Sebmrt,
C Lambrey*,A Marié*,MDebroe A Fournier*.CHU AMIENS _*Uni_
versität Ziekheus Ant werpen — BELCIQUE.
To evaluate the value of the desferrioxamine infusion test
for the prediction of bone aluminium and the histological diag-
nosis of osteomalacia, we performed,,in 14 patients on chronic
hemodislysis and 12 patients on chronic hemoflltration (not ex-
posed to high aluminium in the dialysateor the reinfusion fluid
but taking Al(OH)3,a double bone biopsy after tetracycline label
ling as well as a measurement of their plasma aluminium before
and 44 hours after the IV administration of 2 g of deaferriosa—
mine (Deaf). Bone aluminium was also measured and histomorpho-
metry performed on undecalcified sections. In spite of the fact
that the bone aluminium content was greatly elevated in compari-
son to that of non urernic cadaver (.6±.1 umol/g versus .O7±.04
ymol/g), aluminium staining showed only traces of aluminium in
2 patients. No florid osteomalacia with increased osteoid thick-
ness was present. However 16 cases had decreased apposition ra-
te and/or decreased active mineralization surfaces (OM) in cnn—
trast with 10 cases with only pure hypsrparathyroidism (HPT).
Comparisons of these 2 groups showed no significant difference
am regard Al parameters
Mean SEM Pure HPT 01.1
Basal P aluminium umol/l 2.2+.5 1.4±.4
L( PAl Desferrioxamine umol/l 2.7+.5 2 *.3
_Bone aluminium umol/g O.66±.1 0.55±1
Bone aluminium was better correlated tojPAl Desf (=.15fIPA1
Desf±.2 r = 0.78,p<.01 than to basal PAl (r=.49, p<.05).
Conclusions : 1/ Although Tj PAl Deaf was well correlated to
bone aluminium, it has no predictive value for the histological
diagnosis of mild osteomalacia in patients esposed only to the
risk of oral aluminium intoxication in whom severe osteomalacia
with increased osteoid thickness is absent. 2/ BOne aluminium
does nnt either predict histological osteornalacia.
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GLYCEMIC PROFIL.b OF DIABETIC PATIENTS ON EL) • LLE
OF GLUCOSE BALANCE, Q)F4CENTdATION (F COW ThAREGUL
TORY HOiWE3 AM) TYPE OF UIALYSATE•
P. Torrabadalla, R. Perez Garcia, F. Ana, E. Jt.z,
00, fr • Vasconez, F. Valderrbano.
Hospital Provincial do Madrid. Spain.
Glycemic control is specially difficult in ure-
mia patients on maintenance K.) arii this may accourt
in pert for the poor prognosis of these patients.
In order to investigate the possible causes of
this difficult control we have studied 3 insulin—
dependent diabetics during 9 H) sessions with dia—
lysatos containing 1.5, 2.0 or 2.5 g/l of glucose
and with acetate or bicarbonate as buffer. We mea-
sured glucose, Na, , Ca, insulin, glucagon ,growth
horwone GH), dopemine B hydroxilase LOGH), corti—
aol and ACTH before, during and after H) .9 am, 1
pa and 0 pm of the same day)and on next day (9am
and a pa) .Dia].ysate salutes end total volume were
measured and balances calculated.
Glucose balance showed a linear correlation with
the difference between dialysate glucose and pa-
tient's glycamia before {)• At B pa, 7 h. after I-fl,
a significant rise in glycemia from 210 + 24 to
303 35 mg/dl)waa observed in all patients. bt
on next day (224 at 9 am and 203 at B pn)without —
I-I) and with the same diet and insulin edministra—
tion. This profile appeared with bicarbonate as
well as with acetate dialysate. An aditional dose
of insulin after H) corrected post H) hyperlica—
mis, making easier the post I-fl control. There was
a sicyniicant (p<O.Ol)fa).l of plasma GH lavels af
tar I-I-) • Cortisol rythm W5 almost suprossed. The —
glyccwnia/insulinemia ratio rose roni 04 (at 9 am)
to 176 ug/uU (at B pa)suggesting a rnodiI'ication in
the poripheral resistance to insulin, that may con
tribute to the changes in the glycemic profile.
KINETICS OF RADIOACTIVE IODIDE (1311) TRANSPORT
DURING INTERMITTANT PERITONEAL DIALYSIS (IPD) AND
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD).
Z.J. Twardowski, L. Janicka, A. Tarkowska, H.
Jankowska.
University of Missouri, Columbia, Missouri, U.S.A.
and Medical Academy of Lublin, Poland.
Radioactive iodide is decoupled in the body af-
ter the injection of tagged albumin. This iodide
is transported into the peritoneal cavity indepen-
dently of albumin.
In 7 patients iodide transport was compared dur-
ing 2 IPD sessions, the first immediately follow-
ing the intravenous injection of radiolabled albu-
min and the second 48 hours after the injection.
The same measurements were performed during 4 days
of CAPD in the same patients.
Serum free iodide counts constituted 2-7% of
the total counts in IPD and 2-11% in CAPD. Dialy-
sate free iodide counts constituted 33-65% of the
total counts in IPD and 63-80% in CAPD. During the
first IPD, the iodide clearance rose from 8.1 to
18.8 ml/min within 8 initial exchanges (EX)and re-
mained stable thereafter. The clearances fell from
27.2 to 18.7 mi/mm within the same number of EX
during the second IPD and remained stable there-
after. Iodide clearances remained stable at 5.1
el/mm throughout the entire period of CAPD.
The results indicate that the iodide transport
from the intravascular space to the peritoneal
dialysate may be markedly delayed in spite of the
small molecular weight of the substance. High
iodide clearances in early EX at the second IPD
may reflect the "washout of iodide transported
between dialyses into the peritoneal cavity and
the extravascular space adjacent to the peritoneum
or decoupled in situ from the accumulated tagged
albumin.
KINETICS OF ALBUMIN TRANSPORT IN INTERMITTANT PERI-
TONEAL DIALYSIS (IPD) AND CONTINUOUS AMBULATORY
PERITONEAL DIALYSIS (CAPD)
Z.J. Twardowski, L. Janicka, A. Tarkowska, H.
Jankowska.
University of Missouri, Columbia, Missouri, U.S.A.
and Medical Academy of Lublin, Poland.
In spite of longer dialysis times, CAPD is con-
nected with only slightly higher albumin losses as
compared to IPD.
To explain the mechanism of this phenomenon we
measured radiolabeled albumin levels in plasma and
dialysate during 4 days of CAPD with 3 2.5 L ex-
changes (EX) per day in 7 patients. The measure-
ments were repeated in the same patients during 2
IPD treatments every other day with 2 L hourly EX
for 22 hours.
Percent of the initial specific radioactivity
in the serum was similar during IPD and CAPD (50
vs 48 at 24 hours and 30 vs 30 at 72 hours). During
the first IPD, immediately after radiolabeled albu-
min injection, the albumin clearances rose from
0.37 to 0.85 ml/min within initial 13 EX. During
the second IPD, 48 hours after the injection the
clearances fell from 1.44 to 0.85 mi/mm within the
same number of EX. The clearances remain stable af-
ter the 13th EX. During CAPD the clearances rose
from 0.10 to 0.19 mi/mm within 24 hours after the
injection and remained stable thereafter.
The results indicate that albumin transport from
the intravascular space to the peritoneal dialysate
is delayed for several hours and continues after
the cessation of IPD filling the peritoneal cavity
and an extravascular pool adjacent to the periton-
eum with large amounts of albumin. The washout
of this albumin during the first half of IPD yields
extra albumin losses compensating for the shorter
dialysis time as compared to CAPD.
CH.&NGB OF THE INHIBITION FACTOR OF LYM-
PHOCYTES MIGRATION IN DIALYSED PATIENTS
N.Ursea,Ro:xana Cristian,D.Capa,G.Mir-.
cescu ; "C.Davilla" Hospital — Bucharest
ROMANIA
Previous data have shown a significant
increase of gastririemia in patients with
chronic renal failure , dialysed itera-
tively compared to normal subjects.We
have tested the gastrin effect and the
serum of dialysed patients on the lympho-
cytes migration from dialysed and from
normal patients.In conditions of medium without anti-
gen the lymphocytes migration area from
dialysed patients hasn't been significan
tly changed compared to that from normal
ones.
In presence of the gastrin an inhibi-
tion of lymphocytes migration oocured in
normal as well as in dialysed patients.
The inhibition of lymphocytes migration
in dialysed patients was significantly
increased compared to that obtained from
normal subjects.
In presence of the serum from dialysed
patients (autologous and homologous) has
been also stated a significant increase
of the lymphocytes migration inhibition
from healthy and from dialysed patients.
The obtained data suggest the involv—
ment of the gastrin in the stimulation
of cell immunity by the possible action
of certain receptors of the lyphocytic
membrane.
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Immunological monitoring in haelodialysis IHD) patients before and
after vitaiin e suppleientation.
Casciani C.(J.. . , Taccone-6allucci H., Piazza A., Lubrano
R.e, Monaco P.1., Ausiello C.. Spagnoli B., Bandino D.*. Biardini O.w
Clinica Chirurgica 11 Univ. of Rome, I Clinics Pediatrica I Univ. of
Rupee, Italy.
Vitamin E (sit. El is an antioxidizing agent playing an igortant
structural role in bioIgica1 eembranes. Oral nit. E supplementation
in huaan5 results in decreased bactericidal activity of leukocytes.
Controversial data are reported about the effects on cell mediated
immune responses. Our previous results indicate that HO patients hav
an increased consumption nf cit. E as antioxidizing agent. Effects of
Joil parerteral vit. E supplementation )tocophery1 acetate —
mg/div for 14 days) on a pane) of immunological test (1.1.) were
ntjdied in IA HI patinntn. The following 1.1. ware performed 15 days
before (TA), the daf before the beginning ITI) and the day after the
withdrawal (12) cit. E ad.inistration total IT—RFC) and active
(ARFC) rsetts forming cells, T - lymphocyte subsets (OKT 3+, 01(1
4+. 01(1 8+1, 14/19 ratio, MK activity and PHA biastogenesis. No
significant ariationn of 1.1. were observed in the 18—TI interval.
filer nit. E sapplementtiun 1.1. results showed a significant
decrease ci e 4 — RIC (yf 0.01) and the 81(1 8+ cells number )p(
0.1(2( and a sutoequent decrease of 14/TB ratio (p 8.82). These
results aifht be due to tho antinidizing effect of it. Eon the
ectabo!iso f oruchidnni acid, which plas a role or meebrane
.cturo and yrostanlaudins sfnthnsv.
PiN ADAPTED REtYrILIzATIc* TFfllNI(JE FOR PP 2400
DThLYSER.
.J.M. Vandenbroucke, A. Stragier and
Ypersele de Strihou. University of
edical School, Cliniques Universitaires
Bruxefles.
Successful reutilization techniques have to be
adapted to newly designed dialysers if adequate
results are to be cbta.thed. In 1983 we presented
data on the performance of reutilized PP 2400(Hospal) flat plate dialysers, characterized by a
new design and a nore perrieable PAN rreirbrane,As these results were disaointing the
reutilization method was adapted as follows.
Iiwadiately after restitution of the patient'sblood the dialysers are rinsed with 2° Chl
hypochlorite solution during 5 minutes and stored
in this solution for a further 20 hours. Eff i—
ciency of each dialyser is then autasatically
maasured and formalin 2 % substituted for hyx,-
chlorite until the next use. Performance charac-
teristics of the dialyser were assessed prior to
each use by measuring the changes in conductivity(Vanderibroucke et al. Abstract sutenitted at this
meeting). Only dialysers of at least 90 % of the
original value were retained up to a maximum of
10 uses.
Out of 34 dialysers 19 renamed efficient after
10 uses (with a mean reduction in urea dialysance
of — 6 %); 3 failed the efficiency test after the
10th use, 2 were discarded at the 9th use due to
a membrane leak and 10 failed the efficiency test
after a mean of 5.9 uses (range 2—8).
We conclude that the PP 2400 can be safely reused
up to 10 t:iis with the described reutilization
technique.
AUIATIC MEASURU4ENTS OF DIALYSEPS' DIFFUSIVE
CHABACPERISTICS. J.M. Vandenbroucke, A. Stragier
and C. van Ypersele de Strihou. University of
Lzvain !dical School, Cliniques Universitai.res
St—Luc, Bruxelles.
Reutilization of dialysers (D), undertaken for
econanic reasons, should not be detr3rental to
the patient. Efficiency of the reused U should
thus be monitored. We have previously shown that
measurements such as ultrafiltration capacity,.
blood carparbient volume and flow resistance are
not adequate for this purpose in flat plate U.
We have devised an autanatic technique measuring
directly the D's diffusive capacity : after the
blood restitution phase, Na hypochlorite (2° Chl
at OB 200 ml/min) is dialysed in counter cur-
rent fl with deionised water ((i) = 500 ml/rnin)
at 100 nnnug P. A-V change in [NaJ is measured
by conductivity (cond). In vitro studies have
indeed shown an excellent correlation between [Na
hypochloritej and cond. (r = 0.99; in = 16).
During a two-year period we have validated this
method on reused plate D. The A-V fall in conduc-
tivity across the dialyser (Is coed.) was carpared
with the urea clearance (UC) determined subse-
quently. Overall correlations were excellent (PP
610 — Hospal r 0.90, n 87; Sll — Travenol r0.98, n = 16; PP 2400 — Hospal r = 0.90, in 44).Cxncasional discrepancies between both parameters
were ascribed to the fact that the cond. deter-
mination augmented D performance. To test this
hypothesis we have measured simultaneously Is cond.
and UC using Ned rather than Na hypochiorite
with urea in the test solution. Agreement between
both measurements was excellent (r = 99).
Conclusion : changes in conductivity measurements
provide a very accurate control of dialysers'diffusive characteristics.
A LOW WHITE BLOOD CELL (NBC) COUNT IN PEBITONEAL
DIALYSATE: A RISK FACTOR FOR BACTERIAL PERITONITIS
(BP) IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
(CARD)
J. van der Meulen*, H.A. Verbrugh**, P.L. Oe*,
J. Verhoef.
* Free University Hospital Amsterdam
**Academjc Hospital Utrecht, The Netherlands.
BR is the single most important complication of
CARD. However, not all CAPD patients get BP, where-
as some get recurrent BP. To find out whether a
lack in the local defense of the peritoneal cavity
exists in patients with recurrent BR a prospective
study was started. Perit.oneal dialysate effluent
(POE) was examined serially every 2—3 months after
the training period. Only CARD patients observed
for at least 3 months were analyzed. POE was ob-
tained irs BR—free episodes only i.e.no peritonitis
in the previous 2 weeks. The following data of lo-
cal defense against BR were collected: total number
of NBC and differential count, IgG level, C level
and opsonic activity against St.epidermidis(OA).
Twelve CARD patients fulfilled these criteria
covering 93 patients treatment months (Pm). From
these patients 5 never had BR, observation period
314 PI1'l. The remaining 7 patients had 10 BR episodes
(1 BP/5.9 Pm).
POE Pat.without BP(n5) Rat.with BP(n7)
NBC 10 /1 0.6—100 med 2.5 0.1—13 med 1.3*
IgG g/l 0,03—3.79 med 0.15 0.02—2.19 med 0.10
g/l <0.01—0.02 med <0.01 <0.01—0.03 med 0.01
* p <0.05 Mann—Whitney rank sum test
The differential NBC count revealed significant-
ly reduced number of peritoneal macrophages in BR
patients. Thus low PDE NBC count may predisposeCAPD patients for BR.
C. van
Louvain
St—Luc,
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SERUM FREE 14 AND FREE 13 LEVELS IN PATIENTS WITH
SEVERE RENAL FAILURE
F.L. Van de Vyver, P.P.G. Blockx, M. Verreyen
University of Antwerpen, Antwerpen, Belgium
Serum total thyroxin (TT4), total triiodothyro-
nm (TT3), and free T4 (FT4)levels have repeatedly
been reported to be subnormal in clinically euthy-
roid chronic hemodialysis (CHD) patients.
We measured 114, TT3, 13 uptake (T3U), thyroxin
binding globulin (TBG) levels in 36 CHD patients
and in 34 patients with severe renal failure not
requiring dialysis (SRF). The following ratios were
calculated with these parameters: 1T4/T3U, TT4/TBG,
TT3/T3U, TT3/TBG. Also, FT4 and free T3 (FT3) were
measured prior to heparinization, using direct
methods (Amerlex FT4 and FT3).
Percentages of CHD patients showing abnormally
low values for these parameters were 33% for 114,
31% for TT4/T3U, 11% for TT4/TBG, 39% for FT4, 39%
for 113, 39% for TT3/T3U, 25% for TT3/TBG, 56% for
FT3. Percentages of SRF patients showing abnormally
low values were 0% for 114, 0% for TT4/T3U, 0% for
TT4/TBG, 11% for FT4, 25% for TT3, 14% for TT3/T3U,
8% for TT3/TBG, 50% for FT3. Spearman rank correla-
tion coefficients wereRs=0.76 for TT4/T3U versus
FT4 in CHD and Rs=0.90 in SRF. Correlations were
Rs=0.92 for TT3/T3U versus F13 in CHD and Rs=0.83
in SRF. The ratio of FT4/FT3 was elevated in 28% of
CHD and in 50% of SRF. A few patients were tested
first during SRF and later in CHD and showed a
decrease of all parameters.
These results suggest that total as well as free
thyroid hormone levels are more frequently
decreased in CHD than in SRF, that Amerlex FT4 resp
FT3 are closely correlated with the accepted free
thyroid hormone indices (1T4/T3U resp. TT3/T3U),
and that the conversion of 14 in 13 is more often
reduced in SRF than in CHD.
IS UBEMIC MORBIDITY MORE RELATED TO BUN THAN TO
MIDDLE MOLECULE CLEARANCE ?
J—L. Vanherweghem, P.A. Gevenois, M. Dhaene,
J—C. Stolear, M. Goldman, V. Ninane, C. Thayse.
Erasme Hosp., University of Brussels, Belgium.
Assessing the adequacy of dialysis remains a
matter of debate.We compared thus the morbidity in
our heniodialysed patients(P) according to predialy—
sis BUN levels on one hand and to calculated middle
molecule clearance(MMCresidual creatinin clea—
rance—CrC—+ vitBl2 clearance of the dialyser) on
the other hand.P with systemic diseases or with CrC
above 3 mi/nun were excluded.Fifty—one P incorpora—
ted in a same dialysis schedule were studied during
a foliop—up of 6 to 30 months(900 months/P).Analy—
sis of the data were conducted following two ways:
analysis A compared P with BUN115±12 mg/di(n=26)
to patients with BUN85±9 nug/dl(n25) while analy-
sis B compared P with 4C=37±8(n26) to P with MNC
16±5 l/week(n25).In analysis A both groups of P
had comparable 14C as well as in analysis B both
groups of P had similar BUH.The following items
were recorded:CrC,age,sex,veight,deaths ,hepatitis,
pericarditis ,bacterial infections ,gastro—duodenal
diseases,days of hospitalization,iPTH ievels,motor
nerve conduction velocity ,blood pressure ,hematolo—
gic values ,number of transfusions .Among all these
items ,only the need in transfusions was higher in
P with higher BUN(214.8 vs 14.Luunits/P/year,p<.OO1)
for similar heinatocrit.Lower T4C was associated
with a significant higher morbidity(2.12 vs 1.33
recorded complications/P/year,p<.05) as well as
with more days of hospitalization(15.5 vs 5.31P/
year,p<.OO1).
In our experience global morbidity was thus more
linked to the loss in MMC than to BUN levels,
except for the need in transfusions.
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IS THE REDY CARTRIDGE AN IMPORTANT SOUNCE OF
ALUMINIUM IN CHRONIC HEMODIALYSIS (CHD) 7
F.L. Van de Vyver, P. D'Haese, A.B. Bekaert,
L. Boone, H. Thomas, M.E. De Broe.
University of Antwerpen, Antwerpen, Belgium.
In vivo experiments. Two CHD patients not re-
ceiving desferrioxamine (DFO) and two CR0 patients
who had received 2 g DFO after the foregoing dialy-
sis were each studied twice during an acetate Redy
dialysis. At 30, 60, 120, 180, 240 mm, aluminium
(Al) levels were measured in the dialysate before
(A), and after (B) the Redy 3160 cartridge and in
the Redy machine reservoir, and in the serum of the
arterial and venous lines. Arterial blood pH was
measured concomitantly, while the dialysate pH was
monitored Continuously (before the cartridge).
Ac = (dialysate flow)x(A—B)/A were 6+65 al/mm
without DFO (19 measurements) and 91+140 mi/mm with
DFO (n=19). The gradual increase of dialysate pH
was accompanied by an increase of B for all patients
and by a decrease of Ac in the DFO—treated patients.
Conclusions. Without DFO no significant Al re-
lease from the Redy cartridge. With DFO Al removal
was observed.
Bone aluminium. Two patient groups were studied.
All had been treated with CHD in the same area,
either with Bedy (group A, n=1 , months of dialysis
63±16) or with conventional methods (group B, n7,
months of dialysis 61+40). Al levels in bone were
23+12 .ug/g wet tissue in group A, and 19+11 .ugjg in
group B. The incidence of Al osteomalacia was com-
parable in both groups.
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ABSENCE OF A BENEFICIAL HEMODYNAMIC EFFECT OF
BICARBONATE VERSUS ACETATE HEMODIALYSIS
R.Vanholder, M.Piron, J.M.Billiouw and S.Ringoir.
Renal Division, Department of Medicine, University
Hospital, De Pintelaan, 185, B—9000 Gent, Belgium.
The present study compares data on blood pres-
sure (Be) and clinical tolerance, obtained conse-
cutively in the same patients during acetate (A)
and bicarbonate (B) hemodialysis. Ten patients
were followed over an equal period of A and B
dialysis during 36.8-4-6.8 months per patient. Abso-
lute and relative BP changes were noted. Mean
pre— and postdialysis BP was similar in both
groups, (respectively 113±15 and 116±16 for A and
112±12 and 116±13 mmHg for B). The number of
hypertensive episodes (defined as a BP rise by 30%
towards pre—dialysis or as a diastolic BP.-95
mmRg) was similar in both A and B. The number of
hypotensive episodes (BP fall by 30% or systolic
BP.<100 minHg) was also similar. Fourteen hemo—
dilysis sessions in each group were characterised
by a symptomatic BP—fall. The highest systolic BP
registered per session averaged 161±11 in A and
158±9 mmHg in B (p '0.05). The corresponding
lowest values were 127±8 and 124±8 mmhg (pO.O5).
There was also no significant difference in the
prevalance per 100 dialysis sessions of headache
(0.57±1.23% for B and 0.55+0.73% for A) and muscle
cramps (5.82±4.05% for B and 5.86±4.15% for A)
(p, 0.05). Only vomiting occurred less fre-
quently during B (0.31+0.41%) than during A
(5.73±9.18%) (p < 0.01).
Contrary to what often has been claimed previous-
ly, it is concluded from the present long—term
study that, at least in our hands, B—hemodlalysis
has no specific beneficial effect on blood
pressure in stabilized chronic patients. Except
for vomiting, clinical tolerance is also not
si2nifjcantlv better than for A—hemodialysjs.
INFLUENCE OF FOLIC ACID AND B12 SUPPLEMEN-
TATION ON ANEMIA OF HEMODIALYSIS PATIENTS.
J. Vanpellicom, R.L.Lins, M.Elseviers,
£.1.E.De Broe.
General Hospital Stuivenberg and
University Hospital Antwerp
Antwerp, Pelgium.
Supplementation of water soluble vita-
mins is performed in many dialysis centres
One of the reasons for this attitude is
the possible influence of folic acid and
of vitamin E12 on erythropoiesis. We
examined their role.
Twelf stable dialysis patients, 6 women
and 6 men, with the mean age of 60 years
at the end of the study, received a dose
of multivitamins i.v. at the end of each
dialysis session for a period of 15 to 63
months (mean 40,7 months). The prepara-.
tion contained l000ug of vitamin B12 and
15 mg of folic acid. This supplementation
was withheld afterwards for a period of
24 months, during which the evolution of
different hematologic parameters were
followed.
The results for RBC, May (mean corpus-
cular volume), NCR (mean cell hemoglobirie)
and bloodtransfusion requirements before
and after stop:ing vitamin supplementatior
were compared, using statistical analysis
with Wilcoxon matched pairs signed ranks—
test. No difference was observed.Serumlevels of B12 and red cell levels of folic
acid decreased significantly, but remain-
ed within the normal range.
For adequately nourished patients,ther
is no need for folio acid or B12 supple—
rpentatioZi,even during a long follow—uniaiai tud.y.
Retrospective and prospective analysis of Brescia—
Cimino fiatula survival in single needle
hemodialysis.
R.Vanholder, Liu Jing—Duo, J.M.Billiouw, J. De
Roose, F. Derom and S.Ringoir.
Renal Division, Department of Medicine, University
Hospital, De Pintelaan, 185, 8—9000 Gent, Belgium.
Literature data on fistula survival in single
needle (SN) hemodialysis are scarce. The present
study evaluates Brescia—Cimino A.V. fistula sur—
ival and fistula related complications in 101 of
our patients on SN hemodialysis. Eighty—six
patients were in hospital dialysis and 18 in home
dialysis. Twenty—eight patients had a functional
fistula for more than 5 years and 4 other patients
for more than 10 years. A total number of 22
fistulas had to be replaced in 19 patients. The
most common cause was thrombosis (13), followed by
bleeding (2), hematoma (2), inadequate flow (2),
aneurysm (1), ly-mphedema (1) and infection (1).
A retrospective analysis of the actuarial fistula
survival rates (AFSR) in hospital and home dialy-
sis were undertaken; they were calculated to be
respectively 86 and 94t after 3 years and 80 and
83% after 5 years of hemodialysis. These data
could however have been biased by the fact that
they were based on retrospective analysis. For
that reason, a prospective study was undertaken in
our unit from January 1st 1981 up till now.
Grossly similar results were obtained as with the
retrospective approach, AFSR being 86% after 3
years of hospital dialysis with both the prospec-
tive and retrospective analytical methods.
It is concluded that the AFSR in SN hemodialy—
sis is at least as good as in two needle (TN)
dialysis. The need is stressed for a controlled
prospective multi—center study on fistula survival
in both SN and TN dialysis.
USE OF PERCUTANEOUS FEMORAL CATHETER AND RIGHT ATRI
AL CATHETER FOR REPEATED HEMODIALYSIS IN CHILDREN.
D.Vasmant,R.Alperin,J.Y.Chevaljer,J.C.Mathe,
A.Bensman-H6pital Trousseau 75571 Paris Cedex 12
10 children requiring hemodialysis (H.D.) were
treated when standart arteriovenous vascular acce
was not available. The indications for H.D. was acu
te renal failure In 6 cases and chronic renal failu
re in 4 cases. Ages ranged from 3-16 years (mean:
11,7). The body weight ranges from 16-55 kg(mean
26,3). 2 types of catheters were used.
The femoral vein catheters used in 9 cases were
inserted per cutarc'u,: 1y under local anesthesia fol
lowing Seldingers's technique. HD treatments utill
zed a single needle technique with a unipuncture
clamp. The number of dialysis per patient ranged
from 1 to 23 (mean:8). The 9 patients have been
maintained with this technique from 1 to 50 days(mean:l9,6). The quality of epuration was good. No
infection occuniid. A local hematoma was noted in 2
cases and a vessel thrombosis in 1 case.
The double lumen Hickman catheter was inserted un
der general anesthesia In a 6 years old child wei-
ghting 18 kg. The number of H.D. was 25. It was uti
lized a double needle technique allowing a very go
gd quality of epuration. A dilute heparin solution
(100U/ml) filled the catheter at the end of each
dialyse, Between H,D., no infusion was used. No
episode of thrombosis or infection developed. In
Conclusion : these 2 types of catheters are useful,
however, percutaneous femoral catheter should be
used only for a short period, The preliminary re—
sults with the two lumens Hickman catheter are ye
ry favorable. This technique seems to offer a safe
and efficient method,
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SONOGRAPHIC DIAGNOSIS OF RENAL CYSTIC DISEASE IN CHRONIC HEMO—
DIALYSIS PATIENTS
3. Verbanck, L. Rutgeerts, Ii. Segaert, 6. Verleden, F. Verheist.
Division of Internal medicine,
Heilig Hart Hospital,
Roeselare, Belgium.
We tried to answer the question whether or not acquired
cystic renal parenchyma degeneration is a progressive disease
during chronic hemodialysis.
Real—time sonography of 76 kidneys was performed using
a 3.5 P1Hz linear and sector transducer in chronic hemodialysis
patients. True polycystic kidneys were excluded from the study.
No cysts were detectable in 33 kidneys. 43 kidneys showed
cystic parenchymal degeneration. The figure showes a good
correlation between the nijeber of renal cysts and the dialysis
duration (years).
____ no cysts
= 1—S cysts
— 5 cysts
1h1 I
(years) (1 1— 2—3 3-4 4—5 5—6 6-? 7—8 8—B 9—10
In conclusion, acquired renal cystic disease is a progressive
disease in chronic hemodialysis patients.
Renal sonography in hemodialysis patients at regular inter-
vals can detect progressive renal cystic disease. As a conse-
quence, potential complications like retroperitoneal bleeding,
hematuria, malignant degeneration or de nova stone formation
can be anticipated.
HIGH FLUX HEMOt:AF1IiTATloN
B. von Albertini, 1. Shiriaberger, F. Gardner, and •T, Miller,
(Introduced by J. Coburn), Wadsworth V.A. Medical Center and
Dept of Medicine, UCLA, Los Angeles, Calif orriia, U.S.A.
A r,ew approach to improve the efficiency of dialytic therapy
for ESF.D was developed and clinically tested in which both the
rates of delivery to and of the removal of solute by the artificial
kidney were augmented. Hemodiafiltration for simultaneous high
diffusive and convective solute removal was performed in a new
model Two high flux hollow fit.er devices were used in series in
ar, extracorporeal circuit, Sterile pyrogen free bicarbonate dialy—
sate was delivered in countercurrent mode by an automated sys—
tern providing volumetric control of net ultrafiltratior,. By adjus-
ting differential pressures, maximum Op was obtained in the 1st
while simultaneous automatic volumetric replacement by back-
filtration of dialysate occurred ir, the 2nd device, In this con-
figuration the entire surface area of both devices was available
for diffusion, This technique was clinically tested in 5 patients;
the performances of the three different devices used were rou-
tinely evaluated by whole blood clearance measurements for
BUN, Creatinine and Phosphorus. Only periods with a urea mass
balance error of less than 5'4 are reported (means SD, ml/min)
at Q 1000, 0B ' 0F 125 0 630, Qp 130
Cl BUN Clcr CIp ClBU CICr F
CD Duoflux x 2 409±7 326±8 297±29 457±3 377±3 '346±2
TorayBlLx2 419*10355±15311±25 474*4 378±15387±14
Freser,ius 60 x 2 435±1 355±4 357±7 502*,3 414±10 426±10
These flows were maintained throughout the treatments,
which were uniformly well tolerated by the patients.
Conclusionsl I) The performance of the listed devices with
the described new hemodiafiltration method provides simul-
taneous high diffusive and convective solute removal. 2) Better
utilization of the genuine high blood flows in mature accesses
together with this technique results in a marked increase of
treatment efficiency. 3) Coupled with the better tolerance to high
solute and weight removal rates in the patients, this approach
permits drastic reductions of treatment time over conventional
hemodialysis without sacrificing treatment adequacy.
FACTORS AFFECTING RENAL ANEMIA DURING CAPD AND
HEMODIALYSIS (HD)
Vlacho.jannis, J., Werner, E., Böhnert, U., Roth, P.,
Fink, N.J., Hahn, W., Hoppe, 0., Schoeppe, W.
St. Markus Hospital, Max Planck Institute for
Radiation Research, University Hospitals,
Frankfurt/Main, Federal Republic Germany.
Parameters important to the pathogenesis and
course of renal anemia were investigated in two
studies. First erythropoietin (EP) and hematokrit
(HT) were measured in sera of 7 CAPD patients.
Although each patient showed an increase in HI, no
correlation could be found between absolute values
for EP and HI or between the increase in HI and
any changes in EP.
In a second group of CAPD patients (12) and HO
patients (10) ferrokinetic and erythrokinetic
studies were carried out before and ten months
after the start of dialysis. Red cell life span,
the Hb-synthesis rate and blood loss were measured
using 59—Fe and 51—Cr; clinical data were also
used to verify the results.
Preliminary analysis shows that the mean in-
crease in HI was greater in CAPD patients than in
HO patients. Furthermore we were able to show that
the increase is not due to hemoconcentration. Ihe
reasons for the red cell volume increase appear to
be different for the two groups. On the average HO
patients demonstrated an increase in blood loss, a
decrease in red cell life span and marked improve-
ment in bone marrow function. In contrast CAPD pa-
tients showed less striking improvements in marrow
function with decreased blood losses and increased
red cell life spans.
TRB )LE of POTASSIUM and CALCIUM in the CARDIAC
RHYTHM DISTURBANCES with PATI1PS on MAINIThANCE
HVDIALTSIS
S. V.ljkovi6, Z. Vukui6, S. Strahinji6, S.Kostié
Inst. of Nephrology, Ni', Yugoslavia
Th..effect of K an's lin t)ié appearance of
cardiad rhythm djsturbancee in renal patients on,
maintenace hemodia].ysie wae studied. In 6o
patients the serum K and Ca valuea at the onsót
of cardiac rhythm disturbances were determined
and compared with those originated in the
absehee of cardiac rhythm disturbances.
In 10 pati.nts with sinus tachycardia
statistically significant increase of Ca and K
concentration was found, In 1]. patients with
sinus bradycardia significant decrease of Ca
and ad increase of K was observed. In patients
with suprav.ntrioular paroxyl tachycardia( patients) there were no significant changes
of IC and Ca concetration. In 7 patients with
atria]. .xtrasystoles significant increase of K
and decrease of Ca was noted. In patients with
ventricular xtraaystolea ( 22 patients)
significant deviation of Ca and K values was
found. In k patients with bundle branch blockleft and k patients with AV block first degr.e
there was significant increase of K value.
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• ACUTE PULMONARY HYPERTENSION (APH), LEUKOPENIA AND
HYPOXIA IN EARLY HAEMODIALYSIS.
J.F.Walker, R.M.Lindsay, I.D.Craig, W.J.Sibbald
and A.L.Linton (Intr. by R.M.Lindsay)
University of Western Ontario, London, Canada.
Studies in sheep show that blood exposed to a
dialysis membrane will induce APH. APH may also
occur during clinical haemodialysis. Its re-
lationship to dialysis induced leukopenia and
hypoxia was examined. Volumes of blood (1-15 ml)
were reinjected into sheep after 10 minutes of
static contact with regenerated cellulose (RC),
Cuprophan (C) or cellulose acetate (CA) while
mean pulmonary artery pressure, white blood count
(WBC) and PaO2 were followed. In normals the
degree of APH mirrored the severity of leukopenia
and hypoxia, and was greater with RC and C than
CA (p < 0.01). The induction of leukopenia
(WBC < 1 x 109/L) did not affect the degree of
APH or severity of hypoxia. Lung biopsies did
not reveal the presence of WBC in the pulmonary
capillaries during maximal APH. APH and hypoxia
but not leukopenia were abolished by pre-treatment
with indomethacin. Pro-treating blood with
citrate or EDTA and decomplementation or heat
inactivation of plasma abolished all responses.
These results suggest that the blood/foreign
surface interaction activates complement which
produces a cyclo-oxygenase dependent pulmonary
vasoconstrictor leading to APH and hypoxia.
Leukopenia is an epiphenomenon and pulmonary
sequestration of leukocytes does not cause APH.
The composition of dialysate fluid in bi-
carbonate dialysis.
L. Wagner, 0. Decker, U. Zuher, and U.
Otroach,
Clinic of OenFirology , Ulinihum Uannheim,
University of Hel delberg , OonnFietm , FUGLx cnmmerclally available bicarbonate
concentrates were compared with regard topH, pCO2 and TCO2. Substantial differences
were observed: pd 7.109—7.508, pCO2 41.8—
86 mmdg, TCO2 30.70—36.65 mval/l. Low pH
and a corresponding high p002 stay in-fluence security nd effectivitly of bi-
carbonate dialysis, especially if pts. ar'e
not able to el irninate high concentrations
of gone-rated 002 via respiration. In order
to get an indication for an optimal con—
sea Oration of bicarbonate in the dialysate0 pts. sore diolymed each against dif—
ferertt bicarbonate concentrations (2L .6—
.'l.6 nval/l). Significant differences in
p0, pOd2, -1003—, plasma potassium and redblood call potassium during dialysis andprior to the consecutive dialysis werefound, It is proposed that toe oicarhocate
concentration in the dialysatc has to be
as high as to allow the following predia—
lytic plasma bicarbonate concentration to
re in a normal range . anout 35—0 sival ,'i
The potassium of 030 in bicarbonate diy—
sod pta. s nuch higher' than i-i pta. on
redul a: cli.aiy' is containing ece Late. Our
a reason 0 Lcar000ate ii alysim cool dOe
means; for' the or-even Lior, of tnt r;;ce I in—
tar sotossiut; depletion in tar lcn term
cOre: 1 a bemad 151 !'si a
ACTIVE CHANGES IN PULMONARY VASCULAR TONE AND
RIGHT VENTRICULAR DYSFUNCTION DURING EARLY
HAEMODIALYS IS (HO)
J.F.Walker, R.M.Lindsay, A.A.Driedger, W.J.Sibbald
and A.L.Linton (Intr. by R.M.Lindsay).
University of Western Ontario, London, Canada.
Severe cardio-pulmonary dysfunction occurring
early in Cuprophan (D) dialysis is the major
manifestation of "dialyser hypersensitivity" (DII).
Sheep studies show that blood exposed to C will
cause complement activation, acute pulmonary
hypertension (APH), leukopenia and hypoxia in a
dose related fashion. APH in sheep appears
similar to the human OH reaction. Eight patients
with acute renal failure monitored with Swan-Ganz
catheters were studied during 12 dialyses. On
each occasion a rise in pulmonary vascular
resistance index (PVRI) occurred during the first
15 minutes and four patients developed APH. The
increase in PVRI coincided with complement
activation and leukopenia but preceded maximal
hypoxia. Right and left ventricular ejection
fractions (RVEF, LVEF) were followed by a gated
radionucleide method in eight asymptomatic
chronic renal failure patients during HD with C
or cellulose acetate (CA) . A transient but
significant fall in mean RVEF (> 8%) occurred
with C but without change in LVEF. No changes
occurred during dialysis with CA. Thus, a
spectrum of changes in pulmonary vascular tone
occurs during HO and DH likely occurs when
massive complement activation and severe APH
are induced.
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DISFUNCTION OF AUTONOMIC NERVOUS SYSTEM
AND HYPOTENSION IN THE PATIENTS ON MAINTENANCE
HEMODI A LYSI S
Institute of.Nephrology and Hernodialysis, Nig
Z. Vuku6iá, S. Strahinjit, S. Kostiá; 'I'J.Pavlovié,
S.Veljkovid
Automatic nervous system(ANS)function was .evalua—'
ted in 2o normal aubjects,2o patients on kainte—
nance hemodialysis,lo patoonts with chronic renal
failure treated without hernodialysis, and' 2o pati-
ents with chronic renal diseases and normal renal
function.
ANS function was evaluated specificaly for or—
tostssis (systolic,diastolic and mean arterial
pressure in supine and standing position and hearl
rate in supine and standing position)and heart ra-
te variations(R—R interval) during deep respirati-
on according to Sundkvist (R—R in inspiration,R—R
in expiration and ration R—R as well as E:I)in all
patients with CRF the possibility of coexisted po-
lyneuropathy was determined(neurogical examinstior
and EMG).
The results of study showed that dysfunction of
ANS with hypotension was more frecvently in pati-
ents with coexisted po].yneuropathy (11 ptients or
36%) than in patients without polyneuropsthy(3 pa-
tients or lo%).
In the patients with dysfunction of ANS hypb—
tension was also recorded. In 8 patients hypoten—
sion was ssymptomstic and in 6 patients symptoma-
tic.
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A CLINICAL INDEX TO PREDICT FAILURE RATES
IN CAPD.
J.P._Wauters, G. Halabi and M. Burnier.
Division of Nephrology, University Hospi-
tal, Lausanne, Switzerland.
To investigate the high drop—out rate
of CAPD a risk factor index has been con-
structed considering age, associated di—
sease, socio—familial status, physical
handicap and compliance. The maximal sco-
re indicating the highest risk is 8. Ap-
plying this index to 33 patients at the
time of initiating CAPD therapy, 2 groups
were defined : group 1 (maximal score 3)
consisted of 16 patients (mean age 52,
32—67, global treatment time 206 months),
group 2 (score 4 to 7) consisted of 17
patients (mean age 56 years, 69—78, glo-
bal treatment time 141 months). Mean in-
struction time was 11 4 days (4—16) in
group 1 while in group 2 instruction fai—
led in 7 patients and was at 20 10 days
in the 10 other patients. The mean number
of hospitalisation days was at 21.6/pa-
tient/year in group 1 and 38.4/patient/
year in group 2. The risk of peritonitis
did not differ significatively. Two pa-
tients in group 1 died and 5 in group 2.
The percentage of patients continuing
CAPD was at 93 and 52 % in group 1 and 2
respectively at 6 months (p. 0.05), 63
and 39 % at 12 months (NS) and 49 and 6 %
at 2 years (p-0.05). Conclusion : The
use of a risk factor index appears able
to define, at the start of therapy, which
patients are going to do badly on CAPD.
For those patients other treatment moda-
lities should probably be favored.
ThE PEARMACOKINETICS OF AMEZINIUM IN DIA-
LYSIS 'ATIENTS 3D.Will , K.-U.Seiler2, G. 3eimenstoll , W.
ifiedermayer , O.WasserrnannDept.of Toxicology 211.Medical Clinic of
Internal Medicine, Dept.of Nephrology,
University of Kiel, Forschungsinstitut
Borstel (FRG)
Amezinium (A) is an antihypotensive
drug which is mainly eliminated in an un-
changed form by the renals, whereas 30% is
metabolized. Since no data is available
regarding its pharmacokinetics in dialysis
patients, we investigated the pharmacoki-
netics of A in these patients. 14 patients
took A (Regulton® tablets) in a dose of c.
0.4 mg/kg b.w. just before their breakfast
The concentration of A in the plasma was
measured by HPLC technique. - In principle
we could not observe any significant dif-
ference in the pharmacokinetics of A in
dialysis patients compared with the values
of healthy controls from the literature
(e.g. haf-1ife 12±4 hrs, in healthy con-
trols 13-4 hrs). During hernodialysis the
the concentratios of A decl4ned with a
half—life of 5.2—1.5 hrs (x — S.E.M.). —
Summing up, it doesn't seem necessary to
reduce the dose of A in patients with re-
nal insufficiency, since extrarenal elimi-
nation is able to compensate the loss of
renal elimination.
CHANGES IN TRANSPERITONEAL WATER AND SOLUTE TRANS-
PORT DURING CAPD — A PROSPECTIVE STUDY.
T.—E. Widere' L.C. Smeby, S. Mjland.
Department of Nephrology, University Hospital' and
Institute of Biophysics, University of Trondheim,
Trondheim, Norway.
Correlations between long term changes (A) in
ultrafiltration (UP) and solute transport (SI) has
been investigated prospectively in 7 CAPD patients.
Glucose absorption (GA) and dialysate to blood
equilibration ratios for urea (UE), creatinine (CE)
and uric acid (AX) for 4—5 hours dwelltimes toget-
her with daily fluid intake (Fl) and drainage vo-
lume by each exchange were measured during 2 peri-
ods of 3 months. Five episodes of peritonitis were
also recorded. In 6 of 7 patients UP changed sig-
nificantly from one period to the other. By CAPD
start patients with long term decreased UF needed
higher glucose concentration in dialysate (range
125—244 inmol/l) than did patients with long term
increased UF (range 85—113 mmol/l). When mean
changes () in ST between the two periods were cor-
related with 1JF for all patients, correlation co—
efficientsof +0,70, —0,66, —0,81 and —0,59 for
AGE, ACE and IiAE respectively were obtained.
Note the positive correlations between AGA and AUF,
while ST from blood to dialysate gave a negative
correlation with AUF.
Further conclusions: 1) correlations between
long term changes in UF and initial permeability
(pe) can be suggested, 2) pe were individually
dT?ferent, 3) changes in pe appear earlier and
more often than previously suggested, 4) sponta-
neous fall in UF was an early sign of peritonitis,
5) correlations between intermittent changes in UF
and Fl exist, 6) ST values showed that "membra-
ne" changes leading to a different UF, also influ-
ences SI, but these changes are difficult to depict
with "normal" control routines.
PROLONGED PrTIPIO'PTC THERAPY DOES NOT PREV11T
EARLY RECURREITCE OF CAPD PERITONITIS
D.J.Read, E.J.Eill, A.i.Davison, P.J.Guiilou.
St. James's University Hospital, Leeds, U.K.
ye have shown that, usini; 10 day courses ofintraperitoneal antibiotics, the inierval between
first and second episodes of peritonitis (Ia) on
PA?D is si,nif cantly shorter ham that fror th
start of CAPD t first episode (ha) Ta 2.E —
2.7, Ha = .2 — 3.0 months; p< 0.05. 3.1
episodes, 1/).7 pt. siontal. Only 2 off,patients incidentally -ive pro1oned therap,developed second episoes, with th lonest
recorded intervals.
Suhse-iuentiy we have treated neritonitis for
2 days after initial clearinf, Culture ne=ative
(40) and Gram positive (32) episodes tiers
treated at random with Cefuroxime or Vancomycin,
and Grain neative (22) episodes with amino—
nlycoeide and/or ureidopenicillins. Eith afurther years experience the oriEina contrast
remained ( Tb - 2.2 2.2, lIb = o.3 — 5.1 months;
p< 0.001. 92 episodes, 1/9.27 pt months 1 with
nothing to chose between the different antibiotics.
The similarity of ha and hib demonstrated the
constancy o policy and procedures.
There was ic ivantat':e to pro)on&ed ntiiotic
therapy, shown by the failure to extend lb
compared with Ia. These results would not
support persistent infection ins the cause of
early recurrent peritonitis, aIthnu:h the ro)e of
relapse vs. re—infection must remain
controversial.
1. E.J.Will, D.j.Read, B.Kin1sod.
Lanoet 19:3; 1 : 233—9.
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. EFFECT OF DIALYSATE BUFFER ON POTASSIUM (K)
REMOVAL DURING HAEMODIALYSIS (HD)
• A.J. Williams, J.N. Barnes, J. Cunningham,
F.J. Goodwin, F.P. Marsh.
London Hospital, London, England.
Potassium removal by HD is affected by changes in
the distribution of K across cell membranes and in
dogs a greater fall in plasma (P) K occurs during
acetate (Ac) than during bicarbonate (Bi) infusion.
We have compared the effect of BIHD and AcHD on K
removal from 9 chronic RD patients. Patients
dialyzed for 5 hr using Bi or Ac buffered dialysate
with K 1.5 mmo]Jl. In other respects dialysate
constituents were identical. The complementary
form of HD was used several weeks later. Red blod
cell (RBC) K (mniol/i), PK (smoljl), pH, PaCO2 and
HCO3 were measured before RD and 3 hr, 1 hr, 3 hr
and 5 hr after starting RD. Hourly measurements of
dialymate K, dialysate effluent K and of pooled
effluent K were used to calculate "hourly K
removal" (HKR) and "total K remova" (TKR).
Results pre and post RD were (mean—SD):
cHD
PK
Pre Post
6 27
0:6 0:2
RBCK
Pre Post
1O.5 1O.5
.4 3.8
TKR
mmol
16:
pH
Pre Post
7439 75O
005 0:03
L 44 3O
o6 0:2
1O.7 10.6
8.2 .1 17+
739 750
0:02 0:02
Thanges in K removal during RD were (mean+SD):
I HKR (mmol/hr)
[Hr 1 2 3
FAcHD
IBiHD
l9.24J+.5 15.3+3.5 12.3+3.1 10.5+2.8 9.2+2.5
16.84.3 1'+.0+3.6 12.0+2.81 9.82.2 9.82.2
The data indicate that (1) Ac and BiRD lead to
similar changes in pH, PK and RBCK and (2) the
kinetics of K removal are similar with Ac and BiHD.
EVALUATION OF AUTOMATED DEVICES FOR HEMODIALYZER
REPROCESSING.
N. Deane, R.J. Wineman
Manhattan Kidney Center
New York, U.S.A.
The purpose of the study was to evaluate avail-
able equipment for hemodialyzer reprocessing, by
measuring variability of tests, and changes of
dialyzer properties with usage.
Through cooperation of manufacturers, models of
each of the devices were made available. The study
consisted of cross over comparisons of three pairs
of devices with a common patient pool. For evalua-
tion of changes in dialyzer characteristics, the
manually measured cell volume, automated cell
volume, and ultrafiltration coefficient (KUF) were
recorded. Mean values for each property together
with standard deviations were calculated, as well
as the regression equations for changes in proper-
ties with use. A sampling of dialyzers were used
for determination of urea clearance, creatinine
clearance, and KUF.
Change in Dialyzer Properties with Use: For
the multi—station devices the decline in auto cell
volumes ranged from 3.0 to 11.6% over a total of
12 uses, with a mean of 8.4%. Manually measured
cell volumes decreased ranging from 3 to 11% with
a mean of 7.3%. Changes in KUF ranged from an
increase of 7% to a loss of 14% with an average
decrease of 2.5%. Clearances of urea and creat—
mine showed no trends with up to 12 uses. Consid-
ering all data, only a loose relationship was
shown between KUF (machine) and KUF (measured in
vitro).
Study data show that reprocessed dialyzers are
capable of providing essentially equivalent
therapy to that of a new dialyzer.
ANTICOAGULANT EFFECTS OF A LOW MOLECULAR WEIGHT
HEPARINOID ( ORG 10172) IN HUMAN VOLUNTEERS AND
HAEMODIALYSIS PATIENTS.
J.M. Wilmink, H. ten Cate, Ch.P. Henny, H.R. Buller
M.C. Mooy, S. Surachno, J.W. ten Cate.
Division of Nephrology and Division of Haemostasis
and Thrombosis, Academic Medical Center, Amsterdam.
Org 10172 can be safely applied during acute
haemodialysis of patients with bleeding
complications. It has a mean molecular weight of
6500 D and specific activity of 6.0 anti-Xa u/mg.
In order to analyse anticoagulant effects six human
volunteers recieved repeated single i.v. injections
of 100 and 400 mg of Org 10172, 50 mg heparin or
placebo. Bleeding time, platelet count and plasma
— thromboglobulin were not affected by Org 10172
and heparin. Heparin stimulated ADP—inducedplatelet
aggregation (0.2 uM; p<O.O5) and inhibited the
thrombin induced aggregation (0.3 u/ml;pL0.05)
while the heparinoid lacked these effects.
Heparin increased plasma platelet factor 4, where-
as Org 10172 had no effect. In contrast to heparin
Org 10172 had a minor effect on the activated
partial thromboplastin time and thrombin time,
while both compounds induced anti-Xa activity in
plasma. In a cross—over study in six haemodialysis
patients, both heparin and Org 10172 (4.3 and 2.8
mg/kg body weight) succesfully prevented clotting.
Microscopical analysis of the artificial kidney
membranes showed that the 4.3 mg/kg Org 10172
dosage was as effective as heparin in preventing
fibrin deposition.The haemostatic and coagulation
effects were similar to those observed in the
volunteers. In addition heparin and Org 10172
(4.3 mg/kg) inhibited the Xa—induced platelet
aggregation (0.5 u/ml;p0.01 and p <0.0001
respectively)
EARLY INDICATORS OF 'UREMIC CARDIOMYO-
PATHY': ABNORMAL DIASTOLIC COMPLIANCE
AND SYSTOLIC RESERVE OF LEFT VENTRICULAR
FUNCTION IN ASYMPTOMATIC PATIENTS.
v.wizemann, W.Kramer, G.SchUtterle
Zentrum für Innere Medizin, 6300Giessen,FRG
101 patients on maintainance hemodialy-
sis (HD) were screened by echocardiography.
From those,12 male pts.who had a normal
contractility and no left ventricular di-
latation (coronary artery disease or long
standing arterial hypertension were exclu-
ded) were studied before and after RD by
radionuclide ventriculography during rest
and exercise. Furthermore ,echocardiography
and carotid pulse tracing, phono— and
ECG's were performed.
Ejection fraction (EF) was unchanged pre-
and post RD (65 vs 66%). However, only in
5/12 exercise stress pre HD resulted into
an increase of EF (66 vs 71%) whereas in
7/12 EF decreased (64 vs 52%, pO.OOl).
During postdialysis exercise EF improved
in all patients (pO.OO5). No correlation
was found between exercise EF, weight loss,
hemoglobin, PTH, V or double product.
Predialysis EF resnse was directly rela-
ted to left atrial emptying index(r=0.82)
and left ventricular muscle mass (r=0.74).
Conclusions: Despite preservation of sy-
stolic left ventricular (LV) function,pa-
tients have inappropriate LV mass, abnor-
mal LV diastolic compliance and impaired
systolic reserve unmasked by exercise.De—
tection of these abnormalities demand ef-
forts to reduce LV workload to prevent
irreversible heart failure in pts.on HD.
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ALTERNATIVES TO CUPROPHAN.
Celia Woffindin. NA Hoenich. MK Ward. DNS Kerr.
Department of Medicine,University of Newcastle/Tylle
Modified cellulose membranes such as saponified
cellulose ester(SCE), cellulate(CE) and
regenerated cellulose(RC), together with synthetic
membranes (polymethylmethacrylate (PMMA), poly—
acrylonitrile (PAN15) and ethylenevinylalcohol (EVAL)
are available as alternatives to the commonly used
Cuprophan(CU) membrane. Functional performance and
biocompatibility(leucopenia) of dialysers using
such membranes have been studied.
Clearance of small molecules show that compared
with Cuprophan the benefits offered by these
alternatives are minimal. Clearance of middle
molecules and ultrafiltration characteristics of
modified cellulose membranes and PMMA are
comparable but those of EVAL and PAN15 are
significantly enhanced, limiting their use to
proportionating systems offering ultrafiltration
control.
Biocompatibility of regenerated cellulose and
synthetic membranes are superior to Cuprophan and
it is this factor rather than differences in
functional performance that render these membranes
as a possible alternative to Cuprophan.
Dialyser Membrane SA
lear
—
rea
ance**
.VitBl2
*
UFC
Belico BL612 CU(1l)*** ] ]3 34 43
Cordis 13SSCE SCE(3O) 1.35 174 31 4.1
Cordis 4000 CE(4O) 1.4 142 39 4.9
Terumo TAF12 RC(12) 1.2 170 45 5.9
Kawasumi KF 101 EVAL(38) 1.5 124 31 9.0
Asahi PAN15 PAN(50) 1.1 156 08 27.1
Toray 82 200 pMMA(25) 1.56 159 43 4.7
* ml/hr/mmHg
** in vitro at zero OF and = 200 mi/mm
membrane wall thickness
FACTORS CONTRIBUTING TO ZINC AND COPPER DEFICIENCY
DURING CAPD.
J.H.Turney, A.M. Brownjohn.
Renal Research Unit, General Infirmary, Leeds
Zinc and copper were measured in 23 patients
maintained on CAPD for 2 months — 3 years and
factors contributing to deficiency were assessed.
Plasma albumin, caeroloplasmin and—macroglobulin
had decreased progressively in most patients who
were eating less than 1.3g protein/kg/day. Plasma
zinc (63.6 13. pg/dl9) was lower than normal
(84.7 6.7 pg/dl) and values correlated with
plasma albumin (r = 0.61; p<O.OO1) and caerulo—
plasmin (r r 0.47, p<O.O1). Plasma copper and
caeruloplasmin were normal in all but four patients
and values for copper correlated with caerulo—
plasmin (r = 0.80; p<O.OO1) andv(2— macroglobulin
(r 0.49; p<O.O1(. The loss of transport proteins
into dialysis fluid was measured in 10 patients for
10 days during their initial training. The mean
daily loss was: albumin 6 2g caeruloplasmin
34 . 12 mg and .2—macrog1obulin 89 . 36 mg but
losses were increased during peritonitis.
Erythrocyte zinc and copper were normal in most
patients but whole blood concentrations were less
than 50% of normal in 5 with severe anaemia.
Several patients had symptoms compatible with zinc
deficiency i.e. loss of taste acuity and anorexia.
Deficiency of both elements may contribute to
anaemia and exacerbate protein malnutrition. - The
effects of supplementation are being assessed. It
is concluded that dietary deficiency, loss of
transport proteins and severe anaemia decrease the
availability of zinc and copper.
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NON-ENDOTOXIC LAL—REACTIVE SUBSTANCES FROM PREUSED
HEMODIALYSIS MEMBRANES
S. Yamagamil, N. Niwa2, T. Kishimotol, M. Umedal,
M. Maekawal, S. Tanaka3, S. Takahashi3, T. Norita4,
S. Iwsnaga4 (Intr. by K. Ota).
lDept. of Urology, ZDept. of Bacteriology, Osaka
City University Medical School, Osaka, 3Seikagaku
Kogyo Tokyo Institute, Tokyo, 4Dept. of Biology,
Faculty of Sciences, Kyushu University, Fukuoka,
Japan.
Limulus Amebocyte Lysste (LAL) reactive substan-
ces washed with saline from preused hemodialysis
membranes were analyzed by Iwanaga's chromogenic
substrate method. Saline washings of cellulose
acetate membranes (AL—lOO and F—90), but not of the
polymethyl metacrylate membrane (B1—70), were LAL
positive. The positive reaction of these washings
was not inhibited by Anti—LPS Factor purified from
LAL as well as Polymyxin B which inhibit endotoxin
reaction. The dose response of the positive sub-
stances gave a sharp optimum in the substrate
method which is similar to the characteristics of
—glucan. In order to discriminate an endotoxin
pathway which is triggered by Factor C and endoto—
xin, and an alternative one which is initiated by
Factor G and 6—glucan, Factor C—less and Factor C—
less lysates were prepared. No positive reaction
of the washings was found with the Factor G—less
lysate which reacts only with endotoxin. On the
other hand, Factor C—less lysate did not affect the
positive reaction of the washings. Intravenous
injection of the washings into rabbits resulted in
no pyrogenic reaction. Therefore, it could be con-
cluded that the LAL—reactive substances in the
saline washings from the cellulose acetate membra-
nes tested is not bacterial endotoxin.
GLUTATHIONE PEROXIDASE AND TOCOPHEROL IN PATIENTS
ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
G.A. Young, A.M. Brownjohn, J.H. Turney.
Banal Research Unit, General Infirmary, Leeds
Glutathione peroxidase (GSHPx), a selenium
containing enzyme that metabolises peroxides, is
found in many tissues such as erythrocytes and
platelets. GSHPx may prevent lipid peroxidation
damage particularly in the presence of tocopherol
(vitanuin E), a free radical scavenger. Deficiency
has been associated with haemoiysis, impairment
of platelet function, growth retardation and
myopathy. We have measured GSHPx in blood and
tocopherol in plasma for 23 patients treated by
CAPD for periods of 2 months to 3 years and also
in 12 normals. Mean concentration for the group
of patients was less than normal and in 6 patients
less than 50% of normal. GSHPx correlated with
haemoglobin (r = O.7t; p<O.OO1).
Plasma
Nb Blood GSHPx tocopherol
g/lOOml pg/g Hb pg/mi
Normals (12) 15.0 1.4 20.9 3.6 9.9 2.8
CAPD (23) 9.9 3.1 15.3 7.1 12.0 4.2
p <0.001 <0.01 NS
GSHPx was present in macrophage cells in dia]ysis
fluid and therefore the loss was greatest during
peritonitis. Plasma tocopherol was similar to
normals but was low in patients with severe
hypoalbuminaernia. Deficiency of GSHPx and
tocopherol may be due to inadequate dietary intake
of selenium and vitamin E, loss into dialysis
fluid and increased consumption as antioxidants.
Increased haemolysis may occur due to lipid
peroxidation particularly when vitamin E is
deficient. The effects of supplementation are
being investigated.
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TREATMENT OF ANEURYSMS IN THE VASCULAR
ACCESS FOR HEMODIALYSIS.
G.F. Zanon, P.G. Gamba G.F. Romagnoli D.
Di Landro- G.F. Rizzoni G. Zacchello L.
Pavanello° (Intr. by G. La Greca).
Istituto di Clinica Chirurgica I, Cattedra
di Chirurgia Pediatrica, *Servizio di Emo
dialisi, °Dipartimento di Pediatria -
Padova, Italy.
Venous aneurysm is a late complication
of arteriovenous fistulas (AVF).
In 1100 patients operated of our series,
from 1970 to 1984, Authors observed 9 sub'
jects, 4 children and 5 adults, with venous
aneurysm (0.81%) of the AVF.
In these patients only 6, three children
and three adults, have been operated. Then,
all the pediatric patients received a
functioning renal graft, which allowed
resection of their aneurysm and removal of
vascular access; on the contrary the adults
underwent the resection of aneurysm and a
new vascular access was performed.
The Authors discuss about the more freque
nt site of the aneurysm, the indications
to the operation, the different operative
schedules according to the necessity or not
to mantain the vascular access.
THE ROLE OF ENDOGENOUS OPIOIDS IN BAROREFLEX DYSFUN-
CTION OF DIALYSIS PATIENTS
C.Zoccali, M.Ciccarelli, F.Mallamaci, Q.Maggiore.
Centre Fisiologia Clinica CNR, Reggie Cal., Italy
M.Stornello, E.Valvo, L.Scapellato. Divisione di
Medicina, Ospedale Umberto I", Siracusa, Italy
A defective baroreflex contro]. of heart rate has
been reported in chronic uraemics but its cause is
unclear. Metenkephalin, an endogenous opioid depres-
sing baroreflex sensitivity which is retained in u—
raemic patients (R.Smith,Clin.Endocrin. 15,291,1981)
might account for this dysfunction.
We studied the effect of the opiate antagonist Na
loxone (NAL) on the response to Valsalva manoeuvre
(VM) in 9 uraemic patients (UP) on chronic dialysis,
in 5 diabetics (DP) with normal renal function whose
response to VM was similar to that of UP, and in 7
healthy subjects (HS). VM was performed before (B)
and 1,2 and 3 hrs after (A) of either NAL (.07 mg/
kg) or placebo. With an interval of 48 hrs these tre
atments were crossed over and the same experimental
sequence repeated. NAL caused a progressive increase
in VM ratio in UP [B:l.46±SEM.O9;p(3 hrs):l.73i-.O9;
pO.Ol25] but it did not cause any change in OP [B:
1.32±.ll;A(3 hrs):1.32±.O83 nor in HS CB:1.75±.l5;A
(3 hrs):1.73.i-.l2]. Placebo had no effect in any gro-
up. The increase in VM ratio observed in UP was due
to restoration of the reflex bradycardia of the re-
lease phase of the manoeuvre. In conclusion; NAL in-
creases the subnormal VM ratio of UP. Being peculiar
to uraemic pts, this response is likely due to anta-
gonism of Metenkephalin. Retention of this opioid
may be responsible for the baroreflex dysfunction of
chronic uraemics.
ESTIMATION OF VITAMIN B12 AND ITS CARRIER PROTEINS
(TRANSCOBALANINS) IN DIALYSATE AND THE SERUM OF
PATIENTS ON HAEP4DDIALYSIS.
M. Kesse—Elias, P. Ziroyannis, C. Tjanetou, V.
Aievizou-Terzaki and E. Gyftaki.
Lpt. of Clinical Therapeutics, Athens University,
"Alexandra" i-bspital, Athens, Greece.
Serum vitamin Bi 2 and unsaturated transcobala—
mins (Tc 1,11,111) were measured in the serum, be-
fore and 14 hours after commencement of haemodialy-
sis in 50 patients with end stage chronic renal
failure. Vitamin B12 and unsaturated transcobala-
mins were also estimated in the dialysate. For vi-
tamin B12 estimation Amersham radioassay kit was
used.
fractionation of the three transcobalamins was
achieved after incubation of blood serum and dia—
lysate with vitamin B12 followed by filtration
through a stack of charged cellulose filters com-
posed of one cellulose—nitrate and three DEAE cel-
lulose discs.
The results showed that there is a statistical-
ly significant decrease of serum vitamin B12 du-
ring haemodialysis (before 781.9SE 39.39 pg/ml,
after 663.6OSE 314.91 pg/ml, p=O.025). and an in-
crease in the percentage of serum unsaturated Tc
I (before 23.38SE 0.87 , after 26.148SE 0.80,
p0.O1).
Vitamin B12 was not measurable in the dialysa—
tes but a relative increase of Tc II in the dialy—
sates was noticed (serum Tc II % before haemodia-
lysis 65.21SE 1.33, To II % in the dialysates
69.21sE 0.914).
MECHANISM OF PREMATURE RED BLOOD CELL
(RBC) ELIMINATION IN CHRONIC RENAL INSUF.L
FICIENCY (CR1)
W.Eggert,R.Bleiber,s.woif,J055,Jç Zoel—
iner ( Intr. by K. Zoellner) —1!Td.rens Hospltal,Institute of clinical
and pathological biochemistry, Humboldt
University, Berlin, GDR
G—6—PD,Su].f—ITh and phospholipids of RBC
of uretnic and healthy children after
their separation according to density (
young and old RBC) were investigated.
G—6PD aetvity of uremia RBC decreases
from 6,2o—2,o8U/]. (young cells) to 2,45±
o,61U/l (ol oells)(contro]. group 5,o
o,6 to 1,98—o,38U/l,pO,o1)....S1f...... con
centration increases from o 3g% (young
cells) to o,82g (old oells5(oontrol
group 0,2 to o,49g%,pco,o1).
In spite of high G—6PD—acti itty young and
old uremia RBC produce high Sulf—Hb and
are more oxidatly damaged.
Total phospholipida and main fractions(PE,PS,Sph.Pch) show a decrease to 30—40%from young to old ureinic RBC( control
group to 91%).
Factors contributing to the increased
elimination of uremic RBC:
1 • Increased oxidative damage of Hb and
lipids in old uremic RBC2. Enlarged loss of membrane lipids dur-
ing the process of aging of uremia RBC.
3. CR1 causes changes — qualitative as
well as quantitative — in the aging
process in RBC of uremio children.
• LOW INCIDENCE OF HYPERPARATHYROIDISM IN DIABETIC
RENAL FAILURE
J. Aubia, J. Bosch, J. LLoveras, J. Masramon, A. Or-
TITi, I. LLorach, M. LLorach.
Hosp. Gral. Mare de Dèu YEsperanca. Barcelona-Spain
A lower incidence of renal osteodistrophy has be
en reported in diabetic patients on hemodialisis.Sp
ecifically a lack of hyperparathyroidism (HPT). We
have started a double study to assess this reported
low incidence and to inquire if the cause of this di
fferences between diabetics and non-diabetics might
result from differences of renal handling of minera
is in the course of renal failure. MAT. AND METH.:
Two different studies have compared: 1) A group of
25 diabetics in HD (DHD) vs. a paired group of non
diabetics (NDHD) with the same duration in HD: Ca,
P04, Alk Ph., IPTH.C, clinical, X-Ray signs, bonehy
stologic findings, and vit. D needings were studied
in both groups. 2) 15 patients with diabetic nephro
pathy with GF of 45-5ml/min (D) and 25 with similar
OF values and diverse non diabetic kidney diseases
(ND): GF,TmPO4, N.cAMP and PTH.c were determined in
both. RESULTS: the DHD group showed significantly lo
wer values of: PTH (1.68 07 vs. 3.69 1.lnM), Alk .Ph
340 90 vs. 543 145U/1, % of patients needing vit. D
treatment (20% vs4%), and lower signs of HPT on X—Ra
ys and Bone Biopsy. In study nQ 2 the ND showed in-
creases of PTH and NcAMP inverse correlated toCrC.
These increases lacked in D group. In spite of this
low PTH, the phosphaturia was higher in D group: Tm
P04 (1,52 82mgrs/100—1 vs. 2,9 1.7mgrs/lOOml OF).
CONCLUSSIONS: 1.Diabetic patients are less prone to
develop HPT on hemodialisis than the other uremicpa
tients. 2. This differences are evident already in
the previous phase of progressive renal failure. 3.
This lack of stimulus could be produced by the rela-
tive increased phosphaturia of the diabetic patient
compared with the non-diabetics.
Abstracts
H1GI-1 FLUID INTAkE OR PHARMACOLOGICAL THERAPY IN RE
CURRENT STONE FORMER (RSF) PATIENTS?
Aroldi A. ,Graziani G.,Passerini P. ,Castelnovo C.,
Mandressi A.,Trinchieri A. ,Colussi G.,Ponticelli C.
Div.Nefrologia Osp.Maggiore e Ca Granda Niguarda,
Ist.Urologia dellUniversitA di Milano.
In 37 hypercalciuric NSF pts hydrochiorothiazide
(5Omg),amiloride (5mg) and allopurinol (200mg) were
given daily for 4.8+1.1 yrs to prevent stone recur
rence.The cumulative number of atonea waa 181 in l5
ra before therapy vs 59 in 180 yrs during treatment.
19 pts never relapsed;however in the relapsers the
atone/pt rate(3.2 vs 5.3,P<3.Ol)and the stone/yr ra
te(O.6 vs 1.2.P<O.Ol)significantly decreased during
treatment.After 4 yrs urinary calcium(UCaV mg/24h)
and uric acid(UUAV mg/24h)remained unchanged in the
relapsers while significantly decreased in the 19
pon—relapser pts(tJCaV 326+143 vs 21l+99,P.eO.02;UUAV
591±328 vs 372+155,P<O.O2).
In 14 other pts with no metabolic disorder and in 4
ith hypercalciuria a high fluid intake was recommen
ded to prevent stone recurrence.The cumulative number
of stones decreased from 92 in 73 years to 10 in 72
years(P<3.OOl) .Only the 4 pta with metabolic disorderE
relapsed.
It is concluded that a high fluid intake can prevent
stone recurrence only in pta with no metabolic diso
rder.In pta with metabolic disorder pharmacological
therapy can avoid recurrence in about 50 % of pta,
while in the other 50 % it can only reduce the mci
dence of relapaea.It remains to elucidate whether
theae pta had a low—compliance or represent a sub
group of partial—responders to therapy.
IN VITRO EFFECTS OF CATECHOLAMINE (CA) ON Na EFFLUX
ACROSS PROXIMAL BRUSH BORDER VESICLES(BB).A. Satta,
B. Cofltu,R. Faedda,GF. Branca,and E. Bartoli,Istitu
to di Patologia Medica, University of Sassari,Italy.
Since Catechols are thought to influence proximal
resorption, their effect was studied in rat RB with
the technique of Evera et al.Kinetic experiments of
Na uptake by RB were performed during a 60 secds
incubation in a Tria—Hepes buffer containing Na
as racer.Maximal Na uptake (Vmx) was .78±.28 pM
—6
mm
.mg of protein,and rose tol.35+.48 with 5.10
M Epinephrine (E)(P.(.O5)when1 mEq.L Na was pre-
sent (n=3).The effect o.f E was blcked by 10 and
30 q-L Na (n=l5).With 1 mEq.L hNathe uptake
of Na re linearly up to the 40 and plateaued
at the 60 second of incubation without affecting
Na entry in control and during E.The uptake remain—
ad linear up to 60 seconds without a change in Vmx
aith equimolar Dopamine (D),while the plateau was
eached at 20 seconds already, and Vmx was again
nchanged with Ibupamina (I) (n=2O).In conclusion,
stimulates the maximal rate of Na entry into BB ir
way which is similar to the stimulation induced
y high Na in the medium, without affecting the to—
;al amount of Na entering the BR. D instead atimula-
:es the total amount of Na diffusing while I inhi—
)its it,without affecting the maximal rate of diffu-
ion.Stimulation of Na entry by E,its inhibition by
and the dual effects of D can account for the dif-
'erent physiologic actions obtained in vivo by oth—
rs.CA may play an important role in proximal reaor—
jtion.
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COMBINED TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS
BY ANTICOAGULANT (AC), CORTICOSTEROID (CS) AND
IMBUNOSUPRESSIVE (IS) DRUGS
Belovezhdov,N. ,I. Altunkova
tedical Academy, Sofia, Bulgaria.
Long term combined treatment (from 5 to 72 mths)
was carried out in 21 patients with SLE and histo-
logically proven lupus nephritis, AC therapy was
begun with Heparin,i.v. vor 2—3 mths, followed by
Acenocumarol. CS treatment was carried out with
Prednisolon (60 mg initial dose). In 10 patients
the treatment was initiated with pulse therapy with
Methyiprednisolon (300 mg for 3—5 days). As IS drug
was used Azathioprine (100 mg per day). The pa-
tients were studied for 9 to 79 mths (mean 33,6).
Complete clinical remision was observed in 13 pa-
tientS, partial remision in 4 and no change in cli-
nical state — in 2 patients.
We discuss some advantiges of the combined
treatment with AC,CS and IS in patients with lupus
nephritis and the role of alternate CS therapy in
decrease of the side effects.
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IMMUNESUPPRESSIVE TREATMENT OF THE NEPHROTIC SYNDRO
ME (NS) OF MULTIBYSTEM IMMUNE DISEASES.
N.A. Olmeo,G. Soggia,R. Faedda,A. Satta,E. Bartoli.
Istituto Patologia Medica, Univ. of Sassari, Italy.
Four female patients had the association of NS,
progressive renal failure and a multisystem immune
disease. A patient had hypothyroidism,Addison disea
me and autoimmune diabetes aellitus with membrano-
proliferative glomerulonephritis typeL. The second
had acute thyroiditis with mixed—membranous and
diffuse proliferative changes. The third patient had
Graves disease with a pure epimembranous glomerulo
nephritis plus focal and mesangial sclerosis. Th'e
fourth patient had focal lupus nephritis with acute
thyroiditis. All patients received Prednisone 3 mg
Kgq.o.d. for 60 days, tapered in 4 months and
kept at maintenance levels of 20 ag q.d., and Cyclo
phosphamide 100—150 ag q.d. for 6 months. All pati=
ents but one were cured, with disappearance of pro=
teinuria and an average fall in PCr from 1.43 to
0.80 mg%. The pure membranous gloaerulonephritis had
a partial response with a fall- in protein excretion
to 0.6 gr per day,while PCr remained normal. We con
dude that immunosuppressive treatment may be ex=
tremely helpful in the MS that sccompanies multi—
system autoimmune diseases. The titer-of antithyroid
antibodies rose significantly during treatment and
after being cured, indicating that they may not be
essential in the pathogenesis of the renal disease.
Alternatively, the treatment may de—repress ahalper
cell population, favouring the formation of non—ne=
phritogenic immune complexes in antibody excess.
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EFFECTS OF IMMUNOSUPPRESSIVE TREATMENT IN PURE MEM
BRANOUS AND MIXED—MEMBRANOUS GLOMERULONEPHRITIS.
N.A. Olmeo, C. Soggia,A. Satta,R. Faedda,E. Bartoli
Istituto Patologia Medica,Univ. of Sassari,Italy.
Fourty—two patients with pure membranous (10),
mixed—sembranous( 11) and miscellaneous glomerulone=
phritis(21), had the nephrotic syndrome. They were
treated either with Cyclophosphamide alone(7) , 2—3
mg/Kg q.d.(cumulative dose 24a5gr in 237±44 days),
or with Prednisone (2mg/Kg q.o.d., tapered after 60
days, interrupted after 180 days) or with the combi
nation of both (n=33) . They were followed for an
average of 27.5±19.8 months. Nineteen patients (2
with pure membranous, 8 with mixed,3 with LES and 6
with miscellaneous diseases) were cured:they were
peraanently free from urinary abnormalities and with
normal GFR.Protein excrection fell to less than 200
ag per day.Sixteen patients(7 with pure meabranous,
2 with mixed,l-withLES and 6 with miscellaneous)
were improved with a stable serum creatinine (1.1±
0.5 vs l.2±.6ag%) and a drop in proteinuria from 3.5
to 0.9 gr per day(P<.Ol).Six patients were unchan
ged, though without any disease progression. One pa
tient only, with Dermatitis Herpetiformis and IgA
nephropaty, had a deterioration in renal function,
with a rise in PCr from 1.3 to 1.8 mg%in24months.
Amenorrhea was observed in 5 female, azospermia in
two male patients, Herpes Zooster in one Lupus pati
ent. These data demonstrate that immunosuppressive
treatment is effective in the nephrotic syndrome
with either pure or mixed—membranous lesions. The
cost—benefit ratio seems acceptable.
IT IS POSSIBLE TO DISCOVER KIDNEY LATENT FUNCTIONAL
ALTERATIONS IN DIABETIC PATIENTS? ROLE OF BODILY
EXERC ISE
3. Bellinghieri,V. Savica,A. Mallamace,G. Raneri,
S. Rotondo,B. Ricciardi,F. Consolo
Istituto Pluridisciplinare di Clinica Medica e Tera
pia Medics Generale e Speciale, Università di Messi
na, Italia
We studied to identify kidney latent functional
alterations in diabetic people a control group and
a group of diabetic subjects divided according to
the treatment in 3 sub—groups (dietetic, insulinic,
and with oral agents) measuring diuresis, proteinu—
rim and enzymuria (A—glucosidase and 13—2—sicroglo—
buline) before and after bodily exercise by dread—
mill (40.000 Kgm).
During the period of observation all the subject
drinked water to stisulate the diuresis under a con
tinuous control of heart—frequency and blood pres-
sure.
Our results showed that bodily exercise detersi—
ne enzymuria also when the protheinuria is absent
and that methabolic omeosthasis is really important
during the evolution of diabetic disease.
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HISTOPATIIOLOGIC FINDINGS AND CLINICAL
OUTCOME OF KIDNEY TRANSPLANTATION
L. Berard me H i, C. Beretta, M. Re iteri, L . Mattur
ri,A.Pasciucco and A.Vegeto.
Department of Vascular Surgery aridTrans—
plantatiori,Policlinico Hospital, Milan,
Italy.
The incidence of atherosclerosis is par—
ticulery high in patients on maintenance
hemodialysis;moreover,kidney transplanta-
tion seems to accelerate atherogenesis.
The present study analyzes in 112 recipi—
ents,out of 749 consecutive transplants,th€
atherosclerotic risk factors and anatomical
/histological conditions of vascular sys-
tem at the time of renal transplantation.
Only 47% of sclerotic patients were contern
porery hypertensive at the moment of the
operation. In conclusion,histologicel evi-
dence for vascular damage in the recipient
cannot be correlated with a lower graft
survival at 3 months, if compared to the-
control group (76.4% versus 77%).On the
contrary the expectancy of graft survival
Is vgriificentIy better in the control
group (45.6% versus 24%).The wall conditi-
ons of 37 donors' renal artery were also
histologically examined and correlated
with the early recovery of graft function
and survival after 3 months. The better
preliminary results in the outcome of gra-
fts with sound artery at 3 months (90% ver
sus 58.9%)must be discussed.
.
PREVENTION OF AMYLOIDOSIS IN FAMILIAL MEDITERRA-
NEAN FEVER (FMF) WITh COLCHICINB
S. Cabili, D. Zemer, M. Pras, A. Aviram, E. Sohar
Chaim Sheba Medical Center and Tel-Aviv Medical
Center, Rokach Hospital, Tel-Aviv, Israel
Colchicine is used since 1972 for the preven-
tion of acute attacks of FMF and is effective in
85% of the patients. Our experience shows that it
is even more effective in preventing the develop-
ment of amyloidosis. Before 1972, the prevalence
of amyloidosis among our 470 patients not treated
with colchicine was 27% (the rate of appearance of
new cases nearly equalling the mortality rate from
the disease). After 1972, among 786 patients who
did not have proteinuria when started on colchic-
me, only 3 (0.4%) developed proteinuria during a
follow-up period ranging from 4 to 10 years; 54
patients did not take coichicine (non compliance)-
among those 10 (18.5%) developed amyloidosis. 114
patients had proteinuria when started on coichic-
me and are now followed-up for an average period.
of 5,7 years, the majority did not progress to
renal failure; before the coichicine era, the mean
interval between the appearance of proteinuria and
the onset of renal failure was 2,2 years (53 pati-
ents). However, in patients who had renal failure
(Cr 1.6 ing%) when colchicine was started, treat-
sent did not prevent deterioration - the average
period of progression from onset to terminal renal
failure was ÷ 33 months among treated and non
treated patients.
Colchicine prevents the development of aniyloid-
osis in FMF, and improves the course of the
disease in amyloidotic patients without renal
failure, but does not alter the course of the
disease after the Onset of renal failure.
CARDIAC PERFORNANCE IN DIABETIC RENAL FAILURE.
J. Bergiund, R. Jonasson, L.E. Lins, K. Pehrsson
Divisions of Nephrology and Cardiology, Department
of Medicine, and Department of Clinical Physio-
logy, Thoracic Clinics, Karolinska Hospital,
Stockholm, Sweden.
Cardiac performance at rest and during exer-
cise was assessed by left ventricular catheteri-
zation in ten insulin—dependent diabetics (age
31—48 years), with non—dialysis—requiring uremia.
All patients were treated for arterial hyperten-
sion, but none had clinical signs of heart
disease.
All but one patient had low working capacity
(50 — 130 Watt, mean 84), but only one had a low
cardiac output in relation to oxygen uptake
during submaximal exercise. Nine patients showed
impaired ability to increase left ventricular
stroke work in response to volume load and during
exercise. Left ventricular end—diastolic pres-
sure (LVEDP) at rest was normal in six patients
(8 — 18 mm Hg, mean 13). During exercise all but
one had marked elevation of LVEDP (18 — 53 am Hg,
mean 29).
Arterial hypertension and autonomic neuro—
pathy possibly contributed to the disturbed left
ventricular performance, while anemia, uremia or
volume over—load did not correlate to LVEDP.
Our results suggest that diabetic patients
with moderate uremia suffer from left ventricular
dysfunction. Diabetic patients with progressive
renal failure therefore require dialysis and a
kidney transplant earlier than do patients with
end—stage renal disease of nondiabetjc origin.
TH FFCT OF B1HçET'S ISEAS 01 TH.
FUNCTIONING OF Th KIDNEY ANiJ ON ITS
ANATOMICAL STRUCTURE
a1ar.,Turgan,ç. ,Yasavul,t?. ,Karagöz,
F. rraettepe University,Dept. of
Nephrology,Ankara — Turkey.
Much and varied research has been
carried out on this disease since it was
first reported in 1937.Whlle some people
consider this disease to be of viral
origin,others regard it as autoimmunleed.
This study has been carried out on six
patients.Biochemical tests,such as BUN,
creatinine clearence and ha+, K+,
protein excretion at 24 hour intervals,
were carried out and at the same time,
by means of kidney biopsies and immuno—
fluorescence ,anatomical deviation were
examined.In four cases no major patho-
logical disorder was discovered ,rieither
as regards the tissue of the kidneys
nor in the way they funtioned.In the
other two cases,howevor,both functional
and anatomical abnormalities were
revealed.Further,in one of these,the
presence of amyloldosis was also rioted.
In generai.,when the anatomy of the
kidney was involved in the disorder,
the course of the illness was seen
to be more severe.
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• RADIONUCLEAR DETERMINATION OF GFR AND RPF TO
DETECT EARLY DECREASE OF RENAL FUNCTION IN INSULIN
DEPENDENT DIABETES
C.Cascone,G.Beltramello0,N.Borsato00,P.Calzavara,
t'f.De Luca,F.Susanna,D.Madia°,P.Zanco°°.
Renal Unit,Unit for Metabolic Diseases°,Nuclear
Medicine Service°°,General Hospital ,Castelfranco
Veneto, Italy.
Since some Authors have recently pointed out
the limited value of plasma creatinine as a marker
of GFR in diabetic patients and in front of the
conflicting opinions about the significance of the
microproteinuria in predicting a decline in renal
function,we studied the GFR and RPF with radionu—
clear techniques(Tc 99m—DTPA and I 123—OIH)in 18
patients aged 13—58 years (mean 38)affected by in-
sulin—dependent diabetes from 2—34 years (mean 12)
with normal blood pressure and plasma creatinine.
GFR and RPF were correlated with daily proteinuria
urinary lisozyme and duration of diabetes.
GFR was 67-154 rnl/min (mean 103 + 23),RPF 450—770
mi/mm (mean 611 + 95).
The daily proteinuria was 60-1295 mg (mean 334 +
321).Only two patients had lisozyme in their urine
No significant correlation was found,using linear
regression analysis and Student t-test, between
renal hemodynamic and the other parameters.
Nevertheless some importance may be attributed,for
the pathophysiology of diabetic nephropathy,to our
finding of a slight decrease,in the course of the
disease,of RPF earlier than decrease of GFR.
Our data,although they need confirmation by follow
up studies,seem to contrast with those Authors who
enphasize the role of microproteinuria in the pro-
gression of diabetic nephropathy.
PTh AND H2 ANTAGONISTS IN UREMIA
E.Corvaja, M.Egitto, M.Barillari
IstL[tuto Pluridisciplinare di Clinica Medica Genera
le e Terapia Medica Generale e Speciale dell'Uni—
versità di Messina.
Uremic patients' serum tends to have high para—
thyroid hormone (Pm) concentration.
In uremic hemodialysed patients, the PTh plasma
levels are generally very high.
Previous studies (Simon 1978, Sherwood 1979) ha
ye shown that patients treated with cimetidine ha-
ve had a fall of PTH serum levels; some other
authors have not got the same results.
The effects of the coninonest 1-12 antagonists on
endogenous PTh are enounced in our study which
deals with 8 anuric patients in HD treatment.
Cimetidine (400 mg/die) and ranitidine (150 mg.
die) were administered in cycles of 5 successive
weeks with an interval of 10 weeks.
Basal and weekly imuno reactivity m was mea--
sured in the serum of patients using assays with
different specificity.
During cimetidine treatment mean plasma IPTH de
creased from 326 42 to 232 34 and during rani-
tidine treatment from 308 38 to 226 18.
Our experience demonstrates that the H2 antago-
nists administration in anuric patients in MD cau-
ses the fall of iPTH plasma levels.
Such pharmacological agents, if necessary, can
inrove also the bone-mineral metabolism in HO.
SSA ANTIROOTES, NEW MARKER FOR EARLY DIAGNOSIS
OF WEOENES ORANULOMATOSTS ?
W.Clasen, A.Hornhurq, l.Kindier HO.Sieherth
flept. o4' tnternai Medicine TI, Aachen, Germ.F..
Weneners qranulo''atosis (MO) is a
oranulon'atous 'ascuiitis o the resoiratorv tract
associated with qlom.eruionepbritis (ON) or other
oman "ianFestations.
In contrast to other imnunolonical diseases in
MG no valide serolonical marker or ear1v
diaqnosis has been established so 1ono.
Recently SSA (Snron syndrome A-antihodies
(SSA-ABl were described or such due (Andrassv ef
al. Klin.Wochenschr. (OP.) R1•P73-p7c
In three patients with WO, two with, one without
ON SSA-AB could he demonstrated in strono
correlation to clinical activity f the disease.
Under irnnunosuopressi ye therapy with
cvclopbosphanid (7q/k hodvweiobtl and prednison
(ino/ko) endoaenous creatinine clearance
draMatically increased in natjents with GM,
nulrionarv ini1traths diseoneared, cranulonatous
rhinitis showed healino tendency. n patient
seru" SSA_PR djsaoneared jurino sicien
tbpranv end returned onsitive in active staoes r
disease.
• EFFECTS OF NALOXONE INFUSION ON GONADOTROPHIN AND
.
PROLACTIN LEVELS IN PATIENTS WITH CHRONIC RENAL
FAILURE
G.Cossu,G.B. Sorba,M.Maloli° and G.Delitala*
Servizio di Esodialisi,Ospedale Civile di Sassari,
Clinica Medica°,Cattedra di Endocrinologia*,Univer_
sity of Sassari,Viale S.Pietro n.12,Sassari, Italy.
The adsinistration of naloxone,an opiate recetor
antagonist,has been shown in several studies to
cause a rise in circulating gonadotrophin level,an
effect thought to be sediated at a suprapituitary
level.Abnorsalities in gonadotrophin and prolactin
(Pri) secretion have been desonstrated in patients
gith chronic renal failure(CRF),but the sechanisss
of this disfunction are still unclear.Since high
levels of circulating endogenous oploids have been
desonstrated in patients with CRF,the effects of
naloxone on LH,FSH and Prl secretion was evaluated
in sale patients with CRF on long—ters hesodialysis
treatsent.lOsg rialoxone(or norsal saline) were in—
fised(single blind) to 8 patients(age 2L1_51 years)
and blood specisens for horsone analysis were taken
at intervals for 3 hours.Neither saline nor nab-
xone caused any change in LH,FSH or Pri in patients
with CRF. the contrary,pulsatile LH secretion was
significantly stinulated by naboxone in nornal sub-.
jects.Since naloxone is a specific antagonist of
opiate receptors ,the results would suggest a reduced
hypothabanic opiate activity in patients with CRF.
Nloreover,the high circulating levels of net—enke-
phalin reported in CRF do not represent the patho—
genetic cause of hyperprolactinaenia in CRF.
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• HUMAN PANCREATIC POLYPEPTIDE AND SOMATOSTATIN TN
S CHRONIC RENAL FAILURE.
R.Lugari ,S.DavidP.Dall'Argine,V.Nicolotti ,A.Parmeg
giani,A.Gnudi,ALucianis.ToscanjR.zandomeneghi
Cattedra di Endocrinologia,Universitb di Parma;
:Cattedra di Nefrologia,Universitb di Parma;
Cattedra di Patologia Medica,Universitb di Modena.
Kidneys are the most important sites for the metabo
lisa of Pancreatic Polypeptide(PP).Exogenous Somato
statin(SRIF)clearance rate is reduced in patients
with chronic renal failure(CRF),suggesting that kid
ney may playa role in the metabolism of the hormone.
This study was undertakento assess the behaviour of
PP and endogenous SRTF in two groups of patients.
Group A:lO subjects with CRF(creatinine 2-6mg/di).
Group B:12 uremic patients in chronic dialytictreat
ment(HD).l2 healthy volunteers were examined as con
trols.Two fasting basal blood samplesforPPandSRlp
determinations were collected in groupA and controls
In group B blood samples were collected before and af
ter HD.PP and SRIF were measured by RIA on a]c'nhol
extracts of plasma.No significant variation in SRIF
levels was observed between controls(55-s-l2pg/ml)and
group A(8+l8pg/ml).GroupB showed similar basal SRIF
values(52-i-l5pg/ml)which were not significantly modi
tied by HD(7L1÷22pg/ml).Group A had basal PP levels
significantly higher than controls(l8O+5Opg/ml v.a.
4l÷8;pO.OOl).PP values in group B(725+5l7pgIml;p<
O.OOl)did not change after HD(765i-6l6pg/ml).
In conclusion,PP levels are elevated in CRF and more
markedly in end stage of renal failure.Hemodialysis
has no effect on the PP concentration.The hepaticme
tabolism of SRIF could account for the normal basal
levels of the hormone in these patients.
5 REVERSIBLE TUF3IJLAR DISFUNCTION IN ALCOHOL ABUSE
S.De Marchi ,E.Cecchin*,F.Grimaldi ,A.Basi le,F.Tesio*.
Department Internal Medicine, Ospedale, Codroipo (liD).
*Unitof Nephrology, Ospedale, Pordenone, Italy.
The discovery of an unexp lamed a Ika I me ur I ne pH in
a significant percentage ofalcohol cs prompted usto
evaluete some aspects of their tubular function. We stu-
died 76subjects witha historyof alcohol consumption
of at least 160g a day for 10 years or more.Onlysubjects
withoutclinical and histopathological evidenceof
chronic I ver disease havebeen included in thestudy.
Fractional urinaryexcretion of/32—rnicroglobul in (FE
f32m),sodiuni (FENa),potassium(FEK),chloride (FEd),
calcium (FECa),phosphorus (FEP),uric acid(FEUr),urine
pH and bicarbonatewere measured with in4S hours of ad-
mission and after 30 days of abstinence. The endogenous
creatinine clearancewas inthe normal range nat I pa—
tients.At admission 25 subjects (33%) (Group 1) hada u—
rine pHover 6.4and adai ly bicarbonateexcretion ran—
ging frorn5.S to25.9 rmaol .Thevalues ofFE2m,FENa,FEK,
FECI,FECa,FEP,FEUr weresignificantly increasedas corn
pared to those of 51a Icoho I ics w ith ur me pH under 6.4
(Group 2) and to controls. After 30 days of abstinence
all these parameters inproved and they did not differ
from those of controls. In group 2 subjects at admission
FEJ2m, FENa, FEK, FECI , FECa, FED, FEIJr, urinepH anddai ly
bicarbonate excretion were in the normal range and they
did not modify sign if icant ly dur ing abst inence.
In conclusion these data provide evidence that in
one third of heavy drinkers alcohol abuse causes a corn—
plextubulardisfunctionwhich,at least inthisstage
of thealcohol ic disease, recovers with abstinence.
• IUBULAR F3FICtE AND RENAL LEcTIVrr? ICWAEEZS GLYCUBYL AWIN
IN DIABE1IC 13OACI1XYTIC Fft'PER234)LAR STATES.
G. Delf.tho, G. Canthano, G.M. (higgeri, C. leirolo (Intr. by
A. Sail).
1-bepital of Lavagea, Lavagea (cs) Italy.
Either tubular defecta or an altered renal handling of' glyco—
syl albumin (GA) nay be involved in the pathcgenesis of the pro-
teinuria of diabetic ketoacidotic hypercainDlar cola. We examined
the renal handling of GA and the tubular fuicttcxm in 7 diabetic
petients at the onset of the natabolic derangarnent and after 7
dsys of an adequate insulin and fluid therapy, taking the urina-
ry excretion rates (UER) of Isaunoglubulins G (ig), albumin
(alb.) and B- microglobulin (B2-e) as narkers of the type of
proteinuria. Albumin was purified by pseixb—effinity thrcaatoa
en Affi Gel Blue and the bcund carbdrdrate was evaluated as
hydroxyaethylfural (FW) released after the acid hydrolysis of
the protein. The naan UER at the onset of the natabolic derange-
nnt and after 7 days therapy were respectively 29.23 18 pg/
rain arid 0.27+0.11 for
B2—
a, 76.32+19.6 and 11.63 for
alb.,23.65+9.4and < lOforlgG.Inallcasestherewasa
hig-I statisticalcorrelation between the UER of all proteins and
serus caimlality (p < 0.041). While sennn GA concentration
shcaed only a slignt decrease after 7 days therapy fran 0.3784
nole FF/coles sib, to 0.333 +0.04, the urinary GA con—
centration increased fran 0. 6536 + 0.13 to 1.3342 0.29, with
an increase of the urinary/seruli ratio fran 1.87 0.7 to 3.
0.89. The hign levels of B2 - m UER together with the influa-ae
of seruir omeniality cii the proteinuria indicate that a tubular de
fect is the predominant feature of the proteirirta of diabetic
ketraridotic hypercianolar states. The rapid change of renal se-
lectivity towards GA in this condition, in spite of the constant
GA saran concentration is likely to be considered as the result
of an altered tubular function.
5 IMMUNE FUNCTION (I.F.)AND RENAL TRANSPLANTATION(RTX
IN FABRYS DISEASE (F.D.).
D.Donati,A.Capsoni*,G.Sabbadini*,L.Baratelli ,D.Cas—
sani,A.De Maio,G.Frattini,M.Martegani,L.Gastaldi
(Intr. by R.Rossi)
Divisione di Nefrologia — Ospedale Regionale—Varese
*Clinica Medica II — Università di Milano — Italia
As a high rate of" life—threatening infections is
reported after RTx, transplant is no more recommen-
ded as choice treatment in F.D. Ceramide trihexoside
storage in leucocytea, could impair their host defen
Ce function, and determine this abnormal outcome.
I.F. was investigated in 3 Fabry's (2 on hemodia
lysis) and 6 other hemodialysed patients (pts),mat—
ched for age and time of sobstitutive treatment.
E and active E rosetting cells, Th and Ta, NK, B
linphocytes counts, in vitro response to PHA and in
the MLR; dosage of immunoglobulins (IG) and comple-
ment (C) fractions; polymorphonuclear (PN) cells
functions (chemotaxis, phagocitosis, killing) were
performed.
Total T, Th and Ts number and in vitro responses
were depressed but without significant differences
between the two groups while NK, B, serum IG and C
fractions and PN functions were normal in both.
The high rate of infections in transplanted Fa—
bry's pts cannot be related to a specific IF impair
mentdifferent from the commonly observed uraemic
pattern.
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• FILTRATION FRACTION (FF): AN INDEX OF THE RENAL
DISEASE ACTIVITY IN SLE PATIENTS
H. Favre, P.A. Miescher.
Department of medicine, Geneva, Switzerland.
22 patients fulfilling the ARA criteria for SLE
had a renal disease histologically proven. Renal
plasma flow (RPF) and glomerular filtration rate
(GRF) were estimated by EDTA Cr51 and Hippuran
1125 clearances using a single shot technique on
two occasions at one year interval. 24 h
proteinuria and urinary sediment were also
obtained at the same time. The results are
summarized in the table
Renal No GRF FT Proteinur. Positive
Tt pat. fl ml/min <18% >200 mg/d sediment,
PT 3 0 tF 1 2
FG 4 0 1 2 2
DG 13 5 8 9 5
TOTAL 22 5 9 12 9
MG niesangial— FG focal— DG diffuse glomerulo—
nephritis.
FF was a better parameter to recognize DG than
proteinuris and urinary sediment, with a
sensitivity of 61 % and a specificity of 88 %. In
three patients with this type of SLE glomerulo—
nephritis, FF was the only laboratory parameter
which gave pathological results. All the nine
patients with an initial decrease in FF had
changed their GFR beyond the limits of
reproductibility of the method one year later. By
contrast, there was no correlation between the
renal disease and antibodies to DNA DS,
circulating immune complexes or level of the serum
complement. Based on the results, the following
approach of the SLE glomerulonephritis could be
proposed : a) initial renal biopsy, b) surveying
the evolution on treatment by repeated
measurements of FE.
PROTEINURIA IN PATIENTS WITH CANCER
It. GABRIEL. St. Mary's Hospital, London, England
Clinical glomerulonephritis is occasionally
associated with cancer, thus proteinuria might be
expected in some patients with cancers other than
those of the urinary tract.
Random urine samples were collected 'rom 439
patients with various cancers (vo) and 478 hosp-
ital patients (HF) in whom cancer was not suspect-
ed. The age range in both roups was 20 — 80 yrs.,
mean 55.2 — 24.9 and 58.3 — 22.6, respectively
(p = ns.). Care was taken to obtain urine from
patients without renal tract disease, systemicdiseases which involve the kidney or from patients
taking drugs that may be nephrotoxic. Catheter
cpecimens were not included. Unspun urine was
micmoscoped and urine assayed for total protein
concentration.
Proteinuria was found in 158 36%) patients in
the VC proup (range 0.02 — 1.10 — 0.32 g/l) and
in /+1 (8.6%) of HP patients (range 0.01 — 0.990.46 Wl). The difference is significant; X =
26.55, p < 0.01. Tie presence of proteinuria did
not correlate with aboomalities of urinary sed-
iment.
Proteinuria is thus common in patients with
cancer. Its presenca suggests sub—clinical rena].
damage. This study complements demonstration of
imniunoglobulins and complement components in
gloineruli of patients who have died of cancer.
Glomerular disease may be more common in patients
with tumours than has previously been considered.
. FAMILIAL NWHROPATHIC AMYLOIDOSIS WITH RECURRENT
INDOMETHAC m RESPONSIVE FEVER AND POLYSEROSITIS
r. G. Feest and 3. P. Wallia
Reial Unit, Royal Devon & Exeter Hospital, Exeter,
UK.
A 45 year old woman developed renal failure
from amyloidosis. She is the sixth member in two
successive generations of her family to develop
non—neuropathic nephropathic amyloidosis. She
had a history of recurrent night sweats. During
nine months of CAFD she had recurrent unexplained
fevers, often with pleuritic pain and flittingpleural rubs. She had four episodes of 'sterile'
peritonitis. After transfer to haemodialyeis
fever and symptoms persisted for six months
without evidence of infection, pulmonary embolus,
or auto—immune disorder. Chest x—ray showed
small effusions only. When pericarditis occurred,
despite good dialysis, Indomethacin was given.
There was complete remission of fever and all
symptoms for the first time in six months.
Indomethacin was stopped after two weeks and
fever returned: doses above 25 ag tds were needed
for several weeks to control fever and pleurisy.
Unlike the familial nephropathic amyloidosis
of Ostertag, hepatic involvement in this family is
minimal and is confined to vessels. The amyloid
fibrils in this family differ from those in
familial mediterranean fever, and the inheritance
is dominant. In the kuckle—Wells syndrome
familial nephropathic axnyioid is associated with
urti.caria and nerve deafness as well as fever.
This seems to be a distinct syndrome of auto—
somal dominant familial riephropathic non—neuro—
pathic ainyloidosis, with little hepatic involve-
ment and recurrent Indomethacin responsive fever
and polyserositis. Could early treatment with
Indomethacin prevent rrogrssion of amyloid?
PLASNAPHERESIS AND HAMEODIALYSIS IN PATIENTS WITH
SISTEI4IC DISEASES AND RENAL INVOLVEMENT
V. Gaparovié, D. Ivanovi6, N. Gjurain (Intr.
by M. RadoniO)
Internal Clinic Hebro, Medical Faculty, Zagreb,
Yugoslavia
In 19 patients (pts) with sistemic diseases and
a renal involvment, a deterioration of the renal
function occured and plasmapheresis (PF) and/or
hameodialysis (HO) were performed. There were 8
dand 11 o pts (mean age !t3,9l8,O). In 12 pta
PF, in 14 PF and HD, in 3 pts RD were performed respectively. In 6 pts with plasmocytoma and hypervis.
cosity PF was performed. In 3 ts an improvement
of GFR from (38,832,6 to 50,6—33,8 ml/rnin) occured
in 1 pt I-ID had to be performed at the begining. In
2 pts with Macroglobulinemia PF was performed. In
one pt GFR improved from 30,2 to 39,8 ml/min, cold
antibody concentration decreased but he died du-
ring second admision in the course of medical tre-
atment. The second patient improved after PF with
disappearance of antierytrocyte antibodies. There
were 11 pts with rapid deterioration of the renal
function: 6 pts with sistemic lupus erythematodes,
2 with Sy Good—Pasture, 1 Weener Granulomatosis
and 1 with Polyarteritis nodosa. In 8 pts PF was
performed, 3 pta died, 5 survieved with the improv-
ement GFR from 211,912,7 to 35,515,6 ml/min in 4
pta and 1 remained on HO. Other 3 pta were treated
with corticosteroids and cytostatics only, 2 de-
veloped terminal renal failure, in 1 GFR improved
to 20 ml/min.
We concluded that PF has benefitial effect and
performed early in the course of the mentioned
diseases, in adition to medical treatment prevents
the deterioration of the renal function.
•
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[HE MEMBRANO PROLIFERATIVE GLOMERULONEPHRITIS (MPGN.
ASSOCIATED WITH CIRRHOSIS GOOD EVOLUTION AFTER
STEROIDS AND PLASMA EXCHANGE (PE) THERAPY. C.Genin,
J.C. Sabatier, B. Laurent, P. Laurent, R. Gonthier,
F. Berthoux * Service de Néphroloqie, Hôpital Nord
Saint—Etienne, France.
24 patients with evident histological or clinico—
biological signs of cirrhosis were studied.lO pa-
tients presented a MPGN type I, 13 a Mesanqial G.N.
and 1 a Clomeruiosclerosis.22 out of 24 had IqA de-
posits in the mesangium. MPGN appeared significantly
more severe than the other types of GN 6/10 patients
had a proteinuria higher than 3 0/24 h vs 3/14 (p 0.05)
8/10 had a renal failure vs 5/14 (P0.O5)(serum crea-
tinine5ROpiol/i : 2/10 vs 2/14 ; 2UR—5mprol/l 5/10 vs
2/14 ;42Wnol/1 1/10 vs 1/14. By contrast, frequency
of macroscopic haematuria (4/10 vs 7/14) and presence
of circulating immune complexes (5/9 vs 3/12) in Clq
precipitation by PEG 2 % assay were not significan-
tly different. Complement was normal in all cases.
8 out 10 patients with MPGN were treated by a least
a total dose of 3.5 g Prednisolone injected partly
by pulses and 3 of them by P.E. in addition. 8 pa-
tients had a good evolution disappearance (3 cases)
or very significant improvement of urinary signs
(5 cases). Renal function has been normalized in 3
cases, improved in 1 case and stabilized in 2 cases.
2 cases continued to worsen (very evoluted renal
failures and one of them has not been treated). I
patient had a control biopsy after 3 years (at the
time when urinary sions had disappeared and renal
function improved) : qiomerular lesions were mild
without significant deposits in irnmunofluorescence.
MPGN associated with cirrhosis may have a good evo-
lution. Steroids P.E. appear to be able to rever-
se advanced chronic renal failure, in association
with interruption of alcohol intoxication.
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URINARY E)ERETICl OF PLBUIN WITh AN ALTERED INREE—DThIEREIC66L
Rt1ATIC IN DIABETIC FtfCTIC4AL REPHROPAINY. EVThEI&E EtJR A
PAIXNETIC ROLE.
G.M. (iBEeri, 0. Candiano, G. Delfina, C. (jeirolo (Intr. by
A. Sodi)
1-bepital of Iavag-ia, Lavagna (GE), Italy.
Ivblecular nmchanim fcs' the renal byperfiltratien of alburdn
(sib.) in diabetic functicnai nephrcpati-gr has been recently hypo
thesized cn the basis of an altered fincticnality of glycceyla—
ted sib. We extend now the thesis to the tertiary stntre of
sib., evaluating the free sulfrydryi groip (SI-I) cx*ithnt of this
protein (taken as a serker of disulftiyde bends breakcbv.n) in se
run and urine of 10 norsel &hjects (N) and 24 diabeticpaents:
8 with noreal albuninuria (A), 8 with fmcticral nehrcpathy (B)
and 8 with clinical nephrqzetlnj (C). Mb. was purified with paeu
ds—ligand chronmthgraphy en inmebilized Cibacrnz-i Blue F3 — GA
and its purity tested by irnm.nelectrcpharetic techniques; SI-I
ccntenta were evaluated by the Einmn prmcedsre. Weile senin sib.
shawed a mean SH centent of 0.452 ÷ 0.032 andes SB/roles sib, in
all xups, the values for urinary aib. were preatly inoreased
in cftut to senrI: 1.67 oq N, 2.03 ÷0.52 grop A
and 2.01 + 0.62 gnip B, giving an urmnary/senn ratio respecti
veiyof2.95+O.54 (N), 4.65+1.17 (A) and4.09±l (B).
('oup C patients showed the sane SI-i xntent in serun arid urina-
ry sib. with a urine/serun ratio of 0.66 +0.1.
These results indicate that sib. rrolecules altered in their
three—dimensional ccnfornmticn cross the glanenilar wall mere
freely than nonasi sib. and that an increased excreticn of the-
se nolecules is the noin featere of diabetic ftnctienai nephro-
pathy. They sian dsscribe the difference between the flUctienal
and the clinical phase of diabetic nephrcpathy in terse of re—
owl selectivity Ixamrds sib.
RAPTDLV PROGRESSI"E GLOMERIJLONFPHRTTT S WITH
IMtIUNOLOGICAL MVOPATHV.
WM.Gliickner, HG.Siebertb, lM.Scbrtider,(RWTH Aachen)
A.Boble (Tiihinnen), GH.Thoenes (MUnchenI
Syrnritnmatic RPGN -,it.h mvnpatbv is a curious
disease, described the first tine by fli' ludne et
ci. (Arcb.Pathol.Lab.Mpd. fll:7?,1°77) in a
patient -,jth a severe rnyooathv lastino over 0
veers.
In nur case we nunc1 a qenerelised musc1e Fibre
atroohv, reeaninq mainly type I Fihrps. Thp
in'unnclunrescence showed toG deposits on the
muscle ihre basement membrane and nositive
vascular staining with IqO, TOA and ToM. There
was nn muscle Fibre necrosis, nor could we find
sions o vasculitis in skin, muscle or nasa1
n!jcoa, In the kidney biopsy the glomeruli showed
fibrinnid necrosis with crescents which were
positive or fibrinr'oqen'I, and serrnental
—
mesannial stainino with ToG and C3.
A the admission the patient suffered prom
— ttplegj with an excessive increase o creatin
kinase (flfl ti/l) and extremely blob myoqlnhin in
serum as well as in urine. Creat.clearance (C I
was reduced to iS mi/mm. In the immunoionil
and serological tests we found only positive
rheumatoid actors, all the other immune
ocrameters includino the ORM-antihodies were
neoat.ive. Two month heore admission the patient
sutfered from oneratively treated otitis media
(no Weqeners oranulomatosisi, four weeks lateron
he not severe qeneralised muscle soreness and
weakness up to tetraplemia with normal CSF and
nerve conductive velocity, tinder a steroid pulse
therapy and subsequent administration 0F
cyclombosphamide, azathioprine and prednisolone
we could observe a recovery f muscle strength
and of Ccr up to now 7flml/r,in.
ULTRASONICALLY GUIDED FINE—NEEDLE ALCOHOLIZATION
(UGFNA) AS SUPPORT TO MEDICAL TREATMENT OF SECONDA-
RY HYPERPARATHYROIDISM (sHPT)
A.Giangrande, P.Cantü, L.Solbiati, C.Ravetto
General Provincial Hospital, Busto Arsizio, Italy
sIIPT frcquently complicates the clinical course
of chronic ui'emia,although more active vitamin D me
tabolites are now available.Parathyroid hyperplasia
which sustains this pattern is seldom influenced by
medical treatment and may require parathyroidectomy
(PTX).In alternative to surgery,in selected cases
(single hyperplasia,uneffective subtotal PTX, seriou
sly ill patient,refusai to surgery) we obtain a re-
duction of parathyroid mass by UGFNA. 10 out of 88
patients (3 M,7 F,age 34—69) with symptomatic si-IPT
and positive US scan were treated with 1 or 2 infil
trations (0.6—1.2 ml sterile absolute ethanol intts
duced with disposable needle 22G,95 mm long). The
tJS diagnosis was preliminarly confirmed with fine—
needle aspiration biopsy and/or 1PTH assay of aspi-
rated material,The tecnique,always well tolerated,
produced an evident change of echopattern already
present after 1—2 wks, a definite reduction of gla-
nd size after 2—3 mo,a complete disappearance of t
e lesion with US in the more favourable cases (six)
after 6 months.With single lesion, a reduced inci-
dence of vitamin 0 hypercalcemia and a permanent us
provement of bone alkaline phosphatase and iPTH
was documented.
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• INTRACELLULAR BICARBONATE (HC031)AND pH(pHj )OF SKE
LETAL MUSCLE IN CHRONIC RENAL FAILURE (CRF).
A.Guariglia,C.Antonucci,E.Coffrini,S.Del Canale,E.
Fiaccdori,F.Reni,P.Vitali,UvArduinafld. A.Bor.
ghe'tti ('tntr.by V.Cambi).
Ist.Clinica Meclica e Nefrologia. PARMA-ITALY
In CRF acidosis the extracellular steady—state
is maintained at the expense of a progressive cell
buffers titratjon(in bone and soft tissues) .me -
purpose of this study was to investigate the rela
tive role of skeletal muscle in this condition,
In 11 controls and 10 CRF patients (GFR range
4—3Oml/m'/1,73m2;pHa 7,30±O,1;PaCO2 27±4;HCO3a 13
all values are expressed as meanSD)muscle biop
sies from quadriceps feim,ris(Bergstrm 1962)for
HCO3and pHj determination by TCO2method(Guariglia
et al.1984)were performed.In CRF significant chan=
ges in both HCO3i(p <.O01)and pH1(p<.OO1)were fou=
nd,resulting in an intracellular acidosis.In all
patients HC03 was strictly related to PaCO2 leve
(°3i=°453 PaCO2 + 4,534;r=O,85;p<.OOl).
Well know are the interrelationships between pH.
and some enzimatic activities( Re].manl 972 ,Alberti e
..uT.nuevL2. - ...
TCO2
naol/mg/w
}ICO3j
imnol/L 5201
pH
12,3 11,7
*1,1
7,05
*,05
8,3**
*1,1
7,4**
*1,6
6,88**
*0,09
r 19,5** 15,2 6.89**
• UNILATERAL !JRETERIC LIGATION IN DIABETIC CD) RATS.
A PATHOLOGIC AND M3RPHOMETRIC STUDY.
G. Hatzigeorgiou, P. Ziroyannis, H. Paraskevakou,
P. Vardas, C. Georgilis and M. vrikakis,
Dept. of clinical Therapeutics, Athens tkiiversity,
"Alexandra" Hospital, Athens, Greece.
The purpose of this study was to investigate the
morphometric (weight, volume and specific gravity
(SG) of the non ligated kidney) and pathologic al-
terations in D and non D rats after ligation of the
right ureter. 31 female iite rats, age and weight
matched, were used and divided into k groups: C
Controls (8), DCily diabetic (8), L=Coly Ligated(8) and DL:Diabetjc plus ligation (7). The experi-
mental diabetes mellitus (DM) was evoked by bolus
IV streptozotocin in a dose 45mg/Kgr BW. Feeding
and watering was standard for all groups and theduration of the experiment lasted 35 days. brpho-
metric results were as follow: Weight in mg: C=
689.1223.2, Ge1O28.7535)48, L=1O96.5031.81, DL=
1236.22±142.28. Volume cm3: C0.7O±0.02, D0,93±0.03
L1.18—O.Oi4, DL:1.37O.Oi4. SG mg/cm3: C=98O.95
10.33, D11OO.3O±11.62, L927.141±i4.A47 arid DL=900.51
The histology of the left kidney showed a
mild increase of the mesangial matrix which affec-
ted 0-5% of the measured glomeruli (20) for the C
group and 15—25%, 20-30% and 145_6O% for the group
L, D and DL respectively. Arznani Ebstein cells were
only observed in groups 0 and DL with a statistical
significant (SS) difference favouring DL group
(p.O01).
In conclusion; 1 )There was a 53 increase in
weight and volume of the left kidney in DL group(p<0.OO1). 2)There was a SS decrease in SO of theleft kidney in DL group (p<0.0O5—0 .001) and 3 )The
percentage of affected glomeruli with a mild in-
crease of the mesangial matrix was much greater in
the DL group (p0.001) as were lesions specific for
DM (p<O.OO1).
MESi4GIAL GLaIERULOPAThY IN RHETJ4ATOID ARThRITIS
H. Helm, J. Mustonen, M. Korpela, A. Pasternack(Intr. by M. Viranta)
University Departments of Biomedical and Clinical
Sciences, Tainpere, Finland
To address the question of rheumatoid glomerulo-
nephritis (GN), renal biopsies were performed on
36 patients with rheumatoid arthritis (RA) and
clinical signs of renal disease. The biopsy speci-
mens, examined by light (124), immunofluorescence
(IF) and electron microscopy (UI), disclosed a min-
imal or mild mesangial glomerulopathy in 10 pa-
tients. In all of them two of the three methods
sed showed abnormalities. In LM the finding con-
sisted of normal glomeruli (2/10) or mild increase
in mesangial matrix and/or cells (8/10). In IF
studies granular mesangial deposits of IgG, 1gM,
and C3 were seen in 7/10 patients. In two cases
a typical finding of IgA (3W was observed. 1iM analy-
sis showed mesangial deposits ranging from rare to
frequent in all patients. Three patients presented
with proteinuria (PU), three with hematuria (HU),
three had both and one the nephrotic syndrome.
We conclude that there is a mesangial (3W in RA
characterized by mild morphological and inanuno-
histochemical alterations. This finding accounted
for one third of our patients and is of importance
because it must be distinguished from other known
causes of PU and in patients with RA. In our
study it was impossible on clinical grounds to
differentiate between mesangial (3W (10 patients)
and membranous GN (8 patients). A possibility
Cxists that the inesangial lesion is a sequel of
PA or a consequence of gold therapy.
SERUM AND URINARY 82 MICROGLOBUIJN LEVELS IN
VITAMIN U DEFICIENCY RICKETS
Dr.E.HASANOLU, Dr.P.CINAZ, Dr.A,HASAN0LU
Serum and Urinary Bz microglobulin levels were studied
in 27 randomly selected infants with Vitamin U deficiency
rickets,their ages ranging from 3 to 20 months,and 11 age—
matched,optimally naurished,healthy infants. None of these
infants had received Vitamin U prior to the study,nor had
they symptoms of steatorrhea or renal disease.
The Serum and Urinary 82 microglobulin were. restudied
in 12 patients after the rickets had been completely cured.
Serum microglobulin was 2.150.25 mg/it in healthy
group and 2.520.15 mg/it in rickets before treatment, and
mg/it after treatment and the difference. was not
significant (p >0.05).
Urinary 82 nicroglobulin levels were 298.7746.79 Mg/it
before treatment and returned to normal values after treat —
meet 90.27i21.59 pg/it and this decreases was statistically
significant (p <0.05).
These results suggest that there is minimal and
reversible disfunction in tubuli reabsorbtion in Vitamin U
deficiency rickets.
metabolism as conse=
quence of an intracel
lular acidosis could
then represent. a"tra
de-off" for the main
tenance of a relative
extracellular steady—
—state.
uopaired Stuet*s't'test**p<.O01
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• INCORPORATION AND EFFECT OF ALUMINUM IN OSTEO-
.
MALIC VERSUS OSTEOFIBROTIC BONE
1. Hess, K. Gautschi, H. Jungbluth, U. Binswanger
Section of Nephrology, Dptm. of Internal Medicine,
and Laboratory of Clinical Pathology, University
of Zurich, Switzerland
Osteomalacia (OM) and osteofibrosis (OF) was
induced in growing rats by feeding a low calcium,
low phosphorus, vitamin D poor diet or a calcium
deficient diet for 2 weeks. Both diets were then
supplemented with Al Cl. 0,1 % and given for
another 2 weeks, when tIe animals were sacrificed
and serum and bones analysed. Results are as
follows (M SD; n = 5 for each group):
Osteofibrosis Osteomalacia
E
-
"
Al (umol/l)
Ca (mmol/1)
P (mmol/l
2,20 0,68
2,27 0,18
2,65 0,31
2,52 + 1,01
2,90 + 0,07
0,43 + 0,12
c
*
Al (imiol/lOOg
Ca (mol/g*)
P (mol/g*)
Mi 6 %
0,13 + 0,04
9,70 0,27
6,53 0,23
46,51+ 2,55
0,19 + 0,03
lO,23 0,58
6,36 + 0,32
44,85+ 1,83
* bone ash Mi: mineral weight
Injections of desferrioxamine (DO) 2 x 40 mg
per kg BW 24 and 12 hours before sacrifice resul-
ted in a decrease of the aluminium by 21 % and an
increase of the % mineral content by 20 % in
osteomalacic animals only. - The aluminium uptake
of bone depends on preexisting pathology. Removal
of aluminium by DO is followed by a rapid mineral
incorporation.
LYMPHO—MONOCYTE AND MACROPHAGE DEFECTS IN RENAL
ANEMIA
S.Lamperi, S. Carozzi.
Division of Nephrology, St. Martin HoSpital, Genoa,
Italy.
The T—lymphocytes ,0KT4—depleted T—lymphocytes,
monocytes, peritoneal macrophages and the bone mar
row early ery-throid progenitor (BFU—e) interactions
have been evaluated in normal subjects and un ure—
mic patients(UP) in predialysis phase, on hemodia—
lysis or CAPD. In the sane subjects the T—cell gro
wth factor (TCGF) activity and the T—cell subset i
dentificaion have also been assessed.
The results show in UP, particularly in the pre
sence of reduced 0KT subset and TCGF activity, a
blockage of the interactions between immunocompe—
tent and bone marrow cells which normally could sti
mulate early erythroid progenitor growth. Since
this blockage is partially removed by CAPD, this
may suggest a more efficient removal of an interac
tion inhibitor with CAPD than with other dialysis
techniques.
The mechanism by which such a material may act
appears unclear, but it is possible to suppose an
inhibiting activity on the production of TCGFby
lympho—monocyte cells which under normal condi-
tions could be considered as an early erythropoie—
sis regulatory factor.
CRITICAL EVALUATICt'I OF PLASMA EXCHANGE
Keller F, Schultze G, Offermann G, Mlzahn M.
(Intr. by M. MDlzahn)
Klinikum Steglitz, Medical Departuent, West-Berlin
Between 1979 and 1983, we performed 297 plasma
exchanges in 30 patients by simultaneous nnbrane
separation and inununosuppressive medication. The
diagnoses of treated patients were: rapidly pro-
gressive glarulonephritis (n=1 0), Goodpasture's
syndrane (n=4), relapsing focal sclerosing gb—
merulonephritis (n=1) and vascular rejection (n=1)
after kidney transplantation, anti-GBM glctnerulo-
nephritis (n=1), renal failure in kappa light—
chain plasmacytana (n=1), hyperviscosity syndranein macroglobulinania (n=1), respiratory failure in
myasthenia gravis (n5), polyradiculitis (n.'2),
endocrine orbitopathy (n=2), thyreotoxicosis (n=1)
and uveitis (n=1). Plasma exchange was nost ef-
fective in treathent of rapidly progressive gb-
merulonephritis, with remission in 70% of the
cases. According to the literature, however, the
same results can be achieved with ininunosuppres-
sion alone. In agreement with the literature, a
remission in 50% of the cases with 000dpasture's
syndrcxne were achievable only by plasma exchange.57% of the patients developed severe canplicaticns
coinciding with or due to (4 cases) plasma ex-
change treatment; 10% of the patients died. We
theref ore conclude that there is no practical
evidence apart fran ininunosuppressive treatment,
that plasma exchange has a beneficial effect on
diseases other than Goodpasture' s syndrane.
RENAL INVOLVEMENT IN A SYNDROME OF VASCULITIS
COMPLICATING HBsAg NEGATIVE CIRRHOSIS OF THE
LIVER.
J.Montoliu, A.Darnell, A.Torras, L.Revert.
Hospital Clinic. Barcelona. Spain.
Six HBsAg negative patients with histologica-
lly proven cirrhosis of the liver (CL) of either
alcoholic (4/6) or cryptogenic (2/6) origin,
presented with recurrent bouts of palpable purpu—
ra in the legs. Skin biopsy of the purpuric le-
sions was performed in 5 cases and uniformly
showed small vessel leukocytoclastic vasculitis.
In addition, all patients had renal failure (se-
rum creatinine 2.7 to 9.6, mean 6.8 mg/dL), pro—
teinuria (0.8 to 3.4, mean 2.3 g/24 hr) and micro
hematuria.
In 4 patients renal biopsy disclosed a prolife
rative glomerulonephritis (GN), diffuse in 2
cases and segmental necrotizing with crescents
in the other 2 cases. An additional patient had
IgM—IgG mixed cryoglobulinemia (type II) and
a diffuse proliferative GN on renal biopsy.
Four patients died in renal failure and of
complications of their CL. Hepatocellular carcino
ma was found in 1 case. In the patient without
renal biopsy renal function and proteinuria impro
ved following steroids and cyclophosphamide.
Thus, HB5Ag negative CL can be complicated
by a syndrome of cutaneous vasculitis with severe
glomerular involvement. The pathogenesis of this
syndrome is unknown but immune complex formation
resulting from intestinal antigen absorption,
undetected chronic viremia or release of tumoral
antigens could intervene.
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ABSENCE OF IgA IN THE GLOMERULAR DEPOSITS OF
PATIENTS WITH CIRRHOSIS OF THE LIVER AND GLOMERIJ—
LOPATHY.
J.Montoliu, A.Darnell, A.Torras, L.Revert
Hospital Clinic. Barcelona. Spain.
Twelve HBsAg negative patients with histologi-
cally documented cirrhosis of the liver of either
alcoholic (8/12) or cryptogenetic (4/12) origin
underwent renal biopsy to investigate proteinuria
hematuria and/or renal failure. Immunofluorescen—
ce was positive for IgA in two patients with
mesangiocapillary glomorulonephritis (MCGN) and
could not be performed in 2 additional patients
with the same diagnosis. However, in the remai
ning 8 patients, immunofluorescence was negative
for IgA and frequently positive for C3, Igs,
1gM and/or fibrinogen. These 8 patients without
IgA were classified as follows: MCGN with subendo
thelial electron dense deposits 2 cases, IgM—IgG
cryoglobulinemia with diffuse endocapillary glome
rulonephritis 1 case, membranous nephropathy
1 case, diffuse endocapillary proliferative glome
rulonephritis 1 case, and vasculitis with focal
segmental necrotizing glomerulitis and rapidly
progressive gloaerulonephritis 2 cases.
These results show that cirrhosis of the liver
can be associated to a wide variety of glomerular
disorders. Contrary to previous belief, IgA is
absent in 2/3 of patients with cirrhosis and
glomerulopathy and therefore the pathogenetic
importance of IgA in the development of glomeru—
lar disease in such patients is doubtful.
NEPHROLOGIC FEATURES OF LATE-ONSET NEPHROPATHIC
CYSTINOSIS (LONC) WITH MASSIVE PROTEINURIA: RENAL
HEMODYNAMIC AND TUBULAR FUNCTION STUDIES.
R.C. Pabico, B.A. McKenna, R.8. Freeman. Univ. of
Rochester Medical Center, Rochester, NY, USA.
The typical Infantile Cystinosis patient pre-
sents with the Fanconi syndrome and early renal
failure. Renal involvement in patients with LONC,
on the other hand, have not been studied thorough-
ly. Three siblings (aged 11—18 yrs, 2 females)
with LONC presented with proteinuria (UprotV
2-15gm/day) and glucosuria; growth and development
were normal; the 18 yr old man had mild azotemla
(SUN—39mg/dl) but the 2 younger sibs had normal
excretory function. Renal hemodynamic functions
(GFR, ERPF) were measured by inulin and PAN clear-
ances. Proximal tubular functions, by reabsorptive
and secretory Tm; 2M, phosphate and uric acid
handling. Distal tubular functions, by urinary
concentration and acidification.
Patient 1 2 Normal
GFR(ml/min/j.73m2) 41 101 141 125±20
ERPF 119 396 536 655±98
TmGlucose/GFR 1.1 1.4 2.5 3.O±.15
TmPAH/GFR 0.4 0.3 0.3 O.65±.1
TmPi/GFR 0.9 3.0 3.0 3.5±.6
FE 82M(%) 14 12 2 <0.1
FE uric acid (%) 50 20 16 12±2
U/Sosm 2.2 2.3 3.3 3.3±.4
Net H excretion was blunted following an oral
dose of NHkC1. Except in patient 1, GFR and ERPF
are only minimally reduced. But proximal tubular
functions, both reabsorptive and secretory, are
quite impaired disproportionate to the change in
GFR. Distal tubular functions are also diminished.
Thus, the entire nephron is afflicted in LONC,
although tubular (both proximal and distal)
functions are more impaired.
CLINICAL AIiD IMMUNOLOGICAL PBATURES OP
SYSTEMIC AMYLOIDOSIS
N.A.Mukhin, N.Njhasabov, L.V.Kozlovskaya
( intr. by I.Taraba )1st Medical Setehenov Inat.,Moseow,USSR
During 20—year period (1962—1982) 151
patients with morphologically confirmed
renal amyloidosia were studied: 101 pa-.
tients had secondary amyloidosia ( 38 —
with rheumatoid arthritis; 28 — with
chronic auppurative processes; 9 — withpulmonary tuberculosis; 26— with paranoo-plastic aniyloidosis); 29 patients — pri-
mary amyloidosia; 21 patients — familialMediterranean fever.
Sixty per cent of the patients had
nephrotio syndrome; 15% — arterial hype?'-tension; in 2r.2% serum creatinine level
exceeded 1 .4mg/lOOznl.
In patients with different forms of
axnyloidosis — secondary, primary and he-
reditary similar immunologica]. changes
were found: the decrease of T—lyrnphocytes
level (31%; 25.9%; 32% reap.); so as of
B—lymphocytes level (6.7%; 6.0%; 8.0%
reap.); inhibited lymphocytes responce
on PHA ( 24.8; 22.1; 28.0 resp.) and
depressed activity of plmgocytosis
(especially attractive phase).
GLYCOSYLATED PROTEINS IN DIABETIC NEPHROPATHY
N.Ramzy, M.Habth,S.Samney,Ii.Dunn,N.E1-Sheemy
&Sh. Doss, Cairo University& Namru 3, Egypt,( 1nt.:.by:R. Bsrpoum jD
Glycosylated proteins (GSP) were incrim-
inated in the pathogenlsis of renal disease.
This study was carried on 10 normal controls, 10
uncomplicated diabetics, 20 patients with diabe-
tic nephropathy(DN) & 25 other diabetics with
other complications. Beside the basic tests for
diagnosis, all cases were tested for glycosylat-
ed haemoglobin(GHB), GSP, glucoprotein(GP) elec-
trophoresis, BUN, serum creatinine & serum B2-
microglobulin(B2M). On comparing the levels of
GSP in our
patients GSP GHP7. a2GP B2NuG/1
to the co: Controls 0.036
7.89 36.56 1656.2
ues, insi— Uncompli— 0.133 11.36 35.62 1693.3
gnificant cated Diab.
difference D.N. 0.590 12.95 42.03 6824.5
in the un-
complicated
*-mmol UHF / mg. protein
group but a significant increase was observed in
the nephropathy group. No significant correlatio
was found between the level of GSP on one hand,
and CUB, duration of diabetic state or type of
treatment on the other. The same group showed
also a significant rise of aGP which was unrel-
ated to the level of GUS or SP. GSP showed a
positive correlation with both proteinuria and
serum B2M, indicating a link between renal
involvement and the rise in GSP. Whether there
is a pathogenic relation between GSP and the
development of nephropathy still awaits further
evidence.
.
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friTABOLIC DISOiERS IN NEPHlXJIAINOSIS
V. Zvara, V. 1èvlsová, J. eznIek
Departhent of Urology, Q*tenius University, School
of dicine, Bratislava, Czechoslovakia
In view of generally accepted theory that re-
phiccalcinosis develops as a consequence of calcium
deposition into netabulically or norphologically
inpaired cells of renal parenchynia scme laboratory
and clinical data were evaluated in a retrospecti-
ve study in 18 patients with rephrocalcinosis, 9 ma
les and 9 females, aged 16 nonths — 48 years at the
t1s of adeission to our hospital.
Laboratory analyses revealed impaired renalfunction in 11 patients, renal tubular acidosis in
1, primary hyperparathyzoidism in 1, hypocalciuric
hypercalcemia in 1, intermittent hypercalcemia in 2
hypercalciuria in 7, impaired renal tubular reab-
sorption of phosphate in 16, hypc*nagnesemia in 13,
hyperuricemia in 12 and mild hyperoxaluria in 9 pa-
tients. In all patients there was coincidence of 2
or mare netabulic disturbances.
The therapeutical procedures and the long term
therapeutical results in the presented group of pa-
tients will he discused in details pointing out
the necessity of early therapy and the importance
of the treatnent of netabolic disturbances.
PRRIOLOMERUL&R GRABTJL(4A (P0): A MARFER OF A PEOU—
LTAR VASCULITIC T)ISOBIER?
C,Rovati, G.Barbiano di Belginjoso, L.Radaeuli, L.
iroi*, E.Lusvarghi*, L.Minetti.
Renal Unit Nignarda Ca'Granda Hopital, Nilan and
Chair of Nephrolor, University of Modena*, Italy,
PG arond necrotic or severely damaged tufts is
a rare finding and granulomatous ON location among
vasculitides is controversial. 7 patients(pte) (ag-
es 36—71 yrs, 6 females) whose renal biopsy showed
a pattern of P0, presented with a rapidly progressi
ye renal failure. Drug exposure was euivocal or
sent, 3. pts had a non—granulomatous inflammatory
—
process of upper or lower respiratory trot,, 1 ne-
crotic skin lesions. In all pta neorotizing or sole
rowing glomerular tufts(4O—1O( of glomeruli), witi
epi-thelial crescents, were surrounded by several la
yers of epitheliold, mononuclear and some giant cel
1, with disruption of Bowman's capsule. 03 and f 1—
brinogen around glomeruli were occasionally found.
Small arteries necrotic changes were observed in 3
pts, 2 pta had a second biopsy showing a reduction
of infiltrate and scarring glomeruli. At follow up
3 pta had a partial recovery of renal function, i
underwent chronic dialysis. Prognosis was worse in
pta with an elevated percent of damaged glomeruli
and arteritis.
Clinical and histological features suggest that
PG can be considered a marker of separate entity ra
thor than a vsriant of hy,ersensi+iity vasculitia
or Wegener's granulnmatosis.
CARPAL OSTEOLYSIS WITH NEPHROPATHY - AN
UNUSUAL INDICATION FOR }ThMODIALYSIS
H. Hornak, W. Rose. E. Rupprecht.
Medical Acadeny Dresden, Dresden, GDR
Hereditary bone dysplasias in combina-
tion with chronic renal disease are among
the rarest syndroms. One of them is idio-
pathic acroosteolysis occuring with as well
as without associated glomerular lesions.
Up to now 17 observations of this geneti—
call.y determined ayndrom were registered.We describe the first case seen in our
country.A 22 year8 old man accepted for therapy of
end—stage renal disease showed resorption
and loss of carpal bones. He had history
of "rheumatism" in both wrists during ear1
childhood. Glomerular damage first was ob-
vious in mild proteinuria. Further typical
malformations as byperteloriam, microgna—
thia and bracbycephalia were present.
In discussion whether the osteoi,ytic pro—
cees was due to later renal osteopathy
x—ray follow—up states the syndrom-caused
origin.
Except a report in 1979 our case is the
only one known to be on EDT. It is unknown
what long—time effects are to expect by
additional dialysis—related bone disease.
Alter 2 years on EDT there is no evidence.
Furthermore there is no experience aboutinfluence of corticoid therapy on the
osteolytic process that could decide on a
chance for rena]. transplantation without
risk.
UTILITY OF A TEST BY ORAL CALCIUM LOAD (OCL) FOR
MONITORING OF PATIENTS WITH CALCIUM NEPHROLITHIASI
(NL).
K.S. Ang, P. Simon, G. Cam.
La Beauchée Hospital St—Brieuc, France.
A predilection for NL exist in a group of pati-
ents wtih primary hyperparathyroidism (PHPT) who
had hypercalciuria (H). Between Jan. 1, 1980 and
Dec. 31, 1983, we have investigated 160 patients
with H and NL by a test of OCL (1 g Ca load). Four
days before, a low calcium diet ( 400 mg/day) was
carefully controlled. Normal test (N) was obtained
if urinary Ca/Cr (smol/umol) 0.30 fasting and
0.48 after load. In 96 patients (60 %), absorptive
hypercalciuria (AH) was demonstrated, in 63 (39.4
%) renal hypercalciuria (RH). PHPT was histologi-
cally diagnosed in 23 patients (14.3 %) 16 RH,
6 AH, 1 N.
All patients with PHPT, 12 AN and 10 RH had a
second test of' OCL. Before PTX, 4 from PHPT had i—
dentical results (2 AH and 2 RH), 1 AH became RH.
After PTX, 16 patients with RH before surgery be-
came AH (8), N (6) or remained AN (2). Six patients
with AN became N (4) or remained AH (2). Among pa-
tients with 'primary" hypercalcemia, 8 to 12 monthE
later, 8 from 12 AH had identical results, 2 beca-
me RH with biological signs of PHPT, 2 had N. Seven
from 10 RH had identical results, 3 became AH whose
2 with signs of' PHPT.
Thus, the test of OCL repeating showed that bio-
chemical abnormalities in urine remained after mo-
nitoring of 8 to 12 months. The principal advanta-
ge of such monitoring was to detect normo or few
hypercalcemic primary hyperparathyroTdism.
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ACUTE AND CHRONIC RENAL INSUFFICIENCY AND LEUKOSES
S.Sua, R.Durutovi6,B.Dumovi6,R.Pantovi6
Clinic of Nephrology,Military Medical Academy,
Beograd ,Yugoslavia
It is known that in patients with leukosis often
are found leukosis Infiltration in the kidneys.
However,these infiltrations rarely affect the re-
nal function because of which in hematological and
nephrologlc literature there is a few data on acute
renal insufficlency(ARI) and chronic renal insuffi.
clency(CRI) in leukoses.Up to now the mechanism
of development of renal insufficiency are not cle-
arly explained although It is known that the impo.-
rtant role has purine metabolism disorder with 'the
increased formation of the uric acid and its pre-
cipitation orimarily in the distal tubules.Three
male patients are presented.Two patients had chro-
nic lymphatic leukosis with CR1 and the third one
had acute lymphoblastic leukosis with ARI.In their
clinical picture dominated uremic syndrome while
in two patients with CR1 nephrotic syndrome predo—
minated.Together with the standard findings the
renal biopsy was performed and the tissue was
studied by light,fluorescent and electron micro—
scopes.The therapy consisted of cytostatics,cor—
ticosteroids and hemodialysis.A high degree of
rehabilitation was achieved In all three patients.
However,the patient with acute lymphoblastic leu—
kosis died of sudden mass bleeding from the ga-
strointestinal tract.The second patient with chro-
ni c lymphatic leukosi 5 also died due to myocardial
infarction while the third one is alive,he is not
on dialysis but receives corticosteroids and cyto-
statics.
DIALYSIS AND TRANSPLANTATION IN END
STAGE LUPUS NEPHRITIS.
C.R. Swanepoel, R. van Zyl-Smit, J. Jacob
son, A. Pontin, M.D. Pascoe and *E. du
Toit. (Introduced by M.J.D. Cassidy).
Groote Schuur Hospital and *provincial
Lab for Tissue Immunology, Cape Town,South Africa.
Sixteen patients with end stage lupus
nephritis (LN) were studied over a 6 year
period. HLA system associations arid T
lymphocyte subset imbalance were examined.
Female to male ratio was 2:2::l and mean
age 33 (r 13 to 49). Mean duration of
lupus from diagnosis to dialysis was 84
months. The prevalent native kidney his-
tology was type IV (WHO classification).
Eleven renal allografts were performed on
9 patients. Graft rejection occurred in
3 patients. A total of 4 deaths were re-
corded, all due to sepsis. Only 3 patients
had clinical evidence of lupus activity.
A1 - B8 haplotype was present in 37% of
patients and A1 — B8 — DR3 haplotype in
25%. T cell subset analysis in 9 patients
revealed elevated OKT8 levels and in 8 of
these reduced OKT4/OKT8 ratios. 14 patien-
ts were used as controls; 10 had normal
OKT8 levels and 11 a normal OKT4/OKT8
ratio. We conclude that the preponderence
of A1, B8 and DR3 in lupus patients,
either singly or as haplotypes appear to
imply ultimate poor renal prognosis. Lu-
pus inactivity may be related to the in-
creased OKT8 cell subset. Renal trans-
plantation is well tolerated with no
recurrences in the graft.
LUPUS GLOMERULONEPHRITIS
S.Sua, B.Dumovié,B.Pantovié,J.Zogovié
Clinic of Nephrology,Milltary Medical Academy
Beograd ,Yugoslavia
Systemic lupus erythematosus(SLE) in its evolu-
tion involves a series of organs and systems,but
the involvement of the kidney is one of the most
severe complications of this serious disease.
Today there are numerous opinions that renal
lesions are found in 100% of patients with syste-
mic lupus.In the last 10 years 165 patients,llO
females and 55 males aging 16—52 years were tre-
ated at our Clinic.The diagnosis of lupus gb—
merulonephritis was established on the basis of
known criteria.Re.nal biopsy was performed in 85
patients.Pathohistological finding showed various
forms of glomerulonephritis(mesangioproliferative,
focalproliferati ye ,diffuse proli ferative, membra—
nous).Renal insufficiency of various degrees
was found in 85% of our patients.Hemodialysis
and peritoneal dialysis were applied in I0%.
Longlasting complete remission was achieved in
10% of our patients which lead to stoppage of
hemodialysis.Howevør, together with dialysis,the
corticosteroid and immunosupressive therapy were
applied in all patients.
. PLASMA RENIN ACTIVITY (PRA), ALDOSTERONE LEVELSAND DISTAL URINARY ACIDIFICATION (DUA) IN DIABE
TICS WITH CHRONIC RENAL FAILURE (cRF).
J.M. Tabernero, J.Grande, J.Miralles,J. Macias,
SERV. NEFROLOGIA. HOSP. CLINICO.SALAMANCA.SPAIN
The PRA, plasma aldosterone levels and their
relationship to (DUA) were stdied in 13 tips I
diabetics with CRF Cl 2k.ll—6.7. These were —
compared with 23 hea1y controls, 9 CRY without
diabetes and 8 diabetics without CRY.
Dabetes+CRY group: PRA(ng/ml/min) Supine -
O.3k-.O.21f; Standing O.62O.39; after furoseside
O.92O.5O. These values were lower(p.O.OO1)than
controls and CRF groups and(p(O.O5) conpared to
diabetics only after Lurosemide. Aldosterone —
(g/ml) supine 7.61—55.25; standing ll5.768O7
after furosemide 153.95—103.99, lower (p<O.Ol)
compared to control and CRF groups, (p<O.OO].)
compared with diabetics only post furosemide.
Acidification after a short NH C]. overload. Un
nary pH in diabetics+CRF k.72±kl, similar to
controls and diabetics and lower than CRF(pO.O3
NH(pmol/min) 27.27—6.72, low compared with the
diabetic and CRF groups (p<0.03) and N.S.with
controls. Titratab].e acidity (rmol/min) 15.9
5.78 similar to diabetic and CRF groups and low
(p<O.OOl) comared to controls. Serum K:Diabe—
tics÷CRF 5.00—0.35 mEq/l, highjp<O.O0l)compa
ed to other 3 groups. Plasma H C03:17.71—O.95,
lower (p0.00l) than controls and diabetics and
(p<O.05) compared to CRY.
These data reveal that overall the diabetic+
CRF group presents hyporeninaemic hypoaldostero
nism with type IV renal tubular acidosis. This
disturbance is due to the association of both
processes and not to either of them alone.
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• LUPUS NEPHRITIS IN MALES AND FEMALES
I.E. Tareyeva, Janushkevitoh T.N. (Intr.
by I. Taraba)
1st Medical Setchenov Inst., Moscow, USSR
The course of lupus nephritis (LN) in
51 males (15—52 years old) was compared
with that in 337 females (16—60 years
old). 105 out of 388 patients had
nephrotio syndrome, 191 had arterial
hypertension. Kidney biopsy was performedin 105 oases.
The nephrotio syndrome ocoured with
equal frequency in males and females
(reap, in 27% and 32%). Arterial
hypertension was more likely to develop
in male patients, in three of them
myocardial infarction oooured. Rapidly
progressive LN with severe hypertension
and early renal failure was much more
frequent in men (in 23,5% and in 6,7% of
cases, reap.), 10 year survival rate was
31% in males and 70% in females.
While over—all male: female ratio was1:6,6, in the older age group (over 40
years old) it fell to 1:15 (2 males
and 30 females); the course of LN in
these 30 females was relatively benign,
10—year survival rate being 95%.
Thus, the course of LN appeared to be
more severe in our male patients.
Na,K—ATPase IN RENAL CORTEX OF RATS WITH
EXPERIMENTAL CIRRHOSIS OF THE LIVER.
D. Conesa, A. Teiedor, J.M. López Novoa, L.Hernando
Fundación Jiménez Di'az. Madrid. Spain.
In order to study one of the mechanism of increa-
sed tubular reabsorption of water and sodium in rats
with experimental cirrhosis of the liver (CL), Na,K—
ATPase activity and its kinetic properties were analy.-
sed in the microsomal fraction from renal cortex of
CL rats and their controls (C).
Microsomal fraction was obtained by sequential
centrifugation at 1500 g x 30 mm. and 101000 g x
90 mm. Na,K—ATPase was assayed by the Fiske—
SubbaRow method.
Results are displayed on the next table
Specific activity(mu/mg prot)S0 Na (mM) 9.2 1.6 15.2 1.8'
n (Hill coefficient) Na 1.6 0.1 1.5 0.1
S05 K (mM) 1.0 ÷ 0.2 0.9 0.2
n K 1.0 0.1 2.6
S05 ATP (mM) 0.08+ 0.05 0.12+ QØj±
n ATP 1.00± 0.05 1.00÷ 0.14
Ki ouabain (pM) 100 20.2 19.9 5.1
optimum pH 8.0 7.7(X SEM) tp .0.05
These results show that Na,K—ATPase from renal
cortex of cirrhotic rats has higher specific activity,
higher Na and ATP affinity, and a different pK of the
active site. We conclude that differences in Na,K—
ATPase kinetical properties must play a role in the
water and Na retention observed in cirrhotic rats.
LYMPHOCYTE SBNSIBILIZATION IN LUPUS
NEPHRITIS AND RENAL AMYLOIDOSIS
S.N. Savitaky, I,E, Tareyeva, I.N.
Osipova, N.A. [i1hin cIntrby I. Taraba)
1st Medical Setohenov Inst., Moscow, USSR
Lymphocyte sensibilization with two
antigens — renal glomerular basement
membrane (GBM) and amyloid fibril CAP) —
was studied by migration inhibition testin 34 patients with lupus nephritis (LN),
31 patients with renal amyloidosia and
72 patients with chronic glomeruloneph—
ntis (aN). In all cases kidney biopsy
was performed.
The lymphocyte sensibilization to GEM
was revealed in the majority of LN and
chronic GN patients (76,4% and 76,3%,
reap.) and in no one of renal amyloidosis
patients. Contrary to this, cell
sensitization to AP was revealed in all
renal anyloidosis patients and was not
found in any of LN and ohronio GN
patients. No one of the healthy 44
controls responded to any of the
antigens.
The results suggest that migration
inhibition test with GEM and AP may be
a useful tool in differential diagnosis
of nepbritis (both LN and chronic aN)
and renal amyloidosia.
• ULTRASTRUCTURAL MARKERS OF TUBULAR TRANS..
PORI' IN EXPERIMENTAL DIABETES INSIPIDUS
L.Cieciura, Z.Kidawa, i3.Jaezczuk—Jarosz,
K.Trznadel, J.Konopaoki
Department of Histology and Embryology,
and 2nd Clinic of Internal Diseases,
Military Medical Academy, L4d, Poland.
The studies were aimed at stereologic
analysis of differences in tubular trans-
port markers between diabetes insipidue
and control group. Intracellular spaces
and basal infolded ohaxmels were conside-.
red as the markers of water transport,
while mitochondrial metabolic steady eta—
tea were considered as the active trans-
port markers. The investigations were per.
formed on Wistar rats with diabetes insi—
pidus induced by eleotrocoagulation of
hypothalamic supraoptio nuclei with high-
frequency current. TEM observations reve-
aled morphometric differences in the sur-
face area and volume of intercellular spa.
oe and basal infolded channels in the di-
stal tubules. Stereologic markers of mi—
tochoncLrial metabolic states demonstrated
significant differences in the distal tu-
bules between diabetes insipidus and con-
trol group. In diabetes insipidus volume
and surface area of' intercellular spaces
and basal infolded channels in the distal
tubule were decreased and mitochondrial
energetic state was lowered. These trans-
port markers were applied for evaluation
of 10 oligobiopsies from patients with
glomerulonephritis. Evaluation of the ne—
phron tubule function may introduce new
elements to the pathogenesis and diagnose
of chronic renal failure.
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HEITOCF—SC TOE TEITT PTJRPURA: 4 3URVEY OP
100 CHIlDREN.
A. Urowska,M.Uszycka_KarczI Pediatric Olinic,Gdausk,PolandA study of 100 children with HP wss un
dertaken.The age of 60 boys and 40 girls
ranged from 2—15 yrs/6,5yrs/.A preceding
infection was present in )5 caees.All
children had a typical skin rash, 58 had
abdom!.nal pains,57had joint involvement.
Renal symptoms were found in 69 pts.They
included slight proteinuria and/or hcma—
tuna/i 8 case s/,hear pro teinunia/hematu—
n±a,'l 4/,nephrotie syndrome/i 7/, acute ne—
phritic syndrome/7/,nephrotic and nephri—
tic onset/I 2/, isolated hypertension/1/.
Renal biopsy was performed in )6 cases,
revealing the following changes ceording
to ISKDC grading:II°—3 cases,III —24 pta,
IV°—7 cases,V°—2 cases.IT'P studies showed
characteristic IgA ataining.Ultrestructu—
rul studies showed mainly mesangial and
subendcthelia]. deposits.No favourable ef-fect of uncontrolled trials of therapy
aith s-teroids,cyclophosphcmide and indo—
methacine was demonstrated.
Renal symptoms were freauently persia—
tent,reeoiving ithin a year of onset in
only 0 T)tS.At last ioliow—up another 8
pts were healthy,17 had slight abnorniali—
ties,9 had active renal disease,2 had CT'
and 3 were dead.Tn spite-of persistent
changes the overall prognosis of F13 neph
ntis i good.Indicatcrs of poor outoons
include:se-v-ere clinic:l manifestation/mi-
xed nephrotio d neph::L-ie onaet,hyper—
tension/,advanced morphological changes,
older 'a :1t onset and female sex.
• LOW MOLECULAR WEIGHT PROTEINURIA IN
DIABETIC CHILDREN - A MARKER OF EARLY
DIABETIC 1EPHROPATHY2? 1R. Wartha , D. Gekle (Intr. by 0. Mehis
University Cildren's Hospitals Heidelberg
and Wtirzburg , FRG.
24-h urine samples of 67 diabetic and
30 healthy children aged 1—17 years with-
out clinical signs of nephropathy were
examined by SDS—polyacrylamide gel electro-
phoresis (SDS—PAGE). In all patients
urinary protein excretion was negative to
Albustix, all had normal plasma creatinine
values and all were normotensive. SDS-PAGE
permits the differentiation of a glomeru—
lar and tubular proteinuria. As indicator
of the origin of proteinuria the glomerulo-
tubular protein ratio (GTPR) was deter-
mined by dividing the mass of excreted
urinary proteins above 68 000 dt by the
mass of proteins below 68 000 dt.
The GTPR—values were significantly lower
in the diabetic patients. 35 % of the
diabetics showed GTPR-values lower than
0.7 which was the lowest value seen in the
control group. The low molecular weight
proteinuriä did not correlate with age,
total proteinuria, urinary volume or hemo-
globin A1 blood values. But there was a
significát correlation (p-cO.05) with the
duration of diabetes mellitus.
The data clearly express a low molecular
weight proteinuria which occurs many years
earlier than the onset of albuminuria.
• THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN
INFUSION (CSII) ON RENAL FUNCTION IN TYPE I
• DIABETIC PATIENTS WITH AND WITHOUT PROTEINURIA.
E. van Ballegooie, P.E. de Jong, A.J.M. Donker,
W.J. Sluiter.
Depts. of Clinical Endocrinology and Nephrology,
University Hospital, Groningen, The Netherlands.
The effect of CSII on renal function was studied
in 12 type I diabetic patients (age 23—58 yr,
duration of diabetes 4—46 yr). Serum creatinine
was -<.110 umol/l in all patients. Urinary protein
excretion was less than 250 mg/24h in 7 patients
(group I) and >0.5 g/24h in 5 roup II). Initial
GFR (measured as clearance of 1 I—iothalamate and
corrected for body surface area) was higher in
group I (136 8.5 mi/mm) compared with group II
(103.2 4.6 ¶min; p.<.O.O2). ERPF (measured as
clearance of 1—hippurate) similarly was higher
in group I (582 37.0, and 529.6 32.8 ml/min
respectively).
After start of CSII,mean (± SEM) blood glucose
levels fell from 13.0 0.4 to 6.1 0.4 mmol/l
(p< 0.01) in the 12 patients, glycosylated
haemoglobin (HbA1) levels from 12.0 0.5% to 8.2
0.2% (p<. 0.01). These changes were similar both
in group I and IL GFR decreased in both groups
after 1—3 months of CSII, probably due to correctia
of hyperfiltration, and remained stable for the
next 10—12 months in group I (126.3 6.1 vs
127.1 7.3), but deteriorated in group II (98.6
4.4 vs 78.0 6.0). Proteinuria disappeared in 1
patient. These results indicate that adequate blood
glucose control with CSII does, at least during the
first year, not prevent deterioration of GFR in
type I diabetic patients with proteinuria. This
suggests that other factors than blood glucose
control are involved in the course of renal
function.
MIXED IgA/lgG CRYOGLOBULINEMIA WITH RAPID PRO-
GRESSIVE GLOMERULONEPHAITIS (RPGN)
M. Weber, H. Köhler, J. Fries, W. Thoenes, K.-H. Meyer zum
Büschenfelde (intr. by D. Höffler), University of Mainz, FRG
Mixed cryoglobulins may present with a typical clinical
syndrome thought to be due to immune complex-like de-
position of the cold insoluble proteins. There have been only
few cases of lgA/lgG cryoglobulinemia reported, none associated
with RPGN.
A 48-year old man was administered to the hospital 1982.
8 years previously diagnosis of ankylosing spondylitis was
established. 4 month prior to admission he noticed fatigue and
arthralgia. Laboratory data revealed an ESR of 141 mm nW but
otherwise normal data. On examination he had fever, crural
edema, dyspnoe and diarrhoe. The s-creatinine was 12.9 mg%.
A s-cryoglobulin was found composed of monoclonal IgAl-
kappa and polyclonal IgG. After separation of the cryo-
components by affinity chromatography, cross mixing studies
demonstrated that the cryo-lgA exerts antiglobulin activity
against human lgG. Renal biopsy revealed intra-extracapillar
glomerulonephritis of the immune complex-type with crescent
formation. One glomerulus exhibited obstructing protein pre-
cipitates in the capillary loops. lmmunofluorescence studies
demonstrated granular deposits of IgA/lgG/C3 in glomeruli and
the arteriolar walls. Treatment consisting of a combination of
intermittend hemodialysis/plasmapheresis (PP) and administra-
tion of immunosuppressive drugs (ID) was sufficient in re-
moving the cryoglobulins from the serum. This was paralleled
by clinical improvement, a fall of s-creatinine to 2.8 mg% and
an increase in urinary protein excretion to 19 g/day. After
finishing PP and reduction of the ID, fever recurred and cryo-
globulins again were detectable. An increase in drug dosis and
reinstitution of PP could control the cryoglobulinemia but the
patient developed sepsis and died.
A possible role of the cryoglobulins in the development of the
RPGN is suggested by the corresponding composition of the
circulating cryoglobulin and the glomerular immunoglobulin
pattern, by the demonstration of occlusive intraglomerular
protein thrombi similar to those seen in IgM/lgG cryo-
globulinemia and by the fact that removal of the cryoglobulins
was paralleled by a dramatic improvement in renal function.
Thus lgA/lgG cryoglobulinemia may be considered as an
autoimmune form of RPGN.
Abstracts 627
628 Abstracts
• ACUTE RENAL FAILURE IN INFANCY WITH PARTIAL
DEFICIENCY OF HYPOXANTHINE-GUANINE-PHOSPHORIBOSYL-
• TRANSFERASE ( HGPRT
A. -M. Wi ngen ,W. Löffler, R. Wal dherr ,K.Schärer
Children's Hospital and Institute of Pathology,
University of Heidelberg,Department of Internal
Medicine,University of Munich, FRG
A 3—week old boy presenting with pneumonia and
severe metabolic acidosis showed features of acute
renal failure (plasma creatinine: 3,1 mg/dl, uric,
acid: 11,5 mg/dl). Renal biopsy at the age of 2
months revealed severe crystal nephropathy. HGPRT
activity in lysed erythrocytes was 31,6 nmol/nig
protein/hr at the age of 2 1/2 months and dropped
to 0,4-0,8 nmol/mg/hr at 8 months to 2 years
(normal controls: 50-120 nmol/mg/hr). HGPRT activity
in cultured fibroblasts was 0,8 nmol/mg/hr. The
father of the child had suffered an attack of
gouty arthritis at the age of 17 years. His plasma
uric acid now is slightly elevated, but HGPRT
activity is normal .The mother is healthy but HGPRT
activity in fibroblasts is only 20 nmol/mg/hr in
presence of normal values in ersthrocytes. The
maternal grandfather suffered from gouty arthritis
and urate nephropathy since age. 24 years and is on
dialysis therapy since age 42 years. His HGPRT
activity in erythrocytes was 19 nmol/mg/hr and in
fibroblasts 0,8 nmol/mg/hr.The propositus was
treated with low purine diet,high fluid intake,
alkalinisation of urine and allopurinol. GFR
gradually improves up to the' age of 2 years
(110 nil/min/1,73m ).The boy showed normal growth
and neuropsychomotor development.To our knowledge
he is the youngest patient recorded with urate
nephropathy,renal failure and proven X-linked
partial HGPRT deficiency without any neurological
abnormalities as found in Lesch—Nyhan syndrome.
• INSULIN RECEPTORS IN DIABETIC AND NON-DIA-
BETIC PATIENTS WITH MODERATE AND SEVERE
• RENAL INSUFFICIENCY
R. Zj,ç)ç,, J. Bahlmann, U. Plener, A. Dwenger
Department of Medicine, Div. of Clinical
Biochemistry, Medical School,Hannover, FRG
Impaired glucose metabolism in uremia
appears to be mainly caused by-an insulin
resistance in peripheral tissues. One of
the possible mechanisms on the cellular
level was investigated by measuring 125 J-
insulin binding to red blood cells in 15
diabetic (D) and 14 non-diabetic (ND) pa-
tients with renal diseases and in 13 heal-
thy controls (C). In D and ND the influence
of moderate (<300) and severe (>300 mol/l
serum creatinine) renal insufficiency on in-
sulin receptors was studied. Receptor aff i-
iities (1(a) and concentrations (Xo) were
calculated by nonlinear regression analysis
sssuming a one-class receptor model. Re-
sults of receptor affinity and concentra-
ion in healthy controls corresponded to
?ublished data. The degree of renal failure
ad no influence on insulin binding para-
tueters in both subgroups of D and ND. There
fore, the data of the total groups are
summarized: 8
Ka(1O 1/mol) Xo (nmol/l)
group C 8.9 1,6 0.061 0.014
group D 9.6 1.1 0.080 0.024
group ND 10.6 - 2.5 0.067 - 0.016
This demonstrates no differences in the
first step of insulin binding between the
groups investigated. We conclude that the
nechanisms responsible for the peripheral
insulin resistance in uremia is localized
n the postreceptor level.
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RENAL TRANSPLANTATION IN THE MIDDLE EAST -FIVE
YEAR EXPERIENCE
G.M.Abouna,A.G.White,A.S.Kumar,S.K.Dadah,P.John,
O.F.Omar, S.G.Silva and G.Kusma
Department of Organ Transplantation,Faculty of
Medicine, Kuwait University ,KUWAIT.
Over the last 5 years 180 renal transplants have
been carried out in Kuwait for patients with end
stage renal failure aged 4—57 years. 138 were from
living donors and 42 from cadavers which were imp-
orted from USA and Europe. Donor recipient select-
ion was based on ABO grouping,HLA typing,MLC and
direct lymphocyte crossmatch. Prophylactic immuno-
suppression was with Prednisolone and Azathioprine
and recently with Cyclosporin A in cadaveric trah-
splantation. Treatment of acute rejection was with
high pulse dose steroid therapy or intravenous ALG
infusion. Hospital mortality was 1.76%. In living
donor transplantation the actuarial patient
survival is 95%, 94%, 93%, 92%, 91% and the graft
survival is 93%, 90%, 88%, 87%, 87% at 1, 2, 3, 4
and 5 years after transplantation respectively. In
cadaveric transplantation the actuarial patient
survival is 80.0% and graft survival is 56% at 1,
2 and 3 years respectively. It is concluded that a
highly successful regional living donor renal
transplantation programme can be developed in this
part of the World and because of non-availability
of cadaveric kidneys locally reliance has to be
made on imported cadaveric grafts which are often
suboptimal.
.
CON1TEHSTON FT0M CYCLOSPORIN A (CYA) AND
PREDNISOLONE (P) TO P AND AZATHIOPRINE (A).
• SAFE OR UNSAFE?
D. Ad", .1. Mir'ael. T. Vlassis, P. Mc.Master.
Pe'al end T'ansplantation TJni, Q'een
Elizabeth Hospital, Birminam, En'la"d.
OP C) corse,ive renal allorrect rcipierts
w'ose initi&l imm'inos'ppression was CvA + P.
20 were coeted to P + A as collows 1. t
peiie'ts converted bena'se of continuir
reectior all lost their nrafts. 2. ' patienfs
we—e co'verted heca'se o nephrotnxicity
with ore r.reFt lost. 3. 9 patients were con-
'e'td for miscellaneous reasons with ore
death and one nraft los. Eneouraed by
these observations and because of the
potential lon' term hazards of CyA nephro-
toxicity we prospectively studied first
renal alloraft recipients randomized at
3 months to conti'ue CyA + P or to be
converted to P + A. 8 patients were
continued on CyA + P with no rraft losses,
rejection or deaths. Of six patients
converted to P + A, 1 died of infection arid
k de"eloped acute rejection. Conversion
from CrA ÷ P to P + A at 3 months post
transplant is not safe.
• DOES CYCLOSPOPIN A (CYA) INHIBIT RENAL
PROSTAGLANDIN SYNThESIS
D. Mu, C.J. tote, J.H. Turney, J. Michael,
PMcMaster.
Rena]. and Transplant Unit, Qveen Elizabeth
Hospital and Department of Physiolor'y,
Birniinrham, En'land.
We postulated that the nephrotoxicit".
hyper+ension and hvperkalaernia caused by CyA
co"ld he explained if this dru inhibited
renal prostarlandin synthesis. Urinary
PGE2 excretion was therefore measured in
female renal allorreft recipients treated
with CyA (n=11) or with prednisolone and
azathioprine (P + A) (n=11). The mean
"riflery POE2 excretion in patients on CyA
of 9O pmoles/ hr. was lower although not
sirnificntly so than in patiens on P + A
(2033 pmoles/k hr). 5/11k patients on CyA
had a urinary POE2 excretion less than
500 pmoles/ hr in contrast to only 1/11
patients on P + A. These data su-cest that
CyA may inhibit renal prostarlardin
synthesis.
ANERGY AS A PREDICTIVE FACTOR FOR THE OUT-
COME OF RENAL TRANSPLANTATION (Tx).
F. Anaya, R. Prez GarcIa, R. Jofre, P. To
rrabadella, F. Valderrbano.
Hospital Provincial de Madrid. Madrid.Spain.
Since 1981 delayed type hypersensitivi-
ty has been studied in patients awaiting
kidney Tx, using multipuncture with 7 an-
tigens (MULTITESTR). According with our
previous data, anergy (score<5 mm) was re-
lated to blood transfusions (BT) ,a single
BT inducing anergy in responsive (score >
10 mm) patients.
Previously tested patients (N=47) were
grafted from Cadaver donors during this
time. In an attempt to examine the rela-
tions of pre—Tx BT and/or anergy on the
outcome of renal TX, actuarial graft survi
val (AGS) at one year was calculated in
these patients according to the number of
blood units received (0 and1;<5 and5;
(10 and .10).
Pre-c Blood transfusions (units)
0 1 <5 *5 <10 10
N 5 42 15 32 26 21
1 year N3S 80 86 80 87.5 80.7 87.5
There was no significant difference
with pre—Tx BT. However, AGS in anergic pa
tients was 90 % at one year (N=30), but in
responsive patients was 64 % at one year
(N=13) pc.Ol. There was no differeRce in
the mortality rate, incidence of rejection
and of infections. We conclude that anergy
per se is a good predictive factor for the
outcome of cadaver kidney Tx irrespective-
ly to pre—Tx blood transfusions.
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ROLE OF RENAL TRA8EPLANTATION (TX) ON HYPERTENSION
(HI).
F. Anaya, R. Perez—Garcia, P. Torrabadella, M. Al-
varez de Lara, 13. Barril, F. \Jalderr6beno.
Hospital Provicial de Madrid. Spain.
In order to evaluate the role of' Tx on HI, we
studied 60 Ix recipients, 41 males and 19 females,
with a mean age of 35,9+12 years.Fifty one recei——
ved kidneys from cadaveric donors and 9 from li-—
ving related donors.Four patients underwent bilate
ral nephrectomy prior to Ix. Patients were classi-
fied according to HT and systemic repercussions as:
l/Normotensive, 2/Mild HI (M.HT). 3/Moderate RI
(MO.HI),snd 4/Severe HI (S.HT), wen the patients
were on maintenance dialysis (HD)(average time on
dialysis was 37.8±24 months) and 6 months after Tx
aiell as at the end of the follow—up period (from
6 to 89 months post—Tx).
Patients Normal M.HT MO.HT S.HT n
HD 26 17• 23 7' o
Tx6m. 25 16 17 2 60
Ix late 25 11 16 1
—
53
Creatinine 1.3+0.6 1.5±0.37 2.6+0.85 (x÷S.E.)
Evethough the number of patients in the diffe——
rent HI groups is similar before and after Tx. The
re were frequent individual changes from one group
to another. The evolution was as follows: 19 pa——
tients (35,8%)were always normotensive(or transien
tly mild hypertensive); 16 patients (30,2%)were a!
wars hypertensive; 9 patients (l7%)had moderate to
severe HI that disappeared after Tx; 9 patients
(l7%)had moderate HI only after Tx(5 only in the
early period post—Tx,and 4 only in late Tx follow—
—up).Renal function correlated with the degree of
hypertension after transplantation. HT in dialysis
does not imply a greater risk of HI after TxrFour
patients presented severe HI after Ix,three of
them related to renal allograftatery atenosis.
PNEUMOCYSTIS CARINII PNEUMONIA IN RENAL TRANSPLANT
REd PIENTS
F.W. Ballardie, C.G. Winearls, A.J. Rees,
G. Williams (Intr. by G. Williams)
Hammersmith Hospital, London, England.
Pneumocystis carinii pneumonia (PCP) is reported
to be a rare primary pulmonary infection When low
dose maintenance steroids are used. In a cohort
of 132 patients treated With low dose prednisolone
since 1978, 6 episodes of PCP occurred in 5
patients, 2 to 66 months after transplant.
Diagnosis was achieved by cytology of bronchial
lavage (2), transbronchial biopsy (1), open lung
biopsy (1) and clinically (2). Clinical features
at presentccion were fever (100%) and malaise
(50%) with normal chest radiograph (50%); respir-
atory symptoms were absent in 83%. Diagnosis was
delayed 2 to 16 days, when pulmonary symptoms,
infiltrates and hypoxia (P02 6.6—8.8) were present
in all patients. Autologous labelled neutrophil
scans (2) showed a diffuse lung uptake, preceding
'radiographic abnormality (1) • Associated
)pportunist infection was common cytomegalovirus
(2), herpes simplex (2), and Candida (2).
Pneumocystis antibody titres did not contribute to
diagnosis.
All survived after treatment with high dose
co—trimoxazole. Fever lysis occurred within 24
hours in the absence of other infection. Folinic
acid did not reverse side effects of therapy —
neutropenia and thrombocytopenia (3) and resulted
in temporary failure to respond in one. Lung
function after recovery from PCP was impaired in
all patients,
Our experience indicates Pneumocystis pneumonia
after renal transplantation is not rare. Non-
specific features at presentation result in
diagnostic difficulty and delay, Side effects of
treatment are potentially serious.
RELATIONSHIP BETWEEN DELAY IN TREATMENT AND GRAFT
OUTCOME IN RENAL ALLOGRAFT ACUTE REJECTION.
C. Antignac, R. Drachman, MF. Gagnadoux, N. Brayer
HOpital des Enfants—Malades, Paris, France.
The interval between the last normal creatinine
(s. crest.) level and the treatment of acute rejec-
tion was studied in 48 children with renal allo—
grafts (42 from cadaveric donors, 6 from living re-
lated donors), and a first acute rejection occuring
24 days to 42 months after the graft ; all had s.
crest, levels below 100 )JMol/l before the acute re-
jection (mean 82,pMol/l). Rejection treatment was
standard (high—dose cc'ticosteroids antilymphocyte
serum).S. creat. returned to initial levels within
one month after the beginning of the treatment in
29 cases (Group I). In 19 cases (Group II) the s.
creat. remained high (mean l351iMol/l). The mean
interval between the last normal s. creat. level
and the treatment differed significantly for the 2
groups (21 days in group I versus 46 days in group
II (p.O,Ol) . Children whose treatment started wi-
thin 10 days after the last normal s. creat. level
had significant better reponses to treatment (14
"group I"/17) than others (15 "group I"/3l) (p<
0,05). At the end of the follow up, 13 children h8—
ye a normal renal function, 9 lost their graft
(from chronic rejection) and the remaining 26 have
chronic renal failure ; the 13 children with normal
s. creat. levels (26 to 67 months after the graft)
were treated after a mean interval of 12 days ver—
sue 36 days for the patients with chronic rejection
(p<tJ ,05).
These results emphasize the need for an early
treatment of acute rejection, thus requiring fre-
quent creatinine checking, even long after the
transplantation.
LARLY INFECTIONS IN STANDARD IMMUNOSUPPES—
SED AND CY—A TREATED KIDNEY RECIPIENTS.
A. Vegeto, L. Berordinelli , E. PozzoH , E.Rivo I—
ta, A. Pasc i ucco, N. Bruno.
Department of Vascular Surgery and Trans—
plantation,PoI cl inico Hospital, Mi Ian,
Italy.
We compared the mortality and morbidity
from infection in our last 89 consecutive
transplantations,out of the total number
of 749;53 patients treated with CY—A +pre—
dnisone and 36 with standard immunosuppres
sive therapy were randomly included.
Urinary tract,oropharinx and sputum inve-
stigations were routinely performed.Vesi—
cal catheter,wound drainage and CVP cathe-
ter were also sent to our laboratory in
order to look for microrganisms.
A lower number of grafted kidneys were re-
moved becquse of rejection in the CyA+ste—
roids group (9.4% versus 25%).Only one
death occurred in the CyA group,due to an
ictus cerebri.However no more patient or
graft were lost becouse of any cause.
Clinically significant infections occurred
8 times (22.2%) in the standard immunosup—
pressed group and 15 times (28.3%) in the
CyA treated group.No differences could be
demonstrated in the incidence of clinical-
ly significant and subclinical infections
in patients receiving the two immunosuppes
sive protocols.
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OUTCOME OF 360 "TWIN" NECROKIDNEYS
L.Berardtnelli,M.Raiteri,R.Canal,R.Florio,
A.Vazzola and A.Vegeto.
Department of Vascular Surgery and Trans—
plantation,Pol cl inico Hospital,Mi Ian, Ital>
A number of studies about the fate of
paired necrokidney grafts had been previo-
usly accompl ished,but the limiting factor
of them consists in their multicentre so-
urce of data. The present study compares
the outcome of 360 "twin" grafts,coming
from the same donor,all removed,transplan—
ted and followed by the same surgical teaTh
The paired recovery of function,graft sur-
vival at 3,6,12 months,serum creatininee—
mia at one month,have been studied and
separately correlated with the donor age,
sex and cause of death.The data were then
compared with the same parameters of 340
control kidney grafts of our clinical ma—
terial,coming from different cadaver do—
nors.49 living donor grafts were not con-
sidered in this study.All kidneys had a
minimum follow—up period of 3 months.
Our preliminary results show that no signi
ficative correlation can be stated to
explain the graft survival of twin kidneys
from the same donor. On the contrary,as
regards the functional behaviour,the va-
lues of creatinineemia at one month appe-
ars to be significantly similar for the
paired groups,if compared with creatinine
values of control individual grafts.
PLATELET TRANSFUSIONS PREPARATIVE FOR
KIDNEY TRANSPLANTATION
H.Betuel, F. Robert, D.Cantarovitch° and J.Trae—
ger.
°Transplantation Unit and Histocompatibility Lab.
LYON, FRANCE.
In Rhesus monkeys 3 transfusions of purified
platelets led to a prolongation of kidney grafts
similar to the effect of whole blood but without
formation of cytotoxic antibodies (cyt. ab). In man,
the beneficial effect of pre—transplant transfusions
is marred by the development of cyt. ab which delay
transplantation Transfusion of purified platelets
was therefore applied to recipients previously
untransfused and without pregnancy.
Platelets were purified by 3 centrifugations. Two
pooled units of blood yielded 7Xl0-0 platelets,
contaminated with 7X io leucocytes (roughly equi-
valent to 0,lml of blood). One pool of platelets was
injected weekly during 5 weeks, corresponding to
the platelets of 10 (5X2) different donors.
Screening for antibodies followed each transfusion.
So far 14 patients have completed their program
13 did not develop cyt.ab; one patient was immu-
nized at the second injection, on account of unre-
corded transfusions 12 years ago. Two patients
have been transplanted with good clinical follow-up.
By way of comparison, 40% of recipients who receive
blood transfusions are sensitized. In summary,
transfusions of purified platelets in man do not
induce anti-HLA antibodies; the effect on kidney
graft survival need more cases to be appreciated.
PREDNISOLONE DOSAGE IN KIDNEY TRANSPLANT
PATIENTS - SHOULD IT BE BASED ON BODY
WEIGHT?
H. Bergrorn, J. Jervell, A. Flatmark,
National Hospital, Oslo, Norway.
To study the possible correlation be-S
tween body weight(b.wt.) and serum con-
centrations of prednisolone(p), 11 kid-.
ey trnsplant patients (b.wt. 68.4— 10.7,
mean — 1 SD, range 40—99 kg) were studied
after oral administration of p. 10 mg.
P. concentrations were measured for 14
hours by radioimmunoassay, free p. by
equilibrium dialysis.
There was a woak(r =
—0.21) but stati-
stically significant( p 0.05) negative
correlation between b.wt. and peak predni-
solone concentration. There was no signi-
ficant correlation between b.wt. and area
under the time—concentration curve for
botal(protein bound + free)(r = —0.07)
or free (r = 0.09) prednisolone.
These results suggest that the dosing
f prednisolone on a b.wt. basis will have
only minor effects on the measured serum
concentrations of total and free predni—
solone.
HLA-DR DEFINED, REPEATED, SMALL ALIQUOT, ThIRD
PARTY BLOOD TRANSFUSIONS
L. Burrows, H. Schanzer, G. Martinelli, M. Fotino
The Mount Sinai Hospital, Department of Surgery
The New York Blood Center, New York, New York U.S.A.
In a single center trial, prospective recipients
not previously transfused, received a single unit
of CPDA-stored blood in 3 equal aliquots on Day 0,
14 and 28. For each recipient, the blood donor was
chosen from a pool of HLA-DR defined donors with a
similar antegenic specificity to the prospective
recipient,but differing at one or more alleles at
the A,B,C or DR locus. 27 cadaveric recipients
and 6 living related donor recipients are included.
20 cadaveric kidneys are functioning well between
5-35 months with the majority at more than 1 year.
Of the 7 cadaveric kidneys lost within 3 months,
2 were unrelated to rejection. Anti-rejection
therapy in this series consisted of Imuran and
Prednisone, and occasionally Anti-Thymocyte
Globulin (ATG). Rejection crises were generally
mild and easily reversed. Of 6 living-related
donor recipients, with a one haplotype, high stimu-
lation mixed lymphocyte culture (MLC) index donors
similarly pre-treated with transfusions from a
single third party blood donor, 5 are doing well
between 10-40 months after transplantation.
In conclusion, multiple small aliquot trans-
fusions obtained from a single highly defined
donor, represents a very effective method of pro-
ducing a beneficial transfusion effect when
standard inmmunosuppression is used.
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• CYCLOSPORINE TWICE DAILY DECREASES REJECTION AND
NEPHROTOXIC EPISODES IN RENAL ALLOGRAFT RECIPIENTS
D.M. Canafax, C. Prieto, H. Hedaya, N.L. Ascher,
D.E.R. Sutherland, R.L. Simmons, J.S. Najarian
(Intr. by C.M. Kjellstrand) University of Minnesota
Minneapolis, Minnesota
A comparison of once and twice daily cyclospor—
me (CsA) dosing was made to determine the effects
on incidence of acute rejection episodes and CsA
nephrotoxic events. 235 liLA—mismatched renal allo—
graft recipients were treated with CsA and low—dose
prednisone and retrospectively analyzed. Acute
rejection episodes were defined as rapidly rising
creatinine levels (Cr) of at least 0.5 mg/dl with
biopsy evidence or a decrease in Cr in response to
Increased prednisone doses. CsA nephrotoxic events
were defined as a slowly rising Cr with biopsy evid
ence or a decrease in Cr in response to decreased
C5A doses. Of the 116 patients given CsA once
daily 46 (40%) had at least 1 rejection episode, 71
(61%) at least 1 CsA nephrotoxic event, 14 (12%)
grafts lost and 18 (16%) deaths. Of the 84 pat-
ients given CsA twice daily 16 (19%) had at least
1 rejection, 32 (38%) at least 1 nephrotoxic event,
1(1%) graft lost and 3 (4%) deaths. The differ-
ences were significant at p< 0.05. The median time
to first rejections was 1 month for both once and
twice daily patients. The median time to first C5A
nephrotoxlc event was 2 months for once daily and
1 month for twice daily patients. Mean and median
Cr for both groups was 2.1 mg/dl. Mean patient
follow—up was 19±13 months for once daily and 6±4
months for twice daily dosing. Actuarial graft
survival was 80% for once daily and 96% for twice
daily dosing at 1 year.
It can be concluded that twice daily C5A dosing
greatly reduces the Incidence of first rejection
and nephrotoxic events and improves 1 year graft
survival.
REVERSAL OF METHVLPREDNISOLONE RESISTANT ACUTE
ALLOGRAFT REJECTION WITH ANTI-THYMOCYTE GLOBULIN
S. Chatterjee, R. Mendez, R. Mendez, T. Bogaard,
M. Hernandez
University of California, Davis, and St. Vincent's
Hospital, Los Angeles, U.S.A.
Between January 1982 and June 1983, 201 renal
transplants were performed in one center. All allo-
graft recipients whose rejections were methyipred—
nisolone (M-P) resistant were treated consecutively
with adjunctive anti-thymocyte globulin (ATG).
There were 52 such patients in this 11 yrs. period,
9 of whom were insulin dependent diabetics. Source
of 43 recipients were from cadaver and that of 9
were from living related haploidentical donors.
Routine prophylaxis consisted of prednisone and
azathioprine. Primary treatment for acute rejection
episode consisted of i.v. solu—medrol 1 gm daily
for 3—6 days. All patients received 3-6 gm of N—P
prior to ATG therapy except one who received 1 gm
only. ATG was given i.v. daily for 14-16 days with
a total dose of 12-14 gm. Most common side effects
were fever, chills, skin rash and leukopenia.
Thrombocytopenia occurred in 23 patients (44%). In-
fectious complications were noted to be present in
17 patients (32%). The reversal of rejection was
impressive; 40 of 52 (77%) rejection episodes were
successfully reversed. One year graft survival in
this group was 30 of 52 (57%) which included 3 pa-
tients who died with functioning grafts. Sepsis was
not the cause of death in these patients. One year
patient survival was remarkably satisfactory, 3 of
52 died achieving a 1 year patient survival of 95%.
Our study suggests that 1) ATG is very effective in
reversing acute rejections even in fl—P resistant
cases. 2) One year patient survival and graft sur-
vival were highly satisfactory. 3) Morbidity from
infectious complications were high.
T—CELL GROWTH FACTOR(TCGF)ACTIVITY INHIBITION IN
DTJCED BY GLUCORTICOID AND CYCLOSPORINE-A IN CADAVE
SIC KIDNEY ALLOGRAFT RECIPIENTS
S.Carozzi, S. Lamperi
Division of Nephrology, St. Martin Hospital, Genoa,
Italy.
Recently, various AA demonstrate that the cyto—
toxic T—lymphocyte proliferation in a primary mixed
lymphocyte response(MLR) is mediated by a soluble
BCGF, released by mitogen/antigen stimulated T—cel-
Studies were undertaken to assess the TCGF acti
vity, in 68 cadaveric kidney allograft recipients,
of whom 4O were on hemodialysis (HD), 28 on CAPD
and in 14 normal volunteers for control. The study
was performed under basal condition and with the
addition of Dexamethasone (DXM) or Cyclosporine—A
(CyA).
The results demonstrate a significant reduction
of TCGF basal activity(p<O.0O5) in RD patients in
comparison to the CAPD and normal subjects. The ma
ximal inhibition(>85%), not—significantly correla-
ted to the basal TCGF activity, in obtained either
by the addition of DXM or CyA in 86% of the sub-
jects and only with CyA in 14%.
Therefore these results confirm the distinct si
tes of action of two drugs, the presence of an in-
dividual sensitivity of them, developing a further
possibility of controlled application of immunosup-
pression in the clinical practice of kidney allo—
graft.
HLA-DRW 6 POSITIVE RECIPIENTS ARE HIGH RESPONDERS
IN RENAL TRANSPLANTATION
S. Chatterjee, R. Mendez, R. Mendez, T. Bogaard,
B. Self, P. Bhattacharya
University of California, Davis, and St. Vincent's
Hospital, Los Angeles, U.S.A.
Between 1980-83 we performed 516 renal trans-
plants in one center who received a mm. of 3 units
of blood. All donors and recipients were tested
for HLA-A, B, and DR antigens. Of 46 DRW 6 pos.
recipients 23 received kidneys from DRW 6 pos.
donors and the other 23 received kidneys from DRW 6
neg. donors. There were 31 additional DRW 6 pos.
donors whose recipients were DRW 6 neg. We asked
two questions: 1) Among the DRW 6 pos. recipients
is there a significantly better rate of success
with DRW 6 matched kidneys than without? 2) Do
kidneys from DRW 6 pos. donors given to neg. recip-
ients result in a poorer result than the overall
success rate of 50%?
Group Recipient Donor n 1 yr graft
survival (fl
I Pos Neg 23 7
II Pos Pos 23 20
III Neg Pos 31 22
One sided test (Z test) for comparing the propor-
tions between Groups I and II was highly signifi-
cant p < .001. But similar comparison between
Group III and the standard rate of 50% was not
statistically significant (p > .95). We conclude
that DRW 6 may represent an important marker for
immune response gene, and optimal DR matching for
this allele will significantly improve the graft
survival. There is no indication that DRW 6 pre-
sent in the donor has any detrimental effect on
neg. recipients.
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C5b-9 (X2t4PLEX OF CCt4PLENT IS FOUND IN
SUBEPITILIAL DEPOSITS OF STE I IDIOPAThIC
NthBRANOUS NEPHr)PM'HY (INN), B1JI' NOT OF STAGE I
DE NOVO MEIBRTNOUS NEPHPOPM'HY (C!MN) AND 'lOXIC
INDUcED ME4BPANOUS NEPHROPATHY (ThN).
J.P. Cosyns*, M. Kazatchkine**, N. Hinglais**, J
Bariety** (Intr. by C. van Ypersele de Strihou).
*Up4jJersjty of Louvain Medical School, Cliniques
Universitaires St—Luc, Bruxelles, *INSERM U 28,
Hbpital Broussais, 75014 Paris.
Biopsy specinens fran 6 stage I and 4 stage II
DNMN, fran 10 stage I 1YN, fran 4 stage I and 2
stage Il-Ill INN have been examined by indirect
inisunofluorescence using a nonospecific antibody
to C5b-9 (provided by S. Bhakdi, Mikrobiologie
Institut, Giessen, DER).The subepithelial deposits were stained for
anti-IgG, but not for anti-C5b—9 in all stage I
DNNN and IT1N. In all stage I—Il-Ill INN and in
all stage II DNMN, the subepithelial deposits
were stained for anti-IgG and for anti-C5b-9.
The absence of C5b—9 in the subepithelial depo-
sits of stage I DN and ¶t!'IN vs its presence in
stage I INN is probably due to the earlier
detection of the sembranous nephropathy in
patients with DNMN and ThN who are carefully
followed-up.Our observations suggest that C5b-9 does not
participate to the initial subepithelial deposi-
tion of ixrmune material in DNNN and ThN. A
different involvenent of C5b-9 in the pathogene-
sis between DNMN plus '1W vs INN may not be
excluded.
• CYCLOSPORINE(CyA)—INDIJCED
.
DESPITE CONTROLLED CyA BL0() LEVELS IN A RENAL
ALLOGRAFT RECIPIENT.
J. B. Dossetor, 1. Kovlthavongs, M. Salkie, J.
Preiksaitis.
University of Alberta, Edmonton, Alberta, Canada
J.S., a male, aged 55, in renal failure
because of chronic glomerulonephritis received a
HLA—identical renal allograft from his sister in
May '83. Postoperative management was with
cyclosporine, prednisone (20 mg on alt. days)
and sulfinpyrazone (Anturan 100mg, 4x per d).
Unexpectedly high doses of CyA were needed to
give blood CyA levels of 50-200 ug/L Thus, for
8 months, daily CyA dose was 1300—1500 mg/d.
Serum creatinine remained under 200 umol/L. In
the 8th month he was investigated for malaise
and fever and was found to have developed both a
tender splenomegaly and two monoclonal peaks in
serum gamma globulins, one I9GL, the other IgMK,
indicating a lymphoproliferative disorder. Both
light chains were present in urine. On stopping
sulfinpyrazone, without altered dose of CyA, CyA
blood levels immediately rose three fold (to
nearly 400 ug/L). Off sulfinpyrazone, 300 mg/d
of CyA gave levels of 50—100 ug/L. On this dose
the monoclonal peaks almost disappeared within 2
months and he felt very well. The spleen became
normal. CMV infection was not implicated.
Although the longterm outcome remains unknown,
we conclude that sulfinpyrazone interfered with
CyA assays and lead to excessive CyA dosage with
induction of ?—malignant lymphoid clones. The
rapid reduction of serum monoclonal protein and
splenomegaly suggests that CyA-induced lympho—
proliferation may be reversible if the dose is
drastically reduced.
SYSTEMATIC SURVEY OF IMMUNOGLOBULIN ABNORMALITIES
(IA), FREQUENCY AND EVOLUTION IN TRANSPLANT PEOPLE.
P. Deteix, Ni. Brusa, C. Chapuis-Cellier, Z. Ghais,
N. Lefrancois, C. Pouteil—Noble, J.L. Touraine,
3. Traeger.
Clinic of Nephrology, INSERM 0.80, laboratory of
biochemistry B, hOpital E. Herriot, Lyon, France.
Lymphoproliferative syndromes (LS) associated
with IA can occur in transplant patients. At least
20% of transplant people have IA, most of them
without any symptomatology and any evident cell
proliferation. Systematic survey of IA has been es-
tablished for now one year in our group for new
patients. Screening method is isoelectric focusing
on thin layer in a 3.5 — 9.5 pH gradient.
From march 1983 to february 1984 we performed
organ transplantation in 100 patients. Patients'
serum studies were performed weekly during 45 days
and regularly after. We observed IA in 12 patients,
abnormality appeared from 10 days to 9 months after
transplantation (7 patients with restriction of Ig
heterogeneity, 5 with monoclonal component
4 IgGK, 1 IgMK). IA were seen with ciclosporin and
with conventional therapy (azathioprine, prednisone
antilymphocyte globulins). We saw only in a few ca-
ses association with viral infection. Two patients
developped LS and died soon after IA discovery
(lymphoblastold cell lines started from bone marrow
cultures). IA disappeared spontaneously or after
immunosuppressive therapy reduction in 4 patients
1 to 4 months after IA discovery. 6 patients have
still IA after a 1 to 7 months survey.
IA frequency in transplant patients is rather
high. Evolution is variable and unpredictable.
Transformation of isolated IA in LS is still diffi-
cult to predict. Isoelectric focusing must be used
routinely to detect such IA. Further investigation
will allow to precise clinical value of IA.
FINE NEEDLE ASPIRATION BIOPSY (FNAB) IN RENAL
TRANSPLANTATION (Tx)
Egidi F., De Vecchi A., Tarsntino A., Rivolta E.,
Ponticelli C.
Nephrology Division Ospedsie Msggiore Milano Italy
In 40 Cyclosporine(Cy) and in 49 Azathioprine(Az)
treated pstients(pts.),470 FNAB were performed in the
early post—Tx period(l—90 days) .Quslitstive exsmina
tion of tubular and endothelial cells allowed to id
entify tubular necrosia(ATN),Cy toxicity(TOX) and to
tal necrosis.The diagnosis was confirmed by the fol
lowing clinical outcome.A semiquantitative index wa
used according to HNyry to assess the presence of im
munoactivation, i .e.corrected increment(CI) .Results:
Retrospective pta. FNAB false
diagnosis TOXATN — CI results
Normal function 20 — — 2.5÷0.9 0
Anuria(norejection)6 3/6 3/6 2.3÷0.9 0
Anuria + rejection 8 5/8 3/8 5.5±0.8 0
Rej.before therapy 36 7/36 4/36 5.5÷1.1 3/36
Rej.after therapy (Methilpredniaolone pulses)
reversible 25 5/25 — 4.3÷1.2 0
irreversible 11 3/11 — .'l0 0
Cy toxicity 15 15/15 — 3.5÷1.4 0
Cy toxicity÷rej. 7 7/7 — 5.7÷1.5 0
Total necrosis 4 — — undetectable
In almost all the aspirates from pts. with irrevers
ble rej. machrophages were present,while the most
frequent inflammatory cells in the aspirates from pt
with reversible rej. were T and B lymphoblssts.No
clinical complications were observed after FNAB. In
conclusion our data confirm that FNAB is an useful
tool in monitoring renal Tx in the early period.
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A PROSPECTIVE STUDY OF ESRD PATIENTS ASSIGNED TO A
CADAVERIC TRANSPLANT (CT) WAITING LIST.
G. Rodin, K. Voshart, S. Fenton, D. Cattran, P.
Halloran, C. Cardella, University of Toronto,
Toronto, Canada.
Renal transplantation has been considered super-
ior to dialysis as a treatment for ESRD, although
most studies of quality of life are poorly con-
trolled or do not include transplant failures. We
have conducted a prospective study of the quality
of life of ESRD patients assigned to a waiting list
(WL) for CT. Measures included the Sickness Impact
Profile (SIP) to assess illness—related psycho-
social and physical dysfunction. Patients were
assessed when placed on the waiting list and at 6
monthly intervals subsequently and following CT.
Those who received a CT (N34) did not differ from
Dther WL patients (N=23) in age, duration of dialy-
sis or subsequent mortality, There were 6/34 (18%)
Iraft failures. Compared to their pretransplant
status, patients with successful CT (N=28) showed
an overall improvement of 51% on the SIP (p.OOl)
with significant improvements in emotional behavior
(p<.000), social interactions (p.(,.Ol), ambulation
(p<,.000), sleep and rest (p<.Ol), home management
(p <.05) and recreation and hobbies (p<.0007).
By contrast there was no significant change after 6
months in WL patients or CT patients with a graft
failure. Preliminary results show a similar sig-
nificant improvement 12 months after successful CT
but no significant change with graft failures com-
pared to pretransplant status.
We have quantified the marked improvement in
psychosocial and physical functioning following a
successful CT. More surprising is that morbidity
was not increased with graft failures. This pros-
pective study thus provides objective support for
CT as an optimal treatment for ESRD.
PRESERVATION 2ND FUTIONAL STUDY OF PIDXfl'4PL 'TUBU-
LES BY THE "IN VITEO" ISOLATED MICItPERFUSED TBUHNI
JE.-D.Fa3.kenstein; S.A.Draibe;O.L.RaflDs;.J.F
redo.-Nephrology Division.Escola Paulista de dici
na. São Paulo, Brasil.
The effects of preservation solutions are in
general studied in the whole kidney. It would be of
interest to study the direct effect of preservation
solutions on the tubule and if there is a preferen-
tial via which could better preserve the cellularlayer. Therefore the effect of the Collins solution
(CS)on the fluid absorption (Jv) in the proxinal con-
voluted tubules (PCTs) was studied with the microper
fusion technique. In the first group (El) rabbit
renal cortical slices (FCS) were stored (SI') in CS
for periods of 0 to 97 hs after which PCI's were
dissected in CS and perfused in the lum.inal side
and bathed in the peritubular side with a plasmalike solution (PS). In the other two groups the Jv
eas neasured during the control period with PS in
the both sides, after that GI was added only in
the bath side (E2) or only in the luminal side (E3)
follcMed by the recovery periods. Results were:
Jv (nl.mn'.n*i11)
G)UP Sr (ha) CONT)L RBUCNERY
El(n"16) 0—97 1.11±0.15 ——
E2(n=7) 0 1,15±0.24 1.05±0.17
E3(n'S) 0 0.83±0.15 *014±009
Values are MF.PN±SEM paired t test (p<O.OS)
The group El showed a normal Jv, the E2 group a
c*xplete reoovery of Jv and the E3 group a decrease
(pO .05) in Jv during the recovery period. Thesedata suggest that the peritubular side could be the
preferential via which preserve the cellular layer
by the Collins solution. Furthernre, this approach
may be used to test the influence of preservation
solutions on the cell viability of the renal tubule.
L\CTATE DEHYD1XEASE ?CIVITY (1DB) IN RABBIT REL
ORPEX STORED IN SSrERAL PRESE11ATION SOLUTIONS. -D.
Faikenstein;L.E. Santo;T.Martinez;H.Ajzen;J.F.Fi9ti
redo.Nephrology Division.Escola Paulista de dici-
na, São Paulo, Brasil.
Inpaiint of renal function by acute tubular
necrosis in the post transplanted kidney could be
asscciated with an increase in intracellular serum
enzynes. Therefore, the purpose of this study is to
evaluate the effect of clinical and experirental
preservation solutions on renal cortical tissue by
neasuring LDH release as a tissue marker of cell
viability. 'Tb test this hypothesis, tissue fran
renal cortex of rabbit was incubated in several pre
servation solutions at 4cC and the capacity of the
tissue in releasing 1DB during several periods was
neasured. The 1DB assay was perforned in the solu-
tions using a Boehringer test kit in a AWt-l00 auto
analyzer. The results were:
1DB U/]4m of tissue
SODIUMBU
PERIODS
(BE)
KREBS
SELEIT (1)
(CONrHOL)
COLLINS
GTIJCX)SE (2)
33OnOsm
PHOSPHATE
+SIXHOSE (3)
500nOsni
1 0.7±0.3 0.4±0.1 0.3±0.1
24 3.5±1.0 1.9±0.5 1.8±0.3
48 6.9±2.1 3.2±1.4 3.3±0.9
72 8.5±2.3 5.3±1.7 3.8±0.7
96 7.8±1.9 7.7±1.4 3.6±0.7
120 7.3±1,8 6.8±0.8 3.9±0.7
MHAN±S4 (n=5) paired t test (p<U .05)
Our data have shown that solutions which preser-
ved the kidney clinically as the solution 2 and ex-
perinentally as the 3 were the solutions which pre-
sented lower IDH activity after 1 hour when cuipa-
red with the control (p<O.OS) .These data suggest
that the preservation solutions could change the
renal cell netabolism preventing 1DB release.
FUNCTIONAL BEHAVIOR OF THM iSOL(1'ED RAT KIONEY SUB-
MITTED 'TO DIFFEREHT REHAL PRESERVATION SOIJJTIONS.J.D
Slroes;D. Sigulen;H.Ajzen;J.F.Fiqueiredo. -Nephrology
Division.Escola Paul ista de dicina. São Paulo,Bra-
sil.
Systematical studies involving preservation solu-
tions and paraneters of renal function still are nee
dod to better understand the characteristics of the
preserved kidney. In this protocol the effects of
different solutions were studied with the "in vitro"
isolated rat kidney preparation. In the this protocol
the effects of different solutions were studied with
the "in vitro" isolated rat kidney preparation. The
protocol consist of a control group (Co) inwhich Kid-
neys were perfused with a plasma like solution at 3>
C.The experinental groups consist of kidneys preser-
tied and stored at 49C for 1 to 24hs (SI') after flus-
hing them with Aquactella (Al ,P,24) phosphate tuffer(PB1 ,ps24) and Collins (Cl,C24)solutions. Later ST ki±1
neys were perfused as the control.GFR, fractional so-
3ium excretion (FINa) ,proteinuria (UP) and glicosuria(UG) were neasured.
PARAMETERS Co Ai Cj PBi A2z C2, PB
GFR 0.80 0.54* 0.73 0.61 0.27* 0.05* *0.36
ml/min/g 0.01 0.03
FENa% 23.1* 38.6* 18.6 323* 81.4* 71.6* 82.6*
±3.3 ±5.8 ±2.7 ±2.1 ±7.4 ±7.8 ±3.5
110 70 110* 70 140* 230* 60 290*
pg/nm ±2O ±30 ±17 ±20 ±20 ±10 ±50
UP 0.4 1.2* 2.6* 1.5* 34* 1.4* 9.2*
ug/min ±0.03 ±0.3 ±0.9 ±0.1 ±0.5 ±0.5 ±1.8
MEAN±SEM paired t test p<O.O5 j5
In our experEnental conditions kidneys stored for
lhr decreased the GFR and increased Up and UG canpa-
red to the control (p<O.O5)excepted the Cl group
which did not change the FENa and UG. Kidneys preser
ved for 24bs deeply decreased the GFP. and increased
the ETEa and UP. These data suggest different beha-
vior of glane±ular and tutular function with these
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THE SIGNIFICANCE OF TRANSFUSION-INDUCED
INMUNOREGULATORY ANTIBODIES
M A Forwell, J D Briggs, B J B Junor,
G P Sandilands, Renal Unit and Department of
Pathology, Western Infirmary, Glasgow
The aim of this study was to investigate the
suggestion that transfusion—induced enhancement of
renal allograft survival is mediated by Fc -
receptor (FcR) blocking antibodies.(1) IgG
from 100 patients and controls (obtained from
serum by DEAN chromatography)was tested by FcR
blocking activity using a rosette inhibition assay.
Following transfusion siiificantly more
non-uraemic than uraemic subjects developed FcR
blocking IgG (p<O.001), and there was a reduction
in the percentage of peripheral blood lymphocytes
bearing unreacted FcR.
No correlation was found in 52 patients between
pretranspiant FcR-blocking IgG and 3—month
allograft survivial. Retrospective analysis of
data from 43 patients tran5planted in 1978 showed
that 5—year graft survival correlated with blood
transfusion (p.0.00i) but not with Fc B—blocking
activity. Fractionation of 21 sera over
discontinuous sucrose gradients showed that
rejection was associated with maximal FcR—
blocking activity in the IgG peak and graft
survival with activity in peaks corresponding to
small circu)ating immune complexes.
These results confirm the production by
transfusion of Fc2 blocking IgG which does not
however correlate with graft survival. The
"tranefusion effect" on graft survival may be
mediated by mnafl circulating immune complexes
with Fc H blocking activity.
() acLecd AM, et al Lancet (982) ii 468
URINARY ENZIMES:NON INVASIVE TEST FOR NE-
PHROTOXICITY DURING IMMUNOSUPPRESSIVE AGE-
NTS IN RENAL TRANSPLANTATION
A. Montanari,M. Briganti,R. Cocchi,G. Emi—
liani,A. Fabbri,M. Mandreoli,M.Fusaroli.
Division of Nephrology and Dialysis,S.M.
delle Croci Hospital,Ravenna,Italy
In order to evaluate the renal tubular
damage in renal transplant recipients trea
ted with Cyclosporin A(CyA)we have measur-
ed the urinary excretion of:N-acetil-—glu
cosaminidase (NAG) ,aminopeptidase (AAP)and
G-glutamyltransferase(GGT)in 6 patients on
mean dose of 7.9mg/Kg/die of CyA(group A)
and in 6 patients on a mean dose of 14.4mg
/die of prednisolone and 1mg/Kg/die of aza
thioprine(group B),the two groups were corn
pared with controls(group C).
Age Tr.months P.cr. NAG AAP GGT
A 49*8.9 1.9*0.5 6.9±3 12±9 25*E
B 44±9.5 1.8±0.6 6.2±4 13±8 24±c
C 34±7 / O.8±O.l 3±1.2 1.8 21
These findings suggest that in the lth
month of therapy with immunosuppressive age
nts,urinary enzirnes are significant1y(p(4co
higher than in 7th,l3th,l9th month,in group
A and B.
In conclusion urinary enzimes excretion
didn't appear modified by means doses of
CyA that we have used in comparison with
conventional therapy.
A PROSPECTIVE STUDY OF A TRIPLE ASSOCIATION : CY—
CLOSPORINE A (CyA) + CORTICOSTEROIDS (CS) + AZA
THIOPRINE (AZA) IN IMMUNOLOGICALLY HIGH RISK RENAL
TRANSPLANTATION (RI)
D. Fries, C. Kechrid, M. Hammouche, B. Charpentier
BSpital Paul Brousse 94800 Villejuif, France
The immunosuppressive properties of CyA were re-
ported to be optimized in experimental RT by its
association with CS and AZA. We have explored the
potential interest of this triple regimen, CyA be-
ing given at lower dose (8 mg/kg/d) than usual to
avoid overiinmunosuppression and nephrotoxicity.
Among 117 kidneys grafts performed during 1983, 36
patients were considered as immunologically high
risk patients Group I (5) 2nd transplantation.
Group II (8) high responders with a poor matching.
Group III (23) histologically proved rejection
occuring during the 2 first months and resistant to
2 previous courses of high dose methyl prednisolone
and ALG.
1. Overimmunosuppression could not be documented.
In only 4 patients, a < 3.000 wbc count could sug-
gest some additive effect of CyA upon the myelotoxi
city of AZA. The incidence of infections did not
increase. Nephrotoxicity was suspected in 7/36 pa-
tients, proved in only two.
2. The effect of this triple regimen on graft sur-
vival will be discussed, taking in account an his-
torical control group of 257 RT performed from ja-
nuary 1980 to december 1982. For instance for group
III patients, graft survival at 3rd month is 87 %
in CyA patients vs 78 1.
Conclusions the triple association is a safe pro-
cedure ; the continuation of AZA allows lower dose
of CyA, avoiding overilsmunosuppression and nephro—
toxicity. Results concerning graft survival will
be actualized at the time of the meeting.
NATURAL KILLER ACTIVITY IN PATIENTS RECEI-
VING RENAL TRANSPLANT
Fusaroli M., Monti G., Lauria F.
Dept. of Nephrology and Dialysis — S. Maria
delle Croci Hospital — Ravenna, Italy
Natural killer activity (NKa) and membra
ne phenotype of I—lymphocyte subsets were
performed in two groups of patients recei-
ving renal transplantation. The group A was
treated with steroid and azatioprine, the
group B received Cyclosporine A, as sole in
munosuppressive agent. All patients have a
serum creatinine less than 1.7mg/di, and
any viral infection episode occurred. The
mean duration of renal transplant was ,l
year. In all patients we have study NKa a-
gainst target cells and T—lymphocyte subpo—
pulations defined by monoclonal antibodies
0KT, OKT4, OKT8 and cytotoxic cells identi
fie by antibodies Leu7, Leu11, A10
OKT4 OKT8 T It Leu Leu1 A1group A 41* 22 ll. 7. 6.
group B 24* 23 1.04* 12.6 9.3 4.5
* p<0.00l
e have observed a significative reduction
of helper cells and OKT /OKT8 ratio <1 in
the Cyclosporine treated group. The NKa was
uniformely reduced in the two groups of pa-
tients.
In conclusion both immunosuppressive treat
ments have a similar effect on the decrease
of natural killer functions.
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IMMUNOLOGICAL MONITORING OF RENAL ALLO-
GRAFTS IN PATIENTS TREATED WITH LOW DOSES
OF STEROIDS.
F.Giacchino,G.P.Segoloni,M.Pozzato,M.For—
mica,A.Vercellone,G.Piccoli.
Medical Nephrology, University of Turin,
San Giovanni Hospital, Turin, Italy.
T cell subpopulations were studied in
31 renal transplant recipients (20 males,
11 females ,mean age 39+8 years)using mono—
clonal antibodies (OKT3, OKT4, OKT8 — Or-
thoclone).
All patients were treated with low do-
ses of steroids and azathioprine.
One of 12 patients (8) with pre—trans-
plant OKT4/OKT8 ratios) 1.5 (group A) and
6/19 patients (32°)with pre—trarisplant
OKT4/OKT8 ratios . 1.5 (group B) lost
their graft within 3 months due to rejec4-
tion. No significant modification of
OI(T4/OKT8 ratios was found during rejec-
tion episodes.
P—creatinine was significantly lower in
group A than in group B, at 6 months
(1.3±0.2 mg/lOO ml vs. 2±0.3 mg/l00 ml;
p< 0.05).
Our results suggest that pre—transplarit
T cell subsets are of prognostic value for
renal allografts in patients receiving low
doaes of steroids.
PJME-CATJSE CONSIT)ERAP IONS IN I)EFINJNG THE
VARTAT TON BETWEEN TRANSPLANT CENTRE RESTJUFS IN
THE UK & IRElAND FROM 1977-1981.
W.R. Giiks, B.A. Bradley,*N. Selwood
MRC Biostastic Unit, Cambridge.
U.K. Transplant Service, South Western Regional
Transfusion Centre, Sout.hmead, Bristol.
The Centre variation iq a poorly defined
statistical phenomenon. Current practices fail
to account for random variability and ignore the
differential patterns of failure due to different
causes.
When the frequency distribution of pooled data
for 1977 to 1981 was examined according to the
cause of failure of the 1st transplant, a marked
difference in the timing of loss was revealed.
A novel method was developed for the cat gor—
isation of centres according to their actuarial
survival such that random variability was
accounted for,
Variations in the centres rate of failure due to
'Death with a functionary transplant' (DWS'F) were
shown to be indistinguishable from random varia-
bility, but both rejection and non—i inwolng rel
failure was found to be legitimate basis for
ranking. However, centre ranking based on ear).y
rejection loss (0—25 days) failed to exhibit a
significant relationship with later rejection
loss (26—100 days). Loss through non—imaunologica
causes failed to show any dependance on either
loss from DWSF or rejection. It was suggested
that this simple, novel method of ranking
centres based on tiwe—case parameters gives a
more accurate reflection of differenc es in
clinical practices.
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PROGNOSTIC FACTORS FOR KIDNEY GRAFF SURVTVAL -
AN ANALYSIS OF 2531 TRANSPLANTS IN THE UNITED
KINGDOM & IRELAND 1978-81.
W.R. Gilks, S.M. Gore, B.A. Bradley*, N. Selwood.
MRC Biostastios Unit, Ca.bridge.
*UK. Transplant Service, South Western Regional
Transfusion Centre, Southmead, Bristol.
An analysis is presented of 2531 Cadaveric first
kidney transplants performed between 1978 and
1981, notified to the U.K. Transplant Service
through the collaborating 31 transplant
centres in the U.K. and Ireland. The analysis
paid particular attention to data quality and to
differences between transplant centres.
The results of analysing multi —factorially many
recipient , donor , matching and operation factor
revealed that a long period of pre—transpiant
dialysis, accidental donor death and good B—locus
matching, were conducive towards lowering the
risk of graft failure, whilst the opposite was
found for a high antibody reaction frequency, a
long donor anoxia time and 2 or more arterial
anastomoses.
The study also identified a sub—group of locally
transplanted patients, who had a very poor
prognosis for graft survival.
This subgroup consisted of recipients aged 45 or
over who received locally retrieved kidneys that
were mismatched for the lILA—B antigens
SUCCESSFUL RFN!'L TRANSPLANTATION DOES NOT CORRECT
THYROID ABNORMALITIES IN 1IREIC PATIENTS
C.(iordano,N.C..De Santo,C.Carella,O.Caoodicasa,
G.Bazzato,V.Nioli,O.Amato,F.Nuzzi,A.Tarchini,lJ.Coli
V.Landini,V.Bordoni,V.De Simone,E.'1ottola,F.Canuano
University of Naples,University of Ancona,Umberto
I Hospital Mestre, Italy
The coal of this work was to study the effects
of a well functionino renal transolant( TX ) on
thyroid abnormalities which are present in uremia
We have studied 15 pts( 11 M ) aoed lB-49 vrs
6-96 months after transplantation and measured:T-3
T-4,FT-3,rT-3,TSH,TBr.,OH( by RI!' ),FT-4( by RI!' an1
dialysis ),hTO( by IRNtA).In addition the TSP and
1-3 response to to TRH( 2ODn Lv. ) was evaluated
and data were compared by t test with those in 40
aqe and sex matched healthy controls.
T—3 was normal( but 4 ots had values 2 SD below
normal.T-4 was reduced( oO.0Ol vs normal and 7
pts had values 2 SD below norinal.rT-3 was increa-
sed( P<O.OOl vs normal ) and 3 ots had normal
values.TSH,hTG,GH,TBO were normal as it was FT-4
with both methods.TSH response was diminished and
delayed( peak at 60 mm ) and 3 nts had TSH concen
trations hiqher than normals at 120 min.T-3
response to ISH was normal.
After TX a low 1-4 syndrome is evident which is
associated with diminished and delayed TSH resnons
and does not correlated with steroid usaoe.Ry oro-
per evaluation of steroid effects on TBO-,T-3,T-4
and 1—4 kinetics it is possible to demonstrate thai
TX does not correct thyroid abonormalities in
uremic oatients.
Abstracts 637
HUMAN MILK IgA CONCENTRATION AFTER SUCCESSFUL RENAL
TRANSPLANTATION
D. Grekas, Z. Gianopoulos, I. Tzafetas, A. Tourkan-
toni s.
1st Medical Department, University of Thessaloniki,
Thessaloniki, Greece.
There is no evidence so far that maintenance do-
se of immunosuppressive drugs is realy risk to the
babies during gestation and lactation time. Human
milk immunoglobulin IgA is the most important of
all protective factors against a range of several
infections. Two women aged 21 and 26 years respec-
tively, had a good outcome of pregnancy after rq-
nal transplantation. Although breast feeding has
been discouraged they chose to breast-feed their in-
fants for 4 and 5 months respectively. Serum and
milk IgA levels were determined in both these pati-
ents. The results were compared with those of two
normal control subjects who were not receiving im-
munosuppressive drugs. The IgA level in the breast
milk of two patients was similar to that in the con
trols at the 1st week after the delivery while
a slight reduction of serum IqA levels were obser-
ved. Durinq a 4-months follow-up the breast milk
IgA levels ranged within the lower normal limits.
Also the two infants aged now 30 and 24 months re-
spectively have so far normal WBC and no increase
in incidence of infections. It is suggested that
human milk IgA levels are not suppressed by irnu—
nosuppressive therapy after renal transplantation.
EFFECT OF CICLOSPORIN ON THE PROXIMAL TUBULAR
FUNCTION OF THE RAT KIDNEY. H.-U. Gutsche, E.
Delz , M. LUneburg , K.-H. Gnutzmann , and W.
Niedermayer, Depts. Special, Nephrol ., and Sur-
gery, Univ. of Kiel, Germany.
Nephrotoxicity is one of the major side
effects of immunosuppression with ciclosporin.
Apart from morphological alterations of tubular
cells, little is known about functional defects
of the nephron segments involved. The present
study was designed to investigate the electrolyte
transport of the end-proximal tubule and of
the loop of Henle by analyzing the electrolyte
concentration of early distal tubular fluid
obtained from surface nephrons of rat kidneys
during free flow and pulse stop flow micropunc-
ture experiments (Gutsche 1980). After admini-
stration of 15 mg ciclosporin by gavage for
8-10 days the conductivity of fluid from the
early distal tubule and from the diluting segment
was significantly increased. The NaC1 concentra-
tions during free flow sampling were calculated
as 98,9 and 54,6 meq/L in ciclosporin animals
and 62,3 and 29,2 in controls.
These results and further micro-stop-flow
data reflect a transport impairment with in the
proximal tubule and the loop of Henle. As demon-
strated here, the NaC1 concentration at the
macula densa of ciclosporin treated rats was
regularly above the threshold of feedback stimu-
lation (Schnermann et al. 1976). We assume that
tubuloglomerular feedback operation might be
involved with the reversible GFR decrease ob-
served at elevated blood levels of ciclosporin.
• IMPROVEMENT OF THE CYCLOSPORIN A HANL)LING
BY ALG IN THE EARLY POSTOPERATIVE PERIOD
H. Grundmann, P. Wienand, U. Hesse
Chirurgische Universittsklinik Köln-
Lindenthal, Germany
The value of a prophylactic ALC treat-
ment after transplantation was examined in
a prospectively randomized study of 94 pa-
tients. The control group was treated with
azathioprine and steroids only. The imme-
diate function after transplantation with-
out dialysis was in the ALG group 68.1%,in
the control group 17%. The 6 month graft
survival rate was 76.6% (ALG group) and
61% (control group). In a 3rd group prophy
lactic ALG combined with azathioprine and
steroids was given in 31 patients for 10
days after transplantation and was then
replaced by cyclosporin A and steroids
only. In this group the immediate function
rate was 74.2%, the 3 month survival rate
92%. There was no rejection episode in the
first 10 days after transplantation.
1.) ALG combined with cyclosporin A
gives better results than prophylactic ALG
treatment only. 2.) Since most of the kid-
neys had started to function at least at
the 10th pop day, cyclosporin A could be
given at this moment to all patients, anu-
nc kidneys had not to be excluded. Thus
this method of treatment can be applied in
the same way to functioning and less func-
tioning kidneys and the handling of cyclo—
sporin A in the early postoperative period
becomes much easier especially in kidneys
with ATN after transplantation.
iRANdPLANTATION Dr iMPORTED CADAVER KIDNEYS
N. Haberal,Z. Oner, M. Karamehmet, I.Ydnia
N. Bilgin.
Hacettepe Univ. Hosp. Tx. Center, Ankara,
Turkey.
From Jan. 1, 1983 to Dec. 31, 1983, 122
renal transplantations were performed in
our center, Of these, 104(85.3%) were from
cadavers & i8(14.8%)from living related.
104 kidneys were transplanted to 100(79
males, 21-females) patients. The majority
of the kidneys came from the U.S. & the re-
mainder from Europe, via air—freight,
packed in ice. The cold ischemia time (CIT
of 100 kidneys ranged from 48—108:59 hours
(average CIT:69:09 hrs). The CIT of 4
kidneys ranged from 23-48 hrs. 9(8.7%) of
the 104 kidneys didn't function at all. Of
the 95 that did function, 7(7.4%) showed
function for less than 30 days. At the end
of 1 mc. patient survival rate was 94.8% &
graft function 87.5%. At the end of 3 mos.
patient survival was 90.5% & graft functior.
64.6%. At the end of 12 mos. patient sur-
vival was 79% & graft function 57%. As
immunosuppresive agents Azathioprine &
Prednisone were used. Only 1 patient re-
ceived Cyclosporin A, but the graft didn't
function at all. 21 patients died as a re-
sult of various complications. The acute
rejection rate was 18% & chronic rejection
was 30%, especially after 3 mos.
This study showed that imported cadaver
kidneys can be transplanted with CIT of up
to 108 hrs, with a negative cross—match &
without checking HLA & DR typing, still
provides satisfactory results.
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TRANSPLANTATION OF CADAVER KIDNEYS FROM
ANENCEPHALIC NEONATES DONORS
M. Hall, P. Kinnaert, F. Janssen,
J. Vangeertruyden
Université Libre de Bruxelles (Intr. by
P. Vereerstraeten)
The kidney of two anencephalic donors were
transplanted to 2 recipents (14 and 24 years
old) in our department. The patients are
presently living with a functionning graft
2,5 to 6 years posttransplantation. One
patient is hypertensive but blood pressure is
medically controlled.
Transplanted kidneys increased in size and in
function following the same pattern as normal
neonates kidneys.
Results of an investigation in different
European transplant groups (11 cases) and
reports of the litterature (18 cases) are
discussed.
Technical problems with the anastomosis of the
kidneys have been responsible for circulatory
failure and thrombosis in several cases.
Congenital kidney anomalies could be "elimi-
nated" by sonographic procedure or demonstra-
ted by exposure during the donor nephrectomy
procedure.
More studies are needed before this category
of donors can be used safely.
HETEROGENIC REPLACEMENT OF TEE RENAL VEIN
IN CADAVER KIDNEY TRANSPLANTATION
U. Hesse, H. Grundmann
Chirurgische Universitätsklinik Kbln —
Lindenthal, Germany
Thrombosis of the renal graft vein occurs
in O.5—4A of all cases after kidney trans-
plantation. Causes are kinking, throinbo—
sis of the pelvic vein, local heinatomas
and lymphoceles. But injury of the renal
vein during cadaver nephrectomy and sub-
sequent surgical repair can also lead to
renal vein thrombosis.
In 244 renal grafts (1978—1983) we saw 16
kidneys with a damaged vein. In 12 veins
the leakages were sutured, very short
veins were anastomosed to the external
iliac vein. 2 of these had to be explan—
ted because of unrepairable vein throm-
bosis.
In 4 cadaver kidneys which veins were in-
jured or cut off during cadaver nephrec—
tony a solco graft was used to replace or
lengthen the defective vein respectively.
Resul: 2 kidneys had immediate function
the 3th started diureses after 13 days,
the 4- after 24 days. 3—6 months after
transplantation the serum creatinin
levels were between 1.4—1.6 mg/a. One kid-
ney is working already 5 years (1.5 ng%).
Conclusion: The replacement of damaged
renal veins by bovine graft in kidney
transplantation can avoid venous throm-
bosis successfully.
METABOLIC EFFECTS OF CONVERSION FROM CYCLOSPORIN A
(CyA) TO AZATHIOPRINE (Aza) IN RENAL TRANSPLANT
RECIPIENTS
K. Harris, G.I. Russell, S.P. Parvin, P.S. Veitch,
J. Walls, Area Renal Unit & Univ. Dept. of Surgery,
Leicester General Hosp., Leicester. U.K.
Nephrotoxicity and hepatoxicity are well
recognised complications of CyA in renal transplant
recipients. It has also been suggested that a
deterioration in glucose control may occur. Recent
experience in this unit has indicated an apparent
higher incidence of diabetes than previously seen
in patients treated with Aza. Current practice
involves initial treatment with CyA and steroids
with conversion to Aza and steroids st 3 months
post transplant. Ten patients were studied pre
conversion and 1 month post conversion. Renal
function, glucose tolerance tests (GTT), fasting
insulin, cholesterol and triglyceride levels were
measured. Prédnisolone dose remained at 30 mgm
alternate days throughout.
Results (means+SEM) Pre Post
Conversion Conversion
Fast, blood sugar 4.8+0.3 4.8+0.1 NS
(imso 1/1)
A.U.C. (GTT) 848+70 731+47 NS
Fast. P. Insulin (lu/l) 16+3.1 16.7+2.5 MS
P. cholesterol (mmol/l) 7.7+0.4 6.4+0.4 p<O.OOS
P. triglyceride (mmol/1) 2.4+0.1 1.5±0.2 p(O.OO5
Renal function improved following conversion (S.
creatinine 162+19 to 128±13 umol/l; p(O.Ol): serum
potassium remaining constant. Mean cyclosporin
level was 164+34 ng/ml at conversion.
In conclusion glucose tolerance is not affected
by CyA. However lipid metabolism is significantly
improved with cessation of the drug, The results
indicate a primarily hepatic effect rather than a
peripheral effect. CyA may potentiate the effects
of prednisolone therapy.
EXPERIENCE WITH A NEW BIOPSY NEEDLE FOR
KIDNEY GRAFTS.
R. Horsch, W. Kreul3er, K. Dreikorn,
R. Waldherr, L. RHhl
Department of Urology/Pathology, Nephrolog
University Heidelberg, FRG
Renal biopsy is a well established me-
thod of monitoring patients with kidney
grafts. In recent years fine needle biopsy
(FNB)has received much attention. However
its clinical value is restricted. On the
other hand complications with the Tru—
Cut—Needle (TCN) ( 2 mm) are more fre-
quent. We report our experiences on 49
renal transplant biopsies with a new cut—
biopsy—needle of smaller diameter (1,2mm)
In 6/49 biopsies (with or without ultra-
sound guidance) less than 3 glomeruli were
obtained, in 43/49 more than 4. Indication
for biopsies was deterioration of renal
function, acute interstial (14) or vascu-
lar (15) or chronic rejections (18) and
cyclosporin—toxicity (2). Complications:
I gross haematuria, I intrarenal AV—fistu-
la. The new out—needle is an alternative
to FNB and TCN—biopay. It allows safe
histological evaluation with less compli-
cations than with the Tru—Cut—Needle.
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COMPARISON OF ThREE IMMUNO-SUPPRESSIVE REGIMENS IN
KIDNEY TRNSPLANTATION : CyA, ATG and CyA, ATG and
CONVENTIONAL TREATMENT - A ONE-CENTER RANDOMIZED
STUDY
M. HOURMANT, J.P. SOULILLOU and J. GUENEL
Service Ndphroiogie and Immunologie Clinique
Cliii NANTES, France
Three randomized strategies have been compared in
73 kidney recipients (to date) : —group I(n=27) re-
ceived the same treatmentas group I, converted for
CyA alone (6-8 mg/kg/day) during the 2nd month —
Group III had CyA (15 mg/kg/day) as initial treat-
ment, with low dose CS. Follow-up periods ranged
from 1 to 20 months. One patient died, 2 lost their
kidneys for rejection before entering the 2nd—month
CyA randomization. Graft survival was 88% in grou I
and 100% in group II. Both groups had similar one-year
creatininemia (14.2+5 mg/i VS 14.7+2.5 mg/i). 51%
and 38% patients of respectively group I and II expe—
riencedat least one rejection episode. Severalpara-
meters including ONT lymphocyte subpopulations, PTH,
cholesterolemia, hypertension were investigated and
not found significantly different at6 and 12 months
The major complications of CyA therapy encountered
were: —amild hepatotoxicity in 9/31 patients —
nephrotoxicityin4 patients only. Group III (15 pa-
tients to date) is yet too small to allow definiti-
ve conclusions nevertheless, 3 rd month creatini—
nemia seems to be clearly higher than in group I and
group II. Our data indicate so far that sequential as-
sociationof ATGandCyAis safe, and by comparison
with ATG (group I) is effective in preventing re-
jection, avoids corticosteroid side—effects, has
proven to be poorly nephrotoxic and with reference
to transplant function, and the number of nephro—
toxic episodes is less nephrotoxic than initial
CyA (group III).
THE ROLE OF HLA MATCHING IN GRAFT St.JRVI-
VAL USING CYCLOSPORIN A AND LOW DOSE
STEROIDS.
J.E. Jacobson and A.R. Pontin. (Intro-
duced by M.J.D. Cassidy).
Groote Schuur Hospital, Cape Town. South
Africa.
Thirty seven recipients received cada-
ver kidney allografts from beating heart
donors. All recipients had received a
minimum of five units of packed celled
blood at monthly intervals. Collins' 2
perfusion and ice storage was used to
preserve donor kidneys for between 14 —
49 hours.
Inurtunosuppression consisted of Cyclo—
sporin A and low dose steroids (24 mg
daily) and rejection episodes were treat-
ed with 500 mg boluses of methyl-predni-
solone IV.
Selection criteria were based on:
(a) clinical assessment (b) ABO compati-
bility and Cc) negative recipient donor
crossmatch.
HLA A, B, C and Dr antigens were iden-
tified in all donors and recipients butplayed no role in selection. All 37
eci1ets received mismatched kidneys.
Matched antigens varied between 3 and 0
with a mean of 1 with this regimen and
patient follow up of 1 - 12 months,
grat survival was 38% and patient sur-
vival 95%.
I4UN0SUPPRFSSICt WITH CICIIJSPORINE (CS) AFTER
RENAL TRANSPLANTATICN IN PATINPS WITH WEGENER' S
GRANUID?WIOSIS (WG).
ml. HOyer, H. Pndresen, H.-J. Ludwig, K. Sack
Thansplant Unit, dical University Ltibeck (F1E)
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The value of cyclophosphainide (C?) or azathio-
prine (AZ) and steroids in the treatirent of WG
is wall docunEnted. An analogous effect of CS
has not yet been reported to our knowledge.
2 patients with histologically proved WG and
AZ-pretreatzrent received a cadaveric renal graft.
Postoperatively inirunosuppression was switched
to CS. One patient had a severe leucopenia( 800/nm3) at the nomant of transplantation,
and during the following 3 nonths he presented
a probably CS-induced anorexia, a septicemia, a
deap venous thrombosis of the right and left leg,
and an aphthous stoniatitis although leucocytes
had increased to normal counts after 3 weeks.
19 rronths after transplantation the patient is
doing wall with a normal renal function and with-
out any prove of an active WG. The second patient
denonstrated no problems at all and equally shows
a normal renal function and no signs of WG 5
nonths after transplantation. So we suppose CS
being as effective as AZ or CP when used in trans-
planted patients with WG on one hand but avoiding
the side effects of the conventional drugs on the
other hand.
AN ACUTE TOXOPLASMOSIS FOLLOWING A RENAL TRANSPLANTA-
TION.
P. Petitjean, W. Gessler, H. Tongio, E. Candolfi,
J. Wailer, B. Molet, T. Kien, U. JAHN.
CHU de Strasbourg — France.
Acute toxoplasmosis (Tx A) is ensued by a high
mortality rate in immunocompromised patients.
We report the case of a 35 years old women who
developed Tx A 2 months after renal transplantation.
The onset of the disease was sudden : temperature
elevation to 400 with abdominal pain, subsequently
myalgia and appearance of lymphadenopathies. The
diagnosis was confirmed at the 15th day after onset b3
the increase of anti—toxoplasmosis 1gM from 0 to 1/3l
IgG increased from 0 to 25 UI/mi and in the early
increase of anti—toxoplasmosis IgA. The inoculation of
an excised lymphadenopathy to mice produced Tx A.
At the time of onset the immunosuppressive trestmet
comprised : Azathioprine 150 mg/day and Prednisone
35 mg/day. The diagnosis led to immediate suppression
of Azathioprine and Prednisone dosis was reduced in
15 days to 10 mg/day. Pyrimethamine combined with
Spiramycine and Sulfonamide have been administered
over a period of 2 months with a successfull effect on
the clinical signs. The transplant function remained
within normal range. Signs of graft rejection (increase
of plasma creatinine level and kidney histology)
occured 3 months after the beginning of the Tx A. Anti
rejection therapy with Prednisone was undertaken and
combined with Cyclosporine A.
A follow up of 7 months has shown no recurrence of
the infection, but after the rejection transplant
plasma creatinine level remained at 2.8 mg/dl. This
case deserved to be reported because of its favorable
outcome, the notion Tx transmission by transplantatior
and finally the role of specific anti—toxoplasmosis
IgA in the early diagnosis.
RENAL TRANSPLANTATION IN CHILDREN CHRONICALLY
INFECTED WITH URINARY TRACT ABNORMALITIES
F. Janssen, M. Hall, J. Van Geertruyden and
P. Kinnaert (Intr. by P. Vereerstraeten).
Free University of Brussels, Belgium
Children with chronic renal failure secondary
to congenital abnormalities and chronic infections
of the urinary tract have usually been considered
as poor candidates for transplantation. Our expe-
rience with nine boys (aged 2 to 13 years) trans-
planted with a cadaver kidney clearly indicates
that these patients are actually excellent trans-
plant candidates provided two conditions are ful-
filled
1°) causes of obstruction of the lower urinary
tract should be removed and
20) in order to suppress chronic pyuria a bilateral
ureteronephrectomy should be performed at least six
weeks prior to kidney transplantation.
The primary cause of renal failure was obstruction
of the lower urinary tract in three children (2
posterior urethral valves, 1 anterior urethral val-
ve) and bilateral obstruction of the ureteropelvic
junction in one case. The five other patients had
megaureters and reflux (type IV and V). All these
children except one had been operated on one to
four times before they were referred for renal
transplantation. After kidney transplantation, two
stenoses of the uretero—vesical junction were cor-
rected surgically and one asymptomatic granuloma
of the distal extremity of the transplanted ureter
was discovered by sonography and cauterized by
endoscopy. Presently, nine children have a functio-
ning graft (four or them had a second graft)
without urinary infection three months to seven
years after transplantation. No kidney was lost due
to urologic failure.
NEEDLE BIOPSY (NB) OF THE RENAL GRAFT:
CONFORMITY OF ASSESSMENT (CA) AND ADEQUA-
CY OF SANPLE (AS)
J. Jirka, +p Rossmann, I. Reneltová,
V. Zástava, V. Koandrle
Institute for Clinical & Experimental Me-
dicine and Institute for Microbiology
SAV, Prague, Czechoslovakia
In 176 renal allograft recipients /6
excisions, 168 NB, 18 autopsies and 106
graftectomies (A/E)/ a retrospective stu-
dy was done to assess CA (proportion of
cases agreed on by two pathologists, same
samples, double blind assay, 114 NB and
62 A/E,.nephrolOgist as referee) and AS
(proportion of cases with conform diagnos-
es from NB and A/E samples, n=75, achiev-
ed at least by one pathologist).
CA of NB samples was 72.3, that of A/E
ones 83.9%. In 18/41 (43.9%) cases of dis-
agreement it concerned obliterative angio-
pathy and its differentiation from other
arterio(lo)pathies. Further evolution
confirmed conclusions of nephropatholo—
gist in 49%, those of general pathologist
in 16%; 39% of differences in opinion re-
mained unsolved.
Three out of 114 NB samples (2.9%) we-
re not diagnostic. As for AS, in 16/75
cases (21.3%) diagnoses based on NB samp-
les differred from those based on A/E
samples. In all instances except for one
(focal necrosis, 1.3%) the difference was
explicable by progression of lesion (7),
infeotion (1), cessation of immunosuppres—
sion (4) and similarity of lesion (oblit-
erative angiopathy vs. degenerative end—
arteritis, 3).
POST-TRANSPLANT BACTERIAL INFECTION AND
IRREVERSIBLE RENAL ALLOGRAFP REJECTIONJ. Jirka, H. Lika, 4P. Rossmann,I. Reneltova
IKEM & öSAV, Prague, CzechoslovakiaIn a previous study a relationship was
found between the number of episodes of
bacterial infection (E.B.I.) and those of
rejection: in recipients with G+ and mixed
E.B.I. the correlation was positive, in
those with G— E.B.I. it was negative (1).
This observation seemed to corroborate so-
me of experimental data on skin transplan-
tation (Tx) (2).
In order to check this relationship by
long—term graft survival, a prospective
study was undertaken on the same subjeots
using cumulative graft loss by rejection
(3) and prevalence of types of rejection
lesion (4) for comparison between recipi-
ents with G+ or mixed (n45, A), those
with G- (n=42, B) and those free of any
F.B.I. (n=29, C). In the period between
the end of the 5th and 8th post-Tx years
graft loss by rejection in B was lower
than that in A and C but the difference
was not significant. Similarly no differ-
ence was found in relative proportions of
the individual types of rejection nephro—
pathy. Conclusion: post-Tx E.B.I. do not
increase allograft loss by rejection.
l/Lika,M.et al. ,Czeoh.Med. ,l:1978,83—9O
2/Rapaport,F.T.& Chase,R.M. ,Vox Sang. (Ba-
sel) ,ll: 1966,345—349
/Jirka,J.et al. ,Proc.EDTA,17:l980,4O7—4l2
//nossrnann,P.& Jirka,J. :Rejection Nephro—
pathy.Elsevier, Amsterdam, 1979
DONOR SPECIFIC TRANSFUSION (DST) IN RENAL TRANS-
PLANTATION - IS IT WORTH IT?
A.S.Kumar, A.G.White, M. Samhan, K.v.Johny,G.Kusma
and G.M.Abouna.
Department of Organ Transplantation, Faculty of
Medicine, Kuwait University, KUWAIT.
In a controlled prospective study 20 patients
were given DST before transplantation and their
graft survival compared with a concurrent control
group of another 20 recipients. The DST protocol
consisted of 200 mls of stored blood given on three
occasions at 2 week intervals under continous
immunosuppression with Azathioprine in order to
reduce sensitization. The donors had 2 or more BLA
mismatches with positive MLR with their respective
recipients. The experimental and control group were
comparable in age, sex,RLA mismatch, donor source,
pretranspient random transfusion and post transpl-
ant immunosuppression. Donor—recipient crossmatch
were repeated after each DST and a repeat MLR and
crossmatch just prior to transplantation carried
out.
One of the DST recipients (5%) developed a
positive crossmatch and was not transplanted. The
remaining 19 were successfully transplanted. Two
patients in the DST and one in the control group
were lost at 5 months.The actuarial patient and
graft survival were 89% at 6 months and at one year
in the DST group compared to 95% in the control
group.There were no significant differences in the
incidence,timing,severity and number of acute reje-
ctions between the two groups.We conclude that
while DST using stored blood under immunosuppressi—
on greatly minimizes recipient sensitization,in our
programme neither patient nor graft survival are
improved and we therefore do not consider this to
be a justifiable procedure.
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REDUCTION OF OPHTHALMOLOGIC COMPLICATIONS AFTER
RENAL TRANSPLANTATION BY CYCLOSPORIN A TREATMENT
IN COMPARISON TO CONVENTIONAL IMT'IUNOSUPPRESSION.
H. Kopsa,H.Bettel heim,E.Winkler,P.Schmidt,J.Zazgor—
nik,P.Balcke. 1st Med.Clinic,2nd Ophthal.Clinic,
University of Vienna, Austria.
63 renal transplant patients were screened for
ocular findings after successful grafting.41 cases
(group I)received prednisolone and azathioprfne,the
observation time ranged from 1—40 months (mean ob-
servation time 8,7 months). In 22 recipients (group
II) low dose steroid therapy and cyclosporin A were
administered for 2—19 months (mean observation time
9,3 months) after surgery. Ocular check up compri-
sed clinical examination of the eye, slitlamp,tono—
metry, visual acuity and fundoscopy.
Results: Recurrent subconjunctival haemorrhages
and calcium deposits in the conjunctival tissue
occured in 61 p.c. of group I and 41 p.c. of group
II. The incidence of posterior subcapsular cataract
(PSC) was 61 p.c. in the patients under conventio-
nal iniliunosuppression and 23 p.c. under cyclosporin
A. Visual acuity in cases with PSC was not impaired
except in 1 case of group I. Dose reduction of cor-
ticosteroids was followed by diminution of PSC.
Elevated intraocular pressure and steroid glaucoma
respectively were measured in 2 cases of group I.
Fundoscopic findings in group I/Il were pigmentary
irregularities of the fundus (44 p.c./41 p.c.),al—
terations of the foveolar region (12 p.c./15 p.c.)
and of papilla N.optici (3 p.c./O p.c.).
Conclusion:Under cyclosporin A administration with
low dose prednisolone subconjunctival haemorrhages
and PSC occured less frequently than under conven-
tional iniliunosuppression.
SIGNIFICANCE OF POLYACRYL.ANIDE GEL ELECTROPHORESIS
(PGE) AND 13 2—MICROGLOBULIN (13 2 M) FOR THE DIA-
GNOSIS OF REJECTION IN RENAL TRANSPLANTATION (TPL)
N. Kreul3er, K. Dreikorn, 2. Horsch, H.P. Geisen,
E. Ritz, L. RHhl.
Dept. of Urology and Nephrology, University of
Heidelberg, FRG.
In pts. with TPL it is often difficult to dif-
ferentiate between acute renal failure (ARF),
superimposed rejection, acute and chronic rejec-
tion. Therefore, in this study the significance
of 2 new noninvasive procedures was evaluated in
178 pts. with renal TPL between 1982—1983: Mea-
surement of PGE and 132M with RIA. Rejection was
verified by clinical course and/or biopsy and
radionuclide examination. Results: 82N in serum:
in pts. with good functioning grafts 132M fell by
80 % within the first 3 days after TPL. In pta.
with non functioning grafts (ARF) the decrease
was still 50 %, whereas in pta. with irre-
versible rejection 132M increased.
132M in urine: within the 1st. week after success—
full TPL 132M fell into the normal range. In pts.
with rejection 32M increased by 100 %, in many
cases (25 %) 1—2 days prior to rejection.
PGE in urine: acute interstitial rejection was
characterized by tubular proteinuria with the
typical appearance of very low molecular weight
proteins; in contrast, vascular rejection is asso-
ciated with glomerular proteinuria.
Measurement of 132M in serum and urine and of
PGE allows immediate evaluation of kidney trans-
plant viability and early diagnosis of rejection,
even in pts. with postoperative ARF. Therefore,
these determinations seem to be clinically help-
ful in differentiating various cauaes of distur-
bed function of renal grafts.
CYCLOSPORIN-A D8TBRNINATION IN CAPILLARY BLOOD
F, K rem er,A .8 oh d e,T. £ isen baue r,P. £ .1 sea er,lf. H. Hil d ebran d
University Hospital, Robert-Koch-Str.40, 34 Göttingen, FRG.
Cyclomporin-A (Cy-A) blood level monitoring in kidney
transplant patients has great clinical importance in dis-
tinguishing between nephrotoxicity with high levels and
rejection with low levels. According to clinical experience
blood levels 500- 1000 ng/ml seem to exclude naphrotoxicity
and rejection. Nith respect to the greet variation of bio-
availability frequent Cy-A blood level monitoring seems to
be the most important measure to assure good transplant
function. -So far blood sampling has bean a major problem.
Deep freezing of the blood caused incomplete hemolysis, and
heparinisation of blood samples did not exclude clot
formation and uneven distribution of erythrocytes. This
resulted in errors when total blood concentration was
determined by radioimmunoassay.
In order to exclude these errors and to simplify out-
patient monitoring of CY-A treatment a new and simple method
was developed for capillary blood analysis.
Using a 2opl-end-to-end Ca5EDTA glas capillary tube
blood was taken from an ear lobe. The blood filled tube was
then shaken in a vial containing lal buffer with detergent
(0,05 N TRIS buffer pH 8,5 with 0,03% Tween 20> until the
capillary tube contained only pink buffer solution. In this
condition the hemolysed blood could be analysed weeks later.
The difference between venous and capillary Cy-A blood
levels was much less (+ 12,5%) than the intraindividual
day-to-day variation under steady-stats conditions (venous
blood 33%, capillary blood 20%). The variation coefficient of
values determined in blood from right and left ear lobe was
less than 10%. - In summary: The analysis of Cy-A in capillary
blood gave relieble results, allowed long-time storage of
samples and patients had the requested freedom During leave
Trom hospital capillary blood was taken by relatives and than
zailed for analysis to the kidney transplant center.
From 18 transplant patients under Cy-A imaunosuppression so
far none has lost his kidney with capillary blood monitoring.
POLYCYTHEMIA ERYTHROPOIETIN-INDEPENDENT AFTER
.
RENAL TRANSPLANTATION
S.Lamperi, S. Carozzi
Division of Nephrology, St. Martin Hospital, Genoa,
Italy.
The growth of erythroid progenitor cells(BFU—e)
drawn from peripheral blood of 140 patients, 9 with
polycythemia(P) and 31 non—polycythemic(NP) after
kidney transplantation, were studied in"in vitro
cultures" with or without adding erythropoietin(Ep).
Simultaneously in the same subjects the serum ery—
thropoietin(sEp) levels by fetal mouse liver cells
assay were evaluated. The data obtained were compa
red to those of 12 normal subjects.
The results show a significant increase of sEp
(133% p<O.OO1) and of BFU—e growth(18% and 68% p<
0.001) in "in vitro cultures", respectively with or
without adding Ep in the P patients: such an increa
se of BFIJ—e did not verify utilizing peripheral
blood depleted of monocyte or T—lymphocyte cells.
On the contrary, in NP patients, in presence of
a significant increase of sEp levels(129% p<O.OO1),
the BFU—e growth were observed only with the Np ad
dition in the culture.
These results suggest that in " in vitro cultu-
res " of polycythemic transplanted patients, the
hyperproliferation of erythroid progenitor cells,
could be connected more to the cellular interac-
tions than to the presence of erythropoietin.
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U/POSM FOR THE DIAGNOSIS OF OVERHYDRATION AFTER
KIDNEY TRANSPLANTATION UNDER CONVENTIONAL IMMUNO—
SUPPRESSION (CI) AND AFTER CYCLOSPORIN A (CyA).
Lange,H.; Ebel,H.; Paicllik,A.
Department of Nephrology, Center of Internal Medi-
cine, University of Marburg, F.R.G.
At normal tubular vasopressin action a plasmahy—
potonic urine (U/Posm<1,O) Indicates overhydration
whereas at tubular vasopressin unresponsiveness a
diluted urine would occur even at dehydration. Sin-
ce kidneys after acute ischemla have been said to
be unresponsive to vasopressin at least transiently
the existence of a tubular maximum of solute free
water (TmCH2O) was tested in the transplanted kid-
ney.
20 recipients of cadaveric kidneys were subjec-
ted to an increasing tubular solute load (Mannitol
10%, i.v.). The TmCH2O was adopted, when the tubu-
lar reabsorption of solute free water (TcH2O=V(U/
Pose-i) was constant or increasing over the whole
range of urinary flow rate (i.e. regression of Cosm
vers. V was bO.96OOO). 10 patients were treated
with steroids and azthioprine (CI) and 10 patients
received CyA. The results were compared with those
of normal kidneys.
All 10 recipients with CI showed a TmCH2O. Re-
ferring to 100 ml of GFR a TmCH2O=6.79t2.6 el/mm.
was obtained. This was not differentfrom normal
subjects. In contrast all 10 patients under CyA did
not show a TniCH2O. A diluted urine was excreted ir-
respectively of their state of hydration and the os-
motic load. Whereas the functioning nephrons after
kidney transplantation under CI appear to respond
to vasopressin like normal nephrons they do not un-
der CyA. Hence, the U/Pose is of only limited value
for the assessment of overhydration when CyA is
used after kidney transplantation.
AN IMPORTANT INFLUENCE ON KIDNEY GRAFT SURVIVAL OF
LOW DONOR SPECIFIC MLC VERSUS lILA—DR MATCHING.
E.Langhoff,B.K.Jacobsen,P.Platz,L.P.Ryder,A.Svej-
gaard,K.Olgaard and the Copenhagen Study Group of
Kidney Transplantation. Tissue T'ping Laboratory
and Med. Dep.P,Rigshospitalet, Copenhagen, Denmark.
An association has been demonstrated between DR-
ccgnatibi lity and good graft survival (GS) .The mi-
xed leucocyte reaction (MLC) indicates the biologi—
cal activity of the DR—locus, but an adequate at-
tempt to clarify the relative importance of MLC or
DR incompatibility has not been made.Accordingly we
undertook such a study.
Frozen cells obtained before transplantation from
42 kidney graft recipients and corresponding nero—donors were studies.All donors and recipients were
lILA-ABC and DR typed.Two large MLC experiments were
performed confronting respectively 25 and 17 respon-
der cells from recipients with cells from the speci-fic donor as well as the other donors.This allowed
determination of the double normalized response
(DNR) of the donor specific MLC.All patients were
given concentionally inrnunosuppressive therapy pred-
nisone/azathioprin) .The observation time was at
least 12 months after transplantation.
The DNR was significantly lower in patients with
functioning grafts than in those with graft failures
(p<.o2) .There was a significant correlation between
low DNR (DNR5o) and compatibility for 2 DR anti—
gens.The 12 months survival was 83% when DNR was <So
and 40% when DNR was >5o (p<.oo6) .When analysing for
DR canpatibility 12 months GS was 70% when compati—
5ility for two antigens could be demonstrated and
50% for DR incaipatible ones (p>.o5).
In conclusion when adequately stabilized a strong
relationship was demonstrated between the donor spe-
cific MLC reaction and GS.The effect of low MLC on
S is stronger than that of DR compatibility and
anparable to recent results with cyclosporin.
lIfE IMPACT OF INDIVIDUAL GLUCDOORI'ICOID SENSITIVITY
ON GRAFr PRcXNOSIS.
K .Langhoff, K.Olgaard, S .Madsen, J.Ladefoged
Med. Dep. P, Rigshospitalet, Copenhagen, Denmark.
Kidney allraft rejection may occour despite
low MW (mixed leucocyte culture) response and DR
matching .Recently an inter—individual difference in
the in vitro iimmnosuppressive effect of glucocorti-
coids has been demonstrated.The present investiga-
tion,therefore, examined if graft failure was rela-
ted to differences in patient sensitivity to gluco—
corticoids in vivo and in vitro.
Peripheral blood lymphocytes (PBL) fran 31 kid-
ney recipients were isolated on lymphoprepR before
and again 12 h after transplantation and v. adxni—
nistration of 150 m methyiprednisolone (NP). The
PBL were stinulated with mitogen (PEA) and cultured
for 72 h followed by 20 h of incubation with C1 4thy-
midine before harvesting and counting the isotope
uptake. The in vitro resistance to steroid was tes-
ted by addition of 0, .05, .25, .5, 1 .0 ug of MP
pet- ml culture.
The PEA response in vivo decreased (pcO.O2)
after administration of NP to patients who maintain-
ed a good graft function 3 months after transplanta-
tion (n = 22) as opposed to no influence of MP on
the PEA response in patients with graft failure(n = 9) within 3 months. The PEA response of lympho-
cytes obtained before transplantation was signifi-
cantly (p<O.OO1) more sensitive to in vitro suppres
sion by NP in patients whose grafts were well func-
tioning 3 months after transplantation.
Thus, as no suppression could be demonstrated in
patients with graft failure,we conclude that the
susceptibility of lymphocytes to suppress ion by NP
is of great inportance for the outcane of kidney al
lografts. The in vitro test may therefore be an bn—
portent supplement to the examination of future kid
ney allografts recipients.
• CLINICAL RESULTS AND CYCLOSPORINE EFFECT ON PREDNI-
SOL1E METABOLISM.
E.Langhoff,S .Madsen,K.Olgaard,J.Ladefoged.
Med. Dep. P, Rigshospitalet ,Copenhagen,Denmark.
In a randomized study extended over one year 40
necrograft recipients were allocated to imiunosup-
pression with either cyclosporine (CyA) /prednisone
or azathioprin/prednisone. Prednisolone degradation
in plasma was measured by high pressure liquid
chromatography (HPLC) .Total prednisolone clearance,
calculated from the area under the plasma concentra
tion - tine curve, and half-life were determined
for each patient.
The cuimulated graft survival in the CyA-group
was 70% versus 51% in the Aza-group.Significantly
fewer biopsy verified rejections occured in the
CyA-treated group (p<O.Ol) .The pharmacokinetic part
of the study showed a significantly lower predniso-
lone clearance in patients treated with CyA (1 .9
0.5 mi/mm/kg) compared to patients given conven-
tional therapy (2. 6to.5 mi/mm/kg) .Accordingly
plasma half — lives of prednisolone were signifi-
cantly increased in the CyA—grOUp (4.2t1.4h) can—
pared to the Aza-group (2. 9O .6h) .T was identi-
cal in the two groups indicating no difference in
absorbtion or prednisone/prednisolone transformna-
tion.
We conclude that adjunctive steroid treatment
should for metabolic reasons be given in reduced
doses in CyA treated patients.
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RECURRENCE OF EXTRACAPILLARY GLOMERULO-
NEPHRITIS (EG) IN TWO RENAL TRANSPLANTS
WITHIN THE SAME PATIENT
G. E. Leimenstoll, P. Zabel, R. Schoel,
K. Muller-Hermelink, W. Niedermayer
Department of Nephrology and Department of
Pathology, University of Kiel, Kiel, F.R.G
A 25 ys male suffered from EG and devel
oped endstage renal failure despite treat-
ment with cyclophosphamide and steroids.
Two years later he was transplanted with
a 4 out of 6 antigen matched allograft
and succeeded with another renal involv-
ment of EG in the transplanted kidney. Th
treatment consisted of azathioprine, ste-
roids and ATG. After 4 month the allograft
had to be removed. Ten months later a,
second allograft was transplanted. This
time the immunosuppression consisted of
ciclosporin A and steroids. Again three
month later the renal function deteriora-
ted. Histologically and imnunohistologi-
cally in all three kidneys (own, and two
allografts) the sane diagnosis was present
Obviously in this patient no improvement
could be obtained by the applied therapy
in all three instances. A possible success
for further transplantation in this pa-
tient seems questionable.
• TRANSFUSION-INDUCED ENHANCEMENT OF PROSTAGLANDIN E
.
(PGE) AND THROMBOXANE (TxB) RELEASE IN PROSPECTIVE
KIDNEY GRAFT RECIPIENTS
V. Lenhard, G. Maassen, G. Opelz.
University Institute of Ininunology,
Heidelberg, West Germany
Pretranspiant blood transfusions (BT) improve
kidney graft survival. Beside specific immuno—
regulation by T suppressor cells or anti—idiotypic
antibodies the influence of nonspecific factors is
being discussed. Prostaglandins have attracted
particular attention because they have high imuno—
suppressive activity. We studied in 25 non—
transfused dialysis patients the prostanoid release
of peripheral mononuclear cells following three
deliberate BT. Spontaneous and LPS—induced PGE as
well as TXB2 was determined in cell—free culture
supernatants by fluid phase RIA. Cell kinetics of
transfused patients exhibited a more rapid onset
and steeper increase of prostanoid production.
After 24 hr incubation, the spontaneous and
LPS-induced PGE release of pre- and post-BT cells
was significantly different (Pre BT: 2.1 and 5.1
ng/ml; post 3 81: 5.0 and 7.9 ng/ml; p <0.01).
Similarly, pre-BT cells released considerably lower
amounts of TXB2 than post—BT cells (Spontaneous
release: 39 vs. 88 ng/ml; LPS—induced release: 62
ng/ml vs. 129 ng/ml; p<O.O5). The enhanced PGE and
TXB release of post—BT cells is not caused by an
incease merely of monocyte numbers. In addition,
there was a correlation between the number of ST
and the amount of prostanoid release. In con-
clusion, BT induce in potential kidney recipients
an enhanced release of prostanoids by activation of
monocytes. The role of those immunoregulatory
mediators for graft outcome seems worthwhile to be
further studied.
PHARMACOKINETICS OF CICLOSPORIN A (CS-A) IN
RENAL ENDSTAGE FAILURE
G. E. Leimenstoll, P. Zabel, H. Jessen,
W. Niedermayer
Department of Nephrology, University of
Kiel, Kiel, F.R.G.
For optimal dosis regimen of CS-A in 12
patients waiting for renal transplantation
the pharmacokinetic properties were studied
CS-A blood-level were studied (RIA-method)
after a single oral dose of 7,5 mg/kg BW
and an intravenous dose of 5 mg/kg BW giving
over a 4 hour period. 8 blood samples were
taken in 24 hours. The pharinacokinetics were
evaluated by using a two-compartment model.
We found no differences between the 13-phases
of p.o. and i.v. applications (t112 = 11.8
+ 3.06 h) and a first-pass effect'ranging
between 7.3 % to 62.9 % using the total
areas under the blood concentration versus
time curve (AUC). Since liver function was
normal in all patients an individual entera]
absorption of CS-A is to be considered.
Conclusions:
1. For constant bloodlevels a continous i.v
application is preferable.
2. In case of oral administration the do-
sage is to be determined prior to t.rans-
plantion. This dosage can be calculated by
the AUC according to E =0f'xdt/.c dosef'xdt
The CS-A blood level were confirmed in 6
patients after transplantation.
GLOMERULOPATHY IN RENAL ALLOGRAFTS FROM PATIENTS
MITH ACTIVE CYTOMEGALOVIRUS INFECTION
F. Løve Jepsen & E. Spencer (Intr. by H.E.Hansen)
University Institute of Pathology & Medical
Department C, Kommunehospitalet, Aarhus,
Denmark.
A distinctive diffuse glomerulopathy has been
reported by Richardson et al. (NEJM 305:57,1981)
to be present in renal grafts from patients with
viremic cytomegalovirus (CMV) infection.
We reviewed 50 graft biopsies taken 30-180
days after renal allotranspiantation at a time
when cytomegalovirus is common. The glomerulo-
pathy was found in 14: 7 had a reactivated CMV
infection, I had a primary infection, but 6 of
the 14 had rio serologic evidence of active CMV
infection at all. The differences between the
groups were not statistically significant.
We conclude that the ylomerulopathy described
by Richardson et al. is not specifically associa-
ted with CMV infection.
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• SHORT TERM KIDNEY PRESERVATION - TO PERFUSE OR NOT
.
TO PERFUSE WITH THE NEW BELZER II SOLUTION
R. McCabe, C. Lattes, D. Lorieo, W. Ramey, P.
Manning, J. Lin, M. Jean-Jacques and N. Hardy
Columbia University—St. \Luke's—Roosevelt Hospital
Center, New York, New York, U.S.A.
For short term kidney preservation, metabolic
precursors must be supplied, toxic byproducts
eliminated, rnicrocirculation and membrane poten-
tials protected and cell swelling secondary to
ischemia minimized. Clinically and experimental-
ly, we have reported better results with perfu-
sion. Post transplant acute renal failure (ARF)
was noted in only 17% of 41 kidneys perfused con-
tinually with either cyroprecipiated plasma (CPP)
or plasma protein fraction (PPF). ARF was noted
in 59% of 92 kidneys perfused after more than 1
hr of cold storage vs. 50% of 18 kidneys cold
stored in C2 Solution for 21-58 hrs (mean 37.2).
We have concluded that either method is prefer-
able to the combination, probably because of in-
creased cell swelling and depletion of high ener-
gy phosphate during the preservation period.
With the new Belzer II Perfusate that is forti-
fied with adenosine, has a phosphate buffer, and
the impermeant anion gluconate that reduces cell
swelling, we have noted ARF in only 5 (17%) of 29
kidneys perfused. 13 of these had a mean cold
storage in C2 Solution of 10.5 hrs (Range 2-36)
11 of which functioned imediately (85%).
On the basis of our initial experience, we sug-
gest that all kidneys even those cold stored in
excess of 24 hrs be perfused with Belzer II Per-
fusate if cyclosporine immunosuppression is con-
templated and the preservation time will be pro-
longed in order to identify a cytotoxic negative
recipient.
PROSPECTIVE CONTROLLED TRIAL WITH ANTILYIIFOCYTIC
GLOBULIN (A.L.G.), IN FIRST CADAVERIC RENAL
TRANSPLANTS TREATED WITH LOW-DOSE STEROIDS BOTH
IN PROPHYLAXIS AND REJECTION THERAPY.
R.Maiorca,L.Cristinel Ii ,S.Scolari ,S.Sandrini,G.
Brunori ,G.Tonini*,B.Salerni*,L.Lojacono.
Dept.of Nephrology and Inst.of Surgical Pathol.,
Spedali Civili and University. Brescia, Italy.
63 patients with first cadaveric renal tran-
splant were randomly allocated to 2 subgroups:
(A),(33) controls; (B),(3O), A.L.G.(Behringwerke)
treated (20 mg/Kg in the first 14 days and 20
mg/Kg for 10 days for any rejection). Both
(A)and(B) had the basic treatment proposed by Mc
Geown et al. Rejection treatment was 975 mg i.v.
niothylprednisolone (NP) in 7 days (200, 200, 200,
150, 100, 75, 50). (A)and(B) did not differ in
age, sex, transfusions, HLA, AB matches.Minimurn
follow up:12 months.One year survivals were:
patients 100% (A) and 95%(B), p: NS; graft 78%
(A) and 69% (B), p:NS. 2.3 rejections/pat. were
registered in (A) and 1.9 in (B) (p: NS); cumu-
lative steroid dosage at 6 and 12 months was less
in (B) (p 0.05). Appearance of first rejection
was similar in (A) and (B). A higher % of bacte-
rial infection in (B) (p: NS) but no differences
in viral infections were observed. One patient
(B) died fron Aspergillosis.
Conclusion. A reduced steroid need was the only
advantage from adding ALG to our low-dose steroid
schedule. However, the risk of an increased
infective morbidity, though unproved, is strongly
suspected.
SELECTION OF RENAL TRANSPLANT RECIPIENTS USING THE
EA INHIBITION ASSAY: A FURTHER EVALUATION
A. MacLeod, R. Mason, A. Mather, K. Stewart,
J. Engeset, 0. Power, N. Edward, S. Urbaniak,
G. Catto.
Department of Medicine, University of Aberdeen and
Blood Transfusion Service, Aberdeen, Scotland, U.K.
We have previously shown retrospectively that
the presence of Fc receptor blocking antibodies,
detected by the Erythrocyte Antibody inhibition
(EAI) assay in recipient pre-transplant serum cor-
related with improved allograft survival. This test
was used prospectively to select recipients for
transplantation. Of 26 patients 8O° of those with
but only 55 of those without EAI had grafts sur-
viving 3 months (mo). 3 of those from the prospec-
tive and 5 from the retrospective study had grafts
which failed within 3 mo. These failures were
further analysed. In /8 cases EAI was directed
.gainst B lymphocytes from all members of both a
normal and leukaemic (CLL) panel and leucoaggluti—
nation (LA) noted. IgG and 1gM preparations showed
that LA occurred in the IgG fraction of serum. In
the retrospective study only 2/23 of those with
selective EAt whereas 3/3 of those with unselective
activity had grafts which failed in less than a
year (p < 0.005). Furthermore 2/2 of those with
antidonor EAI and B lymphocytotoxicity against donor
ymphocytes in pre—transplant serum whereas only
1/13 showing EAI along had grafts which failed in
3 mo.(p < 0.05). In the retrospective study /7 of
those with EAI and cytotoxicity against the CLL
panel whereas 1/19 of those with EAI alone had
grafts which failed in a year (p < 0.02). The
results suggest that the EA inhibition assay may
prove useful in the selection of recipients for
transplantation but not where unselective activity
occurs or B lymphocytotoxicity coexists.
POVIDONE-IODINE INSTILLATION AS TREATMENT
OF LYMPHOCELE AFTER RENAL TRANSPLANTATION.
J.L.Teruel, R. Marcn, E. Martin, C. Quere
da, T. Mayayo and J. OrtuAo
Centro Ramón y Cajal. Madrid. Spain.
Four patients with well functioning
renal cadaveric grafts, developed a
perirrenal collection between 1 and 16
months after surgery. 1-lydronefrosis of the
graft and deterioration of the renal
function were evidenced. Lymphocele was
diagnosed by punction in all cases.
Through a 3 way Foley catheter
percutaneously inserted and connected to a
closed drainage system, 10 per cent of
povidone—iodine solution was insti12ed,5O
ml twice a day for 30 minutes, into the
lymphatic cavity. The lymph secretion was
reduced immediately and the Foley catheter
could be removed after 2-4 weeks.
The procedure was painless and no
complications were observed. In one case
the treatment was performed on an
outpatient basis. Recurrences has not been
noted after 5 to 22 months of followup.
In our opinion the povidone-iodine
instillation constitutes the initial
approach to treatment of symptomatic
lymphocele.
KIDNEY PRESERVATION FOR TRANSPLANTATION: THE
EFFECT OF INTERNEDIATE NORNOTHERNIC PERFUSION
V.C. Marshall, P. Jablonski, B Howden, J Tange
Department of Surgery, Monash University,
Melbourne, Victoria, Australia
Kidney preservation for orthotopic isografting
in the ret has been successful for only 24 hours,
even when contralateral nephrectomy is delayed.
A heterotopic rat kidney transplant model has
been developed in our laboratory, with immediate
contralateral nephrectomy, to study the effect of
intermediate normothermic perfusion on effectiveness
of preservation.
An isosmolar albumin—citrate—magnesium solutiop
was shown on testing to give optimal early function
after preservation when used either for flushing
and hypothermic storage, or for continuous
hypothermic perfusion preservation.
Preservatlon for 48 hours was studied using
hypothermic storage and continuous perfusion. Half
of each group had an intermediate period of one
hour ex—vivo normothermic perfusion by temporary
transplantation of the kidney into a host rat for a
period of one hour after 24 hours of hypothermic
storage or perfusion. At the end of the ex—vivo
perfusion period the kidney was removed, reflushed
and preserved as before for a further 23 hours
prior to transplantation into the recipient rat.
Intermediate perfusion significantly improved
early and late function and histology (p < 0.01
when used with hypothermic storage and with
perfusion preservation. Intermediate perfusion of
1 hour gave 100% survival with 48 hours of perfusion
preservation, but not with hypothermic storage.
Intermediate perfusion was duplicated by an in vitro
normothermic blood perfusion to allow evaluation of
tndividual components of the procedure.
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• LONG TERM OUTCOME OF RENAL FUNCTION AND PROTEINURIA IN
KIDNEY TRANSPLANT DONORS.
o. Mathilla, P—O Attmari, M. Aurell, I. Blohmé, H.
Brynger, G. Granérus, G. Westberg.
Department of Nephrology, Sahlgrenska sjukhuset, Uni-
versity of Göteborg, Sweden.
Experimental data in animals have demonstrated sus-
tained hyperfiltration and structural abnormalities in
the remnant glomeruli after renal ablation. The rele-
vance of these experiments to the long term outcome of
the remaining kidney in kidney donors is disputed. We
have examined our living donors who underwent nephrec—
tomy (Nx) between 1965 and 1973 (n61). Ten were dead
and 16 were not available for the study. The control
group was ten healthy men born 1927.
Resylts: 1) GFR varied between 38—104 mI/mm per
1.73 m, this was 76.1 + 2 (SEM) per cent of the
pre—Nx value.
2) Blood Pressure: pre Nx Follow—up
MAP mntlg 103 + 1.6 p<O.OO1 112 + 2.3
3) The mean urinary excretion of protein and 52—mic—
roglobulin was not significantly different from that
of controls. Urinary albumin excretion was higher in
donors: 68.8 mg/24 h (range 5—620) vs 12.1 (8—23)
mg/24 h p<O.O5. Three donors had definite glomerular
proteinuria while two donors had tubular proteinuria.
Even in these the renal function was, however, remar-
kably good (GFR 63—84 mI/mm).
Conclusion: Ten to 18 years after donor nephrec—
tomy we found no evidence for a long term deterio-
ration of renal function. The iI,ortance of the mode-
rate albuminuria in the donor group is difficult to
evaluate and follow—up studies after an even longer
period are required.
PROLONGATION OF RAT CARDIAC ALLOGRAFTS BY PRETRANS-
PLANT DONOR-SPECIFIC TRANSFUSIONS WITH HEAT TREATED
BLOOD (HBT)
G.P. Martinelli, D. Racelis, H. Schanzer
The Mount Sinai Medical Center, New York City, USA
The beneficial effect of blood transfusions (BT)
is well established in transplantation. Sensitizat-
ion, however, remains the main problem associated
with BT. The purpose of this study was to investi-
gate whether heat treatment of the blood would dimi-
nish the sensitizing effect of BT while maintaining
their benefits. Fresh heparinized blood was heated
at 45°C for 60(ACI HBT). 1.5 ml were administered
IV on days (—8) with respect to grafting (day zero).
Controls received: a)BUF HBT b)fresh ACI BT c)fresh
BUF BT d)no treatment. Graft survival in the ACI HBT
group was clearly greater than in controls (p<O.OOl).
Treatment ACI graft survival s.d.
ACI HBT 7,11,14,14,14,15,15,16 13.2 2.9
BIJF HBT 5,6,7,7,8,8,8,8 7.1 1.1
ACI BT 6,6,8,8,9 7.4 1.3
BUF BT 7,7,7,9 7.5 0.7
none 6,6,6,7,7,7,7,8 6.7 0.7
The humoral anti-ACI cytotoxic response to the
BTs measured on the day of grafting was profoundly
diminished by the heating process (titers:ACI HBT
<20; ACI BT 10580±7842). Posttransplant titers in
the ACI HBT group were also well below those in the
BUF HBT controls.
Day 0 Day 5(post Tr) Day 12(post Tr)
ACI HBT <20 <20 71 46!
BUF HBT <20 <302 224 1634 1208
We are currently investigating the mechanism of
this phenomenon. In conclusion,these data show that,
in this model, heat treatment of blood potentiates
the effect of BT while diminishing their sensiti-
zing effects. This may have implication for clini-
cal protocols involving BT.
ANTITHYMOCYTE GLOBULIN (A1GAfWIMFRVES GRAFT
SURVIVAL OF STEROID RESISTANT REJECTIONS.
R.L. Mehta* and D.B. Ornt. Introduction by
R.C. Pabico. Dept. of Medicine, University of
Rochester, Rochester, N.Y., U.S.A.
Episodes of renal transplant rejection which do
not respond to steroid therapy may lead to graft
loss of over 90% within 1 yr. Our center began to
treat patients with steroid resistant rejection
with ATGAM (Upjohn) in 1981. A retrospective
analysis of our experience was done to determine
if ATGAM affected the rate of graft loss. Eight-
een patients (4 LRD and 14 CAD) received 22
courses of ATGAM for rejections resistant to
steroids. Of these 22 rejections, 6 were first
rejection, 9 second rejection, and 7 third
rejection episodes. Initial steroid therapy for
rejections consisted of increasing the maintenance
dose of prednisone to 3 mg/kg!
day in divided doses for 3
days. Patients who had no
fall in serum creatinine with—
in 5-7 days were considered
resistant to steroids and
received ATGAM 10—15 mg/kg IV - _______________
for 14—21 days. Graft sur-
vival post ATGAM was 75% at 3 mos. and 69% at 1 yr
(Fig). To determine if ATGAM significantly
improved graft outcome in steroid resistant
rejection, a retrospective review of graft outcome
was done in a group of control patients who failed
to respond to IV prednisone before advent of ATGAII
therapy. This group included 21 patients (4 LRD
and 17 CAD) and was similar in age and sex distri-
bution as the AIGAM group. Graft survival in this
group was 19% at 3 mos. and 6.3% at 1 yr. We con-
clude, ATGAM substantially improves graft survival
in patients with steroid resistant rejection.
PROSPECTIVE TYPING FOR HLA-DR IN CADAVERIC RENAL
ALLOGRAFT RECIPIENTS
R. Mendez, R. Mendez, S. Chatterjee, T. Bogaard,
B. Self
St. Vincents Hospital, Los Angeles, and University
of California, Davis, U.S.A.
We undertook a prospective study to determine
the mutual effect of 1) DR typing and random blood
transfusion and 2) HLA A-B and DR typing. Between
Jan. 1980 and Dec. 1982, 238 consecutive cadaveric
transplant recipients underwent HLA A-B as well as
DR typing. All patients (pts.) received minimum of
3 units of packed red cells (average 8.2 units)
prior to transplant except 10 who opted against
transfusion. These 10 pts. received 2 DR match
kidneys. Pts. were categorized by the number of DR
matches and then stratified according to the HLA A-
B matches. One year graft survival was:
HLA MATCH
3-4 2 1 0
2 6 8 16 21
1 18 40 42 20
0 13 32 20 2
N (1 yr surv)
51
66.7%
120
67.4%
67
64.5%
N 37 80 78 43
71% 70.7% 65.5% 58%
The degree of matching for HLA-DR antigens bore no
significant influence on the success of the grafts.
In terms of HLA-A and B matching it was beneficial
to have 2—4 antigen match than 0 antigen match; 1
year graft survival being 71% vs 58% respectively.
In the recipients who received 2 DR match kidneys,
the 1 year graft survival for the transfused group
was 68%, compared to that of the nontransfused
group of 40%.
B-COLD LYMPHOCYTOTOXINS DO NOT ENHANCE HUMAN
CADAVERIC RENAL ALLOGRAFT
R. Merdez, S. Chatterjee, R. Mendez, T. Bogaard
St. Vincents Medical Center, Los Angeles, and
University of California, Davis, U.S.A.
Transplantation in the presence of positive B—
cell cross match is controversial. Additionally it
has been claimed that results of 2 DR matching is
most impressive in high antibody patients (pts.).
We undertook a prospective study to determine the
effect of DR matching in relation to pts. with or
without high antibodies and to see if presence of
cold B-cell antibodies enhances the graft survival;
228 consecutive cadaver transplant pts. were tested
by cytotoxicity against T and B lymphocytes at 5°C
and 37°C. The pts. were then divided into 4 groups:
B-cold, B-warm, T-warni and no antibodies. Pts. were
divided according to DR matches and then stratified
according to the tyce and/or the level of circula-
ting antibodies. The graft survival was not signi-
ficantly different.
100
No antibody
75
50
25
6mo lZmo
In pts. with high antibody level , 2 DR matching did
not improve their craft survivals. One year graft
survival with 2 DR matches was 51% compared to 47%
with no DR matchino. As far as HLA—A-B loci were
concerned the graft survival at 1 year was 78% in
1-2 mismatches vs 36% in 3—4 mismatches. We con-
clude that B—cold antibodies did not enhance the
graft survival and 2 DR matching does not improve
the poor result seen in pts. with high antibodies.
THE DATA OF NORTH ITALY TRANSPLANT PROGRAM (NITp)
F. Mercuriali, N. ScaLamogna, C. Pizzi, F. Poll, G.
Sirchia
Mercuriali (Intr. by G. Sirchia)
Centro Trasfusionale e di Immunologia dei
Trapianti, OspedaLe Maggiore, riiLano, Italy
NITp is a transplant organization made up of 3
regions coordinated by a reference Laboratory. The
organization serves an area with 17 milLion
inhabitants and 1,300 dialysis patients on the
waiting list for transplantation.
In the Last four years of activity about 800
cadaver kidney transplants have been performed. The
effectiveness of the program has greatly increased
over these years with a 30% mean annual increment.
In 1983 there were 9 cadaver donors/i million
inhabitants, resulting in 283 transpLants (14.5/1
million inhabitants), providing a graft for 88% of
the patients enrolled that year. Major factors for
the success of the program have been: 1) optimal
size of the area; 2) policy of selection of the
patients to be transplanted that gives the
possibility of using locally about 50% of the
kidneys procured; 3) scrupulous balance between
kidneys received and given among the Centers; 4)
good cooperation and coordination among the
participating Centers; 5) identification and
monitoring of the major factors affecting the
program quality. Problems which have arisen are: 1)
accumulation in the waiting list of immunized
patients; 2) imbalance in the waiting list for ABO
blood groups; 3) increasing number of patients
waiting for a second graft.
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THE RAPID EFFECTS OF PREDNISOLONE ON CELLULAR
IMMUNITY
P.F.W. Miller, J.T. Brocklebank, C. Ramsden,
P.J. Guillou
Departments of Paediatrics and Surgery,
St. James's University Hospital, Leeds. U.K.
The dosage and frequency of prednisolone used
for imrnunosuppression in many renal conditions
appears to have been arrived at arbitrarily and
modified by clinical experience. We have studied
the effects of prednisolone on lymphocyte numbers
and function in 6 nephrotic children and 4
controls.
After a dose of 60 mg m2 of prednisolone the
total peripheral lymphocytes were counted and
percentages of OKT3, OKT4 and OKT8 T-cell
subsets were measured 0, 1.5 and 4 hours later.
Lymphocyte function was determined by H3 thymidine
uptake and Interleukin-2 (IL-2) production after
concanavalin A (con A) stimulation.
The mean peripheral lymphocyte count fell
quickly from 2.9 to 1.3, to 0.78 x 11 at
times 0, 1.5 and 4 hours (p < 0.01). The
percentages of each of the T-cell subsets remained
unchanged. Lymphocyte responsiveness was promptly
reduced; after Con A stimulation the mean H3
thymidine uptake fell from 51,700 to 32,700 to
21,400 cpm at time 0, 1.5 and 4 hours respectively
(p < 0.01). This was accompanied by highly
significant reduction and even abolition of IL—2
production.
These reductions in peripheral lymphocyte
numbers and responsiveness represent marked
immunosuppressive changes and last less than 24
hours. Our observations suggest that a more
rational therapy might be to give prednisolone
at 4 hourly intervals to achieve optimal
immunosuppress ion.
REVERSAL OF THE DERANGED TONIC DOPAMINERGIC INHIBI
TION OF ALDOSTERONE IN CHRONIC RENAL FAILURE AFTER
RENAL TRANSPLANTATION(TX).
L.Ruilope, R.Garcia-Robles, J.Parada, J.Alcazar,
C.Prieto, J.Nieto, L.F.de Villa, B.Miranda, M.Pra—
ga, J.Sancho,J.L.Rodicio.
12 Octubre &Ramón y Cajal Hospitals & Dept. Expt.
Endocrinol .Universldad Complutense. Madrid. Spain.
Increased aldosterone secretion in CRF is a well
known fact. We have investigated the role of the
tonic dopaminergic inhibition on aldosterone secre
tion in CRF. Sixteen normotensive patients in he—
niodialysis program(HP),8 TX and 5 normotensive vo—
lunteers(NV)were included in our study. The first
experiment included measurements of PRA and plasma
A(PA)levels, both basal and after sodium depletion
induced by isolated ultrafiltration(15 ml/kg/lh)in
HP and by furosemide(8O mg per os)in TX and NV.In
HP the basal values of PA were higher(p<O.O5)and
those of PRA lower(p<O.05)than in TX and NV,but
both parameters were closely related(r=O.627;p
0.Ol).The second experiment included measurements
of the response of PRA,PA,plasma potassium. corti—
sol and prolactin(PRL)to metoclopramide(lO mg i.v.)
administration at -l5 0, 10',15,2O',30'and 60
min.We found no variation of PRA,potassiurn and cor
tisol in HP,TX and NV.Basal PRL was higher in HP
(p<O.02), but its response as well as that of PA
was blunted when compared to TX and NV(p<O.O1).Si-
milar response of PA was observed in TX and NV.The
tests were repeated in HP after treatment with Li—
suride(O.O25 mg/8h/15d),a dopamine agonist.There
was a definite decrease of PA both basal and after
ultrafiltration and metoclopramide together with a
significant diminution of PRL(p<0.05-0.O1). We con
dude that there is an alteration in the dopaminer
gic control of A secretion in CRF.This alteration
disappears after a successful renal transplant.
LOW DOSES OF CYCL,OSPORIN—A IN RENAL TRANSPLANTATION
G.Givati ,L.Broggi,G.Busnach,B.Brando,L.S.Belli ,15.
Del Pavero,L.Belli,L.Minetti
Renal Unit ,Niguarda Hospital,Milano,Italy
The superiority of Cyclosporin A (GSA) vs. con-
ventional treatment in kidney transplantation has
been claimed by several reporta,but most of them
also indicate its toxicity.
To investigate the effects of reduced CSA don-
gem,20 consecutive necrokidney recipients (group R
have been treated with a starting dose of 10mg/kg,
then adjusted to get blood trough levels (BPL) bet-
ween 200—400mcg/ml. An historical control group of
20 patients (group A) received s. starting GSA dose
ci' 15mg/kg until day 15,then tapered if OSA BTI
i000mcg/ml.Both groups received the sane methyl—
precinisolone (NP) dosage.
GROUP A
Days 30 90
GROUP R
30 90
S.(h'eat. 2+0.8 1.A+.5
(SA mg/kg 6.4+2.1 6.Oi-1.6
RTLmcg/ml 78+295 150+169
Jvmphocytem/mm 1655 1666
LFTJ3/2 ratio 12+A .8+.3
1.8+1.1 i.t+.8
6.6+1.1 5.0+.8
51i1+320 351+130
1A12 153
1.5+.6
.8+.1
At dm.y u,p-t. avul grart aurvivai were 100 and 05
in gvouo A, 95 and 95/ in group . Rn average,2.1
500mg NP ilses/pt were given in group A, vs. 1.6i group B I" 'ect,i,r sncs,
Our preliminary resul+e supes+ that lower mi—
tial. and following does 0r OS.A gettng BIT. in a
200100 mcg/ml range Ire as srf s ae sua1
MONITORING OF NK—1 AND NK—15 SUBSETS AND NATURAL
.
KILLER (NK) ACTIVITY IN KIDNEY Tx RECIPIENTS UNDER
CYCLOSPORINE TREATMENT
Renna Molajoni E. ,BarnabaV. ,Bachetoni A. ,LevreroM.,
Cinti P. ,AlfaniD. & Cortesini R.
II Patologia Chirurgica & I Clinica Medica
University of Rose "La Sapienza' — Rome
—Italy
Leu 7(NK—1),Leu 11 (NK—15) subsets and natural kill
er activity were studied inl3patients before trans
plantation and among them,1O,periodically inthepost
operative period. NK activity was assessed against
K562 cells,a myelogenous leukemia cell line,ina4h
51Cr release assay at various effector/target ratio
(50:1,25:1,6:1) .Moreover the maximum cytotoxic poten
tial (Vmax) of patients' effector cells was determi-
ned according to Ullberg & Jondal (1981).
Results. Pre—transplant study showeda significant
reduction of NK activity (20.1+2.2 vs 29.9+2.9 at 50:1
ratio;p<O.02),even more marked at lower ratio (15.1
1.5 at 6:l;p-.O.OO1) with a defect in Vmax capacity
(4.22+7.lvs8.73+5.2;pO.oo1) in all patients.NK—1+
and NK—15+ cell number was normal or slightly in-
creased in all Subjects (16.5+3.Ovsl7.6+2.l for NK1
and 16.1+2.5 vs 18.2+3.7 for NK15+ cells).Post—trans
plant evaluation under cyclosporine regimen showed
a quantitative reduction of NK cells (8.6+1.9 for
NK1 and 10.4±2.2 for NK15 cells) while no changes in
NK activity and killing capacity (Vmax) have been
seen.
The AA conclude that in spite ofanumerical decrea
se both in Leu7 and Leull subsets,NK activity was
not affected by cyclosporine treatment.
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A SIX MONTHS COURSE OF ANTILYMPHOCYTE GLO-
BULINS (ALG) IN CADAVER KIDNEY ALLOGRAFTS
(CAD) RECIPIENTS.
G Mourad, 3 Seignalet , A Argues, F Parlongue, G
Chong, M Pouliquen, C Jullien, C 1Mion.
Depts Nephrology and Immunology , University Hospital,
Montpellier, France.
Between Jan. 1978 and Oct. 1983, CAD recipients
(65 M, 25 F; mean age 37.4÷3.5 yrs) were treated by
low dose prednisolone (Lo): .5 mg/kg/day and azathio-
prine (Az) (Group I: 25 pts) or received Lo+Az with a 6
mos course of IV ALG: 5 mg/kg/day (Group II: 65 pts);
in Group II, P was introduced at day 16 or earlier if
rejection (R) occurred. R episodes were treated with IV
methyl-P. ALG was infused in arteriovenous fistulaes
or shunts during 4 hrs, in decreasing dosages. After
discharge from hospital, ALG infusions were realised
at home by patients themselves. In group II, 41 from 65
pts received the 6 mos ALG course; in 24 pts (group
III), ALG was stopped earlier. ALG protocol was
effective in preventing early post transplantation (T)
morbidity as was Lo alone. Morbidity in the 3 groups
was low (wound infection 3%, bacterial pneumonia 2%,
osteonecrosis 3%, GI bleeding 0%) and there was no
death. One year graft survival was similar in groups 1,
II and III (88%, Vs 89, Vs 87). In group II versus 1+111, R
incidence was lower and R type was milder (3C, p<O.05)
at I mo, but this advantage disappeared at 6 & 12 mos.
Similarly, steroid doses, lower in group II at one mo,
were identical in the 3 groups (9532+1609 mg Vs
9637+3069) at 6 & 12 mos. Despite ALG reduction,
total lymphocytes count was lower in group II Vs
groups I & III at the end of etch interval (end of
month): 718+300 Vs 1328±515/mm at 6 mos. ALG is
effective in preventing early post T morbidity during
the 1st mo. However, at the end of the 1st year, the 6
mos ALG protocol was not associated with any
significant advantage.
URINE EXCRETION OF AECORHIC ACID IN CHRO-
NIC RENAL FAILURE ND RENAL TRANEPLANT
PATIENTç .
..Lyd1Ik ,K.Derzsiova ,.v.Tako ,V.Priby—lirv4,J.ezrek,V1.Zvnra
IVth Ne.Clin.Fecu1ty Hosp.Ko4ice,Urol.
Clin.Netl.Inst.Hlth.Bretisleva,Czechosio—
For'ty—sevc'n otierits /sufferinc' fro'nitic9ney 'sese with vrirus lo—
reru1or ittiori r3t! 25 reel
trorisolant oetent5 were inveot'nte'.Io
cli nctents frection exrrtion of' n-'-urr
er Dx'bic /fO '
estict e9.1. TUe i- FE were incr'cse
oetpnts ufferin on chronic renol
f'lure.Hyoerbolie re1tionsbip between
C, and FE1q+ /r=C,7552,p O,O1i',etween
end FE 'rC,7243,p< 0,01/ wos found.
2. Liner correlation between FE
in renal patients with verus1oneruar f'1tration rate was found /r=
O,972,o< 0,01'.
3. 1lyperh'1ic relotianshie between C
and FEN /r=0,73O,p< O,01/,hetween
nn' F "r=O,7510,p< 0,01/ ir. renal
transolnt oet4erits was found.
4. Linear correlation between FE, + arid
FE. in renal transplant catients w
fond /r=0,87E,p 0,01/.
The changes of AA transport in residual
nephrons may he caused either by ostholo—
pied chanes of tubular cells or by toeto—
holic chnnipes affectinp AA tubular trans-
port.
BENEFICIAL EFFECTS OF DONOR SPECIFIC BLOOD
TRANSFUSION (DST) AND LOW DOSE STEROID (LO) IN
HAPLO-IDENTICAL LIVING RELATED
TRANSPLANTATION (LR'). 2G Moucd, 3 Seignalet , G Chong, 3 Guiter , H
Navratil , C Mion 1 2Divisions Nephrology, Immunology , Urology , University
Hospital, Montpelher-NImes, France.
In Nov. 1981, we began a programme of DST in one-
haplotype related donor-recipient pairs. 5 fresh whole
blood transfusions (100 ml each) were drawn from the
prospective donor, at 2 weeks interval. ABO, Rh corn-
patibilities, a negative cross-match (CM) and an infor-
med acceptance of risks of immunisation were necessa-
ry. Anti-T and B lymphocytes antibodies were monitor-
ed. Mixed lymphocyte cultures were performed before
and 15 days after DST. LRT was realised if all sera
were negative on a direct CM against donor total lym-
phocytes at 37°C. LO protocol included (mg/kg/day):
prednisolone .5, tappered down to .25 at 3 mos, Az 2-3
and ALG 5 for I mo. 17 pairs were included; 3 were
excluded (2 positive CM; 1 donor eventually refusing
donation despite a negative CM). 14 pts were transp-
lanted. Morbidity was very low: 13 grafts functionned
immediately; 1 presented a reversible acute tubular
necrosis; I ureteral necrosis was successfully repaired.
There were 2 asymptomatic urinary tract infections (no
wound sepsis no viral nor fungal infection). There were
only 23±5 in-hospital days. S creat at 3 mos was 124.5
pmol/1. The number of reversible rejections episo-
des was 0 in 7 pts, I in 3, and 2 in 3 others. 13 pts
have presently good graft function; 1 graft failed at 13
mos post LRT. DST protocol provides highly encoura-
ging results. The possibility to eliminate anti donor
sensitisation by association of Az to DST before LRT
and to reduce the incidence of rejection after LRT
with CyA should improve further the long term results
of haplo identical LRT.
PNEUMJCYSTIS CARENII PNEtJMCtUAS [N PATIENTS
RECIEVING RENAL TRNSPLTNTATI(.
L. Nielsen, J. Ladefoged.
University Hospital, Rigshospitalet, Medical
Departmant P, Division of Nephrology,
2loo Copenhagen 0, Denmark.
Pneuiiucystis Carinii (P.c) as the cause of pneuno-
nia was found within 12 months after transplantation
in 6 out of a total of 55o patients, who had a total
of 680 kidney transplantations performad.
The diagnosis o P.c was confirmad by denonstra-
tion of the micrcorganism in secrete from the tra-
chea or in lung tissue obtained by thin-needle pinc-
ture, together with exclusion of other known patho-
genic microorganism in the same material • The syrip-
toms and the clinical cause of the pnenraonias was
rather different from those associated with bacte—
rias or fungi. Fever and dysprioe were the main
syiiptoms with no or few stetoscopical findings.
X-ray examination showed diffuse infiltration of
the lungs, and fibrosis often persisted after the
infection.
The mortality in untreated cases was high,
whereas patients treated with sulfa and triiretoprim
responded well. Pulmonary insufficiens arid shock
were the main causes of deaths.
The diagnosis is rather difficult to obtain, and
several cases suspicious for P.c who were treated
by exclusion with sulfa and trinetoprim responded,
bet the diagnosis coold not be verified microsko—
pically.
Examination for P.C should be dome early in
atypical cases of pneumonia in kidney—transplanted
patients and treatnent instituted especially in
cases where dyspnoe is the main clinical syriptom.
. GLOMERULAR C3b RECEPTOR LOSS IN RENAL PLLOGRAFTS.
F. Nolaq9, H. Hartley, R. Reuben, K. Welsh,
3. S. Cameron.
Guy's Hospital, London, U.K.
Receptors for C3b complement are present in
normal human glomeruli but are absent or decreased
in glomerular lesions. No such study has been
undertaken in renal grafts, although an increased
number of mononuclear infiltrating cells
(particularly monocyte/macrophages) is found in
glomeruli from rejecting patients. It is not
known if these cells are involved in an active
immunological process. We have studied 21 renal
transplant biopsies (11 rejecting) from patients
treated with cyclosporine (11) or Azathioprine(1Q),
using an indirect immunoperoxidase technique and
an anti-C3b receptor monoclonal antibody (T05).
Normal C3b receptor staining was detected in 16
biopsies (7 rejecting), but 5 biopsies (4 rjectiOr1,
1 CMV) showed focal losses of C3b receptor.
Epithelial C3 deposition was demonstrated in 2/4
of these 5 patients in contrast with 1/11 of the
remaining 16. A panel of other McAb revealed that
glomeruli from the 5 patients with loss of C3b
receptor had significantly higher (p<O.OS) number
of leucocytes (2D1+) , T cells (UCHT1+), T cyto—
toxic/suppressor cells (UCHT4+) , natural killer
cells (Leu 7+) and macrophages (FMC 32+) with
macrophages = 15.2 glomerulus) predominating
over T lymphocytes (5 = 8.3). T helper/inducer
cells, although increased in number, did not
differ significantly. We conclude that changes
in glomerular C3b receptor in renal grafts are
associated with cellular infiltration, indicating
an active process.
.
I'IOLCGY AND POSIS OF DE NOVO GRFI'
M4BRNO(JS NEPHPATHY (DNG,IN). Y. Pirson, J.
Ghysen1 J.P. Cosyns, J.P. Squifflet, G.P.J.
Alexandre, C. van Ypersele de Strihou. University
of Louvain Medical School, Cliniques
Universitaires St—Luc, Bruxelles.
DNG1N is a recently recognized catplication of
renal transplantation (TP). In order to assess
its etiology and prognosis e review 23 cases of
de novo (certain 17, probable 6) C4N obselved
anong 1117 grafts (G). DNG1N developed in 12 %
(2/17) of HE2—identical living donor (113) reci-
pients vs only in 2 % of both 1/2 identical ID
(3/148) and cadaver donor (CD) (18/926) reci-
pients (p <.05). In the latter group, all DNGIN
patients had 2 and 10 (56 %) .< 1 HLA-AB mis-
matches. Good carpatibility seems thus to pre-dispose to I11N. In 2 cases appearance of G1N(absent in a previous G biopsy) was associated
with worsening of chronic rejection lesions.
Repeat biopsies after denonstration of 1N in 2
other cases shed parallel progression of (4N
and chronic rejection lesions. Evolution was
assessed in 19 patients with a potential follow—
up > 12 (m 36) nonths (m). Proteinuria developed
14 (range 3—48) m post TI', 4N was diagnosed 12(range 4—44) m later. Remission occurred in 2(11 %) and end stage renal failure in 6 (32 %)patients; serum creatinine (SC) doubled after
biopsy in 9 patients (47 %). The 2—fold rise in
SC was nore frequent (although non-significantly)
in CD G, when SC > 1.7 rr/dl or nephrotic rangeproteinuria was present at the tire of biopsy.
We conclude that DNG'IN develops preferentially inll-matched G, is associated with chronic
rejection and, contrary to other reports, carries
a rather poor prognosis.
PROLONGATION OF GRAFT SURVIVAL BY DONOR SPECIFIC
TR1'NSPLANTATION
O.Otubo,I. Takahashi, R.Yanagisawa, H.Nozaki,
M. Nishimura, H. Kawaguchi, V. Takeda, S. Tomikawa,
H. Sugimoto, J. Yamauchi, N. Akiyama
The Inst. of Med. Science, Univ. of Tokyo
Since 1976, we have initiated a prospective
study in an attempt to improve the graft survival
by donor specific transfusion.
Included in this study were patients who recieved
kidney transplants from HLA haplo identical living
donors excluding BLA identical sibling.
All recipients exhibited a high mixed lymphocyte
reactivity with the donor lymphocytes. Both DST
(n=43) and control groups (non DST n16) were
matched with age, sex and treatment as well.
DST was given as follows, 200 ml each of fresh
whole given within 24 hours after collection.
Patients were grafted two weeks after the last r.
Immunosupressive agents included azathioprine,
predonisolone and ALG. A direct cross match test
including T warm, B warm and B cold cytotoxic
antibodies was performed prior to the operation.
If T warm is positive we postponed transplantation
until T warm becames negative. Three patients
became T warm positive. Two of three T warm
positive patients became negative afterward, so
recieved kidney transplantation with good renal
function.
The graft survival rate at one year was 95.3 % for
the DST group and 62.5 % for the non DST group.
In conclusion DST results in a reduced rate of
rejection episodes and marked prolongation of
graft survival.
THE INFLUENCE OF SURGICAL TECHNIQUE AND EXPERIENCE
ON THE INCIDENCE OF SURGICAL DAMAGE OF CADAVERIC
DONOR KIDNEYS
.R.Ploeg, R.vanSchilfgaarde, W.Felthuis, G.C. Persijn
University Hospital Leiden,Dept. of Surgery,Holland
Cadaveric donor nephrectomies can be performed
either by using the 'en bloc' technique or by sep-
arate removal of both kidneys. The main argument in
favour of the 'en bloc' technique comes from the
surgical experience that it reduces the risk of da-
maging the donor kidneys, esp. in the presence of
anatomical abnormalities. We have analyzed the com-
plete Eurotranspiant cadaveric donor material (3,398
donors, 6,621 kidneys) from 1977—1981. It concentra-
tes on the incidence of surgical lesions of the do-
nor kidneys as influenced by: (1) surgical techni-
que applied in relation to anatomical abnormalities
(2) experience of the procurement team. In the pre-
sence of a normal anatomy (77.11,5,104/6,621) the
incidence of surgical lesions was similar after 'en
bloc' and separate removal (overall 7.7%,392/5,1D4)
However, in the presence of anatomical abnormalities
(22.91,1,517/6,621) the overall incidence rose to
20.4% (31O/l,5l7)(p'cO.Ol). Next, we compared the in
cidence of surgical lesions in relation to the year
ly number of donor nephrectomies, in order to in-
vestigate the influence of surgical experience. Sur-
gical lesions in one or both kidneys were observed
in 26% of the donors nephrectomized by teams per-
forming 5 or less nephrectomies per year, but only
in 17% of donor if the yearly number of nephrecto—
mies was 20 or more (pO.OI). We conclude that the
incidence of surgical lesions is significantly re-
duced by using the 'en bloc' as opposed to the sep-
arate nephrectomy technique, as well as by increa-
sing experience of procurement teams in terms of
yearly numbers of nephrectomies performed per team.
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YOUNG CADAVER DONORS FOR KIDNEY PROCUREMENT:
GRAFT SURVIVAL AND SURGICAL DAMAGE
R.Ploeg,R.van Schilfgaarde,W. Felthuis,G.G. Persijri
Dept.of Surgery, University Hospital Leiden, Holland
We have analyzed all 6,621 cadaver donor kidneys
reported to Eurotranspiant from 1977—1981 in respect
to both donor (D) and recipient (R) age, by compar-
ing 1—yr graft survival (GS) in each age—decade of
both D and R. The GS of kidneys from D under 10 yrs
old (50%) was significantly lower than the GS of kid
neys from D in their 2nd (66%), 3rd (68%), and 4th or
more (62%) decade (p<O.Ol), irrespective of the age
of R. The GS of kidneys from D over 10 yrs old was
similar in all age—categories of R (66%). The infer-
ior GS of pediatric kidneys could not be explained
by differences in HLA—match or pretransplant R blood
transfusions. Neither could it be attributed to surg
ical damage induced during the pediatric (as opposed
to adult) nephrectoiny. Elsewhere we showed that with
normal anatomy the overall incidence of surgical
lesions was 7.7%, whereas it increased to 20.4% if
the anatomy was abnormal (pO.OOl). Nowwe found that
younger D age appears to reduce the effect of ana-
tomical abnormalities on the incidence of surgical
lesions, since with abnormal anatomy lesions occurr
ed in 15.9% of kidneys from D under 20 yrs old and
in 23.3% of kidneys from older 0 (p'O.OOI). With
normal anatomy this incidence was 7.3% and 7.9%,
respectively. Finally,we found that GS of kidneys
from very young 0 (below 5 yrs old) was 50% when
single kidneys were transplanted to different Rs,
and 66% when both kidneys were 'en bloc' transplan-
ted to one R (pO.IO). We conclude that kidneys from
cadaveric 0 under 10 yrs old have significantly re-
duced GS as compared to those from older D which
cannot be explained by an increased incidence of
surgical lesions. Kidneys from D under 5 yrs old
should preferably be transplanted 'en bloc' to one
recipient.
* EDTA—ERA member
KTTTIIT TREAP)\UFrTT AS FROPHYLAXTS IN
PRVTTIG 01 0—0°TJAL CP P1ICAmTO1S
TOiI,OWpr0 KINFY TRA:SPLAJTT
G.Prati,P.Tesn,.ReCehin,A. iolo,
.Calvani,.AncoriaIII Division of Surgery,General Jospital
Verona, Italy
rinety patients (gronp I) were givenTanitidine following kidney transplant in
order to prevent gastro—duodenal cOmpliCa.—
ti one.
All the patients with a good kidneyftnctiori underweit gastro—dxodeal elide—
scopy with biopay before dischar:e from
hospitai.,Ioreover,gastriC fanotionality
was assessed by acidornetry.
The results were compared with those
obtained from other patients (group Ti)
who were not treated with Tanitidine after
kidney transplant.
Grouip I patients showed a sioificant
decrease (p 0,01) of inflammatory lesions
in the gastro—duodenal mucous membrane,
both endoscopiccily and histologically.
These patients showed also a complete
normalization of the basal acid oItpnt
(tAo)
ITo side--effects or lahorutory values
relatec to treatment were noted.?ecause of these reasons,tlie usefilneso
of Ranitidine treetrnerit as propriylaxis
after kidney transplant Co lid he sugest.
VIRAL SELECTION OF RENAL--CRAFT DONO. R1tATTON
WITH THE VIRAL AND IMEUNOLOGICAL STATUS OF THE
RECIPIENT.
C.Pouteil Noble,P.M.Piatti,S. El Yafi,S.Bosshard,
M.Aymard,J.L.Touraine,R.Betuel,and J.Traeger.
mlinic of Nephrology,INSERM U.8O,H6pital E. llerriot
Iyon , France
220 kidney—graft recipients have been followed for
Cytomegalovirus(CMV)and Herpes Simplex(HS) infec—
dons from January 1982 to March 1984 in our Unit
)y virological urinary analysis and serological
tests(CF and ELISA) bef,re and once a week after
cransplantation.Similar humoral tests were perfor—
ned in 28 livlng—related(LR) and 80 cadaveric(C)
lonors.Incidence of CMV and HS infections was 67%
md 43% in the whole group.In the LR recipients
(LRR) the Incidence was 53% for CMV and 4811 for PS
Lofections while in C recipients (CR) was of 71%
br CMV and of 42% for HS.Seropositivity(SP)was 78%
or CMV and 68% for HS in LRR while in CR was 87%
or CMV and 87% for I-LS.SP for CMV and HS was 61%
nd 75% in LR—donors while in C—donors was 80% for
.;IIV and 78% for HS.In LRR 14% of primary CMV infec—
.ions(PCMI) and 5% of primary HS infections(PHSI)
as observed.InCR 8% of PCMI and 7% ofPHSI was ob—
erved.Recurrent CMV and HS infections occurred in
6% and 95% of LRR and 92% and 93% of CR respective
y.Highest inôidence of infection was noted in do-
or—recipient SP.buf - the. lqst.one in donor—red—
•ient seronegative(SN).In SN pticnts the duration
f dialysi was shorter than SF patients.Tncidèoce
f PCMI was related to transfusion numbers and dia-['sis duration.No correlation was noted between
CA—matching(A.B nd uR) and GIIV or PS infections.
o conclusion risI cf CMV nd 115 infocticns in PP
-cipients shoul3 be onsidred as high o;in SN
cipients and SI' recIpients should be included in
ny prophylactic treatment as soon as the donor
shown be seropositive.
GLYCOSILATED PROTEINS IN RENAL TRANSPLANTATION
C.Quereda; J.Sabater; J.L.Teruel; J. Gzlez. Reval—
derfa y J. Ortuno.
Centro "Ramôn y Cajal".— Madrid. Spain.
Despite diabetes is a frequent complication of
corticosteroid therapy in renal transplantation,
the levels of glycosilated proteins in trasplanted
patients have not been enough studied and their
relation with therapy and vascular complications
are not known.
We have determined glycosilated haenoglobin
levels in 32 trasplant recipients using two
different methods: a conventional microcolumn
chromatographic tecnique (HbA1) and the chemical
thiobarbituric acid method (GHb), in order to avoid
the possible interference with carbamylated
haemoglobin. Plasmatic glycosilated proteins (PGP)
were also determined with this technique. Two
control groups were used: 26 healthy controls and
19 non—uremic diabetic patients.
HbA1, GHb and POP levels were higher in the
transplant group than in the healthy controls and
slighly lower than in diabetic patients. There is
a significant correlation between them and means
of fasting glycemia, highest glycemia and
glycosuria during the previous three months, and,
also, with the amount of Prednisone administered
in this period. Their levels decrease with time
but remain significantly rised more than one year
after renal transplantation.
We conclude that glycosilation of proteins is
increased in renal transplant, reflecting an
abnormal carbohydrate metabolism, related to
corticosteroid therapy.
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SERSM LIPIDS AND APOPROTEITIS IN DIAJYSET)
AND TR SPLATNT) PATIEST
'.Recchia,P.Dean,S. P.Prsti,A.J:wlo,
E. Galvani, S. An coma
III Division of Surgery,Gerieral Hosoital,
Verona, Italy
Serum lipid and apopro-tein levels weredetermined in 93 patients 5 to 174 months
after sccesafA1 renal transplant and in65 dialysed pwtients in order to evalate
the incidece of l.ioid abnormalities.
Patients were chosen by exc1udin' tlae
factors known to influenca lioidaemia.
Serum triglyceride,cholesteroi,total
sooprotein (apo) A an apo B,high—density—
lipoprotein cholesterol (frDI,-chol.),glccose,
PTH an creatinine ieveis were meascred.
Lipoprotein electrophoresis was erformed.
erum triglyceride,c±oles-terol and apoB
levels reselted similar in transplant and
dilyi patient and significantly higher(p 0,01) tccn in age and sex—matched
controls.
Serum IT)L_c}iol.anci apo A concentrations
in transplart :roup were not sinificantly
different in nonuremic controls and higher
(p 0,01) than in dialysed patients.
Go relation was found between serumiinid levels and steroid treatment,serumglucose,creatinne and. PTH levels.
Though iiyperlipidaemie is common after
kidney tratspLant,normal flGLchol. and
ape A concentrations in serum may redice
the risk of crdiovascular disease,major
cause of dectG ii patients on long—term
maintenance nernodici.ysis.
INFLUENCE OF BLOOD TRANSFUSIONS (BT) ON TUMOUR
GROWTH.
EXPERIMENTAL STUDIES IN THE RAT.
W. RBBler, K. Dreikoro, V. Lenhard, W.J. Zeller
and P. Scholler
Dept. of Urology, Dept. of Immunology,
University of Heidelberg,
German Cancer Research Centre Heidelberg, FRG
The beneficial effect of pretranaplant blood
transfusions on kidney graft survival is well
documented. Specific immunoregulatiori by T—
suppressor cells or anti—idiotypic antibodies as
well as non—specific immunosuppressive factors
are discussed. It is speculated that ST might be
hazardous in patients with malignancies. We stu-
died in a rat model the effect of BT on tumour
growth. Four groups of BD—9 rats (n 15) were
transplanted with two different malignant neuro—
genie tumours. Two groups were pretreated by
five monthly BT (1 ml, donor: Sprague Dawley
rats). Two groups represented non transfused
controls. The tumour weights in the transfused
groups were 35/55 g compared to 35/60 g in the
controls (not significant). Our findings are in
contrast to those published by Francis et al.
1983. Further studies have to clarify this
clinically relevant question. The influence of
BT on autochthone tumour growth is currently
being studied by us. Preliminary results will
also be presented.
PITUITARY ADRENAL AXIS JPPRESSION AND RECOVERY IN
RENAL TRANSPLANT RECIPIENTS RETURNING TO DLtLYSLS.
R.S.C. Rodgei, M. Watson, L. Sellars, 5.8. Cook,
H. Wilkinson, N.E. Ward, *D.N.S. Kerr.)cpartaents of Medicine and Clinical Biochemistzy,
University of Newcastle upon Tyne, U.K. *Royal
Postgraduate Medical School, London, U.K.
The 30 minute corLisoi response to exogenous ACTH
(Synacthen) was used to identify pituitary adrenal
(PA) axis suppression in 17 regular dialysis pat-
ients in whem steroid withdrawal was coutenpiated
following renal transplant failure. 8 patients
(group 1) had received prednisolone for 2—10 raths
(mean 4.2 mtds) and 9 patients (group 2) for 3—10
yrs (mean 7.2 yrs). PrednisoLone therapy was sub-
stituted cy hydrocoinisone 30 ug daily, reducing
over 2 mths to 10 mg daily. Synacthen tests and
baseline ACTS levels were measured monthly.
6/8 patients in group 1 and aLl. 9 patients in
group 2 had an impaired response to synacthen at
tiie onset of steroid withdrawal • PA axis recovery
was estaclished in 5 paLients in group 1 after 2
mths and 7 patients after 6 nths. Only 1 patient in
group 2 achieved PA recovery within 6 mtlis. No cases
of acute adrenal insufficiency have ôeen observed
using this regime. Plamna ACTS levels were high
prior to PA axis recovery in over 80% of patients.
The cortisoi response to insulin induced hypogly-
cemia (ulood g1ucose2 mmoi/1) was impaired in 2/6
patients with nomial synacthen tests. 3 mths later
5/6 patients showed a noniral cortisol response to
hypoglycemia (1SF).
Steroid therapy in renal transpianeation induces
profound PA axis suppression which is slow to re-
cover. The 1ST data suggests that complete pituit-
ary recovery lags oehiuid adrenal recovery. With-drawal can be safely achieved bt steroid cover
should cc given during periods ci' stress until the
PA axis has ucen shown to respond norisally.
INFLUENCE OF PREOPERATIVE BLOOD TRANSFUSIONS ON
GRAFT SURVIVAL IN CANINE KIDNEY TRANSPLANTATION
N. RöBler, K. Dreikorn, 0. Opelz, R. Waidhear
und L. Röhl,
Dept. of Urology, Inst. of Immunology, Inst. of
Pathology, University of Heidelberg, FRG
The beneficial effect of preoperative trans-
fusions has been documented in clinical and ex-
perimental renal transplantation. We studied the
effect of different preoperative transfusion pro-
tocols in canines: 1. no transfusion, 2. 30 ml,
3. 5 x 30 ml, 4. 5 x 100 ml. Recipients were bi-
laterally nephreotomised Fox hounds, receiving
standard immunoauppression. Kidneys were ob-
tained from mongrels unrelated to the blood
donors. Each experimental group existed of
9 animals. Graft function was evaluated by
s.crestlnine and survival. Histopathological
examinations were performed. In contrast to
the findings of ether authors, a significant
beneficial effect of blood transfusions was
not observed. The influence of blood trans-
fusions in canine renal transplantation
appears to be complex.
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QUANTITATIVE AND FUNCTIONAL EVALUATION OF
SUPPRESSOR CELLS IN RECIPIENTS BEFORE AND
AFTER KIDNEY ALLOTRANSPLANTATION
L.Sainoshenkova, A.Sochnev (Tnt. by G.Kakuk)
Riga Medical Institute, Riga, USSR
Redistribution has been demonstrated of
the number of oligoreceptor and multire-
ceptor theophylline—sensitive T suppressors
in preoperative recipients of renal allo-
grafts as compared to healthy test donors.
Functional activity of Con A-induced T sup-
pressors in these patients was found less
frequently than in normal subjects. No sig-
nificant correlation was established bet-
ween quantitative and functional parame-
ters of T suppressors which testifies to
heterogeneity of the given cell population.
Studies of various T suppressor subpopula-
tions acquire even greater importance in
view of differentiated effect of hemodia-
lyses, hemotransfusions, allotranspiants,.
immunosuppressive drugs etc. upon immuno-
regulatory system of patients. No increas-
ed activity of Con A-induced suppressor
cells ass ievmaled duriag thc first woeS
following the last hemotransfusion which
should be taken into account when identi-
fying high risk groups for kidney trans-
plantation. Reduced functional activity of
T suppressors and increased activator cells
were registered in recipients with rejec-
tion episodes. Patients with long-function-
ing transplants had high level of Con A-
induced T suppressors.
EVALUATION OF RENAL TRANSPLANT FUNCTION WITH v-CAME-
RA AND ggm Tc DTPA.
G. Sakellario.u, T. Tsobanelis, S. Tsifoutis, E.Alexopoulos,
D. Memmos, K. Psarakos, N. Papadimitriou.
2nd Prop. Department of Medicine, Aristotelian Uni-
versity of Thessaloniki, Greece.
The use of radionuclides is now considered asapo-
cedure for detecting rejection and other postopera-
tive complications. From January 1980 till February
1984, 277 renal transplant scans in 80 patients were
performed. Six to 8mCi of 99mTc DTPA were given IV and Se-
rial imaging far the first 3Oseconds and over the sub-
sequent 2Ominutes re obtained on X-ray-film. At the
same time data were processed and analysed by using
a minicomputer. For the quantitative evaluation of the
first pass histogram a simple perfusion index (BP)was
calculated. This index was determined from the equa-
tion BP=Peak countofthefirstjjjstogram x 1000
Administered dose
-
1) In patients with normal renal graft function theM
BP(±SD) was 6.O(±2.4)(range 4.2-12.0). 2)Six patients
with hyperacute rejection presented a BPindex<LO.3)In
19 patients with acute rejection the BP index was<3.O
(N BP=1.8±O,6,rangel.2-2.9).4) In 18 patients with
chronic rejection the EP index was<2.0 (MBP=1.3±O.5).
A highly statistical significant negative correlation
was found between SCr and BP index (r'0.593, p<0.0O1).
In addition,a significant decrease of the BP values
during the acute rejection in comparison with the
prior to rejection values were found. In conclusion,
an immediate reduction of the BP index is an additi-
onal valid test that can help in diagnosing rejecti-
on. The early changes of the BP index, the atoxicsa-
fe and repeatable of the method seems to represent
its advantages.
CAPO AND CyA - EFFECTIVE TREATNT FOR DIABETICS
WITH END STAGE RENAL FAILURE (ESRF)
M. Searle, V.7. Sharman, h.A. Lee, M. Slapak
Wessex Regional Penal Unit, Portsmouth, UK.
In the P years since January 1980 we have treated
10 diabetics with TURF (6% of program entrants).
Mean age was 04 years (range 25—55). Mean duration
of diabetes 21 years (7—32). Mean initial 'rectin—
me 925 umol/l (6201300). All had retinopathy;
7c% clinical evidence of neurnoathy. None had clin-
ical evidence of iachaemic heart or neripheral vasc-
ular disease.
Initial treatment was with CAPD, Mean duration
7.8 months (1—25). No serious morbidity or mortal-
ity occurred; there was one birth. 1 treatment
failure occurred due to peritonitis and he ia now
controlled on diet alone. Peritonitis rate was 1
episode per 6 oatient months, equal to non-diabetics
on our orogram. Catheter loss was 1 in 36 patient
months (ci. I in 24 non-diabetica).
The need for hypertensive drugs fell from 76% to
02% of patients on starting CAPD. Subcutaneous
Insulin requirements increased from a mean of 00 to
49 units daily.
11 patients (79%) were grafted using CyA as the
major immunosuppressive agent. The mean post-
transplant period at i.i.84 was 8.8 months (1-20).
' patient died and 1 rejected his graft. 9 grafts
remain with stable function and creatinine • 350mol/l
3 patients have had no steroids; 4 still require
smaLl doaes )Omgs daily. The average dose of
methyiprednisolone given as "pulse therapy" for
rejection episodes was 2.7 grams.
We conclude that CAPU is effective treatment for
diabetic patients with ESRF. CyA enables transplant-
ation with minimal steroid usage. This transforms
the outlook for these patients who will form a
growing proportion of our program.
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• IMPAIRED FIBRINOLYSIS AFTER KIDNEY TRANSPLANTATION
.
Seitz,R; Michalik, R.; Egbring, R.; Karges, H.E.
and H. Lange
Department of Hematology, Department of Nephrology,
Center of Internal Medicine, University of Marbura
and Behringwerke AG, Marburg, F.R.G.
An impaired fibrinolysis was assumed to partici-
pate in the pathogenesis of thrombosis and graft re-
jection after kidney transplantation.
The plasma levels of plasminogen, a2—antiplasmin,
the neoantigen of the plasminogen—a2-antiplasmin—
complex (NA), antithrombin III and fibrinogen of 9
consecutive recipients were determined with the
technique of Laurell and Mancini respectively befo-
re and repeatedly after cadaveric kidney transplan-
tation.
In 4 patients irreversible graft rejection led
to removal of the graft. Widespread thrombotic le-
sions were observed at histological examination of
all rejected kidneys. These 4 patients showed accor
dingly a decrease in the plasrninogen levels whereas
the a2—antiplasmin levels rose, indicating an im-
paired fibrinolysis. In none of them the NA was
discovered.
In contrast 4 of the remaining 5 patients who
left the hospital with a functioning graft, did not
show any alteration of plasminogen and a2—antiplas-
mm respectively. The fifth patient whose plasmino-
gen level decreased showed a severe acute rejection
with thrombotic lesions, which could be overcomeS
The plasma activity of antithrombin III and fi—
brinogen were always in the normal range.
The lowered plasmmnogen levels and the corres-
ponding excess of a2-antiplasmin are suggested to
be due to a diminished production of plasniinonen,
rather than it's consumption since no NA was detec-
ted in any recipients plasma.
• KIDNEY TRANSPLANTATION IN PATIENTS ON CONTINUOUS
AMBULATORY PERITONEAL DIALYSIS
• Z. Shaoira, D. Shmueli, A. Yussim, G. Boner,
C. Haimovitz', Servadio
Beilinson Medical Center, Petah Tiqva and Soroka
Hospital*, Beer Sheva, Israel
Since continuous ambulatory peritoneal dialysis
(CAPD) was begun in 1977, increasing numbers of
such patients are on the waiting list for kidney
transplantation.
However, it appears that several centers prefer
hemodialysis patients for kidney transplantation.The
reluctance to transplant CAPD patients results main-
ly from fear of peritonitis,especially in patients
who have already had episodes of peritonitis during
their treatment. In the 45 months April 1980-Dec-
ember 1983, 32 patients on CAPD received 1st cadaver
renal grafts. Over the same period, 105 hemodialysis
patients were transplanted with 1st cadaver renal
grafts. The two groups of patients were similar in
matter of pretransplant blood transfusions,mean age,
distribution of primary renal disease,HLA matching
and immunosuppressive therapy. Of 14 CAPD patients,
at least one episode of peritonitis each was docu-
mented before the transplantation. In 4 patients,the
peritionitis subsided just before the kidney graft-
ing. The actuarial graft and patient survival was
57% and 84.4%,respectively for the CAPD patients and
55.8% and 85.3% in the hemodialysis group. No pa-
tient from the CAPD group had postoperative periton-
itis.The similar results in both groups and the lack
of evidence of postoperative peritonitis in the CAPD
patients indicate that kidney transplantationi ihese
patients has no higher risks than in hemodialysis
patients.
• T CELLS SUBSETS IN RENAL TRANSPLANTED PATIENTS DE-
.
FINED BY THEOPHYLLINE SENSITIVITY AND MONOCLONAL
ANTIBODIES.
Z. Shapita. B. Shohat, A. Yussim, D. Shmueli,
C. Servadio.
Beilinson Medical Center, Petah Tiqva and the Tel
Aviv University Sackler School of Medicine,Israel.
T cell subsets were determined in peripheral
blood obtained from 26 patients after receiving a
first cadaver kidney graft. T cell subsets were
tested by two different methods: the theophylline
sensitivity test and the monoclonal antibodies
OKT4 and OKT8 . In 13 of the 26 patients, clin-
ical acute rejection episode was evident post-oper-
atively. No significant difference was found in the
percentages of OKT8 cells between the rejecting and
non-rejecting patients; however much lower values of
theophylline sensitive T-suppressor cells were found
in the rejecting group.Mean value of T-suppression
was 13.5% compared with a mean value of 21% in the
patients of the non-rejecting group. In addition, 5
patients in acute rejection who could be tested also
for T helper percentages showed much higher percent-
ages than the patients who were not in acute reject-
ion episode, 51% as compared to 29% T helper cells
respectively. The discrepancies found between the
two methods - could be attributed to the fact that
theophylline sensitivity measures only suppressor
cells while the OKT8 measure two cell subsets: the
T cytotoxic and T suppressor lymphocytes. The ratio
OKT4/OKT8 was below one in the non-rejecting patients
and normal in the patients in acute rjection episo-
des.According to our findings,the theophylline sensi-
tivity method as well as the ratio OKT4/OKT8 may be
a helpful laboratory test to confirm a clinically
suspected acute rejection episode.
MONITORING OF INFECTIOUS COMPLICATIONS
AFTER RENAL TRANSPLANTATION
A.Sochnev, B.Shif, E.Arjkova, A.Burshtein,
L.Samoshenkova (lntr. by G.Kakuk).
Riga Medical Institute, Riga, USSR
Analysis of 211 cadaveric kidney trans-
plantations revealed that 60.4% of patients
with the first transplant and 71% after
retranspiantation developed infectious com-
plications. In 18.3% infections were the
immediate cause of death. The most common
infections were those of the urinary tract
(26.1%), respiratory infections (19.7%),in—
flammation at the transplantation site
(18.5%), septicemia (18.5%). Pretranspian-
tation monitoring in uraemic patients on
regular dialysis treatment enabled us to
identify clinical immunological risk fac-
tors related to infections:haemodialysis
count below 30, high level of lymphocyto-
toxic antibodies (50%) , creatinine clearan-
ce below 4.5+1.1 ml/min, reduced in vitro
lymphocyte blastogenic responsiveness to
mitogens and decreased phagocytic activity
of PMNC. Investigation of immunological pa-
rameters during infection episodes showed
a decrease in aE-RFC, blasttransformation
of cultured T- and B-lymphocytes to PHA and
PWM, increase in phagocytosis. Infection
incidence was considerably higher in pati-
ents with irreversible rejection episodes
as compared to those with reversible ones
(56.5% and 39.7%, respectively).
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ARTERIO-VENOUS-FISTULAS THROMBOSIS AFTER
KIDNEY-TRANSPLANTATION
A. Soliman, H.—J. Logering, H.—D.
Jakubowski, F.W. Eigler, D. Paar
Dept.of General Surgery and Dept. of Clini-
cal Chemistry, University Clinics Essen,
F .R.G.
The fact of more frequent thrombosis of
a.-v. fistula after kidney transplantation
isawell—knowri fact. The aim of this paper
was the evaluate the frequency and possi-
ble causes of this event.
In 315 patients with end stage of renalfailure who underwent kidney transplanta-
tion, 63 fistulas thrombosis occurred in
53 patients. Out of 190 patients of this
group there were 32 fistulas thrombosis in
27 patients, while out of 125 female pa-
tients there were 31 fistulas thrombosis
in 26 patients. Fistula thrombosis occur-
red more in patients with diabetic nephro—
pathy (7 fistula—thrornbosis in 11 patients).
About 50 % of fistula thrombosis occurred
during the first week, and about 50 % from
these thrombosis occurred on the first day
after transplantation.
30 patients who underwent kidney trans-
plantation were examined in regard to se-
veral blood parameters preoperatively, in
addition 18 of them on each of the first 4
days after transplantation and 12 of them
when a fistula thrombosis occurred.
The following parameters seemed to play
a significant role in the cause of fistula
thrombosis: ;) high fibrinogen, 2) high
Beta—globulins, 3) decreased thrombin time,
4) positive Fibrin—Monomer test in compa-
rison with patients after transplantation
but without fistula thrombosis.
URINANALYSIS ABNORMALITIES AND THEIR SIGNIFICANCE
IN MONITORING RENAL ALLOGRAFT DYSFUNCTION
B.Spohn,H.Bauer, M.Scholz, R.Guth, H.E.Franz
Sektion Nephrologie, Department Innere Med.I,
Universitt Ulm, W.Germany
Papanicolaou staining of the urinary sediment
has shown to enable on accurate identification of
the various morphologic entities. Using the cyto-
centrifuge and the Papanicolaou stain more than
5000 semiquantitative urine specimens have been
evaluated in 50 conventionally and 51 Cyclosporin A
(CyA) treated patients. The clinical-chemical dia-
gnosis of acute rejection (AR) was supported by
sonographic, szintigraphic, fine needle cytologic
and angiographic analyses. 54 of the 61 observed
AR exhibited besides various Amounts of proximal
and distal tubular cells an exfoliation of'2O col-
lecting duct cells (CDC) per 10 High Power Fields
(HPFs) accompanied by a lymphocyturia of72O/1O
HPF's in 34/61 AR. In 5 AR only a lyrnphocyturia was
found. Two subacute AR in the CyA-group showed a
false negative urine cytologic pattern. Two obser-
ved ureteral leakages could be predicted because of
exfoliation of big ureteral fragments. 10 of 14 vi-
rus infections showed typical cytopathic changes.
Non—AR causes of graft dysfunction (n=38) like tu-
bular injury due to drugs (CyA md.), urinary
tract infections, crystaluria or acute tubular ne-
crosis have been accompanied by lymphocyturia in 25
cases whereas in 8 events only a short time eleva-
tion of CDC was seen. In conclusion an elevation of
CDC far more reliably documents an AR than do lym-
phocytes. Whereas AR damages the collecting duct
system together with the other renal structures,
damage of non—AR origin involves the collecting
duct system in severe cases only.
LONG TERM SUCCESSFULLY TRANSPLANTED KIDNEY PATIENTS
AN IMMUNOLOGICAL MONITORING.
G. Spagnoli, C. Ausiello, M. Valeri, A. Piazza, B.
Evangelista, F. Pisani and C.U. Casciani.
1st. CNR 'Tipizzazione Tissutale', LAquila, Italy;
II Università br Vergata, Roma, Italy.
Six patients with excellent long term renal gra-
ft function (three for more than six yrs —A group-
and three for more than eleven yrs -B group-) were
studied. Three patients received a renal allograft
from living related donors. All patients were trea-
ted with a similar immunosuppressive therapy, incl-
uding azathioprine and corticosteroids. Phenotyping
characterization of lymphocyte subsets was perform-
ed by standard indirect immunofluorescence methods
by using commercially available monoclonal antibod-
ies (OKT and Leu series). Natural Killer Activity
NKA) was used as natural immunity parameter whereas
PHA stimulation and MLC were used as T cell functi-
on parameters. Only one patient of the B group sho-
wed altered T4/T8 ratio (0.8) although with normal
T3 count, while for all the others these parameters
did not differ from the control group. The same pa-
tient and the A group patients showed highly depre-
ssed levels of NKA against 51-Cr labeled K562 targ-
et cells whereas NKA levels within the controls ra-
nge where detected in the other patients. Blastogen-
esis and MLC agait pooled stimulator cells gave co-
mparable results in patients and controls. Autologo-
us MLC showed a higher 3H-Thymidine uptake compared
with control values (P40.01) suggesting that a hig—
h autologous responsivity improveikidney grafts.
DIURNAL RHYTHM OF PHOSPHATE EXCRETON IN KIDNEY
CRAFT RECIPIENTS
V. Stefanoviá, M.A. Iviá, S. Strahinjió
Institutes of Nephrology and Physiology, Faculty
of Medicine, NiA, Yugoslavia
Diurnal variations of phosphate excretion were
studied in 13 grafted patients, 19—83 months after
kadaver kidney transplantation. Patients were
examined under two conditions: recumbent in
hospital and normal activity at home.Unrestricted
died was given. Urine was collected in 3hrperiods.
Marked variations in the quantity of phosphate
excretion and 4mrdered diurnal rhythm, with one
or two peak values were recorded in recumbent
patients. In six patients a higher daily excretion
of phosphate (mean 35.7 mmolI24 h) was found,serum
phosphate being in the limits of normal. Seven
other patients showed mean phosphate exretion of
14.8 mmol/24 h, with a subnormal early morning
phosphate. Cyclic—GMP excretion was mamal in the
late afternoon. Peak excretion in the same
patients apparently correlated with maximal
phosphate excretion.
Phosphate excretion under normal activity was
studied one year later in 7 patients and 8 healthy
controls. Daily phosphate excretion and diurnal
rhythm in supine patients roughly correlated with
controls, Excretion of cyclic—GMP correlated with
peak phosphate excretion also, however correlation
was les constant than in recumbent patients.
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. THROMBOXANE B2 (TxB2) AND 82-MICROGLOBULIN(8MG) AS EARLY INDICATORS OF RENAL ALLOGRAF
• REJECTION
H.B. Steinhauer, B. Wilms, P. Schollmeyer
(Intr. by R. Kluthe). University of Freiburg
Dept. of Internal Med. IV, Freiburg, F.R.G.
An early step in the immunological course
of renal allograft rejection is the activa-
tion of cellular blood components which is
associated with increased intra-renalfor-
mation of arachidonic acid (AA) metabolites
A study in 34 renal transplant pat'ents
was undertaken to investigate the diagnostic
value of urinary TXB2, the hydrolysis pro.-
duct of the AA metabolite TXA2, in compari-
son to 6MG which excretion is affected by
changes of glomerular filtration and tubu-
lar reabsorption.
The clinical diagnosis of acute trans -
plant rejection was confirmed by an increas
of urinary TXB2 in more than 90% of rejec-
tion episodes. Sufficient therapy of re-
jection was followed by the decrease of TXB2
and 6IG excretion. TXB2 was found to be
more stable in dependence on urine pH value
and temperature than 6MG. No false-positive
results occured for TXB2 whereas an increase
of urinary 8MG was obtained during acute
tubular necrosis, urinary tract infection
and cyclosporine A nephrotoxicity.
The determination of TXB2 excretion per-
mits the non-invasive evaluation of renal
transplant rejection. Because of its higher
stability and the lack of false-positive
results TXB2 seems to be a more reliable
indicator of allograft rejection than 8MG.
RENAL TRANSPLANTATION IN PATIENTS WITH
AMYLOIDOSIS.
C.E. Stroemsaether, P. Fauchald, A. Flatmark.
The National Hospital, Oslo, Norway.
Previous reports have indicated that
transplantation in patients with amloidosis is
less successfull than in patients with primar,
renal diseases. Our impression is not quite the
same, and we therefore wish to present the results
from our center.
From 1974 to April 1983 21 renal
transplantations were carried out in 20 patients
with amloidosjs. The amloidosis was considered
as primar in 3 patients, while 6 patients had
amloidosis secondary to regional enteritis, 10
had rheumatic diseases and one patient had
chronic osteomelitis.
At the time of follow—up from 6 to 98 months
after transplantation, 13 patients were alive with
functioning graft and one patient was back on
hemodialsis. Seven patients had lived with
functioning graft for 4 years or more. All deaths
occured early after transplantation and were
most1 due to infectious complications.
Graft biopsies have not been performed, but
recurrence in the grafts has not created an
serious problems. The results in this group of
patients are not substantiall different from the
total transplantation results at our center.
VARICELLA-ZLTER VIRUS (VZV) INFEC]IC FOLUJVING
RENAL TRANSPLANTATI(
M.E.Stevens. A.N.Hillis, A.Hart, J.M.Bone, Renal
Unit & Department of Medical Microbiology, Royal
Liverpool Hospital, Liverpool, U.K.Dissinated VZV infection in adult iniiaino—
suppressed patients is rare but well documented,
highly infectious and may be fatal. A fulminant
case of dissinated VZV infection presenting as
pancreatitis in a renal transplant recipient and 7
associated episodes of VZV infection(4 patients,3
relatives) were linked to a brief exposure to
herpes zoster (HZ) 10 days previously.
Infection control procedures included closure of
the transplant ward and transplant waiting list and
isolation of 30 high exposure/high risk patients
who were given zoster imnunoglobulin (ZIG),l(XX) mg
i.m. Four further patients, 3 treated with
Cyclosporin A developed VZV infection over 4 weeks
(2 varicella, 2 HZ) and despite Acyclovir i.v.
1Q/kg/8 hourly for 5—10 days in 3 cases, severe
visceral dissnination occurred in one.
Patients transplanted between Nov. 1979 &Dec.
1982 who retained their graft for longer than 3
months (total:lol) were studied by questionnaire
to assess the frequency of VZV infection post
transplantation and the relationship with modes of
ininunosuppression. Eleven episodes in 10 patients
occurred, 73% within 12 months of transplantation
and none within 2 months. There was no increased
frequency in patients on Cyclosporin A (3/27)
ccnlpared to those on steroids/Imuran (7/74). ZIG,
cohort isolation and Acyclovir for proven
infections may have limited the extent of this
VZV outbreak in high risk inmunosuppressed
patients.
• RENL FtNCTION ND BLOOD ?RESStJRE AFTER DONOR HEPH-
REC'IOMY. J.°.T'on, j.K. Thrd, H. Wllkinron,
D.N. '. Kerr. Rl Vict'r4 Infirm"'y, N'a "t a
u'ri Tvne, Ei'GLED.
Kidney onorr not by orm—
rc'ntor hv'arffltrstion of th' nlning kin'y
4n th early yesrc after nephrectomy (Nx) hut long
term f&low un is acking. We oompred 8 'short
t"xm" donors 4.' + O. (FI) yrs post Nx (range 1.
—°,9 yrm) "ith 7 "°ng trrm" donor" 0./
'"rt Nv (range 0.c1—2O.7 v-re). Nose rre—N sor1v'
'r"stinine and cr"tinine enc's ''are not dg—
ni1 s'ntly differsnt bet'-een th t' ravos an1
'ub1eot" nrcrinotenive st the time of Ny,
"SHORT TERM" "LONG TERIi" P
DONORS DONORS
Current tge (yre) 51. - i, c3..4 1•
4erum nra tininc
(umoT/I) 104.0 2.8 98. + OCratt, c]ecrsnc
(ml.s/min/l.73m ) 74.9 + 7.8 81.5 2.7 NR
SDTA clearanc
(ml /min/1.73m ) ' + 7. 7'.° 7.3 (0.01
rinsry albumin
excretion (ug/min) 7. .3 8. 2. NE
The mean current blood prea"ure of the "long-
term" donors is mignificantly greater than that of
the "short term" donors (,44 v I systolic, 90 vs
84 rescectiveiy (p<O.05)). De novo diastolic
hyrertension (>95 mmBg) has developed th 11 of the
"long—term" donors but in only of the "rhort term'
graup.
This study demonstrates that the function of the
solitary kidney ic not s4vereely affected by pra—
longed compensatory hyperfi] tretion. However, thereis an increased risk of hypertension in "long term"
kidney donors.
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RENAL TRANSPLANTATION FOLLOWING REMOVAL AND
PREVENTION OF BESYNTRESIS OF ANTI-lILA
ANTIBODIES
D Taube, N Thick, RI Welsh, JS Cameron, CS Ogg,
CJ Rudge, DG Williams
Renal Unit, Guyts Hospital, London, England
The development of anti—liLA antibodies in
patients awaiting renal transplantation is a major
problem. Two thirds of our patients with these
antibodies have lILA antibody directed against one
or two lILA antigens. These antibodies in high
titre cross—react with multiple lILA antigens
producing high panel reactivity and frequent
positive crosematohes with potential donor cells.
By reducing the titre of these antibodies, it
should be possible to decrease the number of
these cross—reactions and panel reactivity. Using
plasma exchange, prednisolone and cyclophosphamide
we have successfully removed and prevented the
re—synthesis of anti—HLA antibody in five patients
mean age 31.6, range 14—52 years. The titres
and specificities of the liLA antibodies were
determined by standard lymphocytotoxicity and
absorption tests. Prior to treatment, the
patients had a mean panel reactivity of 88.6%,
range 80—97% with liLA antibody titres ranging
between 1/128 and 1/16. Following treatment, the
ptients mean panel reactivity was 33.8%, range
22—43% with antibody titres ranging between 1/8
and 1/2. All five patients have been trans-
planted. Pre—treatmemt sera from four of the
patients gave positive croasmatohes with their
donor's cells, whereas the post treatment cross—
matches were negative. Four of the patients
have functioning allografts up to 18 months post
transplantation. The fifth patient died of
septioaemia six weeks following transplantation
with a poorly functioning allograft.
lILA CLASS I MISMATCHING DOES INFLUENCE RE-
TRANSPLANTATION AFTER GRAFT FAILURE
N Thick, D Taube, K Welsh, JS Caneron
Renal Unit, Guy's Hospital, London, Hngland.
Patients with anti—HLA Class I antibodies
because of failed grafts or blood transfusion are
extremely difficult to transplant, and consume
considerable resources.
We show here that lILA Class I matching of first
allografts can minimise this problem. We have
examined anti—ma Class I antibodies in 100
patients who had lost their first allografts and
had not developed anti—ma antibodies as a result
of previous blood transfusions or pregnancy. ma
antibody specificity was determined uaing
oomputerised 2 x 2 statistioal analysis. Cross—
reactivity was oharaoterised by dilution, specific
absorption and backtesting. 70% of patients
produced anti—ma Class I antibodies, of which
24% were broadly specific and 74% narrowly
specific. 81% of narrowly specific antibodies
were directed against a mismatched ma antigen on
the failed graft.
The degree of ma mismatch significantly
(p o.ol) increases aenaitination, and some ma
antigens (Al and A2) are significantly (p <o.os)
more antigenic than others. Since these ma
antigens occur cozamonly, their careful matching
will significantly increase the probability of
patients whose first grafts fail, obtaining a
second allograft. This in turn will reduce
oosta by lightening the load on ohronio dialysis
facilities, or allow more patients to be
aooepted if the budget is fixed.
• THE USE OF CICLOSPORINE (C) ONLY IN CADAVERIC RENAL
TRANSPLANT RECIPIENIS (CRTR): CONVERSION TO PREDNI—$ SOLONE (P) AND AZATHIOPRINE (A) AFTER 4 MONTHS.
A.M. Tegress, A.J.M. Donker, S. Meijer, W.J.van Son
F.J. v/d. Woude, M.J.H. Slooff and L.B.v/d. Slikke.
University Hospital, Groningen, the Netherlands.
The aim of our investigation was 1. to avoid the
initial high doses of P by using C, 2. to study
the nature of the renal function (RE) abnormalities
during C treatment alone, 3. to investigate RF be-
fore and after conversion from C to P/A at 4 months
Forty four CRTR were treated with C exclusively.
Rejection episodes (R) were diagnosed on clinical
grounds and ultrasonography. In addition, I to 3
biopsies were obtained in 31/44. R were treated
with 3 times I g. of Solu Medrol' iv. per R. If
more than 3 R occured, CRTR were converted to P/A.
Elective converaion at 4 months was carried out by
adding 10 mg. P b.i.d. during 1 week to C treat-
ment. Thereafter, C was replaced by A, while P was
continued. Effective renal plasma flow (ERPF) and
glomerular filtration rate (GFR) were measured re-
peatedly using '31I—hippurate and '251—thalamate
respectively.
30/44 CRTR had immidiate diuresis. 19/44 CRTR
had repeated R and were converted to P/A before 4
months. In this group, 3 kidneys were lost. 21/44
CRTR were electively converted from C to P/A at
4 months without loss of kidneys. Four CRTR were
kept on permanent C therapy. In the two groups of
patients who were converted to P/A, a striking
increase in both ERPF and GFR was observed. It is
concluded that during C treatment a low—grade,
steroid sensitive rejection exists. Conversion to
P/A from C only after 4 months seems to be a safe
procedure.
.
CYC1C$FOR]]4 NEFRROPAI}IY AFTER HEART AND HEART—LUNG
TRANSPIANTATICM
J. Goldstein, Y. Ihous, F. Wellens, J.L. Laclerc, IL.
Vacherweghan, P. Vereerstraeten, G. Prian, C. Toussaint
Cliniques Univeraitsires de Bruxellea, Hôpitn]. i2rns:o,
Brussels, Belgium
Fran ?'hrch 1982 to Lecanber 1983, 10 patients (Bra) under—
sent orthotopic heart transplantation sod 1 Pt received heart—
lung en bloc. During the let postoperative (FO) no, insuno—
suppression consisted of low doses steroids with cyclosporin
(Cs), 8—20 mg/kg/d. During this periml, 6 fts necessitated
dialysis (4 deaths) ebile the 5 other Ike did not require it
(2 deaths). Fran 2 to 14 FO sos, sean daily Ca doses ranged
fran 6.1 to 8.0 mg/kg and blood urea (EU) end serum creatinine
(Scr) levels increased fran 51±18 and 1.24.0.2 mg/dl pre—
operatively to 137±7 and 3.54(3.3 mg/dl at 14 no. Fran 15 to
22 sos, sean daily Cs dose was tapered fran 6.5441.9 to 3.8+
0.5 mg/kg 5cr decreased to 2.9 40.3 mg/dl without change
INThJlevel. Chmsrchl2l9B4, SPtsaresurvivingst7, B,
20, 21, 22 sos without rejection.
Renal histology ems assessed postsortea in 6 Iks (6-40 d
postoperatively) and by biopsy in 3 long—tens survivors (23—
22
.os). EArly changes consisted of tiiiular necrosis,
cubulorrhexis aid interstitial edern. Latc rena]. biopsies
showed extensive interstitial, fibrosis and arterial, glaimru—
lsr end tubular changes similar to those of nephrosngio—
sclerosis.
Cs appears thus as a very efficient immunosuppressive drug
f or heart and heart—lung transplantations but chronic Cs
nephropsthy occurred in the 3 Pta surviving over 12 sos.
At the doeage used, Cs induced early acute tubule—interstitial
nephritis, leading to extensive fibrosis in late postoperative
course. It is hoped that nephrotoxicity will be avoided with
reduction of Cs dosage in the future.
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EARLY FCFTOPERAUVE (CURSE OF (3DAVER KIL8EY GRAFTS (0(G) IRFATET
Wfffl U)L—]XEES OF CYCIIITIRJRIN (CS) AND PREIIMISI1CUE (PD)
P. Vereerstraeten, P. Kinnaert, C. Toussaint
Cliniques Universitaires de Bruxelles, Hôpital Erasio,
Brussels, Belgium
Early postoperative course of CKG sos analyzed in 2 groups of
patients (Pts) notched for age, sex, blood transfusions, duratOr
of ischemia, HLA ininunization, HLA—A and —B niiarotch but nor for
lILA—DR mimiotch (significantly greater in Group 1). Pts of
Group 1 (01) were treated with (IS/PD and Pts of Group 2 (02)
with azathioprine/prednisolone (AZ/PD).
During the first 2 wks, 8/18 Pts of Gi and 7/18 Pts of 02
necessitated dialysis; 4 rejection (R) episodes (2 irreversible)
occurred in Cl and 12 (1 irreversible) in G2. Incidence of
infections and of hypertension sos similar in both groups. in
Gi, sean daily (IS dose decreased fran 15 (day 1) to 6 (days 6—
14) mg/kg, with 24 hr—trough serum (IS levels (RIA) of 110-291)
ng/ml, while PD dose ranged fran 0.4 to 0.8 mg/kg. In 02, daily
AZ dose sos 2 mg/kg and daily PD dose ranged fran 1.2 to 2.2
mg/kg. Mean blood urea (EU), serum creatinine (8cr) and plasm
potassium (PK) levels were similar in both groups.
Fran sIts 3to]3, 3 reversible R occurred in the 10 Pta of 01
md 4(1 ixreversihie) in the 10 Pta of 02; 2 infecticro were recorded
in 01 and 5 in 02; hypar tension sos observed in 5/10 Pis of Gi and
in 3/10 Pts in 02. In 01, sean daily (IS dose ranged fran 4.5
to 5.5 mg/kg, with 24 hr—trough (IS serum levels of 94—112 np/mi,
while PD dose decreased fran 0.5 to 0.2 mg/itg. In 02, sean
laily dose of AZ sos 2 neJkg and nean dose of PD decreased f ran
1.0 to 0.5 mg/kg. PU, 5cr and PK decreased in both groups
fran 78 to 66 (Cl) and fran 81) to 57 (G2) pe/dl for EU, fran 1.8
to 1.5 (Cl) and fran 1.8 to 1.2 (02) mg/il for 5cr, fran 4.8 to
4.4 () and fran 4.2 to 3.8 (02) mEg/i for PR.
Thus, ccmpared to AZ/PD-treated CRC, early course of low-bas
IS/PD-treated 0KG sos characterized by 50-60 5 decrease in R ard
corticosteroid dosage at the cost of 16—25 5 incrtsents in 8cr
and in Hi at the end of 3 sos. Duly further experiannt will
denunstrate true benefit of low—doses CS/PD over AZ/PD regimen
in 0(0.
TOTAL ISCHEMIA TIME AND HLA MATCHING ON RENAL
GRAFT SURVIVAL.
Trovati A. ,Monari C. ,Tamburro M.L.,Lattanzi R.,
Poli L. and Cortesini R.
IIPatologia Chirurgica,University of Rome,Italy
The influence of total ischemia time and HLA (A
and B) matching on one year renal graft survival
was snalized in 280 consecutive renal csdaveric
sod living related donors grafts. The whole time
was not divided into warm and cold ischemia time
because of the little warm ischemia time of the
most transplants. We define as graft survival the
oneyear renal function and as graft failure the
loss of the kidney or of the patient as a result
both of a irreversible rejection and non immunolo-
gical complications. We divided total ischemia ti-
mes into 6 time groups: Ol hour,15,510,l030,
3O50,more than 50 hours.
There are only n 12 0—match and 12 full—house gra
its with no determinant results.
The one--two—three—matches grafts with a considera-
ble number of cases show a non significant corre-
lation between HLA,ischemia time and oneyear
graft survival
ISCHEMIA TIME AND 1 YEAR GRAFT SURVIVAL
-)
n % n n %n %
0
1
1 0
1 0
2 0 3
2 50 4 O54O75 12 75
2 41 63 8 62 32
311 55 4 50 7
4 66711 lOO 1
47 43 70
4329 65
100 333
O—lh 1—Sb 5—lob lO—3Oh 30—SOb
PLASMAPHERESIS (PP) IN THE TREATMENT OF ACUTE VAS-
CULAR PFJECTION. AN ALTERNATIVE TO CYCLOSPORINE ?
F. Valderrâbano, F. Anaya, J. Luiio, R. Perez Gar-
cia, V. Barrio, P. Torrabadella.
Hospital Provincial de Madrid. Madrid. Spain.
During 1982 and 1983 acute rejection was trea-
ted with 1 g methyl—prednisolone (MP) on 3 conse-
cutive days. In case of no response, a percutane-
ous renal biopsy was performed 5—6 days after MP.
When cellular rejection was present a new course
of MP was given, but in patients with vascular re-jection (proliferative vasculopathy) the treatment
was PP only (6 sessions during 6 consecutive days;
40—50 mi/kg body weight of exchange per session).
When both cellular and vascular components of re-jection were present, PP + TIP were used.
53 patients were treated according to this pro-
tocol and the actuarial graft survival was 82 % at
one year. In contrast the actuarial graft survival
at one year of patients grafted during 1980—1981
(N=35) was 65.2 % (p<.Ol). The xanrtality rate did
not change (patients survival 1980—81: 96.5 %;1982
83: 95 %). Iimnunosuppression was similar: predni—
sone and azathioprine.
PP was performed in 13 patients and improved
renal function in 9 of them (69.2 %). The only
secondary effect was a decrease in coagulation
factors in 2 patients without bleeding complica-
tions. None of the patients treated with PP died.
We conclude that steroid resistant rejection
requires performance of a histological study and
treatment according with the lesions (MP, PP or
TIP + PP). This treatment may be an alternative
safer than cyclosporine with similar results.
. RESULTS OF TRANSPLANTATION OF KIDNEYS FROM DIABETIC
DONORS
Hm van Goor, GD Kramer, AN Tegzess, MJH Slooff.
Renal—Transplantation Unit, University Hospital
Groningen, the Netherlands
Diabetic donors are still reluctantly accepted
as potential donors. The reason is a supposed poor
graft function caused by diabetic lesions. The
results of transplantation of 6 kidneys from 3
donors with insulin dependent diabetes mellitus
for respectively 10, 17 and 18 years are reported.
Donor age was 21, 37 and 59 years. All donors had
a stable bloodpressure, abundant diuresis, a
normal creatinin clearance and absence of proteinu-
na. One graft failed after three days due to
rejection. The remaining 5 grafts are still func-
tioning. Duration of graft function and creatinin
clearance at last follow up control are shown in
the table.
graft function (months) 18 18 6 6 3
creatioin clearance (ml/min) 50 60 48 53 70
None of the patients died during their follow up
period. Biopsies of the 5 surviving grafts were
taken variing periods after transplantation. Three
out of 5 biopsies taken at 6 months after trans-
plantation showed marked decrease of the diabetic
lesions. One biopsy, taken short after trans-
plantation showed no diabetic lesions. In one
biopsy no improvement was observed. From these
results it seems justified that kidneys from
insulin dependent diabetic donors with a normal
creatinin clearance and absence of proteinuria are
accepted for transplantation.
5Oh -
n
1 100
4 50
35 52
7 71
1 0
0 %
2 100-
12 42
2 0
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PNEUNATOSIS INTESTINALIS IN PATiENTS AFTER CADAVE—
RIC KIDNEY TRANSPLANTATION: POSSIBLE RELATIONSHIP
WITH AN ACTIVE CYTOMEGALOVIRUS (CMV) INFECTION.
W.J. van Son, F.J. van der Woude, E. van der Jagt,
A.J.M. Donker, S. Meijer, N.H. Slooff, T.H. The,
A.M. Tegzess and L.B. van der Slikke.
University Hosp4tal, Groningen, The Netherlands.
Pneumatosis intestinalis is a disea3e of which
the pathogenesis is still under discussion. Re-
ports of pneumatosis intestinalis in patients with
a kidney transplant are rare. The condition is be—
lieved to be related to the presence of an obstruc-
tive duodenal ulcer or to the immunosuppressive
drugs used in these patients. We report of 4 pa-
tients with pneumatosis intestinalis following re-
nal transplantation, in two cases complicated by a
pneumoperitoneum. Only 2 patients had an (non ob-
structive) duodenal ulcer. However all patients
had a severe CMV infection. Two patients had a
primary infection while 2 patients had a reactiva-
tion of CMV. One patient died because of a disse-
minated CMV infection. Multiple inclusion bodies
were found at postmortem examination in lungs, li-
ver and at the site of ulcers in the gastrointes-
tinal tract.
In a control population of 382 patients trans-
planted between 1971—1983 we could find 18 pa-
tients, without an active CMV infection but with a
gastric or duodenal ulcer. In none of these pa-
tients we could demonstrate pneumatosis intestina—
lis
Our data are consistent with the hypothesis
that a causal relationship exists between pneuma—
tosis intestinalis and CMV infection. Secondly,
these data stress the importance of a keen aware-
ness of the possibility of CMV infection in pa-
tients with free air under the diaphragm and/or
abdominal symptoms. In these patients unnecessary
surgery should thus be avoided.
• STUDY OF INTERLEUKINE 2 (1L2) PRODUCTION AND RES-
.
PONSIVENESS OF PERIPHERAL BLOOD LYMPHOCYTES (PBL)
OF KIDNEY ALLOGRAFT RECIPIENTS.
112 is required for activated cytotoxic lymphocytes
expansion, therefore, this reagent is likely invol-
ved in rejection. In this study we monitored the
PBL-112—production and responsiveness, before and
after grafting. PBL were serialy harvested before
grafting, after grafting in stable condition and
immediatly before treatment of rejection episodes.
112 levels were assessed on 112 dependant CTLL2
murine cell line. The data show that there is no
difference in the PHA, the lectin—free 112 or the
PHA + 112 induced blastogenesis before or after ei-
ther grafting or rejection, the values were not mo-
dified in patients under Cyclo A. Allogenic respon-
siveness against a pooi of 7 random donors were si-
milar in all qroups.
PHA-induced 112 decreased (P< .001) after grafting
(n=42) compared to either pregrafting or normal in-
dividuals (n=16) samples. However rejecting patient
PBL (n=24) produced more 112 than stable recipients
PBL (n=18). Methylprednisolone (1.2 mg/nil) or
cyclo A (2.5 mg/nil) drarnati caly decreased ( > 75%)
the 112 yield of PBL from any group studied. Thus
the results showthatl)transplanted patients, taken
as a whole group, produced lower PHA-induced 112
than controls or hemodialysed patients 2) rejecting
recipients produced higher PHA—induced 112 than
stable recipients.
a H. Vi4, R. Garriou, M. Bonneville, JF. Moreau,
JP. Soulillou— Labo Immunologie Clinique—U211—
INSERN et Service do Ndphrologie— Nantes—France—
. IX)ES REW'.L FAIUJRE INDUCE A DECPEASE IN CYCLOSPO-
PINE A BLCOD LEVElS ?
• M. Burnier, J.P. Wauters, J.L.
Divisions of Nephrology arid Clinical Pharniacolo—
gy. University Hospital, Lausanne, Switzerland.
The relationship between renal function and
cyclosporine A (CyA) blood levels was evaluatedin 9 patients receiving a cadaveric renal allo—
graft. 4 patients were started on CyA i.v. before
transplantation at the dose of 5 mg/kg/day and
were switched 48 hrs later to an oral dose of 10
mg/kg/day. S patients with stable renal function
changed from conventional therapy to CyA starting
with an oral dose of 10 mg/kg/day. The CyA dose
was adapted to obtain blood levels between 100
and 400 ng/ml. Blood CyA levels were measured
twice weekly by RIA 12 to 14 hrs after the eve—
fling dose. Low CyA levels were found during renalfailure due to acute tubular necrosis or rejec-
tion episodes and CyA levels constantly increased
when renal function improved under a fixed dose
of CyA. CyA 10 mg/kg/day given orally resulted in
significantly higher blood levels in non—uraemic
than in uraemic transplanted patients. In pa-tients receiving between 9 and 12 mg/kg/day si-
gnificant negative correlations were found bet-
ween blood CyA and plasma creatinine (r=—O.65,
n=23, p - 0.001) or plasma urea levels (r=—0.72,
n=23, p 0.001). In vitro studies showed no ef-
fect of uremic serum on CyA measurements. Since
diarrhea also induced low blood CyA levels, a de-
crease in gastro—intestinal absorption of CyA du-
ring uraemia is suggested. Conclusion : it ap-
pears that after renal transplantation uraemia
decreases CyA blood levels; therefore, when renal
failure occurs, careful monitoring of blood CyA
levels is mandatory.
FVNUATI ON OF TECIGJETflfl1—99n TIN COLLOID IN THE
DIA0000IS OF REhaL TRANSPLANT REJECTION
N. C. H. Wijlirgie, T. Hawkins, P. H. Keavey,
H. Wilkiason
Departnents of Nephrolor and Nuclear Medicine,
Freemen Hospital, Newcastle upon Tyne, U.K.
It has been reported that the accnulation of
intravenousJ.y adninis tered Technetium sulphur
colloid in a transplanted kidney is of value in
the diagnosis of graft rejection.
We have evaluated the use of Technetium tin
colloid in the diagnosis of rejection occurring
more than 1 month after grafting in 10 patients.The scans in these patients were performed at a
time when plasma creatinine was rising rapidly
in the absence of evidence of obstruction and
rejection was cojfinned by biopsy in the majority.
Comparison was made with 6 patients without
evidence of rejection studied at similar time
intervals foflowing transplantation.
A quantitative method was used which related
the accuinujd activity at 12-16 minutes post-
injection (x) to the initial activity in thegraft over 0—4 minutes (y). 7/ patients who had
rejection had an index ranging from 64—172%.
6/6 patients who had no evidence of rejection had
an index ranging from -45%.
The % uptake index did not diCier significantly from a sinilar index obtained with studies of
longer duration involving scanning at 20-24
minutes. The results suggest that Tecbnetium-99
tin colloid may be of value in the diagnosis of
renal transplant rejection.
Abstracts 659
CONVERSION FROM AZATHIOPRINE TO CYCLOSPORINE
IN 12 RENAL ALLOGRAFT RECIPIENTS
R.Windeck, N.Graben, A.Daul, H.Jakubowski
Dlv. of Renal and Hypertensive Diseases and
Div. of Surgery, Universitaetsklinikum,
0-4300 Essen, F.R.G.
12 renal transplant patients, in whom immu-
nosuppressive therapy with azathioprine(AZA)
and prednisone (P) resulted initially in
good kidney function were studied. Steroid
resistant rejection (n9) or leucopenia •even
at AZA doses of <25 mg/d with concomittant
deterioration of kidney function (n=3) ceu-
sed us to change therapy from AZA+P to
cyclosporine (CYC)+P.
Cyclosporine was started p.o. with 6 mg/kg
b.w. By retrospective analysis the outcome
was favourable in 9 pts: their creatinine
levels rose from 2.0 - 6.4 (m=3.6) mg/dl
in the first month by an average of 1.2 mg/
dl, but after 3 months levels were back to
3.8 mg/dl in 8 pts. After 6 months creati-
nine had fallen to 3.2 mg/dl in 5 pts. 3 pts
followed for 12 months have creatinine le-
vels unaltered since cyclosporine therapy
started.
In 3 pts with higher starting levels of
creatlnine (4.9 - 6.4 mg/dl) kidney func-
tion deteriorated slowly and dialysis had
to be started 7 months after conversion from
AZA+P to CYC+P.
Steroid resistant chronic rejection under
AZA+P can be treated with conversion to
CYC÷P, preferably when creati4iine is less
than 4 mg/dl.
IMPROVED BIOAVAILABILITY OF CYCLOSPORIN A
(Cs-A) IN LONG-TERM TREATMENT AFTER RENAL
TRANSPLANTATION
P. Zabel, G. E. Leimenstoll, H. Jessen,
W. Niedermayer
Department of Nephrology, University of
Kiel, Kiel, West-Germany
Pharmacokinetics of CS-A in patients
with ERF and after transplantation (Tx)
was studied. CS-A levels in whole blood
were measured in RIA-technic. The optimal
daily dosage of CS-A was correlated to
the areas under blood concentration ver-
sus time curve (AUC) after a single oral
dosage of 7,5 mg/kg BW CS-A.
We found a significant difference in the
AUC reflecting the absorbed dosage of
CS-A in patients prior to Tx and after-
wards. All 29 patients needed smaller
amounts of CS-A after Tx in comparison
to the initial data. Thus, a post trans-
plantation adjustment of the necessary
dosage of CS-A is mandatary to achieve
a maintenance blood level of CS-A (4oo-
8oo ng/ml). We conclude an improved bio-
availability of Cs-A in long-term treat-
ment.
DONOR—SPECIFIC BLOOD TRPSFUSION FOR HAPLOTYPE
MATCHED DONORS — IMPACT ON A DIALYSIS PROGRAMME.
C.G. Winearls, A.J. Rees, G. Williams.
Renal Transplant Unit, Hammersmith Hospital
Du Cane Road, London Wl2 OHS.
Since the end of 1981, a policy of donor—
specific transfusion for haplotype matched
recipients of living related donor kidneys has
been adopted. 17/18 of the transplants continue
to function 3 months — 2 years post transplant.
There was one early death from sepsis, one patient
has chronic rejection (plasma creatinine
>500 pmols/l) but the remainder have good graft
function (plasma creatinines 200 pmols/l) . No
recipient has been sensitised to the donor but 3
had severe accelerated rejections and in 2 this
required dialysis. 2 patients had 4 rejection
episodes. Over this period 114 local patients
have been treated in this dialysis programme
(44 nld and 71 new patients), Of these 61 (54%)
remain on dialysis; 22 (19%) received successful
cadaver transplant; 16 (14%) successful LBD
transplants, (2 full house match) and 15 (13%)
have died. The success of haplotype matched LRD
transplants with DST has reduced the pressure on
dialysis fcilittes significantly.
